Name	Gene(s)	Condition(s)	Clinical significance (Last reviewed)	Review status	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	
NM_198576.3(AGRN):c.1058A>G (p.Gln353Arg)	AGRN	not specified|Myasthenic syndrome, congenital, 8	Benign(Last reviewed: Dec 4, 2017)	criteria provided, multiple submitters, no conflicts	1	976963	1	1041583	128291	133740
NM_198576.3(AGRN):c.1198C>T (p.Arg400Trp)	AGRN	Myasthenic syndrome, congenital, 8	Likely benign(Last reviewed: Oct 6, 2017)	criteria provided, single submitter	1	977356	1	1041976	474098	447005
NM_198576.3(AGRN):c.2183A>T (p.Glu728Val)	AGRN	not specified|Myasthenic syndrome, congenital, 8	Benign(Last reviewed: Jul 28, 2017)	criteria provided, multiple submitters, no conflicts	1	979748	1	1044368	128294	133743
NM_198576.3(AGRN):c.3264G>C (p.Leu1088Phe)	AGRN	not specified|not provided|Myasthenic syndrome, congenital, 8	Benign/Likely benign(Last reviewed: Jan 9, 2018)	criteria provided, multiple submitters, no conflicts	1	982213	1	1046833	128298	133747
NM_198576.3(AGRN):c.3404A>G (p.Gln1135Arg)	AGRN	not specified|Myasthenic syndrome, congenital, 8	Benign(Last reviewed: Aug 11, 2017)	criteria provided, multiple submitters, no conflicts	1	982722	1	1047342	128299	133748
NM_198576.3(AGRN):c.3866C>T (p.Pro1289Leu)	AGRN	not specified|Myasthenic syndrome, congenital, 8	Benign/Likely benign(Last reviewed: Jan 9, 2018)	criteria provided, multiple submitters, no conflicts	1	983506	1	1048126	128304	133753
NM_198576.3(AGRN):c.3964C>T (p.Arg1322Trp)	AGRN	not specified|Myasthenic syndrome, congenital, 8	Benign/Likely benign(Last reviewed: Mar 13, 2018)	criteria provided, multiple submitters, no conflicts	1	983604	1	1048224	128305	133754
NM_198576.3(AGRN):c.4540G>A (p.Ala1514Thr)	AGRN	not specified|not provided|Myasthenic syndrome, congenital, 8	Benign/Likely benign(Last reviewed: Feb 7, 2018)	criteria provided, multiple submitters, no conflicts	1	984971	1	1049591	128309	133758
NM_198576.3(AGRN):c.4996G>A (p.Val1666Ile)	AGRN	not specified|Myasthenic syndrome, congenital, 8	Benign(Last reviewed: Aug 9, 2017)	criteria provided, multiple submitters, no conflicts	1	985826	1	1050446	128312	133761
NM_198576.3(AGRN):c.5353G>A (p.Asp1785Asn)	AGRN	not specified|not provided|Myasthenic syndrome, congenital, 8	Conflicting interpretations of pathogenicity(Last reviewed: Feb 18, 2018)	criteria provided, conflicting interpretations	1	986732	1	1051352	128314	133763
NM_198576.3(AGRN):c.5726G>C (p.Ser1909Thr)	AGRN	not specified|Myasthenic syndrome, congenital, 8	Benign/Likely benign(Last reviewed: Aug 7, 2017)	criteria provided, multiple submitters, no conflicts	1	989207	1	1053827	128318	133767
NM_032348.3(MXRA8):c.1238T>A (p.Ile413Asn)	MXRA8	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	1	1289293	1	1353913	402162	389106
NM_001170535.2(ATAD3A):c.158C>T (p.Thr53Ile)	ATAD3A	not specified|not provided|Harel-Yoon syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 31, 2017)	criteria provided, conflicting interpretations	1	1447806	1	1512426	225697	227512
NM_015102.4(NPHP4):c.1852G>A (p.Glu618Lys)	NPHP4	Nephronophthisis 4|Nephronophthisis|not specified	Benign(Last reviewed: May 7, 2017)	criteria provided, multiple submitters, no conflicts	1	5965455	1	5905395	240965	238342
NM_031475.2(ESPN):c.2257T>C (p.Trp753Arg)	ESPN	not specified|Inborn genetic diseases	Uncertain significance(Last reviewed: Oct 9, 2017)	criteria provided, multiple submitters, no conflicts	1	6512088	1	6452028	225044	226886
NM_022787.3(NMNAT1):c.[53A>G];[769G>A]	NMNAT1	Cone-rod dystrophy	Pathogenic	no assertion criteria provided	1|1	10042688	1|1	9982630	438483	45795|188783
NM_022787.3(NMNAT1):c.769G>A (p.Glu257Lys)	NMNAT1	Leber congenital amaurosis 9|Leber congenital amaurosis|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	1	10042688	1	9982630	37134	45795
NM_005957.4(MTHFR):c.1033C>T (p.Arg345Cys)	MTHFR	Homocysteinemia due to MTHFR deficiency	Pathogenic(Last reviewed: Dec 3, 2004)	criteria provided, single submitter	1	11854919	1	11794862	222896	224594
NM_005957.4(MTHFR):c.604C>A (p.Pro202Thr)	MTHFR	Homocysteinemia due to MTHFR deficiency	Pathogenic	no assertion criteria provided	1	11856439	1	11796382	222894	224596
NM_005957.4(MTHFR):c.416C>T (p.Thr139Met)	MTHFR	Homocysteinemia due to MTHFR deficiency	Pathogenic	no assertion criteria provided	1	11861277	1	11801220	222893	224597
NM_000302.3(PLOD1):c.2032G>A (p.Gly678Arg)	PLOD1	Ehlers-Danlos syndrome, hydroxylysine-deficient	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	1	12034713	1	11974656	14366	29405
NM_000302.3(PLOD1):c.[136C>T];[2075C>T]	PLOD1	Ehlers-Danlos syndrome, hydroxylysine-deficient	Likely pathogenic(Last reviewed: May 20, 2015)	no assertion criteria provided	1|1	12034756	1|1	11974699	427816	215017|215016
NM_001127660.1(MFN2):c.526G>A (p.Gly176Ser)	MFN2	Charcot-Marie-Tooth disease, type 2A2A	Likely pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	1	12057405	1	11997348	243074	244148
NM_001141974.2(ATP13A2):c.3214G>A (p.Ala1072Thr)	ATP13A2	Parkinson disease 9|not specified|not provided|History of neurodevelopmental disorder	Benign(Last reviewed: Apr 20, 2017)	criteria provided, multiple submitters, no conflicts	1	17312743	1	16986248	128475	133924
NM_022089.3(ATP13A2):c.3430G>A (p.Ala1144Thr)	ATP13A2	not specified|not provided|History of neurodevelopmental disorder	Benign(Last reviewed: Apr 15, 2016)	criteria provided, multiple submitters, no conflicts	1	17312829	1	16986334	128474	133923
NM_022089.3(ATP13A2):c.2836A>T (p.Ile946Phe)	ATP13A2	Parkinson disease 9|not provided|Spastic paraplegia 78, autosomal recessive|History of neurodevelopmental disorder	Uncertain significance(Last reviewed: Mar 19, 2018)	criteria provided, multiple submitters, no conflicts	1	17314656	1	16988161	128469	133918
NM_022089.3(ATP13A2):c.943G>A (p.Gly315Arg)	ATP13A2	Parkinson disease 9	Likely pathogenic(Last reviewed: Jan 29, 2013)	criteria provided, single submitter	1	17326602	1	17000107	209136	205722
NM_022089.3(ATP13A2):c.881G>A (p.Arg294Gln)	ATP13A2	Parkinson disease 9|not specified|not provided|Spastic paraplegia 78, autosomal recessive|History of neurodevelopmental disorder	Benign(Last reviewed: Aug 22, 2017)	criteria provided, multiple submitters, no conflicts	1	17326767	1	17000272	128476	133925
NM_015047.2(EMC1):c.2602G>A (p.Gly868Arg)	EMC1|EMC1-AS1	not specified|Cerebellar atrophy, visual impairment, and psychomotor retardation	Uncertain significance	criteria provided, single submitter	1	19547328	1	19220834	219101	216790
NM_015047.2(EMC1):c.245C>T (p.Thr82Met)	EMC1	not specified|Cerebellar atrophy, visual impairment, and psychomotor retardation	Conflicting interpretations of pathogenicity(Last reviewed: Dec 3, 2017)	criteria provided, conflicting interpretations	1	19570485	1	19243991	219100	216792
NM_000478.5(ALPL):c.215T>C (p.Ile72Thr)	ALPL	Infantile hypophosphatasia	Likely pathogenic(Last reviewed: Aug 21, 2014)	criteria provided, single submitter	1	21887623	1	21561130	188928	186615
NM_000478.5(ALPL):c.346G>A (p.Ala116Thr)	ALPL	Adult hypophosphatasia|Childhood hypophosphatasia|Infantile hypophosphatasia|Odontohypophosphatasia|Hypophosphatasia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, multiple submitters, no conflicts	1	21889651	1	21563158	13677	28716
NM_000478.5(ALPL):c.400_401delACinsCA (p.Thr134His)	ALPL	Infantile hypophosphatasia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 24, 2016)	criteria provided, multiple submitters, no conflicts	1	21889705 - 21889706	1	21563212 - 21563213	188877	186616
NM_000478.5(ALPL):c.407G>A (p.Arg136His)	ALPL	Childhood hypophosphatasia|Infantile hypophosphatasia|Hypophosphatasia	Pathogenic/Likely pathogenic(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	21889712	1	21563219	13675	28714
NM_000478.5(ALPL):c.535G>A (p.Ala179Thr)	ALPL	Infantile hypophosphatasia	Likely pathogenic(Last reviewed: Aug 1, 2014)	criteria provided, single submitter	1	21890596	1	21564103	13662	28701
NM_000478.5(ALPL):c.542C>T (p.Ser181Leu)	ALPL	Infantile hypophosphatasia|not provided	Likely pathogenic(Last reviewed: Sep 12, 2017)	criteria provided, multiple submitters, no conflicts	1	21890603	1	21564110	188798	186617
NM_000478.5(ALPL):c.667C>T (p.Arg223Trp)	ALPL	Infantile hypophosphatasia	Likely pathogenic(Last reviewed: Oct 9, 2014)	criteria provided, single submitter	1	21894615	1	21568122	189001	186618
NM_000478.5(ALPL):c.791A>G (p.Lys264Arg)	ALPL	Infantile hypophosphatasia	Likely pathogenic(Last reviewed: Apr 9, 2014)	criteria provided, single submitter	1	21894739	1	21568246	188750	186619
NM_000478.5(ALPL):c.871G>A (p.Glu291Lys)	ALPL	Infantile hypophosphatasia	Likely pathogenic(Last reviewed: May 20, 2014)	criteria provided, single submitter	1	21900166	1	21573673	188792	186621
NM_000478.5(ALPL):c.1250A>G (p.Asn417Ser)	ALPL	Infantile hypophosphatasia|Hypophosphatasia, perinatal lethal|not provided	Likely pathogenic(Last reviewed: Jul 17, 2018)	criteria provided, multiple submitters, no conflicts	1	21903075	1	21576582	13679	28718
NM_005529.6(HSPG2):c.4916C>T (p.Thr1639Met)	HSPG2	Schwartz Jampel syndrome type 1|not specified	Conflicting interpretations of pathogenicity(Last reviewed: May 19, 2017)	criteria provided, conflicting interpretations	1	22188289	1	21861796	197080	194241
NM_005529.6(HSPG2):c.2357A>G (p.Asn786Ser)	HSPG2	Schwartz Jampel syndrome type 1	Uncertain significance(Last reviewed: Jul 30, 2015)	criteria provided, single submitter	1	22205601	1	21879108	209161	205727
NM_000147.4(FUCA1):c.422G>T (p.Gly141Val)	FUCA1	Fucosidosis	Likely pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	1	24192083	1	23865593	488520	481388
NM_016124.4(RHD):c.452G>A (p.Gly151Asp)	RHD|RSRP1	Blood group antigen abnormality	Affects(Last reviewed: Mar 3, 2016)	no assertion criteria provided	1	25617248	1	25290757	253025	247432
NM_020451.2(SELENON):c.409A>G (p.Thr137Ala)	SELENON	Eichsfeld type congenital muscular dystrophy|not specified|SEPN1-Related Disorders	Conflicting interpretations of pathogenicity(Last reviewed: Jul 31, 2017)	criteria provided, conflicting interpretations	1	26131638	1	25805147	130284	135731
NM_020451.2(SELENON):c.425G>A (p.Cys142Tyr)	SELENON	Eichsfeld type congenital muscular dystrophy|not specified|SEPN1-Related Disorders	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	26131654	1	25805163	95963	101859
NM_020451.2(SELENON):c.583G>A (p.Ala195Thr)	SELENON	Eichsfeld type congenital muscular dystrophy|not specified|not provided	Benign(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	1	26135116	1	25808625	95966	101862
NM_020451.2(SELENON):c.1506C>A (p.Asn502Lys)	SELENON	Eichsfeld type congenital muscular dystrophy|not specified|SEPN1-Related Disorders	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	26140573	1	25814082	95959	101855
NM_024887.3(DHDDS):c.124A>G (p.Lys42Glu)	DHDDS	Retinitis pigmentosa 59	Pathogenic(Last reviewed: Oct 18, 2016)	criteria provided, multiple submitters, no conflicts	1	26764719	1	26438228	30709	39666
NM_017837.3(PIGV):c.1022C>A (p.Ala341Glu)	PIGV	Hyperphosphatasia with mental retardation syndrome 1|not provided|Hyperphosphatasia-intellectual disability syndrome|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Feb 6, 2018)	criteria provided, multiple submitters, no conflicts	1	27121547	1	26795056	1284	16323
NM_000760.3(CSF3R):c.922C>T (p.Arg308Cys)	CSF3R	Severe congenital neutropenia|Neutropenia, severe congenital, 7, autosomal recessive	Pathogenic(Last reviewed: Jun 1, 2013)	criteria provided, single submitter	1	36937914	1	36472313	161982	171707
NM_012090.5(MACF1):c.16131T>G (p.Phe5377Leu)	MACF1	Abnormality of the corpus callosum	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	1	39951304	1	39485632	438598	432210
NM_032793.4(MFSD2A):c.1205C>A (p.Pro402His)	MFSD2A	Primary autosomal recessive microcephaly 15	Likely pathogenic	no assertion criteria provided	1	40433585	1	39967913	522579	513191
NM_000310.3(PPT1):c.837G>C (p.Gln279His)	PPT1	Ceroid lipofuscinosis neuronal 1|not specified|not provided|Neuronal Ceroid-Lipofuscinosis, Recessive|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jan 5, 2018)	criteria provided, multiple submitters, no conflicts	1	40539817	1	40074145	130023	135469
NM_000310.3(PPT1):c.713C>T (p.Pro238Leu)	PPT1	Ceroid lipofuscinosis neuronal 1	Likely pathogenic(Last reviewed: Nov 27, 2015)	no assertion criteria provided	1	40544245	1	40078573	236407	237963
NM_000310.3(PPT1):c.707T>A (p.Val236Glu)	PPT1	Ceroid lipofuscinosis neuronal 1	Likely pathogenic(Last reviewed: Mar 26, 2015)	no assertion criteria provided	1	40544251	1	40078579	236409	237964
NM_000310.3(PPT1):c.541G>A (p.Val181Met)	PPT1	Ceroid lipofuscinosis neuronal 1	Likely pathogenic(Last reviewed: Jun 27, 2014)	criteria provided, single submitter	1	40546155	1	40080483	188857	186623
NM_000310.3(PPT1):c.401T>C (p.Ile134Thr)	PPT1	not specified|not provided|Neuronal Ceroid-Lipofuscinosis, Recessive|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	1	40557033	1	40091361	130022	135468
NM_000310.3(PPT1):c.229A>G (p.Met77Val)	PPT1	not provided	Uncertain significance(Last reviewed: Mar 24, 2014)	criteria provided, single submitter	1	40558075	1	40092403	130020	135466
NM_000310.3(PPT1):c.133T>C (p.Cys45Arg)	PPT1	Ceroid lipofuscinosis neuronal 1	Likely pathogenic(Last reviewed: Apr 20, 2015)	no assertion criteria provided	1	40558171	1	40092499	236408	237966
NM_000310.3(PPT1):c.125G>A (p.Gly42Glu)	PPT1	Ceroid lipofuscinosis neuronal 1	Likely pathogenic(Last reviewed: Aug 28, 2014)	criteria provided, single submitter	1	40558179	1	40092507	56179	70818
NM_000310.3(PPT1):c.3G>A (p.Met1Ile)	PPT1	Ceroid lipofuscinosis neuronal 1|Neuronal ceroid lipofuscinosis	Likely pathogenic(Last reviewed: Jun 30, 2017)	criteria provided, multiple submitters, no conflicts	1	40562908	1	40097236	56193	70832
NM_005857.4(ZMPSTE24):c.325T>G (p.Cys109Gly)	ZMPSTE24	Lethal tight skin contracture syndrome|Mandibuloacral dysplasia|not provided	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	40733512	1	40267840	130790	136235
NM_148960.2(CLDN19):c.388G>T (p.Gly130Cys)	CLDN19	Hypomagnesemia 5, renal, with ocular involvement	Pathogenic	no assertion criteria provided	1	43204092	1	42738421	560599	551674
NM_015284.3(SZT2):c.498G>T (p.Gln166His)	SZT2	Early infantile epileptic encephalopathy 18	Uncertain significance(Last reviewed: Jul 16, 2018)	no assertion criteria provided	1	43870221	1	43404550	559530	550253
NM_015284.3(SZT2):c.2086C>T (p.Arg696Trp)	SZT2	Early infantile epileptic encephalopathy 18	Uncertain significance(Last reviewed: Dec 25, 2017)	no assertion criteria provided	1	43888818	1	43423147	487580	480627
NM_015284.3(SZT2):c.6553C>T (p.Arg2185Trp)	SZT2	not provided|Early infantile epileptic encephalopathy 18	Likely pathogenic(Last reviewed: Aug 21, 2017)	criteria provided, single submitter	1	43904696	1	43439025	429775	421247
NM_174963.4(ST3GAL3):c.382A>G (p.Thr128Ala)	ST3GAL3	not specified|not provided	Benign(Last reviewed: Apr 20, 2017)	criteria provided, multiple submitters, no conflicts	1	44290530	1	43824858	130378	135825
NM_174963.4(ST3GAL3):c.1286G>A (p.Arg429Gln)	ST3GAL3	not provided|Early infantile epileptic encephalopathy	Conflicting interpretations of pathogenicity(Last reviewed: Dec 20, 2017)	criteria provided, conflicting interpretations	1	44395844	1	43930172	130377	135824
NM_020365.4(EIF2B3):c.97A>G (p.Lys33Glu)	EIF2B3	Leukoencephalopathy with vanishing white matter	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	1	45446744	1	44981072	560922	552045
NM_001128425.1(MUTYH):c.1258C>A (p.Leu420Met)	MUTYH	MYH-associated polyposis|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	1	45797157	1	45331485	41752	50191
NM_001128425.1(MUTYH):c.1187G>A (p.Gly396Asp)	MUTYH	Endometrial carcinoma|MYH-associated polyposis|Pilomatrixoma|Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas|Carcinoma of colon|Neoplasm of stomach|not specified|not provided|Hereditary cancer-predisposing syndrome|Small intestine carcinoid|MUTYH-associated polyposis	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	1	45797228	1	45331556	5294	20333
NM_001128425.1(MUTYH):c.700G>A (p.Val234Met)	MUTYH	MYH-associated polyposis|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 29, 2018)	criteria provided, conflicting interpretations	1	45798151	1	45332479	135989	139701
NM_001128425.1(MUTYH):c.536A>G (p.Tyr179Cys)	MUTYH	Endometrial carcinoma|MYH-associated polyposis|Pilomatrixoma|Carcinoma of colon|Neoplasm of stomach|not specified|not provided|Hereditary cancer-predisposing syndrome|MUTYH-associated polyposis	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	1	45798475	1	45332803	5293	20332
NM_015506.2(MMACHC):c.[271dupA];[482G>A]	MMACHC	Bull's eye maculopathy|Methylmalonic acidemia with homocystinuria	Likely pathogenic(Last reviewed: Oct 30, 2015)	criteria provided, single submitter	1|1	45973217	1|1	45507545	424754	16460|16464
NM_017739.3(POMGNT1):c.1814G>A (p.Arg605His)	TSPAN1|POMGNT1	Muscle eye brain disease	Likely pathogenic(Last reviewed: Oct 10, 2014)	criteria provided, single submitter	1	46655211	1	46189539	56589	71228
NM_017739.3(POMGNT1):c.1649G>A (p.Ser550Asn)	TSPAN1|POMGNT1	Muscle eye brain disease|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A3	Likely pathogenic(Last reviewed: Jun 25, 2014)	criteria provided, single submitter	1	46656145	1	46190473	3988	19027
NM_017739.3(POMGNT1):c.1298C>T (p.Thr433Met)	TSPAN1|POMGNT1	Muscle eye brain disease|Limb-girdle muscular dystrophy-dystroglycanopathy, type C3|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3|not specified|not provided|Congenital Muscular Dystrophy, alpha-dystroglycan related|Limb-Girdle Muscular Dystrophy, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Jan 3, 2018)	criteria provided, conflicting interpretations	1	46658095	1	46192423	162586	172203
NM_017739.3(POMGNT1):c.753G>T (p.Glu251Asp)	TSPAN1|POMGNT1	Muscle eye brain disease	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	1	46660072	1	46194400	561091	552046
NM_003035.2(STIL):c.3427G>A (p.Asp1143Asn)	STIL	not specified	Benign/Likely benign(Last reviewed: Jul 20, 2017)	criteria provided, multiple submitters, no conflicts	1	47717245	1	47251573	160065	167999
NM_003035.2(STIL):c.3154G>A (p.Gly1052Ser)	STIL	Primary autosomal recessive microcephaly 7	Uncertain significance(Last reviewed: Apr 17, 2014)	criteria provided, single submitter	1	47717518	1	47251846	160062	168002
NM_003035.2(STIL):c.3064G>T (p.Val1022Leu)	STIL	Primary autosomal recessive microcephaly 7|not provided	Uncertain significance(Last reviewed: Jun 14, 2018)	criteria provided, multiple submitters, no conflicts	1	47725974	1	47260302	160061	168003
NM_003035.2(STIL):c.2951A>G (p.His984Arg)	STIL	Primary autosomal recessive microcephaly 7|not specified|not provided|Primary Microcephaly, Recessive	Benign/Likely benign(Last reviewed: Apr 20, 2017)	criteria provided, multiple submitters, no conflicts	1	47726087	1	47260415	94094	99994
NM_003035.2(STIL):c.2948C>T (p.Thr983Ile)	STIL	Primary autosomal recessive microcephaly 7	Uncertain significance(Last reviewed: May 23, 2013)	criteria provided, single submitter	1	47726090	1	47260418	160060	168004
NM_003035.2(STIL):c.2852G>A (p.Ser951Asn)	STIL	Primary autosomal recessive microcephaly 7	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	1	47726186	1	47260514	160059	168005
NM_003035.2(STIL):c.2542G>A (p.Val848Ile)	STIL	Primary autosomal recessive microcephaly 7|not provided	Uncertain significance(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	1	47735380	1	47269708	160056	168007
NM_003035.2(STIL):c.2017A>G (p.Ser673Gly)	STIL	not specified|not provided	Benign/Likely benign(Last reviewed: Oct 27, 2015)	criteria provided, multiple submitters, no conflicts	1	47746113	1	47280441	160053	168009
NM_003035.2(STIL):c.1455G>C (p.Leu485Phe)	STIL	not specified|not provided|Abnormality of brain morphology|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Feb 2, 2018)	criteria provided, conflicting interpretations	1	47746675	1	47281003	160052	168010
NM_001048166.1(STIL):c.1226G>C (p.Ser409Thr)	STIL	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	1	47748039	1	47282367	402198	389114
NM_003035.2(STIL):c.1136C>T (p.Ser379Phe)	STIL	Primary autosomal recessive microcephaly 7|not specified	Conflicting interpretations of pathogenicity(Last reviewed: May 23, 2017)	criteria provided, conflicting interpretations	1	47748129	1	47282457	160049	168013
NM_003035.2(STIL):c.895T>A (p.Phe299Ile)	STIL	Primary autosomal recessive microcephaly 7	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	1	47755235	1	47289563	160069	168016
NM_003035.2(STIL):c.467A>G (p.His156Arg)	STIL	Primary autosomal recessive microcephaly 7|not specified|Primary Microcephaly, Recessive	Uncertain significance(Last reviewed: Feb 20, 2017)	criteria provided, multiple submitters, no conflicts	1	47765811	1	47300139	160068	168017
NM_003035.2(STIL):c.257C>T (p.Ala86Val)	STIL	Primary autosomal recessive microcephaly 7|not specified|not provided|Primary Microcephaly, Recessive	Benign(Last reviewed: Apr 20, 2017)	criteria provided, multiple submitters, no conflicts	1	47767914	1	47302242	21354	34206
NM_003035.2(STIL):c.227C>T (p.Ser76Leu)	STIL	Primary autosomal recessive microcephaly 7	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	1	47767944	1	47302272	160055	168018
NM_003035.2(STIL):c.36G>A (p.Met12Ile)	STIL	Primary autosomal recessive microcephaly 7	Uncertain significance(Last reviewed: Dec 7, 2012)	criteria provided, single submitter	1	47775956	1	47310284	160067	168019
NM_003035.2(STIL):c.26G>A (p.Arg9Gln)	STIL	Primary autosomal recessive microcephaly 7	Uncertain significance(Last reviewed: May 6, 2014)	criteria provided, single submitter	1	47775966	1	47310294	160058	168020
NM_012186.2(FOXE3):c.232G>A (p.Ala78Thr)	FOXE3|LINC01389	Congenital primary aphakia	Likely pathogenic(Last reviewed: Jun 1, 2017)	criteria provided, single submitter	1	47882219	1	47416547	427852	418809
NM_012186.2(FOXE3):c.310C>T (p.Arg104Cys)	FOXE3|LINC01389	Congenital primary aphakia	Likely pathogenic(Last reviewed: Jun 1, 2017)	criteria provided, single submitter	1	47882297	1	47416625	427853	418810
NM_004153.3(ORC1):c.2518G>A (p.Asp840Asn)	ORC1	not provided	Uncertain significance(Last reviewed: Jun 21, 2013)	criteria provided, single submitter	1	52838921	1	52373249	129861	135307
NM_004153.3(ORC1):c.2447T>C (p.Met816Thr)	ORC1	not specified|Meier-Gorlin syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	52838992	1	52373320	129860	135306
NM_004153.3(ORC1):c.2405A>G (p.His802Arg)	ORC1	not provided	Uncertain significance(Last reviewed: Jan 17, 2014)	criteria provided, single submitter	1	52839034	1	52373362	129858	135304
NM_004153.3(ORC1):c.1406G>A (p.Cys469Tyr)	ORC1	not specified|Meier-Gorlin syndrome	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	52851599	1	52385927	129857	135303
NM_004153.3(ORC1):c.1397C>T (p.Thr466Met)	ORC1	not specified|Meier-Gorlin syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	52851608	1	52385936	129856	135302
NM_004153.3(ORC1):c.568G>A (p.Val190Met)	ORC1	not specified|Meier-Gorlin syndrome	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	52861871	1	52396199	129863	135309
NM_004153.3(ORC1):c.400C>T (p.Arg134Trp)	ORC1	not provided	Uncertain significance(Last reviewed: Mar 3, 2014)	criteria provided, single submitter	1	52863359	1	52397687	129862	135308
NM_004153.3(ORC1):c.314G>A (p.Arg105Gln)	ORC1	Meier-Gorlin syndrome 1|Meier-Gorlin syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	52863445	1	52397773	30232	39188
NM_004153.3(ORC1):c.308T>C (p.Leu103Ser)	ORC1	not provided	Uncertain significance(Last reviewed: Apr 2, 2013)	criteria provided, single submitter	1	52863451	1	52397779	129853	135299
NM_000098.2(CPT2):c.149C>A (p.Pro50His)	CPT2	Carnitine palmitoyltransferase II deficiency, infantile|Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced|Carnitine palmitoyltransferase II deficiency|not provided|Pancytopenia|Arthritis|Dysautonomia|Gastrointestinal dysmotility|Polyarticular arthritis|Sinus tachycardia|Chronic pain|Inappropriate sinus tachycardia	Pathogenic(Last reviewed: Sep 18, 2017)	criteria provided, multiple submitters, no conflicts	1	53662764	1	53197092	8954	23993
NM_000098.2(CPT2):c.338C>T (p.Ser113Leu)	CPT2	Carnitine palmitoyltransferase II deficiency, infantile|Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced|Carnitine palmitoyltransferase II deficiency, lethal neonatal|Carnitine palmitoyltransferase II deficiency|Encephalopathy, acute, infection-induced, 4, susceptibility to|not provided|Inborn genetic diseases|Rhabdomyolysis	Pathogenic(Last reviewed: Jun 27, 2018)	criteria provided, multiple submitters, no conflicts	1	53668099	1	53202427	8953	23992
NM_014762.4(DHCR24):c.500T>C (p.Leu167Ser)	DHCR24	Desmosterolosis	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	1	55340878	1	54875205	560988	552047
NM_057176.3(BSND):c.917T>C (p.Leu306Pro)	BSND	not specified	Likely benign(Last reviewed: Nov 29, 2012)	criteria provided, single submitter	1	55474255	1	55008582	46552	55717
NM_013339.4(ALG6):c.391T>C (p.Tyr131His)	ALG6	Congenital disorder of glycosylation type 1C|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Aug 4, 2017)	criteria provided, conflicting interpretations	1	63872032	1	63406361	30422	39379
NM_013339.4(ALG6):c.751A>G (p.Thr251Ala)	ALG6	Congenital disorder of glycosylation type 1C|not specified|not provided	Benign/Likely benign(Last reviewed: Sep 28, 2017)	criteria provided, multiple submitters, no conflicts	1	63877667	1	63411996	128354	133803
NM_013339.4(ALG6):c.911C>T (p.Ser304Phe)	ALG6	Congenital disorder of glycosylation|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	63881552	1	63415881	95531	101430
NM_013339.4(ALG6):c.988G>T (p.Val330Phe)	ALG6	Congenital disorder of glycosylation type 1C	Uncertain significance(Last reviewed: Sep 6, 2017)	criteria provided, single submitter	1	63885041	1	63419370	374388	361159
NM_013339.4(ALG6):c.1135C>T (p.Pro379Ser)	ALG6	Congenital disorder of glycosylation type 1C|not provided	Uncertain significance(Last reviewed: May 23, 2017)	criteria provided, multiple submitters, no conflicts	1	63894606	1	63428935	128350	133799
NM_013339.4(ALG6):c.1442A>G (p.Asn481Ser)	ALG6	not provided	Uncertain significance(Last reviewed: Mar 31, 2014)	criteria provided, single submitter	1	63902609	1	63436938	128351	133800
NM_013339.4(ALG6):c.1465T>G (p.Phe489Val)	ALG6	not provided	Uncertain significance(Last reviewed: Mar 31, 2014)	criteria provided, single submitter	1	63902632	1	63436961	128352	133801
NM_000016.5(ACADM):c.50G>A (p.Arg17His)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Uncertain significance(Last reviewed: Feb 20, 2015)	criteria provided, single submitter	1	76194105	1	75728420	226078	227859
NM_000016.5(ACADM):c.127G>A (p.Glu43Lys)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 25, 2018)	criteria provided, conflicting interpretations	1	76198337	1	75732652	92257	98168
NM_000016.5(ACADM):c.157C>T (p.Arg53Cys)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 23, 2016)	criteria provided, multiple submitters, no conflicts	1	76198367	1	75732682	92258	98169
NM_000016.5(ACADM):c.158G>A (p.Arg53His)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Uncertain significance(Last reviewed: Feb 20, 2015)	criteria provided, single submitter	1	76198368	1	75732683	226066	227865
NM_000016.5(ACADM):c.199T>C (p.Tyr67His)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 27, 2018)	criteria provided, conflicting interpretations	1	76198409	1	75732724	3597	18636
NM_000016.5(ACADM):c.238A>G (p.Arg80Gly)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Uncertain significance(Last reviewed: Feb 20, 2015)	criteria provided, single submitter	1	76198559	1	75732874	226108	227866
NM_000016.5(ACADM):c.250C>T (p.Leu84Phe)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 24, 2018)	criteria provided, multiple submitters, no conflicts	1	76198571	1	75732886	226097	227867
NM_000016.5(ACADM):c.295G>A (p.Gly99Arg)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Uncertain significance(Last reviewed: Feb 20, 2015)	criteria provided, single submitter	1	76199221	1	75733536	226064	227868
NM_000016.5(ACADM):c.296G>T (p.Gly99Val)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided	Uncertain significance(Last reviewed: Oct 1, 2015)	criteria provided, multiple submitters, no conflicts	1	76199222	1	75733537	226063	227869
NM_000016.5(ACADM):c.302G>A (p.Gly101Glu)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Uncertain significance(Last reviewed: Feb 20, 2015)	criteria provided, single submitter	1	76199228	1	75733543	226071	227870
NM_000016.5(ACADM):c.346T>G (p.Cys116Gly)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Uncertain significance(Last reviewed: Feb 20, 2015)	criteria provided, single submitter	1	76199272	1	75733587	226076	227872
NM_000016.5(ACADM):c.347G>A (p.Cys116Tyr)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Oct 4, 2017)	criteria provided, multiple submitters, no conflicts	1	76199273	1	75733588	226068	227873
NM_000016.5(ACADM):c.362C>T (p.Thr121Ile)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided	Pathogenic(Last reviewed: Apr 5, 2018)	criteria provided, multiple submitters, no conflicts	1	76199288	1	75733603	3599	18638
NM_000016.5(ACADM):c.395C>G (p.Pro132Arg)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Conflicting interpretations of pathogenicity(Last reviewed: May 10, 2018)	criteria provided, conflicting interpretations	1	76200483	1	75734798	226055	227875
NM_000016.5(ACADM):c.443G>A (p.Arg148Lys)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 9, 2018)	criteria provided, multiple submitters, no conflicts	1	76200531	1	75734846	198025	195186
NM_000016.5(ACADM):c.447G>T (p.Met149Ile)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Nov 3, 2017)	criteria provided, conflicting interpretations	1	76200535	1	75734850	226059	227877
NM_000016.5(ACADM):c.464T>C (p.Met155Thr)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Feb 20, 2015)	criteria provided, single submitter	1	76200552	1	75734867	226106	227878
NM_000016.5(ACADM):c.503A>C (p.Asp168Ala)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 2, 2017)	criteria provided, conflicting interpretations	1	76205699	1	75740014	226072	227883
NM_000016.5(ACADM):c.508G>T (p.Ala170Ser)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Uncertain significance(Last reviewed: Feb 20, 2015)	criteria provided, single submitter	1	76205704	1	75740019	226056	227884
NM_000016.5(ACADM):c.526G>T (p.Ala176Ser)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Uncertain significance(Last reviewed: Feb 20, 2015)	criteria provided, single submitter	1	76205722	1	75740037	226093	227885
NM_000016.5(ACADM):c.558T>A (p.Asn186Lys)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 12, 2017)	criteria provided, conflicting interpretations	1	76205754	1	75740069	198379	195540
NM_000016.5(ACADM):c.580A>G (p.Asn194Asp)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 25, 2018)	criteria provided, conflicting interpretations	1	76205776	1	75740091	226100	227886
NM_000016.5(ACADM):c.583G>A (p.Gly195Arg)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, multiple submitters, no conflicts	1	76205779	1	75740094	3594	18633
NM_000016.5(ACADM):c.602A>G (p.Tyr201Cys)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Uncertain significance(Last reviewed: Feb 20, 2015)	criteria provided, single submitter	1	76211493	1	75745808	226098	227890
NM_000016.5(ACADM):c.609A>C (p.Leu203Phe)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Feb 20, 2015)	criteria provided, single submitter	1	76211500	1	75745815	226065	227891
NM_000016.5(ACADM):c.661G>A (p.Gly221Arg)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency|not specified	Uncertain significance(Last reviewed: Jun 29, 2017)	criteria provided, multiple submitters, no conflicts	1	76211552	1	75745867	226081	227892
NM_000016.5(ACADM):c.683C>A (p.Thr228Asn)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Apr 25, 2018)	criteria provided, conflicting interpretations	1	76211574	1	75745889	203538	199975
NM_000016.5(ACADM):c.728G>A (p.Arg243Gln)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Uncertain significance(Last reviewed: Feb 20, 2015)	criteria provided, single submitter	1	76215123	1	75749438	226088	227894
NM_000016.5(ACADM):c.742A>G (p.Arg248Gly)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Feb 20, 2015)	criteria provided, single submitter	1	76215137	1	75749452	226089	227895
NM_000016.5(ACADM):c.755T>G (p.Phe252Cys)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Uncertain significance(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	1	76215150	1	75749465	226067	227896
NM_000016.5(ACADM):c.757G>A (p.Glu253Lys)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Dec 20, 2017)	criteria provided, conflicting interpretations	1	76215152	1	75749467	226054	227897
NM_000016.5(ACADM):c.797A>G (p.Asp266Gly)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, multiple submitters, no conflicts	1	76215192	1	75749507	203540	199977
NM_000016.5(ACADM):c.799G>A (p.Gly267Arg)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, multiple submitters, no conflicts	1	76215194	1	75749509	3588	18627
NM_000016.5(ACADM):c.881G>C (p.Arg294Thr)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 29, 2016)	criteria provided, multiple submitters, no conflicts	1	76216167	1	75750482	226075	227899
NM_000016.5(ACADM):c.907G>A (p.Ala303Thr)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Uncertain significance(Last reviewed: Sep 8, 2017)	criteria provided, multiple submitters, no conflicts	1	76216193	1	75750508	226058	227900
NM_000016.5(ACADM):c.928G>A (p.Gly310Arg)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 29, 2017)	criteria provided, conflicting interpretations	1	76216214	1	75750529	193539	190703
NM_000016.5(ACADM):c.977T>C (p.Met326Thr)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Likely pathogenic(Last reviewed: Oct 16, 2014)	criteria provided, single submitter	1	76226838	1	75761153	189019	186632
NM_000016.5(ACADM):c.985A>C (p.Lys329Gln)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic(Last reviewed: Feb 20, 2015)	criteria provided, single submitter	1	76226846	1	75761161	226057	227903
NM_001127328.2(ACADM):c.997A>G (p.Lys333Glu)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency|not provided	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, multiple submitters, no conflicts	1	76226846	1	75761161	3586	18625
NM_000016.5(ACADM):c.1057T>G (p.Tyr353Asp)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Uncertain significance(Last reviewed: Feb 20, 2015)	criteria provided, single submitter	1	76226918	1	75761233	226061	227906
NM_000016.5(ACADM):c.1087G>A (p.Asp363Asn)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Uncertain significance(Last reviewed: Feb 20, 2015)	criteria provided, single submitter	1	76226948	1	75761263	226086	227907
NM_000016.5(ACADM):c.1115C>A (p.Ala372Asp)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Uncertain significance(Last reviewed: Feb 20, 2015)	criteria provided, single submitter	1	76226976	1	75761291	226073	227908
NM_000016.5(ACADM):c.1184A>C (p.Lys395Thr)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Uncertain significance(Last reviewed: Feb 20, 2015)	criteria provided, single submitter	1	76227045	1	75761360	226094	227909
NM_000016.5(ACADM):c.1189T>A (p.Tyr397Asn)	ACADM	Medium-chain acyl-coenzyme A dehydrogenase deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	1	76227050	1	75761365	226095	227910
NM_000350.2(ABCA4):c.5882G>A	ABCA4	Cone-rod dystrophy 3|Age-related macular degeneration 2|Stargardt disease 1|MACULAR DEGENERATION, AGE-RELATED, 2, SUSCEPTIBILITY TO|not provided|Retinal dystrophy|Macular dystrophy|Inborn genetic diseases|ABCA4-Related Disorders	Pathogenic/Likely pathogenic, risk factor(Last reviewed: Jan 4, 2018)	criteria provided, multiple submitters, no conflicts	1	94473807	1	94008251	7888	22927
NM_000350.2(ABCA4):c.5381C>A (p.Ala1794Asp)	ABCA4	Stargardt disease 1|not provided|Retinal dystrophy	Likely pathogenic(Last reviewed: Jan 12, 2017)	no assertion criteria provided	1	94480178	1	94014622	99371	105260
NM_000350.2(ABCA4):c.3113C>T (p.Ala1038Val)	ABCA4	Cone-rod dystrophy 3|Stargardt disease 1|not provided|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Jan 31, 2018)	criteria provided, multiple submitters, no conflicts	1	94508969	1	94043413	7894	22933
NM_000350.2(ABCA4):c.[2588G>C];[5882G>A]	ABCA4	Stargardt disease 1	Pathogenic(Last reviewed: Apr 9, 2013)	criteria provided, single submitter	1|1	94517254	1|1	94051698	424760	22918|22927
NM_000350.2(ABCA4):c.2588G>C	ABCA4	Cone-rod dystrophy 3|Stargardt disease 1|not provided|Peripheral neuropathy|Retinal dystrophy|Abnormal macular morphology|Inborn genetic diseases|Peripheral neuropathy	Conflicting interpretations of pathogenicity(Last reviewed: Apr 23, 2018)	criteria provided, conflicting interpretations	1	94517254	1	94051698	7879	22918
NM_000350.2(ABCA4):c.1964T>G (p.Phe655Cys)	ABCA4	Cone-rod dystrophy 3|Stargardt disease 1	Likely pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, multiple submitters, no conflicts	1	94526289	1	94060733	212727	209342
NM_000350.2(ABCA4):c.1645G>A (p.Ala549Thr)	ABCA4	Stargardt disease 1	Uncertain significance	criteria provided, single submitter	1	94528783	1	94063227	219171	217189
NM_000350.2(ABCA4):c.161G>A (p.Cys54Tyr)	ABCA4	Cone-rod dystrophy 3|Stargardt disease 1|Retinitis pigmentosa 19|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 5, 2016)	criteria provided, multiple submitters, no conflicts	1	94577135	1	94111579	99065	104955
NM_000028.2(AGL):c.4353G>T (p.Trp1451Cys)	AGL	Glycogen storage disease type III	Likely pathogenic(Last reviewed: Aug 19, 2014)	no assertion criteria provided	1	100382159	1	99916603	374339	361162
NM_001918.3(DBT):c.901C>T (p.Arg301Cys)	DBT	Maple syrup urine disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, multiple submitters, no conflicts	1	100680411	1	100214855	94016	99918
NM_001408.2(CELSR2):c.3830C>T (p.Pro1277Leu)	CELSR2	Global developmental delay|Intellectual disability|Global developmental delay	Likely pathogenic	criteria provided, single submitter	1	109801573	1	109258951	402154	389103
NM_001257360.1(AMPD2):c.2327T>G (p.Leu776Arg)	AMPD2	Pontocerebellar hypoplasia, type 9	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	1	110173312	1	109630690	488467	481335
NM_006594.4(AP4B1):c.1439T>C (p.Leu480Ser)	AP4B1|AP4B1-AS1	not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Mar 13, 2016)	criteria provided, multiple submitters, no conflicts	1	114438951	1	113896329	157718	167566
NM_006594.4(AP4B1):c.1189A>G (p.Ile397Val)	AP4B1|AP4B1-AS1	not specified	Benign(Last reviewed: May 5, 2014)	criteria provided, single submitter	1	114441349	1	113898727	157716	167564
NM_006594.4(AP4B1):c.955T>C (p.Phe319Leu)	AP4B1|AP4B1-AS1	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	1	114442685	1	113900063	402201	389105
NM_006594.4(AP4B1):c.803A>G (p.His268Arg)	AP4B1|AP4B1-AS1	Spastic paraplegia 47, autosomal recessive|not specified|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Dec 13, 2017)	criteria provided, conflicting interpretations	1	114442837	1	113900215	157727	167575
NM_006594.4(AP4B1):c.577G>A (p.Val193Ile)	AP4B1	Spastic paraplegia 47, autosomal recessive	Uncertain significance(Last reviewed: Aug 8, 2013)	criteria provided, single submitter	1	114443898	1	113901276	157724	167572
NM_001232.3(CASQ2):c.164A>G (p.Tyr55Cys)	CASQ2	Ventricular tachycardia, catecholaminergic polymorphic, 2|Cardiovascular phenotype	Likely pathogenic(Last reviewed: Sep 22, 2017)	criteria provided, multiple submitters, no conflicts	1	116310999	1	115768378	427946	419261
NM_206996.3(SPAG17):c.4445G>T (p.Arg1482Leu)	SPAG17	not provided	Uncertain significance	no assertion criteria provided	1	118550809	1	118008186	156522	166286
NM_206996.3(SPAG17):c.1069G>C (p.Asp357His)	SPAG17	Cranioectodermal dysplasia 2	Likely pathogenic(Last reviewed: Aug 27, 2017)	criteria provided, single submitter	1	118635883	1	118093260	437866	431460
NM_000198.3(HSD3B2):c.707T>C (p.Leu236Ser)	HSD3B2	Congenital adrenal hyperplasia	Uncertain significance(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	1	119964831	1	119422208	36370	45033
NM_213653.3(HJV):c.959G>T (p.Gly320Val)	HJV	Hemochromatosis type 2A|Hemochromatosis type 1	Pathogenic(Last reviewed: Jan 20, 2017)	criteria provided, multiple submitters, no conflicts	1	145416614	1	146018399	2365	17404
NM_213653.3(HJV):c.497A>G (p.His166Arg)	HJV	Hemochromatosis type 2A	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	1	145415678	1	146019335	545472	535732
NM_000396.3(CTSK):c.926T>C (p.Leu309Pro)	CTSK	Pyknodysostosis	Likely pathogenic(Last reviewed: Jul 19, 2014)	criteria provided, single submitter	1	150769339	1	150796863	8426	23465
NM_000396.3(CTSK):c.830C>T (p.Ala277Val)	CTSK	Pyknodysostosis	Likely pathogenic(Last reviewed: May 30, 2014)	criteria provided, single submitter	1	150771704	1	150799228	8423	23462
NM_021222.2(PRUNE1):c.88G>A (p.Asp30Asn)	PRUNE1	not provided|Abnormality of brain morphology|Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies	Likely pathogenic	criteria provided, multiple submitters, no conflicts	1	150990336	1	151017860	384334	364478
NM_021222.2(PRUNE1):c.316G>A (p.Asp106Asn)	PRUNE1	Abnormality of brain morphology|Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, multiple submitters, no conflicts	1	150991126	1	151018650	402131	389107
NM_021222.2(PRUNE1):c.383G>A (p.Arg128Gln)	PRUNE1	not provided|Abnormality of brain morphology|Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies	Likely pathogenic	criteria provided, multiple submitters, no conflicts	1	150997134	1	151024658	384335	364483
NM_001004432.3(LINGO4):c.1262G>A (p.Arg421Gln)	LINGO4	Polymicrogyria	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	1	151773919	1	151801443	438603	432203
NM_001004432.3(LINGO4):c.851C>T (p.Ser284Phe)	LINGO4	Polymicrogyria	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	1	151774330	1	151801854	438604	432204
NM_012437.5(SNAPIN):c.163C>T (p.Arg55Trp)	SNAPIN	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	1	153631633	1	153659157	402168	389109
NM_006118.3(HAX1):c.376C>T (p.Arg126Trp)	HAX1	Severe congenital neutropenia 3, autosomal recessive	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	1	154246309	1	154273833	561149	552033
NM_001111.5(ADAR):c.3215G>T (p.Ser1072Ile)	ADAR	Aicardi-Goutieres syndrome 6	Likely pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	1	154558329	1	154585853	488463	481331
NM_001111.5(ADAR):c.577C>G (p.Pro193Ala)	ADAR	Symmetrical dyschromatosis of extremities|Aicardi Goutieres syndrome|Aicardi-Goutieres syndrome 6|not provided|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2018)	criteria provided, conflicting interpretations	1	154574541	1	154602065	126395	131928
NM_000157.3(GBA):c.1604G>A (p.Arg535His)	GBA|LOC106627981	Gaucher's disease, type 1|Gaucher disease	Pathogenic(Last reviewed: Feb 9, 2016)	criteria provided, multiple submitters, no conflicts	1	155204793	1	155235002	4311	19350
NM_000157.3(GBA):c.1603C>T	GBA|LOC106627981	Gaucher's disease, type 1	Likely pathogenic(Last reviewed: Jun 10, 2016)	no assertion criteria provided	1	155204794	1	155235003	242383	237954
NM_000157.3(GBA):c.1459G>A (p.Ala487Thr)	GBA|LOC106627981	Gaucher's disease, type 1	Likely pathogenic(Last reviewed: Aug 25, 2015)	no assertion criteria provided	1	155205032	1	155235241	236402	237955
NM_000157.3(GBA):c.[1448T>C];[167T>G]	GBA|LOC106627981	Gaucher's disease, type 1	Likely pathogenic(Last reviewed: Sep 25, 2015)	no assertion criteria provided	1|1	155205043	1|1	155235252	424819	19327|237962
NM_000157.3(GBA):c.[1448T>C];[407C>T]	GBA|LOC106627981	Gaucher's disease, type 1	Likely pathogenic(Last reviewed: Sep 25, 2015)	no assertion criteria provided	1|1	155205043	1|1	155235252	424818	19327|237961
NM_001005741.2(GBA):c.1448T>G (p.Leu483Arg)	GBA|LOC106627981	Acute neuronopathic Gaucher's disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	1	155205043	1	155235252	93449	99356
NM_000157.3(GBA):c.1448T>C	GBA|LOC106627981	Gaucher's disease, type 1|Acute neuronopathic Gaucher's disease|Subacute neuronopathic Gaucher's disease|Parkinson disease, late-onset|Dementia, Lewy body, susceptibility to|Gaucher disease|not provided|Hypomimic face|Parkinsonism|Resting tremor|Thoracolumbar scoliosis|Abnormality of movement	Conflicting interpretations of pathogenicity, risk factor(Last reviewed: Jan 3, 2019)	criteria provided, conflicting interpretations	1	155205043	1	155235252	4288	19327
NM_000157.3(GBA):c.1397T>G (p.Ile466Ser)	GBA|LOC106627981	Gaucher's disease, type 1	Likely pathogenic(Last reviewed: Mar 10, 2012)	no assertion criteria provided	1	155205094	1	155235303	236405	237956
NM_000157.3(GBA):c.[1197G>T];[1603C>T]	GBA|LOC106627981	Gaucher's disease, type 1	Likely pathogenic(Last reviewed: Oct 1, 2015)	no assertion criteria provided	1|1	155206063	1|1	155236272	424820	237957|237954
NM_000157.3(GBA):c.1177C>G (p.Leu393Val)	GBA|LOC106627981	Gaucher's disease, type 1	Likely pathogenic(Last reviewed: Jul 1, 2013)	no assertion criteria provided	1	155206083	1	155236292	236400	237958
NM_000157.3(GBA):c.866G>C (p.Gly289Ala)	GBA|LOC106627981	Gaucher's disease, type 1	Likely pathogenic(Last reviewed: Apr 23, 2013)	no assertion criteria provided	1	155207265	1	155237474	236406	237959
NM_000157.3(GBA):c.835C>G (p.Leu279Val)	GBA|LOC106627981	Subacute neuronopathic Gaucher's disease	Uncertain significance(Last reviewed: Dec 21, 2015)	no assertion criteria provided	1	155207296	1	155237505	375274	362045
NM_000157.3(GBA):c.415G>C (p.Ala139Pro)	GBA|LOC106627981	Gaucher's disease, type 1	Likely pathogenic(Last reviewed: Dec 17, 2013)	no assertion criteria provided	1	155209446	1	155239655	236399	237960
NM_000157.4(GBA):c.160G>T (p.Val54Leu)	GBA|LOC106627981	Gaucher's disease, type 1	Pathogenic(Last reviewed: Sep 11, 2018)	no assertion criteria provided	1	155209824	1	155240033	4313	19352
NM_000298.5(PKLR):c.1456C>T (p.Arg486Trp)	PKLR	Pyruvate kinase deficiency of red cells|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 10, 2018)	criteria provided, multiple submitters, no conflicts	1	155261709	1	155291918	1513	16552
NM_018116.3(MSTO1):c.971C>T (p.Thr324Ile)	MSTO1	MYOPATHY, MITOCHONDRIAL, AND ATAXIA	Likely pathogenic(Last reviewed: Dec 14, 2017)	criteria provided, single submitter	1	155582639	1	155612848	438833	432466
NM_170707.3(LMNA):c.892C>T (p.Arg298Cys)	LMNA	Charcot-Marie-Tooth disease type 2B1|Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, multiple submitters, no conflicts	1	156105059	1	156135268	14498	29537
NM_001012331.1(NTRK1):c.1040G>C (p.Arg347Pro)	NTRK1	Hereditary insensitivity to pain with anhidrosis	Likely pathogenic(Last reviewed: Jun 10, 2014)	criteria provided, single submitter	1	156843614	1	156873822	209178	205721
NM_002241.4(KCNJ10):c.812G>A (p.Arg271His)	KCNJ10	SeSAME syndrome|not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Dec 18, 2017)	criteria provided, multiple submitters, no conflicts	1	160011511	1	160041721	129318	134764
NM_002241.4(KCNJ10):c.811C>T (p.Arg271Cys)	KCNJ10	SeSAME syndrome|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Aug 14, 2017)	criteria provided, multiple submitters, no conflicts	1	160011512	1	160041722	129317	134763
NM_002241.4(KCNJ10):c.53G>A (p.Arg18Gln)	KCNJ10	SeSAME syndrome|not specified|not provided|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Mar 8, 2018)	criteria provided, multiple submitters, no conflicts	1	160012270	1	160042480	129316	134762
NM_004550.4(NDUFS2):c.1054C>G (p.Pro352Ala)	NDUFS2	Mitochondrial complex I deficiency|not specified|not provided	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	161182208	1	161212418	129697	135143
NM_007348.3(ATF6):c.970C>T (p.Arg324Cys)	ATF6	Achromatopsia 7	Pathogenic(Last reviewed: Jun 17, 2015)	criteria provided, single submitter	1	161789483	1	161819693	208172	204434
NM_007348.3(ATF6):c.1699T>A (p.Tyr567Asn)	ATF6	Achromatopsia 7	Pathogenic(Last reviewed: Jun 17, 2015)	criteria provided, single submitter	1	161833082	1	161863292	208176	204438
NM_001174069.1(LMX1A):c.1106T>C (p.Ile369Thr)	LMX1A	Sensorineural hearing loss	Pathogenic(Last reviewed: Mar 14, 2018)	no assertion criteria provided	1	165173160	1	165203923	517667	508758
NM_001267609.1(GPR161):c.56T>A (p.Leu19Gln)	GPR161	not provided|Pituitary stalk interruption syndrome	Likely pathogenic(Last reviewed: Jan 1, 2015)	criteria provided, single submitter	1	168074093	1	168104855	180652	178813
NM_006894.5(FMO3):c.458C>T (p.Pro153Leu)	FMO3	Trimethylaminuria	Pathogenic(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	1	171076952	1	171107811	16308	31347
NM_004319.2(ASTN1):c.3283A>C (p.Met1095Leu)	ASTN1	Abnormality of the corpus callosum	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	1	176852074	1	176882938	438600	432205
NM_004319.2(ASTN1):c.2770C>T (p.His924Tyr)	ASTN1	Abnormality of the corpus callosum	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	1	176863868	1	176894732	438601	432206
NM_004319.2(ASTN1):c.2224G>C (p.Gly742Arg)	ASTN1	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	1	176915087	1	176945951	402149	389110
NM_014625.3(NPHS2):c.871C>T (p.Arg291Trp)	NPHS2|AXDND1	Nephrotic syndrome, idiopathic, steroid-resistant|not provided	Likely pathogenic(Last reviewed: May 5, 2014)	criteria provided, multiple submitters, no conflicts	1	179521740	1	179552605	5369	20408
NM_014625.3(NPHS2):c.868G>A (p.Val290Met)	NPHS2|AXDND1	Nephrotic syndrome, idiopathic, steroid-resistant|Nephrotic syndrome, type 2, susceptibility to|not provided|Idiopathic nephrotic syndrome	Pathogenic/Likely pathogenic, risk factor(Last reviewed: Sep 16, 2018)	criteria provided, multiple submitters, no conflicts	1	179521743	1	179552608	126418	131950
NM_014625.3(NPHS2):c.538G>A (p.Val180Met)	NPHS2	Nephrotic syndrome, idiopathic, steroid-resistant|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 16, 2018)	criteria provided, multiple submitters, no conflicts	1	179526362	1	179557227	5368	20407
NM_014625.3(NPHS2):c.503G>A (p.Arg168His)	NPHS2	Nephrotic syndrome, idiopathic, steroid-resistant|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 5, 2017)	criteria provided, multiple submitters, no conflicts	1	179528845	1	179559710	188730	186605
NM_014625.3(NPHS2):c.502C>T (p.Arg168Cys)	NPHS2	Nephrotic syndrome, idiopathic, steroid-resistant	Likely pathogenic(Last reviewed: Sep 2, 2014)	criteria provided, single submitter	1	179528846	1	179559711	188952	186606
NM_015602.3(TOR1AIP1):c.1427C>T (p.Ala476Val)	TOR1AIP1	Muscular dystrophy, limb-girdle, type 2y	Likely pathogenic(Last reviewed: Nov 14, 2016)	criteria provided, single submitter	1	179887049	1	179917914	522870	513406
NM_018136.4(ASPM):c.10109C>G (p.Thr3370Arg)	ASPM	Primary autosomal recessive microcephaly 5	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	1	197057438	1	197088308	157771	167619
NM_018136.4(ASPM):c.10100G>A (p.Ser3367Asn)	ASPM	Primary autosomal recessive microcephaly 5	Uncertain significance(Last reviewed: Nov 13, 2013)	criteria provided, single submitter	1	197057447	1	197088317	157770	167618
NM_018136.4(ASPM):c.9928A>G (p.Ile3310Val)	ASPM	Primary autosomal recessive microcephaly 5	Uncertain significance(Last reviewed: Dec 3, 2013)	criteria provided, single submitter	1	197059116	1	197089986	157921	167768
NM_018136.4(ASPM):c.9923G>A (p.Arg3308His)	ASPM	Primary autosomal recessive microcephaly 5	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	1	197059121	1	197089991	157920	167767
NM_018136.4(ASPM):c.9911G>A (p.Arg3304Gln)	ASPM	Primary autosomal recessive microcephaly 5|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Apr 14, 2015)	criteria provided, conflicting interpretations	1	197059133	1	197090003	157919	167766
NM_018136.4(ASPM):c.9773A>G (p.His3258Arg)	ASPM	Primary autosomal recessive microcephaly 5|not specified|not provided	Benign/Likely benign(Last reviewed: Apr 19, 2017)	criteria provided, multiple submitters, no conflicts	1	197059382	1	197090252	21638	34490
NM_018136.4(ASPM):c.9662G>A (p.Arg3221Lys)	ASPM	Primary autosomal recessive microcephaly 5	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	1	197059493	1	197090363	157916	167763
NM_018136.4(ASPM):c.9577C>T (p.Arg3193Cys)	ASPM	Primary autosomal recessive microcephaly 5	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	1	197060039	1	197090909	157915	167762
NM_018136.4(ASPM):c.9539A>C (p.Gln3180Pro)	ASPM	Primary autosomal recessive microcephaly 5|not specified|not provided|Primary Microcephaly, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Feb 28, 2018)	criteria provided, conflicting interpretations	1	197060077	1	197090947	21628	34480
NM_018136.4(ASPM):c.9395T>C (p.Leu3132Pro)	ASPM	Primary autosomal recessive microcephaly 5|not provided	Uncertain significance(Last reviewed: Aug 11, 2016)	criteria provided, multiple submitters, no conflicts	1	197061086	1	197091956	157911	167758
NM_018136.5(ASPM):c.9395T>G (p.Leu3132Arg)	ASPM	Primary autosomal recessive microcephaly 5|not specified|not provided|Primary Microcephaly, Recessive	Benign/Likely benign(Last reviewed: Oct 15, 2018)	criteria provided, multiple submitters, no conflicts	1	197061086	1	197091956	21625	34477
NM_018136.4(ASPM):c.9320G>A (p.Arg3107Gln)	ASPM	Primary autosomal recessive microcephaly 5	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	1	197061161	1	197092031	157909	167756
NM_018136.4(ASPM):c.9254T>C (p.Ile3085Thr)	ASPM	Primary autosomal recessive microcephaly 5|not specified|Primary Microcephaly, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Oct 12, 2018)	criteria provided, conflicting interpretations	1	197062222	1	197093092	157906	167753
NM_018136.4(ASPM):c.8741T>C (p.Ile2914Thr)	ASPM	Primary autosomal recessive microcephaly 5|not specified|Primary Microcephaly, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Jan 18, 2018)	criteria provided, conflicting interpretations	1	197069640	1	197100510	157899	167746
NM_018136.4(ASPM):c.8524C>T (p.Arg2842Trp)	ASPM	Primary autosomal recessive microcephaly 5	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	1	197069857	1	197100727	157896	167743
NM_018136.4(ASPM):c.8449G>T (p.Ala2817Ser)	ASPM	Primary autosomal recessive microcephaly 5|Primary Microcephaly, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	197069932	1	197100802	157892	167739
NM_018136.4(ASPM):c.8291A>G (p.Glu2764Gly)	ASPM	Primary autosomal recessive microcephaly 5	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	1	197070090	1	197100960	157891	167738
NM_018136.4(ASPM):c.8203T>G (p.Phe2735Val)	ASPM	Primary autosomal recessive microcephaly 5|not provided|Primary Microcephaly, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Nov 16, 2017)	criteria provided, conflicting interpretations	1	197070178	1	197101048	157890	167737
NM_018136.4(ASPM):c.8009T>C (p.Ile2670Thr)	ASPM	Primary autosomal recessive microcephaly 5|not provided	Uncertain significance(Last reviewed: Nov 2, 2017)	criteria provided, multiple submitters, no conflicts	1	197070372	1	197101242	157884	167731
NM_018136.4(ASPM):c.7939C>A (p.Leu2647Ile)	ASPM	Primary autosomal recessive microcephaly 5|not specified|not provided|Primary Microcephaly, Recessive	Benign(Last reviewed: Aug 2, 2017)	criteria provided, multiple submitters, no conflicts	1	197070442	1	197101312	21611	34463
NM_018136.4(ASPM):c.7860G>C (p.Gln2620His)	ASPM	Primary autosomal recessive microcephaly 5|not specified|not provided|Primary Microcephaly, Recessive	Benign/Likely benign(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	1	197070521	1	197101391	21609	34461
NM_018136.4(ASPM):c.7858C>A (p.Gln2620Lys)	ASPM	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	1	197070523	1	197101393	157882	167729
NM_018136.4(ASPM):c.7841A>G (p.Asp2614Gly)	ASPM	Primary autosomal recessive microcephaly 5	Uncertain significance(Last reviewed: Jun 20, 2013)	criteria provided, single submitter	1	197070540	1	197101410	157881	167728
NM_018136.4(ASPM):c.7817C>A (p.Thr2606Asn)	ASPM	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	1	197070564	1	197101434	157879	167726
NM_018136.4(ASPM):c.7787T>C (p.Val2596Ala)	ASPM	not specified|not provided|Primary Microcephaly, Recessive	Benign/Likely benign(Last reviewed: Apr 19, 2017)	criteria provided, multiple submitters, no conflicts	1	197070594	1	197101464	157878	167725
NM_018136.4(ASPM):c.7684A>G (p.Ser2562Gly)	ASPM	Primary autosomal recessive microcephaly 5|not specified|not provided|Primary Microcephaly, Recessive	Benign(Last reviewed: Aug 2, 2017)	criteria provided, multiple submitters, no conflicts	1	197070697	1	197101567	21605	34457
NM_018136.4(ASPM):c.7670C>G (p.Ser2557Cys)	ASPM	Primary autosomal recessive microcephaly 5|not specified|not provided|Inborn genetic diseases|Primary Microcephaly, Recessive	Uncertain significance(Last reviewed: Jun 12, 2018)	criteria provided, multiple submitters, no conflicts	1	197070711	1	197101581	157875	167722
NM_018136.4(ASPM):c.7576A>G (p.Asn2526Asp)	ASPM	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	1	197070805	1	197101675	157872	167719
NM_018136.4(ASPM):c.7480T>C (p.Tyr2494His)	ASPM	Primary autosomal recessive microcephaly 5|not specified|Primary Microcephaly, Recessive	Benign(Last reviewed: May 31, 2017)	criteria provided, multiple submitters, no conflicts	1	197070901	1	197101771	21599	34451
NM_018136.4(ASPM):c.7428G>T (p.Lys2476Asn)	ASPM	Primary autosomal recessive microcephaly 5|not provided|Primary Microcephaly, Recessive	Uncertain significance(Last reviewed: Jun 9, 2017)	criteria provided, multiple submitters, no conflicts	1	197070953	1	197101823	157869	167716
NM_018136.4(ASPM):c.6727G>T (p.Val2243Leu)	ASPM	not specified|not provided	Benign/Likely benign(Last reviewed: Oct 25, 2017)	criteria provided, multiple submitters, no conflicts	1	197071654	1	197102524	157857	167704
NM_018136.4(ASPM):c.6334C>T (p.His2112Tyr)	ASPM	Primary autosomal recessive microcephaly 5	Uncertain significance(Last reviewed: Jul 9, 2013)	criteria provided, single submitter	1	197072047	1	197102917	157853	167700
NM_018136.4(ASPM):c.6241A>G (p.Lys2081Glu)	ASPM	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	1	197072140	1	197103010	157852	167699
NM_018136.4(ASPM):c.6131A>G (p.Asn2044Ser)	ASPM	Primary autosomal recessive microcephaly 5|Primary Microcephaly, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	197072250	1	197103120	157851	167698
NM_018136.4(ASPM):c.6125A>G (p.Asp2042Gly)	ASPM	Primary autosomal recessive microcephaly 5|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Apr 14, 2015)	criteria provided, conflicting interpretations	1	197072256	1	197103126	157850	167697
NM_018136.4(ASPM):c.6058A>G (p.Thr2020Ala)	ASPM	Primary autosomal recessive microcephaly 5	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	1	197072323	1	197103193	157847	167694
NM_018136.4(ASPM):c.5947A>T (p.Met1983Leu)	ASPM	Primary autosomal recessive microcephaly 5|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 13, 2018)	criteria provided, conflicting interpretations	1	197072434	1	197103304	157844	167691
NM_018136.4(ASPM):c.5923A>G (p.Ile1975Val)	ASPM	Primary autosomal recessive microcephaly 5	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	1	197072458	1	197103328	157843	167690
NM_018136.4(ASPM):c.5846A>G (p.His1949Arg)	ASPM	Primary autosomal recessive microcephaly 5|Primary Microcephaly, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	197072535	1	197103405	157842	167689
NM_018136.4(ASPM):c.5821T>C (p.Cys1941Arg)	ASPM	not specified|not provided|Primary Microcephaly, Recessive	Benign/Likely benign(Last reviewed: Apr 19, 2017)	criteria provided, multiple submitters, no conflicts	1	197072560	1	197103430	157841	167688
NM_018136.4(ASPM):c.5629G>T (p.Ala1877Ser)	ASPM	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	1	197072752	1	197103622	157839	167686
NM_018136.4(ASPM):c.5582A>G (p.Tyr1861Cys)	ASPM	Primary autosomal recessive microcephaly 5	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	1	197072799	1	197103669	157837	167684
NM_018136.4(ASPM):c.5579C>T (p.Ala1860Val)	ASPM	not specified|not provided|Primary Microcephaly, Recessive	Benign/Likely benign(Last reviewed: Apr 19, 2017)	criteria provided, multiple submitters, no conflicts	1	197072802	1	197103672	157836	167683
NM_018136.4(ASPM):c.5510G>A (p.Gly1837Asp)	ASPM	Primary autosomal recessive microcephaly 5|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Oct 10, 2017)	criteria provided, conflicting interpretations	1	197072871	1	197103741	157835	167682
NM_018136.4(ASPM):c.5452C>T (p.Arg1818Cys)	ASPM	Primary autosomal recessive microcephaly 5|not specified|not provided|Primary Microcephaly, Recessive	Uncertain significance(Last reviewed: Jun 11, 2018)	criteria provided, multiple submitters, no conflicts	1	197072929	1	197103799	157834	167681
NM_018136.4(ASPM):c.5292G>A (p.Met1764Ile)	ASPM	Primary autosomal recessive microcephaly 5	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	1	197073089	1	197103959	157832	167679
NM_018136.4(ASPM):c.5224T>C (p.Tyr1742His)	ASPM	Primary autosomal recessive microcephaly 5|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Aug 15, 2017)	criteria provided, conflicting interpretations	1	197073157	1	197104027	157830	167677
NM_018136.4(ASPM):c.5206C>G (p.Gln1736Glu)	ASPM	not specified|not provided	Benign(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	1	197073175	1	197104045	136426	140129
NM_018136.4(ASPM):c.5185C>T (p.Arg1729Trp)	ASPM	not specified|not provided|Primary Microcephaly, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Dec 14, 2017)	criteria provided, conflicting interpretations	1	197073196	1	197104066	95889	101785
NM_018136.4(ASPM):c.5083C>T (p.Arg1695Cys)	ASPM	not specified|Primary Microcephaly, Recessive	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	197073298	1	197104168	157828	167675
NM_018136.4(ASPM):c.5063C>T (p.Thr1688Ile)	ASPM	not specified|not provided|Primary Microcephaly, Recessive	Benign/Likely benign(Last reviewed: Apr 19, 2017)	criteria provided, multiple submitters, no conflicts	1	197073318	1	197104188	157827	167674
NM_018136.4(ASPM):c.4733G>A (p.Arg1578Gln)	ASPM	Primary autosomal recessive microcephaly 5|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 1, 2018)	criteria provided, conflicting interpretations	1	197073648	1	197104518	157825	167672
NM_018136.4(ASPM):c.4496G>T (p.Arg1499Leu)	ASPM	Primary autosomal recessive microcephaly 5|not specified|not provided	Uncertain significance(Last reviewed: May 23, 2017)	criteria provided, multiple submitters, no conflicts	1	197073885	1	197104755	157823	167670
NM_018136.4(ASPM):c.4474G>C (p.Val1492Leu)	ASPM	Primary autosomal recessive microcephaly 5	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	1	197073907	1	197104777	157822	167669
NM_018136.4(ASPM):c.4445G>A (p.Arg1482Gln)	ASPM	Primary autosomal recessive microcephaly 5	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	1	197073936	1	197104806	157821	167668
NM_018136.4(ASPM):c.3698T>C (p.Met1233Thr)	ASPM	Primary autosomal recessive microcephaly 5|not specified|not provided	Uncertain significance(Last reviewed: Jul 5, 2016)	criteria provided, multiple submitters, no conflicts	1	197091332	1	197122202	157806	167653
NM_018136.4(ASPM):c.3269C>T (p.Ser1090Phe)	ASPM	Primary autosomal recessive microcephaly 5|not specified|not provided|Primary Microcephaly, Recessive	Benign/Likely benign(Last reviewed: Jan 24, 2018)	criteria provided, multiple submitters, no conflicts	1	197093361	1	197124231	21575	34427
NM_018136.4(ASPM):c.2968G>A (p.Asp990Asn)	ASPM	Primary autosomal recessive microcephaly 5|not provided|Primary Microcephaly, Recessive	Uncertain significance(Last reviewed: May 23, 2017)	criteria provided, multiple submitters, no conflicts	1	197094290	1	197125160	157800	167647
NM_018136.4(ASPM):c.2914T>G (p.Leu972Val)	ASPM	Primary autosomal recessive microcephaly 5|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Dec 27, 2016)	criteria provided, conflicting interpretations	1	197097642	1	197128512	157798	167645
NM_018136.4(ASPM):c.2218A>T (p.Ile740Leu)	ASPM	not specified|not provided	Benign(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	1	197102681	1	197133551	157792	167639
NM_018136.4(ASPM):c.2195T>C (p.Leu732Ser)	ASPM	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	1	197102704	1	197133574	157791	167638
NM_018136.4(ASPM):c.1987G>T (p.Ala663Ser)	ASPM	not specified|Primary Microcephaly, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	1	197108936	1	197139806	157790	167637
NM_018136.4(ASPM):c.1949C>G (p.Ser650Cys)	ASPM	Primary autosomal recessive microcephaly 5|not provided	Uncertain significance(Last reviewed: Jul 28, 2017)	criteria provided, multiple submitters, no conflicts	1	197108974	1	197139844	157789	167636
NM_018136.4(ASPM):c.1740C>G (p.Ser580Arg)	ASPM	Primary autosomal recessive microcephaly 5|not provided	Uncertain significance(Last reviewed: Oct 4, 2016)	criteria provided, multiple submitters, no conflicts	1	197111642	1	197142512	157786	167633
NM_018136.4(ASPM):c.1495A>G (p.Lys499Glu)	ASPM	Primary autosomal recessive microcephaly 5	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	1	197111887	1	197142757	157782	167629
NM_018136.4(ASPM):c.1451A>G (p.Asn484Ser)	ASPM	not specified|not provided	Benign(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	1	197111931	1	197142801	157781	167628
NM_018136.4(ASPM):c.1388G>A (p.Ser463Asn)	ASPM	Primary autosomal recessive microcephaly 5	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	1	197111994	1	197142864	157780	167627
NM_018136.4(ASPM):c.1288A>G (p.Arg430Gly)	ASPM	Primary autosomal recessive microcephaly 5|not specified|not provided|Primary Microcephaly, Recessive	Benign/Likely benign(Last reviewed: Apr 19, 2017)	criteria provided, multiple submitters, no conflicts	1	197112094	1	197142964	21553	34405
NM_018136.4(ASPM):c.1201A>G (p.Met401Val)	ASPM	Primary autosomal recessive microcephaly 5	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	1	197112181	1	197143051	157779	167626
NM_018136.4(ASPM):c.1007C>A (p.Thr336Lys)	ASPM	Primary autosomal recessive microcephaly 5|not specified|Primary Microcephaly, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Mar 18, 2017)	criteria provided, conflicting interpretations	1	197112375	1	197143245	157769	167617
NM_018136.4(ASPM):c.937A>G (p.Ile313Val)	ASPM	Primary autosomal recessive microcephaly 5	Uncertain significance(Last reviewed: May 29, 2014)	criteria provided, single submitter	1	197112445	1	197143315	21624	34476
NM_018136.4(ASPM):c.932G>C (p.Ser311Thr)	ASPM	not specified	Likely benign(Last reviewed: Jan 26, 2017)	criteria provided, single submitter	1	197112450	1	197143320	157910	167757
NM_018136.4(ASPM):c.905G>A (p.Cys302Tyr)	ASPM	Primary autosomal recessive microcephaly 5|not specified|Primary Microcephaly, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Mar 18, 2017)	criteria provided, conflicting interpretations	1	197112477	1	197143347	157903	167750
NM_018136.4(ASPM):c.844A>C (p.Asn282His)	ASPM	Primary autosomal recessive microcephaly 5|not specified|Primary Microcephaly, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Mar 18, 2017)	criteria provided, conflicting interpretations	1	197112538	1	197143408	157893	167740
NM_018136.4(ASPM):c.646G>A (p.Glu216Lys)	ASPM	Primary autosomal recessive microcephaly 5|not specified|not provided|Inborn genetic diseases|Primary Microcephaly, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Aug 22, 2018)	criteria provided, conflicting interpretations	1	197112736	1	197143606	157855	167702
NM_018136.4(ASPM):c.644A>C (p.Glu215Ala)	ASPM	not specified|not provided	Benign(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	1	197112738	1	197143608	136425	140128
NM_018136.4(ASPM):c.601A>G (p.Asn201Asp)	ASPM	Primary autosomal recessive microcephaly 5|Primary Microcephaly, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	197112781	1	197143651	157846	167693
NM_018136.4(ASPM):c.562G>C (p.Val188Leu)	ASPM	Primary autosomal recessive microcephaly 5	Uncertain significance(Last reviewed: Apr 8, 2014)	criteria provided, single submitter	1	197112820	1	197143690	157840	167687
NM_018136.4(ASPM):c.301A>G (p.Lys101Glu)	ASPM	Primary autosomal recessive microcephaly 5	Uncertain significance(Last reviewed: Jan 22, 2014)	criteria provided, single submitter	1	197113227	1	197144097	157801	167648
NM_018136.4(ASPM):c.223G>A (p.Ala75Thr)	ASPM	not specified|not provided|Primary Microcephaly, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Jan 25, 2018)	criteria provided, conflicting interpretations	1	197115345	1	197146215	157793	167640
NM_018136.4(ASPM):c.112G>A (p.Val38Ile)	ASPM	Primary autosomal recessive microcephaly 5	Uncertain significance(Last reviewed: Jul 31, 2013)	criteria provided, single submitter	1	197115456	1	197146326	157776	167623
NM_018136.4(ASPM):c.59C>T (p.Pro20Leu)	ASPM	Primary autosomal recessive microcephaly 5	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	1	197115509	1	197146379	157845	167692
NM_201253.2(CRB1):c.2227G>C (p.Val743Leu)	CRB1	Retinitis pigmentosa 12	Likely pathogenic(Last reviewed: Mar 12, 2013)	criteria provided, single submitter	1	197396682	1	197427552	216912	213518
NM_000574.4(CD55):c.203G>A (p.Ser68Asn)	CD55	Cromer blood group system	Affects(Last reviewed: Oct 19, 2015)	criteria provided, single submitter	1	207495829	1	207322484	224614	226396
NM_014053.3(FLVCR1):c.154G>C (p.Ala52Pro)	FLVCR1	Posterior column ataxia with retinitis pigmentosa|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	213031948	1	212858606	129102	134548
NM_014053.3(FLVCR1):c.1631C>T (p.Thr544Met)	FLVCR1	Posterior column ataxia with retinitis pigmentosa|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	213068595	1	212895253	129103	134549
NM_001287219.2(RPS6KC1):c.2074G>A (p.Gly692Ser)	RPS6KC1	Global developmental delay|Hypoplasia of the corpus callosum|Global developmental delay|Abnormality of the cerebral white matter|Periventricular leukomalacia|Delayed myelination|Muscular hypotonia|Muscular hypotonia	Likely pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	1	213415529	1	213242186	242892	243977
NM_206933.2(USH2A):c.15562A>G (p.Ser5188Gly)	USH2A	not specified|Usher syndrome	Benign(Last reviewed: Sep 17, 2018)	reviewed by expert panel	1	215799170	1	215625828	48468	57630
NM_206933.2(USH2A):c.15494C>G (p.Ala5165Gly)	USH2A	not specified|not provided|Usher syndrome	Likely benign(Last reviewed: Sep 28, 2018)	reviewed by expert panel	1	215802181	1	215628839	282144	266381
NM_206933.2(USH2A):c.14531C>T (p.Thr4844Met)	USH2A	not specified	Likely benign(Last reviewed: Nov 30, 2017)	criteria provided, multiple submitters, no conflicts	1	215821921	1	215648579	48443	57605
NM_206933.2(USH2A):c.14453C>T (p.Pro4818Leu)	USH2A	Usher syndrome, type 2A	Likely pathogenic(Last reviewed: Dec 22, 2016)	criteria provided, single submitter	1	215821999	1	215648657	504509	496179
NM_206933.2(USH2A):c.14419G>A (p.Ala4807Thr)	USH2A	Usher syndrome, type 2A|Retinitis pigmentosa 39|not specified|not provided|Usher syndrome	Uncertain significance(Last reviewed: Sep 28, 2018)	reviewed by expert panel	1	215822033	1	215648691	198366	195527
NM_206933.2(USH2A):c.13010C>T (p.Thr4337Met)	USH2A	Usher syndrome, type 2A|Retinitis pigmentosa 39	Pathogenic/Likely pathogenic(Last reviewed: Mar 24, 2017)	criteria provided, multiple submitters, no conflicts	1	215848243	1	215674901	143172	152890
NM_206933.2(USH2A):c.12700A>C (p.Thr4234Pro)	USH2A	Usher syndrome, type 2A	Likely pathogenic(Last reviewed: Nov 7, 2015)	criteria provided, single submitter	1	215848553	1	215675211	228311	228299
NM_206933.2(USH2A):c.10724G>A (p.Cys3575Tyr)	USH2A	Usher syndrome, type 2A	Likely pathogenic(Last reviewed: Oct 17, 2011)	criteria provided, single submitter	1	215955400	1	215782058	48356	57518
NM_206933.2(USH2A):c.10712C>T (p.Thr3571Met)	USH2A	Usher syndrome, type 2A|Retinitis pigmentosa 39	Pathogenic/Likely pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, multiple submitters, no conflicts	1	215955412	1	215782070	48355	57517
NM_206933.2(USH2A):c.10561T>C (p.Trp3521Arg)	USH2A	Usher syndrome, type 2A|Retinitis pigmentosa 39|Usher syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 25, 2017)	criteria provided, multiple submitters, no conflicts	1	215956104	1	215782762	48352	57514
NM_206933.2(USH2A):c.10342G>A (p.Glu3448Lys)	USH2A	Usher syndrome, type 2A|Retinitis pigmentosa|Retinitis pigmentosa 39|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 17, 2018)	criteria provided, conflicting interpretations	1	215960057	1	215786715	209203	205725
NM_206933.2(USH2A):c.10073G>A (p.Cys3358Tyr)	USH2A	Usher syndrome, type 2A|Retinitis pigmentosa|Retinitis pigmentosa 39|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	1	215963510	1	215790168	197932	195093
NM_206933.2(USH2A):c.9919T>A (p.Cys3307Ser)	USH2A	Retinitis pigmentosa 39	Likely pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, single submitter	1	215972288	1	215798946	548444	538928
NM_206933.2(USH2A):c.9842G>T (p.Cys3281Phe)	USH2A	Usher syndrome, type 2A|Retinitis pigmentosa 39|not specified	Uncertain significance(Last reviewed: Apr 24, 2017)	criteria provided, multiple submitters, no conflicts	1	215972365	1	215799023	179132	172756
NM_206933.2(USH2A):c.8681G>A (p.Arg2894Lys)	USH2A	Retinitis pigmentosa 39	Likely pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, single submitter	1	216051100	1	215877758	495329	486824
NM_206933.2(USH2A):c.8177G>A (p.Gly2726Glu)	USH2A	Usher syndrome, type 2A|Retinitis pigmentosa 39|not specified|Usher syndrome	Uncertain significance(Last reviewed: Sep 28, 2018)	reviewed by expert panel	1	216061814	1	215888472	179542	172902
NM_206933.2(USH2A):c.6670G>T (p.Gly2224Cys)	USH2A	Retinitis pigmentosa|Retinitis pigmentosa 39|not provided	Uncertain significance(Last reviewed: Apr 4, 2016)	criteria provided, multiple submitters, no conflicts	1	216166497	1	215993155	209202	205726
NM_206933.2(USH2A):c.5581G>A (p.Gly1861Ser)	USH2A|LOC102723833	Usher syndrome, type 2A|Retinitis pigmentosa 39|Usher syndrome	Pathogenic(Last reviewed: Sep 14, 2018)	reviewed by expert panel	1	216246634	1	216073292	48535	57697
NM_206933.2(USH2A):c.5039A>G (p.Lys1680Arg)	USH2A|LOC102723833	not specified|not provided|Usher syndrome	Uncertain significance(Last reviewed: Sep 28, 2018)	reviewed by expert panel	1	216258168	1	216084826	166499	172526
NM_206933.2(USH2A):c.3408T>A (p.Ser1136Arg)	USH2A	Usher syndrome, type 2A|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 12, 2018)	criteria provided, conflicting interpretations	1	216373372	1	216200030	418534	405044
NM_206933.2(USH2A):c.2276G>T (p.Cys759Phe)	USH2A	Usher syndrome, type 2A|Retinitis pigmentosa|Retinitis pigmentosa 39|not specified|not provided|Retinal dystrophy|Inborn genetic diseases|USH2A-Related Disorders|Usher syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 5, 2017)	criteria provided, conflicting interpretations	1	216420460	1	216247118	2356	17395
NM_206933.2(USH2A):c.1522G>A (p.Ala508Thr)	USH2A	not specified|not provided	Uncertain significance(Last reviewed: Nov 11, 2016)	criteria provided, multiple submitters, no conflicts	1	216496844	1	216323502	48458	57620
NM_206933.2(USH2A):c.1055C>T (p.Thr352Ile)	USH2A	Usher syndrome, type 2A|Retinitis pigmentosa 39|Usher syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 11, 2017)	criteria provided, multiple submitters, no conflicts	1	216498735	1	216325393	438002	431606
NM_206933.2(USH2A):c.1036A>C (p.Asn346His)	USH2A	Usher syndrome, type 2A|Retinitis pigmentosa 39|not provided|Usher syndrome	Pathogenic(Last reviewed: Sep 14, 2018)	reviewed by expert panel	1	216498754	1	216325412	48347	57509
NM_206933.2(USH2A):c.1000C>T (p.Arg334Trp)	USH2A	Usher syndrome, type 2A|Retinitis pigmentosa 39	Pathogenic/Likely pathogenic(Last reviewed: Aug 30, 2017)	criteria provided, multiple submitters, no conflicts	1	216498790	1	216325448	228411	228349
NM_206933.2(USH2A):c.956G>A (p.Cys319Tyr)	USH2A	Usher syndrome, type 2A|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 1, 2017)	criteria provided, conflicting interpretations	1	216498834	1	216325492	2355	17394
NM_206933.2(USH2A):c.653T>A (p.Val218Glu)	USH2A	Usher syndrome, type 2A|Retinitis pigmentosa|Retinitis pigmentosa 39|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 20, 2017)	criteria provided, conflicting interpretations	1	216538426	1	216365084	48564	57726
NM_012414.3(RAB3GAP2):c.3275G>C (p.Ser1092Thr)	RAB3GAP2	Martsolf syndrome|not specified|Warburg micro syndrome	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	220331205	1	220157863	130079	135525
NM_012414.3(RAB3GAP2):c.2587A>G (p.Thr863Ala)	RAB3GAP2	Martsolf syndrome|Warburg micro syndrome 2|not specified|Warburg micro syndrome	Benign/Likely benign(Last reviewed: Jul 26, 2017)	criteria provided, multiple submitters, no conflicts	1	220344453	1	220171111	130078	135524
NM_012414.3(RAB3GAP2):c.1792A>C (p.Ile598Leu)	RAB3GAP2	not provided	Uncertain significance(Last reviewed: Feb 17, 2014)	criteria provided, single submitter	1	220359071	1	220185729	130076	135522
NM_012414.3(RAB3GAP2):c.938C>T (p.Thr313Ile)	RAB3GAP2	not specified	Likely benign	no assertion criteria provided	1	220369614	1	220196272	130074	135520
NM_000120.3(EPHX1):c.823A>G (p.Thr275Ala)	EPHX1	Hypercholanemia, familial	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	1	226027630	1	225839929	561152	552038
NM_001010867.3(IBA57):c.[167G>A];[826C>T]	IBA57	Multiple mitochondrial dysfunctions syndrome 3	Likely pathogenic(Last reviewed: Aug 2, 2017)	no assertion criteria provided	1|1	228353684	1|1	228165983	433547	427118|427119
NM_001100.3(ACTA1):c.521C>T (p.Pro174Leu)	ACTA1	Nemaline myopathy 3	Likely pathogenic(Last reviewed: Dec 30, 2016)	no assertion criteria provided	1	229568112	1	229432365	374934	361844
NM_152490.4(B3GALNT2):c.1076G>A (p.Cys359Tyr)	B3GALNT2	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11	Uncertain significance(Last reviewed: Oct 5, 2017)	criteria provided, multiple submitters, no conflicts	1	235618946	1	235455634	540916	515581
NM_152490.4(B3GALNT2):c.[1438_1455dup18];[979G>A]	B3GALNT2	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11	Likely pathogenic(Last reviewed: Jul 15, 2014)	criteria provided, single submitter	1|1	235621957	1|1	235458649	424766	213521|213520
NM_000081.3(LYST):c.5719A>G (p.Ile1907Val)	LYST	Chdiak-Higashi syndrome	Uncertain significance(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	1	235937207	1	235773907	561992	553134
NM_000254.2(MTR):c.3518C>T (p.Pro1173Leu)	MTR	METHYLCOBALAMIN DEFICIENCY, cblG TYPE|not provided|Intellectual disability, profound|Inborn genetic diseases|Seizure disorder	Pathogenic/Likely pathogenic(Last reviewed: Mar 28, 2016)	criteria provided, multiple submitters, no conflicts	1	237058770	1	236895470	14278	29317
NM_000547.5(TPO):c.1994G>A (p.Arg665Gln)	TPO	Deficiency of iodide peroxidase	Pathogenic(Last reviewed: Jun 10, 2015)	no assertion criteria provided	2	1497799	2	1494027	374344	361166
NM_015909.3(NBAS):c.5864T>C (p.Leu1955Ser)	NBAS	Short stature, optic nerve atrophy, and Pelger-Huet anomaly	Uncertain significance	criteria provided, single submitter	2	15378671	2	15238547	431715	425207
NM_015909.3(NBAS):c.5129C>T (p.Thr1710Met)	NBAS	Short stature, optic nerve atrophy, and Pelger-Huet anomaly	Uncertain significance	criteria provided, single submitter	2	15427206	2	15287082	431716	425208
NM_015909.3(NBAS):c.680A>C (p.His227Pro)	NBAS	Infantile liver failure syndrome 2	Pathogenic	no assertion criteria provided	2	15674733	2	15534609	424843	411606
NM_020779.3(WDR35):c.3412G>A (p.Glu1138Lys)	WDR35	Chondroectodermal dysplasia	Uncertain significance(Last reviewed: May 1, 2018)	criteria provided, single submitter	2	20113420	2	19913659	558762	549467
NM_001006657.1(WDR35):c.3203A>G (p.Tyr1068Cys)	WDR35	Cranioectodermal dysplasia 2|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Feb 6, 2018)	criteria provided, conflicting interpretations	2	20113990	2	19914229	440412	434040
NM_001006657.1(WDR35):c.3091C>T (p.His1031Tyr)	WDR35	Cranioectodermal dysplasia 2	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	2	20130220	2	19930459	488654	481529
NM_001006657.1(WDR35):c.1415G>A (p.Arg472Gln)	WDR35	Cranioectodermal dysplasia 2	Likely pathogenic(Last reviewed: Aug 27, 2017)	criteria provided, single submitter	2	20153613	2	19953852	437865	431459
NM_001006657.1(WDR35):c.206G>A (p.Gly69Asp)	WDR35	Short rib-polydactyly syndrome, Majewski type|Cranioectodermal dysplasia 2	Conflicting interpretations of pathogenicity(Last reviewed: Aug 15, 2017)	no assertion criteria provided	2	20182232	2	19982471	431796	425298
NM_000182.4(HADHA):c.703C>T (p.Arg235Trp)	HADHA	Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency|not provided	Likely pathogenic(Last reviewed: Oct 20, 2017)	criteria provided, multiple submitters, no conflicts	2	26438018	2	26215149	188987	186667
NM_001287489.1(OTOF):c.5816G>A (p.Arg1939Gln)	OTOF	Deafness, autosomal recessive 9	Pathogenic(Last reviewed: Feb 20, 2018)	criteria provided, single submitter	2	26681086	2	26458218	548986	539468
NM_194248.2(OTOF):c.5816G>A (p.Arg1939Gln)	OTOF	Deafness, autosomal recessive 9|Auditory neuropathy, autosomal recessive, 1	Conflicting interpretations of pathogenicity(Last reviewed: Oct 21, 2014)	no assertion criteria provided	2	26683071	2	26460203	6136	21175
NM_001287489.1(OTOF):c.5375G>A (p.Arg1792His)	OTOF	Deafness, autosomal recessive 9|Nonsyndromic hearing loss and deafness|not provided	Likely pathogenic(Last reviewed: Dec 8, 2016)	criteria provided, multiple submitters, no conflicts	2	26684722	2	26461854	48259	57423
NM_194248.2(OTOF):c.1544T>C (p.Ile515Thr)	OTOF	Deafness, autosomal recessive 9|Auditory neuropathy, autosomal recessive, 1|Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: Feb 14, 2017)	criteria provided, single submitter	2	26705309	2	26482441	6143	21182
NM_004341.4(CAD):c.98T>G (p.Met33Arg)	CAD	not provided|Epileptic encephalopathy, early infantile, 50	Pathogenic/Likely pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, multiple submitters, no conflicts	2	27440760	2	27217892	374829	361734
NM_015636.3(EIF2B4):c.913C>G (p.Arg305Gly)	EIF2B4	Leukoencephalopathy with vanishing white matter|not specified|not provided	Benign/Likely benign(Last reviewed: Nov 2, 2017)	criteria provided, multiple submitters, no conflicts	2	27590038	2	27367171	128990	134437
NM_000348.3(SRD5A2):c.725A>G (p.Tyr242Cys)	SRD5A2	3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Likely pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, single submitter	2	31751306	2	31526236	440485	434112
NM_000348.3(SRD5A2):c.[680G>A];[694C>G]	SRD5A2	3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Pathogenic(Last reviewed: Jan 9, 2017)	criteria provided, single submitter	2|2	31754395	2|2	31529325	427841	18390|362050
NM_000348.3(SRD5A2):c.[548-9T>G];[680G>A]	SRD5A2	3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Pathogenic(Last reviewed: Dec 14, 2016)	criteria provided, single submitter	2|2	31754395	2|2	31529325	427837	18390|361962
NM_000348.3(SRD5A2):c.586G>C (p.Gly196Arg)	SRD5A2	3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Pathogenic(Last reviewed: Feb 1, 2018)	criteria provided, single submitter	2	31754489	2	31529419	548153	538637
NM_000348.3(SRD5A2):c.554T>C (p.Leu185Ser)	SRD5A2	3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency	Uncertain significance(Last reviewed: Jul 23, 2018)	criteria provided, single submitter	2	31754521	2	31529451	549758	540524
NM_000104.3(CYP1B1):c.1159G>A (p.Glu387Lys)	CYP1B1	Glaucoma 3, primary congenital, A|not provided	Pathogenic(Last reviewed: Aug 2, 2018)	criteria provided, multiple submitters, no conflicts	2	38298338	2	38071195	7735	22774
NM_000104.3(CYP1B1):c.1103G>A (p.Arg368His)	CYP1B1	Glaucoma 3, primary congenital, A|Irido-corneo-trabecular dysgenesis|Congenital ocular coloboma|Glaucoma, early-onset, digenic|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Mar 28, 2017)	criteria provided, conflicting interpretations	2	38298394	2	38071251	7739	22778
NM_000341.3(SLC3A1):c.1400T>C (p.Met467Thr)	SLC3A1	Cystinuria|not provided	Pathogenic(Last reviewed: Jan 19, 2018)	criteria provided, multiple submitters, no conflicts	2	44539792	2	44312653	18115	33154
NM_005413.3(SIX3):c.169G>T (p.Gly57Cys)	SIX3	Holoprosencephaly 2	Uncertain significance(Last reviewed: Mar 15, 2017)	criteria provided, single submitter	2	45169412	2	44942273	545577	536075
NM_014171.5(CRIPT):c.8G>A (p.Cys3Tyr)	CRIPT	Short stature with microcephaly and distinctive facies	Likely pathogenic(Last reviewed: Dec 23, 2015)	criteria provided, single submitter	2	46844429	2	46617290	221618	223356
NM_020458.3(TTC7A):c.211G>A (p.Glu71Lys)	TTC7A	Multiple gastrointestinal atresias	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	2	47177528	2	46950389	190395	188223
NM_001288951.1(TTC7A):c.[1616C>T];[2587G>A]	TTC7A	Multiple gastrointestinal atresias	Pathogenic(Last reviewed: Dec 5, 2016)	no assertion criteria provided	2|2	47251473	2|2	47024334	440892	434519|434520
NM_001135659.2(NRXN1):c.3464G>A (p.Ser1155Asn)	NRXN1	not provided	Uncertain significance(Last reviewed: Jan 15, 2014)	criteria provided, single submitter	2	50692600	2	50465462	129821	135267
NM_001135659.2(NRXN1):c.2078G>A (p.Ser693Asn)	NRXN1	not provided	Uncertain significance(Last reviewed: Aug 7, 2013)	criteria provided, single submitter	2	50765576	2	50538438	129816	135262
NM_001135659.2(NRXN1):c.1835A>G (p.Asp612Gly)	NRXN1	Pitt-Hopkins-like syndrome 2	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	2	50779769	2	50552631	561068	552066
NM_001135659.2(NRXN1):c.1412G>A (p.Ser471Asn)	NRXN1	Pitt-Hopkins-like syndrome 2|not specified	Uncertain significance(Last reviewed: Oct 25, 2017)	criteria provided, multiple submitters, no conflicts	2	50847188	2	50620050	206274	201703
NM_001135659.2(NRXN1):c.790C>A (p.Gln264Lys)	NRXN1	Pitt-Hopkins-like syndrome 2|not specified|not provided|History of neurodevelopmental disorder	Uncertain significance(Last reviewed: Nov 29, 2017)	criteria provided, multiple submitters, no conflicts	2	51253590	2	51026452	129817	135263
NM_033109.4(PNPT1):c.1592C>G (p.Thr531Arg)	PNPT1	not specified|Combined oxidative phosphorylation deficiency 13	Conflicting interpretations of pathogenicity(Last reviewed: Oct 31, 2016)	criteria provided, conflicting interpretations	2	55874492	2	55647357	209184	205731
NM_033109.4(PNPT1):c.1525G>A (p.Val509Ile)	PNPT1	not specified|Combined oxidative phosphorylation deficiency 13	Conflicting interpretations of pathogenicity(Last reviewed: Sep 22, 2017)	criteria provided, conflicting interpretations	2	55874559	2	55647424	209185	205732
NM_033109.4(PNPT1):c.1519G>T (p.Ala507Ser)	PNPT1	Combined oxidative phosphorylation deficiency 13|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	2	55874565	2	55647430	215010	210875
NM_033109.4(PNPT1):c.1361C>G (p.Ala454Gly)	PNPT1	Combined oxidative phosphorylation deficiency 13	Likely pathogenic	criteria provided, single submitter	2	55883346	2	55656211	548987	539469
NM_015910.6(WDPCP):c.160G>A (p.Asp54Asn)	WDPCP	Orstavik Lindemann Solberg syndrome	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	2	63719990	2	63492856	162669	172323
NM_003038.4(SLC1A4):c.1369C>T (p.Arg457Trp)	SLC1A4	not provided|Inborn genetic diseases|Spastic tetraplegia, thin corpus callosum, and progressive microcephaly	Pathogenic(Last reviewed: May 4, 2017)	criteria provided, multiple submitters, no conflicts	2	65248050	2	65020916	372158	359063
NM_032208.2(ANTXR1):c.1150G>A (p.Gly384Ser)	ANTXR1	Odontotrichomelic syndrome	Likely pathogenic(Last reviewed: Sep 1, 2014)	criteria provided, single submitter	2	69408978	2	69181846	224853	226692
NM_001002755.2(NFU1):c.544C>T (p.Arg182Trp)	NFU1	Multiple mitochondrial dysfunctions syndrome 1	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	2	69633155	2	69406023	488564	481432
NM_003494.3(DYSF):c.509C>A (p.Ala170Glu)	DYSF	Dysferlinopathy|not specified	Benign(Last reviewed: Dec 26, 2017)	criteria provided, multiple submitters, no conflicts	2	71740897	2	71513767	94334	100234
NM_003494.3(DYSF):c.565C>G (p.Leu189Val)	DYSF	Dysferlinopathy|not specified|Miyoshi myopathy|Limb-Girdle Muscular Dystrophy, Recessive	Benign/Likely benign(Last reviewed: Jan 23, 2018)	criteria provided, multiple submitters, no conflicts	2	71740953	2	71513823	94343	100243
NM_003494.3(DYSF):c.1369G>A (p.Glu457Lys)	DYSF	Dysferlinopathy|not specified|not provided	Benign/Likely benign(Last reviewed: Oct 12, 2017)	criteria provided, multiple submitters, no conflicts	2	71762413	2	71535283	94270	100170
NM_001130987.1(DYSF):c.1721T>C (p.Leu574Pro)	DYSF	Limb-girdle muscular dystrophy, type 2B	Likely pathogenic(Last reviewed: Jul 19, 2017)	no assertion criteria provided	2	71778765	2	71551635	545009	535273
Multiple alleles	DYSF	Limb-girdle muscular dystrophy, type 2B	Likely pathogenic(Last reviewed: Jul 19, 2017)	no assertion criteria provided	2|2	71778768	2|2	71551638	433558	427128|427129
NM_003494.3(DYSF):c.1852G>C (p.Gly618Arg)	DYSF	Limb-girdle muscular dystrophy, type 2B|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 2, 2016)	criteria provided, multiple submitters, no conflicts	2	71780240	2	71553110	217224	213809
NM_003494.3(DYSF):c.2500A>G (p.Ile834Val)	DYSF	Dysferlinopathy|not specified|Miyoshi myopathy|Limb-Girdle Muscular Dystrophy, Recessive	Benign/Likely benign(Last reviewed: Aug 8, 2017)	criteria provided, multiple submitters, no conflicts	2	71791332	2	71564202	94289	100189
NM_003494.3(DYSF):c.[2643+1G>A];[4577A>C]	DYSF	Limb-girdle muscular dystrophy, type 2B	Likely pathogenic(Last reviewed: Nov 19, 2013)	criteria provided, single submitter	2|2	71795213	2|2	71568083	424775	100191|100227
NM_003494.3(DYSF):c.2997G>T (p.Trp999Cys)	DYSF	Miyoshi muscular dystrophy 1|Limb-girdle muscular dystrophy, type 2B	Pathogenic(Last reviewed: Jan 24, 2017)	criteria provided, multiple submitters, no conflicts	2	71797430	2	71570300	6674	21713
NM_003494.3(DYSF):c.3065G>A (p.Arg1022Gln)	DYSF	Dysferlinopathy|not specified	Benign(Last reviewed: Aug 8, 2017)	criteria provided, multiple submitters, no conflicts	2	71797762	2	71570632	94300	100200
NM_003494.3(DYSF):c.3287G>A (p.Arg1096His)	DYSF	Dysferlinopathy|not specified	Benign/Likely benign(Last reviewed: Nov 28, 2017)	criteria provided, multiple submitters, no conflicts	2	71801440	2	71574310	128947	134394
NM_003494.3(DYSF):c.[3516_3517delTT];[5078G>A]	DYSF	Miyoshi muscular dystrophy 1|Limb-girdle muscular dystrophy, type 2B|Myopathy, distal, with anterior tibial onset	Likely pathogenic(Last reviewed: Aug 6, 2013)	criteria provided, single submitter	2|2	71817414 - 71817415	2|2	71590284 - 71590285	424774	213540|213541
NM_003494.3(DYSF):c.3992G>T (p.Arg1331Leu)	DYSF	Dysferlinopathy|not specified	Benign(Last reviewed: Aug 1, 2017)	criteria provided, multiple submitters, no conflicts	2	71838463	2	71611333	94315	100215
NM_003494.3(DYSF):c.4376A>G (p.Asp1459Gly)	DYSF	Dysferlinopathy|not specified	Benign(Last reviewed: Dec 15, 2017)	criteria provided, multiple submitters, no conflicts	2	71840506	2	71613376	128949	134396
NM_003494.3(DYSF):c.5077C>T (p.Arg1693Trp)	DYSF	Miyoshi muscular dystrophy 1|Limb-girdle muscular dystrophy, type 2B|Dysferlinopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 23, 2017)	criteria provided, multiple submitters, no conflicts	2	71892311	2	71665181	217227	213811
NM_003494.3(DYSF):c.5303G>A (p.Arg1768Gln)	DYSF	Limb-girdle muscular dystrophy, type 2B|not specified|not provided	Uncertain significance(Last reviewed: Feb 16, 2017)	criteria provided, multiple submitters, no conflicts	2	71894608	2	71667478	282624	266861
NM_003494.3(DYSF):c.5429G>A (p.Arg1810Lys)	DYSF	Miyoshi muscular dystrophy 1|Limb-girdle muscular dystrophy, type 2B|not provided	Pathogenic(Last reviewed: Aug 9, 2016)	criteria provided, multiple submitters, no conflicts	2	71895972	2	71668842	18443	33482
NM_001130987.1(DYSF):c.5642G>A (p.Gly1881Asp)	DYSF	Limb-girdle muscular dystrophy, type 2B	Pathogenic(Last reviewed: May 29, 2017)	no assertion criteria provided	2	71896337	2	71669207	430739	424285
NM_201647.3(STAMBP):c.112C>T (p.Arg38Cys)	STAMBP	Microcephaly-capillary malformation syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	2	74058095	2	73830968	50793	59802
NM_006463.5(STAMBP):c.299T>A (p.Phe100Tyr)	STAMBP	Microcephaly-capillary malformation syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	2	74072313	2	73845186	50796	59805
NM_201647.3(STAMBP):c.499G>A (p.Glu167Lys)	STAMBP	Microcephaly-capillary malformation syndrome	Uncertain significance(Last reviewed: Dec 11, 2013)	criteria provided, single submitter	2	74074637	2	73847510	160045	168075
NM_006463.5(STAMBP):c.707C>T (p.Ser236Phe)	STAMBP	Microcephaly-capillary malformation syndrome	Pathogenic(Last reviewed: Jan 2, 2018)	no assertion criteria provided	2	74074845	2	73847718	492960	485890
NM_080916.2(DGUOK):c.155C>T (p.Ser52Phe)	DGUOK	Mitochondrial DNA-depletion syndrome 3, hepatocerebral	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	2	74166049	2	73938922	488490	481358
NM_080916.2(DGUOK):c.749T>C (p.Leu250Ser)	DGUOK|DGUOK-AS1	Mitochondrial DNA-depletion syndrome 3, hepatocerebral	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	2	74185314	2	73958187	488491	481359
NM_003849.3(SUCLG1):c.635A>G (p.Gln212Arg)	SUCLG1	Mitochondrial DNA depletion syndrome 9 (encephalomyopathic with methylmalonic aciduria)	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	2	84660514	2	84433390	561121	552067
NM_003849.3(SUCLG1):c.40A>T (p.Met14Leu)	SUCLG1	Mitochondrial DNA depletion syndrome 9 (encephalomyopathic with methylmalonic aciduria)	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	2	84686354	2	84459230	561158	552068
NM_001370.1(DNAH6):c.3167A>T (p.Asp1056Val)	DNAH6	not provided	Uncertain significance	no assertion criteria provided	2	84832709	2	84605585	156519	166284
NM_003896.3(ST3GAL5):c.311A>G (p.His104Arg)	ST3GAL5	Salt and pepper developmental regression syndrome|not specified|not provided	Benign(Last reviewed: Apr 20, 2017)	criteria provided, multiple submitters, no conflicts	2	86088311	2	85861188	130382	135829
NM_004836.6(EIF2AK3):c.2110G>T (p.Ala704Ser)	EIF2AK3|LOC101928371	Wolcott-Rallison dysplasia|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	88874891	2	88575373	128986	134433
NM_004836.6(EIF2AK3):c.1756A>T (p.Ile586Leu)	EIF2AK3	Wolcott-Rallison dysplasia|not specified|not provided|Monogenic diabetes	Benign/Likely benign(Last reviewed: Jan 13, 2017)	criteria provided, multiple submitters, no conflicts	2	88882955	2	88583437	128983	134430
NM_004836.6(EIF2AK3):c.497A>G (p.Gln166Arg)	EIF2AK3	Wolcott-Rallison dysplasia|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	88895123	2	88595605	128988	134435
NM_004836.6(EIF2AK3):c.407C>G (p.Ser136Cys)	EIF2AK3	Wolcott-Rallison dysplasia|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	88913273	2	88613755	128987	134434
NM_001079.3(ZAP70):c.574C>T (p.Arg192Trp)	ZAP70	Combined immunodeficiency|Autoimmune disease, multisystem, infantile-onset, 2	Pathogenic(Last reviewed: Oct 1, 2015)	criteria provided, single submitter	2	98349356	2	97732893	222951	224665
NM_001079.3(ZAP70):c.1079G>C (p.Arg360Pro)	ZAP70	Combined immunodeficiency|Autoimmune disease, multisystem, infantile-onset, 2	Pathogenic(Last reviewed: Oct 1, 2015)	criteria provided, single submitter	2	98351172	2	97734709	222950	224666
NM_001298.2(CNGA3):c.1306C>T (p.Arg436Trp)	CNGA3	Achromatopsia 2|Achromatopsia	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, multiple submitters, no conflicts	2	99012939	2	98396476	9482	24521
NM_001298.2(CNGA3):c.1669G>A (p.Gly557Arg)	CNGA3	Achromatopsia 2|not specified	Uncertain significance(Last reviewed: Oct 30, 2013)	criteria provided, single submitter	2	99013302	2	98396839	9476	24515
NM_015929.3(LIPT1):c.131A>G (p.Asn44Ser)	LIPT1|MITD1	Lipoyltransferase 1 deficiency	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	2	99778551	2	99162088	433559	427130
NM_015929.3(LIPT1):c.[131A>G];[875C>G]	LIPT1|MITD1	Lipoyltransferase 1 deficiency	Pathogenic(Last reviewed: Aug 14, 2017)	no assertion criteria provided	2|2	99779295	2|2	99162832	433560	270108|427130
NM_002518.3(NPAS2):c.1363C>G (p.Pro455Ala)	NPAS2|LOC101927142	Non-obstructive azoospermia	Likely pathogenic(Last reviewed: Aug 1, 2015)	criteria provided, single submitter	2	101592000	2	100975538	242856	243960
NM_006267.4(RANBP2):c.8188A>C (p.Lys2730Gln)	RANBP2	Encephalopathy, acute, infection-induced, 3, suceptibility to	Uncertain significance	criteria provided, single submitter	2	109389398	2	108772942	431720	425206
NM_000272.3(NPHP1):c.793A>T (p.Asn265Tyr)	NPHP1	not specified	Benign(Last reviewed: May 7, 2013)	criteria provided, single submitter	2	110922243	2	110164666	129812	135258
NM_000272.3(NPHP1):c.115C>A (p.Pro39Thr)	NPHP1	Joubert syndrome|Renal dysplasia and retinal aplasia|Nephronophthisis|not specified	Benign/Likely benign(Last reviewed: Apr 7, 2017)	criteria provided, multiple submitters, no conflicts	2	110959026	2	110201449	129813	135259
NM_006343.2(MERTK):c.2192T>C (p.Leu731Ser)	MERTK	Retinitis pigmentosa 38	Likely pathogenic(Last reviewed: Sep 10, 2013)	criteria provided, single submitter	2	112779001	2	112021424	216961	213523
NM_032824.2(TMEM87B):c.1366A>G (p.Asn456Asp)	TMEM87B	not provided	Likely pathogenic(Last reviewed: Oct 22, 2015)	criteria provided, single submitter	2	112856265	2	112098688	223092	224817
NM_012275.2(IL36RN):c.338C>T (p.Ser113Leu)	IL36RN	Pustular psoriasis, generalized|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 29, 2017)	criteria provided, conflicting interpretations	2	113820124	2	113062547	30490	39447
NM_139343.2(BIN1):c.1625A>G (p.Lys542Arg)	BIN1	Autosomal recessive centronuclear myopathy|not specified	Benign(Last reviewed: May 10, 2018)	criteria provided, multiple submitters, no conflicts	2	127808046	2	127050470	158011	167858
NM_139343.2(BIN1):c.1595C>T (p.Thr532Met)	BIN1	Autosomal recessive centronuclear myopathy|not specified	Benign/Likely benign(Last reviewed: Dec 19, 2017)	criteria provided, multiple submitters, no conflicts	2	127808076	2	127050500	158010	167857
NM_139343.2(BIN1):c.696C>A (p.Asn232Lys)	BIN1	Autosomal recessive centronuclear myopathy|not specified|not provided	Uncertain significance(Last reviewed: May 24, 2018)	criteria provided, multiple submitters, no conflicts	2	127821511	2	127063935	158016	167863
Multiple alleles	PTPN18|SMPD4|MZT2B|CCDC115|IMP4|TUBA3E	Congenital disorders of glycosylation type II	Pathogenic	no assertion criteria provided	2|2	131099607	2|	130342034	427823	216019|243976
NM_032357.3(CCDC115):c.92T>C (p.Leu31Ser)	CCDC115	Congenital disorders of glycosylation type II|CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIo	Pathogenic(Last reviewed: Feb 26, 2016)	no assertion criteria provided	2	131099607	2	130342034	218967	216019
NM_032357.3(CCDC115):c.31G>T (p.Asp11Tyr)	CCDC115	Congenital disorders of glycosylation type II|CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIo	Pathogenic(Last reviewed: Feb 26, 2016)	no assertion criteria provided	2	131099668	2	130342095	218963	216009
NM_012233.2(RAB3GAP1):c.1226C>T (p.Thr409Ile)	RAB3GAP1	not provided	Uncertain significance(Last reviewed: Nov 14, 2013)	criteria provided, single submitter	2	135888281	2	135130711	130062	135508
NM_012233.2(RAB3GAP1):c.1325A>G (p.Tyr442Cys)	RAB3GAP1	not specified|Warburg micro syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	135890553	2	135132983	130063	135509
NM_012233.2(RAB3GAP1):c.1793A>G (p.Asn598Ser)	RAB3GAP1	Warburg micro syndrome 1|not specified|Warburg micro syndrome|not provided	Benign(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	2	135893372	2	135135802	130064	135510
NM_012233.2(RAB3GAP1):c.2007C>A (p.His669Gln)	RAB3GAP1	Warburg micro syndrome|not provided	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	135908022	2	135150452	130066	135512
NM_001349.3(DARS):c.1277T>C (p.Leu426Ser)	DARS	Hypomyelination with brainstem and spinal cord involvement and leg spasticity	Likely pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, single submitter	2	136669017	2	135911447	488394	481226
NM_001349.3(DARS):c.389G>C (p.Cys130Ser)	DARS	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	2	136700982	2	135943412	402207	389115
NM_001349.3(DARS):c.242G>A (p.Arg81His)	DARS	Hypomyelination with brainstem and spinal cord involvement and leg spasticity	Uncertain significance(Last reviewed: Sep 13, 2017)	criteria provided, single submitter	2	136719044	2	135961474	488395	481227
NM_002552.4(ORC4):c.287A>G (p.Gln96Arg)	ORC4	Meier-Gorlin syndrome 2	Uncertain significance(Last reviewed: Dec 6, 2013)	criteria provided, single submitter	2	148716374	2	147958805	159484	168038
NM_002552.4(ORC4):c.233A>G (p.Asn78Ser)	ORC4	not specified	Benign(Last reviewed: Mar 28, 2016)	criteria provided, multiple submitters, no conflicts	2	148716428	2	147958859	159483	168039
NM_002552.4(ORC4):c.166C>G (p.Leu56Val)	ORC4	not specified	Benign(Last reviewed: Mar 28, 2016)	criteria provided, single submitter	2	148730367	2	147972798	159482	168040
NM_004543.4(NEB):c.19636A>G (p.Ile6546Val)	NEB|RIF1	not specified|not provided|Nemaline Myopathy, Recessive	Benign(Last reviewed: Feb 27, 2017)	criteria provided, multiple submitters, no conflicts	2	152346979	2	151490465	95126	101026
NM_004543.4(NEB):c.18865G>C (p.Ala6289Pro)	NEB|RIF1	not specified|not provided|Nemaline Myopathy, Recessive	Benign(Last reviewed: Feb 27, 2017)	criteria provided, multiple submitters, no conflicts	2	152352843	2	151496329	95120	101020
NM_004543.4(NEB):c.18392C>T (p.Thr6131Ile)	NEB|RIF1	Nemaline myopathy 2|not specified|not provided	Benign/Likely benign(Last reviewed: Dec 26, 2017)	criteria provided, multiple submitters, no conflicts	2	152363484	2	151506970	129733	135179
NM_004543.4(NEB):c.18278C>T (p.Ser6093Leu)	NEB|RIF1	Nemaline myopathy 2|not specified|Nemaline Myopathy, Recessive	Benign/Likely benign(Last reviewed: Aug 7, 2017)	criteria provided, multiple submitters, no conflicts	2	152364589	2	151508075	129732	135178
NM_004543.4(NEB):c.17329C>T (p.Arg5777Cys)	NEB|RIF1	Nemaline myopathy 2|not provided	Uncertain significance(Last reviewed: Mar 22, 2017)	criteria provided, multiple submitters, no conflicts	2	152380872	2	151524358	129731	135177
NM_004543.4(NEB):c.16753G>A (p.Asp5585Asn)	NEB|RIF1	Nemaline myopathy 2|not specified|Nemaline Myopathy, Recessive	Benign/Likely benign(Last reviewed: Jul 11, 2017)	criteria provided, multiple submitters, no conflicts	2	152383521	2	151527007	129728	135174
NM_004543.4(NEB):c.15089A>T (p.Asp5030Val)	NEB	Nemaline myopathy 2|not specified|Nemaline Myopathy, Recessive	Benign/Likely benign(Last reviewed: Aug 11, 2017)	criteria provided, multiple submitters, no conflicts	2	152404218	2	151547704	129721	135167
NM_004543.4(NEB):c.13202G>C (p.Arg4401Thr)	NEB	not specified|not provided|Nemaline Myopathy, Recessive	Benign(Last reviewed: Feb 27, 2017)	criteria provided, multiple submitters, no conflicts	2	152422076	2	151565562	95109	101009
NM_004543.4(NEB):c.13010A>G (p.Asn4337Ser)	NEB	Nemaline myopathy 2|not specified|not provided	Benign(Last reviewed: May 25, 2018)	criteria provided, multiple submitters, no conflicts	2	152423725	2	151567211	129712	135158
NM_004543.4(NEB):c.11921G>T (p.Arg3974Leu)	NEB	not provided	Uncertain significance(Last reviewed: Mar 31, 2014)	criteria provided, single submitter	2	152427105	2	151570591	129711	135157
NM_004543.4(NEB):c.11659T>A (p.Ser3887Thr)	NEB	Nemaline myopathy 2|not specified|Nemaline Myopathy, Recessive	Benign/Likely benign(Last reviewed: Aug 11, 2017)	criteria provided, multiple submitters, no conflicts	2	152432811	2	151576297	129710	135156
NM_004543.4(NEB):c.11518C>T (p.Arg3840Cys)	NEB	not provided	Uncertain significance(Last reviewed: Dec 23, 2013)	criteria provided, single submitter	2	152466406	2	151609892	129709	135155
NM_004543.4(NEB):c.11000A>G (p.Asp3667Gly)	NEB	Nemaline myopathy 2|not specified	Benign/Likely benign(Last reviewed: Mar 28, 2018)	criteria provided, multiple submitters, no conflicts	2	152468776	2	151612262	129707	135153
NM_004543.4(NEB):c.10419G>C (p.Met3473Ile)	NEB	Nemaline myopathy 2|not specified|Nemaline Myopathy, Recessive	Benign/Likely benign(Last reviewed: Jul 21, 2017)	criteria provided, multiple submitters, no conflicts	2	152473911	2	151617397	129706	135152
NM_004543.4(NEB):c.10080G>C (p.Trp3360Cys)	NEB	not specified|not provided|Nemaline Myopathy, Recessive	Benign(Last reviewed: Apr 24, 2017)	criteria provided, multiple submitters, no conflicts	2	152476028	2	151619514	95102	101002
NM_004543.4(NEB):c.10015G>A (p.Val3339Ile)	NEB	Nemaline myopathy 2|not specified|not provided|Nemaline Myopathy, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: May 16, 2018)	criteria provided, conflicting interpretations	2	152476093	2	151619579	129705	135151
NM_004543.4(NEB):c.8734T>C (p.Ser2912Pro)	NEB	not specified|not provided|Nemaline Myopathy, Recessive	Benign(Last reviewed: Feb 27, 2017)	criteria provided, multiple submitters, no conflicts	2	152496526	2	151640012	129761	135207
NM_004543.4(NEB):c.8318G>A (p.Arg2773Gln)	NEB	Nemaline myopathy 2|not specified|not provided|Nemaline Myopathy, Recessive	Benign/Likely benign(Last reviewed: Aug 2, 2017)	criteria provided, multiple submitters, no conflicts	2	152499143	2	151642629	129758	135204
NM_004543.4(NEB):c.8189A>G (p.Asp2730Gly)	NEB	Nemaline myopathy 2|not specified|not provided|Nemaline Myopathy, Recessive	Benign/Likely benign(Last reviewed: Mar 26, 2018)	criteria provided, multiple submitters, no conflicts	2	152499355	2	151642841	129757	135203
NM_004543.4(NEB):c.7839G>C (p.Lys2613Asn)	NEB	not specified|not provided|Nemaline Myopathy, Recessive	Benign(Last reviewed: Apr 24, 2017)	criteria provided, multiple submitters, no conflicts	2	152500449	2	151643935	95137	101037
NM_004543.4(NEB):c.7310G>A (p.Arg2437Gln)	NEB	Nemaline myopathy 2|not specified|Nemaline Myopathy, Recessive	Benign/Likely benign(Last reviewed: Aug 8, 2017)	criteria provided, multiple submitters, no conflicts	2	152506811	2	151650297	95134	101034
NM_004543.4(NEB):c.6717T>G (p.Ile2239Met)	NEB	Nemaline myopathy 2|not specified|Nemaline Myopathy, Recessive	Benign/Likely benign(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	2	152511874	2	151655360	129755	135201
NM_004543.4(NEB):c.5971C>T (p.His1991Tyr)	NEB	not specified|Nemaline Myopathy, Recessive	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	152515683	2	151659169	129752	135198
NM_004543.4(NEB):c.5567G>A (p.Arg1856Gln)	NEB	Nemaline myopathy 2|not specified|not provided	Benign(Last reviewed: Mar 30, 2018)	criteria provided, multiple submitters, no conflicts	2	152520258	2	151663744	129747	135193
NM_004543.4(NEB):c.5102T>C (p.Val1701Ala)	NEB	Nemaline myopathy 2|not specified|not provided|Nemaline Myopathy, Recessive	Benign/Likely benign(Last reviewed: Mar 26, 2018)	criteria provided, multiple submitters, no conflicts	2	152521983	2	151665469	129745	135191
NM_004543.4(NEB):c.4471G>A (p.Val1491Met)	NEB	not specified|not provided|Nemaline Myopathy, Recessive	Benign(Last reviewed: Feb 27, 2017)	criteria provided, multiple submitters, no conflicts	2	152527572	2	151671058	95131	101031
NM_004543.4(NEB):c.4435G>A (p.Val1479Ile)	NEB	not specified|not provided|Nemaline Myopathy, Recessive	Benign(Last reviewed: Apr 24, 2017)	criteria provided, multiple submitters, no conflicts	2	152527608	2	151671094	129744	135190
NM_004543.4(NEB):c.4407G>C (p.Glu1469Asp)	NEB	Nemaline myopathy 2|not specified|Nemaline Myopathy, Recessive	Benign/Likely benign(Last reviewed: Aug 8, 2017)	criteria provided, multiple submitters, no conflicts	2	152527636	2	151671122	129743	135189
NM_004543.4(NEB):c.3412A>G (p.Asn1138Asp)	NEB	Nemaline myopathy 2|not specified|not provided|Nemaline Myopathy, Recessive	Benign/Likely benign(Last reviewed: Mar 26, 2018)	criteria provided, multiple submitters, no conflicts	2	152534545	2	151678031	129740	135186
NM_004543.4(NEB):c.3081A>T (p.Lys1027Asn)	NEB	not specified|not provided|Nemaline Myopathy, Recessive	Benign(Last reviewed: Feb 27, 2017)	criteria provided, multiple submitters, no conflicts	2	152536498	2	151679984	95128	101028
NM_004543.4(NEB):c.571G>C (p.Glu191Gln)	NEB	Nemaline myopathy 2|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 8, 2017)	criteria provided, conflicting interpretations	2	152580815	2	151724301	129748	135194
NM_004543.4(NEB):c.244A>G (p.Met82Val)	NEB	Nemaline myopathy 2|not provided	Uncertain significance(Last reviewed: Feb 16, 2017)	criteria provided, multiple submitters, no conflicts	2	152584255	2	151727741	129736	135182
NM_024753.4(TTC21B):c.3797C>T (p.Pro1266Leu)	TTC21B	not specified|not provided	Uncertain significance(Last reviewed: Nov 2, 2017)	criteria provided, multiple submitters, no conflicts	2	166737197	2	165880687	130656	136102
NM_024753.4(TTC21B):c.3713G>A (p.Gly1238Glu)	TTC21B	Nephronophthisis 12	Uncertain significance(Last reviewed: Jun 26, 2017)	criteria provided, single submitter	2	166737281	2	165880771	495337	486832
NM_024753.4(TTC21B):c.1846C>T (p.Arg616Cys)	TTC21B	Jeune thoracic dystrophy|Joubert syndrome|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 25, 2017)	criteria provided, conflicting interpretations	2	166773820	2	165917310	130651	136097
NM_024753.4(TTC21B):c.1417C>T (p.Leu473Phe)	TTC21B	Jeune thoracic dystrophy|Joubert syndrome|Nephronophthisis|not specified	Benign/Likely benign(Last reviewed: Aug 10, 2017)	criteria provided, multiple submitters, no conflicts	2	166781158	2	165924648	96137	102031
NM_024753.4(TTC21B):c.1387C>T (p.Pro463Ser)	TTC21B	Jeune thoracic dystrophy|Joubert syndrome|Nephronophthisis|not specified|not provided	Benign/Likely benign(Last reviewed: Oct 12, 2017)	criteria provided, multiple submitters, no conflicts	2	166781188	2	165924678	130649	136095
NM_024753.4(TTC21B):c.838A>G (p.Met280Val)	TTC21B	Jeune thoracic dystrophy|Joubert syndrome|Nephronophthisis|not specified|not provided	Benign/Likely benign(Last reviewed: Dec 9, 2017)	criteria provided, multiple submitters, no conflicts	2	166788324	2	165931814	130661	136107
NM_024753.4(TTC21B):c.826A>G (p.Thr276Ala)	TTC21B	Jeune thoracic dystrophy|Joubert syndrome|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	166788336	2	165931826	130660	136106
NM_024753.4(TTC21B):c.724G>A (p.Asp242Asn)	TTC21B	Jeune thoracic dystrophy|Joubert syndrome|Nephronophthisis|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 15, 2018)	criteria provided, conflicting interpretations	2	166789554	2	165933044	130659	136105
NM_024753.4(TTC21B):c.665A>T (p.Gln222Leu)	TTC21B|TTC21B-AS1	Jeune thoracic dystrophy|Joubert syndrome|Nephronophthisis|not specified|not provided	Benign/Likely benign(Last reviewed: Dec 9, 2017)	criteria provided, multiple submitters, no conflicts	2	166797582	2	165941072	130658	136104
NM_024753.4(TTC21B):c.626C>T (p.Pro209Leu)	TTC21B|TTC21B-AS1	Jeune thoracic dystrophy|Nephronophthisis 12|Nephronophthisis|not provided	Pathogenic(Last reviewed: Dec 20, 2017)	criteria provided, multiple submitters, no conflicts	2	166797621	2	165941111	30935	39892
NM_024753.4(TTC21B):c.601G>A (p.Val201Met)	TTC21B|TTC21B-AS1	Jeune thoracic dystrophy|Joubert syndrome|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	166797646	2	165941136	130657	136103
NM_004525.3(LRP2):c.13250G>A (p.Gly4417Asp)	LRP2	Donnai Barrow syndrome|not specified	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	169996070	2	169139560	129505	134951
NM_004525.3(LRP2):c.12628A>C (p.Ile4210Leu)	LRP2	Donnai Barrow syndrome|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	170003432	2	169146922	129501	134947
NM_004525.2(LRP2):c.12590G>C (p.Gly4197Ala)	LRP2	Donnai Barrow syndrome	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	2	170007408	2	169150898	561055	552056
NM_004525.2(LRP2):c.12280A>G (p.Lys4094Glu)	LRP2	Donnai Barrow syndrome|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	170010985	2	169154475	129500	134946
NM_004525.3(LRP2):c.12125G>A (p.Arg4042His)	LRP2	not provided	Uncertain significance(Last reviewed: Mar 25, 2014)	criteria provided, single submitter	2	170012810	2	169156300	129498	134944
NM_004525.3(LRP2):c.11996T>G (p.Val3999Gly)	LRP2	Donnai Barrow syndrome|not specified	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	170013904	2	169157394	129497	134943
NM_004525.3(LRP2):c.11092G>A (p.Val3698Met)	LRP2	Donnai Barrow syndrome|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	2	170029657	2	169173147	129492	134938
NM_004525.2(LRP2):c.10804G>A (p.Ala3602Thr)	LRP2	not specified|not provided	Likely benign(Last reviewed: Feb 27, 2017)	criteria provided, single submitter	2	170030639	2	169174129	129491	134937
NM_004525.2(LRP2):c.8614G>A (p.Ala2872Thr)	LRP2	Donnai Barrow syndrome|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	170053505	2	169196995	129542	134988
NM_004525.2(LRP2):c.8132G>A (p.Arg2711His)	LRP2	Donnai Barrow syndrome|not provided	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	170059343	2	169202833	129541	134987
NM_004525.2(LRP2):c.7894A>G (p.Asn2632Asp)	LRP2	Donnai Barrow syndrome|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	170060603	2	169204093	129540	134986
NM_004525.3(LRP2):c.7742C>T (p.Thr2581Met)	LRP2	not provided	Uncertain significance(Last reviewed: Mar 24, 2014)	criteria provided, single submitter	2	170060755	2	169204245	129538	134984
NM_004525.2(LRP2):c.4766G>A (p.Arg1589His)	LRP2	Donnai Barrow syndrome|not provided	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	170092504	2	169235994	129525	134971
NM_004525.3(LRP2):c.3836A>C (p.Asp1279Ala)	LRP2	Donnai Barrow syndrome|not specified	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	170097707	2	169241197	129520	134966
NM_004525.2(LRP2):c.3452C>T (p.Pro1151Leu)	LRP2	Donnai Barrow syndrome|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	170100011	2	169243501	129518	134964
NM_004525.2(LRP2):c.3295C>T (p.His1099Tyr)	LRP2	not provided	Uncertain significance(Last reviewed: Mar 21, 2014)	criteria provided, single submitter	2	170101338	2	169244828	129517	134963
NM_004525.2(LRP2):c.2738T>C (p.Met913Thr)	LRP2	not provided	Uncertain significance(Last reviewed: Feb 18, 2014)	criteria provided, single submitter	2	170112648	2	169256138	129514	134960
NM_004525.3(LRP2):c.2618A>G (p.Asn873Ser)	LRP2	not provided	Uncertain significance(Last reviewed: Mar 13, 2014)	criteria provided, single submitter	2	170113655	2	169257145	129513	134959
NM_004525.3(LRP2):c.2603C>G (p.Thr868Ser)	LRP2	not provided	Uncertain significance(Last reviewed: Mar 13, 2014)	criteria provided, single submitter	2	170113670	2	169257160	129512	134958
NM_004525.2(LRP2):c.2006G>A (p.Gly669Asp)	LRP2	Donnai Barrow syndrome|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	170129547	2	169273037	129506	134952
NM_004525.3(LRP2):c.1167T>G (p.Asp389Glu)	LRP2	Donnai Barrow syndrome|not specified|not provided	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	170139387	2	169282877	129494	134940
NM_004525.3(LRP2):c.910G>A (p.Gly304Arg)	LRP2	not provided	Uncertain significance(Last reviewed: Mar 13, 2014)	criteria provided, single submitter	2	170147367	2	169290857	129544	134990
NM_004525.3(LRP2):c.775G>C (p.Gly259Arg)	LRP2	Donnai Barrow syndrome|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	170147502	2	169290992	129539	134985
NM_004525.3(LRP2):c.248A>G (p.Asn83Ser)	LRP2	Donnai Barrow syndrome|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	170175334	2	169318824	129511	134957
NM_004525.3(LRP2):c.92C>T (p.Ala31Val)	LRP2	Donnai Barrow syndrome|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	170177382	2	169320872	129546	134992
NM_025000.3(DCAF17):c.555T>A (p.His185Gln)	DCAF17	Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities|not specified	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	172309651	2	171453141	128890	134337
NM_003705.4(SLC25A12):c.1618G>A (p.Asp540Asn)	SLC25A12	Hypomyelination, global cerebral	Likely pathogenic(Last reviewed: Nov 28, 2017)	criteria provided, single submitter	2	172644425	2	171787915	488597	481465
NM_016653.2(MAP3K20):c.1103T>G (p.Phe368Cys)	MAP3K20|MAP3K20-AS1	Split-hand/foot malformation 1|Split-foot malformation with mesoaxial polydactyly	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	2	174097087	2	173232359	218144	214792
NM_133378.4(TTN):c.96872G>A (p.Arg32291Gln)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Jul 18, 2018)	criteria provided, conflicting interpretations	2	179396766	2	178532039	47675	56839
NM_001267550.2(TTN):c.75833G>A (p.Arg25278His)	TTN|TTN-AS1	not specified|not provided	Uncertain significance(Last reviewed: Aug 30, 2018)	criteria provided, multiple submitters, no conflicts	2	179435026	2	178570299	229518	228639
NM_201548.4(CERKL):c.[674A>T];[769C>T]	CERKL	Retinitis pigmentosa 26	Pathogenic(Last reviewed: Jan 22, 2013)	criteria provided, single submitter	2|2	182423344	2|2	181558617	424768	17403|213531
NM_014362.3(HIBCH):c.830T>A (p.Val277Glu)	HIBCH	Beta-hydroxyisobutyryl-CoA deacylase deficiency	Likely pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, single submitter	2	191109674	2	190244948	488530	481398
NM_014362.3(HIBCH):c.410C>T (p.Ala137Val)	HIBCH	Beta-hydroxyisobutyryl-CoA deacylase deficiency	Pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	2	191152340	2	190287614	242877	243978
NM_014362.3(HIBCH):c.212A>C (p.Gln71Pro)	HIBCH	Beta-hydroxyisobutyryl-CoA deacylase deficiency	Likely pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, single submitter	2	191161546	2	190296820	488531	481399
NM_001044385.2(TMEM237):c.1096G>T (p.Ala366Ser)	TMEM237	Joubert syndrome|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	202490812	2	201626089	130592	136038
NM_005006.6(NDUFS1):c.2129G>A (p.Cys710Tyr)	NDUFS1	Mitochondrial complex I deficiency	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	2	206988964	2	206124240	561063	552061
NM_005006.6(NDUFS1):c.1249A>G (p.Arg417Gly)	NDUFS1	Mitochondrial complex I deficiency	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	2	207006678	2	206141954	561062	552062
NM_005048.3(PTH2R):c.473C>T (p.Ser158Phe)	PTH2R	Syndromic intellectual disability	Likely pathogenic(Last reviewed: Mar 26, 2017)	no assertion criteria provided	2	209307150	2	208442425	428590	420148
NM_032504.1(UNC80):c.5098C>T (p.Pro1700Ser)	UNC80	Hypotonia, infantile, with psychomotor retardation and characteristic facies 2	Likely pathogenic(Last reviewed: Jan 7, 2016)	criteria provided, single submitter	2	210783340	2	209918616	222010	223700
NM_032504.1(UNC80):c.7607G>C (p.Arg2536Thr)	UNC80	Hypotonia, infantile, with psychomotor retardation and characteristic facies 2	Likely pathogenic(Last reviewed: Jan 7, 2016)	criteria provided, single submitter	2	210824431	2	209959707	222011	223701
NM_001875.4(CPS1):c.937A>G (p.Met313Val)	CPS1	Congenital hyperammonemia, type I|not provided	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	211455620	2	210590896	128853	134301
NM_001875.4(CPS1):c.1030A>G (p.Thr344Ala)	CPS1	Congenital hyperammonemia, type I|not specified|not provided	Benign(Last reviewed: May 31, 2017)	criteria provided, multiple submitters, no conflicts	2	211456637	2	210591913	128849	134297
NM_001875.4(CPS1):c.3980G>A (p.Cys1327Tyr)	CPS1	Congenital hyperammonemia, type I	Pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, single submitter	2	211527899	2	210663175	488489	481357
NM_001875.4(CPS1):c.4217C>A (p.Thr1406Asn)	CPS1	Congenital hyperammonemia, type I|not specified	Benign(Last reviewed: May 31, 2017)	criteria provided, multiple submitters, no conflicts	2	211540507	2	210675783	128852	134300
NM_014140.3(SMARCAL1):c.2290C>T (p.Arg764Trp)	SMARCAL1	Schimke immunoosseous dysplasia	Uncertain significance(Last reviewed: Jun 26, 2017)	criteria provided, single submitter	2	217340037	2	216475314	495338	486833
NM_014140.3(SMARCAL1):c.2570G>A (p.Gly857Glu)	SMARCAL1	Schimke immunoosseous dysplasia	Likely pathogenic	no assertion criteria provided	2	217342967	2	216478244	496639	488124
NM_004328.4(BCS1L):c.205C>T (p.Arg69Cys)	BCS1L	GRACILE syndrome|Mitochondrial complex III deficiency|not provided|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Mar 28, 2018)	criteria provided, conflicting interpretations	2	219525915	2	218661192	214160	210770
NM_001257342.1(BCS1L):c.232A>G (p.Ser78Gly)	BCS1L	GRACILE syndrome|not provided	Pathogenic(Last reviewed: Sep 20, 2017)	criteria provided, multiple submitters, no conflicts	2	219525942	2	218661219	6167	21206
NM_004328.4(BCS1L):c.547C>T (p.Arg183Cys)	BCS1L	GRACILE syndrome|Mitochondrial complex III deficiency|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 24, 2018)	criteria provided, conflicting interpretations	2	219526568	2	218661845	6174	21213
NM_000784.3(CYP27A1):c.203T>G (p.Phe68Cys)	CYP27A1	Cholestanol storage disease|not provided	Uncertain significance(Last reviewed: Dec 23, 2016)	criteria provided, multiple submitters, no conflicts	2	219647108	2	218782385	128883	134330
NM_000784.3(CYP27A1):c.1214G>A (p.Arg405Gln)	CYP27A1	Cholestanol storage disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, multiple submitters, no conflicts	2	219679132	2	218814409	4260	19299
NM_000784.3(CYP27A1):c.1420C>T (p.Arg474Trp)	CYP27A1	Cholestanol storage disease	Likely pathogenic(Last reviewed: Jun 22, 2017)	criteria provided, single submitter	2	219679424	2	218814701	4259	19298
NM_005687.4(FARSB):c.1381A>C (p.Thr461Pro)	FARSB	Dilatation|Cerebral calcification|Interstitial pneumonitis|Liver cirrhosis	Pathogenic(Last reviewed: May 28, 2018)	criteria provided, single submitter	2	223478611	2	222613892	545642	536138
NM_005687.4(FARSB):c.1202G>A (p.Arg401Gln)	FARSB	Rajab syndrome|Dilatation|Cerebral calcification|Interstitial pneumonitis|Liver cirrhosis	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	2	223488418	2	222623699	545664	536160
NM_005687.4(FARSB):c.853G>A (p.Glu285Lys)	FARSB	Rajab syndrome|Neurodevelopmental disorder with brain, liver, and lung abnormalities	Likely pathogenic(Last reviewed: Jul 15, 2018)	criteria provided, single submitter	2	223493603	2	222628884	559418	550148
NM_005687.4(FARSB):c.784A>G (p.Lys262Glu)	FARSB	Dilatation|Cerebral calcification|Interstitial pneumonitis|Liver cirrhosis	Pathogenic(Last reviewed: May 28, 2018)	criteria provided, single submitter	2	223496325	2	222631606	545655	536151
NM_005687.4(FARSB):c.767C>T (p.Thr256Met)	FARSB	Rajab syndrome|Interstitial lung and liver disease	Pathogenic/Likely pathogenic(Last reviewed: Feb 8, 2019)	no assertion criteria provided	2	223496342	2	222631623	487455	480513
NM_005687.4(FARSB):c.755T>C (p.Phe252Ser)	FARSB	Rajab syndrome|Dilatation|Cerebral calcification|Interstitial pneumonitis|Liver cirrhosis	Pathogenic(Last reviewed: Feb 8, 2019)	no assertion criteria provided	2	223496354	2	222631635	545694	536186
NM_005687.4(FARSB):c.226T>C (p.Cys76Arg)	FARSB	Dilatation|Cerebral calcification|Interstitial pneumonitis|Liver cirrhosis	Pathogenic	criteria provided, single submitter	2	223507613	2	222642894	545695	536187
NM_022915.3(MRPL44):c.467T>G (p.Leu156Arg)	MRPL44	not provided|Combined oxidative phosphorylation deficiency 16	Pathogenic/Likely pathogenic(Last reviewed: May 5, 2014)	criteria provided, multiple submitters, no conflicts	2	224824538	2	223959821	64624	75588
NM_000091.4(COL4A3):c.1175G>A (p.Gly392Glu)	COL4A3|LOC654841	Alport syndrome, autosomal recessive	Pathogenic	no assertion criteria provided	2	228128520	2	227263804	427770	417659
NM_000091.4(COL4A3):c.3955G>A (p.Gly1319Arg)	COL4A3|LOC654841	Alport syndrome, autosomal recessive	Pathogenic	no assertion criteria provided	2	228167826	2	227303110	373896	360796
NM_025243.3(SLC19A3):c.1049T>C (p.Val350Ala)	SLC19A3	Biotin-thiamine-responsive basal ganglia disease|not specified|not provided|Thiamine Metabolism Dysfunction Syndrome	Benign(Last reviewed: Aug 11, 2017)	criteria provided, multiple submitters, no conflicts	2	228560728	2	227696012	130320	135767
NM_025243.3(SLC19A3):c.541T>C (p.Ser181Pro)	SLC19A3	Biotin-thiamine-responsive basal ganglia disease	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	2	228563890	2	227699174	488596	481464
NM_025243.3(SLC19A3):c.520G>A (p.Val174Ile)	SLC19A3	Biotin-thiamine-responsive basal ganglia disease|not specified|not provided|Thiamine Metabolism Dysfunction Syndrome	Benign/Likely benign(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	2	228563911	2	227699195	130324	135771
NM_025243.3(SLC19A3):c.337T>C (p.Tyr113His)	SLC19A3	Biotin-thiamine-responsive basal ganglia disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	2	228564094	2	227699378	369673	353888
NM_004826.3(ECEL1):c.2023G>A (p.Ala675Thr)	ECEL1	Distal arthrogryposis type 5D	Pathogenic	criteria provided, single submitter	2	233345833	2	232481123	161451	171286
NM_004826.3(ECEL1):c.1858G>A (p.Asp620Asn)	ECEL1	not specified	Likely benign	no assertion criteria provided	2	233346498	2	232481788	128952	134399
NM_004826.3(ECEL1):c.1267G>C (p.Glu423Gln)	ECEL1	not specified	Benign(Last reviewed: Apr 22, 2016)	criteria provided, single submitter	2	233348851	2	232484141	128950	134397
NM_004826.3(ECEL1):c.982C>T (p.His328Tyr)	ECEL1	not specified	Benign(Last reviewed: Aug 15, 2013)	criteria provided, multiple submitters, no conflicts	2	233349588	2	232484878	128957	134404
NM_004826.3(ECEL1):c.426C>A (p.Asp142Glu)	ECEL1	not specified	Benign(Last reviewed: Apr 7, 2016)	criteria provided, single submitter	2	233350938	2	232486228	128954	134401
NM_000751.2(CHRND):c.[1319A>G];[73G>T]	CHRND	Congenital myasthenic syndrome 1B, fast-channel	Pathogenic(Last reviewed: Jun 11, 2014)	no assertion criteria provided	2|2	233399000	2|2	232534290	424708	166333|166332
NM_002242.4(KCNJ13):c.458C>T (p.Thr153Ile)	KCNJ13|GIGYF2	Leber congenital amaurosis 16|Leber congenital amaurosis	Likely pathogenic(Last reviewed: Nov 20, 2012)	criteria provided, single submitter	2	233635615	2	232770905	216947	213535
NM_000541.4(SAG):c.398C>T (p.Ser133Leu)	SAG	Oguchi's disease	Likely pathogenic(Last reviewed: May 9, 2018)	criteria provided, single submitter	2	234231614	2	233322968	559444	550168
NM_000463.2(UGT1A1):c.322C>T (p.Arg108Cys)	UGT1A|UGT1A10|UGT1A8|UGT1A7|UGT1A6|UGT1A5|UGT1A9|UGT1A4|UGT1A1|UGT1A3	Hyperbilirubinemia	Uncertain significance(Last reviewed: Mar 24, 2014)	criteria provided, single submitter	2	234669255	2	233760609	160236	168043
NM_000463.2(UGT1A1):c.476T>C (p.Ile159Thr)	UGT1A|UGT1A10|UGT1A8|UGT1A7|UGT1A6|UGT1A5|UGT1A9|UGT1A4|UGT1A1|UGT1A3	Hyperbilirubinemia	Uncertain significance(Last reviewed: Mar 12, 2013)	criteria provided, single submitter	2	234669409	2	233760763	160237	168044
NM_000463.2(UGT1A1):c.479T>A (p.Val160Glu)	UGT1A|UGT1A10|UGT1A8|UGT1A7|UGT1A6|UGT1A5|UGT1A9|UGT1A4|UGT1A1|UGT1A3	Hyperbilirubinemia	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	2	234669412	2	233760766	160238	168045
NM_000463.2(UGT1A1):c.674T>G (p.Val225Gly)	UGT1A|UGT1A10|UGT1A8|UGT1A7|UGT1A6|UGT1A5|UGT1A9|UGT1A4|UGT1A1|UGT1A3	Lucey-Driscoll syndrome|Gilbert's syndrome|Crigler-Najjar syndrome|not provided|Hyperbilirubinemia	Conflicting interpretations of pathogenicity, other(Last reviewed: Feb 9, 2018)	criteria provided, conflicting interpretations	2	234669607	2	233760961	160239	168046
NM_000463.2(UGT1A1):c.686C>A (p.Pro229Gln)	UGT1A|UGT1A10|UGT1A8|UGT1A7|UGT1A6|UGT1A5|UGT1A9|UGT1A4|UGT1A1|UGT1A3	Crigler-Najjar syndrome, type II|Gilbert's syndrome|not specified|not provided	Conflicting interpretations of pathogenicity, Affects, other(Last reviewed: Sep 17, 2018)	criteria provided, conflicting interpretations	2	234669619	2	233760973	12274	27313
NM_000463.2(UGT1A1):c.748T>C (p.Ser250Pro)	UGT1A|UGT1A10|UGT1A8|UGT1A7|UGT1A6|UGT1A5|UGT1A9|UGT1A4|UGT1A1|UGT1A3	not provided|Hyperbilirubinemia	Uncertain significance(Last reviewed: Jul 27, 2018)	criteria provided, multiple submitters, no conflicts	2	234669681	2	233761035	160240	168047
NM_000463.2(UGT1A1):c.1231G>T (p.Val411Leu)	UGT1A|UGT1A10|UGT1A8|UGT1A7|UGT1A6|UGT1A5|UGT1A9|UGT1A4|UGT1A1|UGT1A3	not provided|Hyperbilirubinemia	Uncertain significance(Last reviewed: Aug 30, 2018)	criteria provided, multiple submitters, no conflicts	2	234677012	2	233768366	160230	168050
NM_000463.2(UGT1A1):c.1354G>T (p.Val452Leu)	UGT1A|UGT1A10|UGT1A8|UGT1A7|UGT1A6|UGT1A5|UGT1A9|UGT1A4|UGT1A1|UGT1A3	Hyperbilirubinemia	Uncertain significance(Last reviewed: May 20, 2014)	criteria provided, single submitter	2	234680957	2	233772311	160231	168051
NM_000463.2(UGT1A1):c.1456T>G (p.Tyr486Asp)	UGT1A|UGT1A10|UGT1A8|UGT1A7|UGT1A6|UGT1A5|UGT1A9|UGT1A4|UGT1A1|UGT1A3	Lucey-Driscoll syndrome|Crigler-Najjar syndrome, type II|Hyperbilirubinemia	Pathogenic(Last reviewed: Apr 10, 2014)	criteria provided, single submitter	2	234681059	2	233772413	12281	27320
NM_015650.3(TRAF3IP1):c.1352T>A (p.Leu451His)	TRAF3IP1	Chondroectodermal dysplasia	Uncertain significance(Last reviewed: May 1, 2018)	criteria provided, single submitter	2	239257474	2	238348833	558763	549468
NM_000030.2(AGXT):c.106C>T (p.Arg36Cys)	AGXT	Primary hyperoxaluria, type I	Likely pathogenic(Last reviewed: Sep 5, 2014)	criteria provided, single submitter	2	241808388	2	240868971	188957	186651
NM_000030.2(AGXT):c.122G>T (p.Gly41Val)	AGXT	Primary hyperoxaluria, type I	Likely pathogenic(Last reviewed: Sep 26, 2014)	criteria provided, single submitter	2	241808404	2	240868987	188985	186652
NM_000030.2(AGXT):c.302T>C (p.Leu101Pro)	AGXT	Primary hyperoxaluria, type I	Likely pathogenic(Last reviewed: Jul 7, 2014)	criteria provided, single submitter	2	241808723	2	240869306	188866	186653
NM_000030.2(AGXT):c.322T>C (p.Trp108Arg)	AGXT	Primary hyperoxaluria, type I	Likely pathogenic(Last reviewed: Jul 19, 2014)	criteria provided, single submitter	2	241808743	2	240869326	188891	186654
NM_000030.2(AGXT):c.346G>A (p.Gly116Arg)	AGXT	Primary hyperoxaluria, type I	Likely pathogenic(Last reviewed: Oct 16, 2014)	criteria provided, single submitter	2	241808767	2	240869350	189021	186655
NM_000030.2(AGXT):c.454T>A (p.Phe152Ile)	AGXT	Primary hyperoxaluria, type I|not provided	Pathogenic(Last reviewed: Jun 14, 2018)	criteria provided, multiple submitters, no conflicts	2	241810796	2	240871379	5645	20684
NM_000030.2(AGXT):c.473C>T (p.Ser158Leu)	AGXT	Primary hyperoxaluria, type I	Likely pathogenic(Last reviewed: Jul 7, 2017)	criteria provided, multiple submitters, no conflicts	2	241810815	2	240871398	204103	200500
NM_000030.2(AGXT):c.481G>T (p.Gly161Cys)	AGXT	Primary hyperoxaluria, type I	Likely pathogenic(Last reviewed: Mar 31, 2014)	criteria provided, single submitter	2	241810823	2	240871406	188738	186656
NM_000030.2(AGXT):c.568G>A (p.Gly190Arg)	AGXT	Primary hyperoxaluria, type I	Likely pathogenic(Last reviewed: Nov 6, 2014)	criteria provided, single submitter	2	241812439	2	240873022	189047	186657
NM_000030.2(AGXT):c.653C>T (p.Ser218Leu)	AGXT	Primary hyperoxaluria, type I	Likely pathogenic(Last reviewed: Sep 24, 2014)	criteria provided, single submitter	2	241813452	2	240874035	188979	186658
NM_000030.2(AGXT):c.1049G>A (p.Gly350Asp)	AGXT	Primary hyperoxaluria, type I	Likely pathogenic(Last reviewed: Sep 25, 2014)	criteria provided, single submitter	2	241817545	2	240878128	188986	186663
NM_152783.4(D2HGDH):c.43C>G (p.Arg15Gly)	D2HGDH	not specified|not provided|D-2-hydroxyglutaric aciduria|D-2-hydroxyglutaric aciduria	Benign/Likely benign(Last reviewed: Nov 8, 2017)	criteria provided, multiple submitters, no conflicts	2	242674682	2	241735267	158420	168054
NM_152783.4(D2HGDH):c.164G>A (p.Arg55Gln)	D2HGDH	not specified|not provided|D-2-hydroxyglutaric aciduria|D-2-hydroxyglutaric aciduria	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	242674803	2	241735388	158414	168055
NM_152783.4(D2HGDH):c.566C>T (p.Pro189Leu)	D2HGDH	D-2-hydroxyglutaric aciduria 1	Pathogenic(Last reviewed: May 19, 2014)	criteria provided, single submitter	2	242683112	2	241743697	158422	168062
NM_152783.4(D2HGDH):c.1012G>A (p.Val338Ile)	D2HGDH	not specified|not provided|D-2-hydroxyglutaric aciduria|D-2-hydroxyglutaric aciduria	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	242690675	2	241751260	158404	168064
NM_152783.4(D2HGDH):c.1066C>T (p.His356Tyr)	D2HGDH	not specified|not provided|D-2-hydroxyglutaric aciduria|D-2-hydroxyglutaric aciduria	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	242690729	2	241751314	158405	168065
NM_152783.4(D2HGDH):c.1082C>T (p.Ala361Val)	D2HGDH	not specified|not provided|D-2-hydroxyglutaric aciduria|D-2-hydroxyglutaric aciduria	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	242690745	2	241751330	158406	168066
NM_152783.4(D2HGDH):c.1184G>A (p.Arg395Gln)	D2HGDH	D-2-hydroxyglutaric aciduria 1	Uncertain significance(Last reviewed: Apr 29, 2014)	criteria provided, single submitter	2	242695307	2	241755892	158408	168068
NM_152783.4(D2HGDH):c.1258G>A (p.Ala420Thr)	D2HGDH	D-2-hydroxyglutaric aciduria 1|not specified|not provided|D-2-hydroxyglutaric aciduria|D-2-hydroxyglutaric aciduria	Conflicting interpretations of pathogenicity(Last reviewed: Apr 30, 2017)	criteria provided, conflicting interpretations	2	242695381	2	241755966	158409	168069
NM_016302.3(CRBN):c.1171T>C (p.Cys391Arg)	TRNT1|CRBN	Mental retardation, autosomal recessive 2|not provided	Likely pathogenic(Last reviewed: Sep 20, 2016)	criteria provided, multiple submitters, no conflicts	3	3192707	3	3151023	209144	205733
NM_001164675.1(SUMF1):c.836C>T (p.Ala279Val)	SUMF1	Multiple sulfatase deficiency|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	3	4458816	3	4417132	2669	17708
NM_001099952.2(ITPR1):c.5360T>C (p.Leu1787Pro)	ITPR1	Spinocerebellar ataxia 29	Pathogenic(Last reviewed: Aug 1, 2016)	no assertion criteria provided	3	4776998	3	4735314	253023	247430
NM_000844.3(GRM7):c.461T>C (p.Ile154Thr)	GRM7	Global developmental delay|Seizures|Hypoplasia of the corpus callosum|Global developmental delay|Brain atrophy|Muscular hypotonia|Muscular hypotonia	Likely pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	3	6903536	3	6861849	242895	243981
NM_000844.3(GRM7):c.1972C>T (p.Arg658Trp)	GRM7	Global developmental delay|Seizures|Intellectual disability|Global developmental delay|CNS hypomyelination|Brain atrophy|Muscular hypotonia|Muscular hypotonia	Likely pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	3	7620565	3	7578878	242900	243982
NM_000844.3(GRM7):c.2024C>A (p.Thr675Lys)	GRM7	Global developmental delay|Seizures|Intellectual disability|Global developmental delay|CNS hypomyelination|Brain atrophy|Muscular hypotonia|Muscular hypotonia	Likely pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	3	7620617	3	7578930	242901	243983
NM_173659.4(RPUSD3):c.748C>T (p.His250Tyr)	RPUSD3	Inborn genetic diseases	Likely pathogenic	criteria provided, single submitter	3	9880832	3	9839148	225005	226898
NM_173659.4(RPUSD3):c.670C>T (p.Arg224Cys)	RPUSD3	Inborn genetic diseases	Likely pathogenic	criteria provided, single submitter	3	9881922	3	9840238	225035	226899
NM_022094.3(CIDEC):c.181T>C (p.Tyr61His)	CIDEC	not specified	Benign(Last reviewed: Nov 4, 2013)	criteria provided, single submitter	3	9918776	3	9877092	128771	134220
NM_022094.3(CIDEC):c.146C>T (p.Thr49Met)	CIDEC	not specified	Benign(Last reviewed: Nov 6, 2013)	criteria provided, single submitter	3	9918811	3	9877127	128770	134219
NM_032492.4(JAGN1):c.3G>A (p.Met1Ile)	JAGN1	Severe congenital neutropenia 6, autosomal recessive|Severe congenital neutropenia	Pathogenic(Last reviewed: Jan 1, 2013)	criteria provided, single submitter	3	9932409	3	9890725	156113	165912
NM_032492.4(JAGN1):c.40G>A (p.Gly14Ser)	JAGN1	Severe congenital neutropenia	Pathogenic(Last reviewed: Jan 1, 2013)	criteria provided, single submitter	3	9932446	3	9890762	190480	188298
NM_032492.4(JAGN1):c.59G>A (p.Arg20Gln)	JAGN1	Severe congenital neutropenia	Pathogenic(Last reviewed: Jan 1, 2013)	criteria provided, single submitter	3	9932465	3	9890781	190479	188299
NM_032492.4(JAGN1):c.63G>T (p.Glu21Asp)	JAGN1	Severe congenital neutropenia 6, autosomal recessive|Severe congenital neutropenia	Pathogenic(Last reviewed: Jan 1, 2013)	criteria provided, single submitter	3	9932469	3	9890785	156115	165914
NM_032492.4(JAGN1):c.130C>T (p.His44Tyr)	JAGN1	Severe congenital neutropenia 6, autosomal recessive|Severe congenital neutropenia	Pathogenic(Last reviewed: Jan 1, 2013)	criteria provided, single submitter	3	9934639	3	9892955	156114	165913
NM_032492.4(JAGN1):c.485A>G (p.Gln162Arg)	JAGN1	Severe congenital neutropenia 6, autosomal recessive|Severe congenital neutropenia	Pathogenic(Last reviewed: Jan 1, 2013)	criteria provided, single submitter	3	9934994	3	9893310	156116	165915
NM_025265.3(TSEN2):c.122G>T (p.Arg41Leu)	TSEN2	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	3	12531421	3	12489922	160104	168084
NM_025265.3(TSEN2):c.122G>C (p.Arg41Pro)	TSEN2	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	3	12531421	3	12489922	160103	168083
NM_025265.3(TSEN2):c.122G>A (p.Arg41His)	TSEN2	Pontoneocerebellar hypoplasia|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	12531421	3	12489922	137752	141455
NM_025265.3(TSEN2):c.322G>T (p.Val108Phe)	TSEN2	Pontocerebellar hypoplasia type 2B|Pontoneocerebellar hypoplasia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	12544774	3	12503275	160111	168087
NM_025265.3(TSEN2):c.377G>A (p.Arg126His)	TSEN2	Pontoneocerebellar hypoplasia|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	12544829	3	12503330	96175	102069
NM_025265.3(TSEN2):c.608C>T (p.Thr203Ile)	TSEN2	Pontocerebellar hypoplasia type 2B	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	3	12545060	3	12503561	160114	168090
NM_025265.3(TSEN2):c.653C>T (p.Pro218Leu)	TSEN2	Pontocerebellar hypoplasia type 2B	Uncertain significance(Last reviewed: Jun 27, 2014)	criteria provided, single submitter	3	12545105	3	12503606	160115	168091
NM_025265.3(TSEN2):c.1013C>G (p.Thr338Arg)	TSEN2	Pontocerebellar hypoplasia type 2B	Uncertain significance(Last reviewed: Feb 25, 2014)	criteria provided, single submitter	3	12560610	3	12519111	160101	168093
NM_004625.3(WNT7A):c.304C>T (p.Arg102Trp)	WNT7A	Ulna and fibula absence of with severe limb deficiency	Pathogenic(Last reviewed: Aug 8, 2016)	no assertion criteria provided	3	13896295	3	13854798	253008	247414
NM_004628.4(XPC):c.2815C>A (p.Gln939Lys)	XPC|TMEM43	Arrhythmogenic right ventricular cardiomyopathy|Xeroderma pigmentosum|not specified|cisplatin response - Toxicity/ADR	drug response(Last reviewed: May 3, 2017)	reviewed by expert panel	3	14187449	3	14145949	190215	187973
NM_004628.4(XPC):c.46C>G (p.Leu16Val)	XPC	Xeroderma pigmentosum|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	14220023	3	14178523	135465	139204
NM_005677.3(COLQ):c.934A>G (p.Ser312Gly)	COLQ	Endplate acetylcholinesterase deficiency|not specified|Congenital Myasthenic Syndrome, Recessive	Benign/Likely benign(Last reviewed: Jul 14, 2017)	criteria provided, multiple submitters, no conflicts	3	15499713	3	15458206	128827	134276
NM_000060.4(BTD):c.100G>A (p.Gly34Ser)	BTD	Biotinidase deficiency	Uncertain significance(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	3	15676986	3	15635479	1899	16938
NM_000060.4(BTD):c.128A>G (p.His43Arg)	BTD	Biotinidase deficiency	Uncertain significance(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	3	15677014	3	15635507	38483	46853
NM_000060.4(BTD):c.133G>A (p.Gly45Arg)	BTD	Biotinidase deficiency|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	3	15677019	3	15635512	24973	36313
NM_000060.4(BTD):c.184G>A (p.Val62Met)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15677070	3	15635563	38487	46846
NM_000060.4(BTD):c.184G>T (p.Val62Leu)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15677070	3	15635563	24979	36319
NM_000060.4(BTD):c.190G>A (p.Glu64Lys)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15677076	3	15635569	24980	36320
NM_000060.4(BTD):c.192G>C (p.Glu64Asp)	BTD	Biotinidase deficiency|not specified	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, multiple submitters, no conflicts	3	15677078	3	15635571	38574	47163
NM_000060.4(BTD):c.194A>G (p.His65Arg)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15677080	3	15635573	24982	36322
NM_000060.4(BTD):c.212T>C (p.Leu71Pro)	BTD	Biotinidase deficiency|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Apr 20, 2018)	criteria provided, conflicting interpretations	3	15677098	3	15635591	38482	47043
NM_000060.4(BTD):c.235C>T (p.Arg79Cys)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Sep 28, 2016)	criteria provided, single submitter	3	15677121	3	15635614	1905	16944
NM_000060.4(BTD):c.236G>A (p.Arg79His)	BTD	Biotinidase deficiency	Uncertain significance(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	3	15677122	3	15635615	38567	46851
NM_000060.4(BTD):c.245C>A (p.Ala82Asp)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15677131	3	15635624	38484	46852
NM_000060.4(BTD):c.245C>T (p.Ala82Val)	BTD	Biotinidase deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2018)	criteria provided, conflicting interpretations	3	15677131	3	15635624	24989	36327
NM_000060.4(BTD):c.248T>C (p.Leu83Ser)	BTD	Biotinidase deficiency	Uncertain significance(Last reviewed: Sep 18, 2017)	criteria provided, single submitter	3	15677134	3	15635627	24991	36329
NM_000060.4(BTD):c.257T>G (p.Met86Arg)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15677143	3	15635636	156000	165804
NM_000060.4(BTD):c.278A>G (p.Tyr93Cys)	BTD	Biotinidase deficiency	Likely pathogenic(Last reviewed: Mar 28, 2018)	criteria provided, single submitter	3	15677164	3	15635657	24993	36331
NM_000060.4(BTD):c.298G>A (p.Ala100Thr)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15677184	3	15635677	24995	36333
NM_000060.4(BTD):c.299C>T (p.Ala100Val)	BTD	Biotinidase deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Apr 3, 2018)	criteria provided, conflicting interpretations	3	15677185	3	15635678	557611	542857
NM_000060.4(BTD):c.310G>T (p.Asp104Tyr)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15683415	3	15641908	24996	36334
NM_000060.4(BTD):c.321T>G (p.Ile107Met)	BTD	Biotinidase deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Feb 13, 2018)	criteria provided, conflicting interpretations	3	15683426	3	15641919	556687	543034
NM_000060.4(BTD):c.326T>G (p.Val109Gly)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15683431	3	15641924	38289	46844
NM_000060.4(BTD):c.334G>A (p.Glu112Lys)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15683439	3	15641932	24998	36336
NM_000060.4(BTD):c.334G>C (p.Glu112Gln)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15683439	3	15641932	24997	36335
NM_000060.4(BTD):c.341G>T (p.Gly114Val)	BTD	Biotinidase deficiency	Likely pathogenic(Last reviewed: Dec 28, 2017)	criteria provided, single submitter	3	15683446	3	15641939	24999	36337
NM_000060.4(BTD):c.356A>G (p.Asn119Ser)	BTD	Biotinidase deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Jun 4, 2018)	criteria provided, conflicting interpretations	3	15683461	3	15641954	25000	36338
NM_000060.4(BTD):c.364A>G (p.Arg122Gly)	BTD	Biotinidase deficiency|not provided	Uncertain significance(Last reviewed: Apr 27, 2018)	criteria provided, multiple submitters, no conflicts	3	15683469	3	15641962	25001	36339
NM_000060.4(BTD):c.382T>G (p.Phe128Val)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15683487	3	15641980	25002	36340
NM_000060.4(BTD):c.424C>A (p.Pro142Thr)	BTD	Biotinidase deficiency|not provided	Likely pathogenic(Last reviewed: Dec 28, 2017)	criteria provided, multiple submitters, no conflicts	3	15683529	3	15642022	25004	36342
NM_000060.4(BTD):c.428G>T (p.Cys143Phe)	BTD	Biotinidase deficiency	Likely pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	3	15683533	3	15642026	587712	578671
NM_000060.4(BTD):c.443G>A (p.Arg148His)	BTD	Biotinidase deficiency|not provided	Likely pathogenic(Last reviewed: Apr 25, 2017)	criteria provided, single submitter	3	15683548	3	15642041	25005	36343
NM_000060.4(BTD):c.445T>C (p.Phe149Leu)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15683550	3	15642043	25007	36345
NM_000060.4(BTD):c.454A>C (p.Thr152Pro)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15683559	3	15642052	25008	36346
NM_000060.4(BTD):c.455C>G (p.Thr152Arg)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15683560	3	15642053	156001	165805
NM_000060.4(BTD):c.469C>T (p.Arg157Cys)	BTD	Biotinidase deficiency|not provided	Likely pathogenic(Last reviewed: Sep 30, 2016)	criteria provided, single submitter	3	15685832	3	15644325	25012	36350
NM_000060.4(BTD):c.470G>A (p.Arg157His)	BTD	Biotinidase deficiency|not provided	Pathogenic(Last reviewed: Dec 19, 2017)	criteria provided, multiple submitters, no conflicts	3	15685833	3	15644326	38290	46845
NM_000060.4(BTD):c.485C>T (p.Ala162Val)	BTD	Biotinidase deficiency	Uncertain significance(Last reviewed: Mar 26, 2018)	criteria provided, single submitter	3	15685848	3	15644341	25014	36351
NM_000060.4(BTD):c.511G>A (p.Ala171Thr)	BTD	Biotinidase deficiency|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 5, 2018)	criteria provided, conflicting interpretations	3	15685874	3	15644367	38298	36353
NM_000060.4(BTD):c.515A>G (p.Asn172Ser)	BTD	Biotinidase deficiency	Uncertain significance(Last reviewed: Nov 9, 2017)	criteria provided, single submitter	3	15685878	3	15644371	25017	36354
NM_000060.4(BTD):c.518T>G (p.Leu173Arg)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	3	15685881	3	15644374	38575	47164
NM_000060.4(BTD):c.528G>T (p.Lys176Asn)	BTD	Biotinidase deficiency|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: May 22, 2018)	criteria provided, multiple submitters, no conflicts	3	15685891	3	15644384	25018	36355
NM_000060.4(BTD):c.557G>A (p.Cys186Tyr)	BTD	Biotinidase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Aug 29, 2017)	criteria provided, multiple submitters, no conflicts	3	15685920	3	15644413	25020	36357
NM_000060.4(BTD):c.559C>T (p.Pro187Ser)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15685922	3	15644415	38274	46832
NM_000060.4(BTD):c.566A>G (p.Asp189Gly)	BTD	Biotinidase deficiency	Uncertain significance(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	3	15685929	3	15644422	587715	578674
NM_000060.4(BTD):c.582C>G (p.Phe194Leu)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	3	15685945	3	15644438	587716	578675
NM_000060.4(BTD):c.583A>G (p.Asn195Asp)	BTD	Biotinidase deficiency|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 3, 2018)	criteria provided, conflicting interpretations	3	15685946	3	15644439	25021	36358
NM_000060.4(BTD):c.584A>G (p.Asn195Ser)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15685947	3	15644440	25022	36359
NM_000060.4(BTD):c.587C>G (p.Thr196Arg)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15685950	3	15644443	25023	36360
NM_000060.4(BTD):c.595G>A (p.Val199Met)	BTD	Biotinidase deficiency	Likely pathogenic(Last reviewed: Sep 16, 2016)	criteria provided, single submitter	3	15685958	3	15644451	25026	36363
NM_000060.4(BTD):c.605A>T (p.Asn202Ile)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15685968	3	15644461	25027	36364
NM_000060.4(BTD):c.625C>T (p.Arg209Cys)	BTD	Biotinidase deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Feb 15, 2018)	criteria provided, conflicting interpretations	3	15685988	3	15644481	458809	452116
NM_000060.4(BTD):c.626G>A (p.Arg209His)	BTD	Biotinidase deficiency|not specified|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 21, 2018)	criteria provided, multiple submitters, no conflicts	3	15685989	3	15644482	92400	98311
NM_000060.4(BTD):c.629A>G (p.Tyr210Cys)	BTD	Biotinidase deficiency|not provided	Likely pathogenic(Last reviewed: Mar 17, 2017)	criteria provided, multiple submitters, no conflicts	3	15685992	3	15644485	38275	46830
NM_000060.4(BTD):c.631C>T (p.Arg211Cys)	BTD	Biotinidase deficiency|not provided	Pathogenic(Last reviewed: Apr 21, 2017)	criteria provided, single submitter	3	15685994	3	15644487	25028	36365
NM_000060.4(BTD):c.632G>A (p.Arg211His)	BTD	Biotinidase deficiency|not provided	Uncertain significance(Last reviewed: Aug 21, 2017)	criteria provided, multiple submitters, no conflicts	3	15685995	3	15644488	25029	36366
NM_000060.4(BTD):c.641A>G (p.Asn214Ser)	BTD	Biotinidase deficiency|not specified	Uncertain significance(Last reviewed: May 24, 2018)	criteria provided, multiple submitters, no conflicts	3	15686004	3	15644497	38579	36367
NM_000060.4(BTD):c.643C>T (p.Leu215Phe)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Jun 21, 2016)	criteria provided, single submitter	3	15686006	3	15644499	25031	36368
NM_000060.4(BTD):c.646T>A (p.Tyr216Asn)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	3	15686009	3	15644502	587720	578679
NM_000060.4(BTD):c.652G>C (p.Glu218Gln)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15686015	3	15644508	25033	36370
NM_000060.4(BTD):c.654G>C (p.Glu218Asp)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15686017	3	15644510	25034	36371
NM_000060.4(BTD):c.664G>C (p.Asp222His)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	3	15686027	3	15644520	25105	36439
NM_000060.4(BTD):c.682G>T (p.Asp228Tyr)	BTD	Biotinidase deficiency|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 2, 2017)	criteria provided, conflicting interpretations	3	15686045	3	15644538	25035	36372
NM_000060.4(BTD):c.683A>G (p.Asp228Gly)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15686046	3	15644539	156002	165806
NM_000060.4(BTD):c.695T>C (p.Phe232Ser)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	3	15686058	3	15644551	587722	578681
NM_000060.4(BTD):c.701C>T (p.Thr234Ile)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15686064	3	15644557	156003	165807
NM_000060.4(BTD):c.709G>A (p.Ala237Thr)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	3	15686072	3	15644565	25036	36373
NM_000060.4(BTD):c.734G>A (p.Cys245Tyr)	BTD	Biotinidase deficiency|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 17, 2018)	criteria provided, conflicting interpretations	3	15686097	3	15644590	38281	46836
NM_000060.4(BTD):c.743T>C (p.Ile248Thr)	BTD	Biotinidase deficiency|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 14, 2017)	criteria provided, conflicting interpretations	3	15686106	3	15644599	25037	36374
NM_000060.4(BTD):c.755A>G (p.Asp252Gly)	BTD	Biotinidase deficiency|not provided	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, multiple submitters, no conflicts	3	15686118	3	15644611	1901	16940
NM_000060.4(BTD):c.757C>T (p.Pro253Ser)	BTD	Biotinidase deficiency	Uncertain significance(Last reviewed: Jan 24, 2017)	criteria provided, single submitter	3	15686120	3	15644613	25039	36376
NM_000060.4(BTD):c.758C>T (p.Pro253Leu)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	3	15686121	3	15644614	38576	47165
NM_000060.4(BTD):c.764T>C (p.Ile255Thr)	BTD	Biotinidase deficiency	Uncertain significance(Last reviewed: Mar 28, 2018)	criteria provided, single submitter	3	15686127	3	15644620	25040	36377
NM_000060.4(BTD):c.770T>A (p.Val257Asp)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	3	15686133	3	15644626	587723	578682
NM_000060.4(BTD):c.794A>T (p.His265Leu)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15686157	3	15644650	25041	36378
NM_000060.4(BTD):c.814T>G (p.Trp272Gly)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	3	15686177	3	15644670	25043	36380
NM_000060.4(BTD):c.832C>G (p.Leu278Val)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15686195	3	15644688	25044	36381
NM_000060.4(BTD):c.833T>C (p.Leu278Pro)	BTD	Biotinidase deficiency	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	3	15686196	3	15644689	25045	36382
NM_000060.4(BTD):c.836T>G (p.Leu279Trp)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15686199	3	15644692	25046	36383
NM_000060.4(BTD):c.856A>G (p.Lys286Glu)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	3	15686219	3	15644712	587727	578686
NM_000060.4(BTD):c.865G>C (p.Ala289Pro)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	3	15686228	3	15644721	50884	46848
NM_000060.4(BTD):c.880A>G (p.Ile294Val)	BTD	Biotinidase deficiency|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 6, 2018)	criteria provided, conflicting interpretations	3	15686243	3	15644736	25047	36384
NM_000060.4(BTD):c.887T>G (p.Val296Gly)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15686250	3	15644743	25048	36385
NM_000060.4(BTD):c.895G>C (p.Ala299Pro)	BTD	Biotinidase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, multiple submitters, no conflicts	3	15686258	3	15644751	439039	432546
NM_000060.4(BTD):c.896C>T (p.Ala299Val)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15686259	3	15644752	25049	36386
NM_000060.4(BTD):c.898A>C (p.Asn300His)	BTD	Biotinidase deficiency|not provided	Likely pathogenic(Last reviewed: Mar 7, 2016)	criteria provided, single submitter	3	15686261	3	15644754	156004	165808
NM_000060.4(BTD):c.929G>A (p.Gly310Glu)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15686292	3	15644785	25050	36387
NM_000060.4(BTD):c.932G>A (p.Ser311Asn)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15686295	3	15644788	25051	36388
NM_000060.4(BTD):c.933T>G (p.Ser311Arg)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15686296	3	15644789	25053	36379
NM_000060.4(BTD):c.934G>A (p.Gly312Ser)	BTD	Biotinidase deficiency	Uncertain significance(Last reviewed: Sep 26, 2017)	criteria provided, single submitter	3	15686297	3	15644790	25054	36390
NM_000060.4(BTD):c.935G>A (p.Gly312Asp)	BTD	Biotinidase deficiency	Uncertain significance(Last reviewed: Oct 19, 2017)	criteria provided, single submitter	3	15686298	3	15644791	25055	36391
NM_000060.4(BTD):c.968A>G (p.His323Arg)	BTD	Biotinidase deficiency|not specified|not provided|Inborn genetic diseases	Uncertain significance(Last reviewed: Feb 15, 2018)	criteria provided, multiple submitters, no conflicts	3	15686331	3	15644824	38278	46833
NM_000060.4(BTD):c.1001T>A (p.Ile334Asn)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	3	15686364	3	15644857	25106	36440
NM_000060.4(BTD):c.1046A>C (p.Asn349Thr)	BTD	Biotinidase deficiency|not provided	Uncertain significance(Last reviewed: Mar 27, 2018)	criteria provided, multiple submitters, no conflicts	3	15686409	3	15644902	25107	36441
NM_000060.4(BTD):c.1096T>C (p.Ser366Pro)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15686459	3	15644952	25058	36394
NM_000060.4(BTD):c.1106C>T (p.Pro369Leu)	BTD	Biotinidase deficiency	Uncertain significance(Last reviewed: Dec 28, 2017)	criteria provided, single submitter	3	15686469	3	15644962	25059	36395
NM_000060.4(BTD):c.1171C>T (p.Pro391Ser)	BTD	Biotinidase deficiency|not specified	Benign/Likely benign(Last reviewed: Jun 4, 2018)	criteria provided, multiple submitters, no conflicts	3	15686534	3	15645027	38570	46849
NM_000060.4(BTD):c.1205A>G (p.Asn402Ser)	BTD	Biotinidase deficiency|not provided	Uncertain significance(Last reviewed: Jun 25, 2018)	criteria provided, multiple submitters, no conflicts	3	15686568	3	15645061	25062	36398
NM_000060.4(BTD):c.1207T>G (p.Phe403Val)	BTD	Biotinidase deficiency|not provided	Pathogenic, other(Last reviewed: Aug 2, 2018)	criteria provided, multiple submitters, no conflicts	3	15686570	3	15645063	143949	16943
NM_000060.4(BTD):c.1211C>T (p.Thr404Ile)	BTD	Biotinidase deficiency	Uncertain significance(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	3	15686574	3	15645067	25065	36401
NM_000060.4(BTD):c.1214T>C (p.Leu405Pro)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15686577	3	15645070	25066	36402
NM_000060.4(BTD):c.1237G>A (p.Gly413Ser)	BTD	Biotinidase deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Dec 14, 2017)	criteria provided, conflicting interpretations	3	15686600	3	15645093	38577	47166
NM_000060.4(BTD):c.1249G>T (p.Val417Phe)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15686612	3	15645105	25070	36406
NM_000060.4(BTD):c.1252T>C (p.Cys418Arg)	BTD	Biotinidase deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Mar 27, 2018)	criteria provided, conflicting interpretations	3	15686615	3	15645108	25069	36405
NM_000060.4(BTD):c.1253G>C (p.Cys418Ser)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15686616	3	15645109	25071	36407
NM_000060.4(BTD):c.1267T>C (p.Cys423Arg)	BTD	Biotinidase deficiency	Uncertain significance(Last reviewed: Mar 26, 2018)	criteria provided, single submitter	3	15686630	3	15645123	25073	36409
NM_000060.4(BTD):c.1268G>C (p.Cys423Ser)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15686631	3	15645124	25074	36410
NM_000060.4(BTD):c.1271G>C (p.Cys424Ser)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15686634	3	15645127	25076	36314
NM_000060.4(BTD):c.1271G>A (p.Cys424Tyr)	BTD	Biotinidase deficiency|not provided	Likely pathogenic(Last reviewed: Dec 7, 2015)	criteria provided, single submitter	3	15686634	3	15645127	25075	36411
NM_000060.4(BTD):c.1309C>G (p.Leu437Val)	BTD	Biotinidase deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Jun 4, 2018)	criteria provided, conflicting interpretations	3	15686672	3	15645165	558593	543139
NM_000060.4(BTD):c.1313A>G (p.Tyr438Cys)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15686676	3	15645169	25079	36414
NM_000060.4(BTD):c.1328T>C (p.Phe443Ser)	BTD	Biotinidase deficiency	Likely pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	3	15686691	3	15645184	587733	578692
NM_000060.2(BTD):c.[511G>A;1330G>C]	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Jan 31, 2017)	criteria provided, single submitter	3|3	15686693	3|3	15645186	25016	16939|36353
NM_001281724.2(BTD):c.1336G>C (p.Asp446His)	BTD	Biotinidase deficiency|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 5, 2018)	criteria provided, conflicting interpretations	3	15686693	3	15645186	1900	16939
NM_000060.4(BTD):c.1333G>A (p.Gly445Arg)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15686696	3	15645189	25081	36416
NM_000060.4(BTD):c.1334G>A (p.Gly445Glu)	BTD	Biotinidase deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Jan 24, 2018)	criteria provided, conflicting interpretations	3	15686697	3	15645190	556288	543146
NM_000060.4(BTD):c.1334G>T (p.Gly445Val)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Mar 10, 2017)	criteria provided, single submitter	3	15686697	3	15645190	25082	36396
NM_000060.4(BTD):c.1339C>T (p.His447Tyr)	BTD	Biotinidase deficiency	Likely pathogenic(Last reviewed: Jul 19, 2017)	criteria provided, single submitter	3	15686702	3	15645195	25083	36417
NM_000060.4(BTD):c.1352G>A (p.Gly451Asp)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15686715	3	15645208	25084	36418
NM_000060.4(BTD):c.1361A>G (p.Tyr454Cys)	BTD	Biotinidase deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Mar 19, 2018)	criteria provided, conflicting interpretations	3	15686724	3	15645217	458806	452267
NM_000060.4(BTD):c.1368A>C (p.Gln456His)	BTD	Biotinidase deficiency|not provided	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	3	15686731	3	15645224	1902	16941
NM_000060.4(BTD):c.1369G>A (p.Val457Met)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15686732	3	15645225	25085	36419
NM_000060.4(BTD):c.1388G>A (p.Cys463Tyr)	BTD	Biotinidase deficiency	Uncertain significance(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	3	15686751	3	15645244	25087	36421
NM_000060.4(BTD):c.1432G>A (p.Ala478Thr)	BTD	Biotinidase deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Apr 12, 2018)	criteria provided, conflicting interpretations	3	15686795	3	15645288	25108	36442
NM_000060.4(BTD):c.1432G>C (p.Ala478Pro)	BTD	Biotinidase deficiency|not provided	Pathogenic(Last reviewed: Jun 12, 2015)	criteria provided, single submitter	3	15686795	3	15645288	25089	36423
NM_000060.4(BTD):c.1455C>G (p.His485Gln)	BTD	Biotinidase deficiency	Conflicting interpretations of pathogenicity(Last reviewed: May 25, 2018)	criteria provided, conflicting interpretations	3	15686818	3	15645311	25090	36424
NM_000060.4(BTD):c.1459T>C (p.Trp487Arg)	BTD	Biotinidase deficiency|not provided	Pathogenic(Last reviewed: Apr 13, 2015)	criteria provided, single submitter	3	15686822	3	15645315	25091	36425
NM_000060.4(BTD):c.1463G>A (p.Gly488Asp)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15686826	3	15645319	25093	36427
NM_000060.4(BTD):c.1466A>C (p.Asn489Thr)	BTD	Biotinidase deficiency	Uncertain significance(Last reviewed: Jan 5, 2018)	criteria provided, multiple submitters, no conflicts	3	15686829	3	15645322	1903	16942
NM_000060.4(BTD):c.1481A>G (p.Tyr494Cys)	BTD	Biotinidase deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Oct 31, 2017)	criteria provided, conflicting interpretations	3	15686844	3	15645337	554671	543054
NM_000060.4(BTD):c.1489C>T (p.Pro497Ser)	BTD	Biotinidase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 21, 2017)	criteria provided, multiple submitters, no conflicts	3	15686852	3	15645345	25094	36428
NM_000060.4(BTD):c.1511T>A (p.Met504Lys)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15686874	3	15645367	25096	36430
NM_000060.4(BTD):c.1526C>G (p.Pro509Arg)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	3	15686889	3	15645382	587738	578697
NM_000060.4(BTD):c.1531C>G (p.Gln511Glu)	BTD	Biotinidase deficiency	Uncertain significance(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	3	15686894	3	15645387	25097	36431
NM_000060.4(BTD):c.1595C>T (p.Thr532Met)	BTD	Biotinidase deficiency|not provided	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, multiple submitters, no conflicts	3	15686958	3	15645451	1897	16936
NM_000060.4(BTD):c.1610G>A (p.Gly537Glu)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15686973	3	15645466	25098	36432
NM_000060.4(BTD):c.1612C>A (p.Arg538Ser)	BTD	Biotinidase deficiency|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Sep 15, 2017)	criteria provided, conflicting interpretations	3	15686975	3	15645468	203642	200042
NM_000060.4(BTD):c.1612C>T (p.Arg538Cys)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, multiple submitters, no conflicts	3	15686975	3	15645468	1898	16937
NM_000060.4(BTD):c.1613G>A (p.Arg538His)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	3	15686976	3	15645469	25099	36433
NM_000060.4(BTD):c.1619A>G (p.Tyr540Cys)	BTD	Biotinidase deficiency	Uncertain significance(Last reviewed: Jun 14, 2017)	criteria provided, single submitter	3	15686982	3	15645475	25101	36435
NM_000060.4(BTD):c.1627G>C (p.Asp543His)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	3	15686990	3	15645483	25102	36436
NM_000060.4(BTD):c.1628A>T (p.Asp543Val)	BTD	Biotinidase deficiency	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	3	15686991	3	15645484	587741	578700
NM_000060.4(BTD):c.1629C>A (p.Asp543Glu)	BTD	Biotinidase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2018)	criteria provided, multiple submitters, no conflicts	3	15686992	3	15645485	25103	36437
NM_001145294.1(NGLY1):c.188T>G (p.Ile63Ser)	NGLY1	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	3	25805735	3	25764244	402216	389119
NM_000404.3(GLB1):c.1768C>T (p.Arg590Cys)	GLB1	Gangliosidosis GM1 type 3|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|GM1 gangliosidosis|GM1 Gangliosidosis|not provided	Pathogenic(Last reviewed: Apr 30, 2018)	criteria provided, multiple submitters, no conflicts	3	33038803	3	32997311	194596	191759
NM_001317040.1(GLB1):c.745C>T (p.Arg249Cys)	GLB1	GM1 gangliosidosis type 2|Gangliosidosis GM1 type 3|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|GM1 gangliosidosis|Morquio syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 18, 2017)	criteria provided, conflicting interpretations	3	33099713	3	33058221	925	15964
NM_000404.3(GLB1):c.446C>T (p.Ser149Phe)	GLB1	GM1 gangliosidosis type 2|Gangliosidosis GM1 type 3|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	3	33109733	3	33068241	553205	543223
NM_000404.3(GLB1):c.[245C>T];[367G>A]	GLB1	Infantile GM1 gangliosidosis	Pathogenic(Last reviewed: Mar 12, 2013)	criteria provided, single submitter	3|3	33110341	3|3	33068849	424779	15967|15974
NM_000404.3(GLB1):c.325C>T (p.Arg109Trp)	GLB1	GM1 gangliosidosis|Morquio syndrome|not specified|not provided	Benign/Likely benign(Last reviewed: May 23, 2017)	criteria provided, multiple submitters, no conflicts	3	33110383	3	33068891	129154	134600
NM_000404.3(GLB1):c.29C>T (p.Pro10Leu)	GLB1	GM1 gangliosidosis|Morquio syndrome|not specified|not provided	Benign(Last reviewed: Aug 31, 2017)	criteria provided, multiple submitters, no conflicts	3	33138549	3	33097057	92904	98811
NM_032806.5(POMGNT2):c.1219C>T (p.Arg407Trp)	POMGNT2	not specified|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8|not provided	Uncertain significance(Last reviewed: Jun 16, 2017)	criteria provided, multiple submitters, no conflicts	3	43121705	3	43080213	129214	134660
NM_018075.4(ANO10):c.1682C>T (p.Thr561Met)	ANO10	Spinocerebellar ataxia, autosomal recessive 10|not specified|Autosomal recessive cerebellar ataxia	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	43591327	3	43549835	128388	133837
NM_018075.4(ANO10):c.1385G>A (p.Arg462Gln)	ANO10	Spinocerebellar ataxia, autosomal recessive 10|not specified|Autosomal recessive cerebellar ataxia	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	43602803	3	43561311	128387	133836
NM_018075.4(ANO10):c.1066A>G (p.Ser356Gly)	ANO10	Spinocerebellar ataxia, autosomal recessive 10|not specified|Autosomal recessive cerebellar ataxia	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	43618280	3	43576788	128386	133835
NM_015340.3(LARS2):c.1520C>G (p.Pro507Arg)	LARS2|LARS2-AS1	Perrault syndrome	Likely pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	3	45533289	3	45491797	517248	496773
NM_015340.3(LARS2):c.1565C>A (p.Thr522Asn)	LARS2|LARS2-AS1	not provided|Perrault syndrome 4|Hydrops, lactic acidosis, and sideroblastic anemia|Perrault syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, multiple submitters, no conflicts	3	45537808	3	45496316	55871	70522
NM_000316.3(PTH1R):c.103G>A (p.Glu35Lys)	PTH1R	Eiken skeletal dysplasia	Uncertain significance(Last reviewed: Jan 16, 2018)	criteria provided, single submitter	3	46935424	3	46893934	545721	536213
NM_033629.4(TREX1):c.340C>T (p.Arg114Cys)	TREX1|ATRIP-TREX1	Aicardi Goutieres syndrome 1	Likely pathogenic(Last reviewed: Jul 15, 2014)	criteria provided, single submitter	3	48508394	3	48466995	209198	205735
NM_033629.5(TREX1):c.341G>A (p.Arg114His)	TREX1|ATRIP-TREX1	Aicardi Goutieres syndrome 1|Vasculopathy, retinal, with cerebral leukodystrophy|Aicardi Goutieres syndrome|Systemic lupus erythematosus, susceptibility to|not provided|Chilblain lupus erythematosus	Conflicting interpretations of pathogenicity, risk factor(Last reviewed: May 25, 2018)	criteria provided, conflicting interpretations	3	48508395	3	48466996	4179	19218
NM_000094.3(COL7A1):c.8371C>T (p.Arg2791Trp)	COL7A1	Recessive dystrophic epidermolysis bullosa|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2015)	criteria provided, conflicting interpretations	3	48603736	3	48566303	212731	209348
NM_000094.3(COL7A1):c.5000G>A (p.Gly1667Glu)	COL7A1	Recessive dystrophic epidermolysis bullosa	Uncertain significance	criteria provided, single submitter	3	48618066	3	48580633	219177	217190
NM_000094.3(COL7A1):c.1A>G (p.Met1Val)	COL7A1	Recessive dystrophic epidermolysis bullosa|not provided	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, multiple submitters, no conflicts	3	48632592	3	48595159	424625	411523
NM_001199162.1(USP19):c.1624G>T (p.Val542Leu)	USP19	Epileptic encephalopathy	Pathogenic	no assertion criteria provided	3	49153189	3	49115756	375397	362140
NM_001199162.1(USP19):c.1536G>T (p.Glu512Asp)	USP19	Epileptic encephalopathy	Pathogenic	no assertion criteria provided	3	49153277	3	49115844	375398	362141
NM_004393.5(DAG1):c.259A>G (p.Ile87Val)	DAG1	Limb-girdle muscular dystrophy-dystroglycanopathy, type C9|not specified|not provided|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 9	Benign/Likely benign(Last reviewed: Feb 6, 2018)	criteria provided, multiple submitters, no conflicts	3	49548226	3	49510793	128884	134331
NM_021971.2(GMPPB):c.859C>T (p.Arg287Trp)	GMPPB	Muscular dystrophy|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14	Pathogenic/Likely pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, multiple submitters, no conflicts	3	49759490	3	49722057	225925	227736
NM_021971.2(GMPPB):c.553C>T (p.Arg185Cys)	GMPPB	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14|Inborn genetic diseases|Muscular dystrophy-dystroglycanopathy	Pathogenic/Likely pathogenic(Last reviewed: Aug 7, 2017)	criteria provided, multiple submitters, no conflicts	3	49760037	3	49722604	60543	75124
NM_013334.3(GMPPB):c.79G>C (p.Asp27His)	GMPPB	Muscular dystrophy|not provided|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14	Pathogenic(Last reviewed: Jun 9, 2018)	criteria provided, multiple submitters, no conflicts	3	49761081	3	49723648	60546	75127
NM_015426.4(POC1A):c.1044G>T (p.Gln348His)	POC1A	not specified	Likely benign	no assertion criteria provided	3	52130666	3	52096650	129984	135430
NM_015426.4(POC1A):c.149C>T (p.Pro50Leu)	POC1A	not specified	Likely benign	no assertion criteria provided	3	52183958	3	52149942	129985	135431
NM_052859.3(RFT1):c.1018G>A (p.Gly340Ser)	RFT1	RFT1 related CDG	Uncertain significance(Last reviewed: Jun 20, 2018)	criteria provided, single submitter	3	53138053	3	53104037	545641	536137
NM_052859.3(RFT1):c.902A>G (p.Tyr301Cys)	RFT1	Congenital disorder of glycosylation type 1N	Likely pathogenic(Last reviewed: Jul 15, 2017)	criteria provided, single submitter	3	53139744	3	53105728	495320	486813
NM_198159.2(MITF):c.1021C>G (p.Arg341Gly)	MITF	Tietz syndrome|Waardenburg syndrome type 2A	Likely pathogenic(Last reviewed: May 15, 2018)	no assertion criteria provided	3	70008431	3	69959280	545117	535381
NM_182896.2(ARL13B):c.1043C>G (p.Thr348Ser)	ARL13B	Joubert syndrome|Joubert syndrome 8|not specified	Benign/Likely benign(Last reviewed: May 31, 2017)	criteria provided, multiple submitters, no conflicts	3	93768268	3	94049424	128452	133901
NM_024548.3(CEP97):c.1148A>G (p.His383Arg)	CEP97	Global developmental delay|Intellectual disability|Global developmental delay	Likely pathogenic	criteria provided, single submitter	3	101476598	3	101757754	402141	389117
NM_000187.3(HGD):c.674G>A (p.Arg225His)	HGD	Alkaptonuria	Likely pathogenic(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	3	120363266	3	120644419	189173	186670
NM_000187.3(HGD):c.365C>T (p.Ala122Val)	HGD	Alkaptonuria	Likely pathogenic(Last reviewed: Jul 3, 2014)	criteria provided, single submitter	3	120369690	3	120650843	188865	186672
NM_000187.3(HGD):c.360T>G (p.Cys120Trp)	HGD	Alkaptonuria	Pathogenic(Last reviewed: Sep 29, 2014)	criteria provided, single submitter	3	120369695	3	120650848	65578	76486
NM_014049.4(ACAD9):c.[1A>G];[796C>T]	ACAD9	Acyl-CoA dehydrogenase family, member 9, deficiency of	Pathogenic(Last reviewed: Aug 30, 2015)	no assertion criteria provided	3|3	128618292	3|3	128899449	424751	214383|214380
NM_014049.4(ACAD9):c.[1595G>A];[976G>A]	ACAD9|KIAA1257	Acyl-CoA dehydrogenase family, member 9, deficiency of	Pathogenic(Last reviewed: Aug 26, 2015)	no assertion criteria provided	3|3	128622922	3|3	128904079	424747	139956|214390
NM_014049.4(ACAD9):c.[1015T>G];[2T>G]	ACAD9	Acyl-CoA dehydrogenase family, member 9, deficiency of	Pathogenic(Last reviewed: Aug 25, 2015)	no assertion criteria provided	3|3	128622961	3|3	128904118	424745	214384|214381
NM_014049.4(ACAD9):c.[1030-1G>T];[1249C>T]	ACAD9	Acyl-CoA dehydrogenase family, member 9, deficiency of	Pathogenic(Last reviewed: Aug 25, 2015)	no assertion criteria provided	3|3	128625063	3|3	128906220	424744	39837|214385
NM_014049.4(ACAD9):c.[1298G>A];[151-2A>G]	ACAD9	Acyl-CoA dehydrogenase family, member 9, deficiency of	Pathogenic(Last reviewed: Aug 27, 2015)	no assertion criteria provided	3|3	128627047	3|3	128908204	424748	214387|214382
NM_014049.4(ACAD9):c.[1237G>A];[1552C>T]	ACAD9	Acyl-CoA dehydrogenase family, member 9, deficiency of	Pathogenic(Last reviewed: Aug 28, 2015)	no assertion criteria provided	3|3	128628253	3|3	128909410	424749	214388|214386
NM_014049.4(ACAD9):c.[1552C>T];[1564-6_1569del]	ACAD9|KIAA1257	Acyl-CoA dehydrogenase family, member 9, deficiency of	Pathogenic(Last reviewed: Aug 29, 2015)	no assertion criteria provided	3|3	128628858 - 128628869	3|3	128910015 - 128910026	424750	214389|214388
NM_014049.4(ACAD9):c.[1594C>T];[359delT]	ACAD9|KIAA1257	Acyl-CoA dehydrogenase family, member 9, deficiency of	Pathogenic(Last reviewed: Aug 25, 2015)	no assertion criteria provided	3|3	128628894	3|3	128910051	424746	39841|213547
NM_014049.4(ACAD9):c.[1846C>T];[359delT]	ACAD9|KIAA1257	Acyl-CoA dehydrogenase family, member 9, deficiency of	Likely pathogenic(Last reviewed: Oct 15, 2013)	criteria provided, single submitter	3|3	128631430	3|3	128912587	424761	213548|213547
NM_052985.3(IFT122):c.1636G>A (p.Gly546Arg)	IFT122	Cranioectodermal dysplasia 1|Cranioectodermal dysplasia	Uncertain significance(Last reviewed: May 1, 2018)	criteria provided, single submitter	3	129198760	3	129479917	65741	76649
NM_024818.4(UBA5):c.907T>C (p.Cys303Arg)	UBA5|NPHP3-ACAD11	Epileptic encephalopathy, early infantile, 44	Uncertain significance(Last reviewed: Feb 15, 2017)	criteria provided, multiple submitters, no conflicts	3	132394186	3	132675342	522846	513414
NM_024818.4(UBA5):c.910G>A (p.Asp304Asn)	UBA5|NPHP3-ACAD11	Epileptic encephalopathy, early infantile, 44	Likely pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	3	132394189	3	132675345	488630	481498
NM_024818.4(UBA5):c.1111G>A (p.Ala371Thr)	UBA5|NPHP3-ACAD11	not provided|Epileptic encephalopathy, early infantile, 44|Spinocerebellar ataxia, autosomal recessive 24	Pathogenic(Last reviewed: May 21, 2018)	criteria provided, multiple submitters, no conflicts	3	132394747	3	132675903	265745	260377
NM_153240.4(NPHP3):c.[2108A>C];[3373C>T]	NPHP3|NPHP3-ACAD11	Adolescent nephronophthisis	Likely pathogenic	no assertion criteria provided	3|3	132403595	3|3	132684751	430662	102410|424190
NM_001063.3(TF):c.1825C>T (p.Arg609Trp)	TF	Atransferrinemia|Atransferrinemia	Likely pathogenic	no assertion criteria provided	3	133494414	3	133775570	218294	214927
NM_025180.3(CEP63):c.5A>T (p.Glu2Val)	CEP63	not provided	Uncertain significance(Last reviewed: Dec 6, 2013)	criteria provided, single submitter	3	134214167	3	134495325	128711	134160
NM_025180.4(CEP63):c.555G>C (p.Gln185His)	CEP63	not specified	Benign(Last reviewed: May 7, 2013)	criteria provided, single submitter	3	134256110	3	134537268	128709	134158
NM_025180.4(CEP63):c.1155C>A (p.Asn385Lys)	CEP63	not specified	Benign(Last reviewed: Apr 16, 2013)	criteria provided, single submitter	3	134267991	3	134549149	128707	134156
NM_025180.3(CEP63):c.1952C>T (p.Ser651Leu)	CEP63	not specified	Benign(Last reviewed: Apr 25, 2013)	criteria provided, single submitter	3	134278270	3	134559428	128708	134157
NM_020191.2(MRPS22):c.404G>A (p.Arg135Gln)	MRPS22	Primary ovarian failure|OVARIAN DYSGENESIS 7	Conflicting interpretations of pathogenicity(Last reviewed: Sep 18, 2018)	no assertion criteria provided	3	139067066	3	139348224	496583	488076
NM_020191.2(MRPS22):c.605G>A (p.Arg202His)	MRPS22	46,XX gonadal dysgenesis|OVARIAN DYSGENESIS 7	Pathogenic(Last reviewed: Oct 16, 2017)	criteria provided, single submitter	3	139069121	3	139350279	441255	434897
NM_001184.3(ATR):c.7300C>G (p.Pro2434Ala)	ATR	Seckel syndrome|not specified|not provided	Benign/Likely benign(Last reviewed: Feb 27, 2017)	criteria provided, multiple submitters, no conflicts	3	142178118	3	142459276	158003	167850
NM_001184.3(ATR):c.7274G>A (p.Arg2425Gln)	ATR	Seckel syndrome|not specified|not provided	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	142178144	3	142459302	136470	140173
NM_001184.3(ATR):c.6961T>C (p.Phe2321Leu)	ATR	Seckel syndrome 1	Uncertain significance(Last reviewed: Jun 5, 2014)	criteria provided, single submitter	3	142184019	3	142465177	158001	167848
NM_001184.3(ATR):c.5732A>G (p.Asn1911Ser)	ATR	Seckel syndrome 1	Uncertain significance(Last reviewed: Jul 21, 2014)	criteria provided, single submitter	3	142215861	3	142497019	157994	167841
NM_001184.3(ATR):c.4995G>T (p.Lys1665Asn)	ATR	Seckel syndrome 1	Likely pathogenic	no assertion criteria provided	3	142226809	3	142507967	559542	550265
NM_001184.3(ATR):c.4835A>G (p.Asn1612Ser)	ATR	Seckel syndrome|not specified|not provided	Benign/Likely benign(Last reviewed: Feb 27, 2017)	criteria provided, multiple submitters, no conflicts	3	142231119	3	142512277	157989	167836
NM_001184.3(ATR):c.4351C>T (p.Arg1451Trp)	ATR	Seckel syndrome|Seckel syndrome 1|not provided	Uncertain significance(Last reviewed: Oct 31, 2017)	criteria provided, multiple submitters, no conflicts	3	142238542	3	142519700	157985	167832
NM_001184.3(ATR):c.4306A>G (p.Asn1436Asp)	ATR	Seckel syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	3	142238587	3	142519745	157984	167831
NM_001184.3(ATR):c.3799G>A (p.Val1267Ile)	ATR	Seckel syndrome 1	Uncertain significance(Last reviewed: Jun 26, 2014)	criteria provided, single submitter	3	142254970	3	142536128	157980	167827
NM_001184.3(ATR):c.3424A>G (p.Ser1142Gly)	ATR	Seckel syndrome 1|not specified	Uncertain significance(Last reviewed: Aug 20, 2015)	criteria provided, multiple submitters, no conflicts	3	142261533	3	142542691	157977	167824
NM_001184.3(ATR):c.2875G>A (p.Val959Met)	ATR	Seckel syndrome|not specified|not provided	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	142269075	3	142550233	157974	167821
NM_001184.3(ATR):c.2290A>G (p.Lys764Glu)	ATR	Seckel syndrome 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 20, 2016)	criteria provided, conflicting interpretations	3	142274770	3	142555928	157970	167817
NM_001184.3(ATR):c.1328G>C (p.Arg443Thr)	ATR	not specified	Benign(Last reviewed: Jul 2, 2013)	criteria provided, single submitter	3	142280106	3	142561264	157963	167810
NM_001184.3(ATR):c.946G>A (p.Val316Ile)	ATR	Seckel syndrome|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	142281298	3	142562456	158006	167853
NM_001184.3(ATR):c.891G>C (p.Lys297Asn)	ATR	not specified|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Oct 11, 2017)	criteria provided, multiple submitters, no conflicts	3	142281353	3	142562511	158005	167852
NM_001184.3(ATR):c.632T>C (p.Met211Thr)	ATR	Seckel syndrome|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	142281612	3	142562770	93668	99571
NM_182943.2(PLOD2):c.801C>A (p.Asn267Lys)	PLOD2	Bruck syndrome 2	Uncertain significance	no assertion criteria provided	3	145809665	3	146091878	545697	536189
NM_000096.3(CP):c.2756T>C (p.Leu919Pro)	CP	Deficiency of ferroxidase	Likely pathogenic(Last reviewed: Jul 28, 2017)	criteria provided, single submitter	3	148896324	3	149178537	431113	424636
NM_000096.3(CP):c.2378G>A (p.Arg793His)	CP	Deficiency of ferroxidase|not specified	Benign(Last reviewed: Oct 3, 2017)	criteria provided, multiple submitters, no conflicts	3	148901300	3	149183513	128839	134287
NM_000096.3(CP):c.1679G>T (p.Cys560Phe)	CP	Deficiency of ferroxidase	Likely pathogenic(Last reviewed: Feb 1, 2017)	criteria provided, single submitter	3	148916188	3	149198401	424620	411511
NM_000096.3(CP):c.1652C>T (p.Thr551Ile)	CP	Deficiency of ferroxidase|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jul 27, 2017)	criteria provided, conflicting interpretations	3	148916215	3	149198428	42125	51291
NM_000096.3(CP):c.1099C>T (p.Arg367Cys)	CP	Deficiency of ferroxidase|not specified	Benign/Likely benign(Last reviewed: May 12, 2017)	criteria provided, multiple submitters, no conflicts	3	148924064	3	149206277	128837	134285
NM_000096.3(CP):c.656T>A (p.Val219Glu)	CP	not provided	Uncertain significance(Last reviewed: Jan 30, 2014)	criteria provided, single submitter	3	148927123	3	149209336	128844	134292
NM_000096.3(CP):c.322C>T (p.His108Tyr)	CP	not provided	Uncertain significance(Last reviewed: Dec 2, 2013)	criteria provided, single submitter	3	148930310	3	149212523	128843	134291
NM_174878.2(CLRN1):c.368C>A (p.Ala123Asp)	CLRN1	Usher syndrome, type 3A	Pathogenic/Likely pathogenic(Last reviewed: Jun 27, 2014)	criteria provided, multiple submitters, no conflicts	3	150659434	3	150941647	48146	57310
NM_001195794.1(CLRN1):c.144T>G (p.Asn48Lys)	CLRN1	Retinitis pigmentosa-deafness syndrome|Usher syndrome, type 3A|Retinitis pigmentosa|not provided|Retinitis Pigmentosa, Dominant	Conflicting interpretations of pathogenicity(Last reviewed: Sep 5, 2017)	criteria provided, conflicting interpretations	3	150690352	3	150972565	4395	19434
NM_024996.5(GFM1):c.748C>T (p.Arg250Trp)	GFM1	Combined oxidative phosphorylation deficiency 1	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	3	158369943	3	158652154	30598	39555
NM_001041.3(SI):c.1730T>G (p.Val577Gly)	SI	Sucrase-isomaltase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 31, 2018)	criteria provided, multiple submitters, no conflicts	3	164764786	3	165046998	1418	16457
NM_000340.1(SLC2A2):c.1246G>A (p.Gly416Ser)	SLC2A2	Fanconi-Bickel syndrome	Likely pathogenic(Last reviewed: Feb 1, 2016)	criteria provided, single submitter	3	170716110	3	170998321	445147	438543
NM_000340.1(SLC2A2):c.329C>T (p.Thr110Ile)	SLC2A2	Fanconi-Bickel syndrome|not specified|not provided	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	170732300	3	171014511	130349	135796
NM_181426.1(CCDC39):c.2540A>G (p.Glu847Gly)	TTC14|CCDC39	Fibrous Sheath Dysplasia	Uncertain significance	no assertion criteria provided	3	180334350	3	180616562	140602	150294
NM_020166.4(MCCC1):c.974T>G (p.Met325Arg)	MCCC1	3 Methylcrotonyl-CoA carboxylase 1 deficiency|Methylcrotonyl-CoA carboxylase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, multiple submitters, no conflicts	3	182763310	3	183045522	1929	16968
NM_003907.3(EIF2B5):c.318A>T (p.Leu106Phe)	EIF2B5	Leukoencephalopathy with vanishing white matter|not provided|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Oct 13, 2017)	criteria provided, conflicting interpretations	3	183854522	3	184136734	195203	192364
NM_003907.3(EIF2B5):c.1268T>C (p.Val423Ala)	EIF2B5	Leukoencephalopathy with vanishing white matter	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	3	183859824	3	184142036	561000	552071
NM_003907.3(EIF2B5):c.1759A>G (p.Ile587Val)	EIF2B5	Leukoencephalopathy with vanishing white matter|not specified|not provided	Benign(Last reviewed: Jan 17, 2018)	criteria provided, multiple submitters, no conflicts	3	183861243	3	184143455	94381	100281
NM_006580.3(CLDN16):c.602G>A (p.Gly201Glu)	CLDN16	Primary hypomagnesemia	Pathogenic	no assertion criteria provided	3	190126112	3	190408323	560390	551446
NM_130832.2(OPA1):c.814C>T (p.Arg272Trp)	OPA1	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	3	193355068	3	193637279	402217	389118
NM_003234.3(TFRC):c.58T>C (p.Tyr20His)	TFRC	Combined immunodeficiency|Immunodeficiency 46	Pathogenic(Last reviewed: Jan 1, 2016)	no assertion criteria provided	3	195802210	3	196075339	218163	214809
NM_014687.3(RUBCN):c.1642A>G (p.Thr548Ala)	RUBCN	Global developmental delay|Nystagmus|Intellectual disability|Global developmental delay|Elbow flexion contracture|Knee flexion contracture|Cerebral hypomyelination|Muscular hypotonia|Muscular hypotonia	Pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	3	197421288	3	197694417	242883	243979
NM_014687.3(RUBCN):c.319G>A (p.Glu107Lys)	RUBCN	Global developmental delay|Nystagmus|Intellectual disability|Global developmental delay|Elbow flexion contracture|Knee flexion contracture|Cerebral hypomyelination|Muscular hypotonia|Muscular hypotonia	Pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	3	197431557	3	197704686	242884	243980
NM_001145642.4(RUBCN):c.50G>A (p.Arg17His)	RUBCN	not specified	Likely benign	no assertion criteria provided	3	197432036	3	197705165	129380	134826
NM_173660.4(DOK7):c.199C>T (p.Pro67Ser)	DOK7	Myasthenia, limb-girdle, familial	Pathogenic(Last reviewed: Mar 1, 2018)	no assertion criteria provided	4	3475231	4	3473504	544694	535238
NM_173660.4(DOK7):c.437C>T (p.Pro146Leu)	DOK7	Pena-Shokeir syndrome type I	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	4	3478174	4	3476447	560990	552078
NM_173660.4(DOK7):c.481G>A (p.Gly161Arg)	DOK7	Myasthenia, limb-girdle, familial	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	4	3478218	4	3476491	560991	552079
NM_173660.4(DOK7):c.514G>A (p.Gly172Arg)	DOK7	Pena-Shokeir syndrome type I	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	4	3478251	4	3476524	560992	552080
NM_173660.4(DOK7):c.589G>A (p.Asp197Asn)	DOK7	Pena-Shokeir syndrome type I|Myasthenia, limb-girdle, familial|not specified|not provided	Benign(Last reviewed: Dec 15, 2017)	criteria provided, multiple submitters, no conflicts	4	3487322	4	3485595	128913	134360
NM_173660.4(DOK7):c.753G>A (p.Ala251=)	DOK7	not specified	Benign(Last reviewed: Jul 8, 2016)	criteria provided, multiple submitters, no conflicts	4	3491504	4	3489777	128914	134361
NM_173660.4(DOK7):c.782G>A (p.Arg261His)	DOK7	Pena-Shokeir syndrome type I|Myasthenia, limb-girdle, familial|not specified	Benign(Last reviewed: Nov 25, 2017)	criteria provided, multiple submitters, no conflicts	4	3494495	4	3492768	128915	134362
NM_173660.4(DOK7):c.887A>G (p.Gln296Arg)	DOK7	not specified	Benign(Last reviewed: Feb 19, 2016)	criteria provided, multiple submitters, no conflicts	4	3494600	4	3492873	128916	134363
NM_173660.4(DOK7):c.967C>T (p.Arg323Cys)	DOK7	Pena-Shokeir syndrome type I|Myasthenia, limb-girdle, familial|not specified	Benign(Last reviewed: Dec 20, 2017)	criteria provided, multiple submitters, no conflicts	4	3494680	4	3492953	128917	134364
NM_173660.4(DOK7):c.1061C>T (p.Ser354Phe)	DOK7	Myasthenia, limb-girdle, familial	Pathogenic(Last reviewed: Mar 1, 2018)	no assertion criteria provided	4	3494774	4	3493047	544830	535270
NM_173660.4(DOK7):c.1243C>T (p.Pro415Ser)	DOK7	not specified	Benign(Last reviewed: Jul 8, 2016)	criteria provided, multiple submitters, no conflicts	4	3494956	4	3493229	128908	134355
NM_173660.4(DOK7):c.1351C>T (p.Arg451Trp)	DOK7	Pena-Shokeir syndrome type I|Myasthenia, limb-girdle, familial|not specified	Benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	4	3495064	4	3493337	128910	134357
NM_173660.4(DOK7):c.1382G>A (p.Gly461Asp)	DOK7	not specified	Benign(Last reviewed: Apr 28, 2016)	criteria provided, multiple submitters, no conflicts	4	3495095	4	3493368	128911	134358
NM_147127.4(EVC2):c.1364C>G (p.Thr455Arg)	EVC2	Chondroectodermal dysplasia|Curry-Hall syndrome|not specified|not provided|Ellis-van Creveld Syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Sep 5, 2017)	criteria provided, conflicting interpretations	4	5642347	4	5640620	193762	190925
NM_147127.4(EVC2):c.973T>C (p.Cys325Arg)	EVC2	Chondroectodermal dysplasia	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	4	5667274	4	5665547	561008	552082
NM_147127.4(EVC2):c.571A>G (p.Asn191Asp)	EVC2	Chondroectodermal dysplasia	Uncertain significance(Last reviewed: May 1, 2018)	criteria provided, single submitter	4	5691019	4	5689292	558764	549474
NM_153717.2(EVC):c.919T>C (p.Ser307Pro)	EVC	Chondroectodermal dysplasia|Curry-Hall syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, multiple submitters, no conflicts	4	5747048	4	5745321	5343	20382
NM_006005.3(WFS1):c.997G>A (p.Val333Ile)	WFS1	not specified|WFS1-Related Spectrum Disorders	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	4	6302519	4	6300792	45463	54630
NM_006005.3(WFS1):c.1024G>A (p.Ala342Thr)	WFS1	not provided	Uncertain significance(Last reviewed: May 16, 2017)	criteria provided, multiple submitters, no conflicts	4	6302546	4	6300819	130747	136193
NM_001145853.1(WFS1):c.1079G>A (p.Cys360Tyr)	WFS1	Diabetes mellitus AND insipidus with optic atrophy AND deafness|WFS1-Related Disorders|not specified	Uncertain significance(Last reviewed: Aug 7, 2018)	criteria provided, multiple submitters, no conflicts	4	6302601	4	6300874	374398	361179
NM_006005.3(WFS1):c.1367G>A (p.Arg456His)	WFS1	not specified|not provided|WFS1-Related Spectrum Disorders|Nonsyndromic Hearing Loss, Dominant	Benign/Likely benign(Last reviewed: May 2, 2017)	criteria provided, multiple submitters, no conflicts	4	6302889	4	6301162	45434	54601
NM_006005.3(WFS1):c.1675G>A (p.Ala559Thr)	WFS1	not specified|not provided|WFS1-Related Spectrum Disorders|Nonsyndromic Hearing Loss, Dominant	Conflicting interpretations of pathogenicity(Last reviewed: Jun 30, 2017)	criteria provided, conflicting interpretations	4	6303197	4	6301470	95322	101221
NM_006005.3(WFS1):c.1726G>A (p.Gly576Ser)	WFS1	not specified|not provided|WFS1-Related Spectrum Disorders|Nonsyndromic Hearing Loss, Dominant|Monogenic diabetes	Benign/Likely benign(Last reviewed: Jun 2, 2017)	criteria provided, multiple submitters, no conflicts	4	6303248	4	6301521	45439	54606
NM_006005.3(WFS1):c.1805C>T (p.Ala602Val)	WFS1	not specified|WFS1-Related Spectrum Disorders|Nonsyndromic Hearing Loss, Dominant|Monogenic diabetes	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	4	6303327	4	6301600	45440	54607
NM_006005.3(WFS1):c.1832G>A (p.Arg611His)	WFS1	not specified|WFS1-Related Spectrum Disorders|Nonsyndromic Hearing Loss, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	4	6303354	4	6301627	45442	54609
NM_006005.3(WFS1):c.2182G>A (p.Gly728Ser)	WFS1	not specified|not provided	Uncertain significance(Last reviewed: Jun 5, 2014)	criteria provided, multiple submitters, no conflicts	4	6303704	4	6301977	130750	136196
NM_001145853.1(WFS1):c.2191A>G (p.Met731Val)	WFS1	Diabetes mellitus AND insipidus with optic atrophy AND deafness	Uncertain significance(Last reviewed: Sep 24, 2014)	no assertion criteria provided	4	6303713	4	6301986	374399	361180
NM_006005.3(WFS1):c.2263T>C (p.Cys755Arg)	WFS1	Diabetes mellitus AND insipidus with optic atrophy AND deafness	Likely pathogenic(Last reviewed: Oct 22, 2013)	criteria provided, single submitter	4	6303785	4	6302058	209206	205739
NM_006005.3(WFS1):c.2452C>T (p.Arg818Cys)	WFS1	not specified|not provided|WFS1-Related Spectrum Disorders|Nonsyndromic Hearing Loss, Dominant|Monogenic diabetes	Conflicting interpretations of pathogenicity(Last reviewed: Jan 31, 2017)	criteria provided, conflicting interpretations	4	6303974	4	6302247	130748	136194
NM_004249.3(RAB28):c.651T>G (p.Cys217Trp)	RAB28	Cone-rod dystrophy 18	Pathogenic(Last reviewed: Feb 1, 2015)	criteria provided, single submitter	4	13371512	4	13369888	225879	227691
NM_001080522.2(CC2D2A):c.1127A>C (p.Glu376Ala)	CC2D2A	Joubert syndrome|Meckel-Gruber syndrome|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	4	15518357	4	15516734	126227	131759
NM_001080522.2(CC2D2A):c.1519A>G (p.Lys507Glu)	CC2D2A	Joubert syndrome|Meckel-Gruber syndrome|not specified|not provided	Benign/Likely benign(Last reviewed: Dec 19, 2017)	criteria provided, multiple submitters, no conflicts	4	15534868	4	15533245	126228	131760
NM_001080522.2(CC2D2A):c.2804G>A (p.Arg935Gln)	CC2D2A	COACH syndrome|Joubert syndrome|Meckel-Gruber syndrome|Meckel syndrome type 6|Joubert syndrome 9|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Feb 21, 2018)	criteria provided, conflicting interpretations	4	15559105	4	15557482	126234	131766
NM_001080522.2(CC2D2A):c.3509G>A (p.Arg1170Lys)	CC2D2A	Joubert syndrome|Meckel-Gruber syndrome|not specified	Benign(Last reviewed: Dec 10, 2017)	criteria provided, multiple submitters, no conflicts	4	15572034	4	15570411	126240	131772
NM_001080522.2(CC2D2A):c.4384T>C (p.Trp1462Arg)	CC2D2A	Meckel-Gruber syndrome	Likely pathogenic(Last reviewed: Oct 29, 2013)	criteria provided, single submitter	4	15597777	4	15596154	126244	131776
NM_001080522.2(CC2D2A):c.4407C>G (p.Ser1469Arg)	CC2D2A	Meckel-Gruber syndrome	Likely pathogenic(Last reviewed: Oct 29, 2013)	criteria provided, single submitter	4	15597800	4	15596177	126245	131777
NM_001080522.2(CC2D2A):c.4667A>T (p.Asp1556Val)	CC2D2A	Joubert syndrome|Meckel-Gruber syndrome|Joubert syndrome 9|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 7, 2017)	criteria provided, conflicting interpretations	4	15601322	4	15599699	217607	214194
NM_000320.2(QDPR):c.472C>T (p.His158Tyr)	QDPR	Dihydropteridine reductase deficiency	Likely pathogenic(Last reviewed: Jul 11, 2017)	criteria provided, single submitter	4	17493928	4	17492305	505871	496317
NM_016955.3(SEPSECS):c.1394G>A (p.Arg465Gln)	SEPSECS	not specified	Likely benign(Last reviewed: Jun 1, 2017)	criteria provided, single submitter	4	25125665	4	25124043	130289	135736
NM_016955.3(SEPSECS):c.1356G>C (p.Lys452Asn)	SEPSECS	Pontoneocerebellar hypoplasia|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	4	25125703	4	25124081	130288	135735
NM_025132.3(WDR19):c.56T>G (p.Phe19Cys)	WDR19	Jeune thoracic dystrophy	Uncertain significance(Last reviewed: May 1, 2018)	criteria provided, single submitter	4	39187395	4	39185775	558760	549469
NM_025132.3(WDR19):c.974T>C (p.Leu325Ser)	WDR19	Jeune thoracic dystrophy	Uncertain significance(Last reviewed: May 1, 2018)	criteria provided, single submitter	4	39217473	4	39215853	558757	549470
NM_025132.3(WDR19):c.3533G>A (p.Arg1178Gln)	WDR19	Asphyxiating thoracic dystrophy 5|Cranioectodermal dysplasia|not provided|Senior-Loken syndrome 8	Conflicting interpretations of pathogenicity(Last reviewed: May 1, 2018)	criteria provided, conflicting interpretations	4	39274649	4	39273029	127158	132656
NM_025132.3(WDR19):c.3758G>A (p.Cys1253Tyr)	WDR19	Jeune thoracic dystrophy	Uncertain significance(Last reviewed: May 1, 2018)	criteria provided, single submitter	4	39278681	4	39277061	558758	549472
NM_000087.3(CNGA1):c.[652C>T];[959C>T]	CNGA1|LOC101927157	Retinitis pigmentosa 49	Pathogenic(Last reviewed: Sep 17, 2013)	criteria provided, single submitter	4|4	47939552	4|4	47937535	424770	31971|213556
NM_000232.4(SGCB):c.452C>G (p.Thr151Arg)	SGCB	Limb-girdle muscular dystrophy, type 2E|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, multiple submitters, no conflicts	4	52895065	4	52028899	8712	23751
NM_000232.4(SGCB):c.341C>T (p.Ser114Phe)	SGCB	Limb-girdle muscular dystrophy, type 2E|Beta-sarcoglycanopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, multiple submitters, no conflicts	4	52895932	4	52029766	42035	51200
NM_025009.4(CEP135):c.335G>A (p.Arg112His)	CEP135	not specified	Benign(Last reviewed: Mar 1, 2013)	criteria provided, single submitter	4	56820412	4	55954246	128703	134152
NM_025009.4(CEP135):c.1220G>A (p.Ser407Asn)	CEP135	not specified	Likely benign	no assertion criteria provided	4	56837545	4	55971379	128692	134141
NM_025009.4(CEP135):c.1675G>A (p.Ala559Thr)	CEP135	not specified	Benign(Last reviewed: Apr 3, 2013)	criteria provided, single submitter	4	56847441	4	55981275	128694	134143
NM_025009.4(CEP135):c.1744A>G (p.Met582Val)	CEP135	not provided	Uncertain significance(Last reviewed: Jan 16, 2014)	criteria provided, single submitter	4	56847510	4	55981344	128695	134144
NM_025009.4(CEP135):c.2305A>C (p.Ile769Leu)	CEP135	not specified	Benign(Last reviewed: Aug 31, 2015)	criteria provided, single submitter	4	56874517	4	56008351	128696	134145
NM_025009.4(CEP135):c.2435C>T (p.Ser812Phe)	CEP135	not provided	Uncertain significance(Last reviewed: Apr 18, 2013)	criteria provided, single submitter	4	56875999	4	56009833	128693	134142
NM_025009.4(CEP135):c.2990C>T (p.Ser997Leu)	CEP135	not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 13, 2015)	criteria provided, conflicting interpretations	4	56884001	4	56017835	128701	134150
NM_000406.2(GNRHR):c.842C>T (p.Thr281Ile)	GNRHR	Hypogonadotropic hypogonadism 7 with or without anosmia	Pathogenic(Last reviewed: Sep 1, 2012)	no assertion criteria provided	4	68606343	4	67740625	126540	132059
NM_000406.2(GNRHR):c.806C>T (p.Thr269Met)	GNRHR	Hypogonadotropic hypogonadism 7 with or without anosmia	Pathogenic(Last reviewed: Sep 1, 2012)	no assertion criteria provided	4	68606379	4	67740661	140611	150302
NM_000406.2(GNRHR):c.[416G>A];[806C>T]	GNRHR	Hypogonadotropic hypogonadism 7 with or without anosmia	Likely pathogenic(Last reviewed: Jul 8, 2015)	no assertion criteria provided	4|4	68619638	4|4	67753920	427817	31069|150302
NM_000406.2(GNRHR):c.392T>C (p.Met131Thr)	GNRHR	Hypogonadotropic hypogonadism 7 with or without anosmia	Pathogenic(Last reviewed: Sep 1, 2012)	no assertion criteria provided	4	68619662	4	67753944	140610	150301
NM_000406.2(GNRHR):c.317A>G (p.Gln106Arg)	GNRHR	Hypogonadotropic hypogonadism 7 with or without anosmia|not provided|Isolated congenital hypogonadotropic hypogonadism|Gonadotropin deficiency	Pathogenic/Likely pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, multiple submitters, no conflicts	4	68619737	4	67754019	16023	31062
NM_000406.2(GNRHR):c.94A>G (p.Thr32Ala)	GNRHR	Hypogonadotropic hypogonadism 7 with or without anosmia	Pathogenic(Last reviewed: Sep 1, 2012)	no assertion criteria provided	4	68619960	4	67754242	126541	132060
NM_058172.5(ANTXR2):c.241T>C (p.Ser81Pro)	ANTXR2	Hyaline fibromatosis syndrome	Likely pathogenic(Last reviewed: Jul 8, 2013)	criteria provided, single submitter	4	80990645	4	80069491	209133	205742
NM_015697.8(COQ2):c.196G>T (p.Val66Leu)	COQ2	Coenzyme Q10 deficiency, primary 1|not specified|not provided|Coenzyme Q10 deficiency, primary	Benign(Last reviewed: May 2, 2017)	criteria provided, multiple submitters, no conflicts	4	84205872	4	83284719	128828	134277
NM_001510.3(GRID2):c.671G>A (p.Arg224Gln)	GRID2	Spinocerebellar ataxia, autosomal recessive 18	Likely pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	4	94032040	4	93110889	488523	481391
NM_001510.3(GRID2):c.2128C>T (p.Arg710Trp)	GRID2	Spinocerebellar ataxia, autosomal recessive 18	Pathogenic(Last reviewed: Feb 21, 2017)	no assertion criteria provided	4	94436497	4	93515346	427806	418553
NM_001203.2(BMPR1B):c.640C>A (p.Arg214Ser)	BMPR1B	Type A2 brachydactyly|Acromesomelic dysplasia, Demirhan type|Fibular hypoplasia and complex brachydactyly|Brachydactyly, type a1, d	Pathogenic	no assertion criteria provided	4	96051067	4	95129916	446284	439689
NM_005390.4(PDHA2):c.679A>G (p.Met227Val)	PDHA2	Oligosynaptic infertility	Pathogenic	no assertion criteria provided	4	96761980	4	95840829	446251	439630
NM_001163436.2(TBCK):c.783G>T (p.Arg261Ser)	TBCK	Hypotonia, infantile, with psychomotor retardation and characteristic facies 3	Uncertain significance	criteria provided, multiple submitters, no conflicts	4	107168444	4	106247287	431722	425213
NM_001184705.2(HADH):c.349G>T (p.Val117Leu)	HADH	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	4	108935674	4	108014518	402187	389120
NM_001184705.2(HADH):c.676T>C (p.Tyr226His)	HADH	Deficiency of 3-hydroxyacyl-CoA dehydrogenase	Likely pathogenic(Last reviewed: Nov 19, 2014)	criteria provided, single submitter	4	108948883	4	108027727	212734	209349
NM_015454.2(LARP7):c.10G>A (p.Glu4Lys)	LARP7	not specified	Likely benign	no assertion criteria provided	4	113565835	4	112644679	129478	134924
NM_015454.2(LARP7):c.651G>C (p.Glu217Asp)	LARP7|MIR302CHG	not specified	Likely benign	no assertion criteria provided	4	113568359	4	112647203	129479	134925
NM_015454.2(LARP7):c.836G>A (p.Arg279Gln)	LARP7|MIR302CHG	not specified	Likely benign	no assertion criteria provided	4	113568544	4	112647388	129480	134926
NM_003619.3(PRSS12):c.2498G>A (p.Arg833Gln)	PRSS12	not specified|Intellectual Disability, Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	119203221	4	118282066	130047	135493
NM_003619.3(PRSS12):c.2324G>A (p.Arg775Gln)	PRSS12	not provided	Uncertain significance(Last reviewed: Nov 14, 2013)	criteria provided, single submitter	4	119203395	4	118282240	130045	135491
NM_003619.3(PRSS12):c.1816G>T (p.Ala606Ser)	PRSS12	not specified|Intellectual Disability, Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	4	119219909	4	118298754	130043	135489
NM_003619.3(PRSS12):c.164G>C (p.Arg55Thr)	PRSS12	not specified|Intellectual Disability, Recessive	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	4	119273712	4	118352557	130042	135488
NM_003619.3(PRSS12):c.19G>A (p.Val7Met)	PRSS12	not provided	Uncertain significance(Last reviewed: Mar 13, 2014)	criteria provided, single submitter	4	119273857	4	118352702	130044	135490
NM_001034194.1(EXOSC9):c.41T>C (p.Leu14Pro)	EXOSC9	PONTOCEREBELLAR HYPOPLASIA, TYPE 1D	Pathogenic(Last reviewed: Jul 30, 2018)	no assertion criteria provided	4	122722620	4	121801465	549845	540570
NM_145207.2(SPATA5):c.2384C>G (p.Pro795Arg)	SPATA5	Epilepsy, hearing loss, and mental retardation syndrome	Likely pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	4	124177214	4	123256059	488610	481478
NM_024582.4(FAT4):c.8015A>T (p.Asp2672Val)	FAT4	not specified|Van Maldergem syndrome 2	Uncertain significance(Last reviewed: Jan 13, 2017)	criteria provided, multiple submitters, no conflicts	4	126370186	4	125449031	420323	406400
NM_001291303.1(FAT4):c.10560G>A (p.Met3520Ile)	FAT4	Van Maldergem syndrome 2	Uncertain significance(Last reviewed: Nov 16, 2016)	criteria provided, single submitter	4	126372725	4	125451570	522864	513417
NM_152778.2(MFSD8):c.1268C>T (p.Ala423Val)	MFSD8	not specified|Seizures|not provided|Neuronal Ceroid-Lipofuscinosis, Recessive	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	4	128842761	4	127921606	129609	135055
NM_152778.2(MFSD8):c.1153G>C (p.Gly385Arg)	MFSD8	Ceroid lipofuscinosis neuronal 7|not specified|Seizures|not provided|Neuronal Ceroid-Lipofuscinosis, Recessive	Benign/Likely benign(Last reviewed: Aug 22, 2017)	criteria provided, multiple submitters, no conflicts	4	128842876	4	127921721	129608	135054
NM_152778.2(MFSD8):c.881C>A (p.Thr294Lys)	MFSD8	Ceroid lipofuscinosis neuronal 7	Likely pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	4	128851955	4	127930800	1006	16045
NM_152778.2(MFSD8):c.268G>C (p.Ala90Pro)	MFSD8	Ceroid lipofuscinosis neuronal 7	Uncertain significance(Last reviewed: Aug 13, 2018)	no assertion criteria provided	4	128865078	4	127943923	559837	550559
NM_001102653.1(OTUD4):c.626G>A (p.Arg209His)	OTUD4	not specified	Uncertain significance(Last reviewed: Apr 18, 2016)	no assertion criteria provided	4	146076615	4	145155463	453299	446883
NM_001102653.1(OTUD4):c.386C>G (p.Ala129Gly)	OTUD4	not specified	Uncertain significance(Last reviewed: Apr 18, 2016)	no assertion criteria provided	4	146080703	4	145159551	453300	446884
NM_006439.4(MAB21L2):c.740G>A (p.Arg247Gln)	LRBA|MAB21L2	Microphthalmia/coloboma and skeletal dysplasia syndrome	Likely pathogenic(Last reviewed: Jun 5, 2015)	criteria provided, single submitter	4	151504921	4	150583769	139623	143246
NM_015271.4(TRIM2):c.2000A>C (p.Asp667Ala)	TRIM2	Charcot-Marie-Tooth disease, axonal, type 2R	Likely pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	4	154245278	4	153324126	243075	244155
NM_004453.3(ETFDH):c.1130T>C (p.Leu377Pro)	ETFDH	Glutaric aciduria, type 2|Glutaric acidemia iic, late-onset|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, multiple submitters, no conflicts	4	159624588	4	158703436	31601	40285
NM_004453.3(ETFDH):c.[1367C>T];[1487T>C]	ETFDH	Glutaric aciduria, type 2	Pathogenic(Last reviewed: Jun 17, 2014)	criteria provided, single submitter	4|4	159627422	4|4	158706270	424776	100972|213553
NM_000027.3(AGA):c.299G>A (p.Gly100Glu)	AGA	Aspartylglucosaminuria	Likely pathogenic(Last reviewed: Aug 18, 2014)	criteria provided, single submitter	4	178360825	4	177439671	55940	70579
NM_000027.3(AGA):c.34G>T (p.Val12Leu)	AGA	Aspartylglucosaminuria|not provided	Likely benign(Last reviewed: Sep 19, 2014)	criteria provided, single submitter	4	178363496	4	177442342	188964	186679
NM_001080477.3(TENM3):c.4046C>G (p.Ala1349Gly)	TENM3	Microphthalmia, isolated, with coloboma 9	Likely pathogenic	criteria provided, single submitter	4	183675566	4	182754413	487483	480539
NM_001080477.3(TENM3):c.7687C>T (p.Arg2563Trp)	TENM3	Microphthalmia, isolated, with coloboma 9	Likely pathogenic	criteria provided, single submitter	4	183721091	4	182799938	487482	480538
NM_199053.2(TRAPPC11):c.2938G>A (p.Gly980Arg)	TRAPPC11	Limb-girdle muscular dystrophy, type 2S	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	4	184622936	4	183701783	60510	75097
NM_001151.3(SLC25A4):c.368C>A (p.Ala123Asp)	SLC25A4	Mitochondrial myopathy|not provided|Myopia|Mitochondrial DNA depletion syndrome 12b (cardiomyopathic type), autosomal recessive|Progressive sensorineural hearing impairment|Hypertrophic cardiomyopathy|Left ventricular hypertrophy|Vertigo|Abnormality of mitochondrial metabolism|Mitochondrial respiratory chain defects	Conflicting interpretations of pathogenicity(Last reviewed: Sep 8, 2017)	criteria provided, conflicting interpretations	4	186066174	4	185145020	18249	33288
NM_207352.3(CYP4V2):c.992A>C (p.His331Pro)	CYP4V2	Bietti crystalline corneoretinal dystrophy|not provided	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, multiple submitters, no conflicts	4	187126358	4	186205204	39275	47881
NM_000128.3(F11):c.325G>A (p.Ala109Thr)	F11	Hereditary factor XI deficiency disease	Likely pathogenic(Last reviewed: May 31, 2014)	criteria provided, single submitter	4	187194331	4	186273177	188810	186681
NM_000128.3(F11):c.1186C>T (p.Arg396Cys)	F11	Hereditary factor XI deficiency disease	Likely pathogenic(Last reviewed: Apr 14, 2014)	criteria provided, single submitter	4	187205296	4	186284142	188760	186691
NM_000128.3(F11):c.1253G>T (p.Gly418Val)	F11	Hereditary factor XI deficiency disease	Likely pathogenic(Last reviewed: Jun 6, 2014)	criteria provided, single submitter	4	187205363	4	186284209	11903	26942
NM_000128.3(F11):c.1613C>T (p.Pro538Leu)	F11|F11-AS1	Hereditary factor XI deficiency disease	Likely pathogenic(Last reviewed: Jan 26, 2015)	criteria provided, single submitter	4	187208874	4	186287720	189154	186694
NM_000128.3(F11):c.1693G>A (p.Glu565Lys)	F11|F11-AS1	Hereditary factor XI deficiency disease|not provided	Likely pathogenic(Last reviewed: May 24, 2014)	criteria provided, single submitter	4	187208954	4	186287800	68186	79077
NM_004168.3(SDHA):c.133G>A (p.Ala45Thr)	SDHA	Pheochromocytoma|Leigh syndrome|Mitochondrial complex II deficiency|Paragangliomas 5|Hereditary cancer-predisposing syndrome|Hereditary renal cell carcinoma	Conflicting interpretations of pathogenicity(Last reviewed: Jun 29, 2018)	criteria provided, conflicting interpretations	5	223666	5	223551	224947	226816
NM_001003841.2(SLC6A19):c.517G>A (p.Asp173Asn)	SLC6A19	Neutral 1 amino acid transport defect|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 24, 2017)	criteria provided, multiple submitters, no conflicts	5	1212453	5	1212338	2019	17058
NM_001003841.2(SLC6A19):c.754G>A (p.Val252Ile)	SLC6A19	not specified	Likely benign	no assertion criteria provided	5	1213668	5	1213553	130353	135800
NM_017755.5(NSUN2):c.2279C>A (p.Pro760Gln)	NSUN2	not specified|Intellectual Disability, Recessive|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	6600064	5	6599951	129841	135287
NM_017755.5(NSUN2):c.529C>T (p.His177Tyr)	NSUN2	not provided	Uncertain significance(Last reviewed: Feb 14, 2018)	criteria provided, multiple submitters, no conflicts	5	6623335	5	6623222	129843	135289
NM_001369.2(DNAH5):c.5177T>C (p.Leu1726Pro)	DNAH5	Ciliary dyskinesia, primary, 3|Ciliary dyskinesia	Pathogenic/Likely pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, multiple submitters, no conflicts	5	13845040	5	13844931	369664	353893
NM_001369.2(DNAH5):c.382G>A (p.Val128Met)	DNAH5	Ciliary dyskinesia, primary, 3	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	5	13923445	5	13923336	561151	552084
NM_016180.4(SLC45A2):c.[1454T>C];[264delC]	SLC45A2	Oculocutaneous albinism type 4	Likely pathogenic(Last reviewed: Aug 27, 2013)	criteria provided, single submitter	5|5	33984425	5|5	33984320	424799	213560|213559
NM_014324.5(AMACR):c.829G>A (p.Glu277Lys)	AMACR|SLC45A2|C1QTNF3-AMACR	Alpha-methylacyl-CoA racemase deficiency|not specified|not provided|Oculocutaneous albinism	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	33989518	5	33989413	128360	133809
NM_014324.5(AMACR):c.717G>T (p.Gln239His)	AMACR|C1QTNF3-AMACR	Alpha-methylacyl-CoA racemase deficiency|not specified|not provided	Benign/Likely benign(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	5	33998768	5	33998663	128359	133808
NM_014324.5(AMACR):c.602T>C (p.Leu201Ser)	AMACR|C1QTNF3-AMACR	Alpha-methylacyl-CoA racemase deficiency|not specified|not provided	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	33998883	5	33998778	128358	133807
NM_014324.5(AMACR):c.524G>A (p.Gly175Asp)	AMACR|C1QTNF3-AMACR	Alpha-methylacyl-CoA racemase deficiency|not specified|not provided	Benign(Last reviewed: Jul 18, 2017)	criteria provided, multiple submitters, no conflicts	5	34004707	5	34004602	128357	133806
NM_014324.5(AMACR):c.25G>A (p.Val9Met)	AMACR|C1QTNF3-AMACR	Alpha-methylacyl-CoA racemase deficiency|not specified|not provided	Benign(Last reviewed: Jul 18, 2017)	criteria provided, multiple submitters, no conflicts	5	34008100	5	34007995	128356	133805
NM_023073.3(CPLANE1):c.9362C>T (p.Thr3121Met)	CPLANE1	Joubert syndrome 17	Uncertain significance(Last reviewed: Jul 9, 2014)	criteria provided, single submitter	5	37108450	5	37108348	158061	167908
NM_023073.3(CPLANE1):c.9184G>A (p.Gly3062Arg)	CPLANE1	Joubert syndrome|Orofaciodigital syndrome 6|not specified|Joubert syndrome 17	Benign/Likely benign(Last reviewed: Dec 7, 2017)	criteria provided, multiple submitters, no conflicts	5	37115116	5	37115014	158060	167907
NM_023073.3(CPLANE1):c.8512C>T (p.His2838Tyr)	CPLANE1	Joubert syndrome|Joubert syndrome 17	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	37138940	5	37138838	158057	167904
NM_023073.3(CPLANE1):c.8182C>A (p.Pro2728Thr)	CPLANE1	Joubert syndrome|Orofaciodigital syndrome 6|not specified|Joubert syndrome 17	Conflicting interpretations of pathogenicity(Last reviewed: Jan 8, 2018)	criteria provided, conflicting interpretations	5	37153871	5	37153769	158055	167902
NM_023073.3(CPLANE1):c.7775C>T (p.Pro2592Leu)	CPLANE1	Joubert syndrome|Orofaciodigital syndrome 6|not specified|Joubert syndrome 17	Benign/Likely benign(Last reviewed: Dec 7, 2017)	criteria provided, multiple submitters, no conflicts	5	37158363	5	37158261	158052	167899
NM_023073.3(CPLANE1):c.6905C>T (p.Thr2302Met)	CPLANE1	Joubert syndrome|not specified|Joubert syndrome 17	Conflicting interpretations of pathogenicity(Last reviewed: Feb 21, 2018)	criteria provided, conflicting interpretations	5	37169221	5	37169119	158050	167897
NM_023073.3(CPLANE1):c.6427A>G (p.Ile2143Val)	CPLANE1	Joubert syndrome|Orofaciodigital syndrome 6|not specified|Joubert syndrome 17	Benign/Likely benign(Last reviewed: Aug 7, 2017)	criteria provided, multiple submitters, no conflicts	5	37170178	5	37170076	158049	167896
NM_023073.3(CPLANE1):c.6098T>G (p.Phe2033Cys)	CPLANE1	Joubert syndrome|not specified|Joubert syndrome 17	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	37173930	5	37173828	158048	167895
NM_023073.3(CPLANE1):c.5512A>G (p.Thr1838Ala)	CPLANE1	Joubert syndrome|Orofaciodigital syndrome 6|not specified|Joubert syndrome 17	Benign/Likely benign(Last reviewed: Nov 6, 2017)	criteria provided, multiple submitters, no conflicts	5	37181017	5	37180915	158042	167889
NM_023073.3(CPLANE1):c.5381C>T (p.Pro1794Leu)	CPLANE1	Joubert syndrome|not specified|Joubert syndrome 17	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	37182902	5	37182800	158040	167887
NM_023073.3(CPLANE1):c.5314A>G (p.Ser1772Gly)	CPLANE1	Joubert syndrome|Orofaciodigital syndrome 6|not specified|Joubert syndrome 17|not provided	Benign/Likely benign(Last reviewed: Nov 6, 2017)	criteria provided, multiple submitters, no conflicts	5	37182969	5	37182867	158038	167885
NM_023073.3(CPLANE1):c.4310T>C (p.Ile1437Thr)	CPLANE1	Joubert syndrome|Orofaciodigital syndrome 6|not specified|Joubert syndrome 17	Benign/Likely benign(Last reviewed: Oct 12, 2017)	criteria provided, multiple submitters, no conflicts	5	37185061	5	37184959	158036	167883
NM_023073.3(CPLANE1):c.4034A>G (p.Gln1345Arg)	CPLANE1	Orofaciodigital syndrome 6	Likely pathogenic(Last reviewed: Sep 1, 2015)	criteria provided, single submitter	5	37187562	5	37187460	224854	226694
NM_023073.3(CPLANE1):c.3743G>A (p.Gly1248Asp)	CPLANE1	Joubert syndrome|Orofaciodigital syndrome 6|not specified|Joubert syndrome 17	Conflicting interpretations of pathogenicity(Last reviewed: Jul 11, 2017)	criteria provided, conflicting interpretations	5	37196028	5	37195926	158031	167878
NM_023073.3(CPLANE1):c.[2080A>G];[6968A>C]	CPLANE1	Orofaciodigital syndrome 6|Joubert syndrome 17	Likely pathogenic(Last reviewed: Dec 31, 2016)	criteria provided, single submitter	5|5	37226617	5|5	37226515	427839	361969|361968
NM_023073.3(CPLANE1):c.1883G>A (p.Arg628Lys)	CPLANE1	Joubert syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Aug 16, 2017)	criteria provided, conflicting interpretations	5	37226814	5	37226712	158029	167876
NM_023073.3(CPLANE1):c.94G>A (p.Val32Ile)	CPLANE1	Joubert syndrome|Orofaciodigital syndrome 6|not specified|Joubert syndrome 17	Benign/Likely benign(Last reviewed: Feb 22, 2017)	criteria provided, multiple submitters, no conflicts	5	37245935	5	37245833	158062	167909
NM_002310.5(LIFR):c.2443A>G (p.Thr815Ala)	LIFR	Stuve-Wiedemann syndrome	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	5	38485975	5	38485873	561051	552088
NM_000082.3(ERCC8):c.769G>A (p.Gly257Arg)	ERCC8	Cockayne syndrome type A	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	5	60194177	5	60898350	590788	581726
NM_002538.3(OCLN):c.4T>C (p.Ser2Pro)	OCLN	Band-like calcification with simplified gyration and polymicrogyria	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	5	68800075	5	69504248	159461	168536
NM_002538.3(OCLN):c.452C>T (p.Ala151Val)	OCLN	Band-like calcification with simplified gyration and polymicrogyria|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Sep 12, 2016)	criteria provided, conflicting interpretations	5	68805369	5	69509542	159460	168539
NM_022132.4(MCCC2):c.1015G>A (p.Val339Met)	MCCC2	3-methylcrotonyl CoA carboxylase 2 deficiency|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 27, 2018)	criteria provided, conflicting interpretations	5	70936845	5	71641018	203805	200099
NM_000521.3(HEXB):c.272G>C (p.Cys91Ser)	HEXB	Sandhoff disease	Uncertain significance(Last reviewed: Jan 15, 2015)	no assertion criteria provided	5	73981357	5	74685532	374340	361184
NM_000521.3(HEXB):c.619A>G (p.Ile207Val)	HEXB	Sandhoff disease|HEXB POLYMORPHISM|not specified|not provided	Benign/Likely benign(Last reviewed: Mar 16, 2017)	criteria provided, multiple submitters, no conflicts	5	73992881	5	74697056	93202	99109
NM_000046.4(ARSB):c.1450A>G (p.Arg484Gly)	ARSB	Mucopolysaccharidosis type VI	Conflicting interpretations of pathogenicity(Last reviewed: Jan 1, 2018)	criteria provided, conflicting interpretations	5	78076372	5	78780549	189224	187113
NM_032119.3(ADGRV1):c.7452A>T (p.Lys2484Asn)	ADGRV1	not specified	Uncertain significance(Last reviewed: Jan 30, 2013)	criteria provided, single submitter	5	89990025	5	90694208	46372	55537
NM_032119.4(ADGRV1):c.12101T>G (p.Phe4034Cys)	ADGRV1	Usher syndrome, type 2C	Likely pathogenic(Last reviewed: Jul 28, 2015)	criteria provided, single submitter	5	90055386	5	90759569	228265	229348
NM_032119.3(ADGRV1):c.14365C>T (p.Arg4789Trp)	ADGRV1	Usher syndrome, type 2C|not provided	Likely pathogenic(Last reviewed: Nov 19, 2016)	criteria provided, multiple submitters, no conflicts	5	90087011	5	90791194	430362	421558
NM_032119.3(ADGRV1):c.16874C>T (p.Ser5625Leu)	ADGRV1	not specified	Uncertain significance(Last reviewed: Sep 12, 2017)	criteria provided, single submitter	5	90136657	5	90840840	504586	496844
NM_032119.4(ADGRV1):c.17920G>T (p.Ala5974Ser)	ADGRV1	not specified|not provided	Uncertain significance(Last reviewed: Feb 21, 2018)	criteria provided, multiple submitters, no conflicts	5	90261295	5	90965478	46295	55460
NM_138773.3(SLC25A46):c.770G>A (p.Arg257Gln)	SLC25A46	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB	Likely pathogenic(Last reviewed: Jul 26, 2018)	no assertion criteria provided	5	110096995	5	110761295	559386	550114
NM_001182.4(ALDH7A1):c.1315A>C (p.Lys439Gln)	ALDH7A1	Pyridoxine-dependent epilepsy|not specified|Seizures	Benign/Likely benign(Last reviewed: Nov 14, 2016)	criteria provided, multiple submitters, no conflicts	5	125887715	5	126552023	128346	133795
NM_001182.4(ALDH7A1):c.1279G>C (p.Glu427Gln)	ALDH7A1	Pyridoxine-dependent epilepsy|Seizures|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 23, 2018)	criteria provided, multiple submitters, no conflicts	5	125887751	5	126552059	17994	33033
NM_001182.4(ALDH7A1):c.1234A>G (p.Thr412Ala)	ALDH7A1	Pyridoxine-dependent epilepsy|not specified|Seizures	Benign/Likely benign(Last reviewed: Jan 5, 2018)	criteria provided, multiple submitters, no conflicts	5	125887796	5	126552104	128345	133794
NM_001182.4(ALDH7A1):c.571A>G (p.Ile191Val)	ALDH7A1	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	5	125912850	5	126577158	402176	389123
NM_001182.4(ALDH7A1):c.373A>G (p.Ile125Val)	ALDH7A1	Pyridoxine-dependent epilepsy|not specified|Seizures	Conflicting interpretations of pathogenicity(Last reviewed: Jan 10, 2018)	criteria provided, conflicting interpretations	5	125919644	5	126583952	128348	133797
NM_005340.6(HINT1):c.289G>A (p.Val97Met)	HINT1	Autosomal recessive axonal neuropathy with neuromyotonia	Likely pathogenic(Last reviewed: Mar 29, 2018)	criteria provided, single submitter	5	130495232	5	131159539	545660	536156
NM_005340.6(HINT1):c.112T>C (p.Cys38Arg)	HINT1	Autosomal recessive axonal neuropathy with neuromyotonia	Likely pathogenic(Last reviewed: Mar 29, 2018)	criteria provided, single submitter	5	130498369	5	131162676	545661	536157
NM_003060.3(SLC22A5):c.43G>T (p.Gly15Trp)	SLC22A5	Renal carnitine transport defect|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 27, 2017)	criteria provided, multiple submitters, no conflicts	5	131705707	5	132370015	6429	21468
NM_003060.3(SLC22A5):c.136C>T (p.Pro46Ser)	SLC22A5	Renal carnitine transport defect|not specified|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	5	131705800	5	132370108	193250	190414
NM_003060.3(SLC22A5):c.430C>T (p.Leu144Phe)	SLC22A5	Renal carnitine transport defect|not specified	Benign/Likely benign(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	5	131714106	5	132378414	25373	36707
NM_003060.3(SLC22A5):c.505C>T (p.Arg169Trp)	SLC22A5	Renal carnitine transport defect	Pathogenic/Likely pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	5	131719846	5	132384154	6422	21461
NM_003060.3(SLC22A5):c.1193C>T (p.Pro398Leu)	SLC22A5	Renal carnitine transport defect|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	5	131726522	5	132390830	25411	36745
NM_003060.3(SLC22A5):c.1340A>G (p.Tyr447Cys)	SLC22A5	Renal carnitine transport defect|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 7, 2017)	criteria provided, multiple submitters, no conflicts	5	131728197	5	132392505	25418	36752
NM_003060.3(SLC22A5):c.1354G>A (p.Glu452Lys)	SLC22A5	Renal carnitine transport defect|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 5, 2018)	criteria provided, conflicting interpretations	5	131728211	5	132392519	25421	36755
NM_003060.3(SLC22A5):c.1403C>G (p.Thr468Arg)	SLC22A5	Renal carnitine transport defect	Likely pathogenic(Last reviewed: Aug 6, 2014)	criteria provided, single submitter	5	131728260	5	132392568	25424	36758
NM_001033503.2(SAR1B):c.409G>A (p.Asp137Asn)	SAR1B	Chylomicron retention disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 22, 2018)	criteria provided, multiple submitters, no conflicts	5	133944133	5	134608443	2923	17962
NM_002488.4(NDUFA2):c.134A>C (p.Lys45Thr)	NDUFA2|TMCO6	Cystic Leukoencephalopathy	Pathogenic	criteria provided, single submitter	5	140026915	5	140647330	214711	211112
NM_020117.10(LARS):c.1292T>A (p.Val431Asp)	LARS	not specified|Infantile liver failure syndrome 1	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	5	145531558	5	146151995	431849	425624
NM_020117.10(LARS):c.242G>T (p.Gly81Val)	LARS	Infantile liver failure syndrome 1	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	5	145551525	5	146171962	561050	552085
NM_024577.3(SH3TC2):c.1586G>A (p.Arg529His)	SH3TC2	Charcot-Marie-Tooth disease, type 4C	Pathogenic(Last reviewed: Oct 31, 2013)	criteria provided, single submitter	5	148407709	5	149028146	2478	17517
NM_000112.3(SLC26A2):c.835C>T (p.Arg279Trp)	SLC26A2	Achondrogenesis, type IB|Atelosteogenesis type 2|Multiple epiphyseal dysplasia 4|Diastrophic dysplasia|Osteochondrodysplasia|not provided|Inborn genetic diseases|SLC26A2-Related Disorders	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	5	149359991	5	149980428	4089	19128
NM_000112.3(SLC26A2):c.1474C>T (p.Arg492Trp)	SLC26A2	Achondrogenesis, type IB|Atelosteogenesis type 2|Multiple epiphyseal dysplasia 4|Diastrophic dysplasia|Achondrogenesis|Osteochondrodysplasia|not specified|Atelosteogenesis|not provided	Benign/Likely benign(Last reviewed: Nov 1, 2017)	criteria provided, multiple submitters, no conflicts	5	149360630	5	149981067	65559	76467
NM_000112.3(SLC26A2):c.2033G>T (p.Gly678Val)	SLC26A2	Achondrogenesis, type IB|Multiple epiphyseal dysplasia 4|Diastrophic dysplasia	Likely pathogenic(Last reviewed: Mar 16, 2014)	criteria provided, single submitter	5	149361189	5	149981626	4094	19133
NM_001146040.1(GLRA1):c.1270G>A (p.Asp424Asn)	GLRA1	Hyperekplexia hereditary	Likely pathogenic	criteria provided, single submitter	5	151202338	5	151822777	545477	535737
NM_000337.5(SGCD):c.290G>A (p.Arg97Gln)	SGCD	Limb-girdle muscular dystrophy, type 2F|Delta-sarcoglycanopathy|not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	Benign/Likely benign(Last reviewed: Aug 8, 2017)	criteria provided, multiple submitters, no conflicts	5	155935708	5	156508698	48117	57281
NM_001099287.1(NIPAL4):c.527C>A (p.Ala176Asp)	NIPAL4	Autosomal recessive congenital ichthyosis 6|not provided|Congenital ichthyosiform erythroderma	Pathogenic(Last reviewed: Apr 4, 2018)	criteria provided, multiple submitters, no conflicts	5	156895736	5	157468728	1731	16770
NM_003314.2(TTC1):c.784T>G (p.Phe262Val)	TTC1|PWWP2A	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	5	159491977	5	160064970	402170	389124
NM_007255.2(B4GALT7):c.808C>T (p.Arg270Cys)	B4GALT7	Ehlers-Danlos syndrome progeroid type|Multiple joint dislocations, short stature, craniofacial dysmorphism, and congenital heart defects|not provided	Pathogenic(Last reviewed: Nov 29, 2016)	criteria provided, single submitter	5	177035995	5	177608994	5613	20652
NM_006261.4(PROP1):c.358C>T (p.Arg120Cys)	PROP1	Pituitary hormone deficiency, combined 2	Likely pathogenic(Last reviewed: Apr 9, 2014)	criteria provided, single submitter	5	177420033	5	177993032	8095	23134
NM_006261.4(PROP1):c.349T>A (p.Phe117Ile)	PROP1	Pituitary hormone deficiency, combined 2	Likely pathogenic(Last reviewed: Jun 14, 2014)	criteria provided, single submitter	5	177420042	5	177993041	8096	23135
NM_006261.4(PROP1):c.152G>C (p.Gly51Ala)	PROP1	Pituitary hormone deficiency, combined 2|not specified|not provided|Combined Pituitary Hormone Deficiency, Recessive	Benign/Likely benign(Last reviewed: Oct 13, 2016)	criteria provided, multiple submitters, no conflicts	5	177421297	5	177994296	188820	186698
NM_006261.4(PROP1):c.3G>C (p.Met1Ile)	PROP1	Pituitary hormone deficiency, combined 2	Likely pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	5	177422932	5	177995931	424617	411512
NM_006567.4(FARS2):c.192C>G (p.Ser64Arg)	FARS2	Combined oxidative phosphorylation deficiency 14	Likely pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	6	5368995	6	5368762	488515	481383
NM_006567.4(FARS2):c.422G>A (p.Gly141Glu)	FARS2	Spastic paraplegia 77, autosomal recessive	Uncertain significance(Last reviewed: Jun 27, 2018)	no assertion criteria provided	6	5369225	6	5368992	545657	536153
NM_006567.4(FARS2):c.431A>G (p.Tyr144Cys)	FARS2	Mitochondrial encephalomyopathy|Global developmental delay|Combined oxidative phosphorylation deficiency 14|not provided|Global developmental delay|Mitochondrial encephalomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jun 13, 2018)	criteria provided, multiple submitters, no conflicts	6	5369234	6	5369001	39824	48423
NM_006567.4(FARS2):c.1082C>T (p.Pro361Leu)	FARS2	Combined oxidative phosphorylation deficiency 14|not provided|Inborn genetic diseases|Spastic paraplegia 77, autosomal recessive	Conflicting interpretations of pathogenicity(Last reviewed: Jun 13, 2018)	criteria provided, conflicting interpretations	6	5613418	6	5613185	214335	211259
NM_006567.4(FARS2):c.1163T>G (p.Ile388Ser)	FARS2	Combined oxidative phosphorylation deficiency 14	Likely pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	6	5613499	6	5613266	488516	481384
NM_198586.2(NHLRC1):c.973G>A (p.Val325Met)	NHLRC1	not provided	Uncertain significance(Last reviewed: Jan 15, 2014)	criteria provided, single submitter	6	18121865	6	18121634	129768	135214
NM_198586.2(NHLRC1):c.332C>T (p.Pro111Leu)	NHLRC1	Lafora disease|not specified|Seizures|not provided	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	18122506	6	18122275	129767	135213
NM_001080.3(ALDH5A1):c.538C>T (p.His180Tyr)	ALDH5A1	Succinate-semialdehyde dehydrogenase deficiency|not specified	Benign(Last reviewed: Aug 10, 2016)	criteria provided, multiple submitters, no conflicts	6	24503590	6	24503362	128343	133792
NM_001080.3(ALDH5A1):c.545C>T (p.Pro182Leu)	ALDH5A1	Succinate-semialdehyde dehydrogenase deficiency|not specified	Benign/Likely benign(Last reviewed: Aug 10, 2017)	criteria provided, multiple submitters, no conflicts	6	24503597	6	24503369	128344	133793
NM_000410.3(HFE):c.187C>G (p.His63Asp)	HFE|LOC108783645	Microvascular complications of diabetes 7|Hemochromatosis type 1|not provided|Hereditary hemochromatosis	Pathogenic, other, risk factor(Last reviewed: Jul 10, 2018)	criteria provided, multiple submitters, no conflicts	6	26091179	6	26090951	10	15049
NM_000410.3(HFE):c.845G>A (p.Cys282Tyr)	HFE	Microvascular complications of diabetes 7|Hemochromatosis type 1|Porphyria cutanea tarda, susceptibility to|Porphyria variegata, susceptibility to|Hemochromatosis, juvenile, digenic|Alzheimer disease, susceptibility to|Transferrin serum level quantitative trait locus 2|not provided|Hereditary cancer-predisposing syndrome|Cutaneous photosensitivity|Porphyrinuria|Hereditary hemochromatosis	Conflicting interpretations of pathogenicity, association, other, risk factor(Last reviewed: Nov 21, 2018)	criteria provided, conflicting interpretations	6	26093141	6	26092913	9	15048
NM_001109809.2(ZFP57):c.1118C>G (p.Ser373Cys)	ZFP57	not provided	Uncertain significance(Last reviewed: Nov 4, 2013)	criteria provided, single submitter	6	29640770	6	29672993	130769	136215
NM_001109809.2(ZFP57):c.1103A>T (p.Asp368Val)	ZFP57	not specified|Transient Neonatal Diabetes, Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	29640785	6	29673008	130773	136219
NM_001109809.2(ZFP57):c.593A>G (p.Asn198Ser)	ZFP57	not specified|Transient Neonatal Diabetes, Recessive	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	29641295	6	29673518	130771	136217
NM_001109809.2(ZFP57):c.559C>T (p.Arg187Cys)	ZFP57	not specified|Transient Neonatal Diabetes, Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	29641329	6	29673552	130775	136221
NM_001109809.2(ZFP57):c.374G>A (p.Arg125Gln)	ZFP57	not specified|Transient Neonatal Diabetes, Recessive	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	29641514	6	29673737	130774	136220
NM_001109809.3(ZFP57):c.113G>A (p.Arg38Gln)	ZFP57	not provided|Transient Neonatal Diabetes, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	29644668	6	29676891	130770	136216
NM_001167734.1(VARS2):c.601C>T (p.Arg201Trp)	VARS2	Combined oxidative phosphorylation deficiency 20|Inborn genetic diseases	Likely pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, multiple submitters, no conflicts	6	30883762	6	30915985	488636	481504
NM_001167734.1(VARS2):c.1100C>T (p.Thr367Ile)	VARS2	Combined oxidative phosphorylation deficiency 20|Inborn genetic diseases	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, multiple submitters, no conflicts	6	30886628	6	30918851	141427	151141
NM_001167734.1(VARS2):c.1258G>A (p.Ala420Thr)	VARS2	not provided|Combined oxidative phosphorylation deficiency 20	Uncertain significance(Last reviewed: May 4, 2017)	criteria provided, single submitter	6	30887868	6	30920091	522814	513421
NM_020442.5(VARS2):c.1400G>C (p.Arg467Pro)	VARS2	Combined oxidative phosphorylation deficiency 20	Likely pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	6	30888447	6	30920670	488637	481505
NM_006295.2(VARS):c.3214T>C (p.Phe1072Leu)	VARS	Delayed speech and language development|Premature birth|Microcephaly|Intellectual disability|Generalized hypotonia|Elevated hepatic transaminases	Uncertain significance(Last reviewed: Jul 18, 2018)	criteria provided, single submitter	6	31747459	6	31779682	559443	550166
NM_006295.2(VARS):c.3173G>A (p.Arg1058Gln)	VARS	Abnormality of brain morphology|NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY	Likely pathogenic	criteria provided, single submitter	6	31747500	6	31779723	402134	389127
NM_006295.2(VARS):c.2825G>A (p.Arg942Gln)	VARS	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY	Pathogenic(Last reviewed: Sep 3, 2018)	no assertion criteria provided	6	31748318	6	31780541	561999	553136
NM_006295.2(VARS):c.2653C>T (p.Leu885Phe)	VARS	Abnormality of brain morphology|NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY	Likely pathogenic	criteria provided, single submitter	6	31748712	6	31780935	402133	389128
NM_006295.2(VARS):c.2074G>C (p.Ala692Pro)	VARS	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY	Pathogenic	no assertion criteria provided	6	31750138	6	31782361	520392	510989
NM_006295.2(VARS):c.1981C>A (p.Pro661Thr)	VARS|VARS2	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY	Likely pathogenic(Last reviewed: Oct 24, 2017)	no assertion criteria provided	6	31750317	6	31782540	522588	513202
NM_006295.2(VARS):c.1300C>G (p.Leu434Val)	VARS	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY	Pathogenic(Last reviewed: Sep 3, 2018)	no assertion criteria provided	6	31753070	6	31785293	561994	553139
NM_006295.2(VARS):c.65C>A (p.Ala22Asp)	VARS	Delayed speech and language development|Premature birth|Intellectual disability|Generalized hypotonia|Elevated hepatic transaminases|Postnatal microcephaly	Uncertain significance(Last reviewed: Jul 18, 2018)	criteria provided, single submitter	6	31762930	6	31795153	559442	550167
NM_000500.7(CYP21A2):c.92C>T (p.Pro31Leu)	CYP21A2|LOC106780800	Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not provided	Pathogenic(Last reviewed: Jun 16, 2016)	criteria provided, multiple submitters, no conflicts	6	32006291	6	32038514	12153	27192
NM_000500.7(CYP21A2):c.274A>G (p.Arg92Gly)	CYP21A2|LOC106780800	Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency	Likely pathogenic(Last reviewed: Jun 15, 2017)	criteria provided, single submitter	6	32006570	6	32038793	448906	442474
NM_000500.7(CYP21A2):c.[377C>G];[518T>A]	CYP21A2|LOC106780800	Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency	Pathogenic(Last reviewed: Sep 16, 2016)	criteria provided, single submitter	6|6	32007203	6|6	32039426	427842	27189|362051
NM_000500.7(CYP21A2):c.[518T>A];[830_841delTCCTGGAAGGGC]	CYP21A2|LOC106780800	Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency	Pathogenic(Last reviewed: Sep 30, 2016)	criteria provided, single submitter	6|6	32007203	6|6	32039426	427840	27189|361971
NM_000500.9(CYP21A2):c.710_719delTCGTGGAGATinsACGAGGAGAA (p.Ile237_Met240delinsAsnGluGluLys)	CYP21A2|LOC106780800	Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not provided	Pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, multiple submitters, no conflicts	6	32007584 - 32007593	6	32039807 - 32039816	189145	186703
NM_000500.7(CYP21A2):c.844G>T (p.Val282Leu)	CYP21A2|LOC106780800	Adenoma, cortisol-producing|Carcinoma, adrenocortical, androgen-secreting|Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: May 30, 2018)	criteria provided, multiple submitters, no conflicts	6	32007887	6	32040110	12151	27190
NM_000500.7(CYP21A2):c.1118G>A (p.Ser373Asn)	CYP21A2|LOC106780800	Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency	Likely pathogenic(Last reviewed: May 17, 2017)	criteria provided, single submitter	6	32008361	6	32040584	448899	442475
NM_000500.7(CYP21A2):c.1136T>A (p.Ile379Asn)	CYP21A2|LOC106780800	Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency	Likely pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	6	32008462	6	32040685	448904	442476
NM_019105.6(TNXB):c.9655G>A (p.Val3219Met)	TNXB	Ehlers-Danlos-like syndrome due to tenascin-X deficiency	Uncertain significance(Last reviewed: Mar 30, 2015)	criteria provided, single submitter	6	32017143	6	32049366	209196	205747
NM_019105.6(TNXB):c.9631A>G (p.Arg3211Gly)	TNXB	Ehlers-Danlos-like syndrome due to tenascin-X deficiency	Uncertain significance(Last reviewed: Mar 8, 2013)	criteria provided, single submitter	6	32017167	6	32049390	209197	205748
NM_080680.2(COL11A2):c.1607G>A (p.Arg536Gln)	COL11A2	Multiple joint dislocations, short stature, craniofacial dysmorphism, and congenital heart defects	Uncertain significance(Last reviewed: Nov 2, 2016)	criteria provided, single submitter	6	33146854	6	33179077	191205	189008
NM_181336.3(LEMD2):c.38T>G (p.Leu13Arg)	LEMD2	Cataract Hutterite type	Pathogenic(Last reviewed: Nov 1, 2015)	criteria provided, single submitter	6	33756856	6	33789079	235192	236890
NM_001145717.1(PNPLA1):c.266C>T (p.Pro89Leu)	PNPLA1	Autosomal recessive congenital ichthyosis 10	Likely pathogenic	no assertion criteria provided	6	36259157	6	36291380	375259	361960
NM_001145717.1(PNPLA1):c.335C>A (p.Ser112Tyr)	PNPLA1	Autosomal recessive congenital ichthyosis 10	Likely pathogenic	no assertion criteria provided	6	36259226	6	36291449	375258	361959
NM_001145717.1(PNPLA1):c.350C>T (p.Thr117Met)	PNPLA1	Autosomal recessive congenital ichthyosis 10	Likely pathogenic	no assertion criteria provided	6	36259241	6	36291464	375257	361958
NM_001145717.1(PNPLA1):c.418T>C (p.Ser140Pro)	PNPLA1	Autosomal recessive congenital ichthyosis 10	Likely pathogenic	no assertion criteria provided	6	36259309	6	36291532	375256	361957
NM_000287.3(PEX6):c.821C>T (p.Pro274Leu)	PEX6	Peroxisome biogenesis disorder 4a (zellweger)|Peroxisome biogenesis disorder 4B|Inborn genetic diseases|Heimler syndrome 2	Pathogenic/Likely pathogenic(Last reviewed: Sep 6, 2018)	criteria provided, multiple submitters, no conflicts	6	42946068	6	42978330	217424	214063
NM_203290.3(POLR1C):c.88C>T (p.Pro30Ser)	POLR1C	Leukodystrophy, hypomyelinating, 11	Pathogenic	no assertion criteria provided	6	43485062	6	43517324	375402	362145
NM_001078177.1(SLC29A1):c.1159A>C (p.Thr387Pro)	SLC29A1	Hemolytic disease of fetus OR newborn due to isoimmunization	Pathogenic(Last reviewed: May 20, 2017)	no assertion criteria provided	6	44200643	6	44232906	429191	421143
NM_020745.3(AARS2):c.2356G>A (p.Ala786Thr)	AARS2	Combined oxidative phosphorylation deficiency 8	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	6	44270547	6	44302810	488461	481329
NM_020745.3(AARS2):c.1774C>T (p.Arg592Trp)	AARS2	Combined oxidative phosphorylation deficiency 8|Pulmonary hypoplasia|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, multiple submitters, no conflicts	6	44272249	6	44304512	30940	39897
NM_020745.3(AARS2):c.1534G>C (p.Asp512His)	AARS2	Combined oxidative phosphorylation deficiency 8|Combined oxidative phosphorylation deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Sep 8, 2017)	criteria provided, conflicting interpretations	6	44272836	6	44305099	357070	300368
NM_020745.3(AARS2):c.985C>T (p.Arg329Cys)	AARS2	Combined oxidative phosphorylation deficiency 8|Combined oxidative phosphorylation deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Sep 8, 2017)	criteria provided, conflicting interpretations	6	44275041	6	44307304	357074	307903
NM_000255.3(MMUT):c.1874A>G (p.Asp625Gly)	MMUT	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	6	49408001	6	49440288	222938	224623
NM_000255.3(MMUT):c.1853T>C (p.Leu618Pro)	MMUT	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	6	49408022	6	49440309	222937	224624
NM_000255.3(MMUT):c.1655C>T (p.Ala552Val)	MMUT	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	6	49412373	6	49444660	222935	224626
NM_000255.3(MMUT):c.1277G>A (p.Gly426Glu)	MMUT	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	6	49419234	6	49451521	222932	224629
NM_000255.3(MMUT):c.1271C>T (p.Pro424Leu)	MMUT	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	6	49419240	6	49451527	222931	224630
NM_000255.3(MMUT):c.1164T>A (p.Asn388Lys)	MMUT	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	6	49419347	6	49451634	222929	224632
NM_000255.3(MMUT):c.1142G>T (p.Gly381Val)	MMUT	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Likely pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	6	49419369	6	49451656	488554	481422
NM_000255.3(MMUT):c.977G>A (p.Arg326Lys)	MMUT	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	6	49421404	6	49453691	222926	224635
NM_000255.3(MMUT):c.974G>A (p.Gly325Asp)	MMUT	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	6	49421407	6	49453694	222925	224636
NM_000255.3(MMUT):c.851G>A (p.Gly284Glu)	MMUT	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	6	49423853	6	49456140	222923	224638
NM_000255.3(MMUT):c.850G>A (p.Gly284Arg)	MMUT	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	6	49423854	6	49456141	222922	224639
NM_000255.3(MMUT):c.828G>C (p.Glu276Asp)	MMUT	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	6	49423876	6	49456163	222921	224640
NM_000255.3(MMUT):c.689C>G (p.Thr230Arg)	MMUT	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	6	49425468	6	49457755	222918	224643
NM_000255.3(MMUT):c.566A>T (p.Asn189Ile)	MMUT	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	6	49425591	6	49457878	222915	224646
NM_000255.3(MMUT):c.560C>G (p.Thr187Ser)	MMUT	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	6	49425597	6	49457884	222914	224647
NM_000255.3(MMUT):c.467A>T (p.Asp156Val)	MMUT	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	6	49425690	6	49457977	222913	224648
NM_000255.3(MMUT):c.415G>A (p.Asp139Asn)	MMUT	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	6	49425742	6	49458029	222912	224649
NM_000255.3(MMUT):c.397G>A (p.Gly133Arg)	MMUT	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	6	49425760	6	49458047	222911	224650
NM_000255.3(MMUT):c.378C>A (p.Asn126Lys)	MMUT	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic	criteria provided, single submitter	6	49426802	6	49459089	222910	224651
NM_000255.3(MMUT):c.[1891delG];[322C>T]	MMUT	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Mar 18, 2014)	criteria provided, single submitter	6|6	49426858	6|6	49459145	424788	16926|213573
NM_000255.3(MMUT):c.2T>C (p.Met1Thr)	MMUT	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency|METHYLMALONIC ACIDURIA, mut(0) TYPE	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, multiple submitters, no conflicts	6	49427178	6	49459465	222903	224657
NM_138694.3(PKHD1):c.10585G>C (p.Glu3529Gln)	PKHD1	Autosomal recessive polycystic kidney disease|not specified|not provided	Benign/Likely benign(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	6	51524339	6	51659541	96367	102261
NM_138694.3(PKHD1):c.10444C>T (p.Arg3482Cys)	PKHD1	Autosomal recessive polycystic kidney disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 22, 2017)	criteria provided, multiple submitters, no conflicts	6	51524480	6	51659682	188896	186706
NM_138694.3(PKHD1):c.9866G>T (p.Ser3289Ile)	PKHD1	Autosomal recessive polycystic kidney disease|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 4, 2017)	criteria provided, conflicting interpretations	6	51611651	6	51746853	167475	176973
NM_138694.3(PKHD1):c.9415G>T (p.Asp3139Tyr)	PKHD1	Autosomal recessive polycystic kidney disease|not specified	Benign/Likely benign(Last reviewed: Aug 30, 2017)	criteria provided, multiple submitters, no conflicts	6	51612999	6	51748201	167479	177368
NM_138694.3(PKHD1):c.8606C>A (p.Thr2869Lys)	PKHD1	Autosomal recessive polycystic kidney disease|not specified|not provided	Benign/Likely benign(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	6	51637536	6	51772738	96436	102330
NM_138694.3(PKHD1):c.8521A>G (p.Met2841Val)	PKHD1	Autosomal recessive polycystic kidney disease|not specified	Benign/Likely benign(Last reviewed: Nov 21, 2017)	criteria provided, multiple submitters, no conflicts	6	51640639	6	51775841	188742	186708
NM_138694.3(PKHD1):c.8345G>C (p.Gly2782Ala)	PKHD1	Autosomal recessive polycystic kidney disease|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 2, 2018)	criteria provided, conflicting interpretations	6	51656129	6	51791331	96431	102325
NM_138694.3(PKHD1):c.7921A>G (p.Thr2641Ala)	PKHD1	Autosomal recessive polycystic kidney disease|not specified	Benign/Likely benign(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	6	51712759	6	51847961	96426	102320
NM_138694.3(PKHD1):c.6992T>A (p.Ile2331Lys)	PKHD1	Autosomal recessive polycystic kidney disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 27, 2018)	criteria provided, multiple submitters, no conflicts	6	51768399	6	51903601	188813	186710
NM_138694.3(PKHD1):c.5725C>T (p.Arg1909Trp)	PKHD1	Autosomal recessive polycystic kidney disease|not specified|not provided	Benign/Likely benign(Last reviewed: Oct 31, 2017)	criteria provided, multiple submitters, no conflicts	6	51875133	6	52010335	96411	102305
NM_138694.3(PKHD1):c.3407A>G (p.Tyr1136Cys)	PKHD1	Autosomal recessive polycystic kidney disease|not specified|not provided	Benign/Likely benign(Last reviewed: Nov 6, 2017)	criteria provided, multiple submitters, no conflicts	6	51893107	6	52028309	167489	177369
NM_138694.3(PKHD1):c.3367G>A (p.Gly1123Ser)	PKHD1	Autosomal recessive polycystic kidney disease	Likely pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, multiple submitters, no conflicts	6	51893147	6	52028349	188959	186712
NM_138694.3(PKHD1):c.2279G>A (p.Arg760His)	PKHD1	Autosomal recessive polycystic kidney disease	Pathogenic/Likely pathogenic(Last reviewed: Jul 11, 2014)	criteria provided, multiple submitters, no conflicts	6	51914955	6	52050157	188876	186714
NM_138694.3(PKHD1):c.2027C>G (p.Pro676Arg)	PKHD1	Autosomal recessive polycystic kidney disease|not specified|not provided	Benign/Likely benign(Last reviewed: Oct 31, 2017)	criteria provided, multiple submitters, no conflicts	6	51917987	6	52053189	96383	102277
NM_138694.3(PKHD1):c.1880T>A (p.Met627Lys)	PKHD1	Autosomal recessive polycystic kidney disease	Pathogenic(Last reviewed: Dec 22, 2014)	criteria provided, single submitter	6	51918920	6	52054122	189098	186715
NM_138694.3(PKHD1):c.1877A>G (p.Lys626Arg)	PKHD1	Autosomal recessive polycystic kidney disease|not specified	Benign(Last reviewed: Jun 28, 2017)	criteria provided, multiple submitters, no conflicts	6	51918923	6	52054125	188736	186716
NM_138694.3(PKHD1):c.664A>G (p.Ile222Val)	PKHD1	Autosomal recessive polycystic kidney disease|not provided	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	6	51935807	6	52071009	406891	395418
NM_001144769.2(DST):c.608C>A (p.Ala203Glu)	DST|LOC101930010	Neuropathy, hereditary sensory and autonomic, type VI	Likely pathogenic(Last reviewed: Aug 14, 2018)	no assertion criteria provided	6	56716212	6	56851414	559660	550381
NM_133645.2(MTO1):c.938G>A (p.Arg313Gln)	MTO1	Combined oxidative phosphorylation deficiency 10	Likely pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	6	74189567	6	73479844	488550	481418
NM_133645.2(MTO1):c.963A>C (p.Lys321Asn)	MTO1	Combined oxidative phosphorylation deficiency 10	Likely pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	6	74189683	6	73479960	488551	481419
NM_133645.2(MTO1):c.1504C>T (p.Arg502Cys)	MTO1	Combined oxidative phosphorylation deficiency 10	Likely pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	6	74191931	6	73482208	488553	481421
NM_133645.2(MTO1):c.1505G>A (p.Arg502His)	MTO1	Combined oxidative phosphorylation deficiency 10|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, multiple submitters, no conflicts	6	74191932	6	73482209	89037	94578
NM_012123.3(MTO1):c.1450C>T (p.Arg484Trp)	MTO1	Combined oxidative phosphorylation deficiency 10	Conflicting interpretations of pathogenicity(Last reviewed: Oct 25, 2017)	criteria provided, conflicting interpretations	6	74191952	6	73482229	408272	395566
NM_001123226.1(MTO1):c.1907T>A (p.Leu636Gln)	MTO1	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	6	74207489	6	73497766	402214	389129
NM_001123226.1(MTO1):c.2053C>A (p.Arg685Ser)	MTO1	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	6	74210312	6	73500589	402215	389130
NM_012434.4(SLC17A5):c.406A>G (p.Lys136Glu)	SLC17A5	Salla disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 30, 2015)	criteria provided, multiple submitters, no conflicts	6	74351533	6	73641810	21493	34345
NM_012434.4(SLC17A5):c.116G>A (p.Arg39His)	SLC17A5	Salla disease	Likely pathogenic(Last reviewed: Nov 30, 2017)	criteria provided, single submitter	6	74354305	6	73644582	431079	424602
NM_015599.3(PGM3):c.1352A>G (p.Gln451Arg)	PGM3	Immunodeficiency 23	Pathogenic(Last reviewed: Jul 3, 2014)	criteria provided, single submitter	6	83881669	6	83171950	140735	150448
NM_015599.3(PGM3):c.737A>G (p.Asn246Ser)	PGM3	Immunodeficiency 23	Pathogenic(Last reviewed: Jul 3, 2014)	criteria provided, single submitter	6	83891505	6	83181786	140732	150445
NM_015599.3(PGM3):c.715G>C (p.Asp239His)	PGM3	Immunodeficiency 23	Pathogenic(Last reviewed: Jul 3, 2014)	criteria provided, single submitter	6	83891527	6	83181808	224830	226663
NM_153816.5(SNX14):c.1108G>A (p.Glu370Lys)	SNX14	Spinocerebellar ataxia, autosomal recessive 20	Pathogenic(Last reviewed: Nov 14, 2016)	no assertion criteria provided	6	86256830	6	85547112	268133	263760
NM_020320.4(RARS2):c.1544A>G (p.Asp515Gly)	RARS2	Pontocerebellar hypoplasia type 6	Likely pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	6	88226566	6	87516848	488585	481453
NM_020320.4(RARS2):c.1327T>C (p.Ser443Pro)	RARS2	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	6	88228436	6	87518718	402195	389132
NM_020320.4(RARS2):c.991A>G (p.Ile331Val)	RARS2	Pontoneocerebellar hypoplasia|not specified|not provided	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	88231226	6	87521508	130100	135546
NM_020320.4(RARS2):c.872A>G (p.Lys291Arg)	RARS2	Pontoneocerebellar hypoplasia|not specified|not provided	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	6	88239266	6	87529548	130099	135545
NM_020320.3(RARS2):c.703G>A (p.Val235Met)	RARS2	Pontoneocerebellar hypoplasia|not specified|not provided	Benign/Likely benign(Last reviewed: May 2, 2017)	criteria provided, multiple submitters, no conflicts	6	88240570	6	87530852	130098	135544
NM_020320.4(RARS2):c.419T>G (p.Phe140Cys)	RARS2	Pontocerebellar hypoplasia type 6|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Apr 7, 2017)	criteria provided, multiple submitters, no conflicts	6	88258341	6	87548623	215055	211289
NM_020320.4(RARS2):c.214C>G (p.Leu72Val)	RARS2	Pontocerebellar hypoplasia type 6	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	6	88272503	6	87562785	561096	552109
NM_020320.4(RARS2):c.1A>G (p.Met1Val)	RARS2	Pontocerebellar hypoplasia type 6|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	6	88299675	6	87589957	225026	226903
NM_012160.4(FBXL4):c.1790A>C (p.Gln597Pro)	FBXL4	not provided|Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	Conflicting interpretations of pathogenicity(Last reviewed: May 23, 2018)	criteria provided, conflicting interpretations	6	99322230	6	98874354	437486	431036
NM_012160.4(FBXL4):c.1772A>C (p.Asp591Ala)	FBXL4	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	Conflicting interpretations of pathogenicity(Last reviewed: Nov 16, 2017)	criteria provided, conflicting interpretations	6	99322248	6	98874372	437812	431044
NM_012160.4(FBXL4):c.1703G>C (p.Gly568Ala)	FBXL4	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	Pathogenic/Likely pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, multiple submitters, no conflicts	6	99322317	6	98874441	66092	76994
NM_012160.4(FBXL4):c.1540T>G (p.Trp514Gly)	FBXL4	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	Likely pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, multiple submitters, no conflicts	6	99323453	6	98875577	437479	431096
NM_012160.4(FBXL4):c.1442T>C (p.Leu481Pro)	FBXL4	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	Likely pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, single submitter	6	99323551	6	98875675	224911	226780
NM_012160.4(FBXL4):c.419T>C (p.Val140Ala)	FBXL4	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	Likely pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, single submitter	6	99374446	6	98926570	375387	362147
NM_021956.4(GRIK2):c.2601G>A (p.Met867Ile)	GRIK2	not specified	Benign(Last reviewed: Apr 1, 2013)	criteria provided, single submitter	6	102516260	6	102068385	129176	134622
NM_018013.3(SOBP):c.319A>G (p.Thr107Ala)	SOBP	not specified|not provided	Likely benign(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	6	107827529	6	107506325	130362	135809
NM_018013.3(SOBP):c.1382A>C (p.His461Pro)	SOBP	not specified	Likely benign(Last reviewed: Aug 7, 2013)	criteria provided, single submitter	6	107955430	6	107634226	130357	135804
NM_018013.3(SOBP):c.1615A>G (p.Ile539Val)	SOBP	not specified|not provided	Benign(Last reviewed: Dec 30, 2016)	criteria provided, single submitter	6	107955663	6	107634459	130360	135807
NM_018013.3(SOBP):c.1810C>A (p.Gln604Lys)	SOBP	not provided	Uncertain significance(Last reviewed: May 8, 2013)	criteria provided, single submitter	6	107955858	6	107634654	130358	135805
NM_018013.3(SOBP):c.2047A>G (p.Ser683Gly)	SOBP	not specified	Benign(Last reviewed: Oct 24, 2013)	criteria provided, single submitter	6	107956095	6	107634891	130361	135808
NM_173560.3(RFX6):c.50C>A (p.Ala17Glu)	RFX6	not specified|Monogenic diabetes	Benign(Last reviewed: Sep 29, 2017)	criteria provided, single submitter	6	117198488	6	116877325	130156	135603
NM_173560.3(RFX6):c.541C>T (p.Arg181Trp)	RFX6	Mitchell-Riley syndrome|Mitchell-Riley syndrome	Likely pathogenic(Last reviewed: Mar 22, 2014)	criteria provided, single submitter	6	117203566	6	116882403	130157	135604
NM_173560.3(RFX6):c.1327C>T (p.His443Tyr)	RFX6	not specified|Monogenic diabetes	Benign(Last reviewed: Mar 24, 2017)	criteria provided, multiple submitters, no conflicts	6	117241617	6	116920454	130148	135595
NM_173560.3(RFX6):c.2369G>A (p.Gly790Glu)	RFX6	not specified|Monogenic diabetes	Likely benign(Last reviewed: Nov 4, 2016)	criteria provided, single submitter	6	117248673	6	116927510	130155	135602
NM_002944.2(ROS1):c.1094G>C (p.Gly365Ala)	ROS1	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	6	117715395	6	117394232	402166	389125
NM_000426.3(LAMA2):c.1798G>A (p.Gly600Arg)	LAMA2	Laminin alpha 2-related dystrophy|not specified	Benign(Last reviewed: Aug 9, 2017)	criteria provided, multiple submitters, no conflicts	6	129571272	6	129250127	92941	98848
NM_000426.3(LAMA2):c.1856G>A (p.Arg619His)	LAMA2	Merosin deficient congenital muscular dystrophy|not specified|Congenital Muscular Dystrophy, LAMA2-related	Benign(Last reviewed: Apr 13, 2017)	criteria provided, multiple submitters, no conflicts	6	129571330	6	129250185	92943	98850
NM_000426.3(LAMA2):c.1930C>G (p.His644Asp)	LAMA2	Laminin alpha 2-related dystrophy|not specified|Congenital Muscular Dystrophy, LAMA2-related	Conflicting interpretations of pathogenicity(Last reviewed: Sep 28, 2017)	criteria provided, conflicting interpretations	6	129573274	6	129252129	129435	134881
NM_000426.3(LAMA2):c.2756G>T (p.Arg919Leu)	LAMA2	Laminin alpha 2-related dystrophy|not specified|Congenital Muscular Dystrophy, LAMA2-related	Benign/Likely benign(Last reviewed: Aug 8, 2017)	criteria provided, multiple submitters, no conflicts	6	129612765	6	129291620	92948	98855
NM_000426.3(LAMA2):c.3296A>G (p.Asn1099Ser)	LAMA2	Laminin alpha 2-related dystrophy|not specified|not provided|Congenital Muscular Dystrophy, LAMA2-related	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	6	129634127	6	129312982	129437	134883
NM_000426.3(LAMA2):c.3412G>A (p.Val1138Met)	LAMA2	Merosin deficient congenital muscular dystrophy|not specified|Congenital Muscular Dystrophy, LAMA2-related	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	129635800	6	129314655	92952	98859
NM_000426.3(LAMA2):c.3613A>G (p.Thr1205Ala)	LAMA2	Laminin alpha 2-related dystrophy|not specified|Congenital Muscular Dystrophy, LAMA2-related	Benign/Likely benign(Last reviewed: Dec 18, 2017)	criteria provided, multiple submitters, no conflicts	6	129636678	6	129315533	129438	134884
NM_000426.3(LAMA2):c.4750G>A (p.Gly1584Ser)	LAMA2	Laminin alpha 2-related dystrophy|not specified	Benign(Last reviewed: Aug 7, 2017)	criteria provided, multiple submitters, no conflicts	6	129687396	6	129366251	92962	98869
NM_000426.3(LAMA2):c.5179G>C (p.Glu1727Gln)	LAMA2	Polymicrogyria|Congenital Muscular Dystrophy, LAMA2-related	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	6	129712743	6	129391598	355276	305750
NM_000426.3(LAMA2):c.5530C>A (p.Arg1844Ser)	LAMA2	Laminin alpha 2-related dystrophy|not specified|not provided|Polymicrogyria	Conflicting interpretations of pathogenicity(Last reviewed: Jan 4, 2018)	criteria provided, conflicting interpretations	6	129722453	6	129401308	92968	98875
NM_000426.3(LAMA2):c.6167C>A (p.Thr2056Lys)	LAMA2	Laminin alpha 2-related dystrophy|not specified|Congenital Muscular Dystrophy, LAMA2-related	Benign/Likely benign(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	6	129762042	6	129440897	129439	134885
NM_000426.3(LAMA2):c.6539A>T (p.Asp2180Val)	LAMA2	Laminin alpha 2-related dystrophy|not specified|not provided|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Dec 7, 2017)	criteria provided, conflicting interpretations	6	129774242	6	129453097	129441	134887
NM_000426.3(LAMA2):c.7431A>T (p.Arg2477Ser)	LAMA2	Laminin alpha 2-related dystrophy|not specified|not provided	Benign/Likely benign(Last reviewed: Jan 4, 2018)	criteria provided, multiple submitters, no conflicts	6	129794489	6	129473344	129442	134888
NM_000426.3(LAMA2):c.7881T>G (p.His2627Gln)	LAMA2	Merosin deficient congenital muscular dystrophy	Likely pathogenic(Last reviewed: Apr 17, 2017)	criteria provided, single submitter	6	129807750	6	129486605	38341	46905
NM_000426.3(LAMA2):c.7906A>G (p.Thr2636Ala)	LAMA2	Merosin deficient congenital muscular dystrophy|not specified|Congenital Muscular Dystrophy, LAMA2-related	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	129813053	6	129491908	92989	98896
NM_000426.3(LAMA2):c.8528A>G (p.Asn2843Ser)	LAMA2	Merosin deficient congenital muscular dystrophy|Laminin alpha 2-related dystrophy|not specified|not provided|Congenital Muscular Dystrophy, LAMA2-related	Benign/Likely benign(Last reviewed: Jan 4, 2018)	criteria provided, multiple submitters, no conflicts	6	129824406	6	129503261	129445	134891
NM_006208.3(ENPP1):c.797G>T (p.Gly266Val)	ENPP1	Arterial calcification of infancy|Hypophosphatemic rickets, autosomal recessive, 2	Pathogenic(Last reviewed: Dec 5, 2013)	criteria provided, single submitter	6	132181528	6	131860388	13594	28633
NM_006208.3(ENPP1):c.1652A>G (p.Tyr551Cys)	ENPP1	Arterial calcification of infancy	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	6	132196932	6	131875792	561004	552092
NM_006208.3(ENPP1):c.2330A>G (p.His777Arg)	ENPP1	Arterial calcification of infancy	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	6	132206089	6	131884949	561005	552093
NM_017651.4(AHI1):c.[2561G>T];[3368C>T]	AHI1	Joubert syndrome 3	Likely pathogenic(Last reviewed: Mar 11, 2014)	criteria provided, single submitter	6|6	135639715	6|6	135318577	424763	101653|213564
NM_017651.4(AHI1):c.3257A>G (p.Glu1086Gly)	AHI1	Joubert syndrome|Joubert syndrome 3|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 3, 2018)	criteria provided, conflicting interpretations	6	135644371	6	135323233	143152	152870
NM_017651.4(AHI1):c.3053A>C (p.Gln1018Pro)	AHI1	Joubert syndrome|not specified|not provided	Benign/Likely benign(Last reviewed: Dec 19, 2017)	criteria provided, multiple submitters, no conflicts	6	135715970	6	135394832	128327	133776
NM_017651.4(AHI1):c.2488C>T (p.Arg830Trp)	AHI1	Joubert syndrome|not specified	Benign/Likely benign(Last reviewed: Aug 8, 2017)	criteria provided, multiple submitters, no conflicts	6	135751024	6	135429886	128324	133773
NM_001134831.1(AHI1):c.2282C>T (p.Ser761Leu)	AHI1	Joubert syndrome 3|not provided	Uncertain significance(Last reviewed: Jul 18, 2014)	criteria provided, multiple submitters, no conflicts	6	135752437	6	135431299	194664	191827
NM_017651.4(AHI1):c.1643G>A (p.Arg548His)	AHI1	Joubert syndrome|not specified	Benign(Last reviewed: Feb 9, 2017)	criteria provided, multiple submitters, no conflicts	6	135768282	6	135447144	128322	133771
NM_000288.3(PEX7):c.74C>T (p.Ser25Phe)	PEX7	Rhizomelic chondrodysplasia punctata type 1|Peroxisome biogenesis disorder 9B	Conflicting interpretations of pathogenicity(Last reviewed: Jan 3, 2018)	criteria provided, conflicting interpretations	6	137143877	6	136822739	188918	186699
NM_000288.3(PEX7):c.400G>A (p.Asp134Asn)	PEX7	Rhizomelic chondrodysplasia punctata type 1	Likely pathogenic(Last reviewed: Mar 2, 2014)	criteria provided, single submitter	6	137166813	6	136845675	188711	186701
NM_001278064.1(GRM1):c.2977T>C (p.Ser993Pro)	GRM1	not specified|Spinocerebellar ataxia, autosomal recessive 13	Benign/Likely benign	no assertion criteria provided	6	146755324	6	146434188	129210	134656
NM_017909.3(RMND1):c.713A>G	RMND1	Mitochondrial diseases|Combined oxidative phosphorylation deficiency 11|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2017)	criteria provided, conflicting interpretations	6	151751289	6	151430154	225255	171703
NM_000125.3(ESR1):c.1181G>A (p.Arg394His)	ESR1	Estrogen resistance	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2018)	no assertion criteria provided	6	152332875	6	152011740	430713	424252
NM_033071.3(SYNE1):c.10748G>A (p.Arg3583Gln)	SYNE1	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	6	152675993	6	152354858	402199	389126
NM_032861.3(SERAC1):c.1577G>A (p.Gly526Glu)	SERAC1	3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome	Uncertain significance(Last reviewed: Apr 16, 2018)	criteria provided, single submitter	6	158535928	6	158114896	446407	439862
NM_004562.2(PRKN):c.823C>T (p.Arg275Trp)	PRKN	Parkinson disease 2|not provided|Parkinson Disease, Juvenile|Young-onset Parkinson disease	Pathogenic(Last reviewed: Jun 19, 2018)	criteria provided, multiple submitters, no conflicts	6	162206852	6	161785820	7050	22089
NM_016098.3(MPC1):c.214A>G (p.Lys72Glu)	MPC1	Mitochondrial pyruvate carrier deficiency	Likely pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	6	166779553	6	166366065	488547	481415
NM_020223.3(FAM20C):c.1228T>A (p.Ser410Thr)	FAM20C	Raine syndrome|not specified	Benign(Last reviewed: Aug 30, 2016)	criteria provided, single submitter	7	295970	7	256004	289269	273506
NM_014855.3(AP5Z1):c.281C>G (p.Ser94Cys)	AP5Z1	Spastic paraplegia 48, autosomal recessive|not specified	Benign(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	7	4821300	7	4781669	128413	133862
NM_014855.2(AP5Z1):c.333G>C (p.Gln111His)	AP5Z1	Spastic paraplegia 48, autosomal recessive|not specified	Benign(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	7	4821352	7	4781721	128414	133863
NM_014855.2(AP5Z1):c.1124T>A (p.Leu375Gln)	AP5Z1	not specified|Spastic Paraplegia, Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	7	4825307	7	4785676	128408	133857
NM_014855.3(AP5Z1):c.2098G>A (p.Val700Met)	AP5Z1	Spastic paraplegia 48, autosomal recessive|not specified	Benign(Last reviewed: Jul 27, 2017)	criteria provided, single submitter	7	4830463	7	4790832	128411	133860
NM_001101.4(ACTB):c.625G>A (p.Val209Met)	ACTB	Baraitser-Winter syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, multiple submitters, no conflicts	7	5568089	7	5528458	127172	132670
NM_001101.4(ACTB):c.64G>A (p.Ala22Thr)	ACTB	Baraitser-Winter syndrome 1	Likely pathogenic(Last reviewed: Aug 15, 2013)	criteria provided, single submitter	7	5569225	7	5529594	128262	133711
NM_001101426.3(CRPPA):c.1220T>C (p.Leu407Ser)	CRPPA|CRPPA-AS1	not specified|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A7|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 7|Congenital Muscular Dystrophy, alpha-dystroglycan related	Conflicting interpretations of pathogenicity(Last reviewed: Jan 4, 2018)	criteria provided, conflicting interpretations	7	16255722	7	16216097	129285	134731
NM_001101426.3(CRPPA):c.979C>G (p.Leu327Val)	CRPPA|CRPPA-AS1	not provided	Uncertain significance(Last reviewed: Jul 6, 2016)	criteria provided, multiple submitters, no conflicts	7	16298592	7	16258967	129290	134736
NM_001101426.3(CRPPA):c.407C>T (p.Ala136Val)	CRPPA	not specified|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A7|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 7|Congenital Muscular Dystrophy, alpha-dystroglycan related	Benign/Likely benign(Last reviewed: Aug 4, 2017)	criteria provided, multiple submitters, no conflicts	7	16445813	7	16406188	129287	134733
NM_001101426.3(CRPPA):c.55A>C (p.Ser19Arg)	CRPPA	not specified|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A7|Congenital Muscular Dystrophy, alpha-dystroglycan related	Benign(Last reviewed: Aug 24, 2016)	criteria provided, multiple submitters, no conflicts	7	16460893	7	16421268	129288	134734
NM_001101426.3(CRPPA):c.32C>G (p.Pro11Arg)	CRPPA	not specified|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A7|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 7	Benign/Likely benign(Last reviewed: Jan 18, 2018)	criteria provided, multiple submitters, no conflicts	7	16460916	7	16421291	129286	134732
NM_001277115.1(DNAH11):c.2966G>A (p.Arg989Gln)	DNAH11	Ciliary dyskinesia, primary, 7|Ciliary dyskinesia	Uncertain significance(Last reviewed: May 24, 2018)	criteria provided, multiple submitters, no conflicts	7	21639703	7	21600085	453287	446887
NM_002047.3(GARS):c.929G>A (p.Arg310Gln)	GARS	GARS-associated growth retardation and developmental delay	Pathogenic	no assertion criteria provided	7	30651759	7	30612143	431181	424704
NM_000823.3(GHRHR):c.281G>A (p.Arg94Gln)	GHRHR	Isolated growth hormone deficiency type 1B	Likely pathogenic(Last reviewed: Apr 22, 2013)	no assertion criteria provided	7	31009494	7	30969879	161436	171271
NM_000823.3(GHRHR):c.418T>C (p.Ser140Pro)	GHRHR	Isolated growth hormone deficiency type 1B	Likely pathogenic(Last reviewed: Apr 22, 2013)	no assertion criteria provided	7	31010785	7	30971170	161435	171272
NM_000823.3(GHRHR):c.495C>A (p.His165Gln)	GHRHR	Isolated growth hormone deficiency type 1B	Likely pathogenic(Last reviewed: Apr 22, 2013)	no assertion criteria provided	7	31011608	7	30971993	161437	171273
NM_138295.4(PKD1L1):c.5072G>C (p.Cys1691Ser)	PKD1L1	Situs inversus totalis|Situs inversus totalis|Heterotaxy, visceral, 8, autosomal	Likely pathogenic(Last reviewed: May 27, 2016)	criteria provided, single submitter	7	47886558	7	47846960	235198	236892
NM_001242888.1(DDC):c.1123C>T (p.Arg375Cys)	DDC	Deficiency of aromatic-L-amino-acid decarboxylase	Likely pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, single submitter	7	50531015	7	50463317	559481	550205
NM_001082971.1(DDC):c.1352G>T (p.Cys451Phe)	DDC	Deficiency of aromatic-L-amino-acid decarboxylase	Likely pathogenic(Last reviewed: Oct 17, 2016)	criteria provided, single submitter	7	50531020	7	50463322	488382	481234
NM_000790.3(DDC):c.1073G>A (p.Arg358His)	DDC	Deficiency of aromatic-L-amino-acid decarboxylase|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 17, 2016)	criteria provided, multiple submitters, no conflicts	7	50537838	7	50470140	379626	371156
NM_000181.4(GUSB):c.1429C>T (p.Arg477Trp)	GUSB	Mucopolysaccharidosis type VII	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	7	65435316	7	65970329	599019	590118
NM_000048.3(ASL):c.578G>A (p.Arg193Gln)	ASL	Argininosuccinate lyase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 22, 2017)	criteria provided, multiple submitters, no conflicts	7	65551784	7	66086797	372306	359828
NM_153033.4(KCTD7):c.172G>A (p.Gly58Arg)	KCTD7	Epilepsy, progressive myoclonic 3	Uncertain significance(Last reviewed: May 17, 2017)	criteria provided, single submitter	7	66098289	7	66633302	469100	457541
NM_153033.4(KCTD7):c.280C>T (p.Arg94Trp)	KCTD7	Epilepsy, progressive myoclonic 3	Likely pathogenic(Last reviewed: Aug 22, 2017)	criteria provided, single submitter	7	66098397	7	66633410	37010	45676
NM_153033.4(KCTD7):c.302G>A (p.Gly101Asp)	KCTD7	Epilepsy, progressive myoclonic 3	Uncertain significance(Last reviewed: Jun 26, 2018)	no assertion criteria provided	7	66098419	7	66633432	548928	539415
NM_153033.4(KCTD7):c.458G>A (p.Arg153His)	KCTD7	Epilepsy, progressive myoclonic 3	Uncertain significance(Last reviewed: Jun 8, 2018)	criteria provided, multiple submitters, no conflicts	7	66103383	7	66638396	561040	552118
NM_153033.4(KCTD7):c.533C>T (p.Ala178Val)	KCTD7	Epilepsy, progressive myoclonic 3	Likely pathogenic(Last reviewed: Jul 11, 2017)	criteria provided, single submitter	7	66103882	7	66638895	559579	550302
NM_016038.3(SBDS):c.98A>C (p.Lys33Thr)	SBDS	Shwachman syndrome	Pathogenic(Last reviewed: Jun 1, 2014)	criteria provided, single submitter	7	66460307	7	66995320	219289	219162
NM_005918.3(MDH2):c.[109G>A];[398C>T]	MDH2	Infantile encephalopathy	Pathogenic	no assertion criteria provided	7|7	75687365	7|7	76058047	427831	260444|262040
NM_005918.3(MDH2):c.398C>T (p.Pro133Leu)	MDH2	Infantile encephalopathy|Epileptic encephalopathy, early infantile, 51	Pathogenic	criteria provided, single submitter	7	75687365	7	76058047	265769	260444
NM_005918.3(MDH2):c.620C>T (p.Pro207Leu)	MDH2	Infantile encephalopathy|Epileptic encephalopathy, early infantile, 51	Pathogenic(Last reviewed: Feb 8, 2017)	no assertion criteria provided	7	75692897	7	76063579	265770	260445
NM_001540.4(HSPB1):c.295C>A (p.Leu99Met)	HSPB1	Distal hereditary motor neuronopathy type 2B	Likely pathogenic(Last reviewed: Dec 30, 2010)	no assertion criteria provided	7	75932324	7	76303007	7485	22524
NM_000466.2(PEX1):c.2088A>G (p.Ile696Met)	PEX1	Zellweger syndrome|not specified	Benign/Likely benign(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	7	92132493	7	92503179	129882	135328
NM_000466.2(PEX1):c.1991T>C (p.Leu664Pro)	PEX1	Zellweger syndrome	Likely pathogenic(Last reviewed: Jun 5, 2014)	criteria provided, single submitter	7	92134126	7	92504812	7517	22556
NM_000466.2(PEX1):c.3G>A (p.Met1Ile)	PEX1	Zellweger syndrome	Likely pathogenic(Last reviewed: Dec 24, 2014)	criteria provided, single submitter	7	92157747	7	92528433	189106	186760
NM_133436.3(ASNS):c.1165G>C (p.Glu389Gln)	ASNS|CZ1P-ASNS	Asparagine synthetase deficiency	Likely pathogenic(Last reviewed: Mar 31, 2018)	no assertion criteria provided	7	97483965	7	97854653	545473	535733
NM_001145715.2(KPNA7):c.1046T>C (p.Leu349Pro)	KPNA7	Intellectual disability, mild	Uncertain significance(Last reviewed: Oct 7, 2014)	criteria provided, single submitter	7	98782640	7	99185017	209170	205755
NM_004722.3(AP4M1):c.26C>T (p.Ser9Phe)	MCM7|AP4M1	Spastic paraplegia 50, autosomal recessive	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	7	99699363	7	100101740	560945	552110
NM_004722.3(AP4M1):c.812G>A (p.Arg271His)	AP4M1	not specified	Benign(Last reviewed: Mar 3, 2016)	criteria provided, single submitter	7	99702947	7	100105324	128405	133854
NM_016188.4(ACTL6B):c.893G>A (p.Arg298Gln)	ACTL6B	Global developmental delay|Intellectual disability|Global developmental delay	Likely pathogenic	criteria provided, single submitter	7	100244637	7	100647014	402140	389133
NM_005045.3(RELN):c.9730G>A (p.Gly3244Ser)	RELN|LOC101927870	Lissencephaly 2|not specified|not provided|Epilepsy, familial temporal lobe, 7|Lissencephaly, Recessive	Benign/Likely benign(Last reviewed: Mar 8, 2018)	criteria provided, multiple submitters, no conflicts	7	103130222	7	103489775	130146	135593
NM_005045.3(RELN):c.8798C>T (p.Thr2933Ile)	RELN|LOC101927870	not specified	Likely benign	no assertion criteria provided	7	103138569	7	103498122	130144	135591
NM_005045.3(RELN):c.8086G>A (p.Ala2696Thr)	RELN	Lissencephaly 2|not specified|not provided|Epilepsy, familial temporal lobe, 7|Lissencephaly, Recessive	Benign/Likely benign(Last reviewed: Dec 8, 2017)	criteria provided, multiple submitters, no conflicts	7	103155665	7	103515218	130143	135590
NM_005045.3(RELN):c.7909C>T (p.Arg2637Cys)	RELN	not provided	Uncertain significance(Last reviewed: Apr 16, 2013)	criteria provided, single submitter	7	103155842	7	103515395	130113	135559
NM_005045.3(RELN):c.6726G>C (p.Arg2242Ser)	RELN	Epilepsy, lateral temporal lobe, autosomal dominant|Lissencephaly 2|not provided|Epilepsy, familial temporal lobe, 7	Uncertain significance(Last reviewed: Dec 15, 2017)	criteria provided, multiple submitters, no conflicts	7	103180848	7	103540401	130135	135581
NM_005045.3(RELN):c.5831T>G (p.Phe1944Cys)	RELN	Lissencephaly 2|not specified|Epilepsy, familial temporal lobe, 7|Lissencephaly, Recessive	Benign/Likely benign(Last reviewed: Dec 29, 2017)	criteria provided, multiple submitters, no conflicts	7	103194245	7	103553798	130131	135577
NM_005045.3(RELN):c.5618C>T (p.Thr1873Ile)	RELN	Lissencephaly 2|not specified|not provided|Epilepsy, familial temporal lobe, 7|Lissencephaly, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Jan 25, 2018)	criteria provided, conflicting interpretations	7	103197603	7	103557156	167582	177377
NM_005045.3(RELN):c.5156C>T (p.Ser1719Leu)	RELN	Lissencephaly 2|not specified|not provided|Epilepsy, familial temporal lobe, 7	Conflicting interpretations of pathogenicity(Last reviewed: Dec 18, 2017)	criteria provided, conflicting interpretations	7	103205779	7	103565332	130126	135572
NM_005045.3(RELN):c.5095G>A (p.Glu1699Lys)	RELN	Lissencephaly 2|not provided|Epilepsy, familial temporal lobe, 7	Uncertain significance(Last reviewed: Jul 19, 2017)	criteria provided, multiple submitters, no conflicts	7	103205840	7	103565393	130124	135570
NM_005045.3(RELN):c.4907A>G (p.Asp1636Gly)	RELN	Lissencephaly 2|not provided|Epilepsy, familial temporal lobe, 7	Uncertain significance(Last reviewed: Sep 18, 2017)	criteria provided, multiple submitters, no conflicts	7	103206700	7	103566253	130123	135569
NM_005045.3(RELN):c.3839G>A (p.Gly1280Glu)	RELN	Lissencephaly 2|not specified|not provided|Epilepsy, familial temporal lobe, 7	Benign/Likely benign(Last reviewed: Jan 5, 2018)	criteria provided, multiple submitters, no conflicts	7	103234202	7	103593755	95219	101119
NM_005045.3(RELN):c.3125C>T (p.Ser1042Leu)	RELN	not provided	Uncertain significance(Last reviewed: Dec 23, 2013)	criteria provided, single submitter	7	103244814	7	103604367	130120	135566
NM_005045.3(RELN):c.2989C>G (p.Leu997Val)	RELN	not specified|not provided|Lissencephaly, Recessive	Benign/Likely benign(Last reviewed: Sep 6, 2018)	criteria provided, multiple submitters, no conflicts	7	103251161	7	103610714	130119	135565
NM_005045.3(RELN):c.2932A>G (p.Thr978Ala)	RELN	Lissencephaly 2|not specified|not provided|Epilepsy, familial temporal lobe, 7|Lissencephaly, Recessive|Rolandic epilepsy	Conflicting interpretations of pathogenicity(Last reviewed: Jan 5, 2018)	criteria provided, conflicting interpretations	7	103251218	7	103610771	130118	135564
NM_005045.3(RELN):c.2434C>G (p.His812Asp)	RELN	Lissencephaly 2|not provided|Epilepsy, familial temporal lobe, 7	Uncertain significance(Last reviewed: Mar 14, 2018)	criteria provided, multiple submitters, no conflicts	7	103275903	7	103635456	130117	135563
NM_005045.3(RELN):c.1888A>C (p.Ser630Arg)	RELN	Lissencephaly 2|not specified|not provided|Epilepsy, familial temporal lobe, 7|Lissencephaly, Recessive	Benign/Likely benign(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	7	103292112	7	103651665	130116	135562
NM_005045.3(RELN):c.1799C>T (p.Ser600Phe)	RELN	Lissencephaly 2|not specified|not provided|Epilepsy, familial temporal lobe, 7	Benign(Last reviewed: Oct 31, 2017)	criteria provided, multiple submitters, no conflicts	7	103292201	7	103651754	95213	101113
NM_005045.3(RELN):c.416C>G (p.Thr139Ser)	RELN	Lissencephaly 2|not specified|Epilepsy, familial temporal lobe, 7|Lissencephaly, Recessive	Benign/Likely benign(Last reviewed: Dec 28, 2017)	criteria provided, multiple submitters, no conflicts	7	103474041	7	103833594	130121	135567
NM_005045.3(RELN):c.26A>C (p.Gln9Pro)	RELN	Lissencephaly 2|not specified|Epilepsy, familial temporal lobe, 7|Lissencephaly, Recessive	Benign/Likely benign(Last reviewed: Dec 18, 2017)	criteria provided, multiple submitters, no conflicts	7	103629778	7	103989331	95217	101117
NM_000441.1(SLC26A4):c.3G>C (p.Met1Ile)	SLC26A4|SLC26A4-AS1	Pendred syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 5, 2018)	criteria provided, multiple submitters, no conflicts	7	107302089	7	107661644	188721	186722
NM_000441.1(SLC26A4):c.17G>T (p.Gly6Val)	SLC26A4|SLC26A4-AS1	Pendred syndrome|not specified|not provided	Benign/Likely benign(Last reviewed: Jan 23, 2018)	criteria provided, multiple submitters, no conflicts	7	107302103	7	107661658	43524	52693
NM_000441.1(SLC26A4):c.84C>A (p.Ser28Arg)	SLC26A4|SLC26A4-AS1	Pendred syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 19, 2017)	criteria provided, multiple submitters, no conflicts	7	107302170	7	107661725	188998	186723
NM_000441.1(SLC26A4):c.85G>C (p.Glu29Gln)	SLC26A4|SLC26A4-AS1	Enlarged vestibular aqueduct|Pendred syndrome|Wolff-Parkinson-White pattern	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, multiple submitters, no conflicts	7	107302171	7	107661726	4839	19878
NM_000441.1(SLC26A4):c.269C>T (p.Ser90Leu)	SLC26A4	Pendred syndrome	Likely pathogenic(Last reviewed: Jun 20, 2014)	criteria provided, single submitter	7	107303845	7	107663400	188842	186727
NM_000441.1(SLC26A4):c.296C>G (p.Thr99Arg)	SLC26A4	Enlarged vestibular aqueduct	Pathogenic(Last reviewed: Jan 3, 2017)	no assertion criteria provided	7	107303872	7	107663427	417623	404601
NM_000441.1(SLC26A4):c.349C>T	SLC26A4	Enlarged vestibular aqueduct|Pendred syndrome|not provided	Likely pathogenic(Last reviewed: Sep 26, 2018)	reviewed by expert panel	7	107312627	7	107672182	43555	52724
NM_000441.1(SLC26A4):c.412G>T (p.Val138Phe)	SLC26A4	Enlarged vestibular aqueduct|Pendred syndrome|not provided|SLC26A4-Related Disorders	Pathogenic(Last reviewed: Sep 19, 2018)	reviewed by expert panel	7	107312690	7	107672245	4835	19874
NM_000441.1(SLC26A4):c.554G>C (p.Arg185Thr)	SLC26A4	Enlarged vestibular aqueduct|Pendred syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 31, 2018)	criteria provided, conflicting interpretations	7	107314747	7	107674302	188878	186731
NM_000441.1(SLC26A4):c.565G>T (p.Ala189Ser)	SLC26A4	Pendred syndrome|not specified	Benign(Last reviewed: Sep 28, 2018)	reviewed by expert panel	7	107314758	7	107674313	43560	52729
NM_000441.1(SLC26A4):c.626G>T (p.Gly209Val)	SLC26A4	Enlarged vestibular aqueduct|Pendred syndrome|not provided	Pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, multiple submitters, no conflicts	7	107315415	7	107674970	4821	19860
NM_000441.1(SLC26A4):c.706C>G (p.Leu236Val)	SLC26A4	Enlarged vestibular aqueduct|Pendred syndrome|not specified	Likely pathogenic(Last reviewed: Sep 10, 2018)	reviewed by expert panel	7	107315495	7	107675050	43565	52734
NM_000441.1(SLC26A4):c.707T>C (p.Leu236Pro)	SLC26A4	Enlarged vestibular aqueduct|Pendred syndrome|not provided	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, multiple submitters, no conflicts	7	107315496	7	107675051	4817	19856
NM_000441.1(SLC26A4):c.716T>A (p.Val239Asp)	SLC26A4	Enlarged vestibular aqueduct|Pendred syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 15, 2016)	criteria provided, multiple submitters, no conflicts	7	107315505	7	107675060	43566	52735
NM_000441.1(SLC26A4):c.898A>C (p.Ile300Leu)	SLC26A4	Pendred syndrome|not specified	Benign/Likely benign(Last reviewed: Jul 31, 2017)	criteria provided, multiple submitters, no conflicts	7	107323779	7	107683334	43570	52739
NM_000441.1(SLC26A4):c.970A>T (p.Asn324Tyr)	SLC26A4	Pendred syndrome|not specified	Benign/Likely benign(Last reviewed: Aug 3, 2016)	criteria provided, multiple submitters, no conflicts	7	107323951	7	107683506	43574	52743
NM_000441.1(SLC26A4):c.1001G>T (p.Gly334Val)	SLC26A4	Pendred syndrome	Likely pathogenic(Last reviewed: Oct 28, 2014)	criteria provided, single submitter	7	107323982	7	107683537	189039	186733
NM_000441.1(SLC26A4):c.1003T>C (p.Phe335Leu)	SLC26A4	Enlarged vestibular aqueduct|Pendred syndrome|not specified|not provided	Likely pathogenic(Last reviewed: Nov 21, 2017)	criteria provided, multiple submitters, no conflicts	7	107329499	7	107689054	4842	19881
NM_000441.1(SLC26A4):c.1079C>T (p.Ala360Val)	SLC26A4	Pendred syndrome	Likely pathogenic(Last reviewed: May 21, 2014)	criteria provided, single submitter	7	107329575	7	107689130	188793	186734
NM_000441.1(SLC26A4):c.1151A>G (p.Glu384Gly)	SLC26A4	Enlarged vestibular aqueduct|Pendred syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, multiple submitters, no conflicts	7	107330570	7	107690125	4820	19859
NM_000441.1(SLC26A4):c.1204G>A (p.Val402Met)	SLC26A4	Enlarged vestibular aqueduct|Pendred syndrome|SLC26A4-Related Disorders	Conflicting interpretations of pathogenicity(Last reviewed: Nov 17, 2016)	criteria provided, conflicting interpretations	7	107330623	7	107690178	43495	52665
NM_000441.1(SLC26A4):c.1226G>A (p.Arg409His)	SLC26A4	Enlarged vestibular aqueduct|Pendred syndrome|not specified|not provided	Pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, multiple submitters, no conflicts	7	107330645	7	107690200	43496	52666
NM_000441.1(SLC26A4):c.1229C>T (p.Thr410Met)	SLC26A4	Enlarged vestibular aqueduct|Pendred syndrome|not provided	Pathogenic(Last reviewed: Sep 17, 2018)	reviewed by expert panel	7	107330648	7	107690203	43498	52668
NM_000441.1(SLC26A4):c.1246A>C (p.Thr416Pro)	SLC26A4	Enlarged vestibular aqueduct|Pendred syndrome|not provided	Pathogenic(Last reviewed: Nov 22, 2017)	criteria provided, multiple submitters, no conflicts	7	107330665	7	107690220	4818	19857
NM_000441.1(SLC26A4):c.1334T>G (p.Leu445Trp)	SLC26A4	Enlarged vestibular aqueduct|Pendred syndrome|not provided	Pathogenic(Last reviewed: Oct 10, 2015)	criteria provided, multiple submitters, no conflicts	7	107334918	7	107694473	4829	19868
NM_000441.1(SLC26A4):c.1363A>T (p.Ile455Phe)	SLC26A4	Pendred syndrome|not specified|not provided	Benign(Last reviewed: Sep 28, 2018)	reviewed by expert panel	7	107335087	7	107694642	43507	52677
NM_000441.1(SLC26A4):c.1489G>A (p.Gly497Ser)	SLC26A4	Enlarged vestibular aqueduct|Pendred syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	7	107336429	7	107695984	43510	19855
NM_000441.1(SLC26A4):c.1586T>G (p.Ile529Ser)	SLC26A4	Enlarged vestibular aqueduct|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, multiple submitters, no conflicts	7	107338528	7	107698083	189160	186737
NM_000441.1(SLC26A4):c.1588T>C (p.Tyr530His)	SLC26A4	Enlarged vestibular aqueduct|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 27, 2016)	criteria provided, multiple submitters, no conflicts	7	107338530	7	107698085	4836	19875
NM_000441.1(SLC26A4):c.1694G>A (p.Cys565Tyr)	SLC26A4	Enlarged vestibular aqueduct|Pendred syndrome	Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	7	107340607	7	107700162	43519	52688
NM_000441.1(SLC26A4):c.1963A>G (p.Ile655Val)	SLC26A4	Enlarged vestibular aqueduct|Pendred syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Apr 19, 2018)	criteria provided, conflicting interpretations	7	107342431	7	107701986	43528	52697
NM_000441.1(SLC26A4):c.1975G>C (p.Val659Leu)	SLC26A4	Enlarged vestibular aqueduct|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, multiple submitters, no conflicts	7	107342443	7	107701998	188889	186740
NM_000441.1(SLC26A4):c.2015G>A (p.Gly672Glu)	SLC26A4	Enlarged vestibular aqueduct|Pendred syndrome	Pathogenic(Last reviewed: Feb 19, 2015)	criteria provided, single submitter	7	107342483	7	107702038	43532	52701
NM_000441.1(SLC26A4):c.2027T>A (p.Leu676Gln)	SLC26A4	Enlarged vestibular aqueduct|Pendred syndrome	Likely pathogenic(Last reviewed: Nov 11, 2014)	criteria provided, single submitter	7	107342495	7	107702050	43533	52702
NM_000441.1(SLC26A4):c.2145G>T (p.Lys715Asn)	SLC26A4	Enlarged vestibular aqueduct|Pendred syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 10, 2018)	criteria provided, conflicting interpretations	7	107350554	7	107710109	43541	52710
NM_000441.1(SLC26A4):c.2162C>T (p.Thr721Met)	SLC26A4	Enlarged vestibular aqueduct|Pendred syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, multiple submitters, no conflicts	7	107350571	7	107710126	4826	19865
NM_000441.1(SLC26A4):c.2168A>G (p.His723Arg)	SLC26A4	Enlarged vestibular aqueduct|Pendred syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 22, 2017)	criteria provided, multiple submitters, no conflicts	7	107350577	7	107710132	4825	19864
NM_000441.1(SLC26A4):c.2171A>G (p.Asp724Gly)	SLC26A4	Enlarged vestibular aqueduct|Pendred syndrome	Pathogenic(Last reviewed: Dec 24, 2015)	criteria provided, single submitter	7	107350580	7	107710135	228396	229545
NM_000441.1(SLC26A4):c.2218G>A (p.Gly740Ser)	SLC26A4	Pendred syndrome|not specified|not provided	Benign/Likely benign(Last reviewed: May 23, 2018)	criteria provided, multiple submitters, no conflicts	7	107350627	7	107710182	43544	52713
NM_000441.1(SLC26A4):c.2291C>T (p.Thr764Met)	SLC26A4	Pendred syndrome|not specified|Nonsyndromic Hearing Loss, Recessive	Uncertain significance(Last reviewed: Sep 28, 2018)	reviewed by expert panel	7	107353039	7	107712594	43546	52715
NM_002291.2(LAMB1):c.5347A>G (p.Ser1783Gly)	LAMB1	Lissencephaly 5	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	7	107564410	7	107923965	561154	552112
NM_002291.2(LAMB1):c.4183G>A (p.Glu1395Lys)	LAMB1	Lissencephaly 5	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	7	107575865	7	107935420	561153	552113
NM_000492.3(CFTR):c.1A>G (p.Met1Val)	CFTR	Cystic fibrosis|not provided	Pathogenic(Last reviewed: Mar 17, 2017)	reviewed by expert panel	7	117120149	7	117480095	53423	68091
NM_000492.3(CFTR):c.2T>C (p.Met1Thr)	CFTR	Cystic fibrosis	Likely pathogenic(Last reviewed: Jul 23, 2014)	criteria provided, single submitter	7	117120150	7	117480096	53622	68290
NM_000492.3(CFTR):c.14C>T (p.Pro5Leu)	CFTR	Cystic fibrosis|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 5, 2018)	criteria provided, conflicting interpretations	7	117120162	7	117480108	35824	44488
NM_000492.3(CFTR):c.200C>T (p.Pro67Leu)	CFTR	Cystic fibrosis|Hereditary pancreatitis|not provided|ivacaftor response - Efficacy	Pathogenic/Likely pathogenic, drug response(Last reviewed: Jul 9, 2018)	reviewed by expert panel	7	117149123	7	117509069	53425	68093
NM_000492.3(CFTR):c.254G>A (p.Gly85Glu)	CFTR	Cystic fibrosis|not provided	Pathogenic(Last reviewed: Mar 3, 2004)	practice guideline	7	117149177	7	117509123	7143	22182
NM_000492.3(CFTR):c.328G>C (p.Asp110His)	CFTR	Cystic fibrosis|not provided|ivacaftor response - Efficacy	Pathogenic/Likely pathogenic, drug response(Last reviewed: Mar 22, 2018)	reviewed by expert panel	7	117171007	7	117530953	7108	22147
NM_000492.3(CFTR):c.350G>A (p.Arg117His)	CFTR	Cystic fibrosis|Hereditary pancreatitis|Congenital bilateral absence of the vas deferens|not provided|ivacaftor response - Efficacy	Pathogenic(Last reviewed: Mar 3, 2004)	practice guideline	7	117171029	7	117530975	7109	22148
NM_000492.3(CFTR):c.964G>A (p.Val322Met)	CFTR	not specified	Uncertain significance(Last reviewed: Oct 20, 2011)	criteria provided, single submitter	7	117180248	7	117540194	43580	52749
NM_000492.3(CFTR):c.1000C>T (p.Arg334Trp)	CFTR	Cystic fibrosis|not provided	Pathogenic(Last reviewed: Mar 3, 2004)	practice guideline	7	117180284	7	117540230	7139	22178
NM_000492.3(CFTR):c.1007T>A (p.Ile336Lys)	CFTR	Cystic fibrosis|not provided	Pathogenic(Last reviewed: Mar 17, 2017)	reviewed by expert panel	7	117180291	7	117540237	53162	67830
NM_000492.3(CFTR):c.1040G>C (p.Arg347Pro)	CFTR	Cystic fibrosis|not provided	Pathogenic(Last reviewed: Mar 3, 2004)	practice guideline	7	117180324	7	117540270	7110	22149
NM_000492.3(CFTR):c.1054C>T (p.Arg352Trp)	CFTR	Cystic fibrosis|Hereditary pancreatitis|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 15, 2018)	criteria provided, conflicting interpretations	7	117180338	7	117540284	35816	44480
NM_000492.3(CFTR):c.1364C>A (p.Ala455Glu)	CFTR|CFTR-AS1	Cystic fibrosis|ivacaftor response - Efficacy	Pathogenic(Last reviewed: Mar 3, 2004)	practice guideline	7	117188849	7	117548795	7111	22150
NM_000492.3(CFTR):c.1408G>A (p.Val470Met)	CFTR|CFTR-AS1	Cystic fibrosis|not specified|not provided	Benign/Likely benign(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	7	117199533	7	117559479	7130	22169
NM_000492.3(CFTR):c.1518C>G (p.Ile506Met)	CFTR|CFTR-AS1	Cystic fibrosis	Pathogenic(Last reviewed: Oct 19, 2015)	no assertion criteria provided	7	117199643	7	117559589	53278	67946
NM_000492.3(CFTR):c.1519A>G (p.Ile507Val)	CFTR|CFTR-AS1	Cystic fibrosis|not provided	Likely benign(Last reviewed: Oct 1, 2017)	criteria provided, multiple submitters, no conflicts	7	117199644	7	117559590	188863	186746
NM_000492.3(CFTR):c.1558G>A (p.Val520Ile)	CFTR|CFTR-AS1	Cystic fibrosis|Hereditary pancreatitis|not provided	Uncertain significance(Last reviewed: Dec 7, 2018)	criteria provided, multiple submitters, no conflicts	7	117199683	7	117559629	35825	44489
NM_000492.3(CFTR):c.1652G>A (p.Gly551Asp)	CFTR|LOC111674475	Cystic fibrosis|Hereditary pancreatitis|not provided|ivacaftor response - Efficacy	Pathogenic(Last reviewed: Mar 3, 2004)	practice guideline	7	117227860	7	117587806	7120	22159
NM_000492.3(CFTR):c.1679G>C (p.Arg560Thr)	CFTR|LOC111674475	Cystic fibrosis|not provided	Pathogenic(Last reviewed: Mar 3, 2004)	practice guideline	7	117227887	7	117587833	7113	22152
NM_000492.3(CFTR):c.1684G>A (p.Val562Ile)	CFTR	Cystic fibrosis|not provided	Uncertain significance(Last reviewed: Nov 5, 2018)	criteria provided, multiple submitters, no conflicts	7	117230411	7	117590357	35830	44494
NM_000492.3(CFTR):c.1727G>C (p.Gly576Ala)	CFTR	Cystic fibrosis|Hereditary pancreatitis|Congenital bilateral absence of the vas deferens|not specified|not provided|Chronic sinusitis|Lung disease, non-specific	Conflicting interpretations of pathogenicity(Last reviewed: Nov 5, 2018)	criteria provided, conflicting interpretations	7	117230454	7	117590400	7165	22204
NM_000492.3(CFTR):c.1865G>A (p.Gly622Asp)	CFTR	Cystic fibrosis|Hereditary pancreatitis|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 15, 2018)	criteria provided, multiple submitters, no conflicts	7	117232086	7	117592032	35833	44497
NM_000492.3(CFTR):c.2768C>A (p.Ala923Asp)	CFTR	Cystic fibrosis	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	7	117243696	7	117603642	35848	44512
NM_000492.3(CFTR):c.2834C>T (p.Ser945Leu)	CFTR	Cystic fibrosis|Hereditary pancreatitis|not provided|ivacaftor response - Efficacy	Pathogenic, drug response(Last reviewed: Nov 5, 2018)	reviewed by expert panel	7	117243762	7	117603708	53575	68243
NM_000492.3(CFTR):c.2900T>C (p.Leu967Ser)	CFTR	Cystic fibrosis|Hereditary pancreatitis|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 5, 2018)	criteria provided, conflicting interpretations	7	117243828	7	117603774	219537	221666
NM_000492.3(CFTR):c.2909G>A (p.Gly970Asp)	CFTR	Cystic fibrosis	Likely pathogenic(Last reviewed: Jan 29, 2016)	criteria provided, multiple submitters, no conflicts	7	117246728	7	117606674	35854	44518
NM_000492.3(CFTR):c.3208C>T (p.Arg1070Trp)	CFTR|LOC111674472	Cystic fibrosis|Congenital bilateral absence of the vas deferens|not provided|ivacaftor response - Efficacy	drug response(Last reviewed: Mar 23, 2018)	reviewed by expert panel	7	117251703	7	117611649	53685	68353
NM_000492.3(CFTR):c.3209G>A (p.Arg1070Gln)	CFTR|LOC111674472	Cystic fibrosis|Hereditary pancreatitis|Congenital bilateral absence of the vas deferens|not provided|ivacaftor response - Efficacy	drug response(Last reviewed: Mar 23, 2018)	reviewed by expert panel	7	117251704	7	117611650	35866	44530
NM_000492.3(CFTR):c.3222T>A (p.Phe1074Leu)	CFTR|LOC111674472	Cystic fibrosis|not provided|ivacaftor response - Efficacy	drug response(Last reviewed: Mar 23, 2018)	reviewed by expert panel	7	117251717	7	117611663	53688	68356
NM_000492.3(CFTR):c.3254A>G (p.His1085Arg)	CFTR	Cystic fibrosis	Likely pathogenic(Last reviewed: Nov 20, 2014)	criteria provided, single submitter	7	117251749	7	117611695	7210	22249
NM_000492.3(CFTR):c.3705T>G (p.Ser1235Arg)	CFTR	Cystic fibrosis|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 3, 2018)	criteria provided, conflicting interpretations	7	117267812	7	117627758	35872	44536
NM_000492.3(CFTR):c.3771T>G (p.Phe1257Leu)	CFTR	Cystic fibrosis	Likely benign(Last reviewed: Mar 18, 2014)	criteria provided, single submitter	7	117282545	7	117642491	53809	68476
NM_000492.3(CFTR):c.3808G>A (p.Asp1270Asn)	CFTR	Cystic fibrosis|Hereditary pancreatitis|Congenital bilateral absence of the vas deferens|not specified|not provided|ivacaftor response - Efficacy	drug response(Last reviewed: Mar 23, 2018)	reviewed by expert panel	7	117282582	7	117642528	7164	22203
NM_000492.3(CFTR):c.3909C>G (p.Asn1303Lys)	CFTR	Cystic fibrosis|Hereditary pancreatitis|not provided	Pathogenic(Last reviewed: Mar 3, 2004)	practice guideline	7	117292931	7	117652877	7136	22175
NM_000492.3(CFTR):c.4056G>T (p.Gln1352His)	CFTR	Congenital bilateral absence of the vas deferens|not provided	Likely pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, multiple submitters, no conflicts	7	117304834	7	117664780	35882	44546
NM_000492.3(CFTR):c.4056G>C (p.Gln1352His)	CFTR	Cystic fibrosis|Hereditary pancreatitis|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 15, 2018)	criteria provided, conflicting interpretations	7	117304834	7	117664780	7237	22276
NM_000492.3(CFTR):c.4118G>T (p.Ser1373Ile)	CFTR	not provided	Uncertain significance(Last reviewed: Feb 19, 2013)	criteria provided, single submitter	7	117304896	7	117664842	128714	134163
NM_000230.2(LEP):c.461T>C (p.Leu154Pro)	LEP	Leptin deficiency or dysfunction	Likely pathogenic(Last reviewed: Sep 7, 2017)	criteria provided, single submitter	7	127894773	7	128254720	448905	442478
NM_001458.4(FLNC):c.[2971C>T];[318C>G]	FLNC	Primary dilated cardiomyopathy	Pathogenic(Last reviewed: Apr 3, 2016)	no assertion criteria provided	7|7	128484099	7|7	128844045	427828	260441|260440
NM_018718.2(CEP41):c.1081T>C (p.Ser361Pro)	CEP41	not specified|not provided	Uncertain significance(Last reviewed: May 20, 2016)	criteria provided, multiple submitters, no conflicts	7	130038773	7	130398932	128704	134153
NM_000083.2(CLCN1):c.501C>G (p.Phe167Leu)	CLCN1	Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form|Myotonia congenita|not specified|not provided|Myotonia	Conflicting interpretations of pathogenicity(Last reviewed: Jun 21, 2018)	criteria provided, conflicting interpretations	7	143018525	7	143321432	209138	205752
NM_000083.2(CLCN1):c.568_569delGGinsTC (p.Gly190Ser)	CLCN1	Congenital myotonia, autosomal recessive form|Congenital myotonia, autosomal dominant form|Myocardial infarction|Headache|not provided|Rigidity|Vertigo|Myotonia of the upper limb|EMG: myotonic discharges	Conflicting interpretations of pathogenicity(Last reviewed: Jun 9, 2018)	criteria provided, conflicting interpretations	7	143018813 - 143018814	7	143321720 - 143321721	209139	205753
NM_022445.3(TPK1):c.576T>G (p.Cys192Trp)	TPK1	Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type)	Likely pathogenic(Last reviewed: Nov 28, 2017)	criteria provided, single submitter	7	144245621	7	144548528	488625	481493
NM_014141.5(CNTNAP2):c.485T>G (p.Val162Gly)	CNTNAP2	Autism 15|Pitt-Hopkins-like syndrome 1|not specified|not provided	Uncertain significance(Last reviewed: Dec 12, 2017)	criteria provided, multiple submitters, no conflicts	7	146741081	7	147043989	128808	134257
NM_014141.5(CNTNAP2):c.1247C>T (p.Ala416Val)	CNTNAP2	Pitt-Hopkins-like syndrome 1|not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Dec 29, 2017)	criteria provided, multiple submitters, no conflicts	7	146829500	7	147132408	128798	134247
NM_014141.5(CNTNAP2):c.1846C>T (p.Pro616Ser)	CNTNAP2	not provided	Uncertain significance(Last reviewed: Oct 30, 2015)	criteria provided, multiple submitters, no conflicts	7	147259298	7	147562206	128801	134250
NM_014141.5(CNTNAP2):c.3193C>A (p.Leu1065Ile)	CNTNAP2	not specified|not provided|History of neurodevelopmental disorder	Uncertain significance(Last reviewed: Dec 14, 2017)	criteria provided, multiple submitters, no conflicts	7	147914562	7	148217470	128804	134253
NM_014141.5(CNTNAP2):c.3791T>C (p.Ile1264Thr)	CNTNAP2	not provided	Uncertain significance(Last reviewed: Dec 10, 2013)	criteria provided, single submitter	7	148106558	7	148409466	128806	134255
NM_170606.2(KMT2C):c.8502A>T (p.Glu2834Asp)	KMT2C	not specified|atypical cerebral palsy	Uncertain significance	criteria provided, single submitter	7	151874036	7	152176951	134773	138512
NM_018941.3(CLN8):c.1A>G (p.Met1Val)	CLN8	Ceroid lipofuscinosis neuronal 8	Pathogenic	criteria provided, single submitter	8	1719221	8	1771055	487522	480573
NM_018941.3(CLN8):c.274C>T (p.His92Tyr)	CLN8	Neuronal ceroid lipofuscinosis|not specified|Seizures|not provided	Benign/Likely benign(Last reviewed: Jan 4, 2018)	criteria provided, multiple submitters, no conflicts	8	1719494	8	1771328	128788	134237
NM_018941.3(CLN8):c.[212C>T];[562_563delCT]	CLN8	Ceroid lipofuscinosis neuronal 8	Likely pathogenic(Last reviewed: Sep 18, 2012)	criteria provided, single submitter	8|8	1728434 - 1728435	8|8	1780268 - 1780269	424769	71352|213579
NM_018941.3(CLN8):c.610C>T (p.Arg204Cys)	CLN8	Ceroid lipofuscinosis neuronal 8	Likely pathogenic(Last reviewed: Feb 12, 2018)	criteria provided, multiple submitters, no conflicts	8	1728482	8	1780316	2804	17843
NM_018941.3(CLN8):c.685C>G (p.Pro229Ala)	CLN8	Neuronal ceroid lipofuscinosis|Ceroid lipofuscinosis neuronal 8|not specified|Seizures|not provided	Benign(Last reviewed: Dec 28, 2017)	criteria provided, multiple submitters, no conflicts	8	1728557	8	1780391	95924	101820
NM_018941.3(CLN8):c.709G>A (p.Gly237Arg)	CLN8	Ceroid lipofuscinosis neuronal 8|not provided	Likely pathogenic(Last reviewed: Jul 6, 2017)	criteria provided, multiple submitters, no conflicts	8	1728581	8	1780415	188917	186761
NM_018941.3(CLN8):c.792C>G (p.Asn264Lys)	CLN8	Ceroid lipofuscinosis neuronal 8	Pathogenic	criteria provided, single submitter	8	1728664	8	1780498	100736	106601
NM_024596.4(MCPH1):c.128T>C (p.Phe43Ser)	MCPH1	Primary autosomal recessive microcephaly 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 29, 2016)	criteria provided, conflicting interpretations	8	6272299	8	6414778	158819	168643
NM_024596.4(MCPH1):c.278C>A (p.Ala93Glu)	MCPH1	Primary autosomal recessive microcephaly 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	8	6289064	8	6431543	158867	168645
NM_024596.4(MCPH1):c.305G>C (p.Ser102Thr)	MCPH1	Primary autosomal recessive microcephaly 1|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Aug 31, 2016)	criteria provided, conflicting interpretations	8	6289091	8	6431570	158868	168646
NM_024596.4(MCPH1):c.433C>G (p.Leu145Val)	MCPH1	Primary autosomal recessive microcephaly 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	8	6293680	8	6436159	158869	168647
NM_024596.4(MCPH1):c.614C>T (p.Pro205Leu)	MCPH1	Primary autosomal recessive microcephaly 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	8	6299621	8	6442100	158871	168649
NM_024596.4(MCPH1):c.634G>A (p.Ala212Thr)	MCPH1	not specified|not provided|Primary Microcephaly, Recessive	Benign/Likely benign(Last reviewed: Jun 14, 2018)	criteria provided, multiple submitters, no conflicts	8	6299641	8	6442120	158872	168650
NM_024596.4(MCPH1):c.647T>C (p.Ile216Thr)	MCPH1	not specified|Primary Microcephaly, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	8	6299654	8	6442133	158873	168651
NM_024596.4(MCPH1):c.790A>G (p.Ile264Val)	MCPH1	not specified|Primary Microcephaly, Recessive	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	8	6302033	8	6444512	158875	168653
NM_024596.4(MCPH1):c.863C>A (p.Pro288His)	MCPH1	not specified|not provided|Primary Microcephaly, Recessive	Benign/Likely benign(Last reviewed: Mar 14, 2018)	criteria provided, multiple submitters, no conflicts	8	6302106	8	6444585	158876	168654
NM_024596.4(MCPH1):c.898A>G (p.Ile300Val)	MCPH1	Primary autosomal recessive microcephaly 1	Uncertain significance(Last reviewed: Apr 29, 2013)	criteria provided, single submitter	8	6302141	8	6444620	158878	168656
NM_024596.4(MCPH1):c.911G>T (p.Arg304Ile)	MCPH1	Primary autosomal recessive microcephaly 1|not specified|Primary Microcephaly, Recessive	Benign/Likely benign(Last reviewed: Aug 2, 2017)	criteria provided, multiple submitters, no conflicts	8	6302154	8	6444633	158879	168657
NM_024596.4(MCPH1):c.940G>C (p.Asp314His)	MCPH1	Primary autosomal recessive microcephaly 1|not specified|Primary Microcephaly, Recessive	Benign(Last reviewed: Aug 2, 2017)	criteria provided, multiple submitters, no conflicts	8	6302183	8	6444662	21705	34557
NM_024596.4(MCPH1):c.1061T>C (p.Val354Ala)	MCPH1	Primary autosomal recessive microcephaly 1	Uncertain significance(Last reviewed: Mar 24, 2014)	criteria provided, single submitter	8	6302304	8	6444783	158815	168658
NM_024596.4(MCPH1):c.1175A>G (p.Asp392Gly)	MCPH1	Primary autosomal recessive microcephaly 1|not specified|Primary Microcephaly, Recessive	Benign(Last reviewed: Aug 2, 2017)	criteria provided, multiple submitters, no conflicts	8	6302418	8	6444897	96126	102020
NM_024596.4(MCPH1):c.1189G>A (p.Val397Met)	MCPH1	Primary autosomal recessive microcephaly 1|Primary Microcephaly, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	8	6302432	8	6444911	158817	168660
NM_024596.4(MCPH1):c.1273T>A (p.Tyr425Asn)	MCPH1	Primary autosomal recessive microcephaly 1|not provided	Uncertain significance(Last reviewed: Jun 11, 2018)	criteria provided, multiple submitters, no conflicts	8	6302516	8	6444995	158818	168661
NM_024596.4(MCPH1):c.1351G>A (p.Glu451Lys)	MCPH1	Primary autosomal recessive microcephaly 1|not specified	Uncertain significance(Last reviewed: Jul 23, 2015)	criteria provided, multiple submitters, no conflicts	8	6302594	8	6445073	158820	168662
NM_024596.4(MCPH1):c.1495G>A (p.Val499Met)	MCPH1	Primary autosomal recessive microcephaly 1|not specified|Primary Microcephaly, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	8	6302738	8	6445217	96129	102023
NM_024596.4(MCPH1):c.1616A>G (p.Asp539Gly)	MCPH1	Primary autosomal recessive microcephaly 1	Uncertain significance(Last reviewed: Mar 8, 2013)	criteria provided, single submitter	8	6302859	8	6445338	158821	168663
NM_024596.4(MCPH1):c.1679G>T (p.Ser560Ile)	MCPH1	Primary autosomal recessive microcephaly 1|not specified	Uncertain significance(Last reviewed: Oct 9, 2015)	criteria provided, multiple submitters, no conflicts	8	6302922	8	6445401	158822	168664
NM_024596.4(MCPH1):c.1738A>G (p.Ser580Gly)	MCPH1	not specified|not provided	Benign/Likely benign(Last reviewed: Apr 27, 2017)	criteria provided, multiple submitters, no conflicts	8	6302981	8	6445460	138185	141888
NM_024596.4(MCPH1):c.1742A>G (p.Glu581Gly)	MCPH1	Primary autosomal recessive microcephaly 1	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	8	6302985	8	6445464	158826	168668
NM_024596.4(MCPH1):c.1806A>C (p.Leu602Phe)	MCPH1	Primary autosomal recessive microcephaly 1	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	8	6303049	8	6445528	158828	168670
NM_024596.4(MCPH1):c.1951G>A (p.Val651Ile)	MCPH1	Primary autosomal recessive microcephaly 1	Uncertain significance(Last reviewed: Apr 16, 2013)	criteria provided, single submitter	8	6335130	8	6477609	158833	168675
NM_024596.4(MCPH1):c.2045C>A (p.Thr682Asn)	MCPH1	not specified|Primary Microcephaly, Recessive	Benign/Likely benign(Last reviewed: Aug 2, 2017)	criteria provided, multiple submitters, no conflicts	8	6338306	8	6480785	158834	168676
NM_024596.4(MCPH1):c.2257G>C (p.Gly753Arg)	MCPH1|MCPH1-AS1	Primary autosomal recessive microcephaly 1	Uncertain significance(Last reviewed: Jan 10, 2013)	criteria provided, single submitter	8	6479017	8	6621496	158847	168689
NM_024596.4(MCPH1):c.2282C>G (p.Ala761Gly)	MCPH1|MCPH1-AS1	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	8	6479042	8	6621521	158849	168691
NM_024596.4(MCPH1):c.2282C>A (p.Ala761Glu)	MCPH1|MCPH1-AS1	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	8	6479042	8	6621521	158848	168690
NM_024596.4(MCPH1):c.2282C>T (p.Ala761Val)	MCPH1|MCPH1-AS1	Primary autosomal recessive microcephaly 1|not specified|Primary Microcephaly, Recessive	Benign(Last reviewed: Aug 2, 2017)	criteria provided, multiple submitters, no conflicts	8	6479042	8	6621521	21702	34554
NM_024596.4(MCPH1):c.2288T>C (p.Phe763Ser)	MCPH1|MCPH1-AS1	Primary autosomal recessive microcephaly 1	Uncertain significance(Last reviewed: Jun 26, 2014)	criteria provided, single submitter	8	6479048	8	6621527	158850	168692
NM_024596.4(MCPH1):c.2429A>G (p.Tyr810Cys)	MCPH1|MCPH1-AS1	Primary autosomal recessive microcephaly 1	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	8	6479189	8	6621668	158858	168697
NM_024596.4(MCPH1):c.2466G>A (p.Gln822=)	MCPH1|MCPH1-AS1	Primary autosomal recessive microcephaly 1	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	8	6500528	8	6643007	158864	168703
NM_024596.4(MCPH1):c.2482C>T (p.Pro828Ser)	MCPH1|MCPH1-AS1	Primary autosomal recessive microcephaly 1|not specified|Primary Microcephaly, Recessive	Benign/Likely benign(Last reviewed: Aug 2, 2017)	criteria provided, multiple submitters, no conflicts	8	6500544	8	6643023	21703	34555
NM_024596.4(MCPH1):c.2487A>C (p.Glu829Asp)	MCPH1|MCPH1-AS1	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	8	6500549	8	6643028	158865	168704
NM_024596.4(MCPH1):c.2499G>T (p.Leu833Phe)	MCPH1|MCPH1-AS1	Primary autosomal recessive microcephaly 1	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	8	6500561	8	6643040	158866	168705
NM_152415.2(VPS37A):c.700C>A (p.Leu234Ile)	VPS37A	Spastic paraplegia 53, autosomal recessive|Idiopathic transverse myelitis	Conflicting interpretations of pathogenicity(Last reviewed: Sep 5, 2017)	criteria provided, conflicting interpretations	8	17133963	8	17276454	522587	513201
NM_177924.4(ASAH1):c.536C>T (p.Thr179Ile)	ASAH1	Jankovic Rivera syndrome	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	8	17919900	8	18062391	560956	552122
NM_177924.4(ASAH1):c.124A>G (p.Thr42Ala)	ASAH1	Jankovic Rivera syndrome	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	8	17933051	8	18075542	560955	552123
NM_000015.2(NAT2):c.191G>A (p.Arg64Gln)	NAT2	Slow acetylator due to N-acetyltransferase enzyme variant	drug response(Last reviewed: Oct 28, 2012)	no assertion criteria provided	8	18257704	8	18400194	726	15765
NM_000237.3(LPL):c.701C>T (p.Pro234Leu)	LPL	Hyperlipoproteinemia, type I	Pathogenic(Last reviewed: May 1, 1993)	no assertion criteria provided	8	19811790	8	19954279	1527	16566
NM_000237.3(LPL):c.755T>C (p.Ile252Thr)	LPL	Hyperlipoproteinemia, type I	Pathogenic(Last reviewed: Jul 24, 1998)	no assertion criteria provided	8	19811844	8	19954333	1554	16593
NM_001017420.2(ESCO2):c.239C>T (p.Ala80Val)	ESCO2	Roberts-SC phocomelia syndrome|not specified	Benign/Likely benign(Last reviewed: Nov 14, 2017)	criteria provided, multiple submitters, no conflicts	8	27634064	8	27776547	21240	34092
NM_001017420.2(ESCO2):c.383G>A (p.Gly128Glu)	ESCO2	Roberts-SC phocomelia syndrome	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	8	27634208	8	27776691	158574	168585
NM_001017420.2(ESCO2):c.1175G>A (p.Cys392Tyr)	ESCO2	Roberts-SC phocomelia syndrome	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	8	27646407	8	27788890	158573	168588
NM_000553.5(WRN):c.340G>A (p.Val114Ile)	WRN	Werner syndrome|not specified	Benign/Likely benign(Last reviewed: Sep 28, 2016)	criteria provided, multiple submitters, no conflicts	8	30921935	8	31064419	130760	136206
NM_000553.5(WRN):c.1161G>A (p.Met387Ile)	WRN	Werner syndrome|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	8	30938704	8	31081188	130757	136203
NM_000553.4(WRN):c.3222G>T (p.Leu1074Phe)	WRN	Werner syndrome|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	8	30999280	8	31141764	130759	136205
NM_000553.4(WRN):c.3236C>T (p.Ser1079Leu)	WRN	Werner syndrome|not specified	Benign/Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, multiple submitters, no conflicts	8	31000144	8	31142628	130756	136202
NM_000553.4(WRN):c.4099T>C (p.Cys1367Arg)	WRN	Werner syndrome|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	8	31024654	8	31167138	130762	136208
NM_001105214.2(ASH2L):c.1444A>G (p.Ile482Val)	ASH2L	Global developmental delay|Intellectual disability|Global developmental delay	Likely pathogenic	criteria provided, single submitter	8	37996340	8	38138822	402148	389134
NM_000349.2(STAR):c.545G>T (p.Arg182Leu)	STAR	Cholesterol monooxygenase (side-chain cleaving) deficiency	Pathogenic(Last reviewed: Oct 1, 2000)	no assertion criteria provided	8	38003586	8	38146068	8988	24027
NM_015214.2(DDHD2):c.557C>T (p.Thr186Met)	DDHD2	not specified	Benign(Last reviewed: Dec 22, 2015)	criteria provided, single submitter	8	38095662	8	38238144	128893	134340
NM_152419.2(HGSNAT):c.518G>A (p.Gly173Asp)	HGSNAT	Mucopolysaccharidosis, MPS-III-C	Pathogenic(Last reviewed: Aug 3, 2016)	criteria provided, single submitter	8	43016605	8	43161462	252961	247363
NM_152419.2(HGSNAT):c.836A>C (p.Asp279Ala)	HGSNAT	Mucopolysaccharidosis, MPS-III-C	Likely pathogenic(Last reviewed: Jan 11, 2017)	no assertion criteria provided	8	43028871	8	43173728	425553	413894
NM_152419.2(HGSNAT):c.1042G>A (p.Val348Met)	HGSNAT	Mucopolysaccharidosis, MPS-III-C	Uncertain significance(Last reviewed: Aug 9, 2017)	criteria provided, single submitter	8	43037317	8	43182174	522867	513428
NM_152419.2(HGSNAT):c.1267G>T (p.Gly423Trp)	HGSNAT	Mucopolysaccharidosis, MPS-III-C|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 9, 2017)	criteria provided, conflicting interpretations	8	43047463	8	43192320	422050	407393
NM_152419.2(HGSNAT):c.1856G>C (p.Trp619Ser)	HGSNAT	Mucopolysaccharidosis, MPS-III-C	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	8	43054660	8	43199517	561029	552124
NM_004056.5(CA8):c.299C>T (p.Ser100Leu)	CA8	not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Oct 12, 2017)	criteria provided, multiple submitters, no conflicts	8	61178602	8	60266043	128539	133988
NM_000370.3(TTPA):c.2T>C (p.Met1Thr)	TTPA	Ataxia with vitamin E deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 26, 2017)	criteria provided, multiple submitters, no conflicts	8	63998579	8	63086020	189186	186763
NM_024790.6(CSPP1):c.1931C>T (p.Pro644Leu)	CSPP1	Joubert syndrome 21	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	8	68049809	8	67137574	438592	432214
NM_024790.6(CSPP1):c.2146C>G (p.Arg716Gly)	CSPP1	Joubert syndrome 21	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	8	68066291	8	67154056	438593	432215
NM_020361.4(CPA6):c.928C>T (p.Leu310Phe)	CPA6|LOC102724708	not provided	Uncertain significance(Last reviewed: Aug 27, 2013)	criteria provided, single submitter	8	68346386	8	67434151	128848	134296
NM_020361.4(CPA6):c.746A>G (p.Asn249Ser)	CPA6|LOC102724708	Temporal epilepsy, familial|not specified|not provided	Benign/Likely benign(Last reviewed: Apr 20, 2017)	criteria provided, multiple submitters, no conflicts	8	68396915	8	67484680	128847	134295
NM_020361.4(CPA6):c.518C>G (p.Ser173Cys)	CPA6	Temporal epilepsy, familial|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	8	68421768	8	67509533	128846	134294
NM_020361.4(CPA6):c.133T>C (p.Phe45Leu)	CPA6	Temporal epilepsy, familial|not specified|not provided	Benign/Likely benign(Last reviewed: Apr 20, 2017)	criteria provided, multiple submitters, no conflicts	8	68536470	8	67624235	128845	134293
NM_017866.5(TMEM70):c.100G>C (p.Ala34Pro)	TMEM70	not specified|not provided|Mitochondrial Complex V (ATP Synthase) Deficiency, Nuclear Type	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	8	74888616	8	73976381	130598	136044
NM_017866.5(TMEM70):c.346C>G (p.Leu116Val)	TMEM70	Nuclearly-encoded mitochondrial complex V (ATP synthase) deficiency 2|not specified|not provided|Mitochondrial Complex V (ATP Synthase) Deficiency, Nuclear Type	Benign/Likely benign(Last reviewed: Jul 25, 2017)	criteria provided, multiple submitters, no conflicts	8	74893419	8	73981184	130599	136045
NM_017866.5(TMEM70):c.748A>G (p.Thr250Ala)	TMEM70	not specified|not provided|Mitochondrial Complex V (ATP Synthase) Deficiency, Nuclear Type	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	8	74893821	8	73981586	130600	136046
NM_017866.5(TMEM70):c.777C>G (p.Asp259Glu)	TMEM70	not specified|not provided|Mitochondrial Complex V (ATP Synthase) Deficiency, Nuclear Type	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	8	74893850	8	73981615	130601	136047
NM_018972.2(GDAP1):c.[347T>C];[62delA]	GDAP1	Charcot-Marie-Tooth disease type 2K|Charcot-Marie-Tooth disease, type 4A|Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive|Charcot-Marie-Tooth disease, recessive intermediate A	Pathogenic(Last reviewed: Jul 1, 2014)	criteria provided, single submitter	8|8	75272408	8|8	74360173	424778	213582|213581
NM_019098.4(CNGB3):c.[1193A>G];[1208G>A]	CNGB3	Stargardt disease 1	Pathogenic(Last reviewed: Mar 12, 2013)	criteria provided, single submitter	8|8	87645092	8|8	86632864	424771	152872|213583
NM_016023.3(OTUD6B):c.647A>G (p.Tyr216Cys)	OTUD6B	Epilepsy|Dysmorphic features|Intellectual disability|Dysmorphic features|Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies	Likely pathogenic(Last reviewed: Jan 9, 2017)	criteria provided, single submitter	8	92090825	8	91078597	375704	362594
NM_153704.5(TMEM67):c.233G>A (p.Cys78Tyr)	TMEM67	Meckel syndrome type 3	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	8	94768015	8	93755787	561133	552127
NM_153704.5(TMEM67):c.406+1361C>T	TMEM67	not specified	Likely benign	no assertion criteria provided	8	94772165	8	93759937	126305	131837
NM_153704.5(TMEM67):c.748G>A (p.Gly250Arg)	TMEM67	Meckel-Gruber syndrome	Likely pathogenic(Last reviewed: Sep 13, 2013)	criteria provided, single submitter	8	94792854	8	93780626	126306	131838
NM_153704.5(TMEM67):c.781G>A (p.Asp261Asn)	TMEM67	Joubert syndrome|Meckel-Gruber syndrome|not specified	Benign(Last reviewed: Apr 19, 2017)	criteria provided, multiple submitters, no conflicts	8	94792887	8	93780659	126307	131839
NM_153704.5(TMEM67):c.1046T>C (p.Leu349Ser)	TMEM67	Bardet-Biedl syndrome|COACH syndrome|Joubert syndrome|Joubert syndrome 6|Meckel-Gruber syndrome|Meckel syndrome type 3|Bardet-Biedl syndrome 14|Nephronophthisis 11	Pathogenic/Likely pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, multiple submitters, no conflicts	8	94793953	8	93781725	56762	71401
NM_153704.5(TMEM67):c.1309C>G (p.Leu437Val)	TMEM67	Joubert syndrome|Meckel-Gruber syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Aug 11, 2017)	criteria provided, conflicting interpretations	8	94798471	8	93786243	126299	131831
NM_153704.5(TMEM67):c.1319G>A (p.Arg440Gln)	TMEM67	Meckel syndrome type 3|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	8	94798481	8	93786253	56764	71403
NM_001142301.1(TMEM67):c.1178T>C (p.Leu393Pro)	TMEM67	Joubert syndrome 6	Uncertain significance(Last reviewed: Jun 26, 2017)	criteria provided, single submitter	8	94800080	8	93787852	495339	486834
NM_153704.5(TMEM67):c.1714G>A (p.Ala572Thr)	TMEM67	Joubert syndrome 6|Inborn genetic diseases	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	8	94807676	8	93795448	521968	511772
NM_153704.5(TMEM67):c.1769T>C (p.Phe590Ser)	TMEM67	COACH syndrome|Joubert syndrome 6	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, multiple submitters, no conflicts	8	94807731	8	93795503	1381	16420
NM_153704.5(TMEM67):c.1810A>G (p.Ile604Val)	TMEM67	Joubert syndrome|Meckel-Gruber syndrome|Nephronophthisis|not specified	Benign(Last reviewed: Jul 26, 2017)	criteria provided, multiple submitters, no conflicts	8	94808165	8	93795937	126301	131833
NM_153704.5(TMEM67):c.2161C>T (p.Pro721Ser)	TMEM67	not specified|not provided	Benign/Likely benign(Last reviewed: Jul 22, 2016)	criteria provided, multiple submitters, no conflicts	8	94811906	8	93799678	126302	131834
NM_001142301.1(TMEM67):c.2218G>A (p.Gly740Ser)	TMEM67	Joubert syndrome 6|Nephronophthisis 11	Pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, single submitter	8	94821089	8	93808861	1382	16421
NM_153704.5(TMEM67):c.2779T>C (p.Phe927Leu)	TMEM67	Joubert syndrome 6	Uncertain significance(Last reviewed: Jun 26, 2017)	criteria provided, single submitter	8	94827547	8	93815319	495340	486835
NM_152416.3(NDUFAF6):c.[328G>T];[611C>T]	NDUFAF6	Leigh syndrome	Pathogenic(Last reviewed: Jan 6, 2017)	no assertion criteria provided	8|8	96059252	8|8	95047024	430874	424415|424414
NM_177965.3(C8orf37):c.533C>T (p.Ala178Val)	C8orf37	Bardet-Biedl syndrome 21	Uncertain significance	no assertion criteria provided	8	96259936	8	95247708	430653	424182
NM_152564.4(VPS13B):c.3G>A (p.Met1Ile)	VPS13B	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	8	100026019	8	99013791	402220	389136
NM_017890.4(VPS13B):c.2485G>A (p.Ala829Thr)	VPS13B	Cohen syndrome|not specified|not provided|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Dec 21, 2017)	criteria provided, multiple submitters, no conflicts	8	100205255	8	99193027	95839	101736
NM_017890.4(VPS13B):c.4247G>A (p.Arg1416Gln)	VPS13B	Cohen syndrome|not specified|not provided|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jan 8, 2018)	criteria provided, multiple submitters, no conflicts	8	100520087	8	99507859	130725	136171
NM_017890.4(VPS13B):c.5360G>A (p.Arg1787His)	VPS13B	not provided	Uncertain significance(Last reviewed: Oct 14, 2014)	criteria provided, multiple submitters, no conflicts	8	100654103	8	99641875	130726	136172
NM_017890.4(VPS13B):c.5878T>G (p.Ser1960Ala)	VPS13B	not specified|not provided	Uncertain significance(Last reviewed: Mar 14, 2017)	criteria provided, multiple submitters, no conflicts	8	100654621	8	99642393	130727	136173
NM_017890.4(VPS13B):c.7441G>A (p.Val2481Ile)	VPS13B	Cohen syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 22, 2018)	criteria provided, conflicting interpretations	8	100789121	8	99776893	95865	101762
NM_017890.4(VPS13B):c.7751T>C (p.Val2584Ala)	VPS13B	Cohen syndrome|not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	8	100791156	8	99778928	95866	101763
NM_017890.4(VPS13B):c.7925T>C (p.Leu2642Pro)	VPS13B	Cohen syndrome	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	8	100796613	8	99784385	561143	552128
NM_017890.4(VPS13B):c.8645C>T (p.Pro2882Leu)	VPS13B	Cohen syndrome|not specified|not provided|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Nov 18, 2017)	criteria provided, conflicting interpretations	8	100831065	8	99818837	95872	101769
NM_017890.4(VPS13B):c.10124C>T (p.Thr3375Ile)	VPS13B	Cohen syndrome|not specified|not provided|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Dec 27, 2017)	criteria provided, conflicting interpretations	8	100861110	8	99848882	130717	136163
NM_017890.4(VPS13B):c.10274C>T (p.Pro3425Leu)	VPS13B	not provided	Uncertain significance(Last reviewed: Mar 18, 2014)	criteria provided, single submitter	8	100865816	8	99853588	130719	136165
NM_017890.4(VPS13B):c.10294G>A (p.Gly3432Arg)	VPS13B	Cohen syndrome|not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: May 16, 2017)	criteria provided, multiple submitters, no conflicts	8	100865836	8	99853608	95821	101718
NM_017890.4(VPS13B):c.10553A>G (p.Asp3518Gly)	VPS13B	not provided	Uncertain significance(Last reviewed: Feb 12, 2014)	criteria provided, single submitter	8	100866095	8	99853867	130720	136166
NM_015713.4(RRM2B):c.662A>G (p.Asn221Ser)	RRM2B	Mitochondrial DNA depletion syndrome, encephalomyopathic form, with renal tubulopathy|not provided|Severe lactic acidosis	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	8	103231064	8	102218836	215094	211320
NM_031466.7(TRAPPC9):c.3457G>A (p.Val1153Ile)	TRAPPC9	not specified|Intellectual Disability, Recessive|History of neurodevelopmental disorder	Uncertain significance(Last reviewed: Oct 13, 2017)	criteria provided, multiple submitters, no conflicts	8	140744338	8	139732095	130617	136063
NM_031466.7(TRAPPC9):c.3091G>A (p.Gly1031Ser)	TRAPPC9	not specified|not provided|Intellectual Disability, Recessive|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Oct 3, 2016)	criteria provided, conflicting interpretations	8	140998947	8	139988739	130629	136075
NM_031466.7(TRAPPC9):c.2834A>C (p.Asp945Ala)	TRAPPC9	not provided	Uncertain significance(Last reviewed: Jun 5, 2013)	criteria provided, single submitter	8	141231574	8	140221475	130616	136062
NM_031466.7(TRAPPC9):c.2767C>T (p.Arg923Trp)	TRAPPC9	not provided	Uncertain significance(Last reviewed: Mar 13, 2014)	criteria provided, single submitter	8	141231641	8	140221542	130627	136073
NM_031466.7(TRAPPC9):c.1313C>T (p.Ala438Val)	TRAPPC9	not specified|not provided|Intellectual Disability, Recessive|History of neurodevelopmental disorder	Uncertain significance(Last reviewed: Oct 27, 2017)	criteria provided, multiple submitters, no conflicts	8	141407834	8	140397735	130612	136058
NM_031466.7(TRAPPC9):c.1274A>G (p.Tyr425Cys)	TRAPPC9	not provided	Uncertain significance(Last reviewed: Feb 14, 2014)	criteria provided, single submitter	8	141415704	8	140405605	130619	136065
NM_031466.7(TRAPPC9):c.160A>G (p.Ser54Gly)	TRAPPC9	not specified|Intellectual Disability, Recessive|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Apr 28, 2017)	criteria provided, multiple submitters, no conflicts	8	141468504	8	140458405	130613	136059
NM_000497.3(CYP11B1):c.1015_1016delGCinsAT (p.Ala339Ile)	CYP11B1|LOC106799833	Congenital adrenal hyperplasia	Uncertain significance(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	8	143957233 - 143957234	8	142875817 - 142875818	35979	44643
NM_000497.3(CYP11B1):c.1003A>G (p.Asn335Asp)	CYP11B1|LOC106799833	Hyperaldosteronism, familial, type I|Congenital adrenal hyperplasia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 23, 2016)	criteria provided, conflicting interpretations	8	143957246	8	142875830	35977	44641
NM_000497.3(CYP11B1):c.264G>A (p.Met88Ile)	CYP11B1	Congenital adrenal hyperplasia	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	8	143960579	8	142879163	35988	44652
NM_178172.5(GPIHBP1):c.331A>C (p.Thr111Pro)	GPIHBP1	Hyperlipoproteinemia, type ID	Pathogenic(Last reviewed: Jul 1, 2014)	criteria provided, single submitter	8	144297169	8	143215294	144018	153749
NM_000445.4(PLEC):c.13286C>T (p.Thr4429Met)	PLEC	Epidermolysa bullosa simplex and limb girdle muscular dystrophy|Epidermolysis bullosa simplex, Ogna type|Epidermolysis bullosa simplex with pyloric atresia|Limb-girdle muscular dystrophy, type 2Q|not specified|Epidermolysis bullosa simplex with nail dystrophy	Benign(Last reviewed: Jul 28, 2017)	criteria provided, multiple submitters, no conflicts	8	144990784	8	143916616	129931	135377
NM_000445.4(PLEC):c.11680G>C (p.Asp3894His)	PLEC	Epidermolysa bullosa simplex and limb girdle muscular dystrophy|Epidermolysis bullosa simplex, Ogna type|Epidermolysis bullosa simplex with pyloric atresia|Limb-girdle muscular dystrophy, type 2Q|not specified|Epidermolysis bullosa simplex with nail dystrophy	Benign(Last reviewed: Aug 2, 2017)	criteria provided, multiple submitters, no conflicts	8	144992390	8	143918222	129926	135372
NM_000445.4(PLEC):c.10139G>C (p.Gly3380Ala)	PLEC	Epidermolysa bullosa simplex and limb girdle muscular dystrophy|Epidermolysis bullosa simplex, Ogna type|Epidermolysis bullosa simplex with pyloric atresia|Limb-girdle muscular dystrophy, type 2Q|not specified|Epidermolysis bullosa simplex with nail dystrophy	Benign(Last reviewed: Jul 28, 2017)	criteria provided, multiple submitters, no conflicts	8	144993931	8	143919763	129922	135368
NM_000445.4(PLEC):c.10127C>T (p.Thr3376Met)	PLEC	Epidermolysa bullosa simplex and limb girdle muscular dystrophy|Epidermolysis bullosa simplex, Ogna type|Epidermolysis bullosa simplex with pyloric atresia|Limb-girdle muscular dystrophy, type 2Q|not specified|Epidermolysis bullosa simplex with nail dystrophy	Benign(Last reviewed: Dec 14, 2017)	criteria provided, multiple submitters, no conflicts	8	144993943	8	143919775	129921	135367
NM_000445.4(PLEC):c.9182C>T (p.Ala3061Val)	PLEC	not specified	Benign/Likely benign(Last reviewed: Nov 3, 2017)	criteria provided, multiple submitters, no conflicts	8	144994888	8	143920720	93089	98996
NM_000445.4(PLEC):c.9154G>A (p.Val3052Ile)	PLEC	Epidermolysa bullosa simplex and limb girdle muscular dystrophy|Epidermolysis bullosa simplex, Ogna type|Epidermolysis bullosa simplex with pyloric atresia|Limb-girdle muscular dystrophy, type 2Q|not specified|Epidermolysis bullosa simplex with nail dystrophy	Benign/Likely benign(Last reviewed: Aug 9, 2017)	criteria provided, multiple submitters, no conflicts	8	144994916	8	143920748	93088	98995
NM_000445.4(PLEC):c.8901C>G (p.Asp2967Glu)	PLEC	Epidermolysa bullosa simplex and limb girdle muscular dystrophy|Epidermolysis bullosa simplex, Ogna type|Epidermolysis bullosa simplex with pyloric atresia|Limb-girdle muscular dystrophy, type 2Q|not specified|not provided|Epidermolysis bullosa simplex with nail dystrophy	Benign(Last reviewed: Jun 18, 2018)	criteria provided, multiple submitters, no conflicts	8	144995169	8	143921001	129960	135406
NM_000445.4(PLEC):c.8576G>A (p.Arg2859His)	PLEC	not specified	Benign(Last reviewed: Jan 13, 2015)	criteria provided, multiple submitters, no conflicts	8	144995494	8	143921326	93087	98994
NM_000445.4(PLEC):c.8131C>T (p.Arg2711Trp)	PLEC	Epidermolysa bullosa simplex and limb girdle muscular dystrophy|Epidermolysis bullosa simplex, Ogna type|Epidermolysis bullosa simplex with pyloric atresia|Limb-girdle muscular dystrophy, type 2Q|not specified|Epidermolysis bullosa simplex with nail dystrophy	Benign(Last reviewed: Aug 7, 2017)	criteria provided, multiple submitters, no conflicts	8	144995939	8	143921771	129958	135404
NM_000445.4(PLEC):c.8093G>A (p.Arg2698Gln)	PLEC	Epidermolysa bullosa simplex and limb girdle muscular dystrophy|Epidermolysis bullosa simplex, Ogna type|Epidermolysis bullosa simplex with pyloric atresia|Limb-girdle muscular dystrophy, type 2Q|not specified|not provided|Epidermolysis bullosa simplex with nail dystrophy	Benign/Likely benign(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	8	144995977	8	143921809	129956	135402
NM_000445.4(PLEC):c.8041T>C (p.Ser2681Pro)	PLEC	not specified	Benign(Last reviewed: Nov 18, 2016)	criteria provided, multiple submitters, no conflicts	8	144996029	8	143921861	93083	98990
NM_000445.4(PLEC):c.6395C>T (p.Ala2132Val)	PLEC	not specified	Benign(Last reviewed: Mar 4, 2016)	criteria provided, multiple submitters, no conflicts	8	144997783	8	143923615	93072	98979
NM_000445.4(PLEC):c.6251C>T (p.Ala2084Val)	PLEC	not specified	Benign(Last reviewed: Jan 13, 2015)	criteria provided, multiple submitters, no conflicts	8	144997927	8	143923759	93071	98978
NM_000445.4(PLEC):c.5558G>A (p.Arg1853Gln)	PLEC	Epidermolysa bullosa simplex and limb girdle muscular dystrophy|Epidermolysis bullosa simplex, Ogna type|Epidermolysis bullosa simplex with pyloric atresia|Limb-girdle muscular dystrophy, type 2Q|not specified|not provided|Epidermolysis bullosa simplex with nail dystrophy	Benign(Last reviewed: Aug 7, 2017)	criteria provided, multiple submitters, no conflicts	8	144998620	8	143924452	93063	98970
NM_000445.4(PLEC):c.4304C>T (p.Ala1435Val)	PLEC	Epidermolysa bullosa simplex and limb girdle muscular dystrophy|Epidermolysis bullosa simplex, Ogna type|Epidermolysis bullosa simplex with pyloric atresia|Limb-girdle muscular dystrophy, type 2Q|not specified|Epidermolysis bullosa simplex with nail dystrophy	Benign(Last reviewed: Dec 14, 2017)	criteria provided, multiple submitters, no conflicts	8	144999874	8	143925706	129948	135394
NM_000445.4(PLEC):c.4046A>G (p.His1349Arg)	PLEC	not specified	Benign(Last reviewed: Jan 13, 2015)	criteria provided, multiple submitters, no conflicts	8	145001031	8	143926863	129947	135393
NM_000445.4(PLEC):c.3964C>T (p.Pro1322Ser)	PLEC	not provided	Uncertain significance(Last reviewed: Aug 20, 2013)	criteria provided, single submitter	8	145001207	8	143927039	129946	135392
NM_000445.4(PLEC):c.3827G>A (p.Arg1276Gln)	PLEC	not specified	Benign(Last reviewed: Jan 13, 2015)	criteria provided, multiple submitters, no conflicts	8	145001588	8	143927420	93046	98953
NM_000445.4(PLEC):c.2629G>A (p.Ala877Thr)	PLEC	Epidermolysa bullosa simplex and limb girdle muscular dystrophy|Epidermolysis bullosa simplex, Ogna type|Epidermolysis bullosa simplex with pyloric atresia|Limb-girdle muscular dystrophy, type 2Q|not specified|Epidermolysis bullosa simplex with nail dystrophy	Benign(Last reviewed: Jul 24, 2017)	criteria provided, multiple submitters, no conflicts	8	145004376	8	143930208	129939	135385
NM_000445.4(PLEC):c.1787G>A (p.Arg596Gln)	PLEC	Epidermolysa bullosa simplex and limb girdle muscular dystrophy|Epidermolysis bullosa simplex, Ogna type|Epidermolysis bullosa simplex with pyloric atresia|Limb-girdle muscular dystrophy, type 2Q|not specified|Epidermolysis bullosa simplex with nail dystrophy	Benign(Last reviewed: Aug 7, 2017)	criteria provided, multiple submitters, no conflicts	8	145006992	8	143932824	129935	135381
NM_000445.4(PLEC):c.1592C>T (p.Ala531Val)	PLEC	not specified	Benign(Last reviewed: Jan 13, 2015)	criteria provided, multiple submitters, no conflicts	8	145007187	8	143933019	129934	135380
NM_000445.4(PLEC):c.968G>A (p.Arg323Gln)	PLEC	Epidermolysa bullosa simplex and limb girdle muscular dystrophy|Epidermolysis bullosa simplex, Ogna type|Epidermolysis bullosa simplex with pyloric atresia|Limb-girdle muscular dystrophy, type 2Q|not specified|Epidermolysis bullosa simplex with nail dystrophy	Benign(Last reviewed: Jul 31, 2017)	criteria provided, multiple submitters, no conflicts	8	145009036	8	143934868	129963	135409
NM_000445.4(PLEC):c.133G>A (p.Gly45Ser)	PLEC	Epidermolysa bullosa simplex and limb girdle muscular dystrophy|Epidermolysis bullosa simplex, Ogna type|Epidermolysis bullosa simplex with pyloric atresia|Limb-girdle muscular dystrophy, type 2Q|not specified|not provided|Epidermolysis bullosa simplex with nail dystrophy	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2017)	criteria provided, conflicting interpretations	8	145049405	8	143975237	129932	135378
NM_001253815.1(SLC52A2):c.185T>G (p.Leu62Arg)	SLC52A2	Brown-Vialetto-Van Laere syndrome 2	Likely pathogenic(Last reviewed: Dec 9, 2016)	criteria provided, single submitter	8	145583337	8	144359677	518453	509043
NM_024531.4(SLC52A2):c.916G>A (p.Gly306Arg)	SLC52A2	Brown-Vialetto-Van Laere syndrome 2|not provided	Pathogenic(Last reviewed: May 11, 2018)	criteria provided, multiple submitters, no conflicts	8	145584068	8	144360408	35470	44139
NM_001253815.1(SLC52A2):c.1259C>T (p.Ala420Val)	SLC52A2	Brown-Vialetto-Van Laere syndrome 2	Conflicting interpretations of pathogenicity(Last reviewed: Jun 28, 2018)	criteria provided, conflicting interpretations	8	145584596	8	144360936	518452	509042
NM_153186.5(KANK1):c.2763C>G (p.Ile921Met)	KANK1	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	9	732609	9	732609	402188	389139
NM_003383.4(VLDLR):c.175G>A (p.Val59Ile)	VLDLR	Congenital cerebellar hypoplasia|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	2635545	9	2635545	130705	136151
NM_003383.4(VLDLR):c.292G>A (p.Glu98Lys)	VLDLR	not provided	Uncertain significance(Last reviewed: Feb 4, 2014)	criteria provided, single submitter	9	2639948	9	2639948	130711	136157
NM_003383.4(VLDLR):c.464G>C (p.Ser155Thr)	VLDLR	not specified	Benign/Likely benign(Last reviewed: Dec 19, 2016)	criteria provided, multiple submitters, no conflicts	9	2643175	9	2643175	130700	136146
NM_003383.4(VLDLR):c.902G>A (p.Arg301Gln)	VLDLR	not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 12, 2018)	criteria provided, conflicting interpretations	9	2643709	9	2643709	130714	136160
NM_003383.4(VLDLR):c.1313G>A (p.Gly438Asp)	VLDLR	not specified	Likely benign	no assertion criteria provided	9	2645574	9	2645574	130702	136148
NM_003383.4(VLDLR):c.1643A>G (p.Lys548Arg)	VLDLR	Congenital cerebellar hypoplasia|not specified	Uncertain significance(Last reviewed: Mar 9, 2017)	criteria provided, multiple submitters, no conflicts	9	2646492	9	2646492	130704	136150
NM_003383.4(VLDLR):c.2291C>T (p.Thr764Met)	VLDLR	Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 1|not specified	Likely benign(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	9	2651454	9	2651454	130708	136154
NM_152629.3(GLIS3):c.2221C>T (p.Leu741Phe)	GLIS3	Diabetes mellitus, neonatal, with congenital hypothyroidism|not specified|Monogenic diabetes	Benign/Likely benign(Last reviewed: Mar 24, 2017)	criteria provided, multiple submitters, no conflicts	9	3828379	9	3828379	129155	134601
NM_152629.3(GLIS3):c.1071C>A (p.Asp357Glu)	GLIS3	Diabetes mellitus, neonatal, with congenital hypothyroidism|not specified	Benign/Likely benign(Last reviewed: Oct 18, 2016)	criteria provided, multiple submitters, no conflicts	9	4117942	9	4117942	129158	134604
NM_152629.3(GLIS3):c.965C>T (p.Ala322Val)	GLIS3	not provided	Uncertain significance(Last reviewed: Nov 4, 2013)	criteria provided, single submitter	9	4118048	9	4118048	129157	134603
NM_152629.3(GLIS3):c.902C>A (p.Pro301Gln)	GLIS3	Diabetes mellitus, neonatal, with congenital hypothyroidism|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	4118111	9	4118111	129160	134606
NM_152629.3(GLIS3):c.805T>C (p.Ser269Pro)	GLIS3	Diabetes mellitus, neonatal, with congenital hypothyroidism|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	4118208	9	4118208	129159	134605
NM_152629.3(GLIS3):c.473G>C (p.Gly158Ala)	GLIS3	not specified|Monogenic diabetes	Benign(Last reviewed: Mar 31, 2017)	criteria provided, multiple submitters, no conflicts	9	4118540	9	4118540	129156	134602
NM_000170.2(GLDC):c.2938A>G (p.Asn980Asp)	GLDC	Non-ketotic hyperglycinemia|Abnormality of brain morphology	Conflicting interpretations of pathogenicity(Last reviewed: Jul 5, 2017)	criteria provided, conflicting interpretations	9	6533142	9	6533142	402186	389138
NM_000170.2(GLDC):c.2177T>A (p.Leu726Gln)	GLDC	Smith-Magenis Syndrome-like	Pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	9	6556178	9	6556178	254210	248725
NM_000170.2(GLDC):c.1940C>T (p.Pro647Leu)	GLDC	Non-ketotic hyperglycinemia|Smith-Magenis Syndrome-like	Conflicting interpretations of pathogenicity(Last reviewed: Jun 5, 2018)	criteria provided, conflicting interpretations	9	6558671	9	6558671	254211	248726
NM_000170.2(GLDC):c.1742C>G (p.Pro581Arg)	GLDC	Non-ketotic hyperglycinemia	Likely pathogenic(Last reviewed: Jan 29, 2013)	criteria provided, single submitter	9	6587249	9	6587249	216936	213593
NM_000155.3(GALT):c.404C>G (p.Ser135Trp)	GALT	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Likely pathogenic(Last reviewed: Dec 2, 2014)	criteria provided, single submitter	9	34647855	9	34647858	25172	36506
NM_000155.3(GALT):c.404C>T (p.Ser135Leu)	GALT	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 19, 2018)	criteria provided, multiple submitters, no conflicts	9	34647855	9	34647858	3618	18657
NM_000155.3(GALT):c.502G>T (p.Val168Leu)	GALT	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Likely pathogenic(Last reviewed: Jul 11, 2014)	criteria provided, single submitter	9	34647953	9	34647956	25189	36523
NM_000155.3(GALT):c.563A>G (p.Gln188Arg)	GALT	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided	Pathogenic(Last reviewed: Jul 9, 2018)	criteria provided, multiple submitters, no conflicts	9	34648167	9	34648170	3614	18653
NM_000155.3(GALT):c.584T>C (p.Leu195Pro)	GALT	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided	Pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, multiple submitters, no conflicts	9	34648350	9	34648353	25222	36556
NM_000155.3(GALT):c.626A>G (p.Tyr209Cys)	GALT	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, multiple submitters, no conflicts	9	34648392	9	34648395	25231	36565
NM_000155.3(GALT):c.775C>T (p.Arg259Trp)	GALT	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 8, 2015)	criteria provided, multiple submitters, no conflicts	9	34648846	9	34648849	189191	186785
NM_000155.3(GALT):c.855G>T (p.Lys285Asn)	GALT	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not specified|not provided	Pathogenic(Last reviewed: Jul 9, 2018)	criteria provided, multiple submitters, no conflicts	9	34649029	9	34649032	3621	18660
NM_000155.3(GALT):c.997C>T (p.Arg333Trp)	GALT	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, multiple submitters, no conflicts	9	34649499	9	34649502	3610	18649
NM_001128227.2(GNE):c.2228T>C (p.Met743Thr)	GNE	Inclusion body myopathy 2|Nonaka myopathy|Sialuria|not provided	Pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, multiple submitters, no conflicts	9	36217396	9	36217399	6025	21064
Multiple alleles	GNE	Nonaka myopathy	Pathogenic(Last reviewed: Jul 6, 2017)	no assertion criteria provided	9|9	36217445	9|9	36217448	430940	21067|357805
NM_005476.5(GNE):c.2086G>A (p.Val696Met)	GNE	Inclusion body myopathy 2|Nonaka myopathy|Sialuria|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, multiple submitters, no conflicts	9	36217445	9	36217448	6028	21067
NM_005476.5(GNE):c.1760T>C (p.Ile587Thr)	GNE	Inclusion body myopathy 2|Nonaka myopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2016)	criteria provided, multiple submitters, no conflicts	9	36219891	9	36219894	188882	186786
NM_005476.5(GNE):c.1571C>T (p.Ala524Val)	GNE	Inclusion body myopathy 2|Nonaka myopathy	Pathogenic(Last reviewed: Jan 16, 2018)	criteria provided, multiple submitters, no conflicts	9	36222836	9	36222839	424619	411514
NM_001128227.2(GNE):c.1225G>T (p.Asp409Tyr)	GNE	Inclusion body myopathy 2|Nonaka myopathy|Sialuria|not provided|GNE myopathy	Pathogenic/Likely pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, multiple submitters, no conflicts	9	36227394	9	36227397	283278	267515
NM_005476.5(GNE):c.829C>T (p.Arg277Cys)	GNE	Inclusion body myopathy 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	9	36234070	9	36234073	188847	186788
NM_001128227.2(GNE):c.830G>A (p.Arg277Gln)	GNE	Inclusion body myopathy 2|Nonaka myopathy|Sialuria|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 26, 2017)	criteria provided, multiple submitters, no conflicts	9	36236861	9	36236864	6030	21069
NM_005476.5(GNE):c.527A>T (p.Asp176Val)	GNE	Inclusion body myopathy 2|Nonaka myopathy|Sialuria|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 16, 2016)	criteria provided, multiple submitters, no conflicts	9	36246117	9	36246120	41233	49657
NM_001128227.2(GNE):c.479G>A (p.Arg160Gln)	GNE	Inclusion body myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2017)	criteria provided, multiple submitters, no conflicts	9	36246258	9	36246261	189156	186790
NM_001128227.2(GNE):c.131G>C (p.Cys44Ser)	GNE	Nonaka myopathy|Sialuria|not provided	Pathogenic(Last reviewed: Nov 15, 2016)	criteria provided, single submitter	9	36249315	9	36249318	496947	488371
NM_012203.1(GRHPR):c.337G>A (p.Glu113Lys)	GRHPR	Primary hyperoxaluria, type II	Likely pathogenic(Last reviewed: Apr 22, 2014)	criteria provided, single submitter	9	37426584	9	37426587	188765	186791
NM_016042.3(EXOSC3):c.673T>C (p.Tyr225His)	EXOSC3	Pontoneocerebellar hypoplasia|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	37780831	9	37780834	129026	134472
NM_016042.3(EXOSC3):c.395A>C (p.Asp132Ala)	EXOSC3	Pontocerebellar hypoplasia, type 1b|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, multiple submitters, no conflicts	9	37783990	9	37783993	31688	40348
NM_016042.3(EXOSC3):c.238G>T (p.Val80Phe)	EXOSC3	Pontocerebellar hypoplasia, type 1b	Likely pathogenic(Last reviewed: Jan 26, 2018)	criteria provided, multiple submitters, no conflicts	9	37784804	9	37784807	129024	134470
NM_016042.3(EXOSC3):c.92G>C (p.Gly31Ala)	EXOSC3	Pontocerebellar hypoplasia, type 1b	Pathogenic(Last reviewed: Nov 28, 2017)	criteria provided, multiple submitters, no conflicts	9	37784950	9	37784953	31691	40351
NM_138691.2(TMC1):c.674C>T	TMC1	Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: Mar 6, 2015)	criteria provided, single submitter	9	75369733	9	72754817	47876	57040
NM_138691.2(TMC1):c.841G>T (p.Gly281Trp)	TMC1	not specified	Uncertain significance(Last reviewed: Aug 26, 2011)	criteria provided, single submitter	9	75387428	9	72772512	47879	57043
NM_138691.2(TMC1):c.1141T>A (p.Tyr381Asn)	TMC1	Nonsyndromic hearing loss and deafness|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 2, 2017)	criteria provided, conflicting interpretations	9	75404150	9	72789234	229314	229701
NM_138691.2(TMC1):c.1333C>T (p.Arg445Cys)	TMC1	Nonsyndromic hearing loss and deafness|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 31, 2016)	criteria provided, conflicting interpretations	9	75406910	9	72791994	179070	174571
NM_017662.4(TRPM6):c.2495A>G (p.Tyr832Cys)	TRPM6	Hypomagnesemia 1, intestinal	Likely pathogenic(Last reviewed: Mar 3, 2017)	criteria provided, single submitter	9	77407583	9	74792667	403726	390703
NM_030940.3(ISCA1):c.259G>A (p.Glu87Lys)	ISCA1	Multiple mitochondrial dysfunctions syndrome|MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5	Pathogenic(Last reviewed: Aug 10, 2017)	no assertion criteria provided	9	88881089	9	86266174	375415	362182
NM_001039803.2(CDK20):c.610T>C (p.Phe204Leu)	CDK20	Global developmental delay|Intellectual disability|Global developmental delay	Likely pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	9	90584788	9	87969873	242894	243986
NM_004560.3(ROR2):c.2805C>G (p.Asp935Glu)	ROR2	Robinow syndrome|Robinow syndrome, autosomal recessive|Brachydactyly|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 15, 2017)	criteria provided, conflicting interpretations	9	94485971	9	91723689	159819	168798
NM_004560.3(ROR2):c.2455G>A (p.Val819Ile)	ROR2	Robinow syndrome|Brachydactyly|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	94486321	9	91724039	159818	168799
NM_004560.3(ROR2):c.2285C>T (p.Ser762Leu)	ROR2	Robinow syndrome|Brachydactyly|not provided|Brachydactyly, type B1Robinow syndrome, autosomal recessive	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	9	94486491	9	91724209	159817	168800
NM_004560.3(ROR2):c.2083G>A (p.Gly695Arg)	ROR2	Robinow syndrome|Brachydactyly|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	94486693	9	91724411	159814	168803
NM_004560.3(ROR2):c.1970G>A (p.Arg657His)	ROR2	not provided|Brachydactyly, type B1Robinow syndrome, autosomal recessive	Uncertain significance(Last reviewed: Aug 28, 2013)	criteria provided, multiple submitters, no conflicts	9	94486806	9	91724524	159813	168804
NM_004560.3(ROR2):c.1045C>G (p.His349Asp)	ROR2	Robinow syndrome|Brachydactyly|not specified|not provided	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	94493330	9	91731048	159810	168807
NM_004560.3(ROR2):c.986G>A (p.Ser329Asn)	ROR2	Robinow syndrome|Robinow syndrome, autosomal recessive|Brachydactyly	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	9	94493389	9	91731107	159824	168808
NM_004560.3(ROR2):c.733A>G (p.Thr245Ala)	ROR2	Robinow syndrome|Brachydactyly|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	94495608	9	91733326	159821	168809
NM_000507.3(FBP1):c.490G>A (p.Gly164Ser)	FBP1	Fructose-biphosphatase deficiency	Pathogenic(Last reviewed: Jul 13, 2017)	criteria provided, multiple submitters, no conflicts	9	97372280	9	94609998	868	15907
NM_000507.3(FBP1):c.355G>A (p.Asp119Asn)	FBP1	Fructose-biphosphatase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 27, 2017)	criteria provided, multiple submitters, no conflicts	9	97380121	9	94617839	214364	211421
NM_000197.1(HSD17B3):c.[194C>T];[239G>A]	HSD17B3	Testosterone 17-beta-dehydrogenase deficiency	Likely pathogenic(Last reviewed: Apr 16, 2013)	criteria provided, single submitter	9|9	99017188	9|9	96254906	424781	19913|213594
NM_000380.3(XPA):c.323G>A (p.Cys108Tyr)	XPA	Xeroderma pigmentosum, type 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 22, 2018)	criteria provided, conflicting interpretations	9	100451882	9	97689600	430367	421768
NM_000035.4(ALDOB):c.1013C>T (p.Ala338Val)	ALDOB	Hereditary fructosuria|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, multiple submitters, no conflicts	9	104184173	9	101421891	188739	186775
NM_000035.4(ALDOB):c.448G>C (p.Ala150Pro)	ALDOB	Hereditary fructosuria|not provided	Pathogenic(Last reviewed: Jul 17, 2018)	criteria provided, multiple submitters, no conflicts	9	104189856	9	101427574	464	15503
NM_005502.3(ABCA1):c.2803A>G (p.Asn935Asp)	ABCA1	Tangier disease	Likely pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	9	107584802	9	104822521	374312	361192
NM_001079802.1(FKTN):c.166C>T (p.Arg56Cys)	FKTN	Fukuyama congenital muscular dystrophy|not specified|Cardiovascular phenotype|Walker-Warburg congenital muscular dystrophy|Dilated Cardiomyopathy, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Aug 4, 2017)	criteria provided, conflicting interpretations	9	108363426	9	105601145	93517	99422
NM_001079802.1(FKTN):c.167G>A (p.Arg56His)	FKTN	not specified|not provided|Cardiovascular phenotype|Walker-Warburg congenital muscular dystrophy	Conflicting interpretations of pathogenicity(Last reviewed: Dec 29, 2017)	criteria provided, conflicting interpretations	9	108363427	9	105601146	93518	99423
NM_001079802.1(FKTN):c.373G>A (p.Gly125Ser)	FKTN	Fukuyama congenital muscular dystrophy|not specified|not provided|Cardiovascular phenotype|Walker-Warburg congenital muscular dystrophy	Benign(Last reviewed: Aug 8, 2017)	criteria provided, multiple submitters, no conflicts	9	108366499	9	105604218	3211	18250
NM_001079802.1(FKTN):c.608G>A (p.Arg203Gln)	FKTN	Fukuyama congenital muscular dystrophy|Limb-girdle muscular dystrophy-dystroglycanopathy, type C4|Congenital muscular dystrophy-dystroglycanopathy without mental retardation, type B4|not specified|Cardiovascular phenotype|Dilated Cardiomyopathy, Recessive	Benign/Likely benign(Last reviewed: Apr 28, 2017)	criteria provided, multiple submitters, no conflicts	9	108366734	9	105604453	93522	99427
NM_005592.3(MUSK):c.299C>T (p.Thr100Met)	MUSK	Pena-Shokeir syndrome type I|not specified|Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency|Congenital Myasthenic Syndrome, Recessive	Benign/Likely benign(Last reviewed: Aug 9, 2017)	criteria provided, multiple submitters, no conflicts	9	113449489	9	110687209	129634	135080
NM_005592.3(MUSK):c.475A>G (p.Ser159Gly)	MUSK	not specified|Congenital Myasthenic Syndrome, Recessive	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	113457799	9	110695519	129636	135082
NM_005592.3(MUSK):c.1239G>A (p.Met413Ile)	MUSK	not specified|Congenital Myasthenic Syndrome, Recessive	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	113538122	9	110775842	129630	135076
NM_005592.3(MUSK):c.2485G>T (p.Val829Leu)	MUSK	Pena-Shokeir syndrome type I|not specified|Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency|Congenital Myasthenic Syndrome, Recessive	Benign(Last reviewed: Aug 9, 2017)	criteria provided, multiple submitters, no conflicts	9	113563143	9	110800863	129633	135079
NM_000031.5(ALAD):c.718C>T (p.Arg240Trp)	ALAD	Porphobilinogen synthase deficiency|not specified	Uncertain significance(Last reviewed: May 16, 2016)	criteria provided, single submitter	9	116151801	9	113389521	16865	31904
NM_000031.5(ALAD):c.520C>T (p.Arg174Cys)	ALAD	Porphobilinogen synthase deficiency	Uncertain significance(Last reviewed: Jul 10, 2018)	no assertion criteria provided	9	116152735	9	113390455	548951	539433
NM_032888.3(COL27A1):c.2089G>C (p.Gly697Arg)	COL27A1	not provided|Steel syndrome	Pathogenic(Last reviewed: Jun 7, 2016)	criteria provided, multiple submitters, no conflicts	9	116958257	9	114195977	143245	152977
NM_018249.5(CDK5RAP2):c.5454T>G (p.Ile1818Met)	CDK5RAP2	not specified|Primary Microcephaly, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Aug 11, 2017)	criteria provided, conflicting interpretations	9	123156914	9	120394636	158164	168710
NM_018249.5(CDK5RAP2):c.5413C>T (p.Leu1805Phe)	CDK5RAP2	Primary autosomal recessive microcephaly 3|not specified	Uncertain significance(Last reviewed: Oct 19, 2016)	criteria provided, multiple submitters, no conflicts	9	123163058	9	120400780	158161	168713
NM_018249.5(CDK5RAP2):c.5359A>C (p.Lys1787Gln)	CDK5RAP2	Primary autosomal recessive microcephaly 3	Uncertain significance(Last reviewed: May 29, 2014)	criteria provided, single submitter	9	123163112	9	120400834	158160	168714
NM_018249.5(CDK5RAP2):c.5152C>G (p.Leu1718Val)	CDK5RAP2	Primary autosomal recessive microcephaly 3|Primary Microcephaly, Recessive	Uncertain significance(Last reviewed: Sep 8, 2017)	criteria provided, multiple submitters, no conflicts	9	123165239	9	120402961	158156	168716
NM_018249.5(CDK5RAP2):c.4822A>G (p.Ser1608Gly)	CDK5RAP2	Primary autosomal recessive microcephaly 3	Uncertain significance(Last reviewed: Jun 19, 2014)	criteria provided, single submitter	9	123169431	9	120407153	158155	168717
NM_018249.5(CDK5RAP2):c.4821G>C (p.Arg1607Ser)	CDK5RAP2	not specified|Primary Microcephaly, Recessive	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	123169432	9	120407154	158154	168718
NM_018249.5(CDK5RAP2):c.4618G>C (p.Val1540Leu)	CDK5RAP2	Primary autosomal recessive microcephaly 3|not specified|Primary Microcephaly, Recessive	Benign(Last reviewed: May 31, 2017)	criteria provided, multiple submitters, no conflicts	9	123170733	9	120408455	21651	34503
NM_018249.5(CDK5RAP2):c.4445A>T (p.Glu1482Val)	CDK5RAP2	not specified	Likely benign(Last reviewed: Aug 26, 2013)	criteria provided, single submitter	9	123171564	9	120409286	158153	168719
NM_018249.5(CDK5RAP2):c.4425G>T (p.Lys1475Asn)	CDK5RAP2	Primary autosomal recessive microcephaly 3	Uncertain significance(Last reviewed: Jan 27, 2014)	criteria provided, single submitter	9	123171584	9	120409306	158151	168721
NM_018249.5(CDK5RAP2):c.4393A>G (p.Met1465Val)	CDK5RAP2	Primary autosomal recessive microcephaly 3	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	9	123173657	9	120411379	158150	168722
NM_018249.5(CDK5RAP2):c.4338T>A (p.Ser1446Arg)	CDK5RAP2	Primary autosomal recessive microcephaly 3|not provided	Uncertain significance(Last reviewed: May 17, 2018)	criteria provided, multiple submitters, no conflicts	9	123173712	9	120411434	158149	168723
NM_018249.5(CDK5RAP2):c.4325C>T (p.Ser1442Leu)	CDK5RAP2	Primary autosomal recessive microcephaly 3	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	9	123173725	9	120411447	158148	168724
NM_018249.5(CDK5RAP2):c.4055A>G (p.Glu1352Gly)	CDK5RAP2	Primary autosomal recessive microcephaly 3	Uncertain significance(Last reviewed: Sep 27, 2013)	criteria provided, single submitter	9	123182188	9	120419910	158147	168725
NM_018249.5(CDK5RAP2):c.3859G>T (p.Ala1287Ser)	CDK5RAP2	Primary autosomal recessive microcephaly 3	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	9	123199669	9	120437391	158145	168727
NM_018249.5(CDK5RAP2):c.3686A>G (p.Asn1229Ser)	CDK5RAP2	Primary autosomal recessive microcephaly 3	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	9	123201713	9	120439435	158144	168728
NM_018249.5(CDK5RAP2):c.3679A>T (p.Ile1227Phe)	CDK5RAP2	Primary autosomal recessive microcephaly 3	Uncertain significance(Last reviewed: Apr 8, 2014)	criteria provided, single submitter	9	123201720	9	120439442	158143	168729
NM_018249.5(CDK5RAP2):c.3285G>C (p.Met1095Ile)	CDK5RAP2	Primary autosomal recessive microcephaly 3	Uncertain significance(Last reviewed: Jul 8, 2013)	criteria provided, single submitter	9	123202114	9	120439836	158140	168731
NM_018249.5(CDK5RAP2):c.3134G>C (p.Arg1045Thr)	CDK5RAP2	Primary autosomal recessive microcephaly 3|not specified|Primary Microcephaly, Recessive	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	123205912	9	120443634	21646	34498
NM_018249.5(CDK5RAP2):c.3065G>A (p.Gly1022Glu)	CDK5RAP2	Primary autosomal recessive microcephaly 3|not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, multiple submitters, no conflicts	9	123205981	9	120443703	21645	34497
NM_018249.5(CDK5RAP2):c.3034C>G (p.Pro1012Ala)	CDK5RAP2	Primary autosomal recessive microcephaly 3	Uncertain significance(Last reviewed: Jun 26, 2014)	criteria provided, single submitter	9	123206012	9	120443734	158137	168733
NM_018249.5(CDK5RAP2):c.2644C>G (p.Leu882Val)	CDK5RAP2	Primary autosomal recessive microcephaly 3	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	9	123215883	9	120453605	158135	168735
NM_018249.5(CDK5RAP2):c.2294C>G (p.Pro765Arg)	CDK5RAP2	not specified|Primary Microcephaly, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	9	123220809	9	120458531	158134	168736
NM_018249.5(CDK5RAP2):c.1712T>C (p.Leu571Pro)	CDK5RAP2	Primary autosomal recessive microcephaly 3|not specified	Benign(Last reviewed: Jul 14, 2016)	criteria provided, multiple submitters, no conflicts	9	123239643	9	120477365	21642	34494
NM_018249.5(CDK5RAP2):c.1433T>C (p.Val478Ala)	CDK5RAP2	Primary autosomal recessive microcephaly 3	Uncertain significance(Last reviewed: May 23, 2013)	criteria provided, single submitter	9	123253634	9	120491356	158131	168739
NM_018249.5(CDK5RAP2):c.1183C>T (p.His395Tyr)	CDK5RAP2	Primary autosomal recessive microcephaly 3	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	9	123280833	9	120518555	158129	168741
NM_018249.5(CDK5RAP2):c.1079C>T (p.Thr360Ile)	CDK5RAP2	not specified	Likely benign(Last reviewed: Jan 4, 2016)	criteria provided, multiple submitters, no conflicts	9	123287277	9	120524999	158126	167979
NM_018249.5(CDK5RAP2):c.923C>T (p.Thr308Ile)	CDK5RAP2	Primary autosomal recessive microcephaly 3|not specified|not provided	Uncertain significance(Last reviewed: Sep 30, 2016)	criteria provided, multiple submitters, no conflicts	9	123290160	9	120527882	158173	168742
NM_018249.5(CDK5RAP2):c.865G>C (p.Glu289Gln)	CDK5RAP2	Primary autosomal recessive microcephaly 3|not specified|Primary Microcephaly, Recessive	Benign(Last reviewed: May 31, 2017)	criteria provided, multiple submitters, no conflicts	9	123291036	9	120528758	21657	34509
NM_018249.5(CDK5RAP2):c.764C>T (p.Ser255Leu)	CDK5RAP2	Primary autosomal recessive microcephaly 3	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	9	123292317	9	120530039	21656	34508
NM_018249.5(CDK5RAP2):c.749C>T (p.Pro250Leu)	CDK5RAP2	Primary autosomal recessive microcephaly 3	Uncertain significance(Last reviewed: Jun 5, 2014)	criteria provided, single submitter	9	123292332	9	120530054	158170	168745
NM_018249.5(CDK5RAP2):c.574C>T (p.Arg192Trp)	CDK5RAP2	Primary autosomal recessive microcephaly 3|Primary Microcephaly, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	123298738	9	120536460	158169	168746
NM_018249.5(CDK5RAP2):c.547G>C (p.Ala183Pro)	CDK5RAP2	Primary autosomal recessive microcephaly 3	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	9	123298765	9	120536487	21654	34506
NM_018249.5(CDK5RAP2):c.533T>C (p.Leu178Pro)	CDK5RAP2	Primary autosomal recessive microcephaly 3|not specified	Uncertain significance(Last reviewed: Mar 23, 2017)	criteria provided, multiple submitters, no conflicts	9	123298779	9	120536501	158159	168747
NM_018249.5(CDK5RAP2):c.34G>C (p.Val12Leu)	CDK5RAP2	Primary autosomal recessive microcephaly 3|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Apr 14, 2017)	criteria provided, conflicting interpretations	9	123342223	9	120579945	158141	168750
NM_003863.3(DPM2):c.227C>G (p.Thr76Ser)	DPM2	Congenital disorder of glycosylation|not specified|Congenital disorder of glycosylation type 1u	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	130698029	9	127935750	128921	134368
NM_016035.4(COQ4):c.[23_33delTCCTCCGTCGG];[331G>T;356C>T]	COQ4	Coenzyme Q10 deficiency, primary, 7	Pathogenic(Last reviewed: Mar 24, 2017)	no assertion criteria provided	9|9|9	131085160 - 131085170	9|9|9	128322881 - 128322891	431013	264313|370322|404620
NM_016035.4(COQ4):c.318G>A (p.Ser106=)	COQ4	not specified|not provided	Benign(Last reviewed: Dec 10, 2015)	criteria provided, single submitter	9	131088076	9	128325797	128832	134280
NM_016035.4(COQ4):c.437T>G (p.Phe146Cys)	COQ4	not provided|Coenzyme Q10 deficiency, primary, 7	Conflicting interpretations of pathogenicity(Last reviewed: Mar 31, 2018)	criteria provided, conflicting interpretations	9	131094466	9	128332187	488487	481355
NM_016035.4(COQ4):c.469C>A (p.Gln157Lys)	COQ4	Inborn genetic diseases|Coenzyme Q10 deficiency, primary, 7	Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2017)	criteria provided, multiple submitters, no conflicts	9	131094498	9	128332219	488488	481356
NM_016035.4(COQ4):c.718C>T (p.Arg240Cys)	COQ4	not provided|Coenzyme Q10 deficiency, primary, 7	Pathogenic/Likely pathogenic(Last reviewed: May 9, 2018)	criteria provided, multiple submitters, no conflicts	9	131095844	9	128333565	189201	187092
NM_001130438.2(SPTAN1):c.1330G>A (p.Val444Ile)	SPTAN1	not specified|Seizures|Abnormality of brain morphology|Early infantile epileptic encephalopathy|Early Infantile Epileptic Encephalopathy, Autosomal Dominant	Conflicting interpretations of pathogenicity(Last reviewed: Dec 11, 2017)	criteria provided, conflicting interpretations	9	131343207	9	128580928	139269	142972
NM_000755.4(CRAT):c.962G>A (p.Arg321His)	CRAT	Neurodegeneration with brain iron accumulation|NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8	Pathogenic(Last reviewed: May 2, 2016)	criteria provided, single submitter	9	131862812	9	129100533	503495	494918
NM_000050.4(ASS1):c.787G>A (p.Val263Met)	ASS1	Citrullinemia type I|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 10, 2017)	criteria provided, multiple submitters, no conflicts	9	133355785	9	130480398	92372	98283
NM_000050.4(ASS1):c.970G>A (p.Gly324Ser)	ASS1	Citrullinemia type I	Pathogenic/Likely pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, multiple submitters, no conflicts	9	133364851	9	130489464	6327	21366
NM_000050.4(ASS1):c.1087C>T (p.Arg363Trp)	ASS1	Citrullinemia type I|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, multiple submitters, no conflicts	9	133370370	9	130494983	6328	21367
NM_000050.4(ASS1):c.1168G>A (p.Gly390Arg)	ASS1	Citrullinemia type I|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 8, 2018)	criteria provided, multiple submitters, no conflicts	9	133374932	9	130499545	6329	21368
NM_006059.3(LAMC3):c.557G>A (p.Arg186His)	LAMC3	Cortical malformations, occipital	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	9	133901855	9	131026468	561148	552132
NM_006059.3(LAMC3):c.4523C>T (p.Thr1508Ile)	LAMC3	Cortical malformations, occipital	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	9	133966969	9	131091582	561049	552133
NM_005085.3(NUP214):c.112C>T (p.Arg38Cys)	NUP214	Progressive microcephaly|Recurrent encephalopathy	Likely pathogenic	no assertion criteria provided	9	134002977	9	131127590	545116	535380
NM_007171.3(POMT1):c.751C>T (p.Arg251Trp)	POMT1	Limb-girdle muscular dystrophy-dystroglycanopathy, type C1|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1|not specified|not provided|Walker-Warburg congenital muscular dystrophy|Limb-Girdle Muscular Dystrophy, Recessive	Benign/Likely benign(Last reviewed: Jan 10, 2018)	criteria provided, multiple submitters, no conflicts	9	134385435	9	131510048	95466	101365
NM_007171.3(POMT1):c.979G>A (p.Val327Ile)	POMT1	Limb-girdle muscular dystrophy-dystroglycanopathy, type C1|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1|not specified|Limb-Girdle Muscular Dystrophy, Recessive	Benign/Likely benign(Last reviewed: Apr 14, 2017)	criteria provided, multiple submitters, no conflicts	9	134386781	9	131511394	95471	101370
NM_007171.3(POMT1):c.1299C>A (p.Asp433Glu)	POMT1	Limb-girdle muscular dystrophy-dystroglycanopathy, type C1|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1|not specified|Walker-Warburg congenital muscular dystrophy|Limb-Girdle Muscular Dystrophy, Recessive	Benign/Likely benign(Last reviewed: Aug 11, 2017)	criteria provided, multiple submitters, no conflicts	9	134390870	9	131515483	95455	101354
NM_007171.3(POMT1):c.1611C>G (p.Ser537Arg)	POMT1	Limb-girdle muscular dystrophy-dystroglycanopathy, type C1|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1|not specified|not provided|Walker-Warburg congenital muscular dystrophy	Conflicting interpretations of pathogenicity(Last reviewed: Dec 20, 2017)	criteria provided, conflicting interpretations	9	134394834	9	131519447	162591	172243
NM_007171.3(POMT1):c.1922C>T (p.Ala641Val)	POMT1	Limb-girdle muscular dystrophy-dystroglycanopathy, type C1|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1|not specified|not provided|Walker-Warburg congenital muscular dystrophy|Limb-Girdle Muscular Dystrophy, Recessive	Benign/Likely benign(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	9	134397464	9	131522077	130011	135457
NM_007171.3(POMT1):c.1987C>T (p.Leu663Phe)	POMT1	Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1	Pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	9	134397529	9	131522142	488581	481449
NM_007171.3(POMT1):c.2203C>T (p.Arg735Cys)	POMT1	Limb-girdle muscular dystrophy-dystroglycanopathy, type C1|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1|not specified|Walker-Warburg congenital muscular dystrophy	Benign/Likely benign(Last reviewed: Dec 7, 2017)	criteria provided, multiple submitters, no conflicts	9	134398452	9	131523065	95463	101362
NM_015046.6(SETX):c.7309C>G (p.Leu2437Val)	SETX	Spinocerebellar ataxia autosomal recessive 1	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	9	135140351	9	132264964	561106	552134
NM_015046.5(SETX):c.[6106G>A];[7149_7151delTTGinsAT]	SETX	Spinocerebellar ataxia autosomal recessive 1	Likely pathogenic(Last reviewed: Aug 13, 2013)	criteria provided, single submitter	9|9	135171259	9|9	132295872	424797	213587|213586
NM_015046.5(SETX):c.6038T>G (p.Val2013Gly)	SETX	Spinocerebellar ataxia autosomal recessive 1	Likely pathogenic(Last reviewed: Apr 4, 2014)	criteria provided, multiple submitters, no conflicts	9	135171327	9	132295940	209189	205757
NM_139025.4(ADAMTS13):c.577C>T (p.Arg193Trp)	ADAMTS13	Upshaw-Schulman syndrome|not provided	Likely pathogenic(Last reviewed: Jul 7, 2017)	criteria provided, single submitter	9	136291356	9	133426236	68823	79714
NM_139025.4(ADAMTS13):c.581G>T (p.Gly194Val)	ADAMTS13	Thrombotic thrombocytopenic purpura	Pathogenic(Last reviewed: Jun 21, 2018)	no assertion criteria provided	9	136291360	9	133426240	559578	550301
NM_139025.4(ADAMTS13):c.2209T>C (p.Cys737Arg)	ADAMTS13	Thrombotic thrombocytopenic purpura	Pathogenic(Last reviewed: Jul 1, 2018)	no assertion criteria provided	9	136307839	9	133442718	559588	550311
NM_139025.4(ADAMTS13):c.3541G>A (p.Gly1181Arg)	ADAMTS13	Thrombotic thrombocytopenic purpura	Pathogenic(Last reviewed: Jul 1, 2018)	no assertion criteria provided	9	136320698	9	133455576	559577	550300
NM_001145320.1(ADAMTSL2):c.493G>A (p.Ala165Thr)	ADAMTSL2	Geleophysic dysplasia 1	Uncertain significance(Last reviewed: Apr 17, 2018)	no assertion criteria provided	9	136405800	9	133540678	524194	514842
NM_003086.3(SNAPC4):c.2401G>C (p.Asp801His)	SNAPC4	SNAPC4-associated inflammatory disease	Uncertain significance(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	9	139275290	9	136380838	522839	513429
NM_003086.3(SNAPC4):c.334C>T (p.Arg112Trp)	SNAPC4	SNAPC4-associated inflammatory disease	Uncertain significance(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	9	139290066	9	136395614	522840	513430
NM_015160.2(PMPCA):c.64C>T (p.Arg22Trp)	PMPCA	Spinocerebellar ataxia, autosomal recessive 2	Pathogenic	no assertion criteria provided	9	139305184	9	136410732	375400	362149
NM_015160.2(PMPCA):c.554G>A (p.Arg185Gln)	PMPCA	Spinocerebellar ataxia, autosomal recessive 2	Pathogenic	no assertion criteria provided	9	139310764	9	136416312	375401	362150
NM_015160.2(PMPCA):c.1066G>A (p.Gly356Ser)	PMPCA	Normal pressure hydrocephalus|Failure to thrive|Optic atrophy|Hypoventilation|Blindness|Optic atrophy|Bilateral ptosis|Hypertrophic cardiomyopathy|Global brain atrophy|Normal pressure hydrocephalus|Chronic lactic acidosis|Restrictive external ophthalmoplegia|Infantile muscular hypotonia|Severe global developmental delay|Diffuse cerebellar atrophy	Pathogenic(Last reviewed: Jan 22, 2016)	no assertion criteria provided	9	139313082	9	136418630	221553	223281
NM_015160.2(PMPCA):c.1129G>A (p.Ala377Thr)	PMPCA	Normal pressure hydrocephalus|Spinocerebellar ataxia, autosomal recessive 2|Failure to thrive|Optic atrophy|Hypoventilation|Blindness|Optic atrophy|Bilateral ptosis|Hypertrophic cardiomyopathy|Global brain atrophy|Normal pressure hydrocephalus|Chronic lactic acidosis|Restrictive external ophthalmoplegia|Infantile muscular hypotonia|Severe global developmental delay|Diffuse cerebellar atrophy	Pathogenic(Last reviewed: Feb 10, 2016)	no assertion criteria provided	9	139313299	9	136418847	221552	223282
NM_019892.5(INPP5E):c.603C>G (p.Ile201Met)	INPP5E	Joubert syndrome|not specified	Benign/Likely benign(Last reviewed: Aug 7, 2017)	criteria provided, multiple submitters, no conflicts	9	139333269	9	136438817	129275	134721
NM_019892.5(INPP5E):c.572C>G (p.Pro191Arg)	INPP5E	not specified	Likely benign(Last reviewed: Jan 24, 2017)	criteria provided, single submitter	9	139333300	9	136438848	129263	134709
NM_006412.3(AGPAT2):c.229C>T (p.Arg77Cys)	AGPAT2	not provided	Uncertain significance(Last reviewed: Feb 17, 2014)	criteria provided, single submitter	9	139571962	9	136677510	128289	133738
NM_001606.4(ABCA2):c.4281C>A (p.Ser1427Arg)	ABCA2	ABCA2-related condition	Uncertain significance(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	9	139908450	9	137013998	522832	513431
NM_001606.4(ABCA2):c.1193C>A (p.Thr398Lys)	ABCA2	ABCA2-related condition	Uncertain significance(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	9	139915218	9	137020766	522833	513432
NM_016219.4(MAN1B1):c.176A>G (p.Asn59Ser)	MAN1B1	not specified|Intellectual Disability, Recessive|History of neurodevelopmental disorder	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	139981627	9	137087175	129574	135020
NM_016219.4(MAN1B1):c.403G>A (p.Val135Ile)	MAN1B1	not provided|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Sep 28, 2016)	criteria provided, conflicting interpretations	9	139983395	9	137088943	129579	135025
NM_016219.4(MAN1B1):c.586C>T (p.Arg196Cys)	MAN1B1	not provided|Intellectual Disability, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	139990809	9	137096357	129572	135018
NM_016219.4(MAN1B1):c.590C>T (p.Pro197Leu)	MAN1B1	Mental retardation, autosomal recessive 15|not specified|Intellectual Disability, Recessive|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jul 24, 2017)	criteria provided, multiple submitters, no conflicts	9	139990813	9	137096361	129580	135026
NM_016219.4(MAN1B1):c.602C>T (p.Pro201Leu)	MAN1B1	not specified|not provided|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Sep 21, 2017)	criteria provided, multiple submitters, no conflicts	9	139990825	9	137096373	129581	135027
NM_016219.4(MAN1B1):c.719A>G (p.Gln240Arg)	MAN1B1	not provided	Uncertain significance(Last reviewed: Oct 22, 2013)	criteria provided, single submitter	9	139992378	9	137097926	129582	135028
NM_016219.4(MAN1B1):c.776A>G (p.His259Arg)	MAN1B1	not provided	Uncertain significance(Last reviewed: Feb 11, 2014)	criteria provided, single submitter	9	139994193	9	137099741	129583	135029
NM_016219.4(MAN1B1):c.1229G>A (p.Arg410His)	MAN1B1	not provided|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Sep 24, 2016)	criteria provided, conflicting interpretations	9	139996099	9	137101647	129569	135015
NM_016219.4(MAN1B1):c.1841G>A (p.Arg614His)	MAN1B1	not provided	Uncertain significance(Last reviewed: Dec 20, 2016)	criteria provided, multiple submitters, no conflicts	9	140002059	9	137107607	129575	135021
NM_016219.4(MAN1B1):c.2020G>A (p.Asp674Asn)	MAN1B1	not provided|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Nov 16, 2016)	criteria provided, conflicting interpretations	9	140002963	9	137108511	129571	135017
NM_001177317.1(SLC34A3):c.575C>G (p.Ser192Trp)	SLC34A3	Autosomal recessive hypophosphatemic bone disease	Pathogenic(Last reviewed: Nov 19, 2013)	criteria provided, single submitter	9	140127675	9	137233223	444094	437702
NM_001177317.1(SLC34A3):c.575C>T (p.Ser192Leu)	SLC34A3	Autosomal recessive hypophosphatemic bone disease|not provided	Pathogenic(Last reviewed: Sep 30, 2017)	criteria provided, multiple submitters, no conflicts	9	140127675	9	137233223	198610	195771
NM_001177317.1(SLC34A3):c.1058G>T (p.Arg353Leu)	SLC34A3	Autosomal recessive hypophosphatemic bone disease	Pathogenic(Last reviewed: Oct 4, 2017)	criteria provided, single submitter	9	140128693	9	137234241	1427	16466
NM_001177317.1(SLC34A3):c.1238C>A (p.Ala413Glu)	SLC34A3	Autosomal recessive hypophosphatemic bone disease	Pathogenic(Last reviewed: Sep 30, 2017)	criteria provided, single submitter	9	140129086	9	137234634	1428	16467
NM_001177317.1(SLC34A3):c.1402C>T (p.Arg468Trp)	SLC34A3	Autosomal recessive hypophosphatemic bone disease	Pathogenic(Last reviewed: Nov 19, 2013)	criteria provided, single submitter	9	140130470	9	137236018	1432	16471
NM_018706.6(DHTKD1):c.[2143C>T];[2185G>A]	DHTKD1	2-aminoadipic 2-oxoadipic aciduria	Likely pathogenic(Last reviewed: Apr 23, 2013)	criteria provided, single submitter	10|10	12154929	10|10	12112930	424772	48163|213596
NM_006214.3(PHYH):c.85C>T (p.Pro29Ser)	PHYH	Phytanic acid storage disease|not specified|not provided	Benign/Likely benign(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	10	13340236	10	13298236	7582	22621
NM_201597.2(CACNB2):c.208C>T (p.Arg70Cys)	CACNB2	Autism spectrum disorder	Uncertain significance(Last reviewed: May 28, 2018)	criteria provided, single submitter	10	18439899	10	18150970	545669	536165
NM_178161.2(PTF1A):c.269G>C (p.Gly90Ala)	PTF1A	not provided|Monogenic diabetes	Uncertain significance(Last reviewed: Oct 27, 2015)	criteria provided, multiple submitters, no conflicts	10	23481728	10	23192799	130054	135500
NM_178161.2(PTF1A):c.787T>C (p.Ser263Pro)	PTF1A	Permanent neonatal diabetes mellitus|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	10	23482635	10	23193706	130055	135501
NM_020824.3(ARHGAP21):c.3491T>G (p.Ile1164Arg)	ARHGAP21	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	10	24884959	10	24596030	402147	389143
NM_021252.4(RAB18):c.592G>A (p.Ala198Thr)	RAB18	not specified|Warburg micro syndrome	Benign/Likely benign(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	10	27826951	10	27538022	130059	135505
NM_018076.4(ARMC4):c.2780T>G (p.Leu927Trp)	ARMC4	Kartagener syndrome|Primary ciliary dyskinesia 23	Pathogenic(Last reviewed: Apr 3, 2013)	criteria provided, single submitter	10	28151382	10	27862453	66045	76951
NM_003174.3(SVIL):c.2348C>T (p.Ser783Leu)	SVIL	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	10	29788083	10	29499154	402169	389144
NM_018109.3(MTPAP):c.1468G>T (p.Val490Leu)	MTPAP	Ataxia, spastic, 4, autosomal recessive	Uncertain significance(Last reviewed: Jul 1, 2015)	no assertion criteria provided	10	30602819	10	30313890	374341	361200
NM_018109.3(MTPAP):c.484C>T (p.Arg162Cys)	MTPAP	Ataxia, spastic, 4, autosomal recessive|not specified|not provided	Benign(Last reviewed: Sep 21, 2015)	criteria provided, multiple submitters, no conflicts	10	30629226	10	30340297	129624	135070
NM_004521.2(KIF5B):c.2252A>G (p.His751Arg)	KIF5B	Global developmental delay|Seizures|Hypoplasia of the corpus callosum|Global developmental delay|Attention deficit hyperactivity disorder|Brain atrophy|Attention deficit hyperactivity disorder	Likely pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	10	32308840	10	32019912	242891	243987
NM_000124.3(ERCC6):c.4238A>G (p.Gln1413Arg)	ERCC6	Cockayne syndrome|not specified|Macular degeneration|Cerebrooculofacioskeletal Syndrome	Benign(Last reviewed: Nov 15, 2016)	criteria provided, multiple submitters, no conflicts	10	50667105	10	49459059	129020	134466
NM_000124.3(ERCC6):c.4186A>G (p.Arg1396Gly)	ERCC6	DE SANCTIS-CACCHIONE SYNDROME|Cerebro-oculo-facio-skeletal syndrome|Cockayne syndrome B|not specified	Uncertain significance(Last reviewed: Feb 9, 2017)	criteria provided, multiple submitters, no conflicts	10	50667157	10	49459111	190173	187986
NM_000124.3(ERCC6):c.3689G>C (p.Arg1230Pro)	ERCC6	Cockayne syndrome|not specified|Macular degeneration|Cerebrooculofacioskeletal Syndrome	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	10	50678317	10	49470271	129018	134464
NM_000124.3(ERCC6):c.3637A>G (p.Arg1213Gly)	ERCC6	Cockayne syndrome|not specified|Macular degeneration|Cerebrooculofacioskeletal Syndrome	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	10	50678369	10	49470323	129017	134463
NM_000124.3(ERCC6):c.3289A>G (p.Met1097Val)	ERCC6	Cockayne syndrome|not specified|Macular degeneration|Cerebrooculofacioskeletal Syndrome	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	10	50678717	10	49470671	129016	134462
NM_000124.3(ERCC6):c.3284C>G (p.Pro1095Arg)	ERCC6	Cockayne syndrome B|Cockayne syndrome|not specified|not provided|Macular degeneration|Cerebrooculofacioskeletal Syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Sep 11, 2018)	criteria provided, conflicting interpretations	10	50678722	10	49470676	1707	16746
NM_000124.3(ERCC6):c.3122A>C (p.Gln1041Pro)	ERCC6	DE SANCTIS-CACCHIONE SYNDROME|Cerebro-oculo-facio-skeletal syndrome|Cockayne syndrome B|Lung cancer|UV-sensitive syndrome|Cockayne syndrome|Age-related macular degeneration 5|not specified|not provided|Macular degeneration|Premature ovarian failure 11|Cerebrooculofacioskeletal Syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Apr 17, 2018)	criteria provided, conflicting interpretations	10	50678884	10	49470838	190164	187995
NM_000124.3(ERCC6):c.2418C>G (p.Cys806Trp)	ERCC6	not specified	Uncertain significance(Last reviewed: Aug 26, 2013)	criteria provided, single submitter	10	50682253	10	49474207	190161	187998
NM_000124.3(ERCC6):c.2008C>T (p.Arg670Trp)	ERCC6	Cockayne syndrome B|Inborn genetic diseases	Pathogenic(Last reviewed: Jul 11, 2017)	criteria provided, multiple submitters, no conflicts	10	50690894	10	49482848	190158	188001
NM_000124.3(ERCC6):c.1996C>T (p.Arg666Cys)	ERCC6	DE SANCTIS-CACCHIONE SYNDROME|Cerebro-oculo-facio-skeletal syndrome|Cockayne syndrome B|Lung cancer|UV-sensitive syndrome|Cockayne syndrome|Age-related macular degeneration 5|not specified|not provided|Macular degeneration|Premature ovarian failure 11|Cerebrooculofacioskeletal Syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Apr 17, 2018)	criteria provided, conflicting interpretations	10	50690906	10	49482860	190156	188003
NM_000124.3(ERCC6):c.1835G>A (p.Arg612Gln)	ERCC6	DE SANCTIS-CACCHIONE SYNDROME|Cerebro-oculo-facio-skeletal syndrome|Cockayne syndrome B|not specified	Uncertain significance(Last reviewed: Aug 24, 2017)	criteria provided, multiple submitters, no conflicts	10	50691549	10	49483503	190154	188006
NM_000124.3(ERCC6):c.1659G>T (p.Lys553Asn)	ERCC6	DE SANCTIS-CACCHIONE SYNDROME|Cerebro-oculo-facio-skeletal syndrome|Cockayne syndrome B|Lung cancer|UV-sensitive syndrome|Cockayne syndrome|Age-related macular degeneration 5|not specified|not provided|Macular degeneration|Premature ovarian failure 11|Cerebrooculofacioskeletal Syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 23, 2017)	criteria provided, conflicting interpretations	10	50708610	10	49500564	190151	188008
NM_000124.3(ERCC6):c.1196G>A (p.Gly399Asp)	ERCC6|PGBD3|ERCC6-PGBD3	Cockayne syndrome|not specified|Macular degeneration|Cerebrooculofacioskeletal Syndrome	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	10	50732280	10	49524234	129013	134459
NM_000124.3(ERCC6):c.670C>T (p.Leu224Phe)	ERCC6|ERCC6-PGBD3	Cockayne syndrome|not specified|not provided|Macular degeneration|Cerebrooculofacioskeletal Syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	10	50732806	10	49524760	190174	188012
NM_020549.4(CHAT):c.25A>G (p.Arg9Gly)	CHAT	not provided	Uncertain significance(Last reviewed: Aug 26, 2013)	criteria provided, single submitter	10	50822260	10	49614214	128723	134172
NM_020549.4(CHAT):c.141C>G (p.Asp47Glu)	CHAT	Familial infantile myasthenia|not specified|not provided	Benign(Last reviewed: Aug 7, 2017)	criteria provided, multiple submitters, no conflicts	10	50822376	10	49614330	128718	134167
NM_020549.4(CHAT):c.358G>A (p.Ala120Thr)	CHAT	not specified|not provided	Benign(Last reviewed: Aug 4, 2016)	criteria provided, multiple submitters, no conflicts	10	50824619	10	49616573	128724	134173
NM_020549.4(CHAT):c.406G>A (p.Val136Met)	CHAT	Familial infantile myasthenia|Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 5, 2018)	criteria provided, conflicting interpretations	10	50827789	10	49619743	279754	264430
NM_020549.4(CHAT):c.711C>G (p.Ser237Arg)	CHAT	Familial infantile myasthenia|not specified	Benign(Last reviewed: Nov 14, 2017)	criteria provided, multiple submitters, no conflicts	10	50830155	10	49622109	128725	134174
NM_020549.4(CHAT):c.727C>T (p.Leu243Phe)	CHAT	Familial infantile myasthenia|not specified|not provided	Benign(Last reviewed: Aug 11, 2017)	criteria provided, multiple submitters, no conflicts	10	50830171	10	49622125	128726	134175
NM_020549.4(CHAT):c.1198G>A (p.Asp400Asn)	CHAT	Familial infantile myasthenia|not specified|not provided	Benign/Likely benign(Last reviewed: Aug 2, 2017)	criteria provided, multiple submitters, no conflicts	10	50854637	10	49646591	128717	134166
NM_020549.4(CHAT):c.1682G>A (p.Arg561Gln)	CHAT	Familial infantile myasthenia|not specified|not provided	Benign/Likely benign(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	10	50863188	10	49655142	128721	134170
NM_001143996.1(OGDHL):c.2162C>T (p.Ser721Leu)	OGDHL	not provided|Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	10	50946295	10	49738249	402144	389145
NM_033056.3(PCDH15):c.5726G>A (p.Arg1909His)	PCDH15	Usher syndrome, type 1F|not specified	Uncertain significance(Last reviewed: Jan 8, 2018)	criteria provided, multiple submitters, no conflicts	10	55581760	10	53822000	46508	55673
NM_033056.3(PCDH15):c.5398G>A (p.Val1800Ile)	PCDH15	Usher syndrome, type 1F|not specified	Benign/Likely benign(Last reviewed: Jan 16, 2018)	criteria provided, multiple submitters, no conflicts	10	55582088	10	53822328	46499	55664
NM_033056.3(PCDH15):c.5359C>T (p.Pro1787Ser)	PCDH15	Retinitis pigmentosa-deafness syndrome|Usher syndrome, type 1F|not specified|Nonsyndromic Hearing Loss, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	10	55582127	10	53822367	46498	55663
NM_033056.3(PCDH15):c.400C>G (p.Arg134Gly)	PCDH15	Deafness, autosomal recessive 23|Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: Dec 15, 2013)	criteria provided, single submitter	10	56128954	10	54369194	4936	19975
NM_003201.2(TFAM):c.533C>T (p.Pro178Leu)	TFAM	Mitochondrial DNA depletion syndrome, hepatocerebral form|Mitochondrial DNA depletion syndrome 15 (hepatocerebral type)	Likely pathogenic(Last reviewed: Oct 1, 2015)	criteria provided, single submitter	10	60150616	10	58390856	221285	222997
NM_020987.4(ANK3):c.12769A>G (p.Ile4257Val)	ANK3	not specified	Likely benign	no assertion criteria provided	10	61815712	10	60055954	128363	133812
NM_020987.4(ANK3):c.9652C>T (p.Leu3218Phe)	ANK3	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	10	61830987	10	60071229	402146	389146
NM_020987.4(ANK3):c.9368A>G (p.Lys3123Arg)	ANK3	not specified	Likely benign	no assertion criteria provided	10	61831271	10	60071513	128385	133834
NM_020987.4(ANK3):c.9349A>G (p.Ile3117Val)	ANK3	not specified	Likely benign	no assertion criteria provided	10	61831290	10	60071532	128384	133833
NM_020987.4(ANK3):c.9137C>G (p.Thr3046Ser)	ANK3	not specified	Likely benign	no assertion criteria provided	10	61831502	10	60071744	128383	133832
NM_020987.4(ANK3):c.8988G>C (p.Gln2996His)	ANK3	not specified	Benign(Last reviewed: May 5, 2015)	criteria provided, single submitter	10	61831651	10	60071893	128381	133830
NM_020987.4(ANK3):c.8655C>A (p.His2885Gln)	ANK3	not specified	Likely benign	no assertion criteria provided	10	61831984	10	60072226	128379	133828
NM_020987.4(ANK3):c.7715T>C (p.Ile2572Thr)	ANK3	not specified	Likely benign	no assertion criteria provided	10	61832924	10	60073166	128377	133826
NM_020987.4(ANK3):c.7225T>C (p.Ser2409Pro)	ANK3	not specified	Benign(Last reviewed: Jul 17, 2015)	criteria provided, single submitter	10	61833414	10	60073656	128375	133824
NM_020987.4(ANK3):c.382A>G (p.Thr128Ala)	ANK3	not specified|not provided	Likely benign(Last reviewed: Aug 11, 2017)	criteria provided, single submitter	10	62038564	10	60278806	128369	133818
NM_001324312.1(SLC25A16):c.92G>T (p.Arg31Leu)	SLC25A16	not provided|Isolated nail anomaly	Conflicting interpretations of pathogenicity(Last reviewed: Jun 12, 2018)	no assertion criteria provided	10	70287041	10	68527284	545498	536004
NM_020999.3(NEUROG3):c.596T>C (p.Phe199Ser)	NEUROG3	not specified	Benign(Last reviewed: Mar 29, 2016)	criteria provided, single submitter	10	71332204	10	69572448	129765	135211
NM_020999.3(NEUROG3):c.499G>A (p.Gly167Arg)	NEUROG3	not specified	Benign(Last reviewed: Mar 29, 2016)	criteria provided, multiple submitters, no conflicts	10	71332301	10	69572545	129764	135210
NM_005041.5(PRF1):c.1337A>C (p.Gln446Pro)	PRF1	Hemophagocytic lymphohistiocytosis, familial, 2	Likely pathogenic(Last reviewed: Apr 22, 2014)	criteria provided, single submitter	10	72358140	10	70598384	216986	213598
NM_001083116.2(PRF1):c.1120T>G (p.Trp374Gly)	PRF1	Hemophagocytic lymphohistiocytosis, familial, 2	Likely pathogenic	no assertion criteria provided	10	72358357	10	70598601	397653	384626
NM_001083116.2(PRF1):c.386G>C (p.Trp129Ser)	PRF1	Hemophagocytic lymphohistiocytosis, familial, 2	Likely pathogenic(Last reviewed: Nov 1, 2017)	no assertion criteria provided	10	72360273	10	70600517	548929	539416
NM_018344.5(SLC29A3):c.52A>G (p.Arg18Gly)	SLC29A3	Histiocytosis-lymphadenopathy plus syndrome|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	10	73082563	10	71322806	130342	135789
NM_018344.5(SLC29A3):c.304T>C (p.Tyr102His)	SLC29A3	Histiocytosis-lymphadenopathy plus syndrome|not specified	Benign/Likely benign(Last reviewed: Dec 29, 2017)	criteria provided, multiple submitters, no conflicts	10	73103969	10	71344212	130335	135782
NM_018344.5(SLC29A3):c.473C>T (p.Ser158Phe)	SLC29A3	Histiocytosis-lymphadenopathy plus syndrome|not specified	Benign(Last reviewed: Sep 11, 2018)	criteria provided, multiple submitters, no conflicts	10	73111408	10	71351651	130341	135788
NM_018344.5(SLC29A3):c.715G>A (p.Val239Ile)	SLC29A3	Histiocytosis-lymphadenopathy plus syndrome|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	10	73115942	10	71356185	130344	135791
NM_018344.5(SLC29A3):c.842T>C (p.Leu281Pro)	SLC29A3	Histiocytosis-lymphadenopathy plus syndrome|not specified	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	10	73121779	10	71362022	130346	135793
NM_018344.5(SLC29A3):c.976A>G (p.Ile326Val)	SLC29A3	Histiocytosis-lymphadenopathy plus syndrome|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	10	73121913	10	71362156	130347	135794
NM_022124.5(CDH23):c.380A>G (p.Asp127Gly)	CDH23|CDH23-AS1	Usher syndrome, type 1D|Usher syndrome	Likely pathogenic(Last reviewed: Sep 10, 2018)	reviewed by expert panel	10	73270920	10	71511163	228491	229846
NM_022124.5(CDH23):c.1369C>T (p.Arg457Trp)	CDH23	Usher syndrome, type 1D	Likely pathogenic(Last reviewed: Apr 1, 2013)	criteria provided, single submitter	10	73406294	10	71646537	178675	174960
NM_022124.5(CDH23):c.2701G>A (p.Glu901Lys)	CDH23	Usher syndrome, type 1D	Likely pathogenic(Last reviewed: Nov 5, 2015)	criteria provided, single submitter	10	73462419	10	71702662	228248	229863
NM_022124.5(CDH23):c.5237G>A (p.Arg1746Gln)	CDH23	Usher syndrome, type 1D|not provided|CDH23-Related Disorders	Pathogenic(Last reviewed: Jun 2, 2017)	criteria provided, multiple submitters, no conflicts	10	73539073	10	71779316	4916	19955
NM_022124.5(CDH23):c.5660C>T (p.Thr1887Ile)	CDH23	not specified|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Jul 19, 2016)	criteria provided, conflicting interpretations	10	73544805	10	71785048	45987	55152
NM_022124.5(CDH23):c.6049G>A (p.Gly2017Ser)	CDH23	Usher syndrome, type 1D	Likely pathogenic(Last reviewed: Nov 23, 2011)	criteria provided, single submitter	10	73550170	10	71790413	46000	55165
NM_022124.5(CDH23):c.6614C>T (p.Pro2205Leu)	CDH23	not specified|not provided|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Oct 10, 2017)	criteria provided, conflicting interpretations	10	73553299	10	71793542	46014	55179
NM_022124.5(CDH23):c.7921G>C (p.Asp2641His)	CDH23|LOC111982869	Usher syndrome, type 1D	Likely pathogenic(Last reviewed: May 7, 2012)	criteria provided, single submitter	10	73565611	10	71805854	46041	55206
NM_001042465.2(PSAP):c.722G>C (p.Cys241Ser)	PSAP	Combined saposin deficiency|Sphingolipid activator protein 1 deficiency	Pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, single submitter	10	73585649	10	71825892	13363	28402
NM_004273.4(CHST3):c.491C>T (p.Pro164Leu)	CHST3	Spondyloepiphyseal dysplasia with congenital joint dislocations	Pathogenic	criteria provided, single submitter	10	73767280	10	72007522	478823	472249
NM_004273.4(CHST3):c.904G>C (p.Asp302His)	CHST3	Spondyloepiphyseal dysplasia with congenital joint dislocations	Pathogenic	criteria provided, single submitter	10	73767693	10	72007935	478822	472248
NM_001123.3(ADK):c.902C>A (p.Ala301Glu)	ADK	Hypermethioninemia due to adenosine kinase deficiency	Pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	10	76430016	10	74670258	29603	38557
NM_007055.3(POLR3A):c.[2554A>G];[367_369delAAG]	POLR3A	Hypomyelinating leukodystrophy 7	Likely pathogenic(Last reviewed: Aug 19, 2014)	criteria provided, single submitter	10|10	79759801	10|10	78000043	424792	40102|213601
NM_000429.2(MAT1A):c.712G>A (p.Glu238Lys)	MAT1A	Hepatic methionine adenosyltransferase deficiency	Uncertain significance	criteria provided, single submitter	10	82036188	10	80276432	431707	425217
NM_000429.2(MAT1A):c.242G>A (p.Arg81Gln)	MAT1A	Hepatic methionine adenosyltransferase deficiency	Uncertain significance	criteria provided, single submitter	10	82043722	10	80283966	431706	425218
NM_004329.2(BMPR1A):c.1217G>T (p.Arg406Leu)	BMPR1A	Juvenile polyposis syndrome|BMPR1A Skeletal Dysplasia Syndrome	Uncertain significance(Last reviewed: Jun 7, 2018)	criteria provided, single submitter	10	88681327	10	86921570	545692	536184
NM_000235.3(LIPA):c.894G>C (p.Gln298His)	LIPA	Lysosomal acid lipase deficiency	Likely pathogenic(Last reviewed: Jul 4, 2017)	no assertion criteria provided	10	90982268	10	89222511	430634	423865
NM_000235.3(LIPA):c.599T>C (p.Leu200Pro)	LIPA	Lysosomal acid lipase deficiency|Wolman disease	Likely pathogenic(Last reviewed: Aug 8, 2017)	criteria provided, single submitter	10	90984925	10	89225168	77	15116
NM_006204.3(PDE6C):c.1958T>C (p.Leu653Pro)	PDE6C	Cone dystrophy 4	Likely pathogenic(Last reviewed: Oct 30, 2012)	criteria provided, single submitter	10	95415539	10	93655782	216982	213603
NM_002860.3(ALDH18A1):c.2294G>A (p.Arg765Gln)	ALDH18A1	Cutis laxa-corneal clouding-oligophrenia syndrome	Likely pathogenic(Last reviewed: Nov 20, 2012)	criteria provided, single submitter	10	97366613	10	95606856	216888	213604
NM_015631.5(TCTN3):c.925G>T (p.Ala309Ser)	TCTN3	Orofacial-digital syndrome IV|not specified|Joubert syndrome 18	Benign(Last reviewed: Jul 26, 2017)	criteria provided, multiple submitters, no conflicts	10	97445357	10	95685600	130579	136025
NM_015631.5(TCTN3):c.193A>C (p.Thr65Pro)	TCTN3	not specified	Benign(Last reviewed: Feb 19, 2016)	criteria provided, multiple submitters, no conflicts	10	97453464	10	95693707	130576	136022
NM_001776.5(ENTPD1):c.401T>G (p.Met134Arg)	ENTPD1|ENTPD1-AS1	Spastic paraplegia 64, autosomal recessive	Uncertain significance(Last reviewed: Sep 7, 2018)	no assertion criteria provided	10	97602239	10	95842482	561218	552356
NM_004376.6(COX15):c.1120T>C (p.Phe374Leu)	COX15	Hepatic failure, early-onset, and neurologic disorder due to cytochrome C oxidase deficiency|not specified|not provided	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	10	101473218	10	99713461	128836	134284
NM_018294.5(CWF19L1):c.776C>T (p.Pro259Leu)	CWF19L1	not specified	Likely benign	no assertion criteria provided	10	102006625	10	100246868	128881	134328
NM_018294.5(CWF19L1):c.479G>A (p.Cys160Tyr)	CWF19L1	not specified	Likely benign	no assertion criteria provided	10	102016044	10	100256287	128879	134326
NM_021830.4(TWNK):c.874C>A (p.Pro292Thr)	TWNK	Perrault syndrome 5	Pathogenic	no assertion criteria provided	10	102748841	10	100989084	488187	481146
NM_021830.4(TWNK):c.1196A>G (p.Asn399Ser)	TWNK	Mitochondrial DNA depletion syndrome 7 (hepatocerebral type)|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Sep 8, 2017)	criteria provided, conflicting interpretations	10	102749163	10	100989406	214185	211434
NM_021830.4(TWNK):c.1523A>G (p.Tyr508Cys)	TWNK	Mitochondrial DNA depletion syndrome 7 (hepatocerebral type)|not provided	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, multiple submitters, no conflicts	10	102750231	10	100990474	4627	19666
NM_033164.3(FGF8):c.365C>T (p.Thr122Met)	FGF8	Holoprosencephaly sequence	Likely pathogenic(Last reviewed: Apr 19, 2018)	criteria provided, single submitter	10	103531266	10	101771509	545458	535718
NM_017649.4(CNNM2):c.364G>A (p.Glu122Lys)	CNNM2	Hypomagnesemia, seizures, and mental retardation	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	10	104678601	10	102918844	192323	190115
NM_032727.3(INA):c.562G>A (p.Gly188Arg)	INA	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	10	105037530	10	103277773	402160	389141
NM_016824.4(ADD3):c.1100G>A (p.Gly367Asp)	ADD3	Cerebral palsy|Cerebral palsy, spastic quadriplegic, 3	Pathogenic(Last reviewed: Jun 28, 2016)	no assertion criteria provided	10	111882007	10	110122249	242273	243827
NM_002775.4(HTRA1):c.614C>G (p.Ser205Cys)	HTRA1	Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy	Pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, single submitter	10	124248979	10	122489463	560164	550880
NM_004092.3(ECHS1):c.817A>G (p.Lys273Glu)	ECHS1	not provided|Mitochondrial short-chain enoyl-coa hydratase 1 deficiency	Pathogenic/Likely pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, multiple submitters, no conflicts	10	135176428	10	133362924	372596	359810
NM_004092.3(ECHS1):c.676G>A (p.Ala226Thr)	ECHS1	Mitochondrial short-chain enoyl-coa hydratase 1 deficiency	Likely pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	10	135179543	10	133366039	488497	481365
NM_004092.3(ECHS1):c.541C>T (p.Arg181Cys)	ECHS1	Mitochondrial short-chain enoyl-coa hydratase 1 deficiency	Likely pathogenic(Last reviewed: May 5, 2017)	criteria provided, single submitter	10	135180471	10	133366967	488384	481236
NM_004092.3(ECHS1):c.518C>T (p.Ala173Val)	ECHS1	not provided|Mitochondrial short-chain enoyl-coa hydratase 1 deficiency	Pathogenic/Likely pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, multiple submitters, no conflicts	10	135180494	10	133366990	377257	364135
NM_004092.3(ECHS1):c.488C>T (p.Pro163Leu)	ECHS1	Mitochondrial short-chain enoyl-coa hydratase 1 deficiency	Likely pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	10	135182453	10	133368949	488498	481366
NM_004092.3(ECHS1):c.476A>G (p.Gln159Arg)	ECHS1	not provided|Mitochondrial short-chain enoyl-coa hydratase 1 deficiency	Pathogenic/Likely pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, multiple submitters, no conflicts	10	135182465	10	133368961	379794	370650
NM_004092.3(ECHS1):c.394G>A (p.Ala132Thr)	ECHS1	Mitochondrial short-chain enoyl-coa hydratase 1 deficiency	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	10	135183428	10	133369924	488499	481367
NM_004092.3(ECHS1):c.160C>T (p.Arg54Cys)	ECHS1	Mitochondrial short-chain enoyl-coa hydratase 1 deficiency	Likely pathogenic(Last reviewed: May 5, 2015)	criteria provided, single submitter	10	135184190	10	133370686	369670	353899
NM_004092.3(ECHS1):c.74G>C (p.Arg25Pro)	ECHS1	Mitochondrial short-chain enoyl-coa hydratase 1 deficiency	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	10	135186764	10	133373260	488500	481368
NM_021008.3(DEAF1):c.676C>T (p.Arg226Trp)	DEAF1	not provided|Inborn genetic diseases|Dyskinesia, seizures, and intellectual developmental disorder	Likely pathogenic(Last reviewed: May 4, 2017)	criteria provided, multiple submitters, no conflicts	11	686986	11	686986	143989	153719
NM_006755.1(TALDO1):c.574C>T (p.Arg192Cys)	TALDO1	Deficiency of transaldolase|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	11	763456	11	763456	381759	372716
NM_024698.5(SLC25A22):c.448C>G (p.Leu150Val)	SLC25A22	not specified|Seizures|not provided|Early Infantile Epileptic Encephalopathy, Autosomal Recessive	Benign/Likely benign(Last reviewed: May 4, 2018)	criteria provided, multiple submitters, no conflicts	11	792692	11	792692	139137	142840
NM_024698.5(SLC25A22):c.179A>G (p.Glu60Gly)	SLC25A22	Early myoclonic encephalopathy	Uncertain significance(Last reviewed: Oct 2, 2013)	criteria provided, single submitter	11	794481	11	794481	159912	168889
NM_024698.5(SLC25A22):c.169G>A (p.Val57Ile)	SLC25A22	not specified|Seizures|Early infantile epileptic encephalopathy	Benign/Likely benign(Last reviewed: Dec 21, 2017)	criteria provided, multiple submitters, no conflicts	11	794491	11	794491	159911	168890
NM_024698.5(SLC25A22):c.151G>A (p.Asp51Asn)	SLC25A22	Early myoclonic encephalopathy|not specified|Seizures|Early infantile epileptic encephalopathy	Conflicting interpretations of pathogenicity(Last reviewed: Nov 19, 2017)	criteria provided, conflicting interpretations	11	794509	11	794509	139131	142834
NM_001909.4(CTSD):c.844G>A (p.Gly282Arg)	CTSD	Ceroid lipofuscinosis neuronal 10|Neuronal ceroid lipofuscinosis|not specified|Seizures|not provided|Neuronal Ceroid-Lipofuscinosis, Dominant/Recessive	Benign/Likely benign(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	11	1775352	11	1754122	128877	134325
NM_001909.4(CTSD):c.173C>T (p.Ala58Val)	CTSD	Ceroid lipofuscinosis neuronal 10|not specified|Seizures|not provided|Neuronal Ceroid-Lipofuscinosis, Dominant/Recessive	Benign/Likely benign(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	11	1782594	11	1761364	128873	134321
NM_000218.2(KCNQ1):c.5C>G (p.Ala2Gly)	KCNQ1	Long QT syndrome 1	Likely pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, single submitter	11	2466333	11	2445103	431053	424582
NM_000218.2(KCNQ1):c.934A>T (p.Thr312Ser)	KCNQ1	Long QT syndrome 1	Likely pathogenic	no assertion criteria provided	11	2604677	11	2583447	522585	513199
NM_000218.2(KCNQ1):c.1691A>G (p.Asp564Gly)	KCNQ1	Long QT syndrome 1	Likely pathogenic(Last reviewed: Feb 18, 2017)	no assertion criteria provided	11	2798221	11	2776991	403694	390668
NM_000518.5(HBB):c.353A>G (p.His118Arg)	HBB|LOC107133510|LOC110006319	beta Thalassemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 14, 2017)	criteria provided, conflicting interpretations	11	5246919	11	5225689	36324	44988
NM_000518.5(HBB):c.328G>A (p.Val110Met)	HBB|LOC107133510|LOC110006319	HEMOGLOBIN SAN DIEGO|beta Thalassemia|not provided|Erythrocytosis 6, familial	Pathogenic/Likely pathogenic, other(Last reviewed: Dec 12, 2017)	criteria provided, multiple submitters, no conflicts	11	5246944	11	5225714	15342	30381
NM_000518.5(HBB):c.309C>A (p.Asn103Lys)	HBB|LOC106099062|LOC107133510|LOC110006319	beta Thalassemia|not specified|not provided	Uncertain significance(Last reviewed: Jun 20, 2017)	criteria provided, multiple submitters, no conflicts	11	5247813	11	5226583	36311	44975
NM_000518.4(HBB):c.208G>A (p.Gly70Ser)	HBB|LOC106099062|LOC107133510	Beta-thalassemia, dominant inclusion body type|Fetal hemoglobin quantitative trait locus 1|Hb SS disease|HEMOGLOBIN CITY OF HOPE|beta Thalassemia|Beta thalassemia intermedia|not provided	Conflicting interpretations of pathogenicity, other(Last reviewed: Dec 12, 2017)	criteria provided, conflicting interpretations	11	5247914	11	5226684	15138	30177
NM_000518.5(HBB):c.92G>A (p.Arg31Lys)	HBB|LOC106099062|LOC107133510	beta Thalassemia|not provided	Likely pathogenic(Last reviewed: Apr 3, 2017)	criteria provided, multiple submitters, no conflicts	11	5248160	11	5226930	36337	45001
NM_000518.4(HBB):c.92G>C (p.Arg31Thr)	HBB|LOC106099062|LOC107133510	beta Thalassemia|Beta thalassemia major|not specified|not provided	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, multiple submitters, no conflicts	11	5248160	11	5226930	15234	30273
NM_000518.5(HBB):c.82G>T (p.Ala28Ser)	HBB|LOC106099062|LOC107133510	Beta-plus-thalassemia|HEMOGLOBIN KNOSSOS|Beta-knossos-thalassemia|beta Thalassemia|not provided	Pathogenic/Likely pathogenic, other(Last reviewed: Dec 12, 2017)	criteria provided, multiple submitters, no conflicts	11	5248170	11	5226940	15239	30278
NM_000518.5(HBB):c.2T>C (p.Met1Thr)	HBB|LOC106099062|LOC107133510	beta^0^ Thalassemia|Beta-thalassemia, lermontov type|beta Thalassemia|not specified|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 10, 2017)	criteria provided, multiple submitters, no conflicts	11	5248250	11	5227020	36310	44974
NM_000543.4(SMPD1):c.739G>A (p.Gly247Ser)	SMPD1	Ceroid lipofuscinosis neuronal 6|Niemann-Pick disease, type B|Niemann-Pick disease, type A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 26, 2017)	criteria provided, multiple submitters, no conflicts	11	6413034	11	6391804	100731	106596
NM_000543.4(SMPD1):c.757G>C (p.Asp253His)	SMPD1	Niemann-Pick disease, type A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 24, 2017)	criteria provided, multiple submitters, no conflicts	11	6413052	11	6391822	93320	99227
NM_000543.4(SMPD1):c.880C>A (p.Gln294Lys)	SMPD1	Niemann-Pick disease, type B|Niemann-Pick disease, type A|Niemann-pick disease, intermediate, protracted neurovisceral	Pathogenic(Last reviewed: Aug 20, 2014)	criteria provided, single submitter	11	6413175	11	6391945	2994	18033
NM_000543.4(SMPD1):c.1426C>T	SMPD1	Niemann-Pick disease, type B|Niemann-Pick disease, type A|Sphingomyelin/cholesterol lipidosis	Pathogenic/Likely pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, multiple submitters, no conflicts	11	6415211	11	6393981	93315	99222
NM_000543.4(SMPD1):c.1430C>T (p.Pro477Leu)	SMPD1	Niemann-Pick disease, type A|not provided	Likely pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, multiple submitters, no conflicts	11	6415215	11	6393985	189075	186827
NM_000543.4(SMPD1):c.1805G>A (p.Arg602His)	SMPD1	Niemann-Pick disease, type A	Likely pathogenic(Last reviewed: Sep 2, 2014)	criteria provided, single submitter	11	6415746	11	6394516	188955	186828
NM_000391.3(TPP1):c.1376A>C (p.Tyr459Ser)	TPP1	Ceroid lipofuscinosis neuronal 2	Likely pathogenic(Last reviewed: Aug 7, 2015)	no assertion criteria provided	11	6636451	11	6615220	218336	215044
NM_000391.3(TPP1):c.1094G>A (p.Cys365Tyr)	TPP1	Ceroid lipofuscinosis neuronal 2|Neuronal ceroid lipofuscinosis|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2018)	criteria provided, multiple submitters, no conflicts	11	6637287	11	6616056	2642	17681
NM_000391.3(TPP1):c.733C>T (p.Arg245Cys)	TPP1	not provided	Uncertain significance(Last reviewed: Oct 2, 2013)	criteria provided, single submitter	11	6638045	11	6616814	130611	136057
NM_000391.3(TPP1):c.605C>T (p.Pro202Leu)	TPP1	Ceroid lipofuscinosis neuronal 2	Likely pathogenic(Last reviewed: Jun 13, 2014)	criteria provided, single submitter	11	6638288	11	6617057	68747	79639
NM_000391.3(TPP1):c.456G>C (p.Arg152Ser)	TPP1	Ceroid lipofuscinosis neuronal 2	Likely pathogenic(Last reviewed: Oct 17, 2015)	no assertion criteria provided	11	6638584	11	6617353	221282	222994
NM_000391.3(TPP1):c.299A>G (p.Gln100Arg)	TPP1	Neuronal ceroid lipofuscinosis|not specified|Seizures|not provided	Benign/Likely benign(Last reviewed: Dec 21, 2017)	criteria provided, multiple submitters, no conflicts	11	6638938	11	6617707	68745	79637
NM_000391.3(TPP1):c.293C>T (p.Thr98Met)	TPP1	Ceroid lipofuscinosis neuronal 2|Neuronal ceroid lipofuscinosis|not specified|Seizures|not provided|Neuronal Ceroid-Lipofuscinosis, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Feb 12, 2018)	criteria provided, conflicting interpretations	11	6638944	11	6617713	130609	136055
NM_003737.3(DCHS1):c.2382G>C (p.Gln794His)	DCHS1	Van Maldergem syndrome 1	Pathogenic(Last reviewed: Mar 5, 2016)	no assertion criteria provided	11	6654716	11	6633485	437929	431551
NM_000352.4(ABCC8):c.4628T>C (p.Leu1543Pro)	ABCC8	Persistent hyperinsulinemic hypoglycemia of infancy	Likely pathogenic(Last reviewed: Nov 9, 2015)	criteria provided, multiple submitters, no conflicts	11	17414656	11	17393109	188836	186811
NM_000352.4(ABCC8):c.4477C>T (p.Arg1493Trp)	ABCC8	Persistent hyperinsulinemic hypoglycemia of infancy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 29, 2017)	criteria provided, multiple submitters, no conflicts	11	17415881	11	17394334	9096	24135
NM_000352.4(ABCC8):c.4411G>A (p.Asp1471Asn)	ABCC8	Persistent hyperinsulinemic hypoglycemia of infancy|Familial hyperinsulinism	Pathogenic/Likely pathogenic(Last reviewed: Feb 17, 2016)	criteria provided, multiple submitters, no conflicts	11	17416719	11	17395172	188931	186812
NM_000352.4(ABCC8):c.4198G>A (p.Gly1400Arg)	ABCC8	Permanent neonatal diabetes mellitus|Persistent hyperinsulinemic hypoglycemia of infancy|Familial hyperinsulinism	Likely pathogenic(Last reviewed: Jun 7, 2014)	criteria provided, multiple submitters, no conflicts	11	17417399	11	17395852	35616	44281
NM_000352.4(ABCC8):c.1678G>A (p.Val560Met)	ABCC8	Permanent neonatal diabetes mellitus|Persistent hyperinsulinemic hypoglycemia of infancy|Transient Neonatal Diabetes, Dominant|Hyperinsulinism, Dominant/Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	17452500	11	17430953	188919	186819
NM_213599.2(ANO5):c.[155A>G];[191dupA]	ANO5	Limb-girdle muscular dystrophy, type 2L|Miyoshi muscular dystrophy 3	Likely pathogenic(Last reviewed: Oct 8, 2013)	criteria provided, single submitter	11|11	22242653	11|11	22221107	424764	17203|194564
NM_213599.2(ANO5):c.616A>G (p.Thr206Ala)	ANO5	Gnathodiaphyseal dysplasia|Limb-girdle muscular dystrophy, type 2L|not specified	Benign(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	11	22249100	11	22227554	128391	133840
NM_213599.2(ANO5):c.749A>G (p.Tyr250Cys)	ANO5	Limb-girdle muscular dystrophy, type 2L|not provided	Uncertain significance(Last reviewed: Aug 15, 2016)	criteria provided, multiple submitters, no conflicts	11	22257809	11	22236263	286191	270428
NM_213599.2(ANO5):c.966A>T (p.Leu322Phe)	ANO5	not specified|not provided|Miyoshi myopathy|Limb-Girdle Muscular Dystrophy, Recessive	Benign/Likely benign(Last reviewed: Jul 12, 2017)	criteria provided, multiple submitters, no conflicts	11	22271870	11	22250324	96687	102580
NM_213599.2(ANO5):c.2272C>T (p.Arg758Cys)	ANO5	Limb-girdle muscular dystrophy, type 2L|Miyoshi muscular dystrophy 3|not provided	Pathogenic(Last reviewed: Jul 31, 2018)	criteria provided, multiple submitters, no conflicts	11	22296151	11	22274605	2166	17205
NM_213599.2(ANO5):c.2646C>G (p.Asn882Lys)	ANO5	Gnathodiaphyseal dysplasia|Limb-girdle muscular dystrophy, type 2L|not specified|not provided	Benign/Likely benign(Last reviewed: Jan 8, 2018)	criteria provided, multiple submitters, no conflicts	11	22301215	11	22279669	128390	133839
NM_003477.2(PDHX):c.1129A>G (p.Ile377Val)	PDHX	Pyruvate dehydrogenase complex deficiency|Pyruvate dehydrogenase E3-binding protein deficiency|not specified|not provided	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	11	35006222	11	34984675	214958	211531
NM_000448.2(RAG1):c.2904C>A (p.Asn968Lys)	RAG1	Histiocytic medullary reticulosis	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	11	36597758	11	36576208	36713	45374
NM_000536.3(RAG2):c.1247G>T (p.Trp416Leu)	RAG2	Histiocytic medullary reticulosis|Recombinase activating gene 2 deficiency|Primary immunodeficiency	Conflicting interpretations of pathogenicity(Last reviewed: Mar 6, 2018)	criteria provided, conflicting interpretations	11	36614472	11	36592922	36717	45378
NM_000536.3(RAG2):c.217C>T (p.Arg73Cys)	RAG2	Severe combined immunodeficiency disease	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	11	36615502	11	36593952	36719	45380
NM_207122.1(EXT2):c.11C>T (p.Ser4Leu)	EXT2	Seizures, scoliosis, and macrocephaly syndrome|Hereditary Multiple Osteochondromatosis	Conflicting interpretations of pathogenicity(Last reviewed: Jul 7, 2018)	criteria provided, conflicting interpretations	11	44129273	11	44107723	304572	326466
NM_018389.4(SLC35C1):c.872C>T (p.Thr291Ile)	SLC35C1	Congenital disorder of glycosylation type 2C	Likely pathogenic(Last reviewed: Nov 27, 2012)	criteria provided, single submitter	11	45832663	11	45811112	216999	213609
NM_004813.2(PEX16):c.859C>T (p.Arg287Cys)	PEX16	Peroxisome biogenesis disorder 8B	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	11	45935398	11	45913847	561075	552151
NM_001105540.1(DGKZ):c.3227C>G (p.Thr1076Arg)	DGKZ	atypical cerebral palsy	Uncertain significance	criteria provided, single submitter	11	46401108	11	46379558	431729	425220
NM_000256.3(MYBPC3):c.1828G>C (p.Asp610His)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2018)	criteria provided, conflicting interpretations	11	47362758	11	47341207	42576	51746
NM_005055.4(RAPSN):c.[524A>G];[829A>G]	RAPSN	Pena-Shokeir syndrome type I|Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency	Likely pathogenic(Last reviewed: Nov 19, 2013)	criteria provided, single submitter	11|11	47469371	11|11	47447819	424794	213612|213611
NM_005055.4(RAPSN):c.264C>A (p.Asn88Lys)	RAPSN	Pena-Shokeir syndrome type I|Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency|Congenital myasthenic syndrome|Muscular Diseases|not provided|Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency|Congenital Myasthenic Syndrome, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Jun 19, 2018)	criteria provided, conflicting interpretations	11	47469631	11	47448079	8046	23085
NM_005055.4(RAPSN):c.172C>T (p.Arg58Cys)	RAPSN	Pena-Shokeir syndrome type I|not specified|Congenital Myasthenic Syndrome, Recessive	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	47470345	11	47448793	130090	135536
NM_004551.2(NDUFS3):c.204C>G (p.Ile68Met)	NDUFS3	Mitochondrial complex I deficiency|Leigh syndrome	Uncertain significance(Last reviewed: Nov 21, 2016)	criteria provided, single submitter	11	47602147	11	47580595	291319	275552
NM_006831.2(CLP1):c.419G>A (p.Arg140His)	CLP1	not provided|Pontocerebellar hypoplasia, type 10	Likely pathogenic(Last reviewed: Feb 28, 2018)	criteria provided, multiple submitters, no conflicts	11	57427367	11	57659895	143934	153655
NM_001173991.2(TMEM216):c.440G>C (p.Arg147Thr)	TMEM216	Joubert syndrome|Meckel-Gruber syndrome|not specified|not provided	Benign(Last reviewed: Jan 19, 2017)	criteria provided, multiple submitters, no conflicts	11	61165741	11	61398269	126297	131829
NM_004183.3(BEST1):c.400C>G (p.Leu134Val)	BEST1	Bestrophinopathy, autosomal recessive	Pathogenic(Last reviewed: Jan 25, 2015)	no assertion criteria provided	11	61723342	11	61955870	427886	418961
NM_004183.3(BEST1):c.422G>A (p.Arg141His)	BEST1	Bestrophinopathy, autosomal recessive|Vitelliform macular dystrophy type 2|Vitreoretinochoroidopathy|not provided|Retinitis Pigmentosa, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	11	61723364	11	61955892	2740	17779
NM_004183.3(BEST1):c.602T>C (p.Ile201Thr)	BEST1	Bestrophinopathy, autosomal recessive|Vitreoretinochoroidopathy|not provided|BEST1-Related Disorders|Retinitis Pigmentosa, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Sep 2, 2016)	criteria provided, conflicting interpretations	11	61724436	11	61956964	99726	105615
NM_022830.2(TUT1):c.1411G>A (p.Ala471Thr)	TUT1	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	11	62344463	11	62576991	402172	389150
NM_012200.3(B3GAT3):c.830G>A (p.Arg277Gln)	B3GAT3	Multiple joint dislocations, short stature, craniofacial dysmorphism, and congenital heart defects|not provided|MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH CONGENITAL HEART DEFECTS	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	11	62384057	11	62616585	30573	39530
NM_032667.6(BSCL2):c.945A>G (p.Glu315=)	BSCL2|HNRNPUL2-BSCL2	Congenital generalized lipodystrophy|Neurologic Disorders/Seipinopathy|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	62458275	11	62690803	128533	133982
NM_005609.3(PYGM):c.1366G>A (p.Val456Met)	PYGM	Glycogen storage disease, type V	Pathogenic/Likely pathogenic(Last reviewed: Sep 4, 2014)	criteria provided, multiple submitters, no conflicts	11	64521028	11	64753556	95290	101189
NM_005186.3(CAPN1):c.1442G>A (p.Arg481Gln)	CAPN1	Spastic paraplegia 76, autosomal recessive	Uncertain significance(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	11	64974022	11	65206551	584446	575494
NM_024649.4(BBS1):c.1169T>G (p.Met390Arg)	BBS1|ZDHHC24	Bardet-Biedl syndrome|Bardet-Biedl syndrome 1|Retinitis pigmentosa|not provided|Retinal dystrophy	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, multiple submitters, no conflicts	11	66293652	11	66526181	12143	27182
NM_024649.4(BBS1):c.1553T>C (p.Leu518Pro)	BBS1|ZDHHC24	Bardet-Biedl syndrome 1	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	11	66298444	11	66530973	12147	27186
NM_000920.3(PC):c.2668G>T (p.Val890Phe)	PC	Pyruvate carboxylase deficiency	Pathogenic(Last reviewed: Apr 25, 2016)	criteria provided, single submitter	11	66617741	11	66850270	487339	480411
NM_022172.2(PC):c.[2095G>A];[2095G>T]	PC	Pyruvate carboxylase deficiency	Likely pathogenic(Last reviewed: Nov 5, 2014)	no assertion criteria provided	11|11	66618639	11|11	66851168	427818	222991|222990
NM_007103.3(NDUFV1):c.1118T>C (p.Phe373Ser)	NDUFV1	Mitochondrial complex I deficiency	Pathogenic	no assertion criteria provided	11	67379405	11	67611934	431452	424968
NM_002496.3(NDUFS8):c.343A>G (p.Lys115Glu)	NDUFS8	Leigh syndrome	Likely pathogenic(Last reviewed: Oct 16, 2012)	criteria provided, single submitter	11	67800721	11	68033254	216970	213613
NM_002496.3(NDUFS8):c.441G>C (p.Met147Ile)	NDUFS8	Leigh syndrome	Likely pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	11	67803788	11	68036321	488561	481429
NM_006019.3(TCIRG1):c.1421C>T (p.Ser474Leu)	TCIRG1	Osteopetrosis autosomal recessive 1	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	11	67815229	11	68047762	561129	552153
NM_001876.3(CPT1A):c.1364A>C (p.Lys455Thr)	CPT1A	Carnitine palmitoyltransferase I deficiency	Likely pathogenic(Last reviewed: Jan 23, 2015)	criteria provided, single submitter	11	68548202	11	68780734	189151	186839
NM_002180.2(IGHMBP2):c.2T>C (p.Met1Thr)	IGHMBP2	Spinal muscular atrophy, distal, autosomal recessive, 1|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Oct 21, 2015)	criteria provided, multiple submitters, no conflicts	11	68671422	11	68903954	217448	214088
NM_002180.2(IGHMBP2):c.200T>C (p.Phe67Ser)	IGHMBP2	Spinal muscular atrophy, distal, autosomal recessive, 1	Uncertain significance(Last reviewed: Jan 21, 2018)	criteria provided, single submitter	11	68673650	11	68906182	496735	488181
NM_002180.2(IGHMBP2):c.[660A>C];[92G>A]	IGHMBP2	Spinal muscular atrophy, distal, autosomal recessive, 1	Likely pathogenic(Last reviewed: Apr 16, 2013)	criteria provided, single submitter	11|11	68679020	11|11	68911552	424782	213615|213614
NM_002180.2(IGHMBP2):c.1193C>A (p.Ala398Glu)	IGHMBP2	Spinal muscular atrophy, distal, autosomal recessive, 1	Likely pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	11	68696783	11	68929315	243080	244162
NM_002180.2(IGHMBP2):c.1478C>T (p.Thr493Ile)	IGHMBP2	Spinal muscular atrophy, distal, autosomal recessive, 1|not provided|Charcot-Marie-Tooth disease, axonal, type 2S	Pathogenic/Likely pathogenic(Last reviewed: Mar 28, 2018)	criteria provided, multiple submitters, no conflicts	11	68701322	11	68933854	217450	214090
NM_002180.2(IGHMBP2):c.1540G>A (p.Glu514Lys)	IGHMBP2	Spinal muscular atrophy, distal, autosomal recessive, 1|Werdnig-Hoffmann disease|not provided|Charcot-Marie-Tooth disease, axonal, type 2S	Pathogenic(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	11	68701934	11	68934466	9112	24151
NM_002180.2(IGHMBP2):c.1616C>T (p.Ser539Leu)	IGHMBP2	Spinal muscular atrophy, distal, autosomal recessive, 1|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Aug 17, 2016)	criteria provided, conflicting interpretations	11	68702010	11	68934542	245629	244681
NM_002180.2(IGHMBP2):c.1720G>A (p.Ala574Thr)	IGHMBP2	Spinal muscular atrophy, distal, autosomal recessive, 1	Uncertain significance(Last reviewed: Jan 21, 2018)	criteria provided, single submitter	11	68702854	11	68935386	496693	488175
NM_002180.2(IGHMBP2):c.1730T>C (p.Leu577Pro)	IGHMBP2	IGHMBP2-related condition	Uncertain significance(Last reviewed: Feb 7, 2017)	criteria provided, single submitter	11	68702864	11	68935396	522868	513441
NM_003824.3(FADD):c.[313T>C];[52_58delAGCGAGC]	FADD	Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations	Likely pathogenic(Last reviewed: Sep 24, 2013)	criteria provided, single submitter	11|11	70052265	11|11	70206159	424777	213617|213616
NM_001360.2(DHCR7):c.1139G>A (p.Cys380Tyr)	DHCR7	Smith-Lemli-Opitz syndrome	Likely pathogenic(Last reviewed: Oct 11, 2017)	criteria provided, multiple submitters, no conflicts	11	71146710	11	71435664	189069	186841
NM_001360.2(DHCR7):c.724C>T (p.Arg242Cys)	DHCR7	Smith-Lemli-Opitz syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, multiple submitters, no conflicts	11	71150032	11	71438986	21275	34127
NM_001360.2(DHCR7):c.470T>C (p.Leu157Pro)	DHCR7	Smith-Lemli-Opitz syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, multiple submitters, no conflicts	11	71152429	11	71441383	488492	481360
NM_001360.2(DHCR7):c.461C>T (p.Thr154Met)	DHCR7	Smith-Lemli-Opitz syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 7, 2017)	criteria provided, multiple submitters, no conflicts	11	71152438	11	71441392	188923	186842
NM_001360.2(DHCR7):c.278C>T (p.Thr93Met)	DHCR7	Smith-Lemli-Opitz syndrome|not provided|Abnormality of brain morphology	Pathogenic/Likely pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, multiple submitters, no conflicts	11	71155082	11	71444036	6783	21822
NM_001360.2(DHCR7):c.3G>A (p.Met1Ile)	DHCR7	Smith-Lemli-Opitz syndrome	Likely pathogenic(Last reviewed: Jul 7, 2014)	criteria provided, single submitter	11	71155996	11	71444950	6791	21830
NM_001360.2(DHCR7):c.1A>G (p.Met1Val)	DHCR7	Smith-Lemli-Opitz syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 16, 2017)	criteria provided, multiple submitters, no conflicts	11	71155998	11	71444952	6794	21833
NM_001145308.4(LRTOMT):c.242G>A (p.Arg81Gln)	LRTOMT	Deafness, autosomal recessive 63|Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: May 20, 2017)	criteria provided, single submitter	11	71817140	11	72106094	543	15582
Multiple alleles	MYH9|ANAPC15|LRTOMT	Deafness, autosomal recessive 63	Likely pathogenic(Last reviewed: Aug 31, 2016)	no assertion criteria provided	11|22	71819708 - 71819709	11|22	72108662 - 72108663	430723	205271|424261
NM_001286577.1(C2CD3):c.5267G>A (p.Gly1756Glu)	C2CD3	Jeune thoracic dystrophy|Joubert syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 1, 2018)	criteria provided, conflicting interpretations	11	73760476	11	74049431	217560	214312
NM_015531.5(C2CD3):c.5227G>T (p.Gly1743Cys)	C2CD3	Jeune thoracic dystrophy|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 1, 2018)	criteria provided, conflicting interpretations	11	73760516	11	74049471	418738	408471
NM_001235.3(SERPINH1):c.1214G>A (p.Arg405His)	SERPINH1	Osteogenesis imperfecta type 10	Uncertain significance(Last reviewed: May 24, 2018)	no assertion criteria provided	11	75283085	11	75572040	545689	536181
NM_000260.3(MYO7A):c.73G>A (p.Gly25Arg)	MYO7A	Deafness, autosomal recessive 2|Usher syndrome, type 1	Pathogenic/Likely pathogenic(Last reviewed: May 14, 2018)	criteria provided, multiple submitters, no conflicts	11	76853809	11	77142763	177722	178185
NM_000260.3(MYO7A):c.77C>A (p.Ala26Glu)	MYO7A	Usher syndrome, type 1	Pathogenic(Last reviewed: Feb 21, 2017)	criteria provided, single submitter	11	76853813	11	77142767	177731	178186
NM_000260.3(MYO7A):c.284A>T (p.Tyr95Phe)	MYO7A	Usher syndrome, type 1	Likely pathogenic(Last reviewed: Dec 26, 2017)	criteria provided, single submitter	11	76858995	11	77147949	164654	176870
NM_000260.3(MYO7A):c.287C>T (p.Thr96Met)	MYO7A	Usher syndrome, type 1	Likely pathogenic(Last reviewed: Nov 5, 2014)	criteria provided, single submitter	11	76866954	11	77155908	179974	178305
NM_000260.3(MYO7A):c.314T>G (p.Val105Gly)	MYO7A	Usher syndrome, type 1	Likely pathogenic(Last reviewed: Aug 20, 2015)	criteria provided, single submitter	11	76866981	11	77155935	228281	231386
NM_000260.3(MYO7A):c.397C>T (p.His133Tyr)	MYO7A	Usher syndrome, type 1	Likely pathogenic(Last reviewed: Nov 18, 2013)	criteria provided, single submitter	11	76867064	11	77156018	43228	52398
NM_000260.3(MYO7A):c.401T>A (p.Ile134Asn)	MYO7A	Deafness, autosomal recessive 2|Usher syndrome, type 1	Likely pathogenic(Last reviewed: Mar 23, 2018)	criteria provided, multiple submitters, no conflicts	11	76867068	11	77156022	43230	52400
NM_000260.3(MYO7A):c.458G>A (p.Cys153Tyr)	MYO7A	Usher syndrome, type 1	Likely pathogenic(Last reviewed: Sep 7, 2016)	criteria provided, single submitter	11	76867125	11	77156079	43249	52419
NM_000260.3(MYO7A):c.494C>T (p.Thr165Met)	MYO7A	Deafness, autosomal recessive 2|Usher syndrome, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, multiple submitters, no conflicts	11	76867729	11	77156683	43264	52434
NM_000260.3(MYO7A):c.587T>C (p.Leu196Pro)	MYO7A	Usher syndrome, type 1	Likely pathogenic(Last reviewed: Sep 17, 2011)	criteria provided, single submitter	11	76867822	11	77156776	43306	52476
NM_000260.3(MYO7A):c.631A>G (p.Ser211Gly)	MYO7A	Deafness, autosomal recessive 2|Usher syndrome, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	11	76867946	11	77156900	43325	52495
NM_000260.3(MYO7A):c.635G>A (p.Arg212His)	MYO7A	Deafness, autosomal recessive 2|Usher syndrome, type 1|Usher syndrome, type 1B	Pathogenic/Likely pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, multiple submitters, no conflicts	11	76867950	11	77156904	11850	26889
NM_000260.3(MYO7A):c.640G>A (p.Gly214Arg)	MYO7A	Deafness, autosomal dominant 11|Deafness, autosomal recessive 2|Usher syndrome, type 1|not provided	Pathogenic(Last reviewed: Jun 13, 2017)	criteria provided, multiple submitters, no conflicts	11	76867955	11	77156909	43327	52497
NM_000260.3(MYO7A):c.977T>A (p.Leu326Gln)	MYO7A	Deafness, autosomal recessive 2|Usher syndrome, type 1|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jun 13, 2017)	criteria provided, conflicting interpretations	11	76869450	11	77158404	164664	176880
NM_000260.3(MYO7A):c.1097T>C (p.Leu366Pro)	MYO7A	Deafness, autosomal recessive 2|Usher syndrome, type 1	Likely pathogenic(Last reviewed: Apr 18, 2017)	criteria provided, multiple submitters, no conflicts	11	76871225	11	77160179	43133	52303
NM_000260.3(MYO7A):c.1208A>G (p.Tyr403Cys)	MYO7A	Deafness, autosomal recessive 2|Usher syndrome, type 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 20, 2018)	criteria provided, conflicting interpretations	11	76872026	11	77160980	178667	178248
NM_000260.3(MYO7A):c.1556G>A (p.Gly519Asp)	MYO7A	Deafness, autosomal recessive 2|Usher syndrome, type 1	Pathogenic/Likely pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, multiple submitters, no conflicts	11	76873900	11	77162854	43151	52321
NM_000260.3(MYO7A):c.1619C>A (p.Pro540His)	MYO7A	Retinitis pigmentosa-deafness syndrome|Deafness, autosomal recessive 2|Usher syndrome, type 1|Nonsyndromic Hearing Loss, Dominant|Nonsyndromic Hearing Loss, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Jan 26, 2017)	criteria provided, conflicting interpretations	11	76873963	11	77162917	228279	231384
NM_000260.3(MYO7A):c.1903T>C (p.Cys635Arg)	MYO7A	not specified	Uncertain significance(Last reviewed: Aug 16, 2013)	criteria provided, single submitter	11	76883899	11	77172853	179146	178264
NM_000260.3(MYO7A):c.2863G>A (p.Gly955Ser)	MYO7A	Usher syndrome, type 1	Likely pathogenic(Last reviewed: Jul 14, 2014)	criteria provided, single submitter	11	76892594	11	77181548	177733	178188
NM_000260.3(MYO7A):c.3476G>T (p.Gly1159Val)	MYO7A	Deafness, autosomal recessive 2|Usher syndrome, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2017)	criteria provided, multiple submitters, no conflicts	11	76895733	11	77184688	43206	52376
NM_000260.3(MYO7A):c.3572G>A (p.Gly1191Asp)	MYO7A	Usher syndrome, type 1	Likely pathogenic(Last reviewed: Jun 30, 2011)	criteria provided, single submitter	11	76900457	11	77189412	43212	52382
NM_000260.3(MYO7A):c.3827C>T (p.Ser1276Leu)	MYO7A	Deafness, autosomal recessive 2|Usher syndrome, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Mar 19, 2018)	criteria provided, conflicting interpretations	11	76901818	11	77190773	178283	175222
NM_000260.3(MYO7A):c.3892G>A (p.Gly1298Arg)	MYO7A	Usher syndrome, type 1	Likely pathogenic(Last reviewed: Jul 17, 2017)	criteria provided, single submitter	11	76901883	11	77190838	164693	175223
NM_000260.3(MYO7A):c.3979G>A (p.Glu1327Lys)	MYO7A	Usher syndrome, type 1	Likely pathogenic(Last reviewed: Feb 21, 2017)	criteria provided, single submitter	11	76903150	11	77192105	177723	175224
NM_000260.3(MYO7A):c.4411T>C (p.Ser1471Pro)	MYO7A	Usher syndrome, type 1	Likely pathogenic(Last reviewed: Jul 26, 2012)	criteria provided, single submitter	11	76908613	11	77197568	43239	52409
NM_000260.3(MYO7A):c.4735G>A (p.Glu1579Lys)	MYO7A	not specified	Uncertain significance(Last reviewed: Dec 21, 2017)	criteria provided, single submitter	11	76910746	11	77199701	504648	497402
NM_000260.3(MYO7A):c.5464A>C (p.Thr1822Pro)	MYO7A	Usher syndrome, type 1	Likely pathogenic(Last reviewed: Jun 21, 2013)	criteria provided, single submitter	11	76915258	11	77204213	178921	175234
NM_000260.3(MYO7A):c.5573T>C (p.Leu1858Pro)	MYO7A	Deafness, autosomal recessive 2|Usher syndrome, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jul 24, 2017)	criteria provided, multiple submitters, no conflicts	11	76916599	11	77205554	43288	52458
NM_000260.3(MYO7A):c.5648G>A (p.Arg1883Gln)	MYO7A	Deafness, autosomal recessive 2|Usher syndrome, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 16, 2018)	criteria provided, multiple submitters, no conflicts	11	76917153	11	77206108	43294	52464
NM_000260.3(MYO7A):c.6062A>G (p.Lys2021Arg)	MYO7A	Deafness, autosomal recessive 2|Usher syndrome, type 1	Conflicting interpretations of pathogenicity(Last reviewed: May 18, 2018)	criteria provided, conflicting interpretations	11	76922207	11	77211162	228282	230249
NM_000260.3(MYO7A):c.6326C>T (p.Thr2109Ile)	MYO7A	Usher syndrome, type 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 25, 2017)	criteria provided, conflicting interpretations	11	76922954	11	77211909	164724	175524
NM_000260.3(MYO7A):c.6560G>A (p.Gly2187Asp)	MYO7A	Deafness, autosomal recessive 2|Usher syndrome, type 1	Conflicting interpretations of pathogenicity(Last reviewed: Apr 13, 2018)	criteria provided, conflicting interpretations	11	76925653	11	77214608	43335	52505
NM_024079.4(ALG8):c.856T>G (p.Trp286Gly)	ALG8	Congenital disorder of glycosylation type 1H|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 15, 2017)	criteria provided, conflicting interpretations	11	77823738	11	78112692	198905	196065
NM_000372.4(TYR):c.229C>T (p.Arg77Trp)	TYR	Tyrosinase-negative oculocutaneous albinism|not provided	Pathogenic(Last reviewed: May 15, 2015)	no assertion criteria provided	11	88911350	11	89178182	99553	105442
NM_000372.4(TYR):c.242C>T (p.Pro81Leu)	TYR	Tyrosinase-negative oculocutaneous albinism|Albinism|not provided|Oculocutaneous albinism|Inborn genetic diseases	Pathogenic(Last reviewed: Mar 28, 2017)	criteria provided, multiple submitters, no conflicts	11	88911363	11	89178195	3772	18811
NM_000372.4(TYR):c.575C>A (p.Ser192Tyr)	TYR	Tyrosinase-negative oculocutaneous albinism|Skin/hair/eye pigmentation, variation in, 3|not specified|not provided|Oculocutaneous albinism	Conflicting interpretations of pathogenicity, association(Last reviewed: Oct 30, 2017)	criteria provided, conflicting interpretations	11	88911696	11	89178528	3778	18817
NM_000372.4(TYR):c.1064C>T (p.Ala355Val)	TYR	Tyrosinase-negative oculocutaneous albinism	Pathogenic(Last reviewed: Apr 17, 2015)	criteria provided, single submitter	11	88961018	11	89227850	212520	207921
NM_000372.4(TYR):c.1118C>A (p.Thr373Lys)	TYR	Tyrosinase-negative oculocutaneous albinism|Oculocutaneous albinism type 1B|Albinism, ocular, with sensorineural deafness|Skin/hair/eye pigmentation, variation in, 3|not provided|Oculocutaneous albinism	Pathogenic(Last reviewed: Aug 30, 2017)	criteria provided, multiple submitters, no conflicts	11	88961072	11	89227904	3774	18813
NM_000372.4(TYR):c.1147G>A (p.Asp383Asn)	TYR	Tyrosinase-negative oculocutaneous albinism|Oculocutaneous albinism type 1B|not provided|Nonsyndromic Oculocutaneous Albinism	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	11	88961101	11	89227933	3775	18814
NM_000372.4(TYR):c.1217C>T (p.Pro406Leu)	TYR	Tyrosinase-negative oculocutaneous albinism|Oculocutaneous albinism type 1B|not provided|Oculocutaneous albinism|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, multiple submitters, no conflicts	11	89017973	11	89284805	3777	18816
NM_000372.4(TYR):c.1336G>A (p.Gly446Ser)	TYR	Tyrosinase-negative oculocutaneous albinism|not provided|Oculocutaneous albinism	Pathogenic/Likely pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, multiple submitters, no conflicts	11	89018092	11	89284924	3801	18840
NM_004268.4(MED17):c.207G>C (p.Glu69Asp)	MED17	Microcephaly, postnatal progressive, with seizures and brain atrophy|not specified	Benign(Last reviewed: May 31, 2017)	criteria provided, multiple submitters, no conflicts	11	93517886	11	93784720	129601	135047
NM_004268.4(MED17):c.571C>T (p.Arg191Trp)	MED17	Microcephaly, postnatal progressive, with seizures and brain atrophy	Likely pathogenic(Last reviewed: Dec 3, 2013)	criteria provided, single submitter	11	93523893	11	93790727	129605	135051
NM_004268.4(MED17):c.1071T>A (p.Phe357Leu)	MED17	not provided	Uncertain significance(Last reviewed: Jan 25, 2013)	criteria provided, single submitter	11	93529634	11	93796468	129596	135042
NM_004268.4(MED17):c.1418C>T (p.Ser473Phe)	MED17	not provided	Uncertain significance(Last reviewed: Dec 18, 2012)	criteria provided, single submitter	11	93535090	11	93801924	129594	135040
NM_005591.3(MRE11):c.2092A>G (p.Met698Val)	MRE11	Ataxia-telangiectasia-like disorder 1|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Dec 28, 2017)	criteria provided, multiple submitters, no conflicts	11	94153326	11	94420160	129622	135068
NM_005591.3(MRE11):c.[168G>T];[497C>T]	MRE11	Ataxia-telangiectasia-like disorder 1	Likely pathogenic(Last reviewed: Oct 29, 2013)	criteria provided, single submitter	11|11	94211948	11|11	94478782	424787	151922|213618
NM_001080463.1(DYNC2H1):c.624_625delGTinsAA (p.Phe209Ile)	DYNC2H1	Jeune thoracic dystrophy|Short-rib thoracic dysplasia 3 with or without polydactyly	Uncertain significance(Last reviewed: May 1, 2018)	criteria provided, single submitter	11	102987301 - 102987302	11	103116572 - 103116573	6509	21548
NM_001080463.1(DYNC2H1):c.5771A>T (p.Asp1924Val)	DYNC2H1	Jeune thoracic dystrophy	Uncertain significance(Last reviewed: May 1, 2018)	criteria provided, single submitter	11	103047060	11	103176331	558743	549481
NM_001080463.1(DYNC2H1):c.[11284A>G;5971A>T]	DYNC2H1	Jeune thoracic dystrophy|Short-rib thoracic dysplasia 3 with or without polydactyly	Conflicting interpretations of pathogenicity(Last reviewed: May 1, 2018)	criteria provided, conflicting interpretations	11|11	103048381	11|11	103177652	558741	21539|21540
NM_001080463.1(DYNC2H1):c.6910G>A (p.Ala2304Thr)	DYNC2H1	Jeune thoracic dystrophy|not provided|Short-rib polydactyly syndrome type III	Conflicting interpretations of pathogenicity(Last reviewed: May 1, 2018)	criteria provided, conflicting interpretations	11	103058085	11	103187356	446539	440164
NM_001080463.1(DYNC2H1):c.7129T>G (p.Phe2377Val)	DYNC2H1	Jeune thoracic dystrophy	Uncertain significance(Last reviewed: May 1, 2018)	criteria provided, single submitter	11	103058304	11	103187575	558751	549483
NM_001080463.1(DYNC2H1):c.[5053G>A];[7784A>G]	DYNC2H1	Short-rib thoracic dysplasia 3 with or without polydactyly	Pathogenic(Last reviewed: Jun 9, 2015)	no assertion criteria provided	11|11	103068737	11|11	103198008	429027	420981|420980
NM_001080463.1(DYNC2H1):c.7919T>C (p.Ile2640Thr)	DYNC2H1	Jeune thoracic dystrophy	Uncertain significance(Last reviewed: May 1, 2018)	criteria provided, single submitter	11	103070036	11	103199307	558737	549484
NM_001080463.1(DYNC2H1):c.8003T>G (p.Val2668Gly)	DYNC2H1	Jeune thoracic dystrophy	Uncertain significance(Last reviewed: May 1, 2018)	criteria provided, single submitter	11	103070120	11	103199391	558739	549485
NM_001080463.1(DYNC2H1):c.8444G>A (p.Ser2815Asn)	DYNC2H1	Jeune thoracic dystrophy	Uncertain significance(Last reviewed: May 1, 2018)	criteria provided, single submitter	11	103075683	11	103204954	558740	549486
NM_001080463.1(DYNC2H1):c.9044A>G (p.Asp3015Gly)	DYNC2H1	Jeune thoracic dystrophy|Short-rib thoracic dysplasia 3 with or without polydactyly|not provided|Narrow chest|Intrauterine growth retardation|Bowing of the long bones|Short Rib Polydactyly Syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 1, 2018)	criteria provided, conflicting interpretations	11	103091449	11	103220720	6503	21542
NM_001080463.1(DYNC2H1):c.10022C>G (p.Pro3341Arg)	DYNC2H1	Jeune thoracic dystrophy	Uncertain significance(Last reviewed: May 1, 2018)	criteria provided, single submitter	11	103116062	11	103245333	558748	549487
NM_001080463.1(DYNC2H1):c.10121G>T (p.Arg3374Leu)	DYNC2H1	Short-rib thoracic dysplasia 3 with or without polydactyly	Likely pathogenic(Last reviewed: Jan 3, 2018)	no assertion criteria provided	11	103124071	11	103253342	488661	481536
NM_001080463.1(DYNC2H1):c.10121G>A (p.Arg3374His)	DYNC2H1	Short-rib thoracic dysplasia 3 with or without polydactyly	Likely pathogenic(Last reviewed: Jul 11, 2014)	criteria provided, single submitter	11	103124071	11	103253342	369660	353901
NM_001080463.1(DYNC2H1):c.10343T>C (p.Leu3448Pro)	DYNC2H1	Jeune thoracic dystrophy|Short rib-polydactyly syndrome, Majewski type|Short-rib thoracic dysplasia 3 with or without polydactyly|Short-rib polydactyly syndrome type III	Likely pathogenic(Last reviewed: Jul 11, 2014)	criteria provided, single submitter	11	103126259	11	103255530	369661	353902
NM_001080463.1(DYNC2H1):c.11069C>T (p.Pro3690Leu)	DYNC2H1	Short-rib thoracic dysplasia 3 with or without polydactyly	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	11	103158287	11	103287558	560996	552147
NM_001080463.1(DYNC2H1):c.[12602C>T;9865G>A]	DYNC2H1	Jeune thoracic dystrophy	Uncertain significance(Last reviewed: May 1, 2018)	criteria provided, single submitter	11|11	103327017	11|11	103456289	558738	265588|440196
NM_000019.3(ACAT1):c.1199A>G (p.His400Arg)	ACAT1	Deficiency of acetyl-CoA acetyltransferase	Likely pathogenic(Last reviewed: Sep 11, 2017)	no assertion criteria provided	11	108018032	11	108147305	438580	432201
NM_000051.3(ATM):c.1A>C (p.Met1Leu)	ATM	Ataxia-telangiectasia syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	11	108098352	11	108227625	187213	183067
NM_000051.3(ATM):c.2T>C (p.Met1Thr)	ATM	Ataxia-telangiectasia syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 24, 2018)	criteria provided, multiple submitters, no conflicts	11	108098353	11	108227626	187275	183068
NM_000051.3(ATM):c.3G>A (p.Met1Ile)	ATM	Ataxia-telangiectasia syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 9, 2018)	criteria provided, multiple submitters, no conflicts	11	108098354	11	108227627	188901	186796
NM_000051.3(ATM):c.378T>A (p.Asp126Glu)	ATM	Ataxia-telangiectasia syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: May 23, 2018)	criteria provided, multiple submitters, no conflicts	11	108106443	11	108235716	128455	133904
NM_000051.3(ATM):c.3118A>G (p.Met1040Val)	ATM	Ataxia-telangiectasia syndrome|B-cell non-Hodgkin lymphoma|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 6, 2018)	criteria provided, conflicting interpretations	11	108143299	11	108272572	3027	18066
NM_000051.3(ATM):c.4258C>T (p.Leu1420Phe)	ATM	Ataxia-telangiectasia syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 23, 2018)	criteria provided, conflicting interpretations	11	108160350	11	108289623	128456	133905
NM_000051.3(ATM):c.5557G>A (p.Asp1853Asn)	ATM	Ataxia-telangiectasia syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Jul 12, 2017)	criteria provided, multiple submitters, no conflicts	11	108175462	11	108304735	128458	133907
NM_000051.3(ATM):c.6088A>G (p.Ile2030Val)	ATM|C11orf65	Ataxia-telangiectasia syndrome|not specified|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	11	108186631	11	108315904	133628	137367
NM_000051.3(ATM):c.6095G>A (p.Arg2032Lys)	ATM|C11orf65	Familial cancer of breast|Ataxia-telangiectasia syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, multiple submitters, no conflicts	11	108186638	11	108315911	181974	180483
NM_000051.3(ATM):c.6899G>C (p.Trp2300Ser)	ATM|C11orf65	Ataxia-telangiectasia syndrome	Likely pathogenic(Last reviewed: Jul 26, 2018)	no assertion criteria provided	11	108196876	11	108326149	559541	550264
NM_000051.3(ATM):c.7271T>G (p.Val2424Gly)	ATM|C11orf65	Familial cancer of breast|Ataxia-telangiectasia syndrome|Ataxia-telangiectasia variant|Breast cancer, susceptibility to|T-cell prolymphocytic leukemia|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic, risk factor(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	11	108199929	11	108329202	3023	18062
NM_000051.3(ATM):c.7502A>G (p.Asn2501Ser)	ATM|C11orf65	Ataxia-telangiectasia syndrome|not specified|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 8, 2018)	criteria provided, multiple submitters, no conflicts	11	108201135	11	108330408	232481	234321
NM_000051.3(ATM):c.8147T>C (p.Val2716Ala)	ATM|C11orf65	Familial cancer of breast|Ataxia-telangiectasia syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 20, 2018)	criteria provided, multiple submitters, no conflicts	11	108205832	11	108335105	142700	152414
NM_000051.3(ATM):c.8494C>T (p.Arg2832Cys)	ATM|C11orf65	Ataxia-telangiectasia syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 10, 2018)	criteria provided, multiple submitters, no conflicts	11	108216545	11	108345818	127459	132916
NM_000051.3(ATM):c.9022C>T (p.Arg3008Cys)	ATM|C11orf65	Ataxia-telangiectasia syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	11	108236086	11	108365359	142187	151901
NM_001931.4(DLAT):c.128C>T (p.Ala43Val)	DLAT	Pyruvate dehydrogenase complex deficiency|not specified|not provided	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	11	111896324	11	112025600	128897	134344
NM_001931.4(DLAT):c.953T>C (p.Val318Ala)	DLAT	Pyruvate dehydrogenase complex deficiency|not specified|not provided	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	11	111908162	11	112037438	128899	134346
NM_001931.4(DLAT):c.1351G>A (p.Asp451Asn)	DLAT	Pyruvate dehydrogenase complex deficiency|not specified|not provided	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	11	111916647	11	112045923	128898	134345
NM_020693.3(DSCAML1):c.1411G>A (p.Val471Ile)	DSCAML1	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	11	117389460	11	117518745	402156	389147
NM_001164277.1(SLC37A4):c.833T>A (p.Ile278Asn)	SLC37A4	Glucose-6-phosphate transport defect|not provided	Likely pathogenic(Last reviewed: Oct 17, 2014)	criteria provided, single submitter	11	118897350	11	119026640	68292	79183
NM_001164277.1(SLC37A4):c.572C>T (p.Pro191Leu)	SLC37A4	Glucose-6-phosphate transport defect|not provided	Likely pathogenic(Last reviewed: Aug 15, 2014)	criteria provided, single submitter	11	118898391	11	119027681	68285	79176
NM_001164277.1(SLC37A4):c.70T>C (p.Tyr24His)	SLC37A4	Glucose-6-phosphate transport defect|not provided	Likely pathogenic(Last reviewed: Mar 3, 2014)	criteria provided, single submitter	11	118900010	11	119029300	68288	79179
NM_001164277.1(SLC37A4):c.1A>G (p.Met1Val)	SLC37A4	Glucose-6-phosphate transport defect	Likely pathogenic(Last reviewed: Jan 28, 2015)	criteria provided, single submitter	11	118900079	11	119029369	189162	186810
NM_021729.5(VPS11):c.2536T>G (p.Cys846Gly)	VPS11	Leukoencephalopathy|Leukodystrophy, hypomyelinating, 12	Pathogenic(Last reviewed: Dec 17, 2015)	no assertion criteria provided	11	118951899	11	119081189	218366	215093
NM_001382.3(DPAGT1):c.1177A>G (p.Ile393Val)	DPAGT1|HMBS	Acute intermittent porphyria|Congenital disorder of glycosylation|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	11	118967758	11	119097048	93728	99631
NM_001382.3(DPAGT1):c.352C>G (p.Leu118Val)	DPAGT1	Congenital disorder of glycosylation type 1J|not provided	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	11	118971484	11	119100774	93730	99633
NM_024769.3(CLMP):c.[29-2A>G];[410G>A]	CLMP	Intestinal pseudo-obstruction	Pathogenic	criteria provided, single submitter	11|11	122968662	11|11	123097954	427825	244181|244180
NM_022370.3(ROBO3):c.1051A>C (p.Thr351Pro)	ROBO3	Gaze palsy, familial horizontal, with progressive scoliosis	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	11	124740927	11	124871031	561157	552150
NM_016952.4(CDON):c.3395C>T (p.Pro1132Leu)	CDON	not provided|Abnormality of brain morphology	Conflicting interpretations of pathogenicity(Last reviewed: Apr 30, 2017)	criteria provided, conflicting interpretations	11	125831855	11	125961960	402206	389148
NM_017547.3(FOXRED1):c.406C>T (p.Arg136Trp)	FOXRED1	Mitochondrial complex I deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, multiple submitters, no conflicts	11	126142963	11	126273068	372745	360002
NM_002017.4(FLI1):c.970C>T (p.Arg324Trp)	FLI1	Bleeding disorder platelet type macrothrombocytopenia|Bleeding disorder, platelet-type, 21	Pathogenic(Last reviewed: Jan 21, 2015)	criteria provided, single submitter	11	128680494	11	128810599	217031	213674
NM_020638.2(FGF23):c.385T>C (p.Ser129Pro)	FGF23	Tumoral calcinosis, familial, hyperphosphatemic	Pathogenic(Last reviewed: Sep 20, 2017)	criteria provided, single submitter	12	4479880	12	4370714	444061	437705
NM_020638.2(FGF23):c.367G>T (p.Gly123Trp)	FGF23	Tumoral calcinosis, familial, hyperphosphatemic	Pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, single submitter	12	4479898	12	4370732	444062	437706
NM_020638.2(FGF23):c.211A>G (p.Ser71Gly)	FGF23	Tumoral calcinosis, familial, hyperphosphatemic|not provided|TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 2	Conflicting interpretations of pathogenicity(Last reviewed: Sep 19, 2017)	criteria provided, conflicting interpretations	12	4488538	12	4379372	5027	20066
NM_005002.4(NDUFA9):c.881C>T (p.Pro294Leu)	NDUFA9	not specified|not provided	Likely benign(Last reviewed: Mar 7, 2016)	no assertion criteria provided	12	4791451	12	4682285	129687	135133
NM_000552.4(VWF):c.2561G>A (p.Arg854Gln)	VWF	von Willebrand disorder|von Willebrand disease type 2N|von Willebrand disease type 1|von Willebrand disease type 2|not provided	Pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, multiple submitters, no conflicts	12	6143978	12	6034812	296	15335
NM_001038.5(SCNN1A):c.1685C>T (p.Ser562Leu)	SCNN1A	Pseudohypoaldosteronism type 1 autosomal recessive	Pathogenic(Last reviewed: Dec 1, 1999)	no assertion criteria provided	12	6457364	12	6348198	9267	24306
NM_138425.3(C12orf57):c.1A>G (p.Met1Val)	C12orf57	Temtamy syndrome|Global developmental delay|Seizures|not provided|Global developmental delay|Corpus callosum abnormalities|Colobomatous microphthalmia	Pathogenic(Last reviewed: May 14, 2018)	criteria provided, multiple submitters, no conflicts	12	7053285	12	6944122	41942	51108
NM_020661.3(AICDA):c.374G>A (p.Gly125Glu)	AICDA	Immunodeficiency with hyper IgM type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	12	8757864	12	8605268	35656	44321
NM_024854.3(PYROXD1):c.464A>G (p.Asn155Ser)	PYROXD1	Myopathy, myofibrillar, 8	Pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	12	21605064	12	21452130	372280	359188
NM_001040436.2(YARS2):c.751A>G (p.Ile251Val)	YARS2	Myopathy, lactic acidosis, and sideroblastic anemia 2	Likely pathogenic(Last reviewed: Apr 1, 2014)	criteria provided, single submitter	12	32908058	12	32755124	209209	205770
NM_001843.3(CNTN1):c.2324G>A (p.Ser775Asn)	CNTN1	Myopathy, congenital, compton-north|not specified	Benign(Last reviewed: Dec 18, 2017)	criteria provided, multiple submitters, no conflicts	12	41410623	12	41016821	128794	134243
NM_153026.2(PRICKLE1):c.2236C>T (p.Pro746Ser)	PRICKLE1	Progressive myoclonus epilepsy with ataxia|not specified|Seizures	Benign/Likely benign(Last reviewed: Jan 8, 2018)	criteria provided, multiple submitters, no conflicts	12	42853871	12	42460069	130026	135472
NM_153026.2(PRICKLE1):c.2071A>G (p.Thr691Ala)	PRICKLE1	Progressive myoclonus epilepsy with ataxia|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 24, 2018)	criteria provided, conflicting interpretations	12	42854036	12	42460234	130025	135471
NM_153026.2(PRICKLE1):c.374T>C (p.Val125Ala)	PRICKLE1	Progressive myoclonus epilepsy with ataxia|not specified|Seizures	Benign/Likely benign(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	12	42863262	12	42469460	130028	135474
NM_153026.2(PRICKLE1):c.370G>A (p.Ala124Thr)	PRICKLE1	Progressive myoclonus epilepsy with ataxia|not specified|Seizures|Rolandic epilepsy	Conflicting interpretations of pathogenicity(Last reviewed: May 31, 2018)	criteria provided, conflicting interpretations	12	42863266	12	42469464	130027	135473
NM_015270.4(ADCY6):c.2975A>G (p.Tyr992Cys)	ADCY6	Lethal congenital contracture syndrome 8	Likely pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	12	49165569	12	48771786	243078	244164
NM_021044.4(DHH):c.1027T>C (p.Cys343Arg)	DHH	46,XY sex reversal, type 7	Likely pathogenic(Last reviewed: Sep 8, 2016)	criteria provided, single submitter	12	49483806	12	49090023	265768	260443
NM_021044.4(DHH):c.634G>A (p.Glu212Lys)	DHH	46,XY sex reversal, type 7	Likely pathogenic	no assertion criteria provided	12	49484199	12	49090416	561190	552296
NM_021044.4(DHH):c.371G>A (p.Arg124Gln)	DHH	46,XY gonadal dysgenesis, partial, with minifascicular neuropathy	Pathogenic	criteria provided, single submitter	12	49485105	12	49091322	560406	551459
NM_000486.5(AQP2):c.559C>T (p.Arg187Cys)	AQP2|LOC101927318	Nephrogenic diabetes insipidus|Diabetes insipidus, nephrogenic, autosomal recessive	Pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	12	50348446	12	49954663	17828	32867
NM_000486.5(AQP2):c.560G>A (p.Arg187His)	AQP2|LOC101927318	Nephrogenic diabetes insipidus	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	12	50348447	12	49954664	35695	44360
NM_000486.5(AQP2):c.563C>T (p.Ser188Phe)	AQP2|LOC101927318	Nephrogenic diabetes insipidus, autosomal	Likely pathogenic	no assertion criteria provided	12	50348450	12	49954667	430573	422801
NM_015665.5(AAAS):c.200C>T (p.Thr67Ile)	AAAS	Glucocorticoid deficiency with achalasia	Uncertain significance(Last reviewed: Sep 28, 2015)	criteria provided, single submitter	12	53714400	12	53320616	427742	417444
NM_002206.2(ITGA7):c.1952G>A (p.Arg651His)	ITGA7	not specified|Congenital Muscular Dystrophy, ITGA7-related	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	56089357	12	55695573	94035	99937
NM_002206.2(ITGA7):c.1617G>T (p.Gln539His)	ITGA7	Muscular dystrophy, congenital, due to integrin alpha-7 deficiency|not specified	Benign(Last reviewed: Dec 6, 2017)	criteria provided, multiple submitters, no conflicts	12	56090803	12	55697019	129292	134738
NM_002206.2(ITGA7):c.824G>A (p.Arg275His)	ITGA7	Muscular dystrophy, congenital, due to integrin alpha-7 deficiency|not specified|Congenital Muscular Dystrophy, ITGA7-related	Conflicting interpretations of pathogenicity(Last reviewed: Aug 11, 2017)	criteria provided, conflicting interpretations	12	56092668	12	55698884	94047	99949
NM_145064.2(STAC3):c.851G>C (p.Trp284Ser)	STAC3	Native American myopathy	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	12	57638105	12	57244322	88744	94325
NM_005269.2(GLI1):c.820G>C (p.Gly274Arg)	GLI1	Bardet-Biedl syndrome	Uncertain significance	no assertion criteria provided	12	57860080	12	57466297	430658	424187
NM_004990.3(MARS):c.920A>G (p.Tyr307Cys)	MARS	Interstitial lung and liver disease	Likely pathogenic	no assertion criteria provided	12	57892235	12	57498452	496635	488120
NM_004990.3(MARS):c.1852C>T (p.Arg618Cys)	MARS	Charcot-Marie-Tooth disease|not specified|Interstitial lung and liver disease|Charcot-Marie-Tooth disease, axonal, type 2u	Uncertain significance(Last reviewed: Mar 3, 2017)	criteria provided, single submitter	12	57906632	12	57512849	156025	165834
NM_000785.3(CYP27B1):c.[1319_1325dupCCCACCC];[1358G>A]	CYP27B1	Vitamin D-dependent rickets, type 1	Pathogenic(Last reviewed: Oct 9, 2016)	criteria provided, single submitter	12|12	58157449	12|12	57763666	427832	262266|264701
NM_001172696.1(TSFM):c.[355G>C];[997C>T]	TSFM	Combined oxidative phosphorylation deficiency 3	Likely pathogenic(Last reviewed: Apr 29, 2014)	criteria provided, single submitter	12|12	58190322	12|12	57796539	424804	20418|213623
NM_014254.2(RXYLT1):c.67G>A (p.Ala23Thr)	RXYLT1	not specified	Benign(Last reviewed: Jan 30, 2016)	criteria provided, multiple submitters, no conflicts	12	64173807	12	63780027	130597	136043
NM_014254.2(RXYLT1):c.469G>A (p.Val157Ile)	RXYLT1	not specified|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 10	Benign(Last reviewed: Dec 11, 2017)	criteria provided, multiple submitters, no conflicts	12	64195911	12	63802131	130596	136042
NM_014254.2(RXYLT1):c.1016A>G (p.Tyr339Cys)	RXYLT1	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 10|Walker-Warburg congenital muscular dystrophy	Conflicting interpretations of pathogenicity(Last reviewed: May 11, 2018)	criteria provided, conflicting interpretations	12	64202556	12	63808776	39604	48203
NM_001178074.1(GRIP1):c.1142G>T (p.Ser381Ile)	GRIP1	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	12	66849245	12	66455465	402209	389155
NM_001178074.1(GRIP1):c.160G>A (p.Val54Ile)	GRIP1	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	12	66935707	12	66541927	402210	389156
NM_024685.4(BBS10):c.1436C>A (p.Ala479Glu)	BBS10	Bardet-Biedl syndrome 10|not provided	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	12	76740329	12	76346549	499947	491371
NM_024685.4(BBS10):c.1241T>C (p.Leu414Ser)	BBS10	Bardet-Biedl syndrome 10	Likely pathogenic(Last reviewed: Aug 27, 2014)	criteria provided, single submitter	12	76740524	12	76346744	188943	186850
NM_024685.4(BBS10):c.539G>A (p.Gly180Glu)	BBS10	Bardet-Biedl syndrome 10	Conflicting interpretations of pathogenicity(Last reviewed: Nov 9, 2017)	criteria provided, conflicting interpretations	12	76741226	12	76347446	488381	481238
NM_005593.2(MYF5):c.283C>T (p.Arg95Cys)	MYF5	Scoliosis|Abnormality of the ribs|External ophthalmoplegia|OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES	Pathogenic(Last reviewed: Oct 26, 2018)	no assertion criteria provided	12	81111125	12	80717346	523662	514310
NM_025114.3(CEP290):c.5237G>A (p.Arg1746Gln)	CEP290	Bardet-Biedl syndrome|Joubert syndrome|Meckel-Gruber syndrome|Renal dysplasia and retinal aplasia|Leber congenital amaurosis|Nephronophthisis|not specified|not provided	Benign/Likely benign(Last reviewed: Jul 21, 2017)	criteria provided, multiple submitters, no conflicts	12	88472996	12	88079219	126262	131794
NM_025114.3(CEP290):c.3710G>A (p.Arg1237His)	CEP290	Bardet-Biedl syndrome|Joubert syndrome|Meckel-Gruber syndrome|Renal dysplasia and retinal aplasia|Leber congenital amaurosis|Nephronophthisis|not specified	Benign/Likely benign(Last reviewed: Aug 15, 2017)	criteria provided, multiple submitters, no conflicts	12	88483128	12	88089351	126257	131789
NM_025114.3(CEP290):c.3442C>G (p.Leu1148Val)	CEP290	Joubert syndrome|Meckel-Gruber syndrome|Nephronophthisis	Uncertain significance(Last reviewed: Oct 31, 2017)	criteria provided, multiple submitters, no conflicts	12	88486477	12	88092700	126255	131787
NM_025114.3(CEP290):c.2717T>G (p.Leu906Trp)	CEP290	Bardet-Biedl syndrome|Joubert syndrome|Meckel-Gruber syndrome|Renal dysplasia and retinal aplasia|Leber congenital amaurosis|Nephronophthisis|not specified	Benign/Likely benign(Last reviewed: Jul 28, 2017)	criteria provided, multiple submitters, no conflicts	12	88500552	12	88106775	126252	131784
NM_025114.3(CEP290):c.2512A>G (p.Lys838Glu)	CEP290	Bardet-Biedl syndrome|Joubert syndrome|Meckel-Gruber syndrome|Renal dysplasia and retinal aplasia|Leber congenital amaurosis|not specified|not provided	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	88500847	12	88107070	100593	106470
NM_025114.3(CEP290):c.1991A>G (p.Asp664Gly)	CEP290	Bardet-Biedl syndrome|Joubert syndrome|Meckel-Gruber syndrome|Joubert syndrome 5|Renal dysplasia and retinal aplasia|Leber congenital amaurosis|Nephronophthisis|not specified|not provided	Benign/Likely benign(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	12	88508258	12	88114481	100592	106469
NM_025114.3(CEP290):c.829G>C (p.Glu277Gln)	CEP290	Joubert syndrome|Meckel-Gruber syndrome|Nephronophthisis|not specified|not provided	Benign(Last reviewed: Aug 14, 2017)	criteria provided, multiple submitters, no conflicts	12	88523494	12	88129717	126269	131801
NM_172240.2(POC1B):c.317G>C (p.Arg106Pro)	POC1B	Cone-rod dystrophy 20	Pathogenic	criteria provided, single submitter	12	89885848	12	89492071	155769	165521
NM_002465.3(MYBPC1):c.1518C>G (p.His506Gln)	MYBPC1	not specified|Distal arthrogryposis	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	102045163	12	101651385	129642	135088
NM_024312.5(GNPTAB):c.235T>G (p.Tyr79Asp)	GNPTAB	I cell disease	Uncertain significance	no assertion criteria provided			12	101790026	598737	589798
NM_000277.2(PAH):c.1301C>A (p.Ala434Asp)	PAH	Phenylketonuria|not provided	Likely pathogenic(Last reviewed: Oct 13, 2014)	criteria provided, single submitter	12	103234192	12	102840414	102586	108322
NM_000277.2(PAH):c.1243G>A (p.Asp415Asn)	PAH	Phenylketonuria|Hyperphenylalaninemia, non-pku|not provided	Pathogenic(Last reviewed: Aug 12, 2018)	reviewed by expert panel	12	103234250	12	102840472	617	15656
NM_000277.2(PAH):c.1241A>G (p.Tyr414Cys)	PAH	Phenylketonuria|Hyperphenylalaninemia, non-pku|not provided	Pathogenic(Last reviewed: Jul 27, 2018)	reviewed by expert panel	12	103234252	12	102840474	593	15632
NM_000277.2(PAH):c.1238G>C (p.Arg413Pro)	PAH	Phenylketonuria|not provided	Pathogenic(Last reviewed: Aug 5, 2018)	reviewed by expert panel	12	103234255	12	102840477	592	15631
NM_000277.2(PAH):c.1223G>A (p.Arg408Gln)	PAH	Phenylketonuria|not provided	Pathogenic(Last reviewed: Aug 5, 2018)	reviewed by expert panel	12	103234270	12	102840492	612	15651
NM_000277.2(PAH):c.1222C>T (p.Arg408Trp)	PAH	Phenylketonuria|not provided	Pathogenic(Last reviewed: Aug 6, 2018)	reviewed by expert panel	12	103234271	12	102840493	577	15616
NM_000277.2(PAH):c.1208C>T (p.Ala403Val)	PAH	Phenylketonuria|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Aug 10, 2018)	reviewed by expert panel	12	103234285	12	102840507	92731	98638
NM_000277.2(PAH):c.1169A>G (p.Glu390Gly)	PAH	Phenylketonuria|Hyperphenylalaninemia, non-pku|not provided	Pathogenic(Last reviewed: Oct 1, 2018)	reviewed by expert panel	12	103237454	12	102843676	625	15664
NM_000277.2(PAH):c.1162G>A (p.Val388Met)	PAH	Phenylketonuria|not provided	Pathogenic(Last reviewed: Aug 5, 2018)	reviewed by expert panel	12	103237461	12	102843683	619	15658
NM_000277.2(PAH):c.1157A>G (p.Tyr386Cys)	PAH	Phenylketonuria|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 11, 2018)	criteria provided, multiple submitters, no conflicts	12	103237466	12	102843688	102538	108274
NM_000277.2(PAH):c.1139C>T (p.Thr380Met)	PAH	Phenylketonuria|Hyperphenylalaninemia, non-pku|not provided	Pathogenic(Last reviewed: Oct 1, 2018)	reviewed by expert panel	12	103237484	12	102843706	628	15667
NM_000277.2(PAH):c.1033G>A (p.Ala345Thr)	PAH	Phenylketonuria|not provided	Likely pathogenic(Last reviewed: Aug 10, 2018)	reviewed by expert panel	12	103238146	12	102844368	102483	108219
NM_000277.2(PAH):c.983C>T (p.Thr328Ile)	PAH	Phenylketonuria|not provided	Uncertain significance(Last reviewed: Aug 10, 2018)	reviewed by expert panel	12	103238196	12	102844418	281073	265310
NM_000277.2(PAH):c.934G>T (p.Gly312Cys)	PAH	Phenylketonuria	Likely pathogenic(Last reviewed: Nov 6, 2017)	criteria provided, single submitter	12	103240708	12	102846930	446506	440021
NM_000277.2(PAH):c.932T>C (p.Leu311Pro)	PAH	Phenylketonuria|not provided	Likely pathogenic(Last reviewed: Dec 2, 2014)	criteria provided, single submitter	12	103240710	12	102846932	578	15617
NM_000277.2(PAH):c.926C>T (p.Ala309Val)	PAH	Phenylketonuria|not provided	Pathogenic(Last reviewed: Aug 10, 2018)	reviewed by expert panel	12	103240716	12	102846938	92753	98660
NM_000277.2(PAH):c.916A>G (p.Ile306Val)	PAH	Phenylketonuria|Hyperphenylalaninemia, non-pku|not provided	Pathogenic(Last reviewed: Aug 10, 2018)	reviewed by expert panel	12	103240726	12	102846948	618	15657
NM_000277.2(PAH):c.898G>T (p.Ala300Ser)	PAH	Phenylketonuria|Hyperphenylalaninemia, non-pku|not provided	Pathogenic(Last reviewed: Aug 10, 2018)	reviewed by expert panel	12	103245479	12	102851701	92751	98658
NM_000277.2(PAH):c.896T>G (p.Phe299Cys)	PAH	Phenylketonuria|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 9, 2018)	criteria provided, multiple submitters, no conflicts	12	103245481	12	102851703	613	15652
NM_000277.2(PAH):c.847A>T (p.Ile283Phe)	PAH	Phenylketonuria|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, multiple submitters, no conflicts	12	103245530	12	102851752	102876	108612
NM_000277.2(PAH):c.842C>T (p.Pro281Leu)	PAH	Phenylketonuria|not provided	Likely pathogenic(Last reviewed: Aug 27, 2018)	reviewed by expert panel	12	103246593	12	102852815	589	15628
NM_000277.2(PAH):c.841C>T (p.Pro281Ser)	PAH	Phenylketonuria|not provided	Likely pathogenic(Last reviewed: Aug 10, 2018)	reviewed by expert panel	12	103246594	12	102852816	92749	98656
NM_000277.2(PAH):c.829T>G (p.Tyr277Asp)	PAH	Phenylketonuria|not provided	Pathogenic(Last reviewed: Aug 5, 2018)	reviewed by expert panel	12	103246606	12	102852828	603	15642
NM_000277.2(PAH):c.820A>G (p.Lys274Glu)	PAH	Phenylketonuria|not provided	Likely benign(Last reviewed: Aug 10, 2018)	reviewed by expert panel	12	103246615	12	102852837	102851	108587
NM_000277.2(PAH):c.818C>T (p.Ser273Phe)	PAH	Phenylketonuria|not provided	Likely pathogenic(Last reviewed: Aug 10, 2018)	reviewed by expert panel	12	103246617	12	102852839	598	15637
NM_000277.2(PAH):c.812A>T (p.His271Leu)	PAH	Phenylketonuria	Uncertain significance(Last reviewed: Aug 10, 2018)	reviewed by expert panel	12	103246623	12	102852845	120287	125881
NM_000277.2(PAH):c.800A>T (p.Gln267Leu)	PAH	Phenylketonuria	Uncertain significance(Last reviewed: Aug 10, 2018)	reviewed by expert panel	12	103246635	12	102852857	225135	227028
NM_000277.2(PAH):c.782G>A (p.Arg261Gln)	PAH	Phenylketonuria|not provided	Pathogenic(Last reviewed: Aug 13, 2018)	reviewed by expert panel	12	103246653	12	102852875	582	15621
NM_000277.2(PAH):c.755G>A (p.Arg252Gln)	PAH	Phenylketonuria|not provided	Pathogenic(Last reviewed: Aug 10, 2018)	reviewed by expert panel	12	103246680	12	102852902	102824	108560
NM_000277.2(PAH):c.754C>T (p.Arg252Trp)	PAH	Phenylketonuria|not provided	Pathogenic(Last reviewed: Aug 13, 2018)	reviewed by expert panel	12	103246681	12	102852903	584	15623
NM_000277.2(PAH):c.745C>T (p.Leu249Phe)	PAH	Phenylketonuria|not provided	Pathogenic(Last reviewed: Aug 12, 2018)	reviewed by expert panel	12	103246690	12	102852912	102821	108557
NM_000277.2(PAH):c.740G>T (p.Gly247Val)	PAH	Phenylketonuria|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, multiple submitters, no conflicts	12	103246695	12	102852917	102818	108554
NM_000277.2(PAH):c.734T>C (p.Val245Ala)	PAH	Phenylketonuria|Hyperphenylalaninemia, non-pku|not provided|Hyperphenylalaninaemia	Pathogenic(Last reviewed: Aug 10, 2018)	reviewed by expert panel	12	103246701	12	102852923	632	15671
NM_000277.2(PAH):c.722G>A (p.Arg241His)	PAH	Phenylketonuria|not provided	Pathogenic(Last reviewed: Aug 10, 2018)	reviewed by expert panel	12	103246713	12	102852935	102804	108540
NM_000277.1(PAH):c.721C>T (p.Arg241Cys)	PAH	Phenylketonuria|not provided	Pathogenic(Last reviewed: Aug 10, 2018)	reviewed by expert panel	12	103246714	12	102852936	102803	108539
NM_000277.2(PAH):c.691T>C (p.Ser231Pro)	PAH	Phenylketonuria|not provided	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	12	103248929	12	102855151	102786	108522
NM_000277.2(PAH):c.688G>A (p.Val230Ile)	PAH	Phenylketonuria|not provided	Likely pathogenic(Last reviewed: Aug 12, 2018)	reviewed by expert panel	12	103248932	12	102855154	102784	108520
NM_000277.2(PAH):c.638T>C (p.Leu213Pro)	PAH	Phenylketonuria|not provided	Pathogenic(Last reviewed: Oct 1, 2018)	reviewed by expert panel	12	103248982	12	102855204	92747	98654
NM_000277.2(PAH):c.611A>G (p.Tyr204Cys)	PAH	Phenylketonuria|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 20, 2017)	criteria provided, multiple submitters, no conflicts	12	103249009	12	102855231	590	15629
NM_000277.2(PAH):c.581T>C (p.Leu194Pro)	PAH	Phenylketonuria|not provided	Likely pathogenic(Last reviewed: Aug 13, 2018)	reviewed by expert panel	12	103249039	12	102855261	102742	108478
NM_000277.2(PAH):c.535T>A (p.Tyr179Asn)	PAH	Phenylketonuria|not provided	Likely pathogenic(Last reviewed: Aug 10, 2018)	reviewed by expert panel	12	103249085	12	102855307	102729	108465
NM_000277.2(PAH):c.533A>G (p.Glu178Gly)	PAH	Phenylketonuria|not provided	Pathogenic(Last reviewed: Aug 10, 2018)	reviewed by expert panel	12	103249087	12	102855309	92746	98653
NM_000277.2(PAH):c.520A>G (p.Ile174Val)	PAH	Phenylketonuria|not provided	Likely pathogenic(Last reviewed: Aug 10, 2018)	reviewed by expert panel	12	103249100	12	102855322	102720	108456
NM_000277.2(PAH):c.511G>A (p.Gly171Arg)	PAH	Phenylketonuria|not provided	Likely pathogenic(Last reviewed: Aug 10, 2018)	reviewed by expert panel	12	103249109	12	102855331	102716	108452
NM_000277.2(PAH):c.508C>G (p.His170Asp)	PAH	Phenylketonuria|not provided	Pathogenic(Last reviewed: Jul 28, 2018)	reviewed by expert panel	12	103260375	12	102866597	92744	98651
NM_000277.2(PAH):c.506G>C (p.Arg169Pro)	PAH	Phenylketonuria	Likely pathogenic(Last reviewed: Oct 18, 2017)	no assertion criteria provided	12	103260377	12	102866599	446524	440042
NM_000277.2(PAH):c.506G>A (p.Arg169His)	PAH	Phenylketonuria|not provided	Likely pathogenic(Last reviewed: Aug 10, 2018)	reviewed by expert panel	12	103260377	12	102866599	102706	108442
NM_000277.2(PAH):c.500A>G (p.Asn167Ser)	PAH	Phenylketonuria|not provided	Uncertain significance(Last reviewed: Aug 13, 2018)	reviewed by expert panel	12	103260383	12	102866605	102703	108439
NM_000277.2(PAH):c.500A>T (p.Asn167Ile)	PAH	Phenylketonuria|not provided	Likely pathogenic(Last reviewed: Aug 28, 2018)	reviewed by expert panel	12	103260383	12	102866605	92743	98650
NM_000277.2(PAH):c.490A>G (p.Ile164Val)	PAH	Phenylketonuria|not provided	Likely pathogenic(Last reviewed: Aug 13, 2018)	reviewed by expert panel	12	103260393	12	102866615	102698	108434
NM_000277.2(PAH):c.473G>A (p.Arg158Gln)	PAH	Phenylketonuria|not provided	Pathogenic(Last reviewed: Aug 5, 2018)	reviewed by expert panel	12	103260410	12	102866632	587	15626
NM_000277.2(PAH):c.472C>T (p.Arg158Trp)	PAH	Phenylketonuria|not provided	Pathogenic(Last reviewed: Aug 10, 2018)	reviewed by expert panel	12	103260411	12	102866633	102693	108429
NM_000277.2(PAH):c.470_471delGAinsAC (p.Arg157Asn)	PAH	Phenylketonuria	Pathogenic(Last reviewed: Nov 13, 2018)	criteria provided, single submitter	12	103260412 - 103260413	12	102866634 - 102866635	590772	581708
NM_000277.2(PAH):c.464G>C (p.Arg155Pro)	PAH	Phenylketonuria|not provided	Likely pathogenic(Last reviewed: Aug 10, 2018)	reviewed by expert panel	12	103260419	12	102866641	102687	108423
NM_000277.2(PAH):c.355C>T (p.Pro119Ser)	PAH	Phenylketonuria	Likely pathogenic(Last reviewed: Jul 29, 2018)	reviewed by expert panel	12	103271326	12	102877548	92741	98648
NM_000277.2(PAH):c.350C>T (p.Thr117Ile)	PAH	Phenylketonuria	Uncertain significance(Last reviewed: Sep 28, 2018)	reviewed by expert panel	12	103288515	12	102894737	120273	125867
NM_000277.2(PAH):c.311C>A (p.Ala104Asp)	PAH	Phenylketonuria|not provided	Pathogenic(Last reviewed: Aug 7, 2018)	reviewed by expert panel	12	103288554	12	102894776	102650	108386
NM_000277.2(PAH):c.299A>G (p.His100Arg)	PAH	Phenylketonuria	Uncertain significance(Last reviewed: Aug 10, 2018)	reviewed by expert panel	12	103288566	12	102894788	306914	315838
NM_000277.2(PAH):c.289A>C (p.Ile97Leu)	PAH	Phenylketonuria|not provided	Uncertain significance(Last reviewed: Aug 7, 2018)	reviewed by expert panel	12	103288576	12	102894798	376937	363815
NM_000277.2(PAH):c.204A>T (p.Arg68Ser)	PAH	Phenylketonuria|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 24, 2018)	criteria provided, multiple submitters, no conflicts	12	103288661	12	102894883	92738	98645
NM_000277.2(PAH):c.194T>C (p.Ile65Thr)	PAH	Phenylketonuria|not provided	Pathogenic(Last reviewed: Apr 21, 2018)	reviewed by expert panel	12	103288671	12	102894893	636	15675
NM_000277.2(PAH):c.169G>A (p.Glu57Lys)	PAH	Phenylketonuria|not provided	Likely pathogenic(Last reviewed: Aug 10, 2018)	reviewed by expert panel	12	103288696	12	102894918	92737	98644
NM_000277.2(PAH):c.165T>G (p.Phe55Leu)	PAH	Phenylketonuria|Hyperphenylalaninemia, non-pku|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, multiple submitters, no conflicts	12	103306572	12	102912794	92734	98641
NM_000277.2(PAH):c.158G>A (p.Arg53His)	PAH	Phenylketonuria|not provided	Uncertain significance(Last reviewed: Aug 10, 2018)	reviewed by expert panel	12	103306579	12	102912801	102601	108337
NM_000277.2(PAH):c.1A>G (p.Met1Val)	PAH	Phenylketonuria|Hyperphenylalaninemia, non-pku|not provided	Pathogenic(Last reviewed: Aug 7, 2018)	reviewed by expert panel	12	103310908	12	102917130	586	15625
NM_018082.5(POLR3B):c.[1568T>A];[1988C>T]	POLR3B	Hypomyelinating leukodystrophy 8, with or without oligodontia and/or hypogonadotropic hypogonadism	Likely pathogenic(Last reviewed: Feb 26, 2013)	criteria provided, single submitter	12|12	106826199	12|12	106432421	424793	40123|213619
NM_018082.5(POLR3B):c.1568T>A	POLR3B	Cerebellar hypoplasia with endosteal sclerosis|Hypomyelinating leukodystrophy 8, with or without oligodontia and/or hypogonadotropic hypogonadism|not provided|Endosteal sclerosis-cerebellar hypoplasia syndrome	Pathogenic(Last reviewed: Jul 28, 2017)	criteria provided, multiple submitters, no conflicts	12	106826199	12	106432421	31166	40123
NM_018082.5(POLR3B):c.2218A>G (p.Thr740Ala)	POLR3B	not specified|Pol III-related leukodystrophy	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	12	106848414	12	106454636	130002	135448
NM_018082.5(POLR3B):c.2774C>A (p.Pro925Gln)	POLR3B	Hypomyelinating leukodystrophy 8, with or without oligodontia and/or hypogonadotropic hypogonadism	Pathogenic	no assertion criteria provided	12	106889893	12	106496115	375867	362748
NM_018082.5(POLR3B):c.2774C>T (p.Pro925Leu)	POLR3B	Cerebellar hypoplasia with endosteal sclerosis|Endosteal sclerosis-cerebellar hypoplasia syndrome	Pathogenic(Last reviewed: Dec 21, 2016)	no assertion criteria provided	12	106889893	12	106496115	375248	361949
NM_130466.3(UBE3B):c.[1773delC];[1A>G]	UBE3B	Kaufman oculocerebrofacial syndrome	Pathogenic(Last reviewed: Apr 4, 2014)	no assertion criteria provided	12|12	109948180	12|12	109510375	427984	166443|166442
NM_130466.3(UBE3B):c.2990G>C (p.Arg997Pro)	UBE3B	Kaufman oculocerebrofacial syndrome|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, multiple submitters, no conflicts	12	109971338	12	109533533	208729	205272
NM_000431.3(MVK):c.803T>C (p.Ile268Thr)	MVK	Mevalonic aciduria|Porokeratosis, disseminated superficial actinic 1|Hyperimmunoglobulin D with periodic fever|not specified|not provided	Pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, multiple submitters, no conflicts	12	110029080	12	109591275	11932	26971
NM_000431.3(MVK):c.1129G>A (p.Val377Ile)	MVK	Mevalonic aciduria|Porokeratosis, disseminated superficial actinic 1|Hyperimmunoglobulin D with periodic fever|not provided	Pathogenic(Last reviewed: Jun 15, 2018)	criteria provided, multiple submitters, no conflicts	12	110034320	12	109596515	11929	26968
NM_032829.2(FAM222A):c.284A>T (p.His95Leu)	FAM222A|FAM222A-AS1	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	12	110206018	12	109768213	402150	389151
NM_001082538.2(TCTN1):c.220+12G>C	TCTN1	Joubert syndrome|not specified|not provided	Benign/Likely benign(Last reviewed: Aug 23, 2017)	criteria provided, multiple submitters, no conflicts	12	111052219	12	110614414	160096	168891
NM_001082538.2(TCTN1):c.940G>A (p.Ala314Thr)	TCTN1	Joubert syndrome 13	Uncertain significance(Last reviewed: Aug 7, 2013)	criteria provided, single submitter	12	111078284	12	110640479	160100	168895
NM_001082538.2(TCTN1):c.1234A>G (p.Ile412Val)	TCTN1	Joubert syndrome|Meckel-Gruber syndrome|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 5, 2018)	criteria provided, conflicting interpretations	12	111080097	12	110642292	93533	99438
NM_001082538.2(TCTN1):c.1396G>T (p.Gly466Cys)	TCTN1	Joubert syndrome|Meckel-Gruber syndrome|not specified	Benign/Likely benign(Last reviewed: Aug 1, 2017)	criteria provided, multiple submitters, no conflicts	12	111082836	12	110645031	160095	168897
NM_000432.3(MYL2):c.3G>A (p.Met1Ile)	MYL2	Familial hypertrophic cardiomyopathy 10|Familial isolated restrictive cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Nov 27, 2017)	criteria provided, conflicting interpretations	12	111358331	12	110920527	444868	438508
NM_015335.4(MED13L):c.6155A>C (p.Asn2052Thr)	MED13L	Mental retardation and distinctive facial features with or without cardiac defects	Uncertain significance	criteria provided, single submitter	12	116406815	12	115969010	431730	425221
NM_015335.4(MED13L):c.1904G>A (p.Ser635Asn)	MED13L	Transposition of the great arteries, dextro-looped 1|Mental retardation and distinctive facial features with or without cardiac defects	Conflicting interpretations of pathogenicity(Last reviewed: Sep 20, 2017)	criteria provided, conflicting interpretations	12	116446314	12	116008509	431731	425222
NM_000017.3(ACADS):c.136C>T (p.Arg46Trp)	ACADS	Deficiency of butyryl-CoA dehydrogenase|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 30, 2017)	criteria provided, multiple submitters, no conflicts	12	121164918	12	120727115	3825	18864
NM_000017.3(ACADS):c.319C>T (p.Arg107Cys)	ACADS	Deficiency of butyryl-CoA dehydrogenase|not provided	Pathogenic(Last reviewed: Nov 10, 2017)	criteria provided, multiple submitters, no conflicts	12	121174897	12	120737094	3826	18865
NM_000017.3(ACADS):c.529T>C (p.Trp177Arg)	ACADS	Deficiency of butyryl-CoA dehydrogenase|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 9, 2018)	criteria provided, multiple submitters, no conflicts	12	121175696	12	120737893	3828	18867
NM_000017.3(ACADS):c.1031A>G (p.Glu344Gly)	ACADS	Deficiency of butyryl-CoA dehydrogenase	Likely pathogenic(Last reviewed: Apr 8, 2014)	criteria provided, single submitter	12	121176944	12	120739141	30612	39569
NM_000017.3(ACADS):c.1138C>T (p.Arg380Trp)	ACADS	Deficiency of butyryl-CoA dehydrogenase|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2018)	criteria provided, multiple submitters, no conflicts	12	121177150	12	120739347	3837	18876
NM_032590.4(KDM2B):c.3050G>A (p.Arg1017His)	KDM2B	Global developmental delay|Microcephaly|Global developmental delay|Muscular hypotonia|Infantile spasms|Muscular hypotonia	Likely pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	12	121880194	12	121442391	242896	243988
NM_152269.4(C12orf65):c.44G>A (p.Arg15Gln)	C12orf65	Combined oxidative phosphorylation deficiency 7|not specified|not provided|Spastic paraplegia	Benign(Last reviewed: Aug 2, 2017)	criteria provided, multiple submitters, no conflicts	12	123738265	12	123253718	128535	133983
NM_032656.3(DHX37):c.1460G>A (p.Arg487His)	DHX37	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	12	125451713	12	124967167	402138	389152
NM_032656.3(DHX37):c.1257C>A (p.Asn419Lys)	DHX37	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	12	125453449	12	124968903	402139	389153
NM_015114.2(ANKLE2):c.1717C>G (p.Leu573Val)	ANKLE2	Microcephaly|Microcephaly 16, primary, autosomal recessive	Likely pathogenic(Last reviewed: Sep 25, 2014)	criteria provided, single submitter	12	133311145	12	132734559	218246	214882
NM_004004.5(GJB2):c.677T>A (p.Val226Asp)	GJB2	Nonsyndromic hearing loss and deafness	Uncertain significance(Last reviewed: Sep 27, 2018)	reviewed by expert panel	13	20763044	13	20188905	585322	576370
NM_004004.5(GJB2):c.677T>G (p.Val226Gly)	GJB2	Deafness, autosomal recessive 1A|Nonsyndromic hearing loss and deafness|not specified	Uncertain significance(Last reviewed: Sep 14, 2018)	reviewed by expert panel	13	20763044	13	20188905	447450	441576
NM_004004.5(GJB2):c.674C>T (p.Pro225Leu)	GJB2	Deafness, autosomal recessive 1A|Nonsyndromic hearing loss and deafness	Uncertain significance(Last reviewed: Sep 20, 2018)	reviewed by expert panel	13	20763047	13	20188908	555720	546920
NM_004004.5(GJB2):c.653G>A (p.Cys218Tyr)	GJB2	Nonsyndromic hearing loss and deafness	Uncertain significance(Last reviewed: Sep 10, 2018)	reviewed by expert panel	13	20763068	13	20188929	585327	576371
NM_004004.5(GJB2):c.617A>G (p.Asn206Ser)	GJB2	Deafness, autosomal recessive 1A|Mutilating keratoderma|Hystrix-like ichthyosis with deafness|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Keratoderma palmoplantar deafness|Knuckle pads, deafness AND leukonychia syndrome|Deafness, autosomal dominant 3a|Deafness, X-linked 2|Nonsyndromic hearing loss and deafness|Hearing impairment|not provided	Pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, multiple submitters, no conflicts	13	20763104	13	20188965	44763	53930
NM_004004.5(GJB2):c.598G>A (p.Gly200Arg)	GJB2	Deafness, autosomal recessive 1A|Deafness, autosomal dominant 3a	Likely pathogenic(Last reviewed: Jan 21, 2016)	criteria provided, single submitter	13	20763123	13	20188984	225222	227135
NM_004004.5(GJB2):c.596C>T (p.Ser199Phe)	GJB2	Deafness, autosomal recessive 1A|Nonsyndromic hearing loss and deafness	Pathogenic/Likely pathogenic(Last reviewed: Sep 15, 2016)	criteria provided, multiple submitters, no conflicts	13	20763125	13	20188986	189183	186854
NM_004004.5(GJB2):c.551G>A (p.Arg184Gln)	GJB2	Deafness, autosomal dominant 3a|Hearing impairment|not provided|Hearing loss	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, multiple submitters, no conflicts	13	20763170	13	20189031	29662	38617
NM_004004.5(GJB2):c.551G>C (p.Arg184Pro)	GJB2	Deafness, autosomal recessive 1A|Nonsyndromic hearing loss and deafness|not provided|Hearing loss	Pathogenic/Likely pathogenic(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	13	20763170	13	20189031	17007	32046
NM_004004.5(GJB2):c.516G>C (p.Trp172Cys)	GJB2	Deafness, autosomal recessive 1A	Likely pathogenic	no assertion criteria provided	13	20763205	13	20189066	590799	581737
NM_004004.5(GJB2):c.478G>A (p.Gly160Ser)	GJB2	Deafness, autosomal recessive 1A|Mutilating keratoderma|Hystrix-like ichthyosis with deafness|not specified|not provided|Nonsyndromic Deafness|Keratitis-Ichthyosis-Deafness Syndrome|Nonsyndromic Hearing Loss, Dominant|Nonsyndromic Hearing Loss, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Apr 9, 2018)	criteria provided, conflicting interpretations	13	20763243	13	20189104	44755	53922
NM_004004.5(GJB2):c.457G>A (p.Val153Ile)	GJB2	Deafness, autosomal recessive 1A|not specified|not provided|Nonsyndromic Hearing Loss, Dominant	Benign/Likely benign(Last reviewed: Sep 24, 2017)	criteria provided, multiple submitters, no conflicts	13	20763264	13	20189125	44754	53921
NM_004004.5(GJB2):c.427C>T (p.Arg143Trp)	GJB2	Deafness, autosomal recessive 1A|Mutilating keratoderma|Hystrix-like ichthyosis with deafness|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Keratoderma palmoplantar deafness|Knuckle pads, deafness AND leukonychia syndrome|Deafness, autosomal dominant 3a|Deafness, X-linked 2|Nonsyndromic hearing loss and deafness|Hearing impairment|not provided|Hearing loss	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, multiple submitters, no conflicts	13	20763294	13	20189155	17009	32048
NM_004004.5(GJB2):c.416G>A (p.Ser139Asn)	GJB2	Deafness, autosomal recessive 1A|Mutilating keratoderma|Hystrix-like ichthyosis with deafness|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Keratoderma palmoplantar deafness|Knuckle pads, deafness AND leukonychia syndrome|Deafness, autosomal dominant 3a|Deafness, X-linked 2|Nonsyndromic hearing loss and deafness|Hearing impairment|not provided|Hearing loss	Pathogenic/Likely pathogenic(Last reviewed: May 21, 2018)	criteria provided, multiple submitters, no conflicts	13	20763305	13	20189166	44749	53916
NM_004004.5(GJB2):c.389G>C (p.Gly130Ala)	GJB2	Deafness, autosomal recessive 1A|Deafness, autosomal dominant 3a|Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, multiple submitters, no conflicts	13	20763332	13	20189193	228264	230434
NM_004004.5(GJB2):c.379C>T (p.Arg127Cys)	GJB2	Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: Nov 30, 2016)	criteria provided, single submitter	13	20763342	13	20189203	163514	175763
NM_004004.5(GJB2):c.365A>T (p.Lys122Ile)	GJB2	Deafness, autosomal recessive 1A|Deafness, autosomal dominant 3a|Nonsyndromic hearing loss and deafness|Hearing impairment|not provided|Hearing loss	Pathogenic/Likely pathogenic(Last reviewed: Oct 20, 2017)	criteria provided, multiple submitters, no conflicts	13	20763356	13	20189217	44742	53909
NM_004004.5(GJB2):c.341A>G (p.Glu114Gly)	GJB2	Deafness, autosomal recessive 1A|not specified|not provided|Nonsyndromic Hearing Loss, Recessive	Benign(Last reviewed: Nov 29, 2017)	criteria provided, multiple submitters, no conflicts	13	20763380	13	20189241	44739	53906
NM_004004.5(GJB2):c.298C>T (p.His100Tyr)	GJB2	Deafness, autosomal recessive 1A|Nonsyndromic hearing loss and deafness|not specified|Hearing impairment|Hearing loss	Pathogenic/Likely pathogenic(Last reviewed: Mar 14, 2017)	criteria provided, multiple submitters, no conflicts	13	20763423	13	20189284	158607	169011
NM_004004.5(GJB2):c.283G>A (p.Val95Met)	GJB2	Deafness, autosomal recessive 1A|Mutilating keratoderma|Hystrix-like ichthyosis with deafness|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Keratoderma palmoplantar deafness|Knuckle pads, deafness AND leukonychia syndrome|Deafness, autosomal dominant 3a|Deafness, X-linked 2|Nonsyndromic hearing loss and deafness|Hearing impairment|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, multiple submitters, no conflicts	13	20763438	13	20189299	44735	53902
NM_004004.5(GJB2):c.279G>A (p.Met93Ile)	GJB2	Deafness, autosomal recessive 1A|Nonsyndromic hearing loss and deafness|not provided	Likely pathogenic(Last reviewed: Jul 20, 2017)	criteria provided, multiple submitters, no conflicts	13	20763442	13	20189303	44733	53900
NM_004004.5(GJB2):c.269T>C (p.Leu90Pro)	GJB2	Deafness, autosomal recessive 1A|Mutilating keratoderma|Hystrix-like ichthyosis with deafness|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Keratoderma palmoplantar deafness|Knuckle pads, deafness AND leukonychia syndrome|Deafness, autosomal dominant 3a|Deafness, X-linked 2|Nonsyndromic hearing loss and deafness|Congenital omphalocele|not specified|Hearing impairment|Omphalocele|not provided|Horseshoe kidney|Short palpebral fissure|Hearing loss	Pathogenic/Likely pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, multiple submitters, no conflicts	13	20763452	13	20189313	17016	32055
NM_004004.5(GJB2):c.250G>T (p.Val84Leu)	GJB2	Deafness, autosomal recessive 1A|Deafness, autosomal dominant 3a|not specified	Pathogenic/Likely pathogenic(Last reviewed: Dec 6, 2016)	criteria provided, multiple submitters, no conflicts	13	20763471	13	20189332	167134	177744
NM_004004.5(GJB2):c.250G>C (p.Val84Leu)	GJB2	Deafness, autosomal recessive 1A|Nonsyndromic hearing loss and deafness|Hearing impairment	Pathogenic(Last reviewed: Jun 22, 2017)	criteria provided, multiple submitters, no conflicts	13	20763471	13	20189332	17032	32071
NM_004004.5(GJB2):c.246C>G (p.Ile82Met)	GJB2	Deafness, autosomal recessive 1A	Likely pathogenic(Last reviewed: Apr 10, 2014)	criteria provided, single submitter	13	20763475	13	20189336	188756	186859
NM_004004.5(GJB2):c.239A>C (p.Gln80Pro)	GJB2	Deafness, autosomal recessive 1A|Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: Apr 4, 2018)	criteria provided, multiple submitters, no conflicts	13	20763482	13	20189343	177735	175905
NM_004004.5(GJB2):c.224G>A (p.Arg75Gln)	GJB2	Deafness, autosomal recessive 1A|Keratoderma palmoplantar deafness|Deafness, autosomal dominant 3a|Nonsyndromic hearing loss and deafness|not provided	Pathogenic(Last reviewed: Jul 29, 2016)	criteria provided, multiple submitters, no conflicts	13	20763497	13	20189358	17027	32066
NM_004004.5(GJB2):c.158G>A (p.Cys53Tyr)	GJB2	Hearing impairment	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	13	20763563	13	20189424	158606	169012
NM_004004.5(GJB2):c.134G>A (p.Gly45Glu)	GJB2	Deafness, autosomal recessive 1A|Keratitis-ichthyosis-deafness syndrome, autosomal dominant	Likely pathogenic(Last reviewed: Dec 13, 2014)	criteria provided, single submitter	13	20763587	13	20189448	17033	32072
NM_004004.5(GJB2):c.119C>G (p.Ala40Gly)	GJB2	Deafness, autosomal recessive 1A	Likely pathogenic(Last reviewed: Aug 20, 2014)	criteria provided, single submitter	13	20763602	13	20189463	188925	186862
NM_004004.5(GJB2):c.109G>T (p.Val37Phe)	GJB2	Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: Oct 5, 2013)	criteria provided, single submitter	13	20763612	13	20189473	179256	175907
NM_004004.5(GJB2):c.109G>A (p.Val37Ile)	GJB2	Deafness, autosomal recessive 1A|Mutilating keratoderma|Hystrix-like ichthyosis with deafness|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Keratoderma palmoplantar deafness|Knuckle pads, deafness AND leukonychia syndrome|Deafness, autosomal dominant 3a|Deafness, X-linked 2|Nonsyndromic hearing loss and deafness|Hearing impairment|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 6, 2018)	criteria provided, conflicting interpretations	13	20763612	13	20189473	17023	32062
NM_004004.5(GJB2):c.107T>C (p.Leu36Pro)	GJB2	not specified|Hearing impairment	Conflicting interpretations of pathogenicity(Last reviewed: Apr 24, 2017)	criteria provided, conflicting interpretations	13	20763614	13	20189475	158604	169014
NM_004004.5(GJB2):c.101T>C (p.Met34Thr)	GJB2	Deafness, autosomal recessive 1A|Mutilating keratoderma|Hystrix-like ichthyosis with deafness|Deafness, autosomal dominant 3a|Nonsyndromic hearing loss and deafness|not specified|not provided|Keratitis-Ichthyosis-Deafness Syndrome|Nonsyndromic Hearing Loss, Dominant|Nonsyndromic Hearing Loss, Recessive|Hearing loss	Conflicting interpretations of pathogenicity(Last reviewed: Dec 29, 2017)	criteria provided, conflicting interpretations	13	20763620	13	20189481	17000	32039
NM_004004.5(GJB2):c.95G>A (p.Arg32His)	GJB2	Deafness, autosomal recessive 1A|Deafness, autosomal dominant 3a|Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Aug 3, 2016)	criteria provided, multiple submitters, no conflicts	13	20763626	13	20189487	44766	53933
NM_004004.5(GJB2):c.94C>T (p.Arg32Cys)	GJB2	Deafness, autosomal recessive 1A|Deafness, autosomal dominant 3a|Nonsyndromic hearing loss and deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, multiple submitters, no conflicts	13	20763627	13	20189488	188758	186863
NM_004004.5(GJB2):c.79G>A (p.Val27Ile)	GJB2	Deafness, autosomal recessive 1A|Deafness, autosomal dominant 3a|not specified|Nonsyndromic Hearing Loss, Recessive	Benign(Last reviewed: May 9, 2017)	criteria provided, multiple submitters, no conflicts	13	20763642	13	20189503	36279	44943
NM_004004.5(GJB2):c.56G>C (p.Ser19Thr)	GJB2	Deafness, autosomal recessive 1A|Nonsyndromic hearing loss and deafness|not provided|Hearing loss	Conflicting interpretations of pathogenicity(Last reviewed: Jan 8, 2018)	criteria provided, conflicting interpretations	13	20763665	13	20189526	21389	34241
NM_004004.5(GJB2):c.44A>C (p.Lys15Thr)	GJB2	Deafness, autosomal recessive 1A|Nonsyndromic hearing loss and deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 9, 2017)	criteria provided, multiple submitters, no conflicts	13	20763677	13	20189538	44752	53919
NM_004004.5(GJB2):c.35G>T (p.Gly12Val)	GJB2	Deafness, autosomal recessive 1A|Deafness, autosomal dominant 3a|Nonsyndromic hearing loss and deafness|Hearing impairment|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, multiple submitters, no conflicts	13	20763686	13	20189547	21387	34239
NM_004004.5(GJB2):c.34G>T (p.Gly12Cys)	GJB2	Deafness, autosomal recessive 1A|Deafness, autosomal dominant 3a|Nonsyndromic hearing loss and deafness|Hearing impairment|not provided|Hearing loss	Likely pathogenic(Last reviewed: Sep 11, 2018)	reviewed by expert panel	13	20763687	13	20189548	44740	53907
NM_004004.5(GJB2):c.1A>G (p.Met1Val)	GJB2	Deafness, autosomal recessive 1A|Nonsyndromic hearing loss and deafness|not specified|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 9, 2017)	criteria provided, multiple submitters, no conflicts	13	20763720	13	20189581	44729	53896
NM_000231.2(SGCG):c.347G>A (p.Arg116His)	SGCG	Severe autosomal recessive muscular dystrophy of childhood - North African type|not specified|Limb-Girdle Muscular Dystrophy, Recessive	Benign/Likely benign(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	13	23824818	13	23250679	92655	98562
NM_000231.2(SGCG):c.787G>A (p.Glu263Lys)	SGCG	Severe autosomal recessive muscular dystrophy of childhood - North African type|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 2, 2018)	criteria provided, multiple submitters, no conflicts	13	23898591	13	23324452	2009	17048
NM_014363.5(SACS):c.10106T>C (p.Val3369Ala)	SACS	Spastic ataxia Charlevoix-Saguenay type|not specified|not provided	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	13	23907909	13	23333770	130199	135646
NM_014363.5(SACS):c.9723G>C (p.Glu3241Asp)	SACS	Spastic ataxia Charlevoix-Saguenay type	Uncertain significance(Last reviewed: Jun 24, 2017)	criteria provided, single submitter	13	23908292	13	23334153	522554	513167
NM_014363.5(SACS):c.8579A>G (p.Asn2860Ser)	SACS	Spastic ataxia Charlevoix-Saguenay type	Uncertain significance(Last reviewed: Jun 24, 2017)	criteria provided, single submitter	13	23909436	13	23335297	522555	513168
NM_014363.5(SACS):c.[11624G>A];[7276C>T]	SACS	Spastic ataxia Charlevoix-Saguenay type	Likely pathogenic(Last reviewed: Jun 10, 2014)	criteria provided, single submitter	13|13	23910739	13|13	23336600	424796	186869|213625
NM_014363.5(SACS):c.4744G>A (p.Asp1582Asn)	SACS	Spastic ataxia Charlevoix-Saguenay type|Spastic paraplegia	Pathogenic/Likely pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, multiple submitters, no conflicts	13	23913271	13	23339132	458265	462633
NM_014363.5(SACS):c.4466A>G (p.Asn1489Ser)	SACS	Spastic ataxia Charlevoix-Saguenay type|not specified|Abnormality of brain morphology|Spastic paraplegia	Conflicting interpretations of pathogenicity(Last reviewed: Dec 20, 2017)	criteria provided, conflicting interpretations	13	23913549	13	23339410	212114	208019
NM_014363.5(SACS):c.814C>T (p.Arg272Cys)	SACS	Spastic ataxia Charlevoix-Saguenay type	Likely pathogenic(Last reviewed: Jun 13, 2017)	criteria provided, multiple submitters, no conflicts	13	23929937	13	23355798	504884	497235
NM_014363.5(SACS):c.696T>A (p.Asn232Lys)	SACS	Spastic ataxia Charlevoix-Saguenay type|not specified|not provided	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	13	23930055	13	23355916	130204	135651
NM_005932.3(MIPEP):c.1745T>G (p.Leu582Arg)	MIPEP	Cardiomyopathy|Left ventricular noncompaction|Cardiomyopathy|Infantile muscular hypotonia|Combined oxidative phosphorylation deficiency 31	Uncertain significance(Last reviewed: Jun 17, 2015)	criteria provided, single submitter	13	24380192	13	23806053	208628	205199
NM_005932.3(MIPEP):c.1534C>G (p.His512Asp)	MIPEP	Cardiomyopathy|Left ventricular noncompaction|Cardiomyopathy|Infantile muscular hypotonia|Combined oxidative phosphorylation deficiency 31	Uncertain significance(Last reviewed: Jun 17, 2015)	criteria provided, single submitter	13	24411700	13	23837561	208633	205204
NM_005932.3(MIPEP):c.1027A>G (p.Lys343Glu)	MIPEP	Cardiomyopathy|Left ventricular noncompaction|Cardiomyopathy|Infantile muscular hypotonia|Combined oxidative phosphorylation deficiency 31	Uncertain significance(Last reviewed: Jun 17, 2015)	criteria provided, single submitter	13	24436467	13	23862328	208632	205203
NM_005932.3(MIPEP):c.916C>T (p.Leu306Phe)	MIPEP	Cardiomyopathy|Left ventricular noncompaction|Cardiomyopathy|Infantile muscular hypotonia|Combined oxidative phosphorylation deficiency 31	Uncertain significance(Last reviewed: Jun 17, 2015)	criteria provided, single submitter	13	24443458	13	23869319	208630	205201
NM_005932.3(MIPEP):c.485T>G (p.Leu162Trp)	MIPEP	Combined oxidative phosphorylation deficiency 31	Uncertain significance(Last reviewed: Aug 14, 2017)	criteria provided, single submitter	13	24453461	13	23879322	584430	575497
NM_005932.3(MIPEP):c.358G>A (p.Asp120Asn)	MIPEP	Combined oxidative phosphorylation deficiency 31	Likely pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	13	24460477	13	23886338	584454	575498
NM_005932.3(MIPEP):c.212T>A (p.Leu71Gln)	MIPEP	Cardiomyopathy|Left ventricular noncompaction|Cardiomyopathy|Infantile muscular hypotonia|Combined oxidative phosphorylation deficiency 31	Uncertain significance(Last reviewed: Jun 17, 2015)	criteria provided, single submitter	13	24460623	13	23886484	208629	205200
NM_018451.4(CENPJ):c.3920C>T (p.Thr1307Ile)	CENPJ|RNF17	Primary autosomal recessive microcephaly 6|not provided	Uncertain significance(Last reviewed: May 31, 2017)	criteria provided, multiple submitters, no conflicts	13	25457412	13	24883274	158214	169015
NM_018451.4(CENPJ):c.3586G>A (p.Asp1196Asn)	CENPJ|RNF17	Primary autosomal recessive microcephaly 6	Pathogenic	no assertion criteria provided	13	25458493	13	24884355	496762	488204
NM_018451.4(CENPJ):c.2852A>G (p.Gln951Arg)	CENPJ	Primary autosomal recessive microcephaly 6|Seckel syndrome|not specified|Primary Microcephaly, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	13	25473696	13	24899558	158205	169023
NM_018451.4(CENPJ):c.2806A>G (p.Ser936Gly)	CENPJ	Seckel syndrome|not specified|Primary Microcephaly, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	13	25478083	13	24903945	158204	169024
NM_018451.4(CENPJ):c.2635T>G (p.Ser879Ala)	CENPJ	Primary autosomal recessive microcephaly 6|Seckel syndrome|not specified|not provided|Primary Microcephaly, Recessive	Benign/Likely benign(Last reviewed: Apr 20, 2017)	criteria provided, multiple submitters, no conflicts	13	25479541	13	24905403	21661	34513
NM_018451.4(CENPJ):c.2470A>T (p.Thr824Ser)	CENPJ	Primary autosomal recessive microcephaly 6|not provided	Uncertain significance(Last reviewed: Jun 2, 2016)	criteria provided, multiple submitters, no conflicts	13	25479706	13	24905568	158202	169025
NM_018451.4(CENPJ):c.2462C>T (p.Thr821Met)	CENPJ	Primary autosomal recessive microcephaly 6|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	13	25479714	13	24905576	30783	39740
NM_018451.4(CENPJ):c.2210A>G (p.Asp737Gly)	CENPJ	Primary autosomal recessive microcephaly 6	Uncertain significance(Last reviewed: Aug 2, 2013)	criteria provided, single submitter	13	25479966	13	24905828	158201	169026
NM_018451.4(CENPJ):c.1960G>A (p.Ala654Thr)	CENPJ	Primary autosomal recessive microcephaly 6|Seckel syndrome|not specified|Primary Microcephaly, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Oct 2, 2017)	criteria provided, conflicting interpretations	13	25480216	13	24906078	158198	169028
NM_018451.4(CENPJ):c.1513G>A (p.Glu505Lys)	CENPJ	Primary autosomal recessive microcephaly 6|Seckel syndrome|Seckel syndrome 4|not provided|Primary Microcephaly, Recessive	Uncertain significance(Last reviewed: May 23, 2017)	criteria provided, multiple submitters, no conflicts	13	25480663	13	24906525	158193	169032
NM_018451.4(CENPJ):c.650G>A (p.Cys217Tyr)	CENPJ	Primary autosomal recessive microcephaly 6	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	13	25484143	13	24910005	158218	169037
NM_018451.4(CENPJ):c.600G>T (p.Gln200His)	CENPJ	Primary autosomal recessive microcephaly 6|Seckel syndrome|not provided|Primary Microcephaly, Recessive	Uncertain significance(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	13	25484193	13	24910055	158216	169038
NM_018451.4(CENPJ):c.452A>G (p.Glu151Gly)	CENPJ	Primary autosomal recessive microcephaly 6	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	13	25486200	13	24912062	21665	34517
NM_018451.4(CENPJ):c.289A>G (p.Thr97Ala)	CENPJ	Primary autosomal recessive microcephaly 6	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	13	25486875	13	24912737	21663	34515
NM_018451.4(CENPJ):c.287A>G (p.His96Arg)	CENPJ	Seckel syndrome|not specified|not provided|Primary Microcephaly, Recessive	Benign/Likely benign(Last reviewed: Sep 23, 2016)	criteria provided, multiple submitters, no conflicts	13	25486877	13	24912739	158206	169040
NM_018451.4(CENPJ):c.253C>A (p.Pro85Thr)	CENPJ	Seckel syndrome|not specified|not provided|Primary Microcephaly, Recessive	Benign/Likely benign(Last reviewed: Apr 20, 2017)	criteria provided, multiple submitters, no conflicts	13	25486911	13	24912773	158203	169041
NM_018451.4(CENPJ):c.216T>G (p.Asp72Glu)	CENPJ	Primary autosomal recessive microcephaly 6	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	13	25486948	13	24912810	158200	169042
NM_018451.4(CENPJ):c.187G>C (p.Asp63His)	CENPJ	Primary autosomal recessive microcephaly 6|Seckel syndrome|not specified|not provided|Primary Microcephaly, Recessive	Benign/Likely benign(Last reviewed: Sep 7, 2017)	criteria provided, multiple submitters, no conflicts	13	25486977	13	24912839	21660	34512
NM_018451.4(CENPJ):c.175A>G (p.Thr59Ala)	CENPJ	Primary autosomal recessive microcephaly 6|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2017)	criteria provided, conflicting interpretations	13	25486989	13	24912851	158196	169043
NM_018451.4(CENPJ):c.163C>G (p.Pro55Ala)	CENPJ	Primary autosomal recessive microcephaly 6|Seckel syndrome|not specified|Primary Microcephaly, Recessive	Benign/Likely benign(Last reviewed: May 29, 2018)	criteria provided, multiple submitters, no conflicts	13	25487001	13	24912863	21659	34511
NM_018451.4(CENPJ):c.68A>G (p.Asn23Ser)	CENPJ	Seckel syndrome|not specified|Primary Microcephaly, Recessive	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	13	25487096	13	24912958	158219	169044
NM_018451.4(CENPJ):c.61A>T (p.Met21Leu)	CENPJ	Seckel syndrome|not specified|not provided|Primary Microcephaly, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Aug 31, 2017)	criteria provided, conflicting interpretations	13	25487103	13	24912965	158217	169045
NM_018451.4(CENPJ):c.61A>G (p.Met21Val)	CENPJ	Primary autosomal recessive microcephaly 6|Seckel syndrome|not specified|Primary Microcephaly, Recessive	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	13	25487103	13	24912965	21666	34518
NM_016529.5(ATP8A2):c.2689G>A (p.Ala897Thr)	ATP8A2	Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 4	Uncertain significance	criteria provided, single submitter	13	26402265	13	25828127	431717	425223
NM_020751.2(COG6):c.1A>G (p.Met1Val)	COG6	Congenital disorder of glycosylation type 2L	Pathogenic(Last reviewed: Dec 20, 2017)	criteria provided, single submitter	13	40229864	13	39655727	487579	480626
NM_005767.5(LPAR6):c.436G>A (p.Gly146Arg)	RB1|LPAR6	Hypotrichosis 8	Pathogenic/Likely pathogenic(Last reviewed: Jun 2, 2015)	no assertion criteria provided	13	48986124	13	48411988	1828	16867
NM_005767.5(LPAR6):c.188A>T (p.Asp63Val)	RB1|LPAR6	Hypotrichosis 8	Pathogenic(Last reviewed: Oct 27, 2015)	no assertion criteria provided	13	48986372	13	48412236	217499	214140
NM_001142279.2(RNASEH2B):c.356A>G (p.Asp119Gly)	RNASEH2B	Aicardi Goutieres syndrome 2|not provided	Likely pathogenic(Last reviewed: Feb 22, 2016)	criteria provided, multiple submitters, no conflicts	13	51509055	13	50934919	191042	188848
NM_024570.3(RNASEH2B):c.529G>A (p.Ala177Thr)	RNASEH2B	Aicardi Goutieres syndrome 2|Aicardi Goutieres syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	13	51519581	13	50945445	1262	16301
NM_000053.3(ATP7B):c.4221T>A (p.Asp1407Glu)	ATP7B	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	13	52509069	13	51934933	157959	167806
NM_000053.3(ATP7B):c.4088C>T (p.Ser1363Phe)	ATP7B	Wilson disease	Likely pathogenic(Last reviewed: Aug 1, 2014)	criteria provided, single submitter	13	52509765	13	51935629	188908	186873
NM_000053.3(ATP7B):c.4039G>A (p.Gly1347Ser)	ATP7B	Wilson disease	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	13	52509814	13	51935678	157956	167803
NM_000053.3(ATP7B):c.4021G>A (p.Gly1341Ser)	ATP7B	Wilson disease	Pathogenic(Last reviewed: Jul 29, 2013)	criteria provided, single submitter	13	52511412	13	51937276	157955	167802
NM_000053.3(ATP7B):c.3895C>T (p.Leu1299Phe)	ATP7B	Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, multiple submitters, no conflicts	13	52511620	13	51937484	189149	186875
NM_000053.3(ATP7B):c.3889G>A (p.Val1297Ile)	ATP7B	Wilson disease|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 22, 2018)	criteria provided, conflicting interpretations	13	52511626	13	51937490	92389	98300
NM_000053.3(ATP7B):c.3886G>A (p.Asp1296Asn)	ATP7B	Wilson disease	Conflicting interpretations of pathogenicity(Last reviewed: Jul 25, 2017)	criteria provided, conflicting interpretations	13	52511629	13	51937493	161207	171156
NM_000053.3(ATP7B):c.3818C>T (p.Pro1273Leu)	ATP7B	Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2017)	criteria provided, multiple submitters, no conflicts	13	52511697	13	51937561	189139	186876
NM_000053.3(ATP7B):c.[2950C>G];[3809A>G]	ATP7B	Wilson disease	Pathogenic(Last reviewed: Apr 2, 2013)	criteria provided, single submitter	13|13	52511706	13|13	51937570	424765	18898|213626
NM_000053.3(ATP7B):c.3809A>G	ATP7B	Wilson disease|not provided	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	13	52511706	13	51937570	3859	18898
NM_000053.3(ATP7B):c.3796G>A (p.Gly1266Arg)	ATP7B	Wilson disease	Pathogenic(Last reviewed: Apr 20, 2017)	criteria provided, multiple submitters, no conflicts	13	52511719	13	51937583	3849	18888
NM_000053.3(ATP7B):c.3733C>T (p.Pro1245Ser)	ATP7B	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	13	52511782	13	51937646	157953	167800
NM_000053.3(ATP7B):c.3659C>T (p.Thr1220Met)	ATP7B	Wilson disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 18, 2017)	criteria provided, multiple submitters, no conflicts	13	52513227	13	51939091	35725	44389
NM_000053.3(ATP7B):c.3646G>A (p.Val1216Met)	ATP7B	Wilson disease|not provided	Likely pathogenic(Last reviewed: Aug 28, 2015)	criteria provided, multiple submitters, no conflicts	13	52513240	13	51939104	188859	186878
NM_000053.3(ATP7B):c.3556G>A (p.Gly1186Ser)	ATP7B	Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 6, 2017)	criteria provided, multiple submitters, no conflicts	13	52515217	13	51941081	188900	186881
NM_000053.3(ATP7B):c.3548C>G (p.Ala1183Gly)	ATP7B	Wilson disease|not specified	Conflicting interpretations of pathogenicity(Last reviewed: May 16, 2017)	criteria provided, conflicting interpretations	13	52515225	13	51941089	157952	167799
NM_000053.3(ATP7B):c.3517G>A (p.Glu1173Lys)	ATP7B	Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Apr 13, 2017)	criteria provided, multiple submitters, no conflicts	13	52515256	13	51941120	189050	186883
NM_000053.3(ATP7B):c.3451C>T (p.Arg1151Cys)	ATP7B	Wilson disease	Likely pathogenic(Last reviewed: Jun 20, 2014)	criteria provided, single submitter	13	52515322	13	51941186	188839	186884
NM_000053.3(ATP7B):c.3443T>C (p.Ile1148Thr)	ATP7B	Wilson disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 20, 2017)	criteria provided, multiple submitters, no conflicts	13	52515330	13	51941194	37122	18902
NM_000053.3(ATP7B):c.3428C>A (p.Thr1143Asn)	ATP7B	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	13	52515345	13	51941209	157950	167797
NM_000053.3(ATP7B):c.3419T>C (p.Val1140Ala)	ATP7B	Wilson disease|not specified|not provided	Benign(Last reviewed: Oct 19, 2017)	criteria provided, multiple submitters, no conflicts	13	52515354	13	51941218	35720	44384
NM_000053.3(ATP7B):c.3305T>C (p.Ile1102Thr)	ATP7B	Wilson disease	Pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, single submitter	13	52516629	13	51942493	430725	424263
NM_000053.3(ATP7B):c.3301G>A (p.Gly1101Arg)	ATP7B	Wilson disease	Likely pathogenic(Last reviewed: May 30, 2014)	criteria provided, single submitter	13	52516633	13	51942497	188808	186885
NM_000053.3(ATP7B):c.3236G>T (p.Cys1079Phe)	ATP7B	Wilson disease	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	13	52518252	13	51944116	424618	411516
NM_000053.3(ATP7B):c.3207C>A (p.His1069Gln)	ATP7B	Wilson disease|not provided	Pathogenic(Last reviewed: Jun 25, 2018)	criteria provided, multiple submitters, no conflicts	13	52518281	13	51944145	3848	18887
NM_000053.3(ATP7B):c.3188C>T (p.Ala1063Val)	ATP7B	Wilson disease|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Sep 8, 2017)	criteria provided, conflicting interpretations	13	52518300	13	51944164	157945	167792
NM_000053.3(ATP7B):c.3101A>G (p.His1034Arg)	ATP7B	Wilson disease|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 22, 2017)	criteria provided, conflicting interpretations	13	52518387	13	51944251	35719	44383
NM_000053.3(ATP7B):c.3053C>T (p.Ala1018Val)	ATP7B	Wilson disease	Likely pathogenic(Last reviewed: Mar 17, 2014)	criteria provided, single submitter	13	52520427	13	51946291	188722	186888
NM_000053.3(ATP7B):c.3011A>C (p.Gln1004Pro)	ATP7B	Wilson disease	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	13	52520469	13	51946333	157943	167790
NM_000053.3(ATP7B):c.3008C>T (p.Ala1003Val)	ATP7B	Wilson disease	Likely pathogenic(Last reviewed: May 14, 2014)	criteria provided, single submitter	13	52520472	13	51946336	188781	186889
NM_000053.3(ATP7B):c.3007G>A (p.Ala1003Thr)	ATP7B	Wilson disease|Epileptic encephalopathy	Pathogenic/Likely pathogenic(Last reviewed: May 9, 2018)	criteria provided, multiple submitters, no conflicts	13	52520473	13	51946337	188802	186890
NM_000053.3(ATP7B):c.2975C>T (p.Pro992Leu)	ATP7B	Wilson disease|not provided	Pathogenic(Last reviewed: Dec 27, 2015)	criteria provided, multiple submitters, no conflicts	13	52520505	13	51946369	188831	186891
NM_000053.3(ATP7B):c.2972C>T (p.Thr991Met)	ATP7B	Wilson disease|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 27, 2018)	criteria provided, conflicting interpretations	13	52520508	13	51946372	35712	44376
NM_000053.3(ATP7B):c.2930C>T (p.Thr977Met)	ATP7B	Wilson disease	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, multiple submitters, no conflicts	13	52520550	13	51946414	35710	44374
NM_000053.3(ATP7B):c.2855G>A (p.Arg952Lys)	ATP7B	Wilson disease|not specified	Benign(Last reviewed: Oct 10, 2016)	criteria provided, multiple submitters, no conflicts	13	52523808	13	51949672	35708	44372
NM_000053.3(ATP7B):c.2828G>A (p.Gly943Asp)	ATP7B	Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Feb 16, 2017)	criteria provided, multiple submitters, no conflicts	13	52523835	13	51949699	189058	186892
NM_000053.3(ATP7B):c.2804C>T (p.Thr935Met)	ATP7B	Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: May 29, 2018)	criteria provided, multiple submitters, no conflicts	13	52523859	13	51949723	188713	186893
NM_000053.3(ATP7B):c.2755C>G (p.Arg919Gly)	ATP7B	Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 2, 2016)	criteria provided, multiple submitters, no conflicts	13	52523908	13	51949772	3857	18896
NM_000053.3(ATP7B):c.2668G>A (p.Val890Met)	ATP7B	Wilson disease|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 7, 2018)	criteria provided, conflicting interpretations	13	52524205	13	51950069	189121	186895
NM_000053.3(ATP7B):c.2623G>A (p.Gly875Arg)	ATP7B	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	13	52524250	13	51950114	157940	167787
NM_000053.3(ATP7B):c.2605G>A (p.Gly869Arg)	ATP7B	Wilson disease|not provided|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Jul 6, 2018)	criteria provided, conflicting interpretations	13	52524268	13	51950132	157939	167786
NM_000053.3(ATP7B):c.2519C>T (p.Pro840Leu)	ATP7B	Wilson disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 22, 2016)	criteria provided, multiple submitters, no conflicts	13	52524464	13	51950328	188879	186898
NM_000053.3(ATP7B):c.2495A>G (p.Lys832Arg)	ATP7B	Wilson disease|not specified|not provided	Benign(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	13	52524488	13	51950352	35707	44371
NM_000053.3(ATP7B):c.2383C>T (p.Leu795Phe)	ATP7B	Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2018)	criteria provided, multiple submitters, no conflicts	13	52531716	13	51957580	188814	186900
NM_000053.3(ATP7B):c.2332C>G (p.Arg778Gly)	ATP7B	Wilson disease	Likely pathogenic(Last reviewed: Nov 20, 2014)	criteria provided, single submitter	13	52532470	13	51958334	156283	166063
NM_000053.3(ATP7B):c.2305A>G (p.Met769Val)	ATP7B	Wilson disease|not provided	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, multiple submitters, no conflicts	13	52532497	13	51958361	35706	44370
NM_000053.3(ATP7B):c.2293G>A (p.Asp765Asn)	ATP7B	Wilson disease	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2016)	criteria provided, multiple submitters, no conflicts	13	52532509	13	51958373	3855	18894
NM_000053.3(ATP7B):c.2128G>A (p.Gly710Ser)	ATP7B	Wilson disease|not provided	Pathogenic(Last reviewed: Sep 28, 2017)	criteria provided, multiple submitters, no conflicts	13	52532674	13	51958538	156281	166061
NM_000053.3(ATP7B):c.2123T>C (p.Leu708Pro)	ATP7B	Wilson disease|not specified|not provided	Pathogenic(Last reviewed: Feb 7, 2017)	criteria provided, multiple submitters, no conflicts	13	52532679	13	51958543	3865	18904
NM_000053.3(ATP7B):c.2071G>A (p.Gly691Arg)	ATP7B	Wilson disease	Likely pathogenic(Last reviewed: Sep 24, 2014)	criteria provided, single submitter	13	52534334	13	51960198	3866	18905
NM_000053.3(ATP7B):c.2002A>G (p.Met668Val)	ATP7B	Wilson disease|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 15, 2017)	criteria provided, conflicting interpretations	13	52534403	13	51960267	157934	167781
NM_000053.3(ATP7B):c.1995G>A (p.Met665Ile)	ATP7B	Wilson disease|not provided|Epileptic encephalopathy	Conflicting interpretations of pathogenicity(Last reviewed: Jun 7, 2018)	criteria provided, conflicting interpretations	13	52534410	13	51960274	157933	167780
NM_000053.3(ATP7B):c.1969A>C (p.Ser657Arg)	ATP7B	Wilson disease|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 13, 2017)	criteria provided, conflicting interpretations	13	52534436	13	51960300	157932	167779
NM_000053.3(ATP7B):c.1934T>G (p.Met645Arg)	ATP7B	Wilson disease	Conflicting interpretations of pathogenicity(Last reviewed: Jun 6, 2018)	criteria provided, conflicting interpretations	13	52535985	13	51961849	3862	18901
NM_000053.3(ATP7B):c.1924G>C (p.Asp642His)	ATP7B	Wilson disease	Likely pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, multiple submitters, no conflicts	13	52535995	13	51961859	189109	186903
NM_000053.3(ATP7B):c.1877G>C (p.Gly626Ala)	ATP7B	Wilson disease|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 16, 2018)	criteria provided, conflicting interpretations	13	52536042	13	51961906	157930	167777
NM_000053.3(ATP7B):c.1607T>C (p.Val536Ala)	ATP7B	Wilson disease|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 16, 2018)	criteria provided, conflicting interpretations	13	52542680	13	51968544	35703	44367
NM_000053.3(ATP7B):c.1366G>C (p.Val456Leu)	ATP7B	Wilson disease|not specified|not provided	Benign/Likely benign(Last reviewed: May 2, 2017)	criteria provided, multiple submitters, no conflicts	13	52544805	13	51970669	35702	44366
NM_000053.3(ATP7B):c.1336G>C (p.Val446Leu)	ATP7B	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	13	52544835	13	51970699	157929	167776
NM_000053.3(ATP7B):c.1216T>G (p.Ser406Ala)	ATP7B	Wilson disease|not specified|not provided	Benign/Likely benign(Last reviewed: May 2, 2017)	criteria provided, multiple submitters, no conflicts	13	52548140	13	51974004	35701	44365
NM_000053.3(ATP7B):c.254G>T (p.Gly85Val)	ATP7B	Wilson disease	Likely pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, multiple submitters, no conflicts	13	52549102	13	51974966	189037	186912
NM_000053.3(ATP7B):c.41C>A (p.Ala14Asp)	ATP7B	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	13	52585433	13	52011297	157958	167805
NM_006346.3(PIBF1):c.1508A>G (p.Tyr503Cys)	PIBF1	JOUBERT SYNDROME 33	Pathogenic	no assertion criteria provided	13	73482688	13	72908550	598934	590021
NM_006493.2(CLN5):c.4C>T (p.Arg2Cys)	CLN5	not specified|Seizures|not provided|Neuronal Ceroid-Lipofuscinosis, Dominant/Recessive	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	13	77566090	13	76991955	128782	134231
NM_006493.2(CLN5):c.1103A>G (p.Lys368Arg)	CLN5|FBXL3	Ceroid lipofuscinosis neuronal 5|not specified|Seizures|not provided|Neuronal Ceroid-Lipofuscinosis, Dominant/Recessive	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	13	77574983	13	77000848	128778	134227
NM_006493.2(CLN5):c.1192C>T (p.Pro398Ser)	CLN5|FBXL3	Ceroid lipofuscinosis neuronal 5|Neuronal ceroid lipofuscinosis|not specified|not provided|Neuronal Ceroid-Lipofuscinosis, Dominant/Recessive	Uncertain significance(Last reviewed: Feb 21, 2018)	criteria provided, multiple submitters, no conflicts	13	77575072	13	77000937	128780	134229
NM_000115.4(EDNRB):c.828G>T (p.Trp276Cys)	EDNRB|EDNRB-AS1	Hirschsprung disease 2|Waardenburg syndrome type 4A	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	13	78475316	13	77901181	16633	31672
NM_001201397.1(EDNRB):c.673G>A (p.Gly225Ser)	EDNRB	Waardenburg syndrome type 4A	Uncertain significance(Last reviewed: May 15, 2018)	no assertion criteria provided	13	78492306	13	77918171	545011	535275
NM_015567.1(SLITRK5):c.2515G>C (p.Glu839Gln)	SLITRK5	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	13	88330158	13	87677903	402167	389157
NM_000282.3(PCCA):c.425G>A (p.Gly142Asp)	PCCA	Propionyl-CoA carboxylase deficiency|not provided	Pathogenic(Last reviewed: Jul 29, 2016)	criteria provided, single submitter	13	100809551	13	100157297	203880	200253
NM_000282.3(PCCA):c.802C>T (p.Arg268Cys)	PCCA	Propionyl-CoA carboxylase deficiency|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 29, 2018)	criteria provided, conflicting interpretations	13	100915068	13	100262814	289402	273639
NM_000123.3(ERCC5):c.760A>G (p.Met254Val)	ERCC5|BIVM-ERCC5	Xeroderma pigmentosum, group G|Xeroderma pigmentosum|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	13	103513944	13	102861594	129012	134458
NM_000123.3(ERCC5):c.1586G>C (p.Cys529Ser)	ERCC5|BIVM-ERCC5	Xeroderma pigmentosum, group G|Xeroderma pigmentosum|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	13	103515085	13	102862735	129010	134456
NM_000123.3(ERCC5):c.3310G>C (p.Asp1104His)	ERCC5|BIVM-ERCC5	Xeroderma pigmentosum, group G|Xeroderma pigmentosum|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	13	103528002	13	102875652	129011	134457
NM_002312.3(LIG4):c.1312T>C (p.Tyr438His)	LIG4	Lig4 syndrome	Likely pathogenic	criteria provided, single submitter	13	108862305	13	108209957	225274	227174
NM_001846.3(COL4A2):c.4987G>A (p.Gly1663Ser)	COL4A2	Porencephalic cyst|Optic nerve hypoplasia	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	13	111164386	13	110512039	311195	327447
NM_024537.3(CARS2):c.[649_651delGAG];[752C>T]	CARS2	Alpers encephalopathy	Pathogenic(Last reviewed: Jan 17, 2014)	criteria provided, single submitter	13|13	111335402 - 111335404	13|13	110683055 - 110683057	424709	167501|167502
NM_000131.4(F7):c.1285G>A (p.Ala429Thr)	F7	Factor VII deficiency	Likely pathogenic(Last reviewed: Jun 30, 2014)	no assertion criteria provided	13	113773206	13	113118892	374352	361209
NM_000359.2(TGM1):c.1621A>C (p.Thr541Pro)	TGM1	Lamellar ichthyosis	Pathogenic	no assertion criteria provided	14	24724594	14	24255388	127067	132580
NM_000359.2(TGM1):c.1363T>C (p.Trp455Arg)	TGM1	Autosomal recessive congenital ichthyosis 1|Ichthyosis	Pathogenic(Last reviewed: Nov 17, 2015)	no assertion criteria provided	14	24727530	14	24258324	217304	213952
NM_000359.2(TGM1):c.919C>G (p.Arg307Gly)	TGM1	not provided|Lamellar ichthyosis	Pathogenic(Last reviewed: Apr 14, 2017)	criteria provided, multiple submitters, no conflicts	14	24728975	14	24259769	372534	360047
NM_000359.2(TGM1):c.910A>T (p.Ile304Phe)	TGM1	Autosomal recessive congenital ichthyosis 1	Likely pathogenic(Last reviewed: Aug 18, 2015)	no assertion criteria provided	14	24728984	14	24259778	243015	244096
NM_007077.4(AP4S1):c.373A>G (p.Ile125Val)	AP4S1	Spastic paraplegia 52, autosomal recessive|not specified|not provided|Spastic paraplegia	Uncertain significance(Last reviewed: Sep 12, 2016)	criteria provided, multiple submitters, no conflicts	14	31553981	14	31084775	128407	133856
NM_025152.2(NUBPL):c.2T>C (p.Met1Thr)	NUBPL	Mitochondrial oxidative phosphorylation disorder	Likely pathogenic(Last reviewed: Mar 4, 2017)	criteria provided, single submitter	14	32030647	14	31561441	517222	497668
NM_025152.2(NUBPL):c.[166G>A;815-27T>C]	NUBPL	Mitochondrial complex I deficiency|MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	14|14	32031331	14|14	31562125	7	15046|59458
NM_025152.2(NUBPL):c.311T>C (p.Leu104Pro)	NUBPL	Mitochondrial complex I deficiency|not provided|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Mar 11, 2016)	criteria provided, conflicting interpretations	14	32068514	14	31599308	209179	205774
NM_021914.7(CFL2):c.457T>G (p.Leu153Val)	CFL2	Nemaline myopathy 7|not provided	Uncertain significance(Last reviewed: Aug 9, 2017)	criteria provided, multiple submitters, no conflicts	14	35182115	14	34712909	128713	134162
NM_024884.2(L2HGDH):c.99G>T (p.Arg33Ser)	DMAC2L|L2HGDH	L-2-hydroxyglutaric aciduria|not specified|not provided	Benign/Likely benign(Last reviewed: Sep 25, 2017)	criteria provided, multiple submitters, no conflicts	14	50778770	14	50312052	158803	169069
NM_024884.2(L2HGDH):c.53T>G (p.Leu18Arg)	DMAC2L|L2HGDH	not specified|not provided	Benign/Likely benign(Last reviewed: Apr 20, 2017)	criteria provided, multiple submitters, no conflicts	14	50778816	14	50312098	158799	169070
NM_020921.3(NIN):c.6068A>G (p.Asn2023Ser)	NIN	not specified	Likely benign	no assertion criteria provided	14	51196251	14	50729533	129801	135247
NM_020921.3(NIN):c.5903C>T (p.Thr1968Met)	NIN	not specified	Likely benign	no assertion criteria provided	14	51196416	14	50729698	129799	135245
NM_020921.3(NIN):c.5800C>G (p.Gln1934Glu)	NIN	not specified	Likely benign	no assertion criteria provided	14	51202311	14	50735593	129798	135244
NM_020921.3(NIN):c.5509T>A (p.Ser1837Thr)	NIN	not specified	Likely benign	no assertion criteria provided	14	51206145	14	50739427	129795	135241
NM_020921.3(NIN):c.5075G>A (p.Cys1692Tyr)	NIN	not specified	Likely benign	no assertion criteria provided	14	51211073	14	50744355	129794	135240
NM_020921.3(NIN):c.4937G>A (p.Arg1646His)	NIN	not specified	Likely benign	no assertion criteria provided	14	51219249	14	50752531	129793	135239
NM_020921.3(NIN):c.4866A>C (p.Glu1622Asp)	NIN	not specified	Likely benign	no assertion criteria provided	14	51219320	14	50752602	129792	135238
NM_020921.3(NIN):c.4837C>T (p.Arg1613Cys)	NIN	not specified	Likely benign	no assertion criteria provided	14	51219349	14	50752631	129791	135237
NM_020921.3(NIN):c.3454G>T (p.Val1152Phe)	NIN	not specified	Likely benign	no assertion criteria provided	14	51224294	14	50757576	129788	135234
NM_020921.3(NIN):c.3331C>G (p.Pro1111Ala)	NIN	not specified	Likely benign	no assertion criteria provided	14	51224417	14	50757699	129787	135233
NM_020921.3(NIN):c.2651A>G (p.Lys884Arg)	NIN	not specified	Likely benign	no assertion criteria provided	14	51225097	14	50758379	129784	135230
NM_000161.2(GCH1):c.704G>A (p.Arg235Gln)	GCH1	Dystonia 5, Dopa-responsive type	Uncertain significance(Last reviewed: Jan 17, 2017)	criteria provided, single submitter	14	55310784	14	54844066	522866	513447
NM_000161.2(GCH1):c.551G>A (p.Arg184His)	GCH1	GTP cyclohydrolase I deficiency	Pathogenic(Last reviewed: Dec 30, 2014)	criteria provided, single submitter	14	55312561	14	54845843	9290	24329
NM_001024858.3(SPTB):c.6095T>C (p.Leu2032Pro)	SPTB	Hereditary spherocytosis	Pathogenic(Last reviewed: Feb 3, 2018)	no assertion criteria provided	14	65234505	14	64767787	522602	513215
NM_015346.3(ZFYVE26):c.5672A>G (p.Asn1891Ser)	ZFYVE26	not specified|Spastic Paraplegia, Recessive	Benign(Last reviewed: Jul 24, 2017)	criteria provided, multiple submitters, no conflicts	14	68234539	14	67767822	130783	136229
NM_015346.3(ZFYVE26):c.4370G>A (p.Cys1457Tyr)	ZFYVE26	not specified|Spastic Paraplegia, Recessive	Benign/Likely benign(Last reviewed: Jul 19, 2017)	criteria provided, multiple submitters, no conflicts	14	68249499	14	67782782	130782	136228
NM_015346.3(ZFYVE26):c.3365C>T (p.Ala1122Val)	ZFYVE26	not specified|not provided|Spastic paraplegia|Spastic Paraplegia, Recessive	Benign/Likely benign(Last reviewed: Sep 30, 2017)	criteria provided, multiple submitters, no conflicts	14	68251934	14	67785217	130781	136227
NM_015346.3(ZFYVE26):c.3308C>T (p.Pro1103Leu)	ZFYVE26	not specified|Spastic paraplegia|Spastic Paraplegia, Recessive	Benign/Likely benign(Last reviewed: Aug 2, 2017)	criteria provided, multiple submitters, no conflicts	14	68251991	14	67785274	130780	136226
NM_015346.3(ZFYVE26):c.3118T>A (p.Ser1040Thr)	ZFYVE26	Spastic paraplegia 15|not specified|Spastic paraplegia|Spastic Paraplegia, Recessive	Benign/Likely benign(Last reviewed: Aug 8, 2017)	criteria provided, multiple submitters, no conflicts	14	68252852	14	67786135	130778	136224
NM_015346.3(ZFYVE26):c.686C>A (p.Ala229Glu)	ZFYVE26	not provided	Uncertain significance(Last reviewed: Mar 6, 2014)	criteria provided, single submitter	14	68274315	14	67807598	130784	136230
NM_001034852.2(SMOC1):c.367T>C (p.Ser123Pro)	SMOC1	Anophthalmos with limb anomalies	Pathogenic	no assertion criteria provided	14	70420238	14	69953521	427815	418799
NM_182476.2(COQ6):c.1016A>T (p.Asp339Val)	ENTPD5|COQ6	not specified|not provided	Benign(Last reviewed: Nov 12, 2013)	criteria provided, single submitter	14	74428000	14	73961297	128833	134281
NM_182476.2(COQ6):c.1216G>A (p.Val406Met)	ENTPD5|COQ6	not specified|not provided	Benign(Last reviewed: Sep 5, 2013)	criteria provided, single submitter	14	74428445	14	73961742	128834	134282
NM_182894.2(VSX2):c.667G>A (p.Gly223Arg)	VSX2	Anophthalmia - microphthalmia	Pathogenic(Last reviewed: Jan 1, 2013)	criteria provided, single submitter	14	74726392	14	74259689	221963	223645
NM_194279.3(ISCA2):c.229G>A (p.Gly77Ser)	ISCA2	Global developmental delay|Failure to thrive|Spastic tetraplegia|Optic atrophy|Muscular hypotonia of the trunk|not provided|Optic atrophy|Global developmental delay|Death in infancy|High CSF lactic acid|Neurodegeration|Multiple mitochondrial dysfunctions syndrome 4|Multiple mitochondrial dysfunctions syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2017)	criteria provided, multiple submitters, no conflicts	14	74961032	14	74494329	183353	181441
NM_014239.3(EIF2B2):c.599G>T (p.Gly200Val)	EIF2B2	Leukoencephalopathy with vanishing white matter|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 30, 2017)	criteria provided, multiple submitters, no conflicts	14	75472570	14	75005867	208575	205176
NM_013382.5(POMT2):c.881A>G (p.Tyr294Cys)	POMT2	Limb-girdle muscular dystrophy-dystroglycanopathy, type C2|not provided	Likely pathogenic(Last reviewed: Jun 15, 2017)	criteria provided, multiple submitters, no conflicts	14	77765840	14	77299497	130017	135463
NM_013382.5(POMT2):c.431T>G (p.Met144Arg)	POMT2	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	14	77772687	14	77306344	402194	389159
NM_013382.5(POMT2):c.161C>A (p.Ala54Glu)	POMT2	Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A2|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2|Limb-girdle muscular dystrophy-dystroglycanopathy, type C2|not specified|not provided|Limb-Girdle Muscular Dystrophy, Recessive	Benign/Likely benign(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	14	77786864	14	77320521	130016	135462
NM_004796.5(NRXN3):c.196A>G (p.Lys66Glu)	NRXN3	Short stature|Relative macrocephaly	Pathogenic	no assertion criteria provided	14	79175653	14	78709310	375395	362158
NM_001201401.1(GALC):c.1918T>G (p.Trp640Gly)	GALC	Galactosylceramide beta-galactosidase deficiency|Abnormality of brain morphology	Conflicting interpretations of pathogenicity(Last reviewed: Apr 18, 2018)	criteria provided, conflicting interpretations	14	88401147	14	87934803	402185	389160
NM_000153.3(GALC):c.1700A>C (p.Tyr567Ser)	GALC	Galactosylceramide beta-galactosidase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, multiple submitters, no conflicts	14	88407873	14	87941529	188969	186914
NM_000153.3(GALC):c.1657G>A (p.Gly553Arg)	GALC	Galactosylceramide beta-galactosidase deficiency	Likely pathogenic(Last reviewed: Dec 31, 2014)	criteria provided, single submitter	14	88411910	14	87945566	189113	186915
NM_000153.3(GALC):c.1591C>T (p.Arg531Cys)	GALC	Galactosylceramide beta-galactosidase deficiency	Likely pathogenic(Last reviewed: Oct 1, 2014)	criteria provided, single submitter	14	88411976	14	87945632	188997	186916
NM_000153.3(GALC):c.1394C>T (p.Thr465Ile)	GALC	Galactosylceramide beta-galactosidase deficiency	Likely pathogenic(Last reviewed: May 15, 2017)	no assertion criteria provided	14	88414167	14	87947823	545725	536217
NM_000153.3(GALC):c.857G>A (p.Gly286Asp)	GALC	Galactosylceramide beta-galactosidase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 26, 2017)	criteria provided, multiple submitters, no conflicts	14	88434730	14	87968386	30619	39576
NM_000153.3(GALC):c.388G>A (p.Glu130Lys)	GALC	Galactosylceramide beta-galactosidase deficiency	Likely pathogenic(Last reviewed: Jun 6, 2014)	criteria provided, single submitter	14	88452887	14	87986543	188817	186923
NM_000153.3(GALC):c.334A>G (p.Thr112Ala)	GALC	Galactosylceramide beta-galactosidase deficiency|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jun 12, 2018)	criteria provided, conflicting interpretations	14	88452941	14	87986597	92503	98412
NM_001201401.1(GALC):c.194G>A (p.Gly65Glu)	GALC	Galactosylceramide beta-galactosidase deficiency	Pathogenic(Last reviewed: Jul 28, 2017)	no assertion criteria provided	14	88459315	14	87992971	433542	427116
NM_024824.4(ZC3H14):c.1522G>A (p.Val508Ile)	ZC3H14	not provided	Uncertain significance(Last reviewed: Aug 29, 2013)	criteria provided, single submitter	14	89069179	14	88602835	130764	136210
NM_024824.4(ZC3H14):c.2206G>A (p.Glu736Lys)	ZC3H14	not provided	Uncertain significance(Last reviewed: Nov 14, 2013)	criteria provided, single submitter	14	89078090	14	88611746	130766	136212
NM_001080414.3(CCDC88C):c.5975T>C (p.Leu1992Pro)	CCDC88C	not specified	Benign(Last reviewed: Sep 29, 2017)	criteria provided, multiple submitters, no conflicts	14	91739081	14	91272737	158118	167971
NM_001080414.3(CCDC88C):c.5954C>G (p.Ser1985Cys)	CCDC88C	not specified	Benign(Last reviewed: Apr 8, 2013)	criteria provided, single submitter	14	91739102	14	91272758	158117	167970
NM_001080414.3(CCDC88C):c.5948G>C (p.Gly1983Ala)	CCDC88C	not specified	Benign(Last reviewed: Apr 8, 2013)	criteria provided, single submitter	14	91739108	14	91272764	158116	167969
NM_001080414.3(CCDC88C):c.5654G>A (p.Arg1885His)	CCDC88C	not specified	Benign(Last reviewed: Apr 8, 2013)	criteria provided, single submitter	14	91739402	14	91273058	158115	167968
NM_001080414.3(CCDC88C):c.3083C>T (p.Ala1028Val)	CCDC88C	not specified	Benign(Last reviewed: Apr 8, 2013)	criteria provided, single submitter	14	91773494	14	91307150	158099	167951
NM_001080414.3(CCDC88C):c.2432C>A (p.Ala811Glu)	CCDC88C	not specified	Benign(Last reviewed: Apr 8, 2013)	criteria provided, single submitter	14	91779728	14	91313384	158096	167948
NM_001080414.3(CCDC88C):c.2204G>A (p.Arg735His)	CCDC88C	not specified	Benign(Last reviewed: Apr 8, 2013)	criteria provided, single submitter	14	91779956	14	91313612	158095	167947
NM_001080414.3(CCDC88C):c.1909C>G (p.Leu637Val)	CCDC88C	not specified	Benign(Last reviewed: Apr 8, 2013)	criteria provided, single submitter	14	91780251	14	91313907	158093	167945
NM_001080414.3(CCDC88C):c.754C>G (p.Leu252Val)	CCDC88C	not specified	Benign(Last reviewed: Apr 8, 2013)	criteria provided, single submitter	14	91805677	14	91339333	158121	167974
NM_001080414.3(CCDC88C):c.322G>A (p.Gly108Ser)	CCDC88C	not specified	Benign(Last reviewed: Apr 8, 2013)	criteria provided, single submitter	14	91826004	14	91359660	158106	167959
NM_001127701.1(SERPINA1):c.1096G>A (p.Glu366Lys)	SERPINA1	FRAXE|PI Z|PI Z(AUGSBURG)|PI Z(TUN)|Alpha-1-antitrypsin deficiency|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Jul 4, 2018)	criteria provided, multiple submitters, no conflicts	14	94844947	14	94378610	17967	33006
NM_000295.4(SERPINA1):c.1093G>A (p.Asp365Asn)	SERPINA1	PI P(ST. ALBANS)|Alpha-1-antitrypsin deficiency|not specified	Likely benign(Last reviewed: May 7, 2015)	criteria provided, single submitter	14	94844950	14	94378613	17962	33001
NM_001127701.1(SERPINA1):c.863A>T (p.Glu288Val)	SERPINA1	PI S|Alpha-1-antitrypsin deficiency|not provided	Pathogenic, other(Last reviewed: Jul 4, 2018)	criteria provided, multiple submitters, no conflicts	14	94847262	14	94380925	17969	33008
NM_001127701.1(SERPINA1):c.839A>T (p.Asp280Val)	SERPINA1	PI P(LOWELL)|PI NULL(CARDIFF)|PI Q0(CARDIFF)|PI P(DUARTE)|Alpha-1-antitrypsin deficiency|not provided	Pathogenic/Likely pathogenic, other(Last reviewed: Jul 15, 2016)	criteria provided, multiple submitters, no conflicts	14	94847286	14	94380949	17975	33014
NM_000295.4(SERPINA1):c.745G>C (p.Gly249Arg)	SERPINA1	Alpha-1-antitrypsin deficiency	Likely pathogenic(Last reviewed: Oct 15, 2014)	criteria provided, single submitter	14	94847380	14	94381043	189018	186925
NM_001127701.1(SERPINA1):c.739C>T (p.Arg247Cys)	SERPINA1	PI F|Alpha-1-antitrypsin deficiency|not specified|not provided|Inborn genetic diseases	Uncertain significance(Last reviewed: Aug 30, 2018)	criteria provided, multiple submitters, no conflicts	14	94847386	14	94381049	17961	33000
NM_001127701.1(SERPINA1):c.230C>T (p.Ser77Phe)	SERPINA1	PI S(IIYAMA)|Alpha-1-antitrypsin deficiency	Pathogenic(Last reviewed: Dec 18, 2014)	criteria provided, single submitter	14	94849345	14	94383008	17992	33031
NM_001127701.1(SERPINA1):c.187C>T (p.Arg63Cys)	SERPINA1	PI I|Alpha-1-antitrypsin deficiency|not provided	Pathogenic/Likely pathogenic, other(Last reviewed: Aug 14, 2017)	criteria provided, multiple submitters, no conflicts	14	94849388	14	94383051	17974	33013
NM_001127701.1(SERPINA1):c.17C>T (p.Ser6Leu)	SERPINA1	PI Z(WREXHAM)|Alpha-1-antitrypsin deficiency|not provided	Uncertain significance(Last reviewed: Jan 9, 2018)	criteria provided, multiple submitters, no conflicts	14	94849558	14	94383221	17970	33009
NM_003384.2(VRK1):c.266G>A (p.Arg89Gln)	VRK1	Pontocerebellar hypoplasia type 1A|not provided|Inborn genetic diseases|Pontocerebellar hypoplasia type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jun 21, 2018)	criteria provided, conflicting interpretations	14	97312481	14	96846144	197213	194374
NM_003384.2(VRK1):c.356A>G (p.His119Arg)	VRK1	Pontocerebellar hypoplasia type 1A|not provided	Likely pathogenic(Last reviewed: Jul 10, 2017)	criteria provided, multiple submitters, no conflicts	14	97313663	14	96847326	209204	205776
NM_003384.2(VRK1):c.706G>A (p.Val236Met)	VRK1	Pontocerebellar hypoplasia type 1A|not specified|Pontocerebellar hypoplasia type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jun 15, 2018)	criteria provided, conflicting interpretations	14	97321690	14	96855353	218924	215733
NM_003384.2(VRK1):c.858G>T (p.Met286Ile)	VRK1	Pontoneocerebellar hypoplasia|not specified|not provided|Pontocerebellar hypoplasia type 1	Uncertain significance(Last reviewed: Jun 26, 2018)	criteria provided, multiple submitters, no conflicts	14	97322892	14	96856555	130730	136176
NM_003384.2(VRK1):c.961C>T (p.Arg321Cys)	VRK1	Pontocerebellar hypoplasia type 1A|not specified|Pontocerebellar hypoplasia type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jun 21, 2018)	criteria provided, conflicting interpretations	14	97326965	14	96860628	209205	205777
NM_015656.1(KIF26A):c.[1378delG];[4925C>T]	KIF26A	Hereditary spastic paraplegia	association	no assertion criteria provided	14|14	104638963	14|14	104172626	428593	420149|420150
NM_199165.2(ADSSL1):c.910G>A (p.Asp304Asn)	ADSSL1	Myopathy, distal, 5	Pathogenic(Last reviewed: Jan 9, 2018)	criteria provided, single submitter	14	105207568	14	104741231	243025	244107
NM_001519.3(BRF1):c.875C>A (p.Pro292His)	BRF1	cerebellar-facial-dental syndrome|Cerebellofaciodental syndrome	Pathogenic(Last reviewed: Jan 5, 2015)	no assertion criteria provided	14	105693011	14	105226674	161426	171266
NM_001519.3(BRF1):c.776C>T (p.Thr259Met)	BRF1	cerebellar-facial-dental syndrome|Cerebellofaciodental syndrome	Pathogenic(Last reviewed: Jan 5, 2015)	no assertion criteria provided	14	105695169	14	105228832	161424	171267
NM_001519.3(BRF1):c.677C>T (p.Ser226Leu)	BRF1	cerebellar-facial-dental syndrome|Cerebellofaciodental syndrome	Pathogenic(Last reviewed: Jan 5, 2015)	no assertion criteria provided	14	105707619	14	105241282	161423	171268
NM_001519.3(BRF1):c.667C>T (p.Arg223Trp)	BRF1	cerebellar-facial-dental syndrome|Cerebellofaciodental syndrome	Pathogenic(Last reviewed: Jan 5, 2015)	no assertion criteria provided	14	105707629	14	105241292	161425	171269
NM_001102610.1(TUBGCP5):c.2180T>G (p.Phe727Cys)	TUBGCP5	Microcephaly	Uncertain significance(Last reviewed: Apr 10, 2018)	criteria provided, single submitter	15	22864222	15	23008846	523634	514282
NM_000275.2(OCA2):c.593C>T (p.Pro198Leu)	OCA2	not provided|Oculocutaneous albinism	Conflicting interpretations of pathogenicity(Last reviewed: Jun 27, 2017)	criteria provided, conflicting interpretations	15	28267700	15	28022554	198063	195224
NM_004667.5(HERC2):c.12801T>A (p.Asp4267Glu)	HERC2	not specified|Mental retardation, autosomal recessive 38|Inborn genetic diseases	Benign(Last reviewed: Mar 29, 2016)	criteria provided, multiple submitters, no conflicts	15	28375310	15	28130164	242878	243992
NM_138704.3(NSMCE3):c.790C>T (p.Leu264Phe)	FAM189A1|NSMCE3	Lung damage, immunodeficiency and chromosome breakage syndrome|Lung disease, immunodeficiency, and chromosome breakage syndrome	Pathogenic(Last reviewed: Mar 17, 2016)	criteria provided, single submitter	15	29561120	15	29268916	267795	263171
NM_138704.3(NSMCE3):c.626C>T (p.Pro209Leu)	FAM189A1|NSMCE3	Lung damage, immunodeficiency and chromosome breakage syndrome|Lung disease, immunodeficiency, and chromosome breakage syndrome	Pathogenic(Last reviewed: Mar 17, 2016)	criteria provided, single submitter	15	29561284	15	29269080	267796	263172
NM_133647.1(SLC12A6):c.940A>T (p.Met314Leu)	SLC12A6	Andermann syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	34546727	15	34254526	159899	169118
NM_002225.4(IVD):c.149G>C (p.Arg50Pro)	IVD	Isovaleryl-CoA dehydrogenase deficiency	Likely pathogenic(Last reviewed: Aug 19, 2014)	criteria provided, single submitter	15	40699841	15	40407640	188922	186929
NM_002225.3(IVD):c.367G>A (p.Gly123Arg)	IVD	Isovaleryl-CoA dehydrogenase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	15	40702898	15	40410699	167199	177782
NM_170589.4(KNL1):c.89C>T (p.Pro30Leu)	KNL1	not provided	Uncertain significance(Last reviewed: Dec 3, 2013)	criteria provided, single submitter	15	40898604	15	40606406	128608	134057
NM_170589.4(KNL1):c.128G>C (p.Arg43Thr)	KNL1	not specified|Primary Microcephaly, Recessive	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	40898643	15	40606445	128586	134035
NM_170589.4(KNL1):c.245T>C (p.Met82Thr)	KNL1	not specified|Primary Microcephaly, Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	40902490	15	40610292	128592	134041
NM_170589.4(KNL1):c.305G>A (p.Arg102Gln)	KNL1	not specified	Benign(Last reviewed: Mar 24, 2014)	criteria provided, single submitter	15	40903051	15	40610853	128580	134029
NM_170589.4(KNL1):c.331A>G (p.Thr111Ala)	KNL1	not provided	Uncertain significance(Last reviewed: May 2, 2013)	criteria provided, single submitter	15	40903678	15	40611480	128581	134030
NM_170589.4(KNL1):c.337A>G (p.Thr113Ala)	KNL1	not specified|Primary Microcephaly, Recessive	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	40903684	15	40611486	128595	134044
NM_170589.4(KNL1):c.805A>G (p.Ile269Val)	KNL1	not specified|Primary Microcephaly, Recessive	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	40913189	15	40620991	128607	134056
NM_170589.4(KNL1):c.1456G>T (p.Ala486Ser)	KNL1	not specified|Primary Microcephaly, Recessive	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	40913840	15	40621642	128588	134037
NM_170589.4(KNL1):c.1571T>A (p.Ile524Asn)	KNL1	not specified	Likely benign	no assertion criteria provided	15	40913955	15	40621757	128577	134026
NM_170589.4(KNL1):c.1793T>C (p.Met598Thr)	KNL1	not specified|Primary Microcephaly, Recessive	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	40914177	15	40621979	128589	134038
NM_170589.4(KNL1):c.2092A>C (p.Ile698Leu)	KNL1	not specified	Likely benign	no assertion criteria provided	15	40914476	15	40622278	128578	134027
NM_170589.4(KNL1):c.2447C>G (p.Thr816Ser)	KNL1	not specified|Primary Microcephaly, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	40914831	15	40622633	128591	134040
NM_170589.4(KNL1):c.2893A>T (p.Met965Leu)	KNL1	not provided	Uncertain significance(Last reviewed: Jun 7, 2013)	criteria provided, single submitter	15	40915277	15	40623079	128579	134028
NM_170589.4(KNL1):c.3827C>T (p.Ala1276Val)	KNL1	not provided	Uncertain significance(Last reviewed: Jan 27, 2014)	criteria provided, single submitter	15	40916211	15	40624013	128597	134046
NM_170589.4(KNL1):c.3853A>G (p.Lys1285Glu)	KNL1	not specified|Primary Microcephaly, Recessive	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	40916237	15	40624039	128598	134047
NM_170589.4(KNL1):c.4417A>G (p.Thr1473Ala)	KNL1	not specified|Primary Microcephaly, Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	40916801	15	40624603	128600	134049
NM_170589.4(KNL1):c.4418C>T (p.Thr1473Ile)	KNL1	not specified|not provided	Uncertain significance(Last reviewed: Jun 15, 2016)	criteria provided, multiple submitters, no conflicts	15	40916802	15	40624604	128601	134050
NM_170589.4(KNL1):c.4457T>C (p.Ile1486Thr)	KNL1	not provided	Uncertain significance(Last reviewed: Jul 30, 2013)	criteria provided, single submitter	15	40916841	15	40624643	128602	134051
NM_170589.4(KNL1):c.5009A>G (p.Lys1670Arg)	KNL1	not specified|Primary Microcephaly, Recessive	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	40917393	15	40625195	128603	134052
NM_170589.4(KNL1):c.5600G>A (p.Arg1867His)	KNL1	not provided	Uncertain significance(Last reviewed: Jul 3, 2013)	criteria provided, single submitter	15	40920815	15	40628617	128583	134032
NM_170589.4(KNL1):c.6412G>A (p.Val2138Ile)	KNL1	not specified|not provided	Uncertain significance(Last reviewed: Mar 10, 2017)	criteria provided, multiple submitters, no conflicts	15	40944222	15	40652024	128606	134055
NM_170589.4(KNL1):c.6560A>G (p.Asp2187Gly)	KNL1	Primary autosomal recessive microcephaly 4|not specified	Uncertain significance(Last reviewed: Oct 26, 2015)	criteria provided, multiple submitters, no conflicts	15	40947173	15	40654975	210577	208192
NM_016013.3(NDUFAF1):c.941C>G (p.Ala314Gly)	NDUFAF1	Mitochondrial complex I deficiency|not specified|not provided	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	41679685	15	41387487	129690	135136
NM_016013.3(NDUFAF1):c.92G>T (p.Arg31Leu)	NDUFAF1	Mitochondrial complex I deficiency|not specified|not provided	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	41689166	15	41396968	129689	135135
NM_016013.3(NDUFAF1):c.26G>A (p.Arg9His)	NDUFAF1	Mitochondrial complex I deficiency|not specified|not provided	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	41689232	15	41397034	129688	135134
NM_000070.2(CAPN3):c.62G>A (p.Gly21Glu)	CAPN3	Limb-girdle muscular dystrophy, type 2A|not specified|not provided|Limb-Girdle Muscular Dystrophy, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Mar 21, 2018)	criteria provided, conflicting interpretations	15	42652065	15	42359867	92419	98330
NM_000070.2(CAPN3):c.133G>A (p.Ala45Thr)	CAPN3	Limb-girdle muscular dystrophy, type 2A	Pathogenic/Likely pathogenic(Last reviewed: Aug 4, 2017)	criteria provided, multiple submitters, no conflicts	15	42652136	15	42359938	217148	213819
NM_000070.2(CAPN3):c.146G>A (p.Arg49His)	CAPN3	Limb-girdle muscular dystrophy, type 2A	Likely pathogenic(Last reviewed: Jan 31, 2018)	criteria provided, multiple submitters, no conflicts	15	42652149	15	42359951	217151	213820
NM_000070.2(CAPN3):c.291C>A (p.Phe97Leu)	CAPN3	Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Jul 15, 2017)	criteria provided, single submitter	15	42652294	15	42360096	548137	538622
NM_000070.2(CAPN3):c.371G>C (p.Gly124Ala)	CAPN3	Limb-girdle muscular dystrophy, type 2A|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 29, 2017)	criteria provided, conflicting interpretations	15	42676742	15	42384544	128571	134020
NM_000070.2(CAPN3):c.479C>G (p.Ala160Gly)	CAPN3	Limb-girdle muscular dystrophy, type 2A|not specified|Limb-Girdle Muscular Dystrophy, Recessive	Benign/Likely benign(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	15	42678464	15	42386266	92417	98328
NM_000070.2(CAPN3):c.551C>T (p.Thr184Met)	CAPN3	Limb-girdle muscular dystrophy, type 2A|not specified	Benign/Likely benign(Last reviewed: Dec 8, 2017)	criteria provided, multiple submitters, no conflicts	15	42680003	15	42387805	128572	134021
NM_000070.2(CAPN3):c.566T>C (p.Leu189Pro)	CAPN3	Limb-girdle muscular dystrophy, type 2A|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 19, 2017)	criteria provided, conflicting interpretations	15	42680018	15	42387820	217158	213823
NM_000070.2(CAPN3):c.706G>A (p.Ala236Thr)	CAPN3	Limb-girdle muscular dystrophy, type 2A|not specified|not provided|Limb-Girdle Muscular Dystrophy, Recessive	Benign(Last reviewed: Apr 28, 2017)	criteria provided, multiple submitters, no conflicts	15	42681199	15	42389001	92420	98331
NM_000070.2(CAPN3):c.[1319G>A];[319G>T]	CAPN3	Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Feb 11, 2014)	criteria provided, single submitter	15|15	42691815	15|15	42399617	424767	213634|213633
NM_000070.2(CAPN3):c.1319G>A	CAPN3	Limb-girdle muscular dystrophy, type 2A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, multiple submitters, no conflicts	15	42691815	15	42399617	217147	213634
NM_000070.2(CAPN3):c.1468C>T (p.Arg490Trp)	CAPN3	Limb-girdle muscular dystrophy, type 2A|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	15	42693952	15	42401754	166790	177281
NM_000070.2(CAPN3):c.1714C>T (p.Arg572Trp)	CAPN3	Limb-girdle muscular dystrophy, type 2A|not provided	Pathogenic(Last reviewed: Apr 21, 2017)	criteria provided, multiple submitters, no conflicts	15	42695169	15	42402971	217152	213830
NM_000070.2(CAPN3):c.1715G>A (p.Arg572Gln)	CAPN3	Limb-girdle muscular dystrophy, type 2A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	15	42695170	15	42402972	17614	32653
NM_000070.2(CAPN3):c.2242C>G (p.Arg748Gly)	CAPN3	Limb-girdle muscular dystrophy, type 2A	Pathogenic(Last reviewed: Jul 15, 2017)	criteria provided, single submitter	15	42702843	15	42410645	548138	538623
NM_000070.2(CAPN3):c.2243G>A (p.Arg748Gln)	CAPN3	Limb-girdle muscular dystrophy, type 2A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, multiple submitters, no conflicts	15	42702844	15	42410646	128570	134019
NM_000070.2(CAPN3):c.2332G>A (p.Asp778Asn)	CAPN3	Limb-girdle muscular dystrophy, type 2A|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Dec 18, 2017)	criteria provided, conflicting interpretations	15	42703150	15	42410952	92413	98324
NM_000070.2(CAPN3):c.2338G>C (p.Asp780His)	CAPN3	Limb-girdle muscular dystrophy, type 2A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 18, 2018)	criteria provided, multiple submitters, no conflicts	15	42703156	15	42410958	195641	192802
NM_000070.2(CAPN3):c.2393C>A (p.Ala798Glu)	CAPN3	Limb-girdle muscular dystrophy, type 2A|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 24, 2018)	criteria provided, multiple submitters, no conflicts	15	42703497	15	42411299	92414	98325
NM_138477.4(CDAN1):c.3389C>T (p.Pro1130Leu)	CDAN1	Congenital dyserythropoietic anemia, type I	Pathogenic(Last reviewed: Sep 1, 2011)	no assertion criteria provided	15	43017748	15	42725550	3177	18216
NM_138477.2(CDAN1):c.3128A>T (p.Asp1043Val)	CDAN1	Congenital dyserythropoietic anemia, type I	Pathogenic(Last reviewed: Sep 1, 2011)	no assertion criteria provided	15	43018584	15	42726386	21750	34602
NM_138477.4(CDAN1):c.3124C>T (p.Arg1042Trp)	CDAN1	Congenital dyserythropoietic anemia, type I	Pathogenic(Last reviewed: Sep 1, 2011)	no assertion criteria provided	15	43018588	15	42726390	3176	18215
NM_138477.2(CDAN1):c.2671C>T (p.Arg891Cys)	CDAN1	Congenital dyserythropoietic anemia, type I|not specified|Congenital dyserythropoietic anemia	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	43020983	15	42728785	21749	34601
NM_138477.4(CDAN1):c.2140C>T (p.Arg714Trp)	CDAN1	Congenital dyserythropoietic anemia, type I	Pathogenic(Last reviewed: Sep 1, 2011)	no assertion criteria provided	15	43022830	15	42730632	21748	34600
NM_138477.2(CDAN1):c.2015C>T (p.Pro672Leu)	CDAN1	Congenital dyserythropoietic anemia, type I|not provided	Likely pathogenic(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	15	43022955	15	42730757	3179	18218
NM_138477.4(CDAN1):c.1787A>G (p.Gln596Arg)	CDAN1	Congenital dyserythropoietic anemia, type I|not specified|Congenital dyserythropoietic anemia	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	43023482	15	42731284	21747	34599
NM_138477.4(CDAN1):c.386G>A (p.Arg129His)	CDAN1	Congenital dyserythropoietic anemia, type I|Congenital dyserythropoietic anemia	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	15	43028683	15	42736485	21752	34604
NM_138477.2(CDAN1):c.320A>T (p.Gln107Leu)	CDAN1	Congenital dyserythropoietic anemia, type I|not specified|Congenital dyserythropoietic anemia	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	43028749	15	42736551	21751	34603
NM_138477.2(CDAN1):c.156C>G (p.Phe52Leu)	CDAN1	Congenital dyserythropoietic anemia, type I|not provided	Likely pathogenic(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	15	43028913	15	42736715	21746	34598
NM_153700.2(STRC):c.4425G>C (p.Trp1475Cys)	STRC	Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: May 17, 2015)	criteria provided, single submitter	15	43895560	15	43603362	165308	175967
NM_153700.2(STRC):c.4171C>G	STRC	Deafness, autosomal dominant 16|Nonsyndromic hearing loss and deafness|not provided	Likely pathogenic(Last reviewed: Sep 17, 2015)	criteria provided, multiple submitters, no conflicts	15	43896606	15	43604408	165311	175969
NM_005313.4(PDIA3):c.170G>A (p.Cys57Tyr)	PDIA3	Intellectual functioning disability	Likely pathogenic	no assertion criteria provided	15	44046024	15	43753826	492933	485864
NM_025137.3(SPG11):c.6899T>G (p.Leu2300Arg)	SPG11	Amyotrophic lateral sclerosis type 5|Spastic paraplegia 11, autosomal recessive	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	15	44858152	15	44565954	560924	552181
NM_025137.3(SPG11):c.3818A>G (p.Lys1273Arg)	SPG11	Spastic paraplegia 11, autosomal recessive|Hereditary spastic paraplegia|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	15	44890903	15	44598705	130365	135812
NM_025137.3(SPG11):c.1388T>C (p.Phe463Ser)	SPG11	Spastic paraplegia 11, autosomal recessive|not specified|Spastic Paraplegia, Recessive	Benign(Last reviewed: Apr 13, 2017)	criteria provided, multiple submitters, no conflicts	15	44943757	15	44651559	41271	49695
NM_025137.3(SPG11):c.1348A>G (p.Ile450Val)	SPG11	Spastic paraplegia 11, autosomal recessive|not specified|Spastic Paraplegia, Recessive	Benign/Likely benign(Last reviewed: May 15, 2017)	criteria provided, multiple submitters, no conflicts	15	44943797	15	44651599	130364	135811
NM_014080.4(DUOX2):c.1462G>A (p.Gly488Arg)	DUOX2	Thyroid dyshormonogenesis 6|Congenital hypothyroidism|Nongoitrous Euthyroid Hyperthyrotropinemia	Pathogenic/Likely pathogenic(Last reviewed: Apr 14, 2017)	criteria provided, multiple submitters, no conflicts	15	45400357	15	45108159	225342	227368
NM_001482.2(GATM):c.330A>T (p.Gln110His)	GATM	Arginine:glycine amidinotransferase deficiency|not specified|not provided|History of neurodevelopmental disorder	Benign(Last reviewed: Apr 20, 2017)	criteria provided, multiple submitters, no conflicts	15	45661678	15	45369480	129138	134584
NM_000338.2(SLC12A1):c.[1522G>A];[735C>G]	SLC12A1	Bartter syndrome, type 1, antenatal	Pathogenic(Last reviewed: Aug 19, 2014)	criteria provided, single submitter	15|15	48539175	15|15	48246978	424798	213636|213635
NM_014985.3(CEP152):c.4939G>T (p.Asp1647Tyr)	CEP152	Primary autosomal recessive microcephaly 9	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	15	49030472	15	48738275	158271	169124
NM_014985.3(CEP152):c.4732C>T (p.Arg1578Cys)	CEP152	Primary autosomal recessive microcephaly 9	Uncertain significance(Last reviewed: Apr 2, 2014)	criteria provided, single submitter	15	49030679	15	48738482	158268	169127
NM_014985.3(CEP152):c.4457T>A (p.Met1486Lys)	CEP152	Primary autosomal recessive microcephaly 9	Uncertain significance(Last reviewed: May 19, 2014)	criteria provided, single submitter	15	49030954	15	48738757	158265	169130
NM_014985.3(CEP152):c.4357A>G (p.Arg1453Gly)	CEP152	Primary autosomal recessive microcephaly 9	Uncertain significance(Last reviewed: Jul 24, 2014)	criteria provided, single submitter	15	49031054	15	48738857	158264	169131
NM_014985.3(CEP152):c.3712G>A (p.Glu1238Lys)	CEP152	Primary autosomal recessive microcephaly 9	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	15	49034253	15	48742056	158259	169136
NM_014985.3(CEP152):c.3613G>A (p.Gly1205Arg)	CEP152	Primary autosomal recessive microcephaly 9	Uncertain significance(Last reviewed: Dec 28, 2012)	criteria provided, single submitter	15	49036491	15	48744294	158258	169137
NM_014985.3(CEP152):c.3355G>A (p.Ala1119Thr)	CEP152	Primary autosomal recessive microcephaly 9	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	15	49044657	15	48752460	158255	169139
NM_014985.3(CEP152):c.3317T>C (p.Val1106Ala)	CEP152	Seckel syndrome|not specified|Primary Microcephaly, Recessive	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	49048128	15	48755931	158254	169140
NM_014985.3(CEP152):c.3313C>G (p.Leu1105Val)	CEP152	Seckel syndrome|not specified|not provided|Primary Microcephaly, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Feb 28, 2018)	criteria provided, conflicting interpretations	15	49048132	15	48755935	158253	169141
NM_014985.3(CEP152):c.3278G>A (p.Cys1093Tyr)	CEP152	Seckel syndrome|not specified|not provided|Primary Microcephaly, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Feb 20, 2017)	criteria provided, conflicting interpretations	15	49048167	15	48755970	158252	169142
NM_014985.3(CEP152):c.3085A>G (p.Met1029Val)	CEP152	Primary autosomal recessive microcephaly 9	Uncertain significance(Last reviewed: Jan 28, 2014)	criteria provided, single submitter	15	49048360	15	48756163	158251	169143
NM_014985.3(CEP152):c.3014A>T (p.Lys1005Ile)	CEP152	Primary autosomal recessive microcephaly 9	Uncertain significance(Last reviewed: Oct 14, 2013)	criteria provided, single submitter	15	49048431	15	48756234	158249	169145
NM_014985.3(CEP152):c.2878T>C (p.Trp960Arg)	CEP152	Seckel syndrome 5|not specified|Primary autosomal recessive microcephaly 9|not provided	Uncertain significance(Last reviewed: May 23, 2017)	criteria provided, multiple submitters, no conflicts	15	49048567	15	48756370	95651	101548
NM_014985.3(CEP152):c.2827G>A (p.Glu943Lys)	CEP152	Primary autosomal recessive microcephaly 9	Uncertain significance(Last reviewed: Dec 12, 2013)	criteria provided, single submitter	15	49048618	15	48756421	158247	169147
NM_014985.3(CEP152):c.2777A>T (p.Glu926Val)	CEP152	Seckel syndrome|Seckel syndrome 5|Primary autosomal recessive microcephaly 9|Primary Microcephaly, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	49048668	15	48756471	158246	169148
NM_014985.3(CEP152):c.2740C>G (p.Leu914Val)	CEP152	Seckel syndrome|not specified|Primary Microcephaly, Recessive	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	49048705	15	48756508	136723	140426
NM_014985.3(CEP152):c.2681C>T (p.Ser894Phe)	CEP152	Seckel syndrome|not specified|Primary autosomal recessive microcephaly 9|Primary Microcephaly, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	15	49052345	15	48760148	158245	169149
NM_014985.3(CEP152):c.2378G>T (p.Ser793Ile)	CEP152	Seckel syndrome|not specified|Primary Microcephaly, Recessive	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	49054772	15	48762575	136722	140425
NM_014985.3(CEP152):c.2362A>G (p.Thr788Ala)	CEP152	Primary autosomal recessive microcephaly 9	Uncertain significance(Last reviewed: Feb 15, 2013)	criteria provided, single submitter	15	49054788	15	48762591	158243	169151
NM_014985.3(CEP152):c.2068C>T (p.Arg690Cys)	CEP152	Primary autosomal recessive microcephaly 9	Uncertain significance(Last reviewed: Mar 18, 2014)	criteria provided, single submitter	15	49059611	15	48767414	158241	169153
NM_014985.3(CEP152):c.1769G>A (p.Ser590Asn)	CEP152	Primary autosomal recessive microcephaly 9	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	15	49064697	15	48772500	158232	169161
NM_014985.3(CEP152):c.1768A>G (p.Ser590Gly)	CEP152	Primary autosomal recessive microcephaly 9	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	15	49064698	15	48772501	158231	169162
NM_014985.3(CEP152):c.1565C>G (p.Ser522Cys)	CEP152	Primary autosomal recessive microcephaly 9	Uncertain significance(Last reviewed: Jan 10, 2013)	criteria provided, single submitter	15	49073405	15	48781208	158228	169165
NM_014985.3(CEP152):c.1516A>G (p.Thr506Ala)	CEP152	Primary autosomal recessive microcephaly 9	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	15	49073454	15	48781257	158227	169166
NM_014985.3(CEP152):c.1180A>G (p.Ile394Val)	CEP152	Seckel syndrome|not specified|Primary autosomal recessive microcephaly 9|not provided|Primary Microcephaly, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Jun 15, 2018)	criteria provided, conflicting interpretations	15	49076311	15	48784114	158224	169168
NM_014985.3(CEP152):c.794A>C (p.Gln265Pro)	CEP152	Primary autosomal recessive microcephaly 9|not provided	Likely pathogenic(Last reviewed: Feb 10, 2016)	criteria provided, multiple submitters, no conflicts	15	49085556	15	48793359	55	15094
NM_014985.3(CEP152):c.161C>T (p.Ser54Leu)	CEP152	Seckel syndrome|not specified|Primary Microcephaly, Recessive	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	49090175	15	48797978	136719	140422
NM_014985.3(CEP152):c.133G>A (p.Asp45Asn)	CEP152	Primary autosomal recessive microcephaly 9	Uncertain significance(Last reviewed: Nov 13, 2013)	criteria provided, single submitter	15	49090203	15	48798006	158226	169176
NM_007347.4(AP4E1):c.257A>G (p.Tyr86Cys)	AP4E1	not provided	Uncertain significance(Last reviewed: Feb 18, 2014)	criteria provided, single submitter	15	51207679	15	50915482	128397	133846
NM_007347.4(AP4E1):c.487T>C (p.Cys163Arg)	AP4E1	Spastic paraplegia 51, autosomal recessive|not specified	Benign(Last reviewed: May 31, 2017)	criteria provided, multiple submitters, no conflicts	15	51217361	15	50925164	128401	133850
NM_007347.4(AP4E1):c.613C>A (p.His205Asn)	AP4E1	not provided|Spastic paraplegia	Uncertain significance(Last reviewed: Apr 26, 2018)	criteria provided, multiple submitters, no conflicts	15	51221276	15	50929079	128402	133851
NM_007347.4(AP4E1):c.1085A>G (p.Tyr362Cys)	AP4E1	not specified|Spastic paraplegia	Benign(Last reviewed: Oct 2, 2017)	criteria provided, multiple submitters, no conflicts	15	51233881	15	50941684	128392	133841
NM_007347.4(AP4E1):c.1283A>G (p.Asn428Ser)	AP4E1	not specified|not provided|Spastic paraplegia	Benign/Likely benign(Last reviewed: Nov 10, 2017)	criteria provided, multiple submitters, no conflicts	15	51240323	15	50948126	128393	133842
NM_007347.4(AP4E1):c.2429C>T (p.Thr810Ile)	AP4E1	not specified	Benign(Last reviewed: Jul 15, 2016)	criteria provided, multiple submitters, no conflicts	15	51289605	15	50997408	128395	133844
NM_007347.4(AP4E1):c.2495C>T (p.Ser832Leu)	AP4E1	not provided|Spastic paraplegia	Uncertain significance(Last reviewed: May 31, 2016)	criteria provided, multiple submitters, no conflicts	15	51289671	15	50997474	128396	133845
NM_000259.3(MYO5A):c.4200C>G (p.Ser1400Arg)	MYO5A	Dystonia|Global developmental delay|Seizures|Nystagmus|Global developmental delay|Dystonia|Cerebellar cortical atrophy	Pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	15	52632432	15	52340235	242881	243993
NM_004855.4(PIGB):c.1220A>G (p.His407Arg)	PIGB	Hyperphosphatasia with mental retardation syndrome 1	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	15	55642993	15	55350795	561082	552184
NM_207036.1(TCF12):c.1720A>C (p.Lys574Gln)	TCF12	Craniosynostosis 3	Uncertain significance(Last reviewed: Mar 13, 2014)	no assertion criteria provided	15	57555447	15	57263249	374376	361215
NM_139242.3(MTFMT):c.626C>T (p.Ser209Leu)	MTFMT	Leigh syndrome|Short stature|Combined oxidative phosphorylation deficiency 15|not provided|Abnormal facial shape|Poor speech|Cytochrome C oxidase-negative muscle fibers|Inability to walk by childhood/adolescence|Decreased activity of mitochondrial complex I|MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, multiple submitters, no conflicts	15	65313871	15	65021533	39827	48426
NM_139242.3(MTFMT):c.374C>T (p.Ser125Leu)	MTFMT	Combined oxidative phosphorylation deficiency 15	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	15	65319214	15	65026876	39829	48428
NM_017882.2(CLN6):c.775G>C (p.Gly259Arg)	CLN6	Ceroid lipofuscinosis neuronal 6	Uncertain significance	criteria provided, single submitter	15	68500639	15	68208301	219176	217194
NM_017882.2(CLN6):c.601A>G (p.Lys201Glu)	CLN6	Ceroid lipofuscinosis neuronal 6|not specified|not provided	Uncertain significance(Last reviewed: Jun 23, 2017)	criteria provided, multiple submitters, no conflicts	15	68502039	15	68209701	128787	134236
NM_017882.2(CLN6):c.407G>A (p.Arg136His)	CLN6	not specified|Abnormality of brain morphology	Conflicting interpretations of pathogenicity(Last reviewed: Oct 29, 2015)	criteria provided, conflicting interpretations	15	68504092	15	68211754	402184	389162
NM_004856.6(KIF23):c.755T>A (p.Leu252His)	KIF23	Microcephaly	Likely pathogenic	criteria provided, single submitter	15	69718429	15	69426090	402143	389163
NM_000520.5(HEXA):c.1510C>T (p.Arg504Cys)	HEXA	Tay-Sachs disease|Gm2-gangliosidosis, chronic	Likely pathogenic(Last reviewed: Apr 18, 2014)	criteria provided, single submitter	15	72637803	15	72345462	3906	18945
NM_000520.5(HEXA):c.1495C>T (p.Arg499Cys)	HEXA	Tay-Sachs disease|Gm2-gangliosidosis, adult-onset	Pathogenic/Likely pathogenic(Last reviewed: Sep 29, 2016)	criteria provided, multiple submitters, no conflicts	15	72637818	15	72345477	3915	18954
NM_000520.5(HEXA):c.1435G>A (p.Ala479Thr)	HEXA	Tay-Sachs disease|not specified	Benign/Likely benign(Last reviewed: Aug 31, 2017)	criteria provided, multiple submitters, no conflicts	15	72637878	15	72345537	287080	271317
NM_000520.5(HEXA):c.1432G>A (p.Gly478Arg)	HEXA	Tay-Sachs disease	Pathogenic(Last reviewed: Mar 22, 2011)	no assertion criteria provided	15	72637881	15	72345540	375364	362116
NM_000520.5(HEXA):c.1397A>G (p.Asn466Ser)	HEXA	Tay-Sachs disease|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 31, 2017)	criteria provided, conflicting interpretations	15	72638600	15	72346259	93190	99097
NM_000520.5(HEXA):c.1385A>T (p.Glu462Val)	HEXA	Tay-Sachs disease	Pathogenic(Last reviewed: Oct 1, 2011)	criteria provided, single submitter	15	72638612	15	72346271	218134	214781
NM_000520.5(HEXA):c.1360G>C (p.Gly454Arg)	HEXA	Tay-Sachs disease	Likely pathogenic(Last reviewed: Sep 30, 2015)	no assertion criteria provided	15	72638637	15	72346296	375363	362117
NM_000520.5(HEXA):c.1306A>G (p.Ile436Val)	HEXA	Tay-Sachs disease|not specified|not provided	Benign(Last reviewed: Sep 22, 2017)	criteria provided, multiple submitters, no conflicts	15	72638892	15	72346551	93189	99096
NM_000520.5(HEXA):c.1178G>C (p.Arg393Pro)	HEXA	Tay-Sachs disease	Pathogenic(Last reviewed: Oct 2, 2011)	criteria provided, single submitter	15	72639020	15	72346679	218337	215045
NM_000520.5(HEXA):c.1121A>C (p.Gln374Pro)	HEXA	Tay-Sachs disease	Pathogenic(Last reviewed: Feb 15, 2015)	no assertion criteria provided	15	72640052	15	72347711	375360	362120
NM_000520.5(HEXA):c.964G>T (p.Asp322Tyr)	HEXA	Tay-Sachs disease	Pathogenic/Likely pathogenic(Last reviewed: Nov 2, 2016)	criteria provided, multiple submitters, no conflicts	15	72641442	15	72349101	221281	222993
NM_000520.5(HEXA):c.964G>A (p.Asp322Asn)	HEXA	Tay-Sachs disease	Pathogenic(Last reviewed: Oct 2, 2011)	criteria provided, single submitter	15	72641442	15	72349101	221280	222992
NM_000520.5(HEXA):c.805G>C (p.Gly269Arg)	HEXA	Tay-Sachs disease	Pathogenic(Last reviewed: Dec 18, 2012)	no assertion criteria provided	15	72642859	15	72350518	375357	362123
NM_000520.5(HEXA):c.788C>T (p.Thr263Ile)	HEXA	Tay-Sachs disease	Likely pathogenic(Last reviewed: Mar 14, 2011)	no assertion criteria provided	15	72642876	15	72350535	375356	362124
NM_000520.5(HEXA):c.637T>C (p.Tyr213His)	HEXA	Tay-Sachs disease	Likely pathogenic(Last reviewed: Nov 17, 2014)	no assertion criteria provided	15	72643509	15	72351168	375355	362125
NM_000520.5(HEXA):c.616G>C (p.Val206Leu)	HEXA	Tay-Sachs disease	Likely pathogenic(Last reviewed: Nov 14, 2014)	no assertion criteria provided	15	72643530	15	72351189	375354	362126
NM_000520.5(HEXA):c.533G>A (p.Arg178His)	HEXA	Tay-Sachs disease|Tay-Sachs disease, B1 variant|Tay-sachs disease, b1 variant|Hexa, dn allele|not provided	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, multiple submitters, no conflicts	15	72645446	15	72353105	3896	18935
NM_000520.5(HEXA):c.532C>T (p.Arg178Cys)	HEXA	Tay-Sachs disease|Tay-Sachs disease, B1 variant|Tay-sachs disease, b1 variant|HEXA, Czechoslovakian allele	Pathogenic(Last reviewed: Aug 23, 2012)	no assertion criteria provided	15	72645447	15	72353106	3897	18936
NM_000520.5(HEXA):c.524A>C (p.Asp175Ala)	HEXA	Tay-Sachs disease	Pathogenic(Last reviewed: Sep 1, 2012)	no assertion criteria provided	15	72645455	15	72353114	375353	362127
NM_000520.5(HEXA):c.509G>A (p.Arg170Gln)	HEXA	Tay-Sachs disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 8, 2017)	criteria provided, multiple submitters, no conflicts	15	72645470	15	72353129	3900	18939
NM_000520.5(HEXA):c.508C>T (p.Arg170Trp)	HEXA	Tay-Sachs disease	Likely pathogenic(Last reviewed: Jan 5, 2016)	criteria provided, single submitter	15	72645471	15	72353130	3925	18964
NM_000520.5(HEXA):c.340G>A (p.Glu114Lys)	HEXA	Tay-Sachs disease	Pathogenic(Last reviewed: Apr 7, 2011)	criteria provided, single submitter	15	72648872	15	72356531	218335	215043
NM_000520.5(HEXA):c.8G>C (p.Ser3Thr)	HEXA	Tay-Sachs disease|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 9, 2017)	criteria provided, conflicting interpretations	15	72668306	15	72375965	438810	432441
NM_000520.5(HEXA):c.2T>C (p.Met1Thr)	HEXA	Tay-Sachs disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, multiple submitters, no conflicts	15	72668312	15	72375971	189126	186940
NM_022369.3(STRA6):c.1913G>C (p.Arg638Pro)	STRA6	Anophthalmia - microphthalmia	Pathogenic(Last reviewed: Jan 1, 2013)	criteria provided, single submitter	15	74472512	15	74180171	221967	223647
NM_022369.3(STRA6):c.1735C>G (p.Pro579Ala)	STRA6	Anophthalmia - microphthalmia	Pathogenic(Last reviewed: Jan 1, 2013)	criteria provided, single submitter	15	74473228	15	74180887	221927	223648
NM_022369.3(STRA6):c.1313A>G (p.Gln438Arg)	STRA6	Anophthalmia - microphthalmia	Pathogenic(Last reviewed: Jan 1, 2013)	criteria provided, single submitter	15	74474789	15	74182448	221966	223649
NM_000781.2(CYP11A1):c.968T>A (p.Met323Lys)	CYP11A1	Adrenal insufficiency, congenital, with 46,XY sex reversal, partial or complete	Likely pathogenic(Last reviewed: Apr 6, 2016)	criteria provided, single submitter	15	74635340	15	74342999	280943	265180
NM_000781.2(CYP11A1):c.937T>C (p.Phe313Leu)	CYP11A1	Adrenal insufficiency, congenital, with 46,XY sex reversal, partial or complete	Uncertain significance(Last reviewed: Mar 29, 2017)	criteria provided, single submitter	15	74635371	15	74343030	403725	390702
NM_006441.3(MTHFS):c.434G>A (p.Arg145Gln)	MTHFS|ST20-MTHFS	MTHFS-related condition	Uncertain significance(Last reviewed: Feb 24, 2016)	criteria provided, single submitter	15	80137730	15	79845388	522831	513454
NM_000137.2(FAH):c.1009G>A (p.Gly337Ser)	FAH	Tyrosinemia type I	Pathogenic/Likely pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, multiple submitters, no conflicts	15	80472514	15	80180172	11869	26908
NM_024580.5(EFL1):c.379A>G (p.Thr127Ala)	EFL1	Shwachman-Diamond-like syndrome	Likely pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	15	82532896	15	82240555	522819	513455
NM_014630.2(ZNF592):c.2777G>A (p.Ser926Asn)	ZNF592	Galloway-Mowat syndrome 1|not specified	Benign/Likely benign	no assertion criteria provided	15	85341859	15	84798628	130840	136284
NM_002693.2(POLG):c.3708G>T (p.Gln1236His)	POLG|FANCI	Fanconi anemia|Mitochondrial diseases|not specified|Seizures|not provided|POLG-Related Spectrum Disorders	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	89859994	15	89316763	21316	34168
NM_002693.2(POLG):c.3428A>G (p.Glu1143Gly)	POLG|FANCI	Progressive sclerosing poliodystrophy|Fanconi anemia|Mitochondrial DNA depletion syndrome 1 (MNGIE type)|Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 1|Cerebellar ataxia infantile with progressive external ophthalmoplegia|Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Mitochondrial diseases|Mitochondrial DNA depletion syndrome 4B, MNGIE type|not specified|Seizures|not provided	Benign/Likely benign(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	15	89861826	15	89318595	21312	34164
NM_002693.2(POLG):c.3293A>C (p.Asn1098Thr)	POLG	not provided	Uncertain significance(Last reviewed: Feb 18, 2014)	criteria provided, single submitter	15	89861961	15	89318730	129995	135441
NM_002693.2(POLG):c.3218C>T (p.Pro1073Leu)	POLG	Progressive sclerosing poliodystrophy|Mitochondrial DNA depletion syndrome 4B, MNGIE type|not provided	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	15	89862217	15	89318986	13516	28555
NM_002693.2(POLG):c.3131T>C (p.Val1044Ala)	POLG	Progressive sclerosing poliodystrophy|Mitochondrial DNA depletion syndrome 1 (MNGIE type)|Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 1|Cerebellar ataxia infantile with progressive external ophthalmoplegia|Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Mitochondrial DNA depletion syndrome 4B, MNGIE type|not specified|Seizures|EEG abnormality|not provided|EEG abnormality	Uncertain significance(Last reviewed: Sep 4, 2018)	criteria provided, multiple submitters, no conflicts	15	89862304	15	89319073	129994	135440
NM_002693.2(POLG):c.2209G>C (p.Gly737Arg)	POLG	Progressive sclerosing poliodystrophy|Cerebellar ataxia infantile with progressive external ophthalmoplegia|Mitochondrial diseases|Mitochondrial DNA depletion syndrome 4B, MNGIE type|Seizures|not provided|POLG-Related Spectrum Disorders|Maternally-inherited progressive external ophthalmoplegia	Conflicting interpretations of pathogenicity(Last reviewed: Jul 13, 2018)	criteria provided, conflicting interpretations	15	89866691	15	89323460	13513	28552
NM_002693.2(POLG):c.1760C>T (p.Pro587Leu)	POLG	Progressive sclerosing poliodystrophy|Mitochondrial DNA depletion syndrome 1 (MNGIE type)|Cerebellar ataxia infantile with progressive external ophthalmoplegia|Mitochondrial diseases|Mitochondrial DNA depletion syndrome 4B, MNGIE type|not specified|Global developmental delay|Seizures|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 14, 2018)	criteria provided, conflicting interpretations	15	89868870	15	89325639	13505	28544
NM_002693.2(POLG):c.1399G>A (p.Ala467Thr)	POLG	Progressive sclerosing poliodystrophy|Mitochondrial DNA depletion syndrome 1 (MNGIE type)|Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 1|Cerebellar ataxia infantile with progressive external ophthalmoplegia|Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Myoclonic epilepsy myopathy sensory ataxia|Mitochondrial diseases|Mitochondrial DNA depletion syndrome 4B, MNGIE type|Seizures|not provided|POLG-Related Spectrum Disorders|POLG- Related Disorders|POLG-related condition	Pathogenic/Likely pathogenic(Last reviewed: Jun 27, 2018)	criteria provided, multiple submitters, no conflicts	15	89870432	15	89327201	13496	28535
NM_002693.2(POLG):c.1235C>T (p.Pro412Leu)	POLG	not provided	Uncertain significance(Last reviewed: Oct 30, 2013)	criteria provided, single submitter	15	89871702	15	89328471	129988	135434
NM_002693.2(POLG):c.[2693T>C];[924G>T]	POLG	Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis	Likely pathogenic(Last reviewed: Aug 8, 2016)	criteria provided, single submitter	15|15	89872273	15|15	89329042	427833	263529|263528
NM_002693.2(POLG):c.911T>G (p.Leu304Arg)	POLG	Progressive sclerosing poliodystrophy|Cerebellar ataxia infantile with progressive external ophthalmoplegia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, multiple submitters, no conflicts	15	89872286	15	89329055	13497	28536
NM_002693.2(POLG):c.830A>T (p.His277Leu)	POLG	Progressive sclerosing poliodystrophy|not specified|not provided|Mitochondrial DNA depletion syndrome|Mitochondrial DNA depletion syndrome|POLG-Related Spectrum Disorders	Conflicting interpretations of pathogenicity(Last reviewed: Mar 2, 2018)	criteria provided, conflicting interpretations	15	89873337	15	89330106	206583	203034
NM_002693.2(POLG):c.752C>T (p.Thr251Ile)	POLG	Progressive sclerosing poliodystrophy|Mitochondrial DNA depletion syndrome 1 (MNGIE type)|Cerebellar ataxia infantile with progressive external ophthalmoplegia|Mitochondrial DNA depletion syndrome 4B, MNGIE type|not specified|Global developmental delay|Seizures|not provided|POLG-Related Spectrum Disorders	Conflicting interpretations of pathogenicity(Last reviewed: May 14, 2018)	criteria provided, conflicting interpretations	15	89873415	15	89330184	13503	28542
NM_002693.2(POLG):c.128A>G (p.Gln43Arg)	POLG	Progressive sclerosing poliodystrophy|not specified|Seizures|not provided	Benign(Last reviewed: Jan 4, 2018)	criteria provided, multiple submitters, no conflicts	15	89876858	15	89333627	129989	135435
NM_002693.2(POLG):c.[2554C>T];[32G>A]	POLG	Cerebellar ataxia infantile with progressive external ophthalmoplegia|Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis	Likely pathogenic(Last reviewed: Mar 18, 2014)	criteria provided, single submitter	15|15	89876954	15|15	89333723	424791	192343|202960
NM_198525.2(KIF7):c.3345C>G (p.His1115Gln)	KIF7	Acrocallosal syndrome, Schinzel type|Hydrolethalus syndrome 2|not specified	Benign/Likely benign(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	15	90172778	15	89629547	129415	134861
NM_198525.2(KIF7):c.3013G>A (p.Gly1005Arg)	KIF7	Acrocallosal syndrome, Schinzel type|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	90174824	15	89631593	96653	102546
NM_198525.2(KIF7):c.2873G>T (p.Ser958Ile)	KIF7	Acrocallosal syndrome, Schinzel type|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	90176073	15	89632842	96651	102544
NM_198525.2(KIF7):c.1895C>T (p.Pro632Leu)	KIF7	Acrocallosal syndrome, Schinzel type|not specified|not provided	Benign/Likely benign(Last reviewed: Nov 15, 2017)	criteria provided, multiple submitters, no conflicts	15	90189151	15	89645920	129407	134853
NM_198525.2(KIF7):c.1220C>A (p.Ala407Asp)	KIF7	Acrocallosal syndrome, Schinzel type|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 8, 2017)	criteria provided, conflicting interpretations	15	90191709	15	89648478	129404	134850
NM_198525.2(KIF7):c.1159C>A (p.Arg387Ser)	KIF7	not specified	Benign(Last reviewed: Sep 4, 2013)	criteria provided, single submitter	15	90191770	15	89648539	129403	134849
NM_198525.2(KIF7):c.1102A>G (p.Thr368Ala)	KIF7	Acrocallosal syndrome, Schinzel type|not specified	Benign(Last reviewed: Mar 29, 2018)	criteria provided, multiple submitters, no conflicts	15	90191827	15	89648596	96649	102542
NM_198525.2(KIF7):c.1013A>G (p.Asn338Ser)	KIF7	not provided	Uncertain significance(Last reviewed: May 15, 2013)	criteria provided, single submitter	15	90191916	15	89648685	129402	134848
NM_198525.2(KIF7):c.154G>A (p.Asp52Asn)	KIF7	Acrocallosal syndrome, Schinzel type|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	90196008	15	89652777	129406	134852
NM_198525.2(KIF7):c.49C>T (p.Arg17Trp)	KIF7	Acrocallosal syndrome, Schinzel type|not specified	Benign/Likely benign(Last reviewed: Jun 1, 2017)	criteria provided, multiple submitters, no conflicts	15	90196113	15	89652882	129418	134864
NM_000057.3(BLM):c.11T>C (p.Val4Ala)	BLM	Bloom syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 1, 2018)	criteria provided, conflicting interpretations	15	91290633	15	90747403	127473	132930
NM_000057.3(BLM):c.1928G>A (p.Arg643His)	BLM	Bloom syndrome|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 11, 2018)	criteria provided, conflicting interpretations	15	91306241	15	90763011	127480	132937
NM_000057.3(BLM):c.2015A>G (p.Gln672Arg)	BLM	Bloom syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Apr 30, 2018)	criteria provided, conflicting interpretations	15	91306328	15	90763098	188963	186948
NM_000057.3(BLM):c.2603C>T (p.Pro868Leu)	BLM	Bloom syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Aug 31, 2016)	criteria provided, multiple submitters, no conflicts	15	91326099	15	90782869	92393	98304
NM_000057.3(BLM):c.3961G>A (p.Val1321Ile)	BLM	Bloom syndrome|not specified|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Aug 12, 2016)	criteria provided, multiple submitters, no conflicts	15	91354521	15	90811291	128530	133979
NM_000057.3(BLM):c.4140T>G (p.Ser1380Arg)	BLM	Bloom syndrome	Uncertain significance(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	15	91358395	15	90815165	374316	361218
NM_001040616.2(LINS1):c.2236A>G (p.Ile746Val)	LINS1	not provided	Uncertain significance(Last reviewed: Mar 18, 2014)	criteria provided, single submitter	15	101109481	15	100569276	129485	134931
NM_001040616.2(LINS1):c.937G>A (p.Glu313Lys)	LINS1	Mental retardation, autosomal recessive 27	Likely pathogenic(Last reviewed: Feb 29, 2016)	no assertion criteria provided	15	101114141	15	100573936	374936	361846
NM_021098.2(CACNA1H):c.2051C>A (p.Pro684His)	CACNA1H	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	16	1254058	16	1204058	402204	389164
NM_021098.2(CACNA1H):c.6898A>G (p.Ile2300Val)	CACNA1H	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	16	1270830	16	1220830	402205	389165
NM_001114331.2(CLCN7):c.1610G>A (p.Arg537Gln)	CLCN7	Osteopetrosis autosomal recessive 4	Likely pathogenic(Last reviewed: Jan 17, 2017)	criteria provided, single submitter	16	1499082	16	1449081	488379	481239
NM_001287.5(CLCN7):c.1165G>A (p.Gly389Arg)	CLCN7	Osteopetrosis autosomal recessive 4	Uncertain significance(Last reviewed: Dec 19, 2017)	no assertion criteria provided	16	1503884	16	1453883	545690	536182
NM_001287.5(CLCN7):c.641A>G (p.Asn214Ser)	CLCN7	Osteopetrosis autosomal recessive 4	Uncertain significance(Last reviewed: Dec 19, 2017)	no assertion criteria provided	16	1509142	16	1459141	545513	536017
NM_014714.3(IFT140):c.3209C>T (p.Ala1070Val)	IFT140	Renal dysplasia, retinal pigmentary dystrophy, cerebellar ataxia and skeletal dysplasia|not specified	Benign(Last reviewed: Oct 26, 2017)	criteria provided, multiple submitters, no conflicts	16	1573890	16	1523889	129261	134707
NM_014714.3(IFT140):c.2177C>T (p.Pro726Leu)	IFT140	Renal dysplasia, retinal pigmentary dystrophy, cerebellar ataxia and skeletal dysplasia|Cranioectodermal dysplasia	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	16	1612008	16	1562007	523181	513809
NM_014714.3(IFT140):c.1565G>A (p.Gly522Glu)	IFT140	Renal dysplasia, retinal pigmentary dystrophy, cerebellar ataxia and skeletal dysplasia|Short-rib thoracic dysplasia without polydactyly	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	16	1621495	16	1571494	97054	102956
NM_014714.3(IFT140):c.1319T>C (p.Leu440Pro)	IFT140|LOC105371046	Renal dysplasia, retinal pigmentary dystrophy, cerebellar ataxia and skeletal dysplasia	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	16	1634258	16	1584257	523184	513810
NM_014714.3(IFT140):c.1192G>A (p.Val398Ile)	IFT140|LOC105371046	Renal dysplasia, retinal pigmentary dystrophy, cerebellar ataxia and skeletal dysplasia|not specified	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	16	1634385	16	1584384	129257	134703
NM_014714.3(IFT140):c.874G>A (p.Val292Met)	IFT140|LOC105371046	Jeune thoracic dystrophy|Renal dysplasia, retinal pigmentary dystrophy, cerebellar ataxia and skeletal dysplasia|Joubert syndrome with Jeune asphyxiating thoracic dystrophy	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	16	1637962	16	1587961	97053	102955
NM_014714.3(IFT140):c.836G>C (p.Arg279Pro)	IFT140|LOC105371046	Renal dysplasia, retinal pigmentary dystrophy, cerebellar ataxia and skeletal dysplasia|not specified	Benign/Likely benign(Last reviewed: May 17, 2017)	criteria provided, multiple submitters, no conflicts	16	1638000	16	1587999	129262	134708
NM_014714.3(IFT140):c.634G>A (p.Gly212Arg)	IFT140|LOC105371046	Jeune thoracic dystrophy|Renal dysplasia, retinal pigmentary dystrophy, cerebellar ataxia and skeletal dysplasia|not provided|Retinal ciliopathy due to mutation in the retinitis pigmentosa-1 gene	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, multiple submitters, no conflicts	16	1642177	16	1592176	31683	40345
NM_014714.3(IFT140):c.454C>T (p.Leu152Phe)	IFT140|LOC105371046	Renal dysplasia, retinal pigmentary dystrophy, cerebellar ataxia and skeletal dysplasia	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	16	1642505	16	1592504	523179	513811
NM_023936.1(MRPS34):c.37G>A (p.Glu13Lys)	MRPS34	Leigh syndrome|COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32	Likely pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, single submitter	16	1823084	16	1773083	430585	423091
NM_005262.2(GFER):c.581G>A (p.Arg194His)	GFER	Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	16	2035992	16	1985991	8691	23730
NM_001089.2(ABCA3):c.128G>A (p.Arg43His)	ABCA3	Primary interstitial lung disease specific to childhood due to pulmonary surfactant protein anomalies	Pathogenic(Last reviewed: Feb 26, 2015)	criteria provided, single submitter	16	2376202	16	2326201	228321	230630
NM_001199107.1(TBC1D24):c.58C>G (p.Gln20Glu)	TBC1D24	Digitorenocerebral syndrome	Pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	16	2546207	16	2496206	91397	96873
NM_001199107.1(TBC1D24):c.118C>T (p.Arg40Cys)	TBC1D24	Digitorenocerebral syndrome	Pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	16	2546267	16	2496266	91396	96872
NM_001199107.1(TBC1D24):c.119G>T (p.Arg40Leu)	TBC1D24	Digitorenocerebral syndrome	Pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	16	2546268	16	2496267	183152	181288
NM_001199107.1(TBC1D24):c.328G>A (p.Gly110Ser)	TBC1D24	Epileptic encephalopathy, early infantile, 1|Digitorenocerebral syndrome|not provided|Deafness, autosomal dominant 65|Caused by mutation in the TBC1 domain family, member 24	Conflicting interpretations of pathogenicity(Last reviewed: Feb 26, 2018)	criteria provided, conflicting interpretations	16	2546477	16	2496476	183154	181290
NM_001199107.1(TBC1D24):c.404C>T (p.Pro135Leu)	TBC1D24	Parkinsonism|Autosomal dominant epilepsy	Pathogenic(Last reviewed: Jan 10, 2017)	no assertion criteria provided	16	2546553	16	2496552	375708	362597
NM_001199107.1(TBC1D24):c.457G>A (p.Glu153Lys)	TBC1D24	Epileptic encephalopathy, early infantile, 1|not specified|Seizures|Deafness, autosomal dominant 65|Caused by mutation in the TBC1 domain family, member 24|Rare genetic deafness	Conflicting interpretations of pathogenicity(Last reviewed: Nov 13, 2017)	criteria provided, conflicting interpretations	16	2546606	16	2496605	207499	203228
NM_020705.2(TBC1D24):c.641G>A (p.Arg214His)	TBC1D24	Epileptic encephalopathy, early infantile, 1|not specified|Seizures|Deafness, autosomal dominant 65|Caused by mutation in the TBC1 domain family, member 24	Conflicting interpretations of pathogenicity(Last reviewed: Mar 5, 2018)	criteria provided, conflicting interpretations	16	2546790	16	2496789	130540	135986
NM_001199107.1(TBC1D24):c.724C>T (p.Arg242Cys)	TBC1D24	Epileptic encephalopathy, early infantile, 1|Digitorenocerebral syndrome|not provided|Early infantile epileptic encephalopathy 16|Deafness, autosomal dominant 65|Caused by mutation in the TBC1 domain family, member 24	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, multiple submitters, no conflicts	16	2546873	16	2496872	91395	96871
NM_001199107.1(TBC1D24):c.999G>T (p.Leu333Phe)	TBC1D24	Digitorenocerebral syndrome	Pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	16	2548254	16	2498253	183155	181291
NM_020705.2(TBC1D24):c.997A>G (p.Asn333Asp)	TBC1D24	not specified|not provided	Uncertain significance(Last reviewed: Jul 13, 2017)	criteria provided, multiple submitters, no conflicts	16	2548270	16	2498269	130541	135987
NM_001199107.1(TBC1D24):c.1078C>T (p.Arg360Cys)	TBC1D24	Parkinsonism	Pathogenic(Last reviewed: Jan 10, 2017)	no assertion criteria provided	16	2548333	16	2498332	375707	362598
NM_001199107.1(TBC1D24):c.1079G>T (p.Arg360Leu)	TBC1D24	Progressive myoclonus epilepsy with ataxia|Intellectual disability|Periodic paralysis|Neurodevelopmental delay	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	16	2548334	16	2498333	183157	181292
NM_020705.2(TBC1D24):c.[1218G>C];[1270T>C]	TBC1D24	Digitorenocerebral syndrome|Myoclonic epilepsy, familial infantile|Early infantile epileptic encephalopathy 16	Likely pathogenic(Last reviewed: Jun 5, 2012)	criteria provided, single submitter	16|16	2549917	16|16	2499916	424803	213639|213638
NM_000243.2(MEFV):c.2282G>A (p.Arg761His)	MEFV	Familial Mediterranean fever|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, multiple submitters, no conflicts	16	3293205	16	3243205	2549	17588
NM_000243.2(MEFV):c.2230G>T	MEFV	Familial Mediterranean fever|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 20, 2018)	criteria provided, conflicting interpretations	16	3293257	16	3243257	2548	17587
NM_000243.2(MEFV):c.2177T>C (p.Val726Ala)	MEFV	Familial Mediterranean fever|Familial mediterranean fever, autosomal dominant|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, multiple submitters, no conflicts	16	3293310	16	3243310	2540	17579
NM_000243.2(MEFV):c.[2084A>G];[2230G>T]	MEFV	Familial Mediterranean fever	Likely pathogenic(Last reviewed: Aug 20, 2013)	criteria provided, single submitter	16|16	3293403	16|16	3243403	424786	17586|17587
NM_000243.2(MEFV):c.2084A>G	MEFV	Familial Mediterranean fever|Familial mediterranean fever, autosomal dominant|not specified|Syncope|not provided|Peripheral neuropathy|Abnormality of the dentition|Urticaria|Intermittent diarrhea|Cachexia|Inborn genetic diseases|Urticaria|Peripheral neuropathy	Conflicting interpretations of pathogenicity(Last reviewed: Mar 5, 2018)	criteria provided, conflicting interpretations	16	3293403	16	3243403	2547	17586
NM_000243.2(MEFV):c.2082G>A (p.Met694Ile)	MEFV	Familial Mediterranean fever|Familial mediterranean fever, autosomal dominant|not provided	Pathogenic(Last reviewed: Oct 10, 2017)	criteria provided, multiple submitters, no conflicts	16	3293405	16	3243405	2539	17578
NM_000243.2(MEFV):c.2080A>G (p.Met694Val)	MEFV	Cryptorchidism|Familial Mediterranean fever|Brachydactyly|Global developmental delay|Autistic behavior|Seizures|Stereotypy|not provided|Abnormal facial shape|Synophrys|Abnormality of the anterior fontanelle|Microcephaly|Macrocephalus|Impaired use of nonverbal behaviors|Generalized hypotonia|Deep plantar creases|Abnormality of the cerebral white matter|Central hypotonia|Profound global developmental delay	Pathogenic/Likely pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, multiple submitters, no conflicts	16	3293407	16	3243407	2538	17577
NM_000243.2(MEFV):c.2040G>C (p.Met680Ile)	MEFV	Familial Mediterranean fever|Familial mediterranean fever, autosomal dominant|not provided	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, multiple submitters, no conflicts	16	3293447	16	3243447	36507	45169
NM_000243.2(MEFV):c.1772T>C (p.Ile591Thr)	MEFV	Familial Mediterranean fever|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 28, 2018)	criteria provided, conflicting interpretations	16	3293880	16	3243880	36506	45168
NM_000243.2(MEFV):c.910G>A (p.Gly304Arg)	MEFV	Familial Mediterranean fever|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 28, 2017)	criteria provided, conflicting interpretations	16	3304158	16	3254158	36513	45175
NM_000243.2(MEFV):c.611G>A (p.Arg204His)	MEFV	Familial Mediterranean fever	Uncertain significance(Last reviewed: Feb 3, 2016)	criteria provided, single submitter	16	3304457	16	3254457	253024	247431
NM_015041.2(CLUAP1):c.338T>G (p.Met113Arg)	CLUAP1	Joubert syndrome	Likely pathogenic(Last reviewed: Sep 7, 2016)	no assertion criteria provided	16	3558407	16	3508407	254179	248682
NM_032444.3(SLX4):c.3136C>T (p.Arg1046Cys)	SLX4	Fanconi anemia, complementation group P	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	16	3640503	16	3590502	561112	552189
NM_032444.3(SLX4):c.2975G>A (p.Gly992Glu)	SLX4	Fanconi anemia|Fanconi anemia, complementation group P	Conflicting interpretations of pathogenicity(Last reviewed: Dec 22, 2017)	criteria provided, conflicting interpretations	16	3640664	16	3590663	319162	342910
NM_032569.3(GLYR1):c.596C>T (p.Ala199Val)	GLYR1	GLYR1-related condition	Uncertain significance(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	16	4873850	16	4823849	522836	513456
NM_032569.3(GLYR1):c.584G>T (p.Gly195Val)	GLYR1	GLYR1-related condition	Uncertain significance(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	16	4873862	16	4823861	522837	513457
NM_019109.4(ALG1):c.773C>T (p.Ser258Leu)	ALG1	Congenital disorder of glycosylation type 1K|Finnish congenital nephrotic syndrome|Congenital disorder of glycosylation|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, multiple submitters, no conflicts	16	5128790	16	5078789	4724	19763
NM_019109.4(ALG1):c.876C>G (p.Phe292Leu)	ALG1	Congenital disorder of glycosylation type 1K	Likely pathogenic(Last reviewed: Jun 23, 2017)	criteria provided, single submitter	16	5129078	16	5079077	522809	513458
NM_019109.4(ALG1):c.877T>C (p.Ser293Pro)	ALG1	Congenital disorder of glycosylation type 1K	Likely pathogenic(Last reviewed: Jun 23, 2017)	criteria provided, single submitter	16	5129079	16	5079078	522808	513459
NM_000663.4(ABAT):c.275G>A (p.Arg92Gln)	ABAT	Gamma-aminobutyric acid transaminase deficiency	Pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	16	8844355	16	8750498	162036	171753
NM_000663.4(ABAT):c.631C>T (p.Leu211Phe)	ABAT	Gamma-aminobutyric acid transaminase deficiency	Pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	16	8862077	16	8768220	162034	171754
NM_000663.4(ABAT):c.659G>A (p.Arg220Lys)	ABAT	Gamma-aminobutyric acid transaminase deficiency	Pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	16	8862105	16	8768248	16216	31255
NM_000663.4(ABAT):c.1433T>C (p.Leu478Pro)	ABAT	Gamma-aminobutyric acid transaminase deficiency	Pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	16	8875217	16	8781360	162035	171755
NM_000303.2(PMM2):c.1A>G (p.Met1Val)	PMM2	Carbohydrate-deficient glycoprotein syndrome type I	Likely pathogenic(Last reviewed: Sep 12, 2014)	criteria provided, single submitter	16	8891740	16	8797883	188965	186951
NM_000303.2(PMM2):c.26G>A (p.Cys9Tyr)	PMM2	Carbohydrate-deficient glycoprotein syndrome type I	Likely pathogenic(Last reviewed: Aug 27, 2014)	criteria provided, single submitter	16	8891765	16	8797908	7720	22759
NM_000303.2(PMM2):c.95_96delTAinsGC (p.Leu32Arg)	PMM2	Carbohydrate-deficient glycoprotein syndrome type I	Pathogenic/Likely pathogenic(Last reviewed: Jun 26, 2016)	criteria provided, multiple submitters, no conflicts	16	8895684 - 8895685	16	8801827 - 8801828	92807	98714
NM_000303.2(PMM2):c.127G>A (p.Val43Met)	PMM2	Carbohydrate-deficient glycoprotein syndrome type I	Likely pathogenic(Last reviewed: Jul 15, 2017)	criteria provided, single submitter	16	8895716	16	8801859	495321	486815
NM_000303.2(PMM2):c.357C>A (p.Phe119Leu)	PMM2	Carbohydrate-deficient glycoprotein syndrome type I|Congenital disorder of glycosylation|Inborn genetic diseases	Pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, multiple submitters, no conflicts	16	8904945	16	8811088	7711	22750
NM_000303.2(PMM2):c.385G>A (p.Val129Met)	PMM2	Carbohydrate-deficient glycoprotein syndrome type I|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	16	8904973	16	8811116	7708	22747
NM_000303.2(PMM2):c.395T>C (p.Ile132Thr)	PMM2	Carbohydrate-deficient glycoprotein syndrome type I	Likely pathogenic(Last reviewed: Jun 3, 2014)	criteria provided, single submitter	16	8904983	16	8811126	7718	22757
NM_000303.2(PMM2):c.422G>A (p.Arg141His)	PMM2	Carbohydrate-deficient glycoprotein syndrome type I|Congenital disorder of glycosylation|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, multiple submitters, no conflicts	16	8905010	16	8811153	7706	22745
NM_000303.2(PMM2):c.470T>C (p.Phe157Ser)	PMM2	Carbohydrate-deficient glycoprotein syndrome type I|Congenital disorder of glycosylation|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 23, 2018)	criteria provided, multiple submitters, no conflicts	16	8905517	16	8811660	188763	186953
NM_000303.2(PMM2):c.484C>T (p.Arg162Trp)	PMM2	Carbohydrate-deficient glycoprotein syndrome type I|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	16	8905531	16	8811674	7709	22748
NM_000303.2(PMM2):c.620T>C (p.Phe207Ser)	PMM2	Carbohydrate-deficient glycoprotein syndrome type I	Likely pathogenic(Last reviewed: Jan 22, 2015)	criteria provided, single submitter	16	8906944	16	8813087	189141	186954
NM_000303.2(PMM2):c.710C>T (p.Thr237Met)	PMM2	Carbohydrate-deficient glycoprotein syndrome type I|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Jun 23, 2018)	criteria provided, multiple submitters, no conflicts	16	8941651	16	8847794	21145	33997
NM_005236.2(ERCC4):c.2624A>G (p.Glu875Gly)	ERCC4	Xeroderma pigmentosum, group F|Cockayne syndrome|not specified|not provided|Fanconi anemia, complementation group Q|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Jun 7, 2017)	criteria provided, multiple submitters, no conflicts	16	14042077	16	13948220	129008	134454
NM_001143979.1(NDE1):c.572C>T (p.Thr191Ile)	NDE1	not specified|not provided	Benign/Likely benign(Last reviewed: Jun 14, 2017)	criteria provided, multiple submitters, no conflicts	16	15785049	16	15691192	138430	142133
NM_001143979.1(NDE1):c.623C>T (p.Ala208Val)	NDE1	Lissencephaly 4|not specified	Uncertain significance(Last reviewed: Aug 13, 2013)	criteria provided, multiple submitters, no conflicts	16	15785100	16	15691243	159014	169187
NM_001143979.1(NDE1):c.872C>T (p.Ser291Phe)	NDE1	Lissencephaly 4|not specified	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	16	15790642	16	15696785	159020	169192
NM_001143979.1(NDE1):c.956C>T (p.Thr319Met)	MYH11|NDE1	Lissencephaly 4|not specified|Cardiovascular phenotype	Uncertain significance(Last reviewed: Jul 17, 2017)	criteria provided, multiple submitters, no conflicts	16	15818056	16	15724199	159022	169194
NM_001171.5(ABCC6):c.793A>G (p.Arg265Gly)	ABCC6	Pseudoxanthoma elasticum|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 29, 2015)	criteria provided, conflicting interpretations	16	16302586	16	16208729	143120	152838
NM_153603.3(COG7):c.2T>C (p.Met1Thr)	COG7	COG7 congenital disorder of glycosylation	Likely pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, single submitter	16	23464314	16	23452993	548709	539193
NM_001083614.1(EARS2):c.328G>A (p.Gly110Ser)	EARS2	Combined oxidative phosphorylation deficiency 12|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, multiple submitters, no conflicts	16	23555992	16	23544671	39789	48388
NM_001083614.1(EARS2):c.320G>A (p.Arg107His)	EARS2	Combined oxidative phosphorylation deficiency 12|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, multiple submitters, no conflicts	16	23556000	16	23544679	449533	445541
NM_001520.3(GTF3C1):c.4096G>A (p.Glu1366Lys)	GTF3C1	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	16	27492500	16	27481179	402157	389166
NM_001042432.1(CLN3):c.1211A>G (p.His404Arg)	CLN3	not specified|Seizures|not provided|Neuronal Ceroid-Lipofuscinosis, Dominant/Recessive	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	28488943	16	28477622	128776	134225
NM_001042432.1(CLN3):c.1210C>A (p.His404Asn)	CLN3	Neuronal ceroid lipofuscinosis|not specified|Seizures|not provided|Neuronal Ceroid-Lipofuscinosis, Dominant/Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Jan 3, 2018)	criteria provided, conflicting interpretations	16	28488944	16	28477623	128775	134224
NM_001042432.1(CLN3):c.1001G>A (p.Arg334His)	CLN3	Juvenile neuronal ceroid lipofuscinosis|Neuronal ceroid lipofuscinosis	Pathogenic/Likely pathogenic(Last reviewed: Sep 28, 2017)	criteria provided, multiple submitters, no conflicts	16	28493481	16	28482160	56244	70883
NM_001042432.1(CLN3):c.313A>G (p.Ile105Val)	CLN3	Neuronal ceroid lipofuscinosis|not specified|Seizures|Neuronal Ceroid-Lipofuscinosis, Dominant/Recessive	Benign/Likely benign(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	16	28499044	16	28487723	128777	134226
NM_003321.4(TUFM):c.989G>C (p.Arg330Pro)	TUFM	Combined oxidative phosphorylation deficiency 4	Likely pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	16	28855356	16	28844035	488629	481497
NM_005881.3(BCKDK):c.847G>A (p.Ala283Thr)	BCKDK	not specified|Branched-chain keto acid dehydrogenase kinase deficiency|not provided	Uncertain significance(Last reviewed: Mar 16, 2018)	criteria provided, multiple submitters, no conflicts	16	31122622	16	31111301	193684	190847
NM_014321.3(ORC6):c.207T>G (p.Ile69Met)	ORC6	not provided|Meier-Gorlin syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	46726305	16	46692393	129865	135311
NM_015069.4(ZNF423):c.3370G>A (p.Glu1124Lys)	ZNF423	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	16	49669693	16	49635782	402221	389167
NM_015069.4(ZNF423):c.266G>A (p.Arg89His)	ZNF423	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	16	49764693	16	49730782	402222	389168
NM_015272.4(RPGRIP1L):c.3790G>A (p.Asp1264Asn)	RPGRIP1L	Joubert syndrome|Meckel-Gruber syndrome|Nephronophthisis|not specified|not provided	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	53639438	16	53605526	126279	131811
NM_015272.4(RPGRIP1L):c.3548C>G (p.Ala1183Gly)	RPGRIP1L	Joubert syndrome|Meckel-Gruber syndrome|not specified	Benign(Last reviewed: Dec 19, 2017)	criteria provided, multiple submitters, no conflicts	16	53653005	16	53619093	95693	101590
NM_015272.4(RPGRIP1L):c.3428C>G (p.Thr1143Ser)	RPGRIP1L	Joubert syndrome|Meckel-Gruber syndrome|Nephronophthisis|not specified	Benign/Likely benign(Last reviewed: Aug 9, 2018)	criteria provided, multiple submitters, no conflicts	16	53656135	16	53622223	95692	101589
NM_015272.4(RPGRIP1L):c.3073G>A (p.Gly1025Ser)	RPGRIP1L	Joubert syndrome|Meckel-Gruber syndrome|Nephronophthisis|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	53671754	16	53637842	126277	131809
NM_015272.4(RPGRIP1L):c.2231G>A (p.Arg744Gln)	RPGRIP1L	Joubert syndrome|Meckel-Gruber syndrome|Nephronophthisis|not specified	Benign/Likely benign(Last reviewed: Jul 24, 2017)	criteria provided, multiple submitters, no conflicts	16	53682949	16	53649037	95690	101587
NM_015272.4(RPGRIP1L):c.685G>A (p.Ala229Thr)	RPGRIP1L	Joubert syndrome|Meckel-Gruber syndrome|Retinitis pigmentosa in ciliopathies, modifier of|Nephronophthisis|not specified	Conflicting interpretations of pathogenicity, risk factor(Last reviewed: Aug 8, 2017)	criteria provided, conflicting interpretations	16	53720436	16	53686524	1078	16117
NM_004530.5(MMP2):c.539A>T (p.Asp180Val)	MMP2	Multicentric osteolysis, nodulosis and arthropathy	Uncertain significance(Last reviewed: Jun 10, 2015)	no assertion criteria provided	16	55519220	16	55485308	374345	361221
NM_000339.2(SLC12A3):c.815T>C (p.Leu272Pro)	SLC12A3	Familial hypokalemia-hypomagnesemia|not provided	Likely pathogenic(Last reviewed: Sep 16, 2018)	criteria provided, multiple submitters, no conflicts	16	56904611	16	56870699	209191	205781
NM_000339.2(SLC12A3):c.[1849C>T];[1919A>G]	SLC12A3	Familial hypokalemia-hypomagnesemia	Pathogenic(Last reviewed: Sep 6, 2016)	criteria provided, single submitter	16|16	56919270	16|16	56885358	427829	260484|260483
NM_000339.2(SLC12A3):c.2221G>A (p.Gly741Arg)	SLC12A3	Familial hypokalemia-hypomagnesemia|Muscle weakness|not provided|Hypokalemia|Hypermagnesemia|Myalgia	Conflicting interpretations of pathogenicity(Last reviewed: Sep 16, 2018)	criteria provided, conflicting interpretations	16	56921879	16	56887967	208612	205181
NM_000339.2(SLC12A3):c.2576T>C (p.Leu859Pro)	SLC12A3	Familial hypokalemia-hypomagnesemia	Likely pathogenic(Last reviewed: Nov 6, 2014)	criteria provided, single submitter	16	56928470	16	56894558	8584	23623
NM_005682.6(ADGRG1):c.265C>T (p.His89Tyr)	ADGRG1	Polymicrogyria, bilateral frontoparietal	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	57685312	16	57651400	158628	169275
NM_005682.6(ADGRG1):c.287G>A (p.Arg96Gln)	ADGRG1	Polymicrogyria, bilateral frontoparietal|not specified	Uncertain significance(Last reviewed: Jun 29, 2017)	criteria provided, multiple submitters, no conflicts	16	57685334	16	57651422	158630	169277
NM_005682.6(ADGRG1):c.401C>T (p.Pro134Leu)	ADGRG1	Polymicrogyria, bilateral frontoparietal|not provided	Uncertain significance(Last reviewed: Mar 8, 2018)	criteria provided, multiple submitters, no conflicts	16	57685448	16	57651536	158631	169278
NM_005682.6(ADGRG1):c.761G>A (p.Arg254Gln)	ADGRG1	Polymicrogyria, bilateral frontoparietal	Uncertain significance(Last reviewed: Jul 7, 2014)	criteria provided, single submitter	16	57688038	16	57654126	158636	169282
NM_005682.6(ADGRG1):c.768G>C (p.Glu256Asp)	ADGRG1	Polymicrogyria, bilateral frontoparietal	Likely pathogenic(Last reviewed: May 8, 2014)	criteria provided, single submitter	16	57688045	16	57654133	158637	169283
NM_005682.6(ADGRG1):c.843C>G (p.Ser281Arg)	ADGRG1	not specified|not provided	Benign/Likely benign(Last reviewed: May 6, 2018)	criteria provided, multiple submitters, no conflicts	16	57689385	16	57655473	137493	141196
NM_005682.6(ADGRG1):c.900G>C (p.Gln300His)	ADGRG1	Polymicrogyria, bilateral frontoparietal	Uncertain significance(Last reviewed: Mar 18, 2014)	criteria provided, single submitter	16	57689442	16	57655530	158639	169285
NM_005682.6(ADGRG1):c.918A>C (p.Gln306His)	ADGRG1	not specified|not provided	Benign(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	16	57689805	16	57655893	158640	169286
NM_005682.6(ADGRG1):c.1048G>A (p.Val350Ile)	ADGRG1	Polymicrogyria, bilateral frontoparietal	Uncertain significance(Last reviewed: May 6, 2013)	criteria provided, single submitter	16	57690168	16	57656256	158613	169289
NM_005682.6(ADGRG1):c.1460T>C (p.Leu487Pro)	ADGRG1	Polymicrogyria, bilateral frontoparietal	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	57693480	16	57659568	158619	169295
NM_005682.6(ADGRG1):c.1478T>C (p.Met493Thr)	ADGRG1	not specified	Benign/Likely benign(Last reviewed: Feb 20, 2014)	criteria provided, multiple submitters, no conflicts	16	57693498	16	57659586	137495	141198
NM_005682.6(ADGRG1):c.1508T>C (p.Leu503Pro)	ADGRG1	Polymicrogyria, bilateral frontoparietal|not provided	Likely pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, multiple submitters, no conflicts	16	57693528	16	57659616	158620	169296
NM_005682.6(ADGRG1):c.1868G>C (p.Trp623Ser)	ADGRG1	Polymicrogyria, bilateral frontoparietal	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	57695794	16	57661882	158625	169301
NM_004614.4(TK2):c.547C>T (p.Arg183Trp)	TK2	Mitochondrial DNA depletion syndrome 2|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	16	66551110	16	66517207	38992	47595
NM_004614.4(TK2):c.416C>T (p.Ala139Val)	TK2	Mitochondrial DNA depletion syndrome 2|not provided|Mitochondrial DNA depletion syndrome|Mitochondrial DNA depletion syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 21, 2017)	criteria provided, multiple submitters, no conflicts	16	66562930	16	66529027	38990	47593
NM_004614.4(TK2):c.361C>A (p.His121Asn)	TK2	Mitochondrial DNA depletion syndrome 2	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	16	66565297	16	66531394	12708	27747
NM_001013838.2(CARMIL2):c.1590C>A (p.Asn530Lys)	CARMIL2	Chronic colitis|Combined immunodeficiency	Pathogenic	criteria provided, single submitter	16	67682876	16	67648973	562177	553351
NM_020457.2(THAP11):c.240C>G (p.Phe80Leu)	THAP11|CENPT	Mental retardation 3, X-linked	Likely pathogenic(Last reviewed: Dec 7, 2016)	criteria provided, single submitter	16	67876697	16	67842794	393304	380161
NM_015386.2(COG4):c.485C>T (p.Thr162Ile)	COG4	Congenital disorder of glycosylation|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	70548297	16	70514394	95697	101594
NM_024306.4(FA2H):c.847G>A (p.Val283Ile)	FA2H	Spastic paraplegia 35|not specified	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	16	74750437	16	74716539	129030	134476
NM_024306.4(FA2H):c.517C>T (p.Pro173Ser)	FA2H	Spastic paraplegia 35	Likely pathogenic(Last reviewed: Apr 15, 2014)	criteria provided, single submitter	16	74760219	16	74726321	216927	213640
NM_024306.4(FA2H):c.289C>G (p.Pro97Ala)	FA2H	Spastic paraplegia 35|not specified|Spastic paraplegia	Benign/Likely benign(Last reviewed: Aug 1, 2017)	criteria provided, multiple submitters, no conflicts	16	74773995	16	74740097	129029	134475
NM_024306.4(FA2H):c.133G>T (p.Gly45Trp)	FA2H	Spastic paraplegia 35	Likely pathogenic(Last reviewed: Sep 29, 2017)	criteria provided, single submitter	16	74808521	16	74774623	584457	575502
NM_001077416.2(TMEM231):c.78C>G (p.Ser26Arg)	TMEM231	not specified	Benign(Last reviewed: Feb 2, 2016)	criteria provided, multiple submitters, no conflicts	16	75590092	16	75556194	130587	136033
NM_005548.2(KARS):c.[1430G>A];[1513C>T]	KARS	Leukoencephalopathy|Leukoencephalopathy|Deafness	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	16|16	75663351	16|16	75629453	437932	431552|431553
NM_005548.2(KARS):c.599C>T (p.Pro200Leu)	KARS	Optic neuropathy|Progressive cerebellar ataxia|Abnormality of the cerebral white matter|Abnormal pyramidal signs|Congenital sensorineural hearing impairment|Inborn genetic diseases	Likely pathogenic	criteria provided, single submitter	16	75669880	16	75635982	224983	226957
NM_130791.3(WWOX):c.548G>T (p.Cys183Phe)	WWOX	Spinocerebellar ataxia, autosomal recessive 12	Uncertain significance(Last reviewed: Apr 30, 2014)	no assertion criteria provided	16	78312531	16	78278634	374382	361276
NM_022041.3(GAN):c.890C>T (p.Pro297Leu)	GAN	Giant axonal neuropathy	Likely pathogenic(Last reviewed: Nov 7, 2018)	no assertion criteria provided	16	81391453	16	81357848	598941	590028
NM_022041.3(GAN):c.1720C>T (p.Arg574Cys)	GAN	Giant axonal neuropathy	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	16	81411127	16	81377522	561016	552190
NM_000101.4(CYBA):c.214T>C (p.Tyr72His)	CYBA	CYBA POLYMORPHISM|not specified|Very early onset inflammatory bowel disease	Benign	criteria provided, single submitter	16	88713236	16	88646828	2263	17302
NM_030928.3(CDT1):c.404C>T (p.Ala135Val)	CDT1	not specified	Benign(Last reviewed: Jul 2, 2013)	criteria provided, single submitter	16	88871222	16	88804814	128676	134125
NM_030928.3(CDT1):c.514C>T (p.Arg172Cys)	CDT1	not provided	Uncertain significance(Last reviewed: Feb 10, 2014)	criteria provided, single submitter	16	88871873	16	88805465	128678	134127
NM_030928.3(CDT1):c.700T>C (p.Cys234Arg)	CDT1	Meier-Gorlin syndrome 4|not specified	Benign	criteria provided, single submitter	16	88872145	16	88805737	128680	134129
NM_030928.3(CDT1):c.742C>T (p.Arg248Cys)	CDT1	not provided	Uncertain significance(Last reviewed: Jan 16, 2014)	criteria provided, single submitter	16	88872187	16	88805779	128681	134130
NM_030928.3(CDT1):c.784A>G (p.Thr262Ala)	CDT1	not specified	Benign	criteria provided, single submitter	16	88872229	16	88805821	128682	134131
NM_030928.3(CDT1):c.900G>C (p.Gln300His)	CDT1	not provided	Uncertain significance(Last reviewed: Apr 2, 2013)	criteria provided, single submitter	16	88872496	16	88806088	128665	134114
NM_030928.3(CDT1):c.1030G>A (p.Glu344Lys)	CDT1	not provided	Uncertain significance(Last reviewed: Jan 17, 2013)	criteria provided, single submitter	16	88872990	16	88806582	128659	134108
NM_030928.3(CDT1):c.1610C>T (p.Ala537Val)	CDT1	not specified	Benign(Last reviewed: Apr 2, 2013)	criteria provided, single submitter	16	88874655	16	88808247	128674	134123
NM_030928.3(CDT1):c.1631A>T (p.Glu544Val)	CDT1	not specified|not provided	Uncertain significance(Last reviewed: May 11, 2016)	criteria provided, multiple submitters, no conflicts	16	88874676	16	88808268	128662	134111
NM_000512.4(GALNS):c.850T>G (p.Phe284Val)	GALNS	Mucopolysaccharidosis, MPS-IV-A|Morquio syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	16	88901669	16	88835261	321200	344556
NM_174917.4(ACSF3):c.1672C>T (p.Arg558Trp)	ACSF3	Combined malonic and methylmalonic aciduria|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 14, 2018)	criteria provided, conflicting interpretations	16	89220556	16	89154148	31134	40091
NM_003119.3(SPG7):c.1045G>A (p.Gly349Ser)	SPG7	Spastic paraplegia 7|not provided|Spastic Paraplegia, Recessive	Pathogenic/Likely pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	16	89598369	16	89531961	6819	21858
NM_003119.3(SPG7):c.1507A>G (p.Thr503Ala)	SPG7	Spastic paraplegia 7|not specified|Spastic Paraplegia, Recessive	Benign/Likely benign(Last reviewed: Apr 14, 2017)	criteria provided, multiple submitters, no conflicts	16	89613123	16	89546715	130369	135816
NM_003119.3(SPG7):c.[1529C>T];[2120delTinsCCAAGTCTGTA]	SPG7	Spastic paraplegia 7	Likely pathogenic(Last reviewed: Apr 23, 2013)	criteria provided, single submitter	16|16	89613145	16|16	89546737	424800	51184|213642
NM_003119.2(SPG7):c.1529C>T	SPG7	Spastic paraplegia 7|Hereditary spastic paraplegia|Optic nerve hypoplasia|Dysarthria|not provided|Gait ataxia|Cerebral cortical atrophy|Spastic paraparesis|Inborn genetic diseases|Spastic Paraplegia, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Oct 5, 2018)	criteria provided, conflicting interpretations	16	89613145	16	89546737	42016	51184
NM_003119.3(SPG7):c.1729G>A (p.Gly577Ser)	SPG7	Spastic paraplegia 7	Likely pathogenic(Last reviewed: Aug 13, 2013)	criteria provided, single submitter	16	89616967	16	89550559	217006	213641
NM_003119.3(SPG7):c.2063G>A (p.Arg688Gln)	SPG7	Spastic paraplegia 7|not specified|Spastic Paraplegia, Recessive	Benign/Likely benign(Last reviewed: Apr 14, 2017)	criteria provided, multiple submitters, no conflicts	16	89620328	16	89553920	130370	135817
NM_002768.4(CHMP1A):c.51G>A (p.Lys17=)	CHMP1A	not specified	Benign/Likely benign(Last reviewed: Nov 8, 2017)	criteria provided, multiple submitters, no conflicts	16	89718031	16	89651623	128732	134181
NM_001160367.1(CDK10):c.512C>G (p.Thr171Ser)	CDK10	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	16	89761129	16	89694721	402153	389169
NM_001160367.1(CDK10):c.857G>A (p.Arg286His)	CDK10	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	16	89762087	16	89695679	402152	389170
NM_000135.2(FANCA):c.3263C>T (p.Ser1088Phe)	FANCA	Fanconi anemia|Malignant tumor of prostate|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jan 25, 2017)	criteria provided, conflicting interpretations	16	89815152	16	89748744	134264	138003
NM_000135.2(FANCA):c.2574C>G (p.Ser858Arg)	FANCA	Fanconi anemia|Fanconi anemia, complementation group A|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 10, 2018)	criteria provided, conflicting interpretations	16	89833576	16	89767168	134256	137995
NM_001481.2(GAS8):c.828C>G (p.Asn276Lys)	GAS8	not provided	Uncertain significance	no assertion criteria provided	16	90103711	16	90037303	156521	166285
NM_001163809.1(WDR81):c.1955C>T (p.Pro652Leu)	WDR81	not specified	Likely benign	no assertion criteria provided	17	1630208	17	1726914	130734	136180
NM_001163809.1(WDR81):c.4603A>G (p.Met1535Val)	WDR81	not specified	Likely benign	no assertion criteria provided	17	1636934	17	1733640	130739	136185
NM_000049.2(ASPA):c.79G>A (p.Gly27Arg)	ASPA|SPATA22	Spongy degeneration of central nervous system|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	17	3379532	17	3476238	188888	186962
NM_000049.2(ASPA):c.454T>C (p.Cys152Arg)	ASPA|SPATA22	Spongy degeneration of central nervous system	Pathogenic(Last reviewed: Oct 22, 2012)	no assertion criteria provided	17	3386814	17	3483520	2606	17645
NM_000049.2(ASPA):c.541C>A (p.Pro181Thr)	ASPA|SPATA22	Spongy degeneration of central nervous system	Likely pathogenic(Last reviewed: Aug 26, 2014)	criteria provided, single submitter	17	3392543	17	3489249	188940	186965
NM_000049.2(ASPA):c.820G>A (p.Gly274Arg)	ASPA|SPATA22	Spongy degeneration of central nervous system	Likely pathogenic(Last reviewed: May 16, 2014)	criteria provided, single submitter	17	3402260	17	3498966	188788	186966
NM_000049.2(ASPA):c.854A>C (p.Glu285Ala)	ASPA|SPATA22	Spongy degeneration of central nervous system|not provided|Canavan Disease, Familial Form	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, multiple submitters, no conflicts	17	3402294	17	3499000	2605	17644
NM_000049.2(ASPA):c.859G>A (p.Ala287Thr)	ASPA|SPATA22	Spongy degeneration of central nervous system|Canavan Disease, Familial Form	Pathogenic/Likely pathogenic(Last reviewed: Aug 4, 2016)	criteria provided, multiple submitters, no conflicts	17	3402299	17	3499005	188803	186967
NM_004937.2(CTNS):c.416C>T (p.Ser139Phe)	CTNS	Juvenile nephropathic cystinosis|Cystinosis|Cystinosis, atypical nephropathic|Nephropathic cystinosis	Likely pathogenic(Last reviewed: May 30, 2014)	criteria provided, single submitter	17	3558601	17	3655307	4458	19497
NM_004937.2(CTNS):c.589G>A (p.Gly197Arg)	CTNS	Cystinosis, ocular nonnephropathic|Nephropathic cystinosis|not provided	Likely pathogenic(Last reviewed: May 22, 2017)	criteria provided, multiple submitters, no conflicts	17	3559997	17	3656703	4451	19490
NM_014604.4(TAX1BP3):c.233T>C (p.Met78Thr)	TAX1BP3|P2RX5-TAX1BP3	TAX1BP3-related arrhythmogenic right ventricular cardiomyopathy	Likely pathogenic(Last reviewed: Nov 27, 2018)	criteria provided, single submitter			17	3664199	598745	589807
NM_000080.3(CHRNE):c.421C>A (p.Pro141Thr)	CHRNE|C17orf107	Congenital myasthenic syndrome 1B, fast-channel	Pathogenic(Last reviewed: Aug 1, 2000)	no assertion criteria provided	17	4805306	17	4902011	135656	139374
NM_006612.5(KIF1C):c.2099C>T (p.Pro700Leu)	KIF1C	Ataxia, spastic, 2, autosomal recessive|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 10, 2017)	criteria provided, conflicting interpretations	17	4925475	17	5022180	209166	205788
NM_006612.5(KIF1C):c.2734C>T (p.Arg912Trp)	KIF1C	Ataxia, spastic, 2, autosomal recessive|Hereditary spastic paraplegia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 27, 2017)	criteria provided, conflicting interpretations	17	4926868	17	5023573	209167	205789
NM_177550.4(SLC13A5):c.1475T>C (p.Leu492Pro)	SLC13A5	Epileptic encephalopathy, early infantile, 25	Pathogenic	no assertion criteria provided	17	6590948	17	6687629	375390	362160
NM_177550.4(SLC13A5):c.680C>T (p.Thr227Met)	SLC13A5	Epileptic encephalopathy, early infantile, 25	Uncertain significance(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	17	6606325	17	6703006	140753	150467
NM_177550.4(SLC13A5):c.655G>A (p.Gly219Arg)	SLC13A5	Epileptic encephalopathy, early infantile, 25	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, single submitter	17	6606350	17	6703031	140752	150466
NM_000018.3(ACADVL):c.664G>A (p.Gly222Arg)	ACADVL	Very long chain acyl-CoA dehydrogenase deficiency|not provided	Likely pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, multiple submitters, no conflicts	17	7125312	17	7221993	92289	98200
NM_000018.3(ACADVL):c.779C>T (p.Thr260Met)	ACADVL	Very long chain acyl-CoA dehydrogenase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 26, 2018)	criteria provided, multiple submitters, no conflicts	17	7125522	17	7222203	21024	33876
NM_000018.3(ACADVL):c.848T>C (p.Val283Ala)	ACADVL	Very long chain acyl-CoA dehydrogenase deficiency|not provided	Pathogenic(Last reviewed: Jun 15, 2018)	criteria provided, multiple submitters, no conflicts	17	7125591	17	7222272	21025	33877
NM_000018.4(ACADVL):c.1405C>T (p.Arg469Trp)	ACADVL	Very long chain acyl-CoA dehydrogenase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, multiple submitters, no conflicts	17	7127359	17	7224040	21017	33869
NM_000018.3(ACADVL):c.1406G>A (p.Arg469Gln)	ACADVL	Very long chain acyl-CoA dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Feb 25, 2015)	criteria provided, multiple submitters, no conflicts	17	7127360	17	7224041	92276	98187
NM_001270447.1(ACADVL):c.1768C>T (p.Arg590Trp)	ACADVL	Very long chain acyl-CoA dehydrogenase deficiency	Uncertain significance	criteria provided, single submitter	17	7127981	17	7224662	219172	217195
NM_000018.3(ACADVL):c.1837C>T (p.Arg613Trp)	ACADVL	Very long chain acyl-CoA dehydrogenase deficiency|not specified|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 11, 2018)	criteria provided, multiple submitters, no conflicts	17	7128285	17	7224966	1623	16662
NM_000018.3(ACADVL):c.1844G>A (p.Arg615Gln)	ACADVL	Very long chain acyl-CoA dehydrogenase deficiency|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 19, 2018)	criteria provided, conflicting interpretations	17	7128292	17	7224973	195448	192609
NM_004870.3(MPDU1):c.218G>A (p.Gly73Glu)	MPDU1	Congenital disorder of glycosylation type 1F|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 9, 2017)	criteria provided, conflicting interpretations	17	7489312	17	7585994	5867	20906
NM_004870.3(MPDU1):c.310G>A (p.Gly104Ser)	MPDU1	Congenital disorder of glycosylation type 1F	Likely pathogenic(Last reviewed: Jul 15, 2017)	criteria provided, single submitter	17	7490017	17	7586699	495318	486816
NM_004870.3(MPDU1):c.377A>C (p.Gln126Pro)	MPDU1	Congenital disorder of glycosylation type 1F	Likely pathogenic(Last reviewed: Jul 15, 2017)	criteria provided, single submitter	17	7490084	17	7586766	495319	486817
NM_001139.3(ALOX12B):c.1579G>A (p.Val527Met)	ALOX12B	Autosomal recessive congenital ichthyosis 2|not provided	Likely pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	17	7978988	17	8075670	212729	209356
NM_001139.3(ALOX12B):c.1562A>G (p.Tyr521Cys)	ALOX12B	Autosomal recessive congenital ichthyosis 2|Ichthyosis|not provided|Congenital ichthyosiform erythroderma	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, multiple submitters, no conflicts	17	7979005	17	8075687	39546	48145
NM_021628.2(ALOXE3):c.1889C>T (p.Pro630Leu)	ALOXE3	Autosomal recessive congenital ichthyosis 1|Autosomal recessive congenital ichthyosis 3|not provided	Pathogenic(Last reviewed: Sep 26, 2017)	criteria provided, multiple submitters, no conflicts	17	8006708	17	8103390	279677	264886
NM_025099.6(CTC1):c.3013A>G (p.Ile1005Val)	CTC1	not specified|Dyskeratosis Congenita, Recessive	Benign(Last reviewed: Aug 8, 2016)	criteria provided, multiple submitters, no conflicts	17	8132763	17	8229445	128861	134309
NM_025099.6(CTC1):c.2458A>G (p.Ile820Val)	CTC1	not specified|Dyskeratosis Congenita, Recessive	Benign(Last reviewed: Aug 8, 2016)	criteria provided, multiple submitters, no conflicts	17	8135061	17	8231743	128860	134308
NM_018127.6(ELAC2):c.2342G>A (p.Arg781His)	ELAC2	Prostate cancer, hereditary, 2|not provided|Combined oxidative phosphorylation deficiency 17	Conflicting interpretations of pathogenicity(Last reviewed: Nov 16, 2017)	criteria provided, conflicting interpretations	17	12896274	17	12992957	5058	20097
NM_018127.6(ELAC2):c.1028T>G (p.Met343Arg)	ELAC2	Combined oxidative phosphorylation deficiency 17	Likely pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	17	12906847	17	13003530	488503	481371
NM_018127.6(ELAC2):c.929A>C (p.Glu310Ala)	ELAC2	Combined oxidative phosphorylation deficiency 17	Likely pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	17	12908360	17	13005043	488504	481372
NM_006311.3(NCOR1):c.97C>T (p.Arg33Cys)	NCOR1	Thin skin|Developmental delay|Hyperlaxity|Thin skin	Likely pathogenic(Last reviewed: Aug 11, 2017)	no assertion criteria provided	17	16097787	17	16194473	431697	425202
NM_004278.3(PIGL):c.4G>A (p.Glu2Lys)	PIGL	Zunich neuroectodermal syndrome	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	16120544	17	16217230	159711	169314
NM_004278.3(PIGL):c.169T>C (p.Phe57Leu)	PIGL	Zunich neuroectodermal syndrome	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	16120709	17	16217395	159701	169316
NM_004278.3(PIGL):c.337G>T (p.Asp113Tyr)	PIGL	Zunich neuroectodermal syndrome	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	16203203	17	16299889	159703	169317
NM_004278.3(PIGL):c.424C>A (p.Leu142Met)	PIGL	Zunich neuroectodermal syndrome|not specified|not provided|Coloboma, Congenital Heart Disease, Ichthyosiform Dermatosis, Intellectual Disability, and Ear Anomalies (CHIME) Syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 30, 2016)	criteria provided, conflicting interpretations	17	16203290	17	16299976	159705	169319
NM_004278.3(PIGL):c.439G>A (p.Asp147Asn)	PIGL	Zunich neuroectodermal syndrome|Coloboma, Congenital Heart Disease, Ichthyosiform Dermatosis, Intellectual Disability, and Ear Anomalies (CHIME) Syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	16216873	17	16313559	159708	169322
NM_004278.3(PIGL):c.500T>C (p.Leu167Pro)	PIGL	Hypertelorism|Zunich neuroectodermal syndrome|Bilateral cleft lip and palate|Low-set ears|not provided|Premature birth|Wide intermamillary distance|Scrotal hypoplasia|Hypertelorism|Postaxial hand polydactyly|Camptodactyly of finger|Coloboma, Congenital Heart Disease, Ichthyosiform Dermatosis, Intellectual Disability, and Ear Anomalies (CHIME) Syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 18, 2017)	criteria provided, conflicting interpretations	17	16220000	17	16316686	30544	39501
NM_004278.3(PIGL):c.535G>A (p.Val179Met)	PIGL	Zunich neuroectodermal syndrome	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	16221097	17	16317783	159714	169327
NM_004278.3(PIGL):c.652C>G (p.Gln218Glu)	PIGL	Zunich neuroectodermal syndrome	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	16221214	17	16317900	159718	169331
NM_016239.3(MYO15A):c.6610C>T (p.Arg2204Cys)	MYO15A	Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	17	18051443	17	18148129	164540	176470
NM_016239.3(MYO15A):c.6863C>T (p.Ser2288Leu)	MYO15A	Nonsyndromic hearing loss and deafness|Nonsyndromic Hearing Loss, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Dec 7, 2017)	criteria provided, conflicting interpretations	17	18052173	17	18148859	322158	327577
NM_016239.3(MYO15A):c.6893G>A (p.Arg2298Gln)	MYO15A	Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: Dec 15, 2017)	criteria provided, single submitter	17	18052203	17	18148889	517648	497563
NM_016239.3(MYO15A):c.8183G>A	MYO15A	Nonsyndromic hearing loss and deafness|not provided|Inborn genetic diseases	Likely pathogenic(Last reviewed: Jun 22, 2017)	criteria provided, multiple submitters, no conflicts	17	18058028	17	18154714	228276	230744
NM_016239.3(MYO15A):c.9620G>A (p.Arg3207His)	MYO15A	Nonsyndromic hearing loss and deafness|not provided|Nonsyndromic Hearing Loss, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Sep 22, 2017)	criteria provided, conflicting interpretations	17	18066565	17	18163251	228973	230751
NM_015681.4(B9D1):c.467G>C (p.Arg156Pro)	B9D1	Jeune thoracic dystrophy	Uncertain significance(Last reviewed: May 1, 2018)	criteria provided, single submitter	17	19247108	17	19343795	558747	549491
NM_000382.2(ALDH3A2):c.551C>T (p.Thr184Met)	ALDH3A2	Sjgren-Larsson syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 15, 2015)	criteria provided, multiple submitters, no conflicts	17	19559758	17	19656445	188768	186957
NM_000382.2(ALDH3A2):c.631A>G (p.Lys211Glu)	ALDH3A2	Sjgren-Larsson syndrome	Pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	17	19559838	17	19656525	438262	431885
NM_000382.2(ALDH3A2):c.[733G>A;901G>C;906delT;909T>G]	ALDH3A2	Sjgren-Larsson syndrome	Pathogenic(Last reviewed: Jun 1, 2017)	criteria provided, single submitter	17|17|17|17	19561110	17|17|17|17	19657797	438264	260161|431886|431887|431888
NM_000382.2(ALDH3A2):c.733G>A (p.Asp245Asn)	ALDH3A2	Sjgren-Larsson syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 15, 2017)	criteria provided, multiple submitters, no conflicts	17	19561110	17	19657797	265459	260161
NM_001142610.1(ULK2):c.1733A>G (p.His578Arg)	ULK2	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	17	19700785	17	19797472	402174	389171
NM_152464.2(TMEM199):c.20C>A (p.Ala7Glu)	TMEM199	Congenital disorders of glycosylation type II|CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIp	Pathogenic(Last reviewed: Feb 29, 2016)	no assertion criteria provided	17	26684713	17	28357690	218965	216017
NM_152464.2(TMEM199):c.[376-1G>A];[40G>C]	TMEM199	Congenital disorders of glycosylation type II	Pathogenic	no assertion criteria provided	17|17	26684733	17|17	28357710	427819	224173|224174
NM_152464.2(TMEM199):c.92G>C (p.Arg31Pro)	TMEM199	Congenital disorders of glycosylation type II|CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIp	Pathogenic(Last reviewed: Feb 29, 2016)	no assertion criteria provided	17	26684785	17	28357762	218964	216010
NM_001254.4(CDC6):c.790A>G (p.Met264Val)	CDC6	not provided	Uncertain significance(Last reviewed: Mar 3, 2014)	criteria provided, single submitter	17	38449837	17	40293585	128637	134086
NM_001254.4(CDC6):c.883G>A (p.Asp295Asn)	CDC6	not specified	Benign(Last reviewed: Jun 21, 2013)	criteria provided, multiple submitters, no conflicts	17	38450248	17	40293996	128638	134087
NM_001254.4(CDC6):c.1321G>A (p.Val441Ile)	CDC6	not specified|Meier-Gorlin syndrome	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	38457151	17	40300899	128635	134084
NM_001552.2(IGFBP4):c.698C>T (p.Thr233Met)	IGFBP4	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	17	38612756	17	40456504	402159	389172
NM_181534.3(KRT25):c.712G>T (p.Val238Leu)	KRT25	Autosomal recessive woolly hair 3|Autosomal Recessive Hypotrichosis with Woolly Hair	Pathogenic(Last reviewed: Feb 20, 2016)	criteria provided, single submitter	17	38907536	17	40751284	242934	244036
NM_000263.3(NAGLU):c.1834A>G (p.Ser612Gly)	NAGLU	Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease, axonal type 2V	Pathogenic(Last reviewed: Jul 18, 2017)	criteria provided, multiple submitters, no conflicts	17	40695858	17	42543840	522823	513465
NM_003632.2(CNTNAP1):c.[1869G>A];[967T>C]	CNTNAP1	Lethal congenital contracture syndrome 7	Pathogenic	no assertion criteria provided	17|17	40838987	17|17	42686969	427821	237757|237756
NM_003632.2(CNTNAP1):c.1163G>C (p.Arg388Pro)	CNTNAP1	Lethal congenital contracture syndrome 7|Congenital hypomyelinating neuropathy 3	Likely pathogenic(Last reviewed: Mar 26, 2017)	criteria provided, single submitter	17	40839856	17	42687838	522842	513467
NM_000151.3(G6PC):c.229T>C (p.Trp77Arg)	G6PC	Glycogen storage disease type 1A	Likely pathogenic(Last reviewed: Dec 29, 2014)	criteria provided, single submitter	17	41053122	17	42901105	12001	27040
NM_000151.3(G6PC):c.247C>T (p.Arg83Cys)	G6PC	Glycogen storage disease, type I|Glycogen storage disease type 1A|Short stature|Hypoglycemia|not provided	Pathogenic(Last reviewed: Jun 27, 2018)	criteria provided, multiple submitters, no conflicts	17	41055964	17	42903947	11998	27037
NM_000151.3(G6PC):c.883C>T (p.Arg295Cys)	G6PC	Glycogen storage disease, type I|Glycogen storage disease type 1A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, multiple submitters, no conflicts	17	41063252	17	42911235	11999	27038
NM_000151.3(G6PC):c.1012G>T (p.Val338Phe)	G6PC	Glycogen storage disease type 1A	Likely pathogenic(Last reviewed: Aug 27, 2014)	criteria provided, single submitter	17	41063381	17	42911364	188945	186979
NM_138387.3(G6PC3):c.778G>C (p.Gly260Arg)	G6PC3	Severe congenital neutropenia 4, autosomal recessive	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	17	42153148	17	44075780	30874	39831
NM_000419.4(ITGA2B):c.[1787T>C];[439C>G]	ITGA2B	Glanzmann thrombasthenia	Pathogenic(Last reviewed: Feb 26, 2013)	criteria provided, single submitter	17|17	42457148	17|17	44379780	424783	17939|213645
NM_001258398.1(CCDC103):c.104G>C (p.Arg35Pro)	CCDC103	not provided	Uncertain significance	no assertion criteria provided	17	42978470	17	44901102	156518	166283
NM_213607.2(CCDC103):c.461A>C (p.His154Pro)	CCDC103	Kartagener syndrome|Ciliary dyskinesia|Ciliary dyskinesia, primary, 17|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 7, 2018)	criteria provided, conflicting interpretations	17	42979917	17	44902549	31698	40358
NM_004287.4(GOSR2):c.200G>A (p.Arg67Lys)	GOSR2|LRRC37A2	Progressive myoclonic epilepsy|not specified|Seizures|not provided	Benign(Last reviewed: Apr 20, 2017)	criteria provided, multiple submitters, no conflicts	17	45008570	17	46931204	129165	134611
NM_004287.4(GOSR2):c.[336+1G>A];[430G>T]	GOSR2|LRRC37A2	Epilepsy, progressive myoclonic 6	Likely pathogenic(Last reviewed: Jan 22, 2013)	criteria provided, single submitter	17|17	45012488	17|17	46935122	424780	39363|208401
NM_018129.3(PNPO):c.347G>A (p.Arg116Gln)	PNPO	Pyridoxal 5'-phosphate-dependent epilepsy|not specified|Seizures	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	46022065	17	47944699	129981	135427
NM_002204.3(ITGA3):c.1973C>G (p.Thr658Arg)	ITGA3	Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital	Likely pathogenic(Last reviewed: Nov 4, 2014)	criteria provided, single submitter	17	48154388	17	50077024	209162	205785
NM_000023.3(SGCA):c.100C>T (p.Arg34Cys)	SGCA	Limb-girdle muscular dystrophy, type 2D|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 20, 2018)	criteria provided, multiple submitters, no conflicts	17	48244791	17	50167430	217250	213838
NM_000023.3(SGCA):c.101G>A (p.Arg34His)	SGCA	Limb-girdle muscular dystrophy, type 2D|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 21, 2017)	criteria provided, multiple submitters, no conflicts	17	48244792	17	50167431	92301	98212
NM_000023.3(SGCA):c.220C>T (p.Arg74Trp)	SGCA	Limb-girdle muscular dystrophy, type 2D	Likely pathogenic(Last reviewed: Jun 2, 2014)	criteria provided, single submitter	17	48245005	17	50167644	188811	186981
NM_000023.3(SGCA):c.229C>T (p.Arg77Cys)	SGCA	Limb-girdle muscular dystrophy, type 2D|not provided	Pathogenic(Last reviewed: Jun 13, 2018)	criteria provided, multiple submitters, no conflicts	17	48245014	17	50167653	9437	24476
NM_000023.3(SGCA):c.293G>A (p.Arg98His)	SGCA	Limb-girdle muscular dystrophy, type 2D|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, multiple submitters, no conflicts	17	48245078	17	50167717	9435	24474
NM_000023.3(SGCA):c.371T>C (p.Ile124Thr)	SGCA	Limb-girdle muscular dystrophy, type 2D|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 2, 2018)	criteria provided, multiple submitters, no conflicts	17	48245366	17	50168005	188733	186982
NM_000023.3(SGCA):c.850C>T (p.Arg284Cys)	SGCA	Limb-girdle muscular dystrophy, type 2D|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 9, 2018)	criteria provided, multiple submitters, no conflicts	17	48247606	17	50170245	9439	24478
NM_022167.3(XYLT2):c.2548G>A (p.Asp850Asn)	XYLT2	Spondyloocular syndrome, autosomal recessive	Likely pathogenic(Last reviewed: Apr 21, 2017)	no assertion criteria provided	17	48437602	17	50360241	548446	538930
NM_017777.3(MKS1):c.1671G>C (p.Leu557=)	MKS1	Bardet-Biedl syndrome|Meckel-Gruber syndrome|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	56283449	17	58206088	126272	131804
NM_017777.3(MKS1):c.110A>G (p.Asn37Ser)	MKS1	Meckel-Gruber syndrome|Bardet-Biedl syndrome 13|Meckel syndrome type 1|Joubert syndrome 28	Uncertain significance(Last reviewed: Dec 11, 2017)	criteria provided, multiple submitters, no conflicts	17	56296061	17	58218700	126271	131803
NM_058216.2(RAD51C):c.935G>A (p.Arg312Gln)	RAD51C	Fanconi anemia, complementation group O|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 28, 2017)	criteria provided, multiple submitters, no conflicts	17	56801431	17	58724070	229887	236243
NM_000334.4(SCN4A):c.4126A>G (p.Asn1376Asp)	SCN4A|GH-LCR	Potassium aggravated myotonia|Paramyotonia congenita of von Eulenburg|Hypokalemic periodic paralysis, type 2|Hyperkalemic Periodic Paralysis Type 1|Congenital myasthenic syndrome, acetazolamide-responsive|Hypokalemic periodic paralysis|not specified|Congenital Myasthenic Syndrome, Recessive|Hyperkalemic Periodic Paralysis	Benign(Last reviewed: Apr 14, 2017)	criteria provided, multiple submitters, no conflicts	17	62020348	17	63942988	130236	135683
NM_000334.4(SCN4A):c.3604G>A (p.Glu1202Lys)	SCN4A|GH-LCR	Potassium aggravated myotonia|Paramyotonia congenita of von Eulenburg|Hypokalemic periodic paralysis|not specified|Congenital Myasthenic Syndrome, Recessive|Hyperkalemic Periodic Paralysis	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	17	62022836	17	63945476	130233	135680
NM_000334.4(SCN4A):c.2717G>C (p.Ser906Thr)	SCN4A|GH-LCR	Potassium aggravated myotonia|Paramyotonia congenita of von Eulenburg|Hyperkalemic Periodic Paralysis Type 1|Hypokalemic periodic paralysis|not specified|Congenital Myasthenic Syndrome, Recessive|Hyperkalemic Periodic Paralysis	Benign/Likely benign(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	17	62028920	17	63951560	21154	34006
NM_000334.4(SCN4A):c.2024G>A (p.Arg675Gln)	SCN4A|GH-LCR	Normokalemic periodic paralysis, potassium-sensitive|Muscular Diseases|Hyperkalemic Periodic Paralysis Type 1|not provided	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	17	62034874	17	63957514	5919	20958
NM_000334.4(SCN4A):c.1570A>G (p.Ser524Gly)	SCN4A	Potassium aggravated myotonia|Paramyotonia congenita of von Eulenburg|Hypokalemic periodic paralysis, type 2|Hyperkalemic Periodic Paralysis Type 1|Congenital myasthenic syndrome, acetazolamide-responsive|Hypokalemic periodic paralysis|not specified|Congenital Myasthenic Syndrome, Recessive|Hyperkalemic Periodic Paralysis	Benign(Last reviewed: Apr 14, 2017)	criteria provided, multiple submitters, no conflicts	17	62041068	17	63963708	130228	135675
NM_007215.3(POLG2):c.544C>T (p.Arg182Trp)	POLG2|MILR1	not provided|Acute hepatic failure	Likely pathogenic(Last reviewed: Aug 2, 2016)	criteria provided, multiple submitters, no conflicts	17	62492543	17	64496425	252958	247359
NM_014877.3(HELZ):c.3322A>G (p.Ile1108Val)	HELZ	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	17	65124832	17	67128716	402158	389173
NM_173477.4(USH1G):c.1373A>T (p.Asp458Val)	USH1G	Usher syndrome, type 1G	Likely pathogenic(Last reviewed: Dec 6, 2015)	criteria provided, single submitter	17	72915558	17	74919463	48127	57291
NM_021734.4(SLC25A19):c.332G>A (p.Ser111Asn)	SLC25A19	not provided	Uncertain significance(Last reviewed: Jan 28, 2014)	criteria provided, single submitter	17	73279631	17	75283550	130329	135776
NM_021734.4(SLC25A19):c.240A>C (p.Lys80Asn)	SLC25A19	Striatal necrosis, bilateral, and progressive polyneuropathy	Likely pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	17	73282433	17	75286352	488598	481466
NM_021734.4(SLC25A19):c.146G>A (p.Arg49His)	SLC25A19	not provided	Uncertain significance(Last reviewed: Dec 12, 2013)	criteria provided, single submitter	17	73282527	17	75286446	130328	135775
NM_207346.2(TSEN54):c.1A>C (p.Met1Leu)	TSEN54	Olivopontocerebellar hypoplasia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	73512642	17	75516561	160132	169400
NM_207346.2(TSEN54):c.12G>T (p.Glu4Asp)	TSEN54	Pontoneocerebellar hypoplasia|not specified|not provided	Benign(Last reviewed: Mar 22, 2018)	criteria provided, multiple submitters, no conflicts	17	73512653	17	75516572	96673	102566
NM_207346.2(TSEN54):c.114T>G (p.His38Gln)	TSEN54	Pontoneocerebellar hypoplasia|not specified|not provided	Benign(Last reviewed: Apr 20, 2017)	criteria provided, multiple submitters, no conflicts	17	73512884	17	75516803	96671	102564
NM_207346.2(TSEN54):c.409A>C (p.Ile137Leu)	TSEN54	Pontoneocerebellar hypoplasia|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	73513677	17	75517596	160134	169402
NM_207346.2(TSEN54):c.568G>A (p.Val190Met)	TSEN54	Pontoneocerebellar hypoplasia|not specified|not provided	Benign/Likely benign(Last reviewed: Jun 14, 2017)	criteria provided, multiple submitters, no conflicts	17	73517536	17	75521455	137758	141461
NM_207346.2(TSEN54):c.919G>T (p.Ala307Ser)	TSEN54	Pontocerebellar hypoplasia type 4|Pontocerebellar hypoplasia type 2A|Pontocerebellar hypoplasia type 5|Congenital cerebellar hypoplasia|Global developmental delay|Hypertonia|not provided|Microcephaly|Amblyopia|Global developmental delay|Olivopontocerebellar hypoplasia|Inborn genetic diseases|Non-syndromic pontocerebellar hypoplasia	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2017)	criteria provided, multiple submitters, no conflicts	17	73518081	17	75522000	2120	17159
NM_207346.2(TSEN54):c.964C>G (p.Leu322Val)	TSEN54	Olivopontocerebellar hypoplasia	Uncertain significance(Last reviewed: Dec 23, 2013)	criteria provided, single submitter	17	73518126	17	75522045	160140	169408
NM_207346.2(TSEN54):c.1041G>C (p.Lys347Asn)	TSEN54	Pontoneocerebellar hypoplasia|not specified|not provided	Benign(Last reviewed: Apr 20, 2017)	criteria provided, multiple submitters, no conflicts	17	73518203	17	75522122	160123	169409
NM_207346.2(TSEN54):c.1114G>A (p.Val372Met)	TSEN54	Pontoneocerebellar hypoplasia|not provided|Olivopontocerebellar hypoplasia	Uncertain significance(Last reviewed: Sep 26, 2016)	criteria provided, multiple submitters, no conflicts	17	73518276	17	75522195	160124	169410
NM_207346.2(TSEN54):c.1166A>C (p.Gln389Pro)	TSEN54	Pontoneocerebellar hypoplasia|not specified|not provided	Benign/Likely benign(Last reviewed: Apr 20, 2017)	criteria provided, multiple submitters, no conflicts	17	73518328	17	75522247	96672	102565
NM_207346.2(TSEN54):c.1181A>G (p.Gln394Arg)	TSEN54	Olivopontocerebellar hypoplasia	Uncertain significance(Last reviewed: Aug 22, 2013)	criteria provided, single submitter	17	73518343	17	75522262	160126	169412
NM_207346.2(TSEN54):c.1310C>T (p.Ala437Val)	TSEN54	Pontoneocerebellar hypoplasia|not specified|not provided	Benign(Last reviewed: Apr 20, 2017)	criteria provided, multiple submitters, no conflicts	17	73519413	17	75523332	160127	169413
NM_207346.2(TSEN54):c.1328C>G (p.Ser443Cys)	TSEN54	not specified|not provided	Benign/Likely benign(Last reviewed: Feb 20, 2018)	criteria provided, multiple submitters, no conflicts	17	73519758	17	75523677	160128	169414
NM_207346.2(TSEN54):c.1447C>G (p.Pro483Ala)	TSEN54	Pontoneocerebellar hypoplasia|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	73520359	17	75524278	137759	141462
NM_207346.2(TSEN54):c.1468C>T (p.Arg490Trp)	TSEN54	Pontoneocerebellar hypoplasia|not specified|not provided	Benign/Likely benign(Last reviewed: Mar 2, 2018)	criteria provided, multiple submitters, no conflicts	17	73520380	17	75524299	160130	169416
NM_207346.2(TSEN54):c.1511T>C (p.Leu504Pro)	TSEN54	Olivopontocerebellar hypoplasia	Likely pathogenic(Last reviewed: Mar 29, 2013)	criteria provided, single submitter	17	73520423	17	75524342	160131	169417
NM_207346.2(TSEN54):c.1573G>C (p.Gly525Arg)	TSEN54	Pontoneocerebellar hypoplasia|not specified|not provided	Benign/Likely benign(Last reviewed: Sep 5, 2017)	criteria provided, multiple submitters, no conflicts	17	73520485	17	75524404	137760	141463
NM_004035.6(ACOX1):c.176G>C (p.Arg59Pro)	ACOX1	Pseudoneonatal adrenoleukodystrophy	Likely pathogenic(Last reviewed: Feb 18, 2014)	criteria provided, single submitter	17	73974708	17	75978627	216884	213647
NM_000152.4(GAA):c.1A>G (p.Met1Val)	GAA	Glycogen storage disease, type II	Likely pathogenic(Last reviewed: May 15, 2014)	criteria provided, single submitter	17	78078386	17	80104587	188785	186987
NM_000152.4(GAA):c.271G>A (p.Asp91Asn)	GAA	Glycogen storage disease, type II|Acid alpha-glucosidase, allele 2|not specified|not provided	Benign/Likely benign, other(Last reviewed: Jul 5, 2018)	criteria provided, multiple submitters, no conflicts	17	78078656	17	80104857	4020	19059
NM_000152.4(GAA):c.569G>A (p.Arg190His)	GAA	Glycogen storage disease, type II	Likely pathogenic(Last reviewed: May 31, 2014)	criteria provided, single submitter	17	78079570	17	80105771	188809	186992
NM_000152.4(GAA):c.596A>G (p.His199Arg)	GAA	Glycogen storage disease, type II|not specified|not provided	Benign(Last reviewed: Sep 4, 2018)	criteria provided, multiple submitters, no conflicts	17	78079597	17	80105798	92486	98395
NM_000152.4(GAA):c.655G>A (p.Gly219Arg)	GAA	Glycogen storage disease, type II|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 7, 2017)	criteria provided, multiple submitters, no conflicts	17	78079656	17	80105857	189065	186993
NM_000152.4(GAA):c.668G>A (p.Arg223His)	GAA	Glycogen storage disease, type II|not specified|not provided	Benign/Likely benign(Last reviewed: Sep 4, 2018)	criteria provided, multiple submitters, no conflicts	17	78079669	17	80105870	92488	98397
NM_000152.4(GAA):c.670C>T (p.Arg224Trp)	GAA	Glycogen storage disease, type II|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 2, 2018)	criteria provided, conflicting interpretations	17	78079671	17	80105872	189188	186994
NM_000152.4(GAA):c.784G>A (p.Glu262Lys)	GAA	Glycogen storage disease, type II|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 22, 2017)	criteria provided, multiple submitters, no conflicts	17	78081447	17	80107648	188806	186996
NM_000152.4(GAA):c.877G>A (p.Gly293Arg)	GAA	Glycogen storage disease, type II|Glycogen storage disease II, adult form|not provided	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, multiple submitters, no conflicts	17	78081617	17	80107818	4036	19075
NM_000152.4(GAA):c.925G>A (p.Gly309Arg)	GAA	Glycogen storage disease, type II|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 24, 2017)	criteria provided, multiple submitters, no conflicts	17	78081665	17	80107866	188797	186997
NM_000152.4(GAA):c.1082C>T (p.Pro361Leu)	GAA	Glycogen storage disease, type II	Pathogenic(Last reviewed: Oct 6, 2016)	criteria provided, single submitter	17	78082294	17	80108495	403712	390687
NM_000152.4(GAA):c.1309C>T (p.Arg437Cys)	GAA	Glycogen storage disease, type II	Likely pathogenic(Last reviewed: Dec 10, 2014)	criteria provided, single submitter	17	78082610	17	80108811	189082	187001
NM_000152.4(GAA):c.1316T>A (p.Met439Lys)	GAA	Glycogen storage disease, type II|Glycogen storage disease	Likely pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, multiple submitters, no conflicts	17	78082617	17	80108818	371305	358501
NM_000152.4(GAA):c.1441T>C (p.Trp481Arg)	GAA	Glycogen storage disease, type II	Likely pathogenic(Last reviewed: Oct 10, 2014)	criteria provided, single submitter	17	78084529	17	80110730	189007	187004
NM_000152.4(GAA):c.1556T>C (p.Met519Thr)	GAA	Glycogen storage disease, type II|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 2, 2016)	criteria provided, conflicting interpretations	17	78084744	17	80110945	189124	187006
NM_000152.4(GAA):c.1561G>A (p.Glu521Lys)	GAA	Glycogen storage disease, type II|Glycogen storage disease type II, infantile	Likely pathogenic(Last reviewed: Nov 20, 2014)	criteria provided, single submitter	17	78084749	17	80110950	4022	19061
NM_000152.4(GAA):c.1726G>A (p.Gly576Ser)	GAA	Glycogen storage disease, type II|not specified|not provided	Benign/Likely benign, other(Last reviewed: Jul 9, 2018)	criteria provided, multiple submitters, no conflicts	17	78085871	17	80112072	92467	98376
NM_000152.4(GAA):c.1843G>A (p.Gly615Arg)	GAA	Glycogen storage disease, type II	Pathogenic/Likely pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, multiple submitters, no conflicts	17	78086465	17	80112666	188786	187009
NM_000152.4(GAA):c.1933G>C (p.Asp645His)	GAA	Glycogen storage disease, type II	Likely pathogenic(Last reviewed: Oct 14, 2014)	criteria provided, single submitter	17	78086719	17	80112920	189013	187011
NM_000152.4(GAA):c.1933G>A (p.Asp645Asn)	GAA	Glycogen storage disease, type II|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 22, 2018)	criteria provided, multiple submitters, no conflicts	17	78086719	17	80112920	188728	187010
NM_000152.4(GAA):c.1935C>A (p.Asp645Glu)	GAA	Glycogen storage disease, type II|Glycogen storage disease type II, infantile	Pathogenic(Last reviewed: Nov 9, 2017)	criteria provided, multiple submitters, no conflicts	17	78086721	17	80112922	4029	19068
NM_000152.4(GAA):c.1942G>A (p.Gly648Ser)	GAA	Glycogen storage disease, type II	Pathogenic/Likely pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, multiple submitters, no conflicts	17	78086728	17	80112929	188902	187012
NM_000152.4(GAA):c.1979G>A (p.Arg660His)	GAA	Glycogen storage disease, type II|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 25, 2017)	criteria provided, multiple submitters, no conflicts	17	78086765	17	80112966	189172	187013
NM_000152.4(GAA):c.2014C>T (p.Arg672Trp)	GAA	Glycogen storage disease, type II|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	17	78086800	17	80113001	188773	187014
NM_000152.3(GAA):c.2065G>A (p.Glu689Lys)	GAA	Glycogen storage disease, type II|Acid alpha-glucosidase, allele 4|not specified|not provided	Conflicting interpretations of pathogenicity, other(Last reviewed: Jul 9, 2018)	criteria provided, conflicting interpretations	17	78087041	17	80113242	4030	19069
NM_000152.4(GAA):c.2104C>T (p.Arg702Cys)	GAA	Glycogen storage disease, type II	Likely pathogenic(Last reviewed: Oct 28, 2014)	criteria provided, single submitter	17	78087080	17	80113281	189040	187016
NM_000152.4(GAA):c.2173C>T (p.Arg725Trp)	GAA	Glycogen storage disease, type II|Glycogen storage disease II, adult form	Pathogenic/Likely pathogenic(Last reviewed: Dec 15, 2016)	criteria provided, multiple submitters, no conflicts	17	78087149	17	80113350	4024	19063
Multiple alleles	GAA	Glycogen storage disease, type II	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	17|17	78090814	17|17	80117015	561160	186561|552208
NM_000152.4(GAA):c.2338G>A (p.Val780Ile)	GAA	Glycogen storage disease, type II|not specified|not provided	Benign(Last reviewed: Sep 4, 2018)	criteria provided, multiple submitters, no conflicts	17	78091405	17	80117606	92476	98385
NM_000152.4(GAA):c.2446G>A (p.Val816Ile)	GAA	Glycogen storage disease, type II|not specified|not provided	Benign/Likely benign(Last reviewed: Aug 1, 2017)	criteria provided, multiple submitters, no conflicts	17	78091513	17	80117714	92477	98386
NM_000152.4(GAA):c.2780C>T (p.Thr927Ile)	GAA	Glycogen storage disease, type II|not specified|not provided	Benign/Likely benign(Last reviewed: Aug 8, 2017)	criteria provided, multiple submitters, no conflicts	17	78092585	17	80118786	92482	98391
NM_001614.3(ACTG1):c.598T>A (p.Phe200Ile)	ACTG1	Baraitser-Winter Syndrome 2	Likely pathogenic(Last reviewed: Jun 28, 2013)	criteria provided, single submitter	17	79478418	17	81511392	128266	133715
NM_001614.3(ACTG1):c.520G>T (p.Ala174Ser)	ACTG1	not provided	Uncertain significance(Last reviewed: Jan 16, 2013)	criteria provided, single submitter	17	79478496	17	81511470	128265	133714
NM_001614.3(ACTG1):c.464C>T (p.Ser155Phe)	ACTG1	Baraitser-Winter Syndrome 2|not provided	Pathogenic(Last reviewed: Sep 25, 2013)	criteria provided, single submitter	17	79478552	17	81511526	29585	38539
NM_005559.3(LAMA1):c.1706G>C (p.Trp569Ser)	LAMA1	Poretti-Boltshauser syndrome	Uncertain significance(Last reviewed: Mar 12, 2018)	criteria provided, single submitter	18	7037608	18	7037609	522848	513475
NM_021074.4(NDUFV2):c.86T>C (p.Val29Ala)	NDUFV2	Mitochondrial complex I deficiency|Parkinson disease, mitochondrial|not specified|not provided	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	18	9117867	18	9117869	9054	24093
NM_006796.2(AFG3L2):c.1951A>G (p.Arg651Gly)	AFG3L2	Spastic ataxia 5, autosomal recessive	Likely pathogenic(Last reviewed: Jan 1, 2016)	no assertion criteria provided	18	12340229	18	12340230	374935	361845
NM_000529.2(MC2R):c.674T>G (p.Leu225Arg)	MC2R	ACTH resistance	Pathogenic(Last reviewed: Apr 20, 2015)	criteria provided, single submitter	18	13884844	18	13884845	444064	437707
NM_000529.2(MC2R):c.424G>T (p.Val142Leu)	MC2R	ACTH resistance	Pathogenic(Last reviewed: Apr 20, 2015)	criteria provided, single submitter	18	13885094	18	13885095	444066	437709
NM_002894.2(RBBP8):c.1071A>C (p.Lys357Asn)	RBBP8	Microcephaly with mental retardation and digital anomalies|Seckel syndrome|not specified|not provided	Likely benign(Last reviewed: Oct 11, 2016)	criteria provided, multiple submitters, no conflicts	18	20572861	18	22992898	130102	135548
NM_002894.2(RBBP8):c.1367A>G (p.His456Arg)	RBBP8	Microcephaly with mental retardation and digital anomalies|Seckel syndrome|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 29, 2017)	criteria provided, conflicting interpretations	18	20573157	18	22993194	130103	135549
NM_002894.2(RBBP8):c.1766G>A (p.Arg589His)	RBBP8	not specified	Benign(Last reviewed: Aug 5, 2016)	criteria provided, multiple submitters, no conflicts	18	20573556	18	22993593	130105	135551
NM_002894.2(RBBP8):c.1865G>A (p.Gly622Glu)	RBBP8	not provided	Uncertain significance(Last reviewed: Dec 6, 2013)	criteria provided, single submitter	18	20573736	18	22993773	130106	135552
NM_000271.4(NPC1):c.3614C>G (p.Thr1205Arg)	NPC1	Niemann-Pick disease, type C	Likely pathogenic(Last reviewed: May 10, 2016)	criteria provided, single submitter	18	21113459	18	23533495	505018	497495
NM_000271.4(NPC1):c.3614C>A (p.Thr1205Lys)	NPC1	Niemann-Pick disease type C1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 21, 2016)	criteria provided, multiple submitters, no conflicts	18	21113459	18	23533495	188747	187020
NM_000271.4(NPC1):c.3557G>A (p.Arg1186His)	NPC1	Niemann-Pick disease type C1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 24, 2017)	criteria provided, multiple submitters, no conflicts	18	21114444	18	23534480	189174	187022
NM_000271.4(NPC1):c.3127A>G (p.Thr1043Ala)	NPC1	Niemann-Pick disease type C1	Pathogenic(Last reviewed: Nov 1, 2015)	no assertion criteria provided	18	21116755	18	23536791	235096	236859
NM_000271.4(NPC1):c.3107C>T (p.Thr1036Met)	NPC1	Niemann-Pick disease type C1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 16, 2017)	criteria provided, conflicting interpretations	18	21116775	18	23536811	2958	17997
NM_000271.4(NPC1):c.3019C>G (p.Pro1007Ala)	NPC1	Niemann-Pick disease type C1|Cataplexy|Cerebellar ataxia|Niemann-Pick disease, type C|Cognitive impairment|Headache|not provided|Speech apraxia|Ataxia|Postural instability|Cataplexy|Cognitive impairment	Conflicting interpretations of pathogenicity(Last reviewed: Apr 24, 2018)	criteria provided, conflicting interpretations	18	21118528	18	23538564	2966	18005
NM_000271.4(NPC1):c.2974G>A (p.Gly992Arg)	NPC1	Niemann-Pick disease type C1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 21, 2016)	criteria provided, multiple submitters, no conflicts	18	21118573	18	23538609	21137	33989
NM_000271.4(NPC1):c.2974G>C (p.Gly992Arg)	NPC1	Niemann-Pick disease type C1|Niemann-Pick disease, type C|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 25, 2017)	criteria provided, multiple submitters, no conflicts	18	21118573	18	23538609	2969	18008
NM_000271.4(NPC1):c.2974G>T (p.Gly992Trp)	NPC1	Niemann-Pick disease type C1|Niemann-Pick disease, type D|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 7, 2017)	criteria provided, conflicting interpretations	18	21118573	18	23538609	2960	17999
NM_000271.4(NPC1):c.2932C>T (p.Arg978Cys)	NPC1	Niemann-Pick disease type C1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 22, 2018)	criteria provided, multiple submitters, no conflicts	18	21118615	18	23538651	2976	18015
NM_000271.4(NPC1):c.2861C>T (p.Ser954Leu)	NPC1	Niemann-Pick disease type C1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, multiple submitters, no conflicts	18	21119369	18	23539405	181457	179794
NM_000271.4(NPC1):c.2848G>A (p.Val950Met)	NPC1	Niemann-Pick disease type C1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, multiple submitters, no conflicts	18	21119382	18	23539418	2971	18010
NM_000271.4(NPC1):c.2819C>T (p.Ser940Leu)	NPC1	Niemann-Pick disease type C1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 18, 2017)	criteria provided, multiple submitters, no conflicts	18	21119411	18	23539447	188716	187026
NM_000271.4(NPC1):c.2801G>A (p.Arg934Gln)	NPC1	Niemann-Pick disease type C1	Likely pathogenic(Last reviewed: Jan 6, 2015)	criteria provided, single submitter	18	21119429	18	23539465	189117	187027
NM_000271.4(NPC1):c.2747A>G (p.Asn916Ser)	NPC1	Niemann-Pick disease type C1|not provided	Uncertain significance(Last reviewed: Jun 19, 2018)	criteria provided, single submitter	18	21119823	18	23539859	374343	361231
NM_000271.4(NPC1):c.2621A>T (p.Asp874Val)	NPC1	Niemann-Pick disease type C1|Niemann-Pick disease, type C|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 5, 2017)	criteria provided, multiple submitters, no conflicts	18	21119949	18	23539985	194810	191973
NM_000271.4(NPC1):c.2572A>G (p.Ile858Val)	NPC1	Niemann-Pick disease type C1|Niemann-Pick disease, type C|not specified|not provided	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	18	21120444	18	23540480	21135	33987
NM_000271.4(NPC1):c.1926G>C (p.Met642Ile)	NPC1	Niemann-Pick disease type C1|Niemann-Pick disease, type C|not specified|not provided	Benign(Last reviewed: Nov 21, 2017)	criteria provided, multiple submitters, no conflicts	18	21124945	18	23544981	92701	98608
NM_000271.4(NPC1):c.1628C>T (p.Pro543Leu)	NPC1	Niemann-Pick disease type C1|Niemann-Pick disease, type C	Pathogenic/Likely pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, multiple submitters, no conflicts	18	21131617	18	23551653	181455	179798
NM_000271.4(NPC1):c.1553G>A (p.Arg518Gln)	NPC1	Niemann-Pick disease type C1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 29, 2016)	criteria provided, multiple submitters, no conflicts	18	21134722	18	23554758	132890	136639
NM_000271.4(NPC1):c.1223T>C (p.Leu408Pro)	NPC1	Niemann-Pick disease type C1	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	18	21136310	18	23556346	561067	552209
NM_000271.4(NPC1):c.1211G>A (p.Arg404Gln)	NPC1	Niemann-Pick disease type C1|Niemann-Pick disease, type C|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 24, 2017)	criteria provided, multiple submitters, no conflicts	18	21136322	18	23556358	188794	187031
NM_000271.4(NPC1):c.709C>T (p.Pro237Ser)	NPC1	Niemann-Pick disease type C1|not specified|not provided	Benign/Likely benign(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	18	21140367	18	23560403	21142	33994
NM_000271.4(NPC1):c.644A>G (p.His215Arg)	NPC1	Niemann-Pick disease type C1|Niemann-Pick disease, type C|not specified|not provided	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	18	21140432	18	23560468	92714	98621
NM_000271.4(NPC1):c.530G>A (p.Cys177Tyr)	NPC1	Niemann-Pick disease type C1|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, multiple submitters, no conflicts	18	21141425	18	23561461	2974	18013
NM_024422.4(DSC2):c.749T>C (p.Phe250Ser)	DSC2	Arrhythmogenic right ventricular cardiomyopathy, type 11	Likely pathogenic(Last reviewed: Mar 2, 2018)	criteria provided, single submitter	18	28667658	18	31087695	523128	513753
NM_030632.2(ASXL3):c.3136G>A (p.Gly1046Arg)	ASXL3	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	18	31322948	18	33742984	402202	389174
NM_144612.6(LOXHD1):c.4217C>T (p.Ala1406Val)	LOXHD1	Deafness, autosomal recessive 77|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jan 26, 2018)	criteria provided, conflicting interpretations	18	44113283	18	46533320	178397	176700
NM_144612.6(LOXHD1):c.1571G>A (p.Arg524His)	LOXHD1	Deafness, autosomal recessive 77|not specified|Nonsyndromic Hearing Loss, Recessive	Uncertain significance(Last reviewed: May 23, 2017)	criteria provided, multiple submitters, no conflicts	18	44171979	18	46592016	47918	57082
NM_005215.3(DCC):c.2071C>A (p.Gln691Lys)	DCC	Developmental Split Brain Syndrome	Uncertain significance(Last reviewed: Jan 26, 2017)	no assertion criteria provided	18	50848434	18	53322064	446760	440336
NM_176787.4(PIGN):c.996T>G (p.Ile332Met)	PIGN	Multiple congenital anomalies-hypotonia-seizures syndrome 1|Abnormality of brain morphology	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, multiple submitters, no conflicts	18	59807680	18	62140447	402190	389175
NM_173630.3(RTTN):c.6535G>C (p.Ala2179Pro)	RTTN	not provided	Uncertain significance(Last reviewed: Mar 13, 2014)	criteria provided, single submitter	18	67672494	18	70005258	130195	135642
NM_173630.3(RTTN):c.6445G>A (p.Ala2149Thr)	RTTN	not specified|Microcephaly, short stature, and polymicrogyria with or without seizures|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	18	67673697	18	70006461	130194	135641
NM_173630.3(RTTN):c.5282T>C (p.Phe1761Ser)	RTTN	not specified	Benign(Last reviewed: Mar 29, 2016)	criteria provided, multiple submitters, no conflicts	18	67718688	18	70051452	130188	135635
NM_173630.3(RTTN):c.5174A>C (p.Lys1725Thr)	RTTN	Microcephaly, short stature, and polymicrogyria with or without seizures	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	18	67721378	18	70054142	561099	552213
NM_173630.3(RTTN):c.5060C>G (p.Ser1687Cys)	RTTN	not specified	Benign(Last reviewed: Dec 8, 2016)	criteria provided, single submitter	18	67721492	18	70054256	130186	135633
NM_173630.3(RTTN):c.4889G>C (p.Arg1630Thr)	RTTN	not specified	Benign(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	18	67727137	18	70059901	130183	135630
NM_173630.3(RTTN):c.4850T>C (p.Met1617Thr)	RTTN	not specified	Benign(Last reviewed: May 30, 2017)	criteria provided, single submitter	18	67727176	18	70059940	130182	135629
NM_173630.3(RTTN):c.3581A>G (p.Glu1194Gly)	RTTN	not specified	Likely benign(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	18	67781783	18	70114547	130177	135624
NM_173630.3(RTTN):c.3337T>C (p.Cys1113Arg)	RTTN	not provided	Uncertain significance(Last reviewed: Jun 15, 2018)	criteria provided, multiple submitters, no conflicts	18	67794784	18	70127548	130176	135623
NM_173630.3(RTTN):c.2990C>T (p.Ala997Val)	RTTN	not provided	Uncertain significance(Last reviewed: Oct 24, 2013)	criteria provided, single submitter	18	67795747	18	70128511	130174	135621
NM_173630.3(RTTN):c.1665C>A (p.Asn555Lys)	RTTN	not specified	Benign(Last reviewed: Dec 8, 2016)	criteria provided, single submitter	18	67836115	18	70168879	130165	135612
NM_173630.3(RTTN):c.805T>C (p.Phe269Leu)	RTTN	not specified	Likely benign	no assertion criteria provided	18	67863773	18	70196537	130198	135645
NM_173630.3(RTTN):c.734A>G (p.Lys245Arg)	RTTN	not specified	Benign(Last reviewed: Feb 4, 2016)	criteria provided, single submitter	18	67863844	18	70196608	130197	135644
NM_173630.3(RTTN):c.376T>G (p.Ser126Ala)	RTTN	not specified	Benign(Last reviewed: Jul 21, 2017)	criteria provided, multiple submitters, no conflicts	18	67871343	18	70204107	130179	135626
NM_173630.3(RTTN):c.376T>A (p.Ser126Thr)	RTTN	not specified	Likely benign	no assertion criteria provided	18	67871343	18	70204107	130178	135625
NM_173630.3(RTTN):c.227C>T (p.Pro76Leu)	RTTN	not specified	Benign(Last reviewed: Oct 6, 2016)	criteria provided, single submitter	18	67871492	18	70204256	130170	135617
NM_001040134.1(PALM):c.71G>A (p.Arg24Gln)	PALM	atypical cerebral palsy	Uncertain significance	criteria provided, single submitter	19	727021	19	727021	431724	425227
NM_001040134.1(PALM):c.461C>T (p.Thr154Met)	PALM	atypical cerebral palsy	Uncertain significance	criteria provided, single submitter	19	736037	19	736037	431725	425228
NM_024407.4(NDUFS7):c.68C>T (p.Pro23Leu)	NDUFS7	Mitochondrial complex I deficiency|Leigh syndrome|not specified|not provided	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	19	1388538	19	1388539	129702	135148
NM_000156.5(GAMT):c.626C>T (p.Thr209Met)	GAMT|NDUFS7	Deficiency of guanidinoacetate methyltransferase|Mitochondrial complex I deficiency|Leigh syndrome|not specified|not provided|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Aug 9, 2017)	criteria provided, multiple submitters, no conflicts	19	1397443	19	1397444	21068	33920
NM_138422.3(ADAT3):c.430G>A (p.Val144Met)	SCAMP4|ADAT3	not provided|Mental retardation, autosomal recessive 36	Pathogenic(Last reviewed: May 5, 2017)	criteria provided, multiple submitters, no conflicts	19	1912476	19	1912477	183301	181459
NM_133261.2(GIPC3):c.122C>A (p.Thr41Lys)	GIPC3	Nonsyndromic hearing loss and deafness|not provided	Likely pathogenic(Last reviewed: Jun 3, 2016)	criteria provided, multiple submitters, no conflicts	19	3585717	19	3585719	163502	176723
NM_005934.3(MLLT1):c.1418G>A (p.Arg473Gln)	MLLT1	Hypertelorism|Global developmental delay|Cerebral atrophy|Short nose|Hypertelorism|Global developmental delay|Abnormal cortical gyration|Muscular hypotonia|Infantile spasms|Muscular hypotonia	Likely pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	19	6213798	19	6213787	242890	243996
NM_020533.2(MCOLN1):c.1084G>T (p.Asp362Tyr)	MCOLN1	Mucolipidosis type IV|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 14, 2018)	criteria provided, multiple submitters, no conflicts	19	7593806	19	7528920	5135	20174
NM_006702.4(PNPLA6):c.1090G>C (p.Ala364Pro)	PNPLA6	not specified|Spastic Paraplegia, Recessive	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	7606908	19	7542022	129977	135423
NM_006702.4(PNPLA6):c.[3242G>T];[3390G>C]	PNPLA6	Boucher Neuhauser syndrome	Pathogenic(Last reviewed: Jun 20, 2017)	no assertion criteria provided	19|19	7622129	19|19	7557243	430849	424391|424392
NM_030957.3(ADAMTS10):c.[2350C>T];[2521T>C]	ADAMTS10	Weill-Marchesani syndrome 1	Pathogenic(Last reviewed: Nov 21, 2016)	criteria provided, single submitter	19|19	8651495	19|19	8586611	427834	263867|263866
NM_000528.3(MAN2B1):c.2782G>C (p.Gly928Arg)	MAN2B1	Deficiency of alpha-mannosidase|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Sep 28, 2017)	criteria provided, conflicting interpretations	19	12758295	19	12647481	287586	271823
NM_000528.3(MAN2B1):c.2426T>C (p.Leu809Pro)	MAN2B1	Deficiency of alpha-mannosidase	Conflicting interpretations of pathogenicity(Last reviewed: Feb 20, 2018)	criteria provided, conflicting interpretations	19	12759960	19	12649146	21210	34062
NM_000528.3(MAN2B1):c.1238A>G (p.Asn413Ser)	MAN2B1	Deficiency of alpha-mannosidase|not specified|not provided	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	12768948	19	12658134	129584	135030
NM_000528.3(MAN2B1):c.1010G>A (p.Arg337Gln)	MAN2B1	Deficiency of alpha-mannosidase|not specified|not provided	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	12772090	19	12661276	93207	99114
NM_000528.3(MAN2B1):c.935C>T (p.Thr312Ile)	MAN2B1	Deficiency of alpha-mannosidase|not specified|not provided	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	12772165	19	12661351	93218	99125
NM_000528.3(MAN2B1):c.832C>G (p.Leu278Val)	MAN2B1	Deficiency of alpha-mannosidase|not specified|not provided	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	12774208	19	12663394	93217	99124
NM_006397.2(RNASEH2A):c.556C>T (p.Arg186Trp)	RNASEH2A	Aicardi Goutieres syndrome 4|Aicardi Goutieres syndrome	Likely pathogenic(Last reviewed: Mar 21, 2017)	criteria provided, single submitter	19	12921137	19	12810323	66068	76972
NM_006397.2(RNASEH2A):c.855C>G (p.His285Gln)	RNASEH2A	Aicardi Goutieres syndrome 4	Uncertain significance(Last reviewed: Sep 6, 2018)	criteria provided, single submitter	19	12924235	19	12813421	598755	589810
NM_000159.3(GCDH):c.262C>T (p.Arg88Cys)	GCDH	Glutaric aciduria, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, multiple submitters, no conflicts	19	13002779	19	12891965	189150	187035
NM_000159.3(GCDH):c.383G>A (p.Arg128Gln)	GCDH	Glutaric aciduria, type 1	Likely pathogenic(Last reviewed: Nov 14, 2014)	criteria provided, single submitter	19	13004345	19	12893531	189063	187037
NM_000159.3(GCDH):c.416C>T (p.Ser139Leu)	GCDH	Glutaric aciduria, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 14, 2015)	criteria provided, multiple submitters, no conflicts	19	13004378	19	12893564	188921	187038
NM_000159.3(GCDH):c.482G>A (p.Arg161Gln)	GCDH	Glutaric aciduria, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 9, 2016)	criteria provided, multiple submitters, no conflicts	19	13004444	19	12893630	188789	187039
NM_000159.3(GCDH):c.528C>G (p.Cys176Trp)	GCDH	Glutaric aciduria, type 1	Likely pathogenic(Last reviewed: Feb 6, 2018)	no assertion criteria provided	19	13006828	19	12896014	524195	514843
NM_000159.3(GCDH):c.533G>A (p.Gly178Glu)	GCDH	Glutaric aciduria, type 1	Likely pathogenic(Last reviewed: Oct 14, 2014)	criteria provided, multiple submitters, no conflicts	19	13006833	19	12896019	189012	187040
NM_000159.3(GCDH):c.550A>G (p.Ser184Gly)	GCDH	Glutaric aciduria, type 1	Uncertain significance	criteria provided, single submitter	19	13006850	19	12896036	431702	425226
NM_000159.3(GCDH):c.680G>C (p.Arg227Pro)	GCDH	Glutaric aciduria, type 1|not provided|Glutaric acidemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 15, 2017)	criteria provided, multiple submitters, no conflicts	19	13007063	19	12896249	2089	17128
NM_000159.3(GCDH):c.769C>T (p.Arg257Trp)	GCDH	Glutaric aciduria, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, multiple submitters, no conflicts	19	13007152	19	12896338	188872	187041
NM_000159.3(GCDH):c.856C>T (p.Pro286Ser)	GCDH	Glutaric aciduria, type 1	Likely pathogenic(Last reviewed: Mar 13, 2015)	criteria provided, single submitter	19	13007727	19	12896913	191374	189179
NM_000159.3(GCDH):c.881G>C (p.Arg294Pro)	GCDH	Glutaric aciduria, type 1	Likely pathogenic(Last reviewed: Jun 7, 2017)	no assertion criteria provided	19	13007752	19	12896938	430833	424376
NM_000159.3(GCDH):c.1060G>A (p.Gly354Ser)	GCDH	Glutaric aciduria, type 1	Likely pathogenic(Last reviewed: Aug 27, 2014)	criteria provided, single submitter	19	13008220	19	12897406	188946	187042
NM_000159.3(GCDH):c.1147C>T (p.Arg383Cys)	GCDH	Glutaric aciduria, type 1	Likely pathogenic(Last reviewed: Jun 29, 2014)	criteria provided, single submitter	19	13008581	19	12897767	188852	187043
NM_000159.3(GCDH):c.1205G>A (p.Arg402Gln)	GCDH	Glutaric aciduria, type 1	Likely pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, multiple submitters, no conflicts	19	13008639	19	12897825	189011	187044
NM_017721.4(CC2D1A):c.566C>T (p.Ala189Val)	CC2D1A	not specified|History of neurodevelopmental disorder	Likely benign(Last reviewed: Nov 30, 2017)	criteria provided, single submitter	19	14024269	19	13913456	128623	134072
NM_017721.4(CC2D1A):c.1015A>C (p.Thr339Pro)	CC2D1A	not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Mar 11, 2016)	criteria provided, single submitter	19	14029627	19	13918814	128613	134062
NM_017721.4(CC2D1A):c.1192G>A (p.Val398Met)	CC2D1A	not provided	Uncertain significance(Last reviewed: Mar 21, 2014)	criteria provided, single submitter	19	14029985	19	13919172	128614	134063
NM_017721.4(CC2D1A):c.1549G>A (p.Val517Met)	CC2D1A	not provided	Uncertain significance(Last reviewed: Jan 24, 2014)	criteria provided, single submitter	19	14031643	19	13920830	128616	134065
NM_017721.4(CC2D1A):c.1634T>C (p.Ile545Thr)	CC2D1A	not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jul 8, 2016)	criteria provided, multiple submitters, no conflicts	19	14031728	19	13920915	128617	134066
NM_017721.4(CC2D1A):c.1739C>T (p.Thr580Ile)	CC2D1A	not specified|not provided|Smith-Magenis Syndrome-like|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Jun 29, 2017)	criteria provided, conflicting interpretations	19	14034243	19	13923430	128618	134067
NM_017721.4(CC2D1A):c.2402C>T (p.Thr801Met)	CC2D1A	not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Mar 17, 2016)	criteria provided, single submitter	19	14038791	19	13927978	128619	134068
NM_017721.4(CC2D1A):c.2657G>A (p.Arg886His)	CC2D1A	not specified|Smith-Magenis Syndrome-like	Conflicting interpretations of pathogenicity(Last reviewed: Sep 14, 2016)	criteria provided, conflicting interpretations	19	14040420	19	13929607	254203	248718
NM_017721.4(CC2D1A):c.2707C>T (p.Arg903Trp)	CC2D1A	not provided	Uncertain significance(Last reviewed: Mar 24, 2014)	criteria provided, single submitter	19	14040470	19	13929657	128621	134070
NM_017721.4(CC2D1A):c.2716G>A (p.Ala906Thr)	CC2D1A	not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Mar 11, 2016)	criteria provided, single submitter	19	14040896	19	13930083	128622	134071
NM_001195422.1(GTPBP3):c.506C>T (p.Ala169Val)	GTPBP3	Combined oxidative phosphorylation deficiency 23	Likely pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	19	17449399	19	17338590	488525	481393
NM_001195422.1(GTPBP3):c.583C>T (p.Arg195Trp)	GTPBP3	Combined oxidative phosphorylation deficiency 23	Likely pathogenic(Last reviewed: Oct 23, 2017)	criteria provided, single submitter	19	17449476	19	17338667	488526	481394
NM_001195422.1(GTPBP3):c.1178T>C (p.Leu393Pro)	GTPBP3	Combined oxidative phosphorylation deficiency 23	Likely pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	19	17451990	19	17341181	488528	481396
NM_000215.3(JAK3):c.1744C>T (p.Arg582Trp)	JAK3	Severe combined immunodeficiency disease	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	19	17947980	19	17837171	36415	45078
NM_001031726.3(C19orf12):c.425A>C (p.Lys142Thr)	C19orf12	Neurodegeneration with brain iron accumulation 4|not specified|Spastic paraplegia 43, autosomal recessive	Benign/Likely benign(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	19	30193653	19	29702746	128538	133987
NM_001031726.3(C19orf12):c.205G>A (p.Gly69Arg)	C19orf12	Neurodegeneration with brain iron accumulation 4|Dystonia|Spastic paraplegia 43, autosomal recessive|Mental deterioration|Dystonia|Tremor|Adult-onset night blindness|Peripheral visual field loss	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, multiple submitters, no conflicts	19	30193873	19	29702966	31157	40114
NM_031448.4(C19orf12):c.161G>T (p.Gly54Val)	C19orf12	Global developmental delay|not provided|Intellectual disability|Global developmental delay	Likely pathogenic(Last reviewed: Mar 10, 2017)	criteria provided, multiple submitters, no conflicts	19	30193884	19	29702977	402183	389176
NM_001126335.1(SLC7A9):c.988G>A (p.Val330Met)	SLC7A9	Cystinuria	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	19	33334847	19	32843941	161392	171225
NM_014270.4(SLC7A9):c.544G>A (p.Ala182Thr)	SLC7A9	Cystinuria|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, multiple submitters, no conflicts	19	33353427	19	32862521	5782	20821
NM_000285.3(PEPD):c.1342G>A (p.Gly448Arg)	PEPD	Prolidase deficiency	Pathogenic(Last reviewed: Feb 25, 2016)	criteria provided, single submitter	19	33878798	19	33387892	213	15252
NM_004646.3(NPHS1):c.2928G>T (p.Arg976Ser)	NPHS1	Finnish congenital nephrotic syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, multiple submitters, no conflicts	19	36330320	19	35839418	188761	187048
NM_004646.3(NPHS1):c.2417C>A (p.Ala806Asp)	NPHS1	Finnish congenital nephrotic syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 7, 2016)	criteria provided, multiple submitters, no conflicts	19	36333370	19	35842468	56473	71112
NM_004646.3(NPHS1):c.2206G>A (p.Val736Met)	NPHS1	Finnish congenital nephrotic syndrome	Pathogenic(Last reviewed: Jan 6, 2017)	no assertion criteria provided	19	36335011	19	35844109	430877	424418
NM_004646.3(NPHS1):c.1868G>T (p.Cys623Phe)	NPHS1	Finnish congenital nephrotic syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	36336332	19	35845430	56453	71092
NM_004646.3(NPHS1):c.1379G>A (p.Arg460Gln)	NPHS1	Finnish congenital nephrotic syndrome	Likely pathogenic(Last reviewed: Aug 29, 2014)	criteria provided, single submitter	19	36339004	19	35848102	56438	71077
NM_004646.3(NPHS1):c.1048T>C (p.Ser350Pro)	NPHS1	Finnish congenital nephrotic syndrome	Likely pathogenic(Last reviewed: Oct 16, 2014)	criteria provided, single submitter	19	36339661	19	35848759	56419	71058
NM_001083961.1(WDR62):c.32G>C (p.Arg11Pro)	WDR62	Primary autosomal recessive microcephaly 2	Uncertain significance(Last reviewed: Apr 3, 2013)	criteria provided, single submitter	19	36545905	19	36055003	160280	169473
NM_001083961.1(WDR62):c.82C>G (p.Arg28Gly)	WDR62	Primary autosomal recessive microcephaly 2	Uncertain significance(Last reviewed: Nov 15, 2012)	criteria provided, single submitter	19	36545955	19	36055053	160307	169474
NM_001083961.1(WDR62):c.142C>T (p.Leu48Phe)	WDR62	Primary autosomal recessive microcephaly 2|not specified|not provided	Benign/Likely benign(Last reviewed: Mar 15, 2018)	criteria provided, multiple submitters, no conflicts	19	36546015	19	36055113	93535	99440
NM_001083961.1(WDR62):c.359C>A (p.Ser120Tyr)	WDR62	Primary autosomal recessive microcephaly 2	Likely pathogenic(Last reviewed: Nov 29, 2012)	criteria provided, single submitter	19	36556886	19	36065984	160292	169478
NM_001083961.1(WDR62):c.589G>A (p.Val197Ile)	WDR62	Primary autosomal recessive microcephaly 2	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	19	36558235	19	36067333	160306	169481
NM_001083961.1(WDR62):c.866A>G (p.Lys289Arg)	WDR62	not specified|not provided|Primary Microcephaly 2 With or Without Cortical Malformations	Conflicting interpretations of pathogenicity(Last reviewed: Dec 8, 2017)	criteria provided, conflicting interpretations	19	36558896	19	36067994	160308	169482
NM_001083961.1(WDR62):c.964G>C (p.Ala322Pro)	WDR62	Primary autosomal recessive microcephaly 2	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	19	36562539	19	36071637	160309	169483
NM_001083961.1(WDR62):c.1225A>G (p.Asn409Asp)	WDR62	Primary autosomal recessive microcephaly 2|not specified|not provided	Likely benign(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	19	36564425	19	36073523	160244	169485
NM_001083961.1(WDR62):c.1312C>T (p.Arg438Cys)	WDR62	Primary autosomal recessive microcephaly 2	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	19	36572413	19	36081511	160246	169487
NM_001083961.1(WDR62):c.1315T>G (p.Phe439Val)	WDR62	not specified	Benign(Last reviewed: Jul 16, 2013)	criteria provided, single submitter	19	36572416	19	36081514	160247	169488
NM_001083961.1(WDR62):c.1480G>A (p.Gly494Arg)	WDR62	Primary autosomal recessive microcephaly 2|Inborn genetic diseases	Likely pathogenic(Last reviewed: Oct 23, 2015)	criteria provided, multiple submitters, no conflicts	19	36574073	19	36083171	160249	169490
NM_001083961.1(WDR62):c.1486C>T (p.Arg496Trp)	WDR62	Primary autosomal recessive microcephaly 2	Uncertain significance(Last reviewed: Sep 17, 2013)	criteria provided, single submitter	19	36574079	19	36083177	160250	169491
NM_001083961.1(WDR62):c.1534C>G (p.Arg512Gly)	WDR62	Primary autosomal recessive microcephaly 2	Uncertain significance(Last reviewed: May 28, 2014)	criteria provided, single submitter	19	36574127	19	36083225	160251	169492
NM_001083961.1(WDR62):c.1576G>A (p.Glu526Lys)	WDR62	Primary autosomal recessive microcephaly 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 14, 2017)	criteria provided, conflicting interpretations	19	36575580	19	36084678	41	15080
NM_001083961.1(WDR62):c.1681A>T (p.Ile561Phe)	WDR62	Primary autosomal recessive microcephaly 2	Uncertain significance(Last reviewed: Jun 10, 2014)	criteria provided, single submitter	19	36577627	19	36086725	160255	169496
NM_001083961.1(WDR62):c.1750A>C (p.Thr584Pro)	WDR62	Primary autosomal recessive microcephaly 2	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	19	36577696	19	36086794	160256	169497
NM_001083961.1(WDR62):c.2281C>T (p.His761Tyr)	WDR62	not specified|Primary Microcephaly 2 With or Without Cortical Malformations	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	19	36583661	19	36092759	137908	141611
NM_001083961.1(WDR62):c.2312A>G (p.Lys771Arg)	WDR62	not specified|not provided	Benign(Last reviewed: Jun 12, 2018)	criteria provided, multiple submitters, no conflicts	19	36583692	19	36092790	160264	169503
NM_001083961.1(WDR62):c.2549T>C (p.Leu850Ser)	WDR62	Primary autosomal recessive microcephaly 2|not specified|not provided|Primary Microcephaly 2 With or Without Cortical Malformations	Benign/Likely benign(Last reviewed: Jun 5, 2017)	criteria provided, multiple submitters, no conflicts	19	36590329	19	36099427	160269	169508
NM_001083961.1(WDR62):c.2566C>T (p.Arg856Cys)	WDR62	Primary autosomal recessive microcephaly 2	Uncertain significance(Last reviewed: Jun 13, 2013)	criteria provided, single submitter	19	36590346	19	36099444	160270	169509
NM_001083961.1(WDR62):c.2584G>T (p.Gly862Cys)	WDR62	Primary autosomal recessive microcephaly 2	Uncertain significance(Last reviewed: Jun 10, 2014)	criteria provided, single submitter	19	36590364	19	36099462	160271	169510
NM_001083961.1(WDR62):c.2896G>A (p.Gly966Arg)	WDR62	Primary autosomal recessive microcephaly 2	Uncertain significance(Last reviewed: Feb 15, 2013)	criteria provided, single submitter	19	36592144	19	36101242	160274	169513
NM_001083961.1(WDR62):c.2945G>A (p.Ser982Asn)	WDR62	Primary autosomal recessive microcephaly 2	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	19	36592193	19	36101291	160275	169514
NM_001083961.1(WDR62):c.3401T>G (p.Met1134Arg)	WDR62	Primary autosomal recessive microcephaly 2|not specified|Primary Microcephaly 2 With or Without Cortical Malformations	Benign/Likely benign(Last reviewed: Jun 5, 2017)	criteria provided, multiple submitters, no conflicts	19	36593915	19	36103013	160285	169522
NM_001083961.1(WDR62):c.3406C>G (p.Arg1136Gly)	WDR62	Primary autosomal recessive microcephaly 2	Uncertain significance(Last reviewed: Apr 18, 2014)	criteria provided, single submitter	19	36593920	19	36103018	160286	169523
NM_001083961.1(WDR62):c.3559G>A (p.Val1187Met)	WDR62	Primary autosomal recessive microcephaly 2	Uncertain significance(Last reviewed: Jul 1, 2014)	criteria provided, single submitter	19	36594289	19	36103387	160290	169527
NM_001083961.1(WDR62):c.3611G>T (p.Gly1204Val)	WDR62	Primary autosomal recessive microcephaly 2	Uncertain significance(Last reviewed: Oct 4, 2013)	criteria provided, single submitter	19	36594341	19	36103439	160293	169529
NM_001083961.1(WDR62):c.3674G>A (p.Arg1225His)	WDR62	not specified|not provided|Primary Microcephaly 2 With or Without Cortical Malformations	Conflicting interpretations of pathogenicity(Last reviewed: Nov 17, 2017)	criteria provided, conflicting interpretations	19	36594404	19	36103502	160295	169531
NM_001083961.1(WDR62):c.3698C>G (p.Ser1233Cys)	WDR62	Primary autosomal recessive microcephaly 2	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	19	36594428	19	36103526	160296	169532
NM_001083961.1(WDR62):c.3929A>T (p.Gln1310Leu)	WDR62	Primary autosomal recessive microcephaly 2|not specified|not provided|Primary Microcephaly 2 With or Without Cortical Malformations	Benign(Last reviewed: Jun 5, 2017)	criteria provided, multiple submitters, no conflicts	19	36594659	19	36103757	93538	99443
NM_001083961.1(WDR62):c.4123G>A (p.Gly1375Ser)	WDR62	Primary autosomal recessive microcephaly 2|not specified|Primary Microcephaly 2 With or Without Cortical Malformations	Conflicting interpretations of pathogenicity(Last reviewed: Jun 5, 2017)	criteria provided, conflicting interpretations	19	36594853	19	36103951	160298	169534
NM_001083961.1(WDR62):c.4170A>C (p.Leu1390Phe)	WDR62	Primary autosomal recessive microcephaly 2|not specified|not provided|Primary Microcephaly 2 With or Without Cortical Malformations	Benign(Last reviewed: Jun 5, 2017)	criteria provided, multiple submitters, no conflicts	19	36595436	19	36104534	160301	169537
NM_001083961.1(WDR62):c.4381T>G (p.Trp1461Gly)	WDR62	Primary autosomal recessive microcephaly 2	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	19	36595739	19	36104837	160303	169539
NM_000540.2(RYR1):c.6502G>A (p.Val2168Met)	RYR1	Malignant hyperthermia, susceptibility to, 1|Minicore myopathy|not provided|RYR1-Related Disorders	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, multiple submitters, no conflicts	19	38985219	19	38494579	12976	28015
NM_000540.2(RYR1):c.7063C>T (p.Arg2355Trp)	RYR1	Minicore myopathy|not provided	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, multiple submitters, no conflicts	19	38990310	19	38499670	133183	136930
NM_000540.2(RYR1):c.11315G>A (p.Arg3772Gln)	RYR1	Malignant hyperthermia susceptibility|Scoliosis|Proximal muscle weakness|not provided|Delayed gross motor development|Pelvic girdle muscle weakness|Progressive distal muscle weakness|Skeletal muscle disease	Conflicting interpretations of pathogenicity(Last reviewed: Nov 1, 2017)	criteria provided, conflicting interpretations	19	39025415	19	38534775	133012	136760
NM_000540.2(RYR1):c.14126C>T (p.Thr4709Met)	RYR1	Myopathy, Central Core|Minicore myopathy|not provided|RYR1-Related Disorders	Pathogenic/Likely pathogenic(Last reviewed: Mar 26, 2018)	criteria provided, multiple submitters, no conflicts	19	39063944	19	38573304	65996	76904
NM_000540.2(RYR1):c.14524G>A	RYR1	not provided|Myopathy, congenital with cores|RYR1-Related Disorders|Skeletal muscle disease	Conflicting interpretations of pathogenicity(Last reviewed: Jan 5, 2018)	criteria provided, conflicting interpretations	19	39071022	19	38580382	133075	38832
NM_001145901.1(SARS2):c.1048T>C (p.Phe350Leu)	SARS2	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	Pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	19	39408569	19	38917929	242874	243995
NM_022835.2(PLEKHG2):c.1708G>A (p.Gly570Arg)	PLEKHG2	not provided|Abnormality of brain morphology	Conflicting interpretations of pathogenicity(Last reviewed: Jun 20, 2017)	criteria provided, conflicting interpretations	19	39913402	19	39422762	402163	389177
NM_001001563.3(TIMM50):c.569G>C (p.Gly190Ala)	TIMM50	Mitochondrial encephalopathy	Pathogenic	criteria provided, single submitter	19	39973525	19	39482885	559479	550203
NM_001001563.4(TIMM50):c.664G>A (p.Ala222Thr)	TIMM50	3-METHYLGLUTACONIC ACIDURIA, TYPE IX	Pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	19	39977103	19	39486463	488622	481490
NM_001001563.4(TIMM50):c.715C>T (p.Arg239Trp)	TIMM50	3-METHYLGLUTACONIC ACIDURIA, TYPE IX	Pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	19	39978719	19	39488079	488623	481491
NM_181882.2(PRX):c.3394G>A (p.Gly1132Arg)	PRX	Charcot-Marie-Tooth disease type 4|not specified	Benign(Last reviewed: Jul 12, 2017)	criteria provided, multiple submitters, no conflicts	19	40900865	19	40394958	130053	135499
NM_181882.2(PRX):c.3248C>G (p.Pro1083Arg)	PRX	Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease, demyelinating, type 4f|not specified	Benign/Likely benign(Last reviewed: Apr 26, 2017)	criteria provided, multiple submitters, no conflicts	19	40901011	19	40395104	130052	135498
NM_181882.2(PRX):c.2763A>G (p.Ile921Met)	PRX	Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease, demyelinating, type 4f|not specified	Benign(Last reviewed: Apr 25, 2017)	criteria provided, multiple submitters, no conflicts	19	40901496	19	40395589	130050	135496
NM_181882.2(PRX):c.2645T>C (p.Val882Ala)	PRX	Charcot-Marie-Tooth disease type 4|not specified	Benign(Last reviewed: Jul 12, 2017)	criteria provided, multiple submitters, no conflicts	19	40901614	19	40395707	130048	135494
NM_004596.4(SNRPA):c.97A>G (p.Ile33Val)	SNRPA	Spliceosomepathy	Likely benign(Last reviewed: Nov 1, 2017)	criteria provided, single submitter	19	41263260	19	40757355	446221	439585
NM_004596.4(SNRPA):c.98T>C (p.Ile33Thr)	SNRPA	Spliceosomepathy	Likely pathogenic(Last reviewed: Nov 1, 2017)	criteria provided, single submitter	19	41263261	19	40757356	446220	439584
NM_004596.4(SNRPA):c.100T>A (p.Phe34Ile)	SNRPA	Spliceosomepathy	Likely pathogenic(Last reviewed: Nov 1, 2017)	criteria provided, single submitter	19	41263263	19	40757358	446205	439567
NM_000660.6(TGFB1):c.1159T>C (p.Cys387Arg)	TGFB1	Encephalopathy|Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome|INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY	Pathogenic(Last reviewed: Dec 4, 2018)	no assertion criteria provided	19	41836971	19	41331066	488346	481175
NM_000660.6(TGFB1):c.328C>T (p.Arg110Cys)	TGFB1	Encephalopathy|Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome|INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY	Pathogenic(Last reviewed: Dec 4, 2018)	no assertion criteria provided	19	41858622	19	41352717	488345	481174
NM_000660.6(TGFB1):c.133C>T (p.Arg45Cys)	TGFB1	Encephalopathy|Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome|INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY	Pathogenic(Last reviewed: Dec 4, 2018)	no assertion criteria provided	19	41858817	19	41352912	487577	480624
NM_000709.3(BCKDHA):c.116C>A (p.Pro39His)	BCKDHA	Maple syrup urine disease|not specified|not provided	Benign/Likely benign(Last reviewed: Feb 8, 2017)	criteria provided, multiple submitters, no conflicts	19	41916549	19	41410644	93341	99248
NM_133444.2(ZNF526):c.281T>C (p.Val94Ala)	ZNF526	not specified	Likely benign	no assertion criteria provided	19	42728836	19	42224684	130837	136281
NM_133444.2(ZNF526):c.566C>T (p.Pro189Leu)	ZNF526	not specified	Benign(Last reviewed: Mar 18, 2014)	criteria provided, single submitter	19	42729121	19	42224969	130838	136282
NM_133444.2(ZNF526):c.1649A>C (p.His550Pro)	ZNF526	not specified	Benign(Last reviewed: Aug 7, 2013)	criteria provided, single submitter	19	42730204	19	42226052	130831	136275
NM_001410.2(MEGF8):c.3059C>T (p.Pro1020Leu)	MEGF8	Carpenter syndrome 2	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	19	42856518	19	42352366	561155	552220
NM_001410.2(MEGF8):c.6109G>T (p.Ala2037Ser)	MEGF8	Carpenter syndrome 2	Uncertain significance(Last reviewed: Feb 23, 2018)	criteria provided, multiple submitters, no conflicts	19	42872643	19	42368491	561156	552221
NM_014297.4(ETHE1):c.586G>A (p.Asp196Asn)	ETHE1	Ethylmalonic encephalopathy	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	19	44012936	19	43508784	488508	481376
NM_014297.4(ETHE1):c.554T>G (p.Leu185Arg)	ETHE1	Ethylmalonic encephalopathy	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	19	44012968	19	43508816	30725	39682
NM_000400.3(ERCC2):c.1846C>T (p.Arg616Trp)	ERCC2	Cerebrooculofacioskeletal syndrome 2|Cerebro-oculo-facio-skeletal syndrome	Pathogenic(Last reviewed: Aug 1, 2001)	no assertion criteria provided	19	45856060	19	45352802	16788	31827
NM_001039885.2(FKRP):c.679G>C (p.Ala227Pro)	FKRP	Fukuyama congenital muscular dystrophy	Pathogenic	no assertion criteria provided	19	47259386	19	46756129	430845	424236
NM_024301.4(FKRP):c.822C>G (p.Ile274Met)	FKRP	not specified|not provided|Walker-Warburg congenital muscular dystrophy	Benign/Likely benign(Last reviewed: Dec 26, 2017)	criteria provided, multiple submitters, no conflicts	19	47259529	19	46756272	129058	134504
NM_024301.4(FKRP):c.826C>A (p.Leu276Ile)	FKRP	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1|Congenital muscular dystrophy-dystroglycanopathy (with or without mental retardation) type B5|Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|Limb-girdle muscular dystrophy|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies type A5|Muscle weakness|Headache|not provided|Gait imbalance|Difficulty walking|Paresthesia|Difficulty climbing stairs|Scapular winging|Difficulty standing|Muscular dystrophy-dystroglycanopathy|Walker-Warburg congenital muscular dystrophy	Pathogenic(Last reviewed: Jul 6, 2018)	criteria provided, multiple submitters, no conflicts	19	47259533	19	46756276	4221	19260
NM_024301.4(FKRP):c.941C>T (p.Thr314Met)	FKRP	Congenital muscular dystrophy-dystroglycanopathy (with or without mental retardation) type B5|Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies type A5|not provided	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, multiple submitters, no conflicts	19	47259648	19	46756391	96115	102009
NM_024301.4(FKRP):c.1027G>C (p.Glu343Gln)	FKRP	not provided|Walker-Warburg congenital muscular dystrophy	Conflicting interpretations of pathogenicity(Last reviewed: Jul 12, 2017)	criteria provided, conflicting interpretations	19	47259734	19	46756477	129055	134501
NM_024301.4(FKRP):c.1036T>C (p.Ser346Pro)	FKRP	Limb-girdle muscular dystrophy-dystroglycanopathy, type C5	Likely pathogenic	no assertion criteria provided	19	47259743	19	46756486	487485	480541
NM_024301.4(FKRP):c.1364C>A (p.Ala455Asp)	FKRP	Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B5|not provided|Walker-Warburg congenital muscular dystrophy	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	19	47260071	19	46756814	4226	19265
NM_007254.3(PNKP):c.1522G>A (p.Glu508Lys)	PNKP	Early infantile epileptic encephalopathy 10|Early infantile epileptic encephalopathy 12|not specified|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Jan 3, 2018)	criteria provided, conflicting interpretations	19	50364549	19	49861292	138725	142428
NM_007254.3(PNKP):c.1433T>G (p.Val478Gly)	PNKP	Early infantile epileptic encephalopathy 12|not specified|Epileptic encephalopathy|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Dec 6, 2017)	criteria provided, multiple submitters, no conflicts	19	50364721	19	49861464	138723	142426
NM_007254.3(PNKP):c.1385G>A (p.Arg462Gln)	PNKP	Early infantile epileptic encephalopathy 10|Early infantile epileptic encephalopathy 12|not specified|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Jan 1, 2018)	criteria provided, conflicting interpretations	19	50364866	19	49861609	95479	101378
NM_007254.3(PNKP):c.1319C>G (p.Ala440Gly)	PNKP	Early infantile epileptic encephalopathy 10|Early infantile epileptic encephalopathy 12|Epileptic encephalopathy	Uncertain significance(Last reviewed: Sep 22, 2016)	criteria provided, multiple submitters, no conflicts	19	50364932	19	49861675	159789	169586
NM_007254.3(PNKP):c.994C>T (p.Pro332Ser)	PNKP	Early infantile epileptic encephalopathy 10|Early infantile epileptic encephalopathy 12|not specified|not provided	Uncertain significance(Last reviewed: Nov 3, 2016)	criteria provided, multiple submitters, no conflicts	19	50365663	19	49862406	159804	169589
NM_007254.3(PNKP):c.968C>T (p.Thr323Met)	PNKP	Early infantile epileptic encephalopathy 10|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 29, 2016)	criteria provided, conflicting interpretations	19	50365689	19	49862432	159803	169590
NM_007254.3(PNKP):c.671G>A (p.Arg224His)	PNKP	Early infantile epileptic encephalopathy 10|Early infantile epileptic encephalopathy 12|not specified	Uncertain significance(Last reviewed: Apr 24, 2018)	criteria provided, multiple submitters, no conflicts	19	50367294	19	49864037	159799	169594
NM_007254.3(PNKP):c.586T>A (p.Tyr196Asn)	PNKP	Early infantile epileptic encephalopathy 12|not specified|not provided|Epileptic encephalopathy|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	19	50367486	19	49864229	138709	142412
NM_007254.3(PNKP):c.538C>A (p.Arg180Ser)	PNKP	Early infantile epileptic encephalopathy 10|Early infantile epileptic encephalopathy 12|not specified|not provided|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Dec 21, 2017)	criteria provided, multiple submitters, no conflicts	19	50367621	19	49864364	95483	101382
NM_007254.3(PNKP):c.416G>A (p.Arg139His)	PNKP	Early infantile epileptic encephalopathy 10|Early infantile epileptic encephalopathy 12|not specified|not provided|Ataxia-oculomotor apraxia 4|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Dec 18, 2017)	criteria provided, conflicting interpretations	19	50368466	19	49865209	159794	169599
NM_007254.3(PNKP):c.302C>T (p.Pro101Leu)	PNKP	Early infantile epileptic encephalopathy 10|not provided	Uncertain significance(Last reviewed: Feb 17, 2015)	criteria provided, multiple submitters, no conflicts	19	50368580	19	49865323	159793	169600
NM_007254.3(PNKP):c.188C>T (p.Ala63Val)	PNKP	Early infantile epileptic encephalopathy 10|Early infantile epileptic encephalopathy 12|not specified|not provided|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Feb 5, 2018)	criteria provided, conflicting interpretations	19	50369666	19	49866409	159792	169601
NM_007254.3(PNKP):c.58C>T (p.Pro20Ser)	PNKP	Early infantile epileptic encephalopathy 10|Early infantile epileptic encephalopathy 12|not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jan 8, 2018)	criteria provided, multiple submitters, no conflicts	19	50370404	19	49867147	95486	101385
NM_153719.3(NUP62):c.848G>C (p.Ser283Thr)	NUP62|IL4I1	not specified	Likely benign	no assertion criteria provided	19	50412217	19	49908960	129849	135295
NM_001145809.1(MYH14):c.5446C>T (p.Arg1816Cys)	MYH14	not specified	Uncertain significance(Last reviewed: Sep 4, 2013)	criteria provided, single submitter	19	50796921	19	50293664	178423	176063
NM_033068.2(ACP4):c.428C>T (p.Thr143Met)	ACP4	Amelogenesis imperfecta, type IJ	Pathogenic(Last reviewed: Oct 28, 2016)	no assertion criteria provided	19	51295037	19	50791780	375700	362590
NM_033068.2(ACP4):c.746C>T (p.Pro249Leu)	ACP4	Amelogenesis imperfecta, type IJ	Pathogenic(Last reviewed: Oct 28, 2016)	no assertion criteria provided	19	51297041	19	50793784	375694	362584
NM_003283.5(TNNT1):c.35A>G (p.Glu12Gly)	TNNI3|TNNT1	Familial restrictive cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	19	55658387	19	55147019	31865	40525
NM_000363.4(TNNI3):c.143A>C (p.Gln48Pro)	TNNI3	Dilated cardiomyopathy 2A|Cardiovascular phenotype	Uncertain significance(Last reviewed: Dec 4, 2015)	criteria provided, single submitter	19	55667978	19	55156610	264596	259051
NM_031229.3(RBCK1):c.1112G>T (p.Cys371Phe)	RBCK1	Glycogen storage disease, type IV|Polyglucosan body myopathy 1 with or without immunodeficiency	Pathogenic(Last reviewed: Mar 3, 2016)	criteria provided, single submitter	20	408039	20	427395	430898	424441
NM_033409.3(SLC52A3):c.1316G>A (p.Gly439Asp)	SLC52A3	Brown-Vialetto-Van Laere syndrome 1	Likely pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	20	741764	20	761120	488380	481243
NM_033453.3(ITPA):c.488C>T (p.Thr163Met)	ITPA	Inosine triphosphatase deficiency|Epileptic encephalopathy, early infantile, 35	Uncertain significance(Last reviewed: Feb 10, 2018)	criteria provided, multiple submitters, no conflicts	20	3202563	20	3221917	431714	425229
NM_182734.2(PLCB1):c.2179T>A (p.Trp727Arg)	PLCB1	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	20	8717810	20	8737163	402193	389184
NM_015192.3(PLCB1):c.2191C>G (p.Pro731Ala)	PLCB1	Early infantile epileptic encephalopathy 12|not specified|Seizures|not provided|Early Infantile Epileptic Encephalopathy, Autosomal Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Dec 28, 2017)	criteria provided, conflicting interpretations	20	8717822	20	8737175	129904	135350
NM_018848.3(MKKS):c.1015A>G (p.Ile339Val)	MKKS	Bardet-Biedl syndrome|McKusick Kaufman syndrome|Bardet-Biedl syndrome 6|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 31, 2018)	criteria provided, conflicting interpretations	20	10389422	20	10408774	100586	106463
NM_024120.4(NDUFAF5):c.836T>G (p.Met279Arg)	NDUFAF5	Mitochondrial complex I deficiency|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	20	13797166	20	13816520	225036	226977
NM_020536.4(KAT14):c.1399G>A (p.Glu467Lys)	KAT14	Global developmental delay|Seizures	Likely pathogenic	criteria provided, single submitter	20	18143317	20	18162673	402155	389178
NM_001042472.2(ABHD12):c.1045G>A (p.Ala349Thr)	ABHD12	Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract|not specified	Benign/Likely benign(Last reviewed: May 9, 2017)	criteria provided, multiple submitters, no conflicts	20	25282967	20	25302331	128253	133702
NM_001258329.1(EPB41L1):c.1912C>T (p.Arg638Cys)	EPB41L1	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	20	34797653	20	36209731	402208	389179
NM_015511.4(AAR2):c.520G>A (p.Val174Met)	AAR2	Global developmental delay|Ventricular septal defect|Patent foramen ovale|Hypoplasia of the corpus callosum|Anteriorly placed anus|Microcephaly|Global developmental delay|Cerebellar malformation|Macule|Ventricular septal defect	Likely pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	20	34828310	20	36240388	242897	243997
NM_015474.3(SAMHD1):c.1293A>T (p.Leu431Phe)	SAMHD1	Aicardi Goutieres syndrome 5	Uncertain significance(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	20	35533884	20	36905481	559589	550312
NM_015474.3(SAMHD1):c.602T>A (p.Ile201Asn)	SAMHD1	Aicardi Goutieres syndrome 5|Aicardi Goutieres syndrome|Chilblain lupus 2|Chilblain Lupus	Conflicting interpretations of pathogenicity(Last reviewed: Aug 6, 2018)	criteria provided, conflicting interpretations	20	35559186	20	36930783	30605	39562
NM_014657.2(TTI1):c.2761G>A (p.Asp921Asn)	TTI1	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	20	36627622	20	37999220	402171	389180
NM_020336.3(RALGAPB):c.[1918A>G];[2324G>T]	RALGAPB	Septo-optic dysplasia sequence|Tubulinopathies	Likely pathogenic(Last reviewed: Oct 6, 2016)	criteria provided, single submitter	20|20	37154553	20|20	38525910	427836	354271|354270
NM_020336.3(RALGAPB):c.2324G>T (p.Arg775Leu)	RALGAPB	Septo-optic dysplasia sequence	Likely pathogenic(Last reviewed: Oct 6, 2016)	criteria provided, single submitter	20	37163795	20	38535152	370037	354270
NM_133170.3(PTPRT):c.206T>C (p.Val69Ala)	PTPRT	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	20	41514455	20	42885815	402165	389182
NM_000022.3(ADA):c.[780+1G>A];[986C>T]	ADA	Severe combined immunodeficiency due to ADA deficiency	Likely pathogenic(Last reviewed: May 21, 2013)	criteria provided, single submitter	20|20	43249032	20|20	44620391	424762	16998|213657
NM_000022.3(ADA):c.704G>A (p.Arg235Gln)	ADA	Severe combined immunodeficiency due to ADA deficiency	Pathogenic/Likely pathogenic(Last reviewed: May 8, 2018)	criteria provided, multiple submitters, no conflicts	20	43251546	20	44622905	228244	231104
NM_000308.3(CTSA):c.799T>A (p.Tyr267Asn)	CTSA	Combined deficiency of sialidase AND beta galactosidase|Galactosialidosis, late infantile	Pathogenic(Last reviewed: Jul 1, 2014)	criteria provided, single submitter	20	44522679	20	45894040	381	15420
NM_022095.3(ZNF335):c.3392G>A (p.Arg1131Lys)	ZNF335	not provided	Uncertain significance(Last reviewed: Feb 10, 2014)	criteria provided, single submitter	20	44578953	20	45950314	130804	136249
NM_022095.3(ZNF335):c.2821G>A (p.Ala941Thr)	ZNF335	not specified	Likely benign	no assertion criteria provided	20	44581154	20	45952515	130800	136245
NM_022095.3(ZNF335):c.2595C>A (p.Asp865Glu)	ZNF335	not specified	Likely benign	no assertion criteria provided	20	44582435	20	45953796	130798	136243
NM_022095.3(ZNF335):c.2167T>G (p.Phe723Val)	ZNF335	not specified	Likely benign	no assertion criteria provided	20	44587926	20	45959287	130796	136241
NM_022095.3(ZNF335):c.1486A>G (p.Lys496Glu)	ZNF335	not provided	Uncertain significance(Last reviewed: Mar 24, 2014)	criteria provided, single submitter	20	44592159	20	45963520	130793	136238
NM_022095.3(ZNF335):c.1319G>T (p.Arg440Leu)	ZNF335	not provided	Uncertain significance(Last reviewed: Mar 19, 2014)	criteria provided, single submitter	20	44592413	20	45963774	130792	136237
NM_022095.3(ZNF335):c.881G>C (p.Ser294Thr)	ZNF335	not specified	Likely benign	no assertion criteria provided	20	44596207	20	45967568	130810	136255
NM_006420.2(ARFGEF2):c.79C>T (p.Pro27Ser)	ARFGEF2	not provided	Uncertain significance(Last reviewed: Mar 13, 2014)	criteria provided, single submitter	20	47538505	20	48921968	128444	133893
NM_006420.2(ARFGEF2):c.169C>T (p.Pro57Ser)	ARFGEF2	not specified|not provided|Periventricular Heterotopia	Conflicting interpretations of pathogenicity(Last reviewed: Jan 26, 2017)	criteria provided, conflicting interpretations	20	47558417	20	48941880	128433	133882
NM_006420.2(ARFGEF2):c.756C>A (p.Asn252Lys)	ARFGEF2	not provided	Uncertain significance(Last reviewed: Mar 17, 2014)	criteria provided, single submitter	20	47570245	20	48953708	128443	133892
NM_006420.2(ARFGEF2):c.2639C>T (p.Pro880Leu)	ARFGEF2	not provided	Uncertain significance(Last reviewed: Jul 16, 2012)	criteria provided, single submitter	20	47605927	20	48989390	128428	133877
NM_006420.2(ARFGEF2):c.4136T>C (p.Phe1379Ser)	ARFGEF2	not provided	Uncertain significance(Last reviewed: Mar 19, 2014)	criteria provided, single submitter	20	47630454	20	49013917	128439	133888
NM_006420.2(ARFGEF2):c.4462A>T (p.Thr1488Ser)	ARFGEF2	not provided|Periventricular Heterotopia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	20	47634040	20	49017503	128441	133890
NM_006420.2(ARFGEF2):c.4939T>A (p.Ser1647Thr)	ARFGEF2	not provided	Uncertain significance(Last reviewed: Oct 30, 2013)	criteria provided, single submitter	20	47645081	20	49028544	128442	133891
NM_006420.2(ARFGEF2):c.5023C>T (p.Arg1675Cys)	ARFGEF2	not provided	Uncertain significance(Last reviewed: Jul 5, 2013)	criteria provided, single submitter	20	47645165	20	49028628	128429	133878
NM_001077490.2(GNAS):c.1235C>T (p.Pro412Leu)	GNAS	Pseudopseudohypoparathyroidism	Uncertain significance(Last reviewed: Jun 28, 2017)	criteria provided, single submitter	20	57429742	20	58854687	584449	575506
NM_207032.2(EDN3):c.332G>T (p.Cys111Phe)	EDN3	Waardenburg syndrome type 4B	Likely pathogenic(Last reviewed: May 15, 2018)	no assertion criteria provided	20	57876744	20	59301689	545507	536012
NM_001794.4(CDH4):c.1351G>A (p.Glu451Lys)	CDH4	Cortical gyral simplification	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	20	60485640	20	61910584	438596	432221
NM_001794.4(CDH4):c.1976G>C (p.Arg659Pro)	CDH4	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	20	60503452	20	61928394	402151	389183
NM_001794.4(CDH4):c.2554G>A (p.Ala852Thr)	CDH4	Cortical gyral simplification	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	20	60511804	20	61936746	438597	432222
NM_005560.4(LAMA5):c.10726G>A (p.Glu3576Lys)	LAMA5	Polymicrogyria	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	20	60885242	20	62310186	438605	432223
NM_005560.4(LAMA5):c.7114G>A (p.Asp2372Asn)	LAMA5	Polymicrogyria	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	20	60893635	20	62318579	438606	432224
NM_032957.4(RTEL1):c.[1346T>C];[3028C>T]	RTEL1|RTEL1-TNFRSF6B	Dyskeratosis congenita, autosomal recessive, 5	Likely pathogenic(Last reviewed: Sep 10, 2013)	criteria provided, single submitter	20|20	62324600	20|20	63693247	424795	76347|213660
NM_206898.1(MRAP):c.1A>G (p.Met1Val)	MRAP	ACTH resistance	Pathogenic(Last reviewed: Sep 30, 2017)	criteria provided, single submitter	21	33671283	21	32298972	444067	437710
NM_206898.1(MRAP):c.3G>A (p.Met1Ile)	MRAP	Glucocorticoid deficiency 2|ACTH resistance	Pathogenic(Last reviewed: Sep 30, 2017)	criteria provided, multiple submitters, no conflicts	21	33671285	21	32298974	1841	16880
NM_017613.3(DONSON):c.1466A>C (p.Lys489Thr)	DONSON	Microcephaly-micromelia syndrome|Inborn genetic diseases|MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES	Conflicting interpretations of pathogenicity(Last reviewed: Mar 5, 2018)	criteria provided, conflicting interpretations	21	34951753	21	33579447	431445	424961
NM_000219.5(KCNE1):c.226G>A (p.Asp76Asn)	KCNE1	Jervell and Lange-Nielsen syndrome 2|Jervell and Lange-Nielsen syndrome 1|Long QT syndrome 5|Arrhythmogenic right ventricular cardiomyopathy|Long QT syndrome|Romano-Ward syndrome|Brugada syndrome|not specified|not provided|Congenital long QT syndrome|Cardiovascular phenotype|Sudden unexplained death|Jervell and Lange-Nielsen syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2018)	criteria provided, conflicting interpretations	21	35821707	21	34449409	13477	28516
NM_000219.5(KCNE1):c.137A>G (p.Tyr46Cys)	KCNE1	Jervell and Lange-Nielsen syndrome	Likely pathogenic(Last reviewed: Mar 31, 2017)	criteria provided, single submitter	21	35821796	21	34449498	517181	497341
NM_000411.7(HLCS):c.1544G>A (p.Ser515Asn)	HLCS	Holocarboxylase synthetase deficiency	Likely pathogenic(Last reviewed: Jun 17, 2017)	criteria provided, single submitter	21	38137449	21	36765148	428585	420143
NM_000411.6(HLCS):c.722G>C (p.Gly241Ala)	HLCS	Holocarboxylase synthetase deficiency	Likely pathogenic(Last reviewed: Jul 21, 2015)	criteria provided, single submitter	21	38309023	21	36936723	369667	353911
NM_020639.2(RIPK4):c.488G>A (p.Gly163Asp)	RIPK4	Curly hair, ankyloblepharon, nail dysplasia syndrome|Popliteal pterygium syndrome lethal type	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	21	43171392	21	41751232	561098	552226
NM_024022.2(TMPRSS3):c.1343T>C (p.Met448Thr)	TMPRSS3	Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: Oct 24, 2015)	criteria provided, single submitter	21	43795829	21	42375720	46104	55269
NM_024022.2(TMPRSS3):c.1276G>A (p.Ala426Thr)	TMPRSS3	Deafness, autosomal recessive 8|Nonsyndromic hearing loss and deafness|not provided	Likely pathogenic(Last reviewed: May 18, 2017)	criteria provided, multiple submitters, no conflicts	21	43795896	21	42375787	46102	55267
NM_024022.2(TMPRSS3):c.1025G>A (p.Gly342Glu)	TMPRSS3	Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: Feb 7, 2013)	criteria provided, single submitter	21	43800249	21	42380140	46093	55258
NM_024022.2(TMPRSS3):c.916G>A (p.Ala306Thr)	TMPRSS3	Nonsyndromic hearing loss and deafness|not provided	Pathogenic(Last reviewed: Apr 4, 2018)	criteria provided, multiple submitters, no conflicts	21	43802210	21	42382101	46131	55296
NM_024022.2(TMPRSS3):c.727G>A (p.Gly243Arg)	TMPRSS3	Deafness, autosomal recessive 8|Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: May 1, 2016)	criteria provided, multiple submitters, no conflicts	21	43803197	21	42383088	178549	176365
NM_024022.2(TMPRSS3):c.413C>A (p.Ala138Glu)	TMPRSS3	Deafness, autosomal recessive 8|Nonsyndromic hearing loss and deafness|not provided|Nonsyndromic Hearing Loss, Recessive	Pathogenic/Likely pathogenic(Last reviewed: Mar 20, 2017)	criteria provided, multiple submitters, no conflicts	21	43808545	21	42388436	46119	55284
NM_024022.2(TMPRSS3):c.310G>A (p.Glu104Lys)	TMPRSS3	Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: May 2, 2016)	criteria provided, single submitter	21	43809050	21	42388941	504522	497791
NM_024022.2(TMPRSS3):c.238C>T (p.Arg80Cys)	TMPRSS3	Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: Oct 24, 2015)	criteria provided, single submitter	21	43809122	21	42389013	228296	231128
NM_033661.4(WDR4):c.[491A>C];[940dup]	WDR4	Microcephalic primordial dwarfism	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	21|21	44282467	21|21	42862357	438743	432369|432368
NM_000071.2(CBS):c.1316G>A (p.Arg439Gln)	CBS	Homocystinuria due to CBS deficiency|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 13, 2017)	criteria provided, conflicting interpretations	21	44478986	21	43058876	189088	187053
NM_000071.2(CBS):c.1136G>A (p.Arg379Gln)	CBS	Homocystinuria due to CBS deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 3, 2015)	criteria provided, multiple submitters, no conflicts	21	44480560	21	43060450	188825	187054
NM_000071.2(CBS):c.1058C>T (p.Thr353Met)	CBS	Homocystinuria due to CBS deficiency|Homocystinuria, pyridoxine-nonresponsive|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, multiple submitters, no conflicts	21	44480638	21	43060528	131	15170
NM_000071.2(CBS):c.1039G>A (p.Gly347Ser)	CBS	Homocystinuria due to CBS deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 29, 2015)	criteria provided, multiple submitters, no conflicts	21	44482421	21	43062311	188801	187055
NM_000071.2(CBS):c.1006C>T (p.Arg336Cys)	CBS	Homocystinuria due to CBS deficiency|not provided	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, multiple submitters, no conflicts	21	44482454	21	43062344	92423	98334
NM_000071.2(CBS):c.919G>A (p.Gly307Ser)	CBS	Homocystinuria due to CBS deficiency|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Homocystinuria, pyridoxine-nonresponsive|Homocystinuria|not provided|Cardiovascular phenotype	Pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, multiple submitters, no conflicts	21	44483098	21	43062988	117	15156
NM_000071.2(CBS):c.833T>C (p.Ile278Thr)	CBS	Homocystinuria due to CBS deficiency|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Homocystinuria, pyridoxine-responsive|Homocystinuria|not specified|not provided|Cardiovascular phenotype	Pathogenic(Last reviewed: May 16, 2018)	criteria provided, multiple submitters, no conflicts	21	44483184	21	43063074	120	15159
NM_000071.2(CBS):c.770C>T (p.Thr257Met)	CBS	Homocystinuria due to CBS deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 7, 2017)	criteria provided, multiple submitters, no conflicts	21	44484068	21	43063958	188927	187056
NM_000071.2(CBS):c.430G>A (p.Glu144Lys)	CBS	Homocystinuria due to CBS deficiency|Homocystinuria, pyridoxine-responsive|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 13, 2017)	criteria provided, multiple submitters, no conflicts	21	44486374	21	43066264	122	15161
NM_000071.2(CBS):c.362G>A (p.Arg121His)	CBS	Homocystinuria due to CBS deficiency	Likely pathogenic(Last reviewed: Aug 28, 2014)	criteria provided, single submitter	21	44486442	21	43066332	188948	187059
NM_000071.2(CBS):c.346G>A (p.Gly116Arg)	CBS	Homocystinuria due to CBS deficiency	Likely pathogenic(Last reviewed: May 16, 2014)	criteria provided, single submitter	21	44486458	21	43066348	188787	187060
NM_000071.2(CBS):c.306G>C (p.Lys102Asn)	CBS	Homocystinuria due to CBS deficiency	Likely pathogenic(Last reviewed: Sep 26, 2014)	criteria provided, single submitter	21	44488629	21	43068519	188989	187061
NM_000071.2(CBS):c.302T>C (p.Leu101Pro)	CBS	Homocystinuria due to CBS deficiency	Pathogenic/Likely pathogenic(Last reviewed: Aug 9, 2017)	criteria provided, multiple submitters, no conflicts	21	44488633	21	43068523	189185	187062
NM_000071.2(CBS):c.233C>G (p.Pro78Arg)	CBS	Homocystinuria due to CBS deficiency	Likely pathogenic(Last reviewed: Sep 26, 2014)	criteria provided, single submitter	21	44488702	21	43068592	188988	187063
NM_000100.3(CSTB):c.10G>T (p.Gly4Trp)	CSTB	Unverricht-Lundborg syndrome	Likely pathogenic	criteria provided, single submitter	21	45196141	21	43776260	431700	425232
NM_000383.3(AIRE):c.62C>T (p.Ala21Val)	AIRE	Polyglandular autoimmune syndrome, type 1|not provided	Likely pathogenic(Last reviewed: Jun 14, 2014)	criteria provided, single submitter	21	45705951	21	44286068	68228	79119
NM_000383.3(AIRE):c.232T>C (p.Trp78Arg)	AIRE	Polyglandular autoimmune syndrome, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	21	45706539	21	44286656	189060	187064
NM_000383.3(AIRE):c.268T>C (p.Tyr90His)	AIRE	Polyglandular autoimmune syndrome, type 1	Likely pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	21	45706575	21	44286692	446118	439465
NM_000383.3(AIRE):c.548C>A (p.Thr183Asn)	AIRE	Polyglandular autoimmune syndrome, type 1|not specified	Benign(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	21	45708237	21	44288354	128333	133782
NM_000383.3(AIRE):c.595G>A (p.Val199Ile)	AIRE	Polyglandular autoimmune syndrome, type 1|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 21, 2017)	criteria provided, conflicting interpretations	21	45708284	21	44288401	128334	133783
NM_000383.3(AIRE):c.755C>T (p.Pro252Leu)	AIRE	Polyglandular autoimmune syndrome, type 1	Benign/Likely benign(Last reviewed: Nov 18, 2017)	criteria provided, multiple submitters, no conflicts	21	45709642	21	44289759	35668	44333
NM_000383.3(AIRE):c.834C>G (p.Ser278Arg)	AIRE	not specified|not provided	Benign(Last reviewed: Oct 11, 2017)	criteria provided, multiple submitters, no conflicts	21	45709906	21	44290023	128340	133789
NM_000383.3(AIRE):c.1322C>T (p.Thr441Met)	AIRE	Polyglandular autoimmune syndrome, type 1|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 7, 2016)	criteria provided, conflicting interpretations	21	45713715	21	44293832	35660	44325
NM_000383.3(AIRE):c.1411C>T (p.Arg471Cys)	AIRE	Polyglandular autoimmune syndrome, type 1|not specified|not provided	Benign/Likely benign(Last reviewed: Aug 11, 2017)	criteria provided, multiple submitters, no conflicts	21	45714294	21	44294411	128332	133781
NM_000211.4(ITGB2):c.[576dupC];[706G>A]	ITGB2	Leukocyte adhesion deficiency type 1	Pathogenic(Last reviewed: Dec 24, 2015)	criteria provided, single submitter	21|21	46321572	21|21	44901657	427820	106622|106624
NM_130445.3(COL18A1):c.1613G>T (p.Gly538Val)	COL18A1	Knobloch syndrome 1	Likely pathogenic(Last reviewed: Feb 3, 2017)	criteria provided, single submitter	21	46901878	21	45481964	427899	418973
NM_006657.2(FTCD):c.1358C>T (p.Thr453Met)	FTCD	GLUTAMATE FORMIMINOTRANSFERASE DEFICIENCY	Conflicting interpretations of pathogenicity(Last reviewed: May 9, 2018)	criteria provided, conflicting interpretations	21	47558507	21	46138593	209155	205796
NM_006031.5(PCNT):c.244G>A (p.Ala82Thr)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2|Microcephalic Osteodysplastic Primordial Dwarfism	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	21	47746480	21	46326566	159570	169609
NM_006031.5(PCNT):c.427C>T (p.Arg143Cys)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2	Uncertain significance(Last reviewed: Jul 16, 2014)	criteria provided, single submitter	21	47754470	21	46334556	159598	169612
NM_006031.5(PCNT):c.428G>A (p.Arg143His)	PCNT	not specified	Likely benign	no assertion criteria provided	21	47754471	21	46334557	159600	169613
NM_006031.5(PCNT):c.445A>T (p.Ser149Cys)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2|not specified	Uncertain significance(Last reviewed: Aug 11, 2017)	criteria provided, multiple submitters, no conflicts	21	47754488	21	46334574	159604	169614
NM_006031.5(PCNT):c.467A>G (p.His156Arg)	PCNT	not specified|Microcephalic Osteodysplastic Primordial Dwarfism	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	21	47754510	21	46334596	159608	169615
NM_006031.5(PCNT):c.506G>A (p.Arg169His)	PCNT	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	21	47754549	21	46334635	159616	169617
NM_006031.5(PCNT):c.520A>G (p.Ile174Val)	PCNT	not specified|Microcephalic Osteodysplastic Primordial Dwarfism	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	21	47754563	21	46334649	138613	142316
NM_006031.5(PCNT):c.711T>G (p.His237Gln)	PCNT	not specified|Microcephalic Osteodysplastic Primordial Dwarfism	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	21	47766113	21	46346199	138615	142318
NM_006031.5(PCNT):c.931G>A (p.Ala311Thr)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2	Uncertain significance(Last reviewed: Jun 16, 2014)	criteria provided, single submitter	21	47766867	21	46346953	159691	169622
NM_006031.5(PCNT):c.1040A>G (p.Lys347Arg)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2|Microcephalic Osteodysplastic Primordial Dwarfism	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	21	47768933	21	46349019	159563	169623
NM_006031.5(PCNT):c.1616C>T (p.Thr539Ile)	PCNT	not specified|Microcephalic Osteodysplastic Primordial Dwarfism	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	21	47773177	21	46353263	159567	169627
NM_006031.5(PCNT):c.2111G>A (p.Gly704Glu)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2|not specified|Microcephalic Osteodysplastic Primordial Dwarfism	Benign(Last reviewed: May 31, 2017)	criteria provided, multiple submitters, no conflicts	21	47777063	21	46357148	159569	169629
NM_006031.5(PCNT):c.2635A>G (p.Thr879Ala)	PCNT	not specified|Microcephalic Osteodysplastic Primordial Dwarfism	Benign(Last reviewed: Jun 22, 2016)	criteria provided, multiple submitters, no conflicts	21	47786524	21	46366609	159575	169634
NM_006031.5(PCNT):c.2710C>T (p.Leu904Phe)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	21	47786599	21	46366684	159576	169635
NM_006031.5(PCNT):c.2714A>G (p.Gln905Arg)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Aug 11, 2017)	criteria provided, conflicting interpretations	21	47786603	21	46366688	159577	169636
NM_006031.5(PCNT):c.3113T>C (p.Val1038Ala)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2|not specified|Microcephalic Osteodysplastic Primordial Dwarfism	Benign(Last reviewed: May 31, 2017)	criteria provided, multiple submitters, no conflicts	21	47787002	21	46367087	159581	169640
NM_006031.5(PCNT):c.3220C>T (p.Arg1074Trp)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2	Uncertain significance(Last reviewed: Aug 22, 2013)	criteria provided, single submitter	21	47801663	21	46381748	159582	169641
NM_006031.5(PCNT):c.3233C>A (p.Ala1078Glu)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2	Uncertain significance(Last reviewed: Jul 24, 2014)	criteria provided, single submitter	21	47801676	21	46381761	159583	169642
NM_006031.5(PCNT):c.3282G>T (p.Gln1094His)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	21	47801725	21	46381810	159584	169643
NM_006031.5(PCNT):c.3487C>T (p.Arg1163Cys)	PCNT	not specified|Microcephalic Osteodysplastic Primordial Dwarfism	Benign/Likely benign(Last reviewed: Jul 20, 2016)	criteria provided, multiple submitters, no conflicts	21	47808679	21	46388764	159589	169646
NM_006031.5(PCNT):c.3580G>A (p.Ala1194Thr)	PCNT	not specified|Microcephalic Osteodysplastic Primordial Dwarfism	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	21	47808772	21	46388857	159590	169647
NM_006031.5(PCNT):c.3581C>T (p.Ala1194Val)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2|Microcephalic Osteodysplastic Primordial Dwarfism	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	21	47808773	21	46388858	159591	169648
NM_006031.5(PCNT):c.3992A>G (p.His1331Arg)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	21	47810736	21	46390821	159594	169651
NM_006031.5(PCNT):c.4139C>T (p.Ala1380Val)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jul 20, 2017)	criteria provided, conflicting interpretations	21	47811214	21	46391299	159595	169652
NM_006031.5(PCNT):c.4175G>A (p.Arg1392Gln)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2	Uncertain significance(Last reviewed: Nov 13, 2013)	criteria provided, single submitter	21	47811250	21	46391335	159596	169653
NM_006031.5(PCNT):c.4285C>T (p.Arg1429Cys)	PCNT	not specified|not provided|Microcephalic Osteodysplastic Primordial Dwarfism	Conflicting interpretations of pathogenicity(Last reviewed: Sep 25, 2017)	criteria provided, conflicting interpretations	21	47817247	21	46397333	159599	169655
NM_006031.5(PCNT):c.4769A>G (p.Asn1590Ser)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2	Uncertain significance(Last reviewed: Jun 12, 2013)	criteria provided, single submitter	21	47819688	21	46399774	159610	169662
NM_006031.5(PCNT):c.4844C>T (p.Thr1615Met)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Apr 20, 2015)	criteria provided, conflicting interpretations	21	47821517	21	46401603	159611	169663
NM_006031.5(PCNT):c.4910C>T (p.Pro1637Leu)	PCNT	not specified|Microcephalic Osteodysplastic Primordial Dwarfism	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	21	47821583	21	46401669	159612	169664
NM_006031.5(PCNT):c.4915A>G (p.Ile1639Val)	PCNT	not specified|Microcephalic Osteodysplastic Primordial Dwarfism	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	21	47821588	21	46401674	159613	169665
NM_006031.5(PCNT):c.5347C>T (p.Pro1783Ser)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	21	47831334	21	46411420	159618	169669
NM_006031.5(PCNT):c.5431C>T (p.Arg1811Cys)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	21	47831418	21	46411504	159619	169670
NM_006031.5(PCNT):c.5522A>G (p.Asn1841Ser)	PCNT	not specified|Microcephalic Osteodysplastic Primordial Dwarfism	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	21	47831509	21	46411595	95336	101235
NM_006031.5(PCNT):c.5677G>T (p.Ala1893Ser)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2	Uncertain significance(Last reviewed: May 8, 2014)	criteria provided, single submitter	21	47831664	21	46411750	159622	169672
NM_006031.5(PCNT):c.5774A>C (p.Gln1925Pro)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	21	47831761	21	46411847	159625	169675
NM_006031.5(PCNT):c.5858G>A (p.Arg1953His)	PCNT	not specified|Microcephalic Osteodysplastic Primordial Dwarfism	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	21	47831845	21	46411931	95340	101239
NM_006031.5(PCNT):c.5879G>A (p.Arg1960Gln)	PCNT	not specified|Microcephalic Osteodysplastic Primordial Dwarfism	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	21	47831866	21	46411952	159626	169676
NM_006031.5(PCNT):c.6290T>C (p.Leu2097Pro)	PCNT	not specified|Microcephalic Osteodysplastic Primordial Dwarfism	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	21	47836122	21	46416208	138621	142324
NM_006031.5(PCNT):c.6374A>C (p.His2125Pro)	PCNT	not specified|Microcephalic Osteodysplastic Primordial Dwarfism	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	21	47836206	21	46416292	138622	142325
NM_006031.5(PCNT):c.6563T>G (p.Met2188Arg)	PCNT	not specified|Microcephalic Osteodysplastic Primordial Dwarfism	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	21	47836395	21	46416481	138624	142327
NM_006031.5(PCNT):c.6571T>C (p.Ser2191Pro)	PCNT	not specified|Microcephalic Osteodysplastic Primordial Dwarfism	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	21	47836403	21	46416489	159634	169682
NM_006031.5(PCNT):c.6572C>A (p.Ser2191Tyr)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2	Uncertain significance(Last reviewed: Nov 13, 2013)	criteria provided, single submitter	21	47836404	21	46416490	159635	169683
NM_006031.5(PCNT):c.6616A>G (p.Thr2206Ala)	PCNT	not specified|Microcephalic Osteodysplastic Primordial Dwarfism	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	21	47836448	21	46416534	159637	169685
NM_006031.5(PCNT):c.6715T>C (p.Trp2239Arg)	PCNT	not specified|Microcephalic Osteodysplastic Primordial Dwarfism	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	21	47836547	21	46416633	138626	142329
NM_006031.5(PCNT):c.6722G>A (p.Ser2241Asn)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	21	47836554	21	46416640	159640	169688
NM_006031.5(PCNT):c.6739C>T (p.His2247Tyr)	PCNT	not specified|Microcephalic Osteodysplastic Primordial Dwarfism	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	21	47836571	21	46416657	138627	142330
NM_006031.5(PCNT):c.6821C>T (p.Pro2274Leu)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2|not specified|Microcephalic Osteodysplastic Primordial Dwarfism	Benign(Last reviewed: May 31, 2017)	criteria provided, multiple submitters, no conflicts	21	47836653	21	46416739	159642	169690
NM_006031.5(PCNT):c.6957T>G (p.Phe2319Leu)	PCNT	not specified	Benign/Likely benign(Last reviewed: May 1, 2016)	criteria provided, multiple submitters, no conflicts	21	47838153	21	46418239	159646	169694
NM_006031.5(PCNT):c.6986C>G (p.Pro2329Arg)	PCNT	not specified|Microcephalic Osteodysplastic Primordial Dwarfism	Conflicting interpretations of pathogenicity(Last reviewed: Jul 18, 2016)	criteria provided, conflicting interpretations	21	47838182	21	46418268	159647	169695
NM_006031.5(PCNT):c.7082A>G (p.Gln2361Arg)	PCNT	not specified|Microcephalic Osteodysplastic Primordial Dwarfism	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	21	47841941	21	46422027	138630	142333
NM_006031.5(PCNT):c.7130C>T (p.Pro2377Leu)	PCNT	not specified|Microcephalic Osteodysplastic Primordial Dwarfism	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	21	47841989	21	46422075	138631	142334
NM_006031.5(PCNT):c.7159G>A (p.Val2387Met)	PCNT	not specified|not provided	Benign/Likely benign(Last reviewed: Jan 13, 2017)	criteria provided, multiple submitters, no conflicts	21	47842018	21	46422104	159650	169698
NM_006031.5(PCNT):c.7297T>C (p.Ser2433Pro)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2	Uncertain significance(Last reviewed: Apr 29, 2014)	criteria provided, single submitter	21	47845862	21	46425948	159654	169700
NM_006031.5(PCNT):c.7404G>C (p.Gln2468His)	PCNT	not specified|not provided|Microcephalic Osteodysplastic Primordial Dwarfism	Benign/Likely benign(Last reviewed: Jan 13, 2017)	criteria provided, multiple submitters, no conflicts	21	47847619	21	46427705	159657	169703
NM_006031.5(PCNT):c.7465G>A (p.Glu2489Lys)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2	Uncertain significance(Last reviewed: Feb 17, 2014)	criteria provided, single submitter	21	47847680	21	46427766	159658	169704
NM_006031.5(PCNT):c.7645G>A (p.Ala2549Thr)	PCNT	not specified|Microcephalic Osteodysplastic Primordial Dwarfism	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	21	47848459	21	46428545	138604	142307
NM_006031.5(PCNT):c.7648G>A (p.Glu2550Lys)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	21	47848462	21	46428548	159660	169706
NM_006031.5(PCNT):c.7652C>T (p.Ala2551Val)	PCNT	not specified|Microcephalic Osteodysplastic Primordial Dwarfism	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	21	47848466	21	46428552	138605	142308
NM_006031.5(PCNT):c.7655G>A (p.Arg2552His)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2|not provided	Uncertain significance(Last reviewed: May 11, 2017)	criteria provided, multiple submitters, no conflicts	21	47848469	21	46428555	159661	169707
NM_006031.5(PCNT):c.7874G>A (p.Arg2625Gln)	PCNT	not specified|Microcephalic Osteodysplastic Primordial Dwarfism	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	21	47850107	21	46430193	138607	142310
NM_006031.5(PCNT):c.7977G>C (p.Gln2659His)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2|not specified|Microcephalic Osteodysplastic Primordial Dwarfism	Benign(Last reviewed: May 31, 2017)	criteria provided, multiple submitters, no conflicts	21	47850484	21	46430570	159670	169716
NM_006031.5(PCNT):c.8258G>A (p.Arg2753His)	PCNT	not specified|Microcephalic Osteodysplastic Primordial Dwarfism	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	21	47851636	21	46431722	138610	142313
NM_006031.5(PCNT):c.8375A>G (p.Gln2792Arg)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2|not specified|Microcephalic Osteodysplastic Primordial Dwarfism	Benign(Last reviewed: May 31, 2017)	criteria provided, multiple submitters, no conflicts	21	47851753	21	46431839	159671	169717
NM_006031.5(PCNT):c.8398C>T (p.Arg2800Trp)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2|not specified	Uncertain significance(Last reviewed: Apr 14, 2015)	criteria provided, multiple submitters, no conflicts	21	47851776	21	46431862	159672	169718
NM_006031.5(PCNT):c.8671G>A (p.Ala2891Thr)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2|not specified|not provided|Microcephalic Osteodysplastic Primordial Dwarfism	Conflicting interpretations of pathogenicity(Last reviewed: May 31, 2017)	criteria provided, conflicting interpretations	21	47852049	21	46432135	138611	142314
NM_006031.5(PCNT):c.8672C>T (p.Ala2891Val)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2	Uncertain significance(Last reviewed: Jul 21, 2014)	criteria provided, single submitter	21	47852050	21	46432136	159674	169720
NM_006031.5(PCNT):c.8707G>C (p.Ala2903Pro)	PCNT	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	21	47852085	21	46432171	159676	169722
NM_006031.5(PCNT):c.8707G>A (p.Ala2903Thr)	PCNT	not specified|Microcephalic Osteodysplastic Primordial Dwarfism	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	21	47852085	21	46432171	159675	169721
NM_006031.5(PCNT):c.8873G>A (p.Arg2958His)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2	Uncertain significance(Last reviewed: Feb 13, 2014)	criteria provided, single submitter	21	47855938	21	46436025	159678	169724
NM_006031.5(PCNT):c.8924T>C (p.Leu2975Pro)	PCNT	not specified|Microcephalic Osteodysplastic Primordial Dwarfism	Conflicting interpretations of pathogenicity(Last reviewed: Jul 18, 2016)	criteria provided, conflicting interpretations	21	47855989	21	46436076	159682	169728
NM_006031.5(PCNT):c.8947C>G (p.Leu2983Val)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	21	47856012	21	46436099	159683	169729
NM_006031.5(PCNT):c.8959C>T (p.Arg2987Trp)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2	Uncertain significance(Last reviewed: Dec 3, 2013)	criteria provided, single submitter	21	47856024	21	46436111	159684	169730
NM_006031.5(PCNT):c.9014C>T (p.Thr3005Met)	PCNT	not specified|Microcephalic Osteodysplastic Primordial Dwarfism	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	21	47856909	21	46436996	159686	169732
NM_006031.5(PCNT):c.9271A>G (p.Ser3091Gly)	PCNT	not specified|Microcephalic Osteodysplastic Primordial Dwarfism	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	21	47858248	21	46438335	138614	142317
NM_006031.5(PCNT):c.9584G>A (p.Arg3195Lys)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	21	47860958	21	46441045	159693	169738
NM_006031.5(PCNT):c.9698C>G (p.Pro3233Arg)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2	Uncertain significance(Last reviewed: Nov 15, 2013)	criteria provided, single submitter	21	47862484	21	46442571	159695	169740
NM_006031.5(PCNT):c.9719C>T (p.Pro3240Leu)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2	Uncertain significance(Last reviewed: May 20, 2014)	criteria provided, single submitter	21	47863741	21	46443828	159696	169741
NM_006031.5(PCNT):c.9735A>C (p.Arg3245Ser)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2|not specified|Microcephalic Osteodysplastic Primordial Dwarfism	Benign(Last reviewed: May 31, 2017)	criteria provided, multiple submitters, no conflicts	21	47863757	21	46443844	159697	169742
NM_006031.5(PCNT):c.9740G>A (p.Arg3247Lys)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	21	47863762	21	46443849	159698	169743
NM_006031.5(PCNT):c.9820T>G (p.Ser3274Ala)	PCNT	Microcephalic osteodysplastic primordial dwarfism type 2	Uncertain significance(Last reviewed: May 6, 2014)	criteria provided, single submitter	21	47863842	21	46443929	159699	169744
NM_001696.3(ATP6V1E1):c.634C>T (p.Arg212Trp)	ATP6V1E1	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	22	18075487	22	17592721	417760	404661
NM_018943.2(TUBA8):c.383C>T (p.Ala128Val)	TUBA8	not specified|not provided	Benign/Likely benign(Last reviewed: Feb 21, 2018)	criteria provided, multiple submitters, no conflicts	22	18609128	22	18126361	160173	169748
NM_018943.2(TUBA8):c.958C>T (p.Arg320Trp)	TUBA8	Polymicrogyria with optic nerve hypoplasia|not specified	Uncertain significance(Last reviewed: May 5, 2016)	criteria provided, multiple submitters, no conflicts	22	18609703	22	18126936	160175	169750
NM_000407.4(GP1BB):c.340C>T (p.Arg114Cys)	GP1BB|SEPT5-GP1BB	Bernard-Soulier syndrome, type B|Bernard-Soulier syndrome, type B	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	22	19711706	22	19724183	158610	169754
NM_152906.6(TANGO2):c.460G>A (p.Gly154Arg)	TANGO2	Cardiac arrhythmia|Intellectual functioning disability|Seizures|Episodic flaccid weakness|Acute rhabdomyolysis|Seizures|Episodic flaccid weakness|Acute rhabdomyolysis|TANGO2-Related Metabolic Encephalopathy and Arrhythmias	Pathogenic(Last reviewed: Apr 11, 2016)	criteria provided, multiple submitters, no conflicts	22	20049061	22	20061538	208823	205385
NM_004782.3(SNAP29):c.2T>C (p.Met1Thr)	SNAP29	Leukodystrophy, hypomyelinating, 2|not provided	Pathogenic(Last reviewed: Apr 11, 2016)	criteria provided, single submitter	22	21213400	22	20859112	279894	264773
NM_012179.3(FBXO7):c.[274G>C];[520T>A]	FBXO7	Parkinson disease 15	Uncertain significance(Last reviewed: Aug 7, 2017)	no assertion criteria provided	22|22	32875119	22|22	32479132	433544	347522|427117
NM_004737.6(LARGE1):c.1994G>A (p.Arg665His)	LARGE1	Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B6|not specified|not provided|Congenital Muscular Dystrophy, alpha-dystroglycan related|Walker-Warburg Syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Apr 16, 2018)	criteria provided, conflicting interpretations	22	33673125	22	33277139	95171	101071
NM_004737.6(LARGE1):c.1949G>A (p.Arg650Gln)	LARGE1	Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B6|not specified|Congenital Muscular Dystrophy, alpha-dystroglycan related|Walker-Warburg Syndrome	Benign/Likely benign(Last reviewed: Dec 11, 2017)	criteria provided, multiple submitters, no conflicts	22	33673170	22	33277184	95170	101070
NM_004737.6(LARGE1):c.251G>C (p.Ser84Thr)	LARGE1	Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B6|Muscular dystrophy|not specified|Congenital Muscular Dystrophy, alpha-dystroglycan related|Walker-Warburg Syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 10, 2017)	criteria provided, conflicting interpretations	22	34046510	22	33650524	95173	101073
NM_004737.6(LARGE1):c.211G>A (p.Glu71Lys)	LARGE1	Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B6|Muscular dystrophy|not specified|not provided|Congenital Muscular Dystrophy, alpha-dystroglycan related|Walker-Warburg Syndrome	Uncertain significance(Last reviewed: May 1, 2018)	criteria provided, multiple submitters, no conflicts	22	34046550	22	33650564	158807	169759
NM_002473.5(MYH9):c.5323A>G (p.Lys1775Glu)	MYH9	not specified|not provided|MYH9-related disorder|Nonsyndromic Hearing Loss, Dominant	Likely benign(Last reviewed: Jun 14, 2017)	criteria provided, multiple submitters, no conflicts	22	36681327	22	36285281	44569	53736
NM_001039141.2(TRIOBP):c.5767G>A (p.Ala1923Thr)	TRIOBP	not specified	Benign(Last reviewed: Jul 6, 2017)	criteria provided, single submitter	22	38153699	22	37757692	178559	176299
NM_003560.3(PLA2G6):c.2396T>A (p.Leu799His)	PLA2G6	Iron accumulation in brain	Likely pathogenic(Last reviewed: Jul 9, 2013)	criteria provided, single submitter	22	38508193	22	38112186	159767	169761
NM_003560.3(PLA2G6):c.2246G>C (p.Trp749Ser)	PLA2G6	not provided|Iron accumulation in brain	Likely pathogenic(Last reviewed: Apr 10, 2015)	criteria provided, multiple submitters, no conflicts	22	38508541	22	38112534	159763	169765
NM_003560.3(PLA2G6):c.2239C>T (p.Arg747Trp)	PLA2G6	Parkinson disease 14	Pathogenic(Last reviewed: Sep 11, 2014)	criteria provided, single submitter	22	38508548	22	38112541	6204	21243
NM_003560.3(PLA2G6):c.2233C>T (p.Arg745Trp)	PLA2G6	Iron accumulation in brain	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	22	38508554	22	38112547	159762	169766
NM_003560.3(PLA2G6):c.2215G>C (p.Asp739His)	PLA2G6	not provided|Iron accumulation in brain	Pathogenic(Last reviewed: Aug 9, 2016)	criteria provided, multiple submitters, no conflicts	22	38508572	22	38112565	159761	169767
NM_001199562.2(PLA2G6):c.1967G>A (p.Arg656His)	PLA2G6	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	22	38509567	22	38113560	402191	389185
NM_003560.3(PLA2G6):c.2128C>T (p.Arg710Cys)	PLA2G6	Infantile neuroaxonal dystrophy|Iron accumulation in brain	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	22	38509568	22	38113561	159759	169769
NM_003560.3(PLA2G6):c.2071G>A (p.Val691Ile)	PLA2G6	Iron accumulation in brain	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	22	38509625	22	38113618	159757	169772
NM_003560.3(PLA2G6):c.2068G>A (p.Val690Ile)	PLA2G6	not provided|Iron accumulation in brain	Uncertain significance(Last reviewed: May 31, 2017)	criteria provided, multiple submitters, no conflicts	22	38509628	22	38113621	159754	169774
NM_003560.3(PLA2G6):c.2066T>G (p.Ile689Ser)	PLA2G6	Iron accumulation in brain	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	22	38509630	22	38113623	159753	169775
NM_003560.3(PLA2G6):c.2030G>T (p.Arg677Leu)	PLA2G6	Iron accumulation in brain	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	22	38511538	22	38115531	159752	169776
NM_003560.3(PLA2G6):c.1978C>T (p.Pro660Ser)	PLA2G6	Iron accumulation in brain	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	22	38511590	22	38115583	159751	169777
NM_003560.3(PLA2G6):c.1973A>C (p.Asn658Thr)	PLA2G6	Iron accumulation in brain	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	22	38511595	22	38115588	159750	169778
NM_003560.3(PLA2G6):c.1932C>G (p.Phe644Leu)	PLA2G6	Infantile neuroaxonal dystrophy	Likely pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	22	38511636	22	38115629	591003	581959
NM_003560.3(PLA2G6):c.1799G>A (p.Arg600Gln)	PLA2G6	Neurodegeneration with brain iron accumulation 2b|not provided|Iron accumulation in brain|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, multiple submitters, no conflicts	22	38512162	22	38116155	159748	169780
NM_003560.3(PLA2G6):c.1754C>T (p.Thr585Ile)	PLA2G6	Iron accumulation in brain	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	22	38512207	22	38116200	159747	169781
NM_003560.3(PLA2G6):c.1699G>A (p.Glu567Lys)	PLA2G6	Iron accumulation in brain	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	22	38516809	22	38120802	159743	169784
NM_001199562.2(PLA2G6):c.1478A>G (p.Glu493Gly)	PLA2G6	Abnormality of brain morphology	Likely pathogenic	criteria provided, single submitter	22	38516868	22	38120861	402192	389186
NM_003560.3(PLA2G6):c.1634A>G (p.Lys545Arg)	PLA2G6	Iron accumulation in brain	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	22	38516874	22	38120867	159741	169786
NM_003560.3(PLA2G6):c.1615G>A (p.Gly539Ser)	PLA2G6	Iron accumulation in brain	Uncertain significance(Last reviewed: May 9, 2014)	criteria provided, single submitter	22	38516893	22	38120886	159740	169787
NM_003560.3(PLA2G6):c.1613G>A (p.Arg538His)	PLA2G6	not provided|Iron accumulation in brain	Pathogenic/Likely pathogenic(Last reviewed: May 21, 2015)	criteria provided, multiple submitters, no conflicts	22	38516895	22	38120888	159739	169788
NM_003560.3(PLA2G6):c.1612C>T (p.Arg538Cys)	PLA2G6	Iron accumulation in brain	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	22	38516896	22	38120889	159738	169789
NM_003560.3(PLA2G6):c.1573G>A (p.Ala525Thr)	PLA2G6	Iron accumulation in brain	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	22	38519120	22	38123113	159735	169792
NM_003560.3(PLA2G6):c.1501G>C (p.Glu501Gln)	PLA2G6	Infantile neuroaxonal dystrophy|Iron accumulation in brain	Conflicting interpretations of pathogenicity(Last reviewed: Mar 29, 2018)	criteria provided, conflicting interpretations	22	38519192	22	38123185	159733	169794
NM_003560.3(PLA2G6):c.1489C>T (p.Leu497Phe)	PLA2G6	Iron accumulation in brain	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	22	38519204	22	38123197	159732	169795
NM_003560.3(PLA2G6):c.1442T>A (p.Leu481Gln)	PLA2G6	Iron accumulation in brain	Pathogenic(Last reviewed: May 21, 2013)	criteria provided, single submitter	22	38519251	22	38123244	159731	169796
NM_003560.3(PLA2G6):c.1117G>A (p.Gly373Arg)	PLA2G6	Infantile neuroaxonal dystrophy|Iron accumulation in brain	Pathogenic/Likely pathogenic(Last reviewed: Dec 5, 2017)	criteria provided, multiple submitters, no conflicts	22	38525530	22	38129523	159728	169799
NM_003560.3(PLA2G6):c.1058C>T (p.Pro353Leu)	PLA2G6	Iron accumulation in brain	Likely pathogenic(Last reviewed: May 27, 2014)	criteria provided, single submitter	22	38528857	22	38132850	159726	169801
NM_003560.3(PLA2G6):c.1039G>A (p.Gly347Arg)	PLA2G6	Infantile neuroaxonal dystrophy	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	22	38528876	22	38132869	561083	552231
NM_003560.3(PLA2G6):c.1027G>A (p.Ala343Thr)	PLA2G6	Infantile neuroaxonal dystrophy|not specified	Benign/Likely benign(Last reviewed: Apr 19, 2017)	criteria provided, multiple submitters, no conflicts	22	38528888	22	38132881	159725	169802
NM_003560.3(PLA2G6):c.994T>C (p.Cys332Arg)	PLA2G6	Iron accumulation in brain	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	22	38528921	22	38132914	159785	169803
NM_003560.3(PLA2G6):c.986G>A (p.Arg329His)	PLA2G6	Iron accumulation in brain	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	22	38528929	22	38132922	159784	169804
NM_003560.3(PLA2G6):c.821T>G (p.Met274Arg)	PLA2G6	Iron accumulation in brain	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	22	38531068	22	38135061	159780	169807
NM_003560.3(PLA2G6):c.673C>T (p.His225Tyr)	PLA2G6	not provided|Iron accumulation in brain	Pathogenic/Likely pathogenic(Last reviewed: Aug 10, 2015)	criteria provided, multiple submitters, no conflicts	22	38536113	22	38140106	159775	169811
NM_003560.3(PLA2G6):c.658G>C (p.Gly220Arg)	PLA2G6	Iron accumulation in brain	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	22	38536128	22	38140121	159774	169812
NM_003560.3(PLA2G6):c.495G>C (p.Gly165=)	PLA2G6	Iron accumulation in brain	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	22	38539226	22	38143219	159771	169814
NM_003560.3(PLA2G6):c.478T>C (p.Cys160Arg)	PLA2G6	Iron accumulation in brain	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	22	38539243	22	38143236	159770	169815
NM_003560.3(PLA2G6):c.386T>C (p.Leu129Pro)	PLA2G6	not provided|Iron accumulation in brain|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Feb 2, 2017)	criteria provided, conflicting interpretations	22	38541484	22	38145477	159768	169816
NM_003560.3(PLA2G6):c.172G>A (p.Val58Ile)	PLA2G6	not specified	Benign(Last reviewed: Aug 15, 2013)	criteria provided, single submitter	22	38565262	22	38169255	159745	169817
NM_003560.3(PLA2G6):c.68G>A (p.Arg23Gln)	PLA2G6	Iron accumulation in brain	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	22	38565366	22	38169359	159776	169819
NM_003560.3(PLA2G6):c.4C>A (p.Gln2Lys)	PLA2G6	Iron accumulation in brain	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	22	38565430	22	38169423	159772	169821
NM_001004426.2(PLA2G6):c.3G>T (p.Met1Ile)	PLA2G6	Infantile neuroaxonal dystrophy	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	22	38565431	22	38169424	429031	420984
NM_000026.3(ADSL):c.440A>T (p.Lys147Met)	ADSL	Adenylosuccinate lyase deficiency|not specified|not provided	Benign/Likely benign(Last reviewed: Apr 11, 2018)	criteria provided, multiple submitters, no conflicts	22	40750289	22	40354285	128278	133727
NM_000026.3(ADSL):c.1277G>A (p.Arg426His)	ADSL	Adenylosuccinate lyase deficiency|not provided	Pathogenic(Last reviewed: May 9, 2018)	criteria provided, multiple submitters, no conflicts	22	40760969	22	40364965	2462	17501
NM_001098.2(ACO2):c.1819C>T (p.Arg607Cys)	ACO2|POLR3H	Infantile cerebellar-retinal degeneration	Likely pathogenic(Last reviewed: Nov 14, 2013)	criteria provided, single submitter	22	41922323	22	41526319	218316	215011
NM_001098.2(ACO2):c.2135C>T (p.Pro712Leu)	ACO2|POLR3H	Infantile cerebellar-retinal degeneration	Likely pathogenic(Last reviewed: Nov 14, 2013)	criteria provided, single submitter	22	41923953	22	41527949	218317	215012
NM_000262.2(NAGA):c.479C>G (p.Ser160Cys)	NAGA	Schindler disease, type 1|Schindler disease, type 3	Likely pathogenic(Last reviewed: Nov 26, 2013)	criteria provided, single submitter	22	42463140	22	42067136	18165	33204
NM_000398.6(CYB5R3):c.757G>A (p.Val253Met)	CYB5R3	Hereditary methemoglobinemia	Pathogenic(Last reviewed: Sep 12, 2017)	criteria provided, single submitter	22	43015928	22	42619922	505719	497548
NM_006486.2(FBLN1):c.1190G>T (p.Cys397Phe)	FBLN1	not provided|Autosomal recessive syndrome of syndactyly, undescended testes and central nervous system defects	Conflicting interpretations of pathogenicity(Last reviewed: May 1, 2014)	no assertion criteria provided	22	45938158	22	45542278	60555	75130
NM_058238.2(WNT7B):c.739C>T (p.Arg247Trp)	WNT7B	Anophthalmia-microphthalmia syndrome	Likely pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	22	46319047	22	45923167	437886	431507
NM_018006.4(TRMU):c.497C>A (p.Ala166Glu)	TRMU	Liver failure acute infantile	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	22	46746206	22	46350309	561137	552233
NM_018006.4(TRMU):c.758T>C (p.Leu253Pro)	TRMU	Liver failure acute infantile	Likely pathogenic(Last reviewed: Jun 10, 2014)	criteria provided, single submitter	22	46748213	22	46352316	217019	213662
NM_018006.4(TRMU):c.1135G>T (p.Gly379Cys)	TRMU	Liver failure acute infantile|not provided|Inborn genetic diseases	Uncertain significance(Last reviewed: May 23, 2018)	criteria provided, multiple submitters, no conflicts	22	46752772	22	46356875	193910	191073
NM_024105.3(ALG12):c.437G>A (p.Arg146Gln)	ALG12	ALG12-congenital disorder of glycosylation	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	22	50304114	22	49910466	3435	18474
NM_015166.3(MLC1):c.1031A>G (p.Asn344Ser)	MLC1	Megalencephalic leukoencephalopathy with subcortical cysts 1|not specified|Megalencephalic leukoencephalopathy with subcortical cysts	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	22	50502491	22	50064062	21521	34373
NM_015166.3(MLC1):c.654C>A (p.Asn218Lys)	MLC1	Megalencephalic leukoencephalopathy with subcortical cysts 1|not specified|not provided	Likely benign(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	22	50512705	22	50074276	21525	34377
NM_015166.3(MLC1):c.617G>T (p.Gly206Val)	MLC1	Megalencephalic leukoencephalopathy with subcortical cysts 1	Pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	22	50512742	22	50074313	242875	243999
NM_015166.3(MLC1):c.512G>T (p.Cys171Phe)	MLC1	Megalencephalic leukoencephalopathy with subcortical cysts 1|not specified|Megalencephalic leukoencephalopathy with subcortical cysts	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	22	50515843	22	50077414	21524	34376
NM_020461.3(TUBGCP6):c.[3139C>T];[5140G>A]	TUBGCP6	Microcephaly with chorioretinopathy, autosomal recessive	Uncertain significance(Last reviewed: Feb 16, 2017)	no assertion criteria provided	22|22	50659649	22|22	50221220	444003	437664|437663
NM_005138.2(SCO2):c.418G>A (p.Glu140Lys)	SCO2|NCAPH2	Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency|Myopia 6|Seizures|not provided|Severe global developmental delay	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, multiple submitters, no conflicts	22	50962423	22	50523994	5681	20720
NM_001953.4(TYMP):c.1412C>T (p.Ser471Leu)	TYMP|SCO2	Mitochondrial DNA depletion syndrome 1 (MNGIE type)|not specified|not provided|Fatal Infantile Cardioencephalomyopathy	Benign(Last reviewed: Jul 10, 2018)	criteria provided, multiple submitters, no conflicts	22	50964236	22	50525807	130693	136139
NM_001257989.1(TYMP):c.1174G>A (p.Gly392Ser)	TYMP|SCO2	Mitochondrial DNA depletion syndrome 1 (MNGIE type)|Mitochondrial neurogastrointestinal encephalomyopathy	Pathogenic(Last reviewed: Aug 29, 2017)	criteria provided, single submitter	22	50964571	22	50526142	223064	224789
NM_001113755.2(TYMP):c.628A>C (p.Ser210Arg)	TYMP	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	22	50966035	22	50527606	440502	434130
NM_005198.4(CHKB):c.940C>T (p.Arg314Cys)	CHKB|CHKB-CPT1B	Muscular dystrophy, congenital, megaconial type|Congenital Muscular Dystrophy, CHKB-related	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	22	51018247	22	50579818	342169	351846
NM_000487.5(ARSA):c.1174C>T (p.Arg392Trp)	ARSA	Metachromatic leukodystrophy|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 7, 2018)	criteria provided, conflicting interpretations	22	51064043	22	50625615	3085	18124
NM_000487.5(ARSA):c.1010A>T (p.Asp337Val)	ARSA	Metachromatic leukodystrophy|Metachromatic leukodystrophy, severe|Leukodystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, multiple submitters, no conflicts	22	51064461	22	50626033	3080	18119
NM_000487.5(ARSA):c.917C>T (p.Thr306Met)	ARSA	Metachromatic leukodystrophy|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 29, 2018)	criteria provided, conflicting interpretations	22	51064644	22	50626216	68159	79050
NM_001085428.2(ARSA):c.632C>A (p.Ser211Tyr)	ARSA	Metachromatic leukodystrophy|Metachromatic leukodystrophy, severe	Pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	22	51064671	22	50626243	3078	18117
NM_000487.5(ARSA):c.827C>T (p.Thr276Met)	ARSA	Metachromatic leukodystrophy|Metachromatic leukodystrophy, severe	Pathogenic/Likely pathogenic(Last reviewed: Mar 23, 2017)	criteria provided, multiple submitters, no conflicts	22	51065046	22	50626618	3075	18114
NM_000487.5(ARSA):c.763G>A (p.Glu255Lys)	ARSA	Metachromatic leukodystrophy|Metachromatic leukodystrophy, late infantile|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 9, 2016)	criteria provided, multiple submitters, no conflicts	22	51065110	22	50626682	3091	18130
NM_000487.5(ARSA):c.739G>A (p.Gly247Arg)	ARSA	Metachromatic leukodystrophy|Metachromatic leukodystrophy, severe|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2018)	criteria provided, multiple submitters, no conflicts	22	51065134	22	50626706	3074	18113
NM_000487.5(ARSA):c.736C>T (p.Arg246Cys)	ARSA	Metachromatic leukodystrophy	Likely pathogenic(Last reviewed: Jun 19, 2014)	criteria provided, single submitter	22	51065137	22	50626709	3073	18112
NM_000487.5(ARSA):c.302G>A (p.Gly101Asp)	ARSA	Metachromatic leukodystrophy|Metachromatic leukodystrophy, adult type|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 27, 2016)	criteria provided, multiple submitters, no conflicts	22	51065757	22	50627329	3053	18092
NM_000487.5(ARSA):c.293C>T (p.Ser98Phe)	ARSA	Metachromatic leukodystrophy|Metachromatic leukodystrophy, late infantile|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 9, 2014)	criteria provided, multiple submitters, no conflicts	22	51065766	22	50627338	3054	18093
NM_005183.3(CACNA1F):c.1966A>T (p.Ile656Phe)	CACNA1F	Cone-rod dystrophy X-linked 3|Congenital stationary night blindness, type 2A	Uncertain significance	no assertion criteria provided	X	49079540	X	49223081	430654	424183
NM_000054.4(AVPR2):c.335G>T (p.Cys112Phe)	AVPR2	Nephrogenic diabetes insipidus, X-linked	Likely pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	X	153171295	X	153905841	374351	361239
NM_003491.3(NAA10):c.215T>C (p.Ile72Thr)	NAA10	N-terminal acetyltransferase deficiency	Pathogenic	no assertion criteria provided	X	153198002	X	153932549	375388	362166
